data_2mre_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mre _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.2 mp0 -99.47 130.39 45.73 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.041 -174.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.7 146.81 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.636 1.174 . . . . 0.0 109.355 176.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 66' ' ' THR . 73.7 m-85 -103.19 100.11 10.0 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.761 0.824 . . . . 0.0 109.89 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 69' ' ' LEU . 93.6 t -101.67 99.91 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -98.89 123.49 43.19 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.587 -169.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.745 HG21 HD13 ' A' ' 69' ' ' LEU . 41.3 p -67.84 166.75 14.85 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.822 0.849 . . . . 0.0 112.927 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.51 -17.03 64.51 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.073 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.4 p -85.87 2.96 43.84 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.335 0.654 . . . . 0.0 111.113 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.05 85.61 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 113.888 0.315 . . . . 0.0 113.888 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.5 135.98 34.22 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.84 0.856 . . . . 0.0 109.841 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.6 m -101.34 124.58 47.24 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.035 0.534 . . . . 0.0 110.683 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.7 mp -107.53 110.54 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.9 0.88 . . . . 0.0 109.495 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -87.03 118.69 26.58 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.568 0.747 . . . . 0.0 109.755 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.6 mm? -103.78 162.37 13.15 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.491 0.716 . . . . 0.0 109.217 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -125.25 72.0 1.23 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.223 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.685 HG22 HG22 ' A' ' 26' ' ' VAL . 2.4 m -134.11 174.16 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.313 0.645 . . . . 0.0 109.572 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 2.7 mm-40 -85.96 148.68 48.7 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.132 0.573 . . . . 0.0 109.61 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.19 -31.38 89.93 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 121.687 1.592 . . . . 0.0 111.287 167.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.6 t -98.52 17.92 17.89 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.397 0.679 . . . . 0.0 110.563 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 12.1 t0 -74.89 -94.96 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 26' ' ' VAL . 12.0 t 176.95 149.28 0.14 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 125.027 1.331 . . . . 0.0 108.828 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.49 -36.09 76.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.856 0.862 . . . . 0.0 110.848 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.15 -40.71 64.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.902 0.881 . . . . 0.0 110.847 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.3 t30 -70.95 -46.03 63.09 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.126 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.685 HG22 HG22 ' A' ' 17' ' ' VAL . 61.1 t -55.19 -49.52 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 124.173 0.921 . . . . 0.0 111.022 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -67.21 -33.71 75.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.318 0.647 . . . . 0.0 111.929 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.25 -30.1 70.87 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.236 171.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 68.8 mmtt -80.79 -28.15 36.41 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.94 -40.44 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-N 119.577 1.08 . . . . 0.0 108.805 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.76 -35.25 75.93 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.304 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.14 -26.4 62.99 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.778 0.831 . . . . 0.0 112.065 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -95.1 -70.1 0.73 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.415 0.286 . . . . 0.0 111.381 -175.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -83.4 -24.36 31.98 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.23 26.79 13.2 Favored Glycine 0 C--N 1.349 1.259 0 O-C-N 123.224 0.327 . . . . 0.0 113.036 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.8 125.79 29.31 Favored Pre-proline 0 N--CA 1.481 1.115 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.95 155.8 68.32 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.888 2.392 . . . . 0.0 112.686 -171.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.26 -11.57 19.75 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.672 2.915 . . . . 0.0 113.918 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.59 -42.53 58.52 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.205 0.602 . . . . 0.0 110.333 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -89.44 -12.54 39.92 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.829 0.852 . . . . 0.0 112.709 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.459 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.86 152.75 31.67 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 123.127 0.571 . . . . 0.0 109.956 173.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 41.8 ttt180 -136.09 134.56 38.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.117 0.567 . . . . 0.0 110.3 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.445 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -94.66 123.35 38.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.873 0.869 . . . . 0.0 110.452 -173.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.5 mt -142.91 126.7 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.078 0.951 . . . . 0.0 109.915 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 84.8 t80 -121.96 124.84 44.98 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.271 1.029 . . . . 0.0 108.9 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.6 17.96 7.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.07 0.948 . . . . 0.0 112.964 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.79 -7.14 59.05 Favored Glycine 0 C--N 1.351 1.385 0 C-N-CA 122.992 0.329 . . . . 0.0 113.88 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.8 ptpt -95.43 135.21 37.35 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -73.69 138.98 45.05 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.445 HD12 ' HB3' ' A' ' 43' ' ' LEU . 18.5 mt -92.03 110.22 21.58 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.876 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.89 139.44 43.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.285 1.034 . . . . 0.0 110.524 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.38 -47.06 69.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.696 1.198 . . . . 0.0 112.362 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.01 -26.11 73.29 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 124.123 0.889 . . . . 0.0 114.019 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 80.0 mtt180 -83.24 176.34 9.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.28 0.632 . . . . 0.0 111.794 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.8 p -111.13 167.13 10.51 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.607 0.763 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.75 -51.33 69.99 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.0 t -57.59 -29.95 64.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.727 1.211 . . . . 0.0 111.733 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.409 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 10.4 t70 -61.06 -48.26 82.54 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.778 0.799 . . . . 0.0 109.645 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.483 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 29.9 m-85 -87.29 18.85 3.49 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.628 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER 72.0 22.2 3.83 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.303 1.041 . . . . 0.0 111.805 177.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -98.94 118.64 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.83 -179.56 4.21 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 10.8 ptmm? -62.97 140.87 58.9 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.618 170.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 64.2 23.57 13.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.164 1.386 . . . . 0.0 112.678 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -75.72 142.12 42.52 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 166.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 61.3 m -101.15 125.76 47.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.501 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -130.84 173.36 11.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.987 1.315 . . . . 0.0 108.876 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -100.45 151.07 21.98 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.762 0.792 . . . . 0.0 111.726 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.745 HD13 HG21 ' A' ' 7' ' ' THR . 3.1 tm? -129.86 123.74 31.55 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 90.9 t -98.73 112.09 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.324 0.65 . . . . 0.0 110.5 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt -78.22 143.72 36.89 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.961 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -124.98 -42.35 2.04 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.724 0.81 . . . . 0.0 110.062 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.49 1.554 0 C-N-CA 123.565 0.746 . . . . 0.0 111.89 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 5.9 m -143.64 167.33 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.193 1.397 . . . . 0.0 110.023 -172.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -94.38 146.48 24.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.171 0.588 . . . . 0.0 111.685 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.57 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.5 t -90.22 102.49 4.96 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.511 ' HD2' HD22 ' B' ' 220' ' ' LEU . 61.2 Cg_endo -66.62 -2.89 8.21 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.115 2.543 . . . . 0.0 114.599 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.24 -64.09 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.003 0.521 . . . . 0.0 110.338 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.2 p -98.84 4.32 47.53 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.67 0.388 . . . . 0.0 111.835 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.06 44.51 97.67 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 115.181 0.832 . . . . 0.0 115.181 169.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.13 136.57 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 117.472 0.636 . . . . 0.0 110.973 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -87.38 123.4 32.29 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.445 HD13 ' HB2' ' B' ' 204' ' ' CYS . 3.9 pt -148.79 162.98 27.79 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.543 1.537 . . . . 0.0 109.013 -169.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.55 153.98 71.6 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.049 1.833 . . . . 0.0 111.333 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.548 ' O ' HG23 ' B' ' 216' ' ' ILE . 2.6 tm-20 -66.97 -36.22 81.72 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.34 1.056 . . . . 0.0 113.217 -168.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 16.7 p -58.82 -41.12 86.08 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.88 0.848 . . . . 0.0 110.14 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -81.03 -19.16 44.48 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.464 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.57 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -71.48 -44.75 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -59.3 -52.65 64.74 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.952 0.901 . . . . 0.0 109.967 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -60.61 -40.13 90.74 Favored 'General case' 0 C--O 1.254 1.296 0 O-C-N 124.401 1.063 . . . . 0.0 111.608 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -43.62 80.4 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.92 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 216' ' ' ILE . 83.4 mt -62.23 -47.04 86.19 Favored 'General case' 0 C--O 1.213 -0.847 0 O-C-N 124.167 0.917 . . . . 0.0 111.144 -177.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -53.83 -32.21 52.06 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 124.112 0.882 . . . . 0.0 111.636 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.3 t -85.06 -39.35 18.09 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.442 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 92.9 m -79.8 -24.84 41.14 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.24 1.016 . . . . 0.0 112.462 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 N--CA 1.479 0.986 0 C-N-CA 123.072 0.549 . . . . 0.0 110.223 -178.062 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 14.9 mp0 -102.85 124.97 49.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.181 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -121.91 159.36 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.475 1.11 . . . . 0.0 108.605 175.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' THR . 61.3 m-85 -114.23 116.3 28.82 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.367 0.603 . . . . 0.0 110.463 -172.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.709 HG12 ' HB2' ' A' ' 69' ' ' LEU . 2.1 t -104.26 117.79 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -109.58 110.31 21.34 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.73 0.812 . . . . 0.0 108.822 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.618 HG23 HD13 ' A' ' 69' ' ' LEU . 40.7 p -66.64 163.16 19.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.481 0.313 . . . . 0.0 111.136 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.36 -19.6 65.58 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.894 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.5 p -78.72 -9.86 59.56 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.959 0.504 . . . . 0.0 110.908 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.44 8.84 62.23 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.683 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -84.32 146.76 27.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.428 0.691 . . . . 0.0 110.267 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -108.27 140.03 42.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.271 0.628 . . . . 0.0 109.903 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -129.99 116.6 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.082 1.353 . . . . 0.0 107.72 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -93.63 120.8 34.35 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -104.64 156.47 17.95 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -127.25 83.02 2.13 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.696 HG23 HG21 ' A' ' 26' ' ' VAL . 33.7 m -146.07 178.75 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.967 0.907 . . . . 0.0 110.25 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -95.4 155.38 38.8 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.485 0.714 . . . . 0.0 109.801 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 21.3 Cg_endo -62.43 -26.97 76.86 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 121.774 1.649 . . . . 0.0 111.833 166.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -93.2 5.16 52.47 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.726 0.81 . . . . 0.0 111.321 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.82 -98.32 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.923 0.889 . . . . 0.0 110.734 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 9.5 t 170.11 143.54 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.353 1.461 . . . . 0.0 109.246 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.99 -32.82 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.602 0.761 . . . . 0.0 110.54 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -54.98 -41.42 71.16 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.361 1.064 . . . . 0.0 110.091 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 9.4 t30 -79.26 -40.68 29.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.136 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.696 HG21 HG23 ' A' ' 17' ' ' VAL . 85.6 t -56.35 -44.43 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 124.112 0.883 . . . . 0.0 110.856 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HZ1' ' HB3' ' A' ' 52' ' ' ASP . 17.6 ptpt -73.45 -29.61 62.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.93 0.492 . . . . 0.0 111.231 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.78 71.84 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.731 168.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 10.0 mmpt? -72.16 -37.88 69.28 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-O 119.181 -0.437 . . . . 0.0 110.785 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.547 HD12 HG22 ' A' ' 5' ' ' VAL . 2.0 mp -55.22 -45.99 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.006 0.431 . . . . 0.0 110.054 172.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -61.9 -33.43 74.22 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.49 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -72.12 -32.31 66.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.543 0.737 . . . . 0.0 111.646 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.3 mmtt -90.65 -66.31 0.94 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.613 0.365 . . . . 0.0 110.975 -172.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -87.91 -26.84 22.52 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.92 29.35 10.63 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.06 126.02 30.25 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.7 154.05 75.82 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.841 2.361 . . . . 0.0 112.473 -173.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 20.7 Cg_endo -56.94 -19.43 32.07 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.557 2.838 . . . . 0.0 113.251 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.61 -35.74 70.57 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.876 0.87 . . . . 0.0 111.024 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -95.2 -27.92 15.29 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 123.486 0.714 . . . . 0.0 112.198 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.491 ' HB2' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -92.5 140.63 29.37 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.637 0.653 . . . . 0.0 109.809 178.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.432 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 19.7 ttt180 -127.8 127.89 44.32 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -96.28 123.21 39.83 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.595 0.758 . . . . 0.0 110.371 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -141.5 129.42 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.017 0.527 . . . . 0.0 109.864 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.551 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 93.7 t80 -130.81 121.98 26.31 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.19 20.81 11.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.718 0.807 . . . . 0.0 113.122 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.09 -16.96 57.77 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.0 ptpt -90.34 135.15 33.86 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.09 135.42 35.32 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD22 ' HB3' ' A' ' 45' ' ' PHE . 20.2 mt -89.29 114.21 25.57 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.689 -172.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 31.0 tt0 -76.95 138.24 39.55 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 123.603 0.761 . . . . 0.0 109.637 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.427 ' HB3' ' HZ1' ' A' ' 27' ' ' LYS . 5.5 p-10 -60.5 -37.79 82.23 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.124 0.89 . . . . 0.0 111.93 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.416 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -67.27 -22.07 72.54 Favored Glycine 0 C--N 1.348 1.235 0 O-C-N 123.675 0.609 . . . . 0.0 114.183 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.543 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 78.7 mtt180 -89.59 177.22 6.6 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.393 0.677 . . . . 0.0 111.511 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 55.6 p -109.9 169.78 8.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.522 0.729 . . . . 0.0 110.43 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 87.1 mt -55.83 -54.86 39.34 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.59 0.556 . . . . 0.0 109.705 173.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 22.8 t -61.73 -22.73 65.62 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.333 1.053 . . . . 0.0 111.798 -176.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.1 -47.39 83.04 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.543 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 36.2 m-85 -86.33 17.02 3.95 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.148 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.442 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER 72.96 9.76 5.39 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.144 1.378 . . . . 0.0 112.404 176.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.1 mt -81.66 123.09 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.7 0.8 . . . . 0.0 108.958 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -110.0 -174.18 2.43 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.181 0.592 . . . . 0.0 109.712 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.44 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 10.2 ptmm? -58.7 144.34 43.84 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.713 172.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 62.33 10.82 4.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.937 1.295 . . . . 0.0 113.644 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -70.06 132.57 46.07 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 118.17 0.441 . . . . 0.0 110.223 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 29.0 m -93.89 130.97 39.75 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.08 160.46 38.89 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.973 0.909 . . . . 0.0 109.416 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -88.7 138.69 31.19 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.203 0.525 . . . . 0.0 111.423 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.709 ' HB2' HG12 ' A' ' 5' ' ' VAL . 2.7 tm? -119.62 135.26 54.88 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.604 HG21 HD13 ' B' ' 220' ' ' LEU . 90.8 t -115.6 115.54 49.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.591 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.505 ' HB3' HD23 ' A' ' 73' ' ' LEU . 67.2 mt -81.27 99.44 8.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.128 173.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -67.69 -40.52 84.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.67 1.188 . . . . 0.0 109.144 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 71' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 125.037 1.335 . . . . 0.0 112.082 172.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' B' ' 201' ' ' LYS . 9.4 mptt . . . . . 0 C--O 1.243 0.73 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.27 -178.5 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.72 0.808 . . . . 0.0 110.314 -165.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -124.95 144.72 50.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.72 0.808 . . . . 0.0 109.352 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.581 ' HA ' HD13 ' B' ' 216' ' ' ILE . 42.0 t -91.09 100.46 2.99 Favored Pre-proline 0 N--CA 1.481 1.093 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.507 ' HD2' HD23 ' B' ' 220' ' ' LEU . 30.1 Cg_endo -58.56 -23.65 65.98 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.983 2.456 . . . . 0.0 114.137 -169.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.37 -53.59 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 C-N-CA 122.22 0.208 . . . . 0.0 111.555 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 17.8 p -103.34 -6.72 21.69 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.7 50.86 39.45 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.527 0.517 . . . . 0.0 114.286 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.0 m -119.09 138.97 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 123.232 0.613 . . . . 0.0 110.271 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -87.44 125.27 34.19 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' B' ' 204' ' ' CYS . 6.5 pt -153.47 157.04 32.8 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 125.136 1.375 . . . . 0.0 109.371 -169.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.19 165.0 31.81 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.417 2.078 . . . . 0.0 112.974 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.521 ' O ' HG23 ' B' ' 216' ' ' ILE . 39.8 tt0 -60.03 -42.1 93.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.69 1.596 . . . . 0.0 115.006 -166.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 35.9 t -70.5 -33.58 71.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.369 -0.832 . . . . 0.0 109.976 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -71.35 -29.34 64.86 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.327 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.581 HD13 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -71.8 -37.0 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -57.49 -54.21 49.4 Favored 'General case' 0 C--O 1.244 0.806 0 O-C-N 123.803 0.689 . . . . 0.0 110.365 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -69.54 -33.3 72.59 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.973 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -46.46 90.52 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 70' ' ' VAL . 91.2 mt -67.91 -37.43 81.7 Favored 'General case' 0 C--O 1.208 -1.09 0 O-C-N 124.129 0.893 . . . . 0.0 111.232 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.04 -32.31 63.91 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 124.538 1.149 . . . . 0.0 110.675 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 33.2 t -93.49 -36.36 12.48 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.513 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 96.9 m -77.8 -24.13 48.91 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.607 0.763 . . . . 0.0 112.802 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 N--CA 1.485 1.308 0 C-N-CA 122.928 0.491 . . . . 0.0 110.459 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.453 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.9 mmt . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.762 0.315 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.6 mp0 -114.07 136.91 52.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.262 0.625 . . . . 0.0 110.552 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -128.82 164.14 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 124.811 1.244 . . . . 0.0 108.721 172.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 66' ' ' THR . 69.4 m-85 -119.72 110.18 16.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.137 -174.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.477 HG21 HD12 ' A' ' 30' ' ' ILE . 50.8 t -97.03 135.22 31.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -122.09 123.77 42.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.837 0.455 . . . . 0.0 110.214 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.618 HG23 HD13 ' A' ' 69' ' ' LEU . 57.0 p -81.18 165.37 21.59 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.974 0.416 . . . . 0.0 111.728 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 70' ' ' VAL . 85.8 mt -71.38 -19.53 62.26 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.459 172.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.0 p -78.57 -17.88 55.45 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.724 0.41 . . . . 0.0 109.967 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.86 23.9 14.42 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 167.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.21 153.01 18.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 172.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -100.4 144.56 29.26 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 170.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.527 HD11 HG22 ' A' ' 7' ' ' THR . 5.1 mp -124.97 113.44 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.826 1.251 . . . . 0.0 107.911 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.0 m -89.45 122.04 32.26 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.3 mm? -111.19 152.36 27.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.561 0.744 . . . . 0.0 109.156 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 1' ' ' MET . 3.0 mp0 -112.81 95.32 5.35 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 26' ' ' VAL . 33.5 m -146.34 -174.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -102.09 155.77 36.05 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 19.7 Cg_endo -57.98 -32.29 94.94 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.018 1.812 . . . . 0.0 111.118 167.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -98.1 18.62 15.7 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.312 0.645 . . . . 0.0 110.808 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -82.13 -92.57 0.06 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.046 0.538 . . . . 0.0 109.808 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.466 HG21 ' H ' ' A' ' 25' ' ' ASN . 15.3 t 177.81 149.49 0.18 Allowed 'General case' 0 C--N 1.367 1.361 0 C-N-CA 124.526 1.13 . . . . 0.0 110.762 174.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.0 mm -65.83 -37.19 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.591 1.157 . . . . 0.0 110.81 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -55.6 -38.57 69.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.181 0.992 . . . . 0.0 111.056 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.497 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 4.9 t-20 -76.64 -39.14 53.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.277 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 17' ' ' VAL . 64.4 t -57.67 -46.9 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 124.471 1.107 . . . . 0.0 110.759 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HA ' HD11 ' A' ' 30' ' ' ILE . 17.2 ptpt -71.3 -27.56 63.49 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.944 0.498 . . . . 0.0 111.795 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.27 -39.43 89.41 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.505 0.503 . . . . 0.0 110.911 169.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 4.4 mmtm -66.15 -37.27 85.25 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.652 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 27' ' ' LYS . 94.3 mt -64.05 -38.42 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.649 0.78 . . . . 0.0 110.915 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.404 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.8 tt0 -64.92 -31.1 72.18 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.036 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.31 -38.91 78.48 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.398 0.279 . . . . 0.0 110.984 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.5 mmtt -85.31 -69.43 0.66 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.078 0.237 . . . . 0.0 110.699 -168.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.7 -20.49 31.12 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 122.087 0.155 . . . . 0.0 111.08 -176.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 88.06 25.96 30.15 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.451 0.469 . . . . 0.0 113.359 171.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.11 125.88 30.15 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -65.47 149.83 87.47 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.939 2.426 . . . . 0.0 112.438 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.05 -17.6 11.56 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 124.325 3.35 . . . . 0.0 114.339 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -74.49 -41.91 59.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.302 0.641 . . . . 0.0 111.2 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.12 -33.56 22.36 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.731 0.812 . . . . 0.0 111.489 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.433 HE22 HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -89.78 149.34 22.75 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 44.3 ttt180 -132.75 131.12 40.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.941 0.496 . . . . 0.0 110.207 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.433 HD21 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -94.84 124.84 39.11 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.687 0.795 . . . . 0.0 110.122 -174.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.7 mt -142.52 132.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.003 0.921 . . . . 0.0 109.139 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 86.6 t80 -135.21 132.31 37.75 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 171.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.49 23.28 12.93 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.889 0.876 . . . . 0.0 112.197 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.33 -7.97 75.29 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 114.516 0.566 . . . . 0.0 114.516 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.8 ptpt -103.28 141.34 36.08 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 117.494 0.647 . . . . 0.0 109.448 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.476 ' NE2' HD23 ' B' ' 224' ' ' LEU . 8.0 tt0 -74.43 131.41 41.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' A' ' 45' ' ' PHE . 20.3 mt -83.25 117.97 23.31 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.407 0.283 . . . . 0.0 110.245 -176.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.76 137.96 38.0 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 123.945 0.898 . . . . 0.0 109.674 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.3 -50.26 67.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.726 1.211 . . . . 0.0 111.843 -174.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.64 -27.39 70.93 Favored Glycine 0 C--N 1.35 1.32 0 O-C-N 124.273 0.983 . . . . 0.0 114.072 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HD3' ' OD2' ' A' ' 58' ' ' ASP . 54.5 mtt180 -77.3 175.73 9.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.316 0.646 . . . . 0.0 112.013 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 65.8 p -111.27 164.08 13.27 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.013 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.9 mt -55.44 -53.33 57.59 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.807 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 9.4 t -66.56 -20.64 66.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.263 1.025 . . . . 0.0 111.339 -173.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.446 ' OD2' ' HD3' ' A' ' 54' ' ' ARG . 12.2 t70 -67.26 -42.18 84.31 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -86.78 16.18 5.05 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.813 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.94 17.43 6.28 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.033 1.333 . . . . 0.0 112.301 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.1 mt -90.45 103.66 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -84.97 -178.97 6.97 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -59.4 143.47 49.62 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 64.28 11.83 6.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.13 1.372 . . . . 0.0 113.573 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.9 m -75.25 149.57 38.82 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.275 0.489 . . . . 0.0 110.614 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.7 m -101.02 130.12 46.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.974 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.61 154.85 48.46 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.95 1.3 . . . . 0.0 108.181 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -87.85 158.7 18.66 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.44 0.638 . . . . 0.0 111.888 -174.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.618 HD13 HG23 ' A' ' 7' ' ' THR . 2.4 tm? -141.94 129.47 21.38 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.545 -1.207 . . . . 0.0 107.829 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.511 HG23 HD11 ' B' ' 220' ' ' LEU . 98.4 t -111.0 117.18 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.755 0.822 . . . . 0.0 110.112 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.68 139.86 30.36 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.123 0.969 . . . . 0.0 110.673 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -118.18 -44.92 2.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.748 0.819 . . . . 0.0 111.583 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 N--CA 1.491 1.599 0 C-N-CA 124.201 1.0 . . . . 0.0 112.425 -178.873 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.52 ' HB2' ' HZ2' ' B' ' 201' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 6.6 m -134.12 -178.86 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 125.379 1.472 . . . . 0.0 109.173 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -109.64 146.18 35.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.19 0.596 . . . . 0.0 111.097 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.531 ' HA ' HD13 ' B' ' 216' ' ' ILE . 49.7 t -89.46 102.36 4.32 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.322 1.049 . . . . 0.0 109.236 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.52 ' HD2' HD22 ' B' ' 220' ' ' LEU . 45.8 Cg_endo -62.28 -10.09 17.34 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.776 2.984 . . . . 0.0 114.984 -166.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 42.4 t -84.07 -60.47 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 123.054 0.542 . . . . 0.0 110.769 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 22.3 p -101.3 -6.99 23.42 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.804 0.441 . . . . 0.0 112.038 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.66 51.05 38.36 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.435 0.54 . . . . 0.0 114.207 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.12 142.22 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 123.008 0.523 . . . . 0.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -92.47 122.36 34.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.491 0.717 . . . . 0.0 109.903 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' B' ' 204' ' ' CYS . 3.8 pt -152.67 160.99 30.39 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.767 1.627 . . . . 0.0 109.387 -169.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.26 158.8 46.67 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.156 1.904 . . . . 0.0 111.629 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.525 ' O ' HG23 ' B' ' 216' ' ' ILE . 2.9 tm-20 -69.75 -28.41 65.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.055 0.942 . . . . 0.0 112.104 -169.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 37.2 p -60.79 -45.82 92.9 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.657 0.741 . . . . 0.0 110.058 169.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -76.8 -18.3 58.5 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.815 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.548 ' O ' ' HG ' ' B' ' 220' ' ' LEU . 0.2 OUTLIER -72.21 -50.16 38.26 Favored 'Isoleucine or valine' 0 C--N 1.364 1.214 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -67.75 -35.61 79.04 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.205 0.316 . . . . 0.0 110.467 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -45.47 94.03 Favored 'General case' 0 C--O 1.254 1.313 0 O-C-N 123.886 0.741 . . . . 0.0 110.967 172.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . 0.422 ' HB3' ' SG ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -59.57 -38.58 81.53 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.78 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 216' ' ' ILE . 79.4 mt -66.21 -39.56 89.7 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 123.972 0.795 . . . . 0.0 111.295 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -55.56 -38.71 69.68 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.945 0.778 . . . . 0.0 110.88 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.2 t -88.24 -31.54 18.98 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.829 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 63.6 m -82.47 -19.73 38.29 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.645 0.778 . . . . 0.0 112.967 -173.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . 0.476 HD23 ' NE2' ' A' ' 49' ' ' GLN . 4.6 pp . . . . . 0 N--CA 1.489 1.498 0 C-N-CA 122.676 0.39 . . . . 0.0 110.928 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.1 mp0 -112.35 155.61 23.85 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.469 0.708 . . . . 0.0 110.201 174.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -142.8 157.08 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 124.793 1.237 . . . . 0.0 109.218 167.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' THR . 39.0 m-85 -112.57 100.49 8.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.372 0.669 . . . . 0.0 110.322 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 69' ' ' LEU . 95.2 t -101.77 104.84 16.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -102.16 127.3 49.15 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.732 0.813 . . . . 0.0 111.137 -172.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.65 HG23 HD11 ' A' ' 69' ' ' LEU . 49.2 p -70.85 166.46 21.02 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-O 121.599 0.714 . . . . 0.0 112.782 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 70' ' ' VAL . 68.4 mt -67.82 -23.52 65.19 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.297 171.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.7 p -78.63 -16.54 57.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.308 0.643 . . . . 0.0 110.397 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.41 5.71 39.54 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-O 119.182 -0.788 . . . . 0.0 114.856 167.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HZ1' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -84.47 151.13 24.82 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.063 0.932 . . . . 0.0 108.586 177.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.1 m -107.01 126.04 51.81 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.013 0.525 . . . . 0.0 110.3 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 7' ' ' THR . 4.7 mp -107.27 110.75 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.797 0.839 . . . . 0.0 109.006 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.9 m -90.31 120.44 31.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.278 0.631 . . . . 0.0 109.446 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.5 mm? -106.9 151.75 24.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.01 0.524 . . . . 0.0 109.833 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -110.69 78.29 1.11 Allowed 'General case' 0 C--O 1.239 0.53 0 O-C-N 124.205 0.941 . . . . 0.0 108.618 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.719 HG21 HG21 ' A' ' 26' ' ' VAL . 3.4 m -144.77 172.07 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.702 0.801 . . . . 0.0 108.981 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -93.11 158.0 38.08 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.65 -34.16 97.73 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.139 1.893 . . . . 0.0 112.074 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.2 t -102.03 21.35 14.93 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.881 0.472 . . . . 0.0 110.611 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -73.03 -87.33 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 26' ' ' VAL . 7.4 t 173.65 148.86 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.461 1.504 . . . . 0.0 109.081 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.478 HG22 ' HE3' ' A' ' 27' ' ' LYS . 44.3 mm -63.19 -38.53 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.322 1.049 . . . . 0.0 110.42 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -60.03 -33.06 71.5 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.374 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.2 t-20 -74.53 -43.26 56.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.719 HG21 HG21 ' A' ' 17' ' ' VAL . 60.6 t -56.35 -47.31 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 124.387 1.054 . . . . 0.0 110.093 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.492 ' HB3' HD22 ' A' ' 43' ' ' LEU . 17.6 ptpt -74.18 -25.93 59.99 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.37 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.62 -34.26 77.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.28 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 73.6 mmtt -72.52 -32.59 66.25 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.557 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 27' ' ' LYS . 1.4 mp -53.42 -45.0 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 119.05 0.841 . . . . 0.0 110.076 168.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.97 -32.99 74.72 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.507 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.99 -34.88 66.71 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.099 0.56 . . . . 0.0 111.328 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.76 -68.7 0.78 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.046 0.539 . . . . 0.0 110.952 -171.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -83.35 -21.74 33.03 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.78 20.8 35.76 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.753 -0.203 . . . . 0.0 112.942 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -107.98 122.72 39.88 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.35 153.43 78.25 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.645 2.23 . . . . 0.0 112.333 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.421 ' HA ' ' HG3' ' A' ' 41' ' ' GLN . 18.4 Cg_endo -56.32 -14.38 12.17 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.715 2.943 . . . . 0.0 113.761 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -75.07 -48.78 22.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.033 0.933 . . . . 0.0 110.628 173.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -80.84 -23.83 38.86 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.511 0.724 . . . . 0.0 111.911 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.501 ' NE2' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.43 153.71 18.34 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.592 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 32.9 ttt180 -134.89 126.48 28.81 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.714 ' HG ' HD11 ' A' ' 50' ' ' LEU . 5.3 tp -100.84 122.61 43.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.839 -166.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.1 mt -139.32 133.05 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.727 0.811 . . . . 0.0 109.954 -173.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.598 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 82.6 t80 -135.32 131.97 37.11 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.78 21.62 12.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.857 0.863 . . . . 0.0 112.468 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.58 10.4 79.58 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.449 -0.341 . . . . 0.0 113.819 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 12.7 ptpt -118.39 147.57 43.41 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.286 0.634 . . . . 0.0 109.373 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.496 ' HB2' HD22 ' B' ' 224' ' ' LEU . 8.0 tt0 -75.94 127.2 32.48 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.127 0.571 . . . . 0.0 109.779 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.714 HD11 ' HG ' ' A' ' 43' ' ' LEU . 25.0 mt -80.75 123.65 28.39 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.039 0.536 . . . . 0.0 109.998 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.75 138.44 32.09 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.152 0.981 . . . . 0.0 109.707 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.53 -39.2 92.82 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.627 1.171 . . . . 0.0 112.28 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.14 -18.57 76.64 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.218 0.949 . . . . 0.0 113.816 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -88.35 178.1 6.66 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.823 0.849 . . . . 0.0 111.563 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.6 p -116.59 168.67 9.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.717 0.807 . . . . 0.0 109.874 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.5 mt -57.54 -50.73 72.13 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.1 t -61.55 -25.64 67.43 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.379 1.072 . . . . 0.0 111.554 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.64 -45.98 84.49 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 121.127 0.489 . . . . 0.0 109.688 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -85.59 17.23 3.36 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.473 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 65.73 19.98 11.45 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.402 1.081 . . . . 0.0 111.776 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.6 mt -85.58 132.68 31.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -115.8 -175.2 2.68 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -61.96 130.41 45.49 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.238 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 72.58 18.18 4.42 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.258 1.423 . . . . 0.0 111.965 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.4 m -71.05 139.92 50.58 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 53.1 m -93.72 129.66 39.98 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.456 0.473 . . . . 0.0 109.986 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.598 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -137.84 166.07 24.92 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.696 1.198 . . . . 0.0 108.891 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -96.65 148.3 23.01 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.349 0.595 . . . . 0.0 111.267 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.65 HD11 HG23 ' A' ' 7' ' ' THR . 2.4 tm? -127.12 130.85 50.6 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 94.0 t -114.02 130.42 68.25 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 124.207 1.003 . . . . 0.0 109.936 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.34 146.29 25.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.317 0.647 . . . . 0.0 110.95 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -117.18 -40.46 3.09 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.28 1.032 . . . . 0.0 110.627 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.494 1.764 0 C-N-CA 124.989 1.316 . . . . 0.0 113.191 -177.615 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 11.2 mptt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.6 m -145.59 -177.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.902 0.881 . . . . 0.0 110.179 -168.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -125.81 146.7 49.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.58 0.752 . . . . 0.0 110.907 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.574 ' HA ' HD13 ' B' ' 216' ' ' ILE . 48.7 t -92.95 96.09 1.29 Allowed Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 124.651 1.18 . . . . 0.0 107.998 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.537 ' HD2' HD23 ' B' ' 220' ' ' LEU . 34.2 Cg_endo -59.79 -17.36 42.76 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.234 2.622 . . . . 0.0 114.483 -168.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.16 -56.93 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 122.789 0.436 . . . . 0.0 110.851 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 14.9 p -103.65 -0.65 29.26 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.435 0.294 . . . . 0.0 111.555 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 69.05 42.11 78.47 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 115.153 0.821 . . . . 0.0 115.153 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.01 137.51 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.318 0.559 . . . . 0.0 110.894 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -89.13 123.77 33.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.211 0.604 . . . . 0.0 109.684 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.403 HD13 ' HB2' ' B' ' 204' ' ' CYS . 6.2 pt -153.55 160.11 31.32 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.845 1.258 . . . . 0.0 110.434 -168.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.18 161.22 16.83 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.172 2.581 . . . . 0.0 113.563 171.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.554 ' O ' HG21 ' B' ' 216' ' ' ILE . 40.3 tt0 -62.79 -44.72 95.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.412 1.485 . . . . 0.0 113.096 -172.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 20.3 m -62.66 -40.99 98.78 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-O 121.978 0.894 . . . . 0.0 110.347 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -73.58 -26.3 60.75 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.249 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -69.54 -43.68 80.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -67.29 -37.42 83.38 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 123.394 0.434 . . . . 0.0 110.421 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -69.59 -40.59 76.61 Favored 'General case' 0 C--O 1.247 0.945 0 O-C-N 123.226 0.329 . . . . 0.0 111.57 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -45.45 93.15 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.48 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.537 HD23 ' HD2' ' B' ' 205' ' ' PRO . 96.3 mt -61.82 -43.62 98.48 Favored 'General case' 0 C--O 1.206 -1.196 0 O-C-N 124.431 1.082 . . . . 0.0 111.153 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.45 -27.21 56.2 Favored 'General case' 0 CA--C 1.553 1.094 0 O-C-N 124.578 1.173 . . . . 0.0 110.767 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.4 t -91.57 -39.8 11.7 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.642 0.777 . . . . 0.0 111.454 172.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 91.4 m -75.04 -23.0 58.07 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.333 1.053 . . . . 0.0 112.899 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . 0.496 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.5 pp . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.753 0.311 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 54.9 mt-30 -107.2 138.5 43.27 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.678 0.791 . . . . 0.0 110.635 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.544 HD13 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -137.57 153.59 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.299 1.04 . . . . 0.0 109.746 176.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' THR . 81.8 m-85 -105.79 107.78 18.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.033 0.933 . . . . 0.0 109.445 -175.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 30' ' ' ILE . 56.1 t -103.67 117.58 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -108.11 119.6 39.95 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.844 0.857 . . . . 0.0 109.615 -171.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.618 HG21 HD13 ' A' ' 69' ' ' LEU . 38.5 p -72.1 165.0 25.19 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.296 0.569 . . . . 0.0 111.461 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.439 HD11 HG21 ' A' ' 70' ' ' VAL . 88.4 mt -70.37 -18.7 63.06 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.165 171.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -79.64 -12.86 59.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.908 0.483 . . . . 0.0 110.809 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.54 18.78 37.19 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.908 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.05 153.44 18.16 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.7 m -100.58 134.28 43.78 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.585 0.754 . . . . 0.0 110.022 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -120.41 109.93 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.96 1.304 . . . . 0.0 107.53 174.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.2 m -94.78 130.35 41.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -112.62 154.48 25.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.72 0.808 . . . . 0.0 109.28 -177.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -110.6 71.87 0.77 Allowed 'General case' 0 C--O 1.242 0.706 0 O-C-N 124.512 1.132 . . . . 0.0 108.887 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.791 HG23 HG21 ' A' ' 26' ' ' VAL . 20.3 m -140.47 172.63 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.514 0.726 . . . . 0.0 110.169 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -102.87 161.88 21.83 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 123.639 0.775 . . . . 0.0 109.95 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.5 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 29.1 Cg_endo -59.41 -37.05 92.22 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 121.868 1.712 . . . . 0.0 111.03 171.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 p -96.64 15.72 20.93 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.872 0.869 . . . . 0.0 111.092 -174.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.75 -98.97 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.771 0.828 . . . . 0.0 109.576 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.1 t 174.75 142.45 0.05 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.989 1.316 . . . . 0.0 109.091 173.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -61.0 -38.84 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.208 1.003 . . . . 0.0 111.848 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 42.7 tt0 -57.47 -35.22 69.89 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.563 0.697 . . . . 0.0 111.483 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.433 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.4 t30 -75.99 -42.23 48.86 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.213 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.791 HG21 HG23 ' A' ' 17' ' ' VAL . 61.8 t -55.27 -47.3 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 124.606 1.191 . . . . 0.0 110.367 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -69.45 -32.2 70.99 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.079 0.551 . . . . 0.0 111.696 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.48 70.44 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.387 0.429 . . . . 0.0 110.838 170.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 8.8 mmpt? -75.96 -35.81 59.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.906 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 5' ' ' VAL . 2.2 mp -57.09 -43.4 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 118.915 0.78 . . . . 0.0 109.666 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.11 -31.76 72.26 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.353 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.36 -30.77 66.56 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.42 0.688 . . . . 0.0 111.541 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 72.2 mmtt -93.55 -70.37 0.71 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 117.624 0.193 . . . . 0.0 110.715 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -80.38 -25.93 38.85 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.24 0.216 . . . . 0.0 111.274 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.32 18.55 30.68 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.311 0.382 . . . . 0.0 113.928 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.75 123.83 41.07 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -70.29 156.64 61.52 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.112 2.541 . . . . 0.0 112.375 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.23 -16.43 17.36 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.713 2.942 . . . . 0.0 114.072 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -71.8 -47.09 55.75 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 120.949 0.404 . . . . 0.0 110.197 173.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -83.2 -21.3 33.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.895 0.878 . . . . 0.0 112.216 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.437 HE22 HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -109.18 153.0 24.39 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.105 0.562 . . . . 0.0 110.515 177.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -138.72 138.08 37.37 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.119 0.567 . . . . 0.0 110.263 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.437 HD23 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -98.06 125.08 42.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.788 0.835 . . . . 0.0 110.373 -174.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -142.86 125.04 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.015 0.926 . . . . 0.0 109.586 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.625 ' HB3' HD21 ' A' ' 50' ' ' LEU . 79.4 t80 -124.67 124.96 43.31 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.43 1.092 . . . . 0.0 108.148 177.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.498 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 60.44 27.0 16.6 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.893 0.877 . . . . 0.0 112.812 175.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.52 -15.89 61.99 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 2.5 ptpt -98.73 142.32 30.43 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -83.18 132.96 35.04 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.7 mt -82.51 116.64 22.04 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.426 0.691 . . . . 0.0 110.996 -175.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 54' ' ' ARG . 32.8 tt0 -83.87 139.45 32.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.485 1.114 . . . . 0.0 110.466 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.5 m-20 -56.25 -47.92 77.57 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.603 1.161 . . . . 0.0 112.795 -172.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.49 -18.2 71.5 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 124.758 1.286 . . . . 0.0 113.893 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 62.5 mtt180 -84.96 177.53 7.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.69 0.796 . . . . 0.0 111.04 175.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.9 p -116.71 170.78 8.33 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.343 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 94.9 mt -57.35 -47.97 80.21 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 47.4 t -62.18 -26.49 68.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.755 1.222 . . . . 0.0 111.6 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 7.7 t70 -61.25 -45.47 94.4 Favored 'General case' 0 C--N 1.357 0.932 0 CA-C-O 121.532 0.682 . . . . 0.0 109.654 177.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.4 15.95 7.11 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.589 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 71.22 8.06 6.3 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.475 1.51 . . . . 0.0 112.309 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mt -77.91 129.56 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -122.83 -176.63 3.45 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -59.16 143.5 48.66 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 68.19 13.3 9.05 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.885 1.274 . . . . 0.0 112.239 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.5 m -84.91 138.76 32.32 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 57.9 m -99.27 127.31 45.25 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 110.187 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.58 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -124.13 173.67 8.15 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.25 1.42 . . . . 0.0 108.585 176.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -108.97 154.96 21.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.496 0.718 . . . . 0.0 110.97 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.618 HD13 HG21 ' A' ' 7' ' ' THR . 2.6 tm? -133.79 126.17 30.02 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.586 HG11 HD13 ' B' ' 220' ' ' LEU . 90.2 t -104.95 115.85 47.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 123.518 0.727 . . . . 0.0 109.993 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.458 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 86.8 mt -85.67 147.79 26.2 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.519 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -121.98 -45.64 2.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.249 1.02 . . . . 0.0 110.127 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.458 ' CD2' ' HB3' ' A' ' 71' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.499 2.006 0 C-N-CA 124.501 1.121 . . . . 0.0 112.976 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' B' ' 201' ' ' LYS . 11.2 mptt . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 m -142.6 -178.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.289 1.036 . . . . 0.0 109.761 -166.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -118.73 146.31 44.86 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.256 0.622 . . . . 0.0 110.599 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.528 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.7 t -83.08 102.64 1.9 Allowed Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.505 ' HD2' HD21 ' B' ' 220' ' ' LEU . 43.7 Cg_endo -62.38 -9.6 15.96 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.319 2.679 . . . . 0.0 114.052 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.78 -65.09 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.311 0.644 . . . . 0.0 110.611 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 18.1 p -100.3 2.46 42.63 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.704 0.401 . . . . 0.0 112.061 -172.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 63.23 38.85 97.14 Favored Glycine 0 N--CA 1.477 1.388 0 N-CA-C 115.494 0.957 . . . . 0.0 115.494 170.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.65 134.41 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.077 0.551 . . . . 0.0 110.482 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -84.74 122.62 29.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.611 0.365 . . . . 0.0 110.029 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 6.0 pt -149.44 158.7 37.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 125.825 1.65 . . . . 0.0 109.484 -171.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.8 162.99 20.07 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.618 2.212 . . . . 0.0 112.839 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.536 ' O ' HG21 ' B' ' 216' ' ' ILE . 39.5 tt0 -65.36 -36.18 83.24 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.459 1.504 . . . . 0.0 113.23 -169.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 34.2 t -69.0 -38.0 79.04 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.098 0.475 . . . . 0.0 110.04 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -76.26 -23.45 54.45 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.2 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.542 ' O ' ' HG ' ' B' ' 220' ' ' LEU . 0.3 OUTLIER -70.91 -43.0 77.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -55.78 -52.87 62.49 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.016 0.823 . . . . 0.0 110.346 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -54.26 -47.48 72.25 Favored 'General case' 0 C--O 1.252 1.221 0 O-C-N 124.307 1.004 . . . . 0.0 111.82 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -35.06 79.13 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.991 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.586 HD13 HG11 ' A' ' 70' ' ' VAL . 71.3 mt -64.62 -51.95 60.01 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 123.529 0.518 . . . . 0.0 110.882 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -58.25 -29.41 65.75 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.569 1.168 . . . . 0.0 111.684 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 46.7 t -81.88 -43.5 18.11 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.435 0.694 . . . . 0.0 110.921 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 69.6 m -81.59 -19.03 42.77 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.251 1.02 . . . . 0.0 113.383 -170.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.491 1.595 0 CA-C-N 118.482 0.583 . . . . 0.0 111.182 -176.768 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 N--CA 1.476 0.825 0 CA-C-O 121.216 0.532 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 18.5 mp0 -92.91 124.57 36.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.488 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.463 HD13 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -122.5 157.56 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.338 1.455 . . . . 0.0 108.212 175.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 64.7 m-85 -116.81 105.51 12.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.431 -172.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.538 HG21 HD13 ' A' ' 30' ' ' ILE . 40.3 t -95.08 122.26 46.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -108.9 120.04 41.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.309 0.644 . . . . 0.0 110.144 -173.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.64 HG22 HD11 ' A' ' 69' ' ' LEU . 31.6 p -77.77 167.08 22.12 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.465 0.65 . . . . 0.0 111.939 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.468 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 82.6 mt -71.28 -20.22 62.24 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.724 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -78.67 -16.94 56.7 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.954 0.502 . . . . 0.0 110.282 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.58 14.8 26.61 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HG2' ' HG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -93.22 152.83 18.96 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.469 0.635 . . . . 0.0 109.436 176.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.9 m -96.29 143.25 27.53 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.1 102.44 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.0 m -84.49 117.39 23.65 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -104.3 153.49 20.96 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.417 ' HG3' ' HG3' ' A' ' 2' ' ' GLN . 4.7 mp0 -114.37 90.63 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.762 HG23 HG22 ' A' ' 26' ' ' VAL . 9.2 m -139.32 169.04 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -90.13 153.13 46.73 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 42.5 Cg_endo -64.13 -26.32 65.29 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 121.975 1.783 . . . . 0.0 111.14 172.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.9 t -100.18 14.33 31.2 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.057 0.943 . . . . 0.0 110.365 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.73 -94.78 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.112 0.565 . . . . 0.0 109.57 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.43 ' O ' HG21 ' A' ' 26' ' ' VAL . 9.2 t 179.58 145.65 0.19 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.521 1.128 . . . . 0.0 109.678 173.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.414 HG22 HD23 ' A' ' 43' ' ' LEU . 46.1 mm -61.8 -36.23 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.168 0.987 . . . . 0.0 111.196 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -57.71 -34.93 69.98 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.428 0.691 . . . . 0.0 111.009 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.7 t-20 -73.95 -43.29 58.73 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.152 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.762 HG22 HG23 ' A' ' 17' ' ' VAL . 38.6 t -57.71 -50.06 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 124.256 0.973 . . . . 0.0 110.735 -178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -67.41 -30.19 69.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.179 0.592 . . . . 0.0 111.232 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.62 78.84 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.653 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 7.2 mmpt? -73.82 -31.63 63.33 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 118.801 -0.618 . . . . 0.0 110.896 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.538 HD13 HG21 ' A' ' 5' ' ' VAL . 1.7 mp -54.26 -47.87 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.638 0.654 . . . . 0.0 110.113 169.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -66.03 -30.81 71.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.395 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.24 -27.74 64.7 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.344 0.658 . . . . 0.0 111.627 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.6 mmtt -100.61 -68.84 0.79 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.711 0.404 . . . . 0.0 110.912 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -83.42 -22.36 32.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.412 0.285 . . . . 0.0 111.311 -175.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.73 6.98 57.0 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 113.883 0.313 . . . . 0.0 113.883 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -95.54 124.07 54.26 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.071 0.549 . . . . 0.0 109.764 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HG2' ' HB2' ' A' ' 40' ' ' GLN . 53.1 Cg_endo -64.31 155.91 62.87 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.525 2.817 . . . . 0.0 113.152 -174.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -56.5 -18.29 24.94 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 124.237 3.291 . . . . 0.0 113.94 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.53 -47.14 16.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.26 0.624 . . . . 0.0 110.748 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.478 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -78.59 -23.8 45.82 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.3 0.64 . . . . 0.0 111.056 -173.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.467 ' HB2' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.06 152.7 19.13 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.586 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 35.4 ttt180 -140.54 116.87 10.68 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 121.844 0.831 . . . . 0.0 109.032 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.715 ' HG ' HD13 ' A' ' 50' ' ' LEU . 10.6 tp -93.84 123.75 37.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.654 -162.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 96.2 mt -140.49 135.45 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 123.291 0.637 . . . . 0.0 110.775 -169.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.526 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 78.6 t80 -136.13 132.85 36.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . . . 66.72 18.15 10.67 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.523 1.129 . . . . 0.0 112.61 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.67 15.48 65.71 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.86 -0.411 . . . . 0.0 113.593 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 13.6 ptpt -124.2 143.9 50.25 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.505 0.722 . . . . 0.0 109.148 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -75.5 130.67 39.27 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.779 0.431 . . . . 0.0 110.349 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.715 HD13 ' HG ' ' A' ' 43' ' ' LEU . 24.9 mt -78.49 122.03 25.33 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 123.21 0.604 . . . . 0.0 110.465 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -77.74 136.29 38.13 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.689 0.796 . . . . 0.0 108.91 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -61.62 -36.97 82.26 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.105 0.878 . . . . 0.0 112.521 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.25 -27.83 69.25 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.98 0.8 . . . . 0.0 113.166 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -76.04 176.83 7.58 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.127 0.571 . . . . 0.0 111.44 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.0 p -114.75 168.75 9.61 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.707 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 85.4 mt -55.71 -52.1 65.05 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.948 0.78 . . . . 0.0 109.532 172.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -59.13 -27.52 65.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.529 1.132 . . . . 0.0 111.83 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.13 -40.05 86.72 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.027 0.531 . . . . 0.0 110.017 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -90.39 21.37 3.91 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.918 0.887 . . . . 0.0 111.41 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 67.17 15.36 10.03 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.451 1.101 . . . . 0.0 111.884 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -88.11 134.36 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -122.9 -173.59 2.74 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.453 0.701 . . . . 0.0 109.266 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 11.7 ptmm? -59.04 144.0 46.7 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.918 170.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 65.05 7.6 4.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.614 1.566 . . . . 0.0 112.968 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -72.4 129.86 39.35 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 118.112 0.414 . . . . 0.0 109.897 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 20.0 m -99.43 140.91 32.91 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.526 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -143.58 173.87 11.27 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.09 0.956 . . . . 0.0 109.344 -175.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -97.54 154.63 17.39 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.691 0.758 . . . . 0.0 111.601 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.64 HD11 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -137.49 119.33 15.22 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.484 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.655 HG22 HD22 ' B' ' 220' ' ' LEU . 53.1 t -93.31 110.31 23.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.581 0.752 . . . . 0.0 110.368 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.6 mt -78.25 137.78 38.29 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.748 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -115.54 -48.62 2.77 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.19 0.996 . . . . 0.0 109.641 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.489 1.497 0 C-N-CA 125.185 1.394 . . . . 0.0 112.196 179.673 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 13.2 mptt . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 6.0 m -145.38 -177.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.135 1.374 . . . . 0.0 109.28 -162.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -115.18 137.2 52.29 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 122.464 0.306 . . . . 0.0 111.522 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.464 ' HA ' HD13 ' B' ' 216' ' ' ILE . 48.8 t -79.91 101.43 0.84 Allowed Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.0 -1.09 8.95 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.796 2.33 . . . . 0.0 114.592 -159.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 23.3 t -93.88 -62.95 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.2 p -89.47 -10.51 46.09 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.745 0.418 . . . . 0.0 111.52 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.14 57.7 17.2 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 124.321 0.962 . . . . 0.0 114.195 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 32.6 m -117.94 135.62 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.399 0.68 . . . . 0.0 109.263 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -83.85 113.03 20.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' B' ' 204' ' ' CYS . 7.9 pt -142.5 156.04 63.73 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.808 1.243 . . . . 0.0 110.287 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.92 163.34 14.04 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.946 2.431 . . . . 0.0 113.186 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.558 ' O ' HG23 ' B' ' 216' ' ' ILE . 43.8 tt0 -65.47 -37.04 85.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.176 1.39 . . . . 0.0 113.131 -166.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 23.3 t -65.48 -43.6 89.72 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.369 0.605 . . . . 0.0 109.743 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -69.81 -25.01 63.57 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.402 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.558 HG23 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -70.24 -44.03 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.324 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -61.88 -46.43 89.46 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 123.686 0.616 . . . . 0.0 110.508 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -47.79 78.9 Favored 'General case' 0 C--O 1.25 1.093 0 O-C-N 124.0 0.813 . . . . 0.0 112.469 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.53 -37.75 88.49 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.569 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.655 HD22 HG22 ' A' ' 70' ' ' VAL . 62.6 tp -62.48 -42.59 99.59 Favored 'General case' 0 C--O 1.215 -0.723 0 O-C-N 124.28 0.988 . . . . 0.0 111.452 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -53.23 -40.35 64.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.856 0.722 . . . . 0.0 110.342 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.2 t -75.53 -41.87 53.99 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.324 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 96.0 m -77.9 -19.04 55.44 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.169 0.987 . . . . 0.0 112.878 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . 0.606 HD21 ' HG ' ' B' ' 220' ' ' LEU . 4.2 pp . . . . . 0 N--CA 1.482 1.17 0 C-N-CA 122.647 0.379 . . . . 0.0 110.73 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.928 0.394 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 77.7 mt-30 -104.72 123.22 47.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.516 0.726 . . . . 0.0 110.572 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.464 HD13 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -123.85 155.27 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.538 1.135 . . . . 0.0 109.623 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -108.28 103.88 13.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.921 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.604 HG13 ' HB2' ' A' ' 69' ' ' LEU . 92.3 t -104.65 100.17 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.99 122.52 43.01 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.595 0.758 . . . . 0.0 111.129 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.636 HG22 HD12 ' A' ' 69' ' ' LEU . 37.4 p -67.71 162.97 22.57 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.608 0.763 . . . . 0.0 112.219 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.33 -15.69 63.39 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.138 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.5 p -80.21 0.01 34.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.47 0.708 . . . . 0.0 111.202 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.53 9.3 75.71 Favored Glycine 0 C--N 1.351 1.39 0 C-N-CA 123.235 0.445 . . . . 0.0 113.376 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -94.23 141.6 28.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.036 0.934 . . . . 0.0 109.237 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 m -105.22 136.6 44.44 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.831 0.452 . . . . 0.0 110.534 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.34 109.84 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.086 0.954 . . . . 0.0 109.021 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.0 m -84.72 122.49 29.17 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.6 mm? -108.95 159.05 17.13 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -124.02 82.25 2.01 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.669 HG23 HG22 ' A' ' 26' ' ' VAL . 15.4 m -140.84 172.6 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.999 0.92 . . . . 0.0 109.775 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.93 149.15 35.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 30.1 Cg_endo -61.79 -27.06 80.18 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.085 1.856 . . . . 0.0 111.904 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.4 t -99.87 16.62 23.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.776 0.43 . . . . 0.0 110.308 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.79 -98.58 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 119.108 -0.472 . . . . 0.0 109.797 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.466 ' O ' HG21 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -170.5 143.85 2.32 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 125.447 1.499 . . . . 0.0 108.786 175.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.37 -37.38 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.885 0.874 . . . . 0.0 110.639 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.98 -36.19 72.27 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.039 0.936 . . . . 0.0 110.849 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 24.3 t-20 -70.84 -46.42 62.76 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.397 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.669 HG22 HG23 ' A' ' 17' ' ' VAL . 67.0 t -55.87 -44.51 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 124.158 0.911 . . . . 0.0 110.85 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -71.93 -30.12 65.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.797 0.439 . . . . 0.0 111.748 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.68 -32.6 74.34 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.809 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 10.3 mmpt? -71.36 -35.21 71.04 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.526 0.516 . . . . 0.0 110.607 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.28 -46.04 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 122.877 0.471 . . . . 0.0 110.47 169.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -65.87 -23.3 66.63 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.3 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.08 -31.03 27.53 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.163 0.985 . . . . 0.0 111.327 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.85 -70.43 0.69 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.621 0.368 . . . . 0.0 110.95 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -86.72 -24.33 25.2 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.724 0.41 . . . . 0.0 111.236 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.48 35.71 8.47 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.436 0.46 . . . . 0.0 112.777 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -111.75 126.11 29.11 Favored Pre-proline 0 CA--C 1.556 1.188 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.49 151.49 79.86 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.221 2.614 . . . . 0.0 112.766 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.26 -13.94 26.82 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.137 3.225 . . . . 0.0 114.25 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.42 -43.66 39.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.377 0.671 . . . . 0.0 110.183 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.46 -35.59 30.37 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.629 0.772 . . . . 0.0 111.124 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.483 HE22 HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -88.76 148.73 23.79 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.806 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 39.8 ttt180 -135.47 130.96 35.52 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.333 0.653 . . . . 0.0 109.432 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.483 HD23 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -95.02 122.69 37.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.498 0.719 . . . . 0.0 110.232 -174.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -141.42 117.74 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.671 0.789 . . . . 0.0 110.027 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.52 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 88.5 t80 -117.38 126.98 53.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.307 1.043 . . . . 0.0 108.644 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.24 23.03 13.29 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.008 0.923 . . . . 0.0 112.691 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.79 1.64 65.5 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 114.274 0.47 . . . . 0.0 114.274 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.5 ptpt -112.56 145.81 39.66 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -80.76 140.97 35.22 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 45' ' ' PHE . 19.8 mt -94.11 122.91 37.12 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.143 0.577 . . . . 0.0 110.538 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.49 140.31 29.66 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.346 1.058 . . . . 0.0 110.186 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.54 -52.04 56.78 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.57 1.548 . . . . 0.0 113.251 -173.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.67 -20.36 70.07 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 124.573 1.171 . . . . 0.0 113.922 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 -82.75 177.33 8.72 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.016 0.526 . . . . 0.0 110.681 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.8 p -116.82 168.79 9.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.317 0.647 . . . . 0.0 109.877 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 98.1 mt -57.21 -52.07 66.79 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -62.75 -25.16 68.06 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.302 1.041 . . . . 0.0 111.445 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.82 -40.95 96.02 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -91.16 17.03 8.68 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.153 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 69.54 17.16 8.01 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.578 1.151 . . . . 0.0 112.215 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.9 mt -87.52 139.78 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -137.6 -167.85 2.21 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -55.66 142.39 34.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.234 0.614 . . . . 0.0 112.031 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 56.24 14.62 1.6 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.248 1.419 . . . . 0.0 114.157 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 m -75.72 132.84 40.77 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.1 m -97.2 124.76 41.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.361 0.6 . . . . 0.0 110.012 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.52 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -127.42 174.67 8.82 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.178 1.391 . . . . 0.0 108.507 176.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -109.08 146.67 33.63 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.505 0.722 . . . . 0.0 111.102 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.636 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -122.28 125.71 46.59 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.806 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 79.5 t -105.26 124.27 59.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 123.62 0.768 . . . . 0.0 110.009 -175.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.518 ' HB3' HD23 ' A' ' 73' ' ' LEU . 83.1 mt -96.64 115.37 27.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.101 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -85.81 -46.06 11.01 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 169.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 71' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 125.42 1.488 . . . . 0.0 113.511 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 12.2 mptt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.59 152.56 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.841 1.256 . . . . 0.0 109.58 -171.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -90.67 146.78 23.74 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.121 0.568 . . . . 0.0 111.584 -173.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.561 ' HA ' HD11 ' B' ' 216' ' ' ILE . 37.4 t -88.69 97.91 0.98 Allowed Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.716 1.206 . . . . 0.0 108.184 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.565 ' HD2' HD23 ' B' ' 220' ' ' LEU . 33.2 Cg_endo -59.62 -14.96 28.56 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.37 2.713 . . . . 0.0 114.777 -168.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 33.4 t -84.37 -46.88 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 122.686 0.395 . . . . 0.0 111.245 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . 0.418 ' SG ' HG21 ' B' ' 209' ' ' VAL . 20.5 p -111.56 -3.36 15.14 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.93 42.75 84.92 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . 0.418 HG21 ' SG ' ' B' ' 207' ' ' CYS . 22.8 m -117.86 133.43 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 117.448 0.624 . . . . 0.0 110.418 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -86.63 121.88 29.76 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 5.9 pt -146.6 162.87 32.29 Favored Pre-proline 0 N--CA 1.484 1.264 0 C-N-CA 124.878 1.271 . . . . 0.0 110.673 -169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -58.33 161.58 13.77 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.678 2.252 . . . . 0.0 113.505 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.542 ' O ' HG21 ' B' ' 216' ' ' ILE . 33.8 tt0 -65.62 -42.56 91.41 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.079 1.351 . . . . 0.0 112.788 -169.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 21.2 m -72.24 -35.89 68.95 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.623 -0.673 . . . . 0.0 110.432 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -74.5 -22.0 59.28 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.331 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.561 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.4 OUTLIER -69.09 -47.17 76.45 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -62.4 -39.2 92.46 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 123.77 0.669 . . . . 0.0 110.862 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -70.65 -42.91 70.2 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.104 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -36.69 84.08 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.565 HD23 ' HD2' ' B' ' 205' ' ' PRO . 87.3 mt -69.74 -42.46 73.89 Favored 'General case' 0 C--O 1.21 -0.995 0 O-C-N 124.321 1.013 . . . . 0.0 111.138 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -58.21 -25.54 61.76 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.505 1.128 . . . . 0.0 110.682 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 30.5 t -89.8 -44.08 10.21 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.056 170.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.8 m -70.19 -20.46 63.12 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.327 1.051 . . . . 0.0 113.062 -171.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.491 1.608 0 C-N-CA 122.909 0.484 . . . . 0.0 112.168 -173.564 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.3 mp0 -95.92 128.56 42.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.693 -172.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.09 147.76 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.793 1.237 . . . . 0.0 108.425 173.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 66' ' ' THR . 31.2 m-85 -103.29 101.58 11.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.283 0.633 . . . . 0.0 109.778 -172.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.43 HG12 ' HB2' ' A' ' 69' ' ' LEU . 11.5 t -96.99 117.93 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -108.28 124.94 51.08 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.442 0.697 . . . . 0.0 109.445 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.617 HG23 HD11 ' A' ' 69' ' ' LEU . 35.3 p -73.16 167.24 21.57 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.489 0.661 . . . . 0.0 111.314 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.474 HD11 HG23 ' A' ' 70' ' ' VAL . 43.2 mt -68.81 -24.05 64.34 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.79 172.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p -78.69 -14.24 59.4 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.6 0.76 . . . . 0.0 110.758 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.99 18.9 32.68 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.033 0.373 . . . . 0.0 114.033 170.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.17 153.16 18.8 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 m -102.0 145.9 28.63 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.042 0.449 . . . . 0.0 110.053 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.498 HD13 HG22 ' A' ' 7' ' ' THR . 5.3 mp -128.88 108.68 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 m -87.91 115.44 25.38 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -103.35 152.2 21.86 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -128.29 79.42 1.9 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.619 HG23 HG21 ' A' ' 26' ' ' VAL . 30.0 m -146.07 179.02 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.673 1.189 . . . . 0.0 109.081 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -85.31 153.12 59.01 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.2 Cg_endo -59.09 -32.82 98.02 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 121.827 1.685 . . . . 0.0 110.85 164.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -91.96 8.88 35.49 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.018 0.927 . . . . 0.0 111.479 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -74.46 -92.3 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.342 0.657 . . . . 0.0 110.074 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 26' ' ' VAL . 8.9 t 177.08 145.5 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.48 1.112 . . . . 0.0 109.84 171.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.75 -34.25 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.177 0.991 . . . . 0.0 110.684 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.68 -40.77 66.24 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.953 0.901 . . . . 0.0 110.66 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.45 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.5 t-20 -77.31 -43.39 33.27 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.031 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.619 HG21 HG23 ' A' ' 17' ' ' VAL . 99.4 t -56.86 -44.25 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 124.361 1.038 . . . . 0.0 110.442 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HB2' ' OE1' ' A' ' 41' ' ' GLN . 16.6 ptpt -71.78 -32.58 67.8 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.947 0.499 . . . . 0.0 110.609 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.09 -28.41 68.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.858 0.463 . . . . 0.0 111.164 169.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.51 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 9.8 mmpt? -72.78 -37.06 67.73 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 122.9 0.48 . . . . 0.0 110.247 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.448 HG13 HG23 ' A' ' 13' ' ' ILE . 2.2 mp -58.53 -42.58 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 118.413 0.551 . . . . 0.0 109.838 172.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.05 -27.98 69.77 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.326 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.33 -27.87 47.21 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.614 0.766 . . . . 0.0 111.622 174.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.3 mmtt -95.69 -68.02 0.82 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.986 -0.446 . . . . 0.0 111.025 -174.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.424 ' HG2' HG23 ' A' ' 30' ' ' ILE . 15.1 pt-20 -85.51 -20.09 30.2 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.703 0.229 . . . . 0.0 111.549 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 24.76 35.68 Favored Glycine 0 C--N 1.347 1.17 0 O-C-N 122.946 0.154 . . . . 0.0 113.231 171.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.47 127.44 27.83 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.8 151.69 74.17 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.975 2.45 . . . . 0.0 112.486 -174.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.519 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 18.6 Cg_endo -57.43 -14.1 15.27 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.976 3.117 . . . . 0.0 114.782 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.21 -44.64 68.23 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 123.486 0.492 . . . . 0.0 110.202 172.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.11 -35.65 20.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.022 0.929 . . . . 0.0 111.882 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.637 HE21 HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -94.16 120.29 34.19 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.014 0.435 . . . . 0.0 109.849 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.602 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.1 ttt180 -106.86 128.7 54.51 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.048 0.939 . . . . 0.0 109.544 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.481 HD21 HE22 ' A' ' 41' ' ' GLN . 4.6 mm? -94.09 127.76 40.09 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.837 0.855 . . . . 0.0 109.653 -174.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -141.54 131.54 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.676 0.79 . . . . 0.0 110.199 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.572 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 74.2 t80 -136.79 128.4 28.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.68 21.79 11.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.512 1.125 . . . . 0.0 112.164 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.66 -0.03 73.18 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.446 -0.641 . . . . 0.0 114.047 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.7 ptpt -112.42 151.51 29.76 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 117.711 0.755 . . . . 0.0 110.394 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.498 ' HB2' HD21 ' B' ' 224' ' ' LEU . 29.5 tt0 -77.32 133.04 38.88 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.171 0.589 . . . . 0.0 110.343 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 45' ' ' PHE . 24.2 mt -85.95 120.47 27.38 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 122.764 0.426 . . . . 0.0 110.258 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.74 136.1 36.68 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 123.731 0.813 . . . . 0.0 109.102 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.42 -38.08 82.9 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.142 0.902 . . . . 0.0 111.591 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.61 -38.52 96.53 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.844 0.715 . . . . 0.0 112.867 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -75.07 177.57 6.3 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.733 0.813 . . . . 0.0 112.034 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 52.7 p -110.43 167.52 10.15 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.66 0.784 . . . . 0.0 110.093 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.1 mt -55.78 -51.4 67.57 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 t -63.19 -24.02 67.69 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.47 1.108 . . . . 0.0 111.771 -175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.13 -31.65 66.2 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.182 0.515 . . . . 0.0 109.909 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -94.53 17.5 13.08 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.626 0.77 . . . . 0.0 111.747 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 68.75 16.65 8.92 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.447 1.099 . . . . 0.0 112.038 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.6 mt -88.05 119.48 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -99.36 179.77 4.47 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -60.3 142.78 54.2 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 68.33 9.5 7.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.918 1.287 . . . . 0.0 113.424 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -70.73 137.59 49.81 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 26.2 m -97.88 126.14 43.11 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.572 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -133.11 172.58 12.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.569 1.147 . . . . 0.0 108.854 -178.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -101.48 154.86 18.46 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.522 0.677 . . . . 0.0 111.68 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.637 HD22 HE21 ' A' ' 41' ' ' GLN . 2.2 tm? -135.88 132.81 37.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.206 -1.361 . . . . 0.0 107.936 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 99.5 t -117.0 124.04 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.929 0.892 . . . . 0.0 110.575 -175.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.443 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 86.5 mt -92.49 120.71 33.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.095 0.558 . . . . 0.0 109.685 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -90.72 -37.21 13.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.095 0.958 . . . . 0.0 109.612 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 71' ' ' LEU . 92.8 mt . . . . . 0 N--CA 1.487 1.379 0 C-N-CA 125.357 1.463 . . . . 0.0 113.154 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.0 m -141.38 -176.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.388 1.075 . . . . 0.0 109.48 -170.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -123.67 143.37 50.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.283 0.633 . . . . 0.0 110.042 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.563 ' HA ' HD13 ' B' ' 216' ' ' ILE . 49.7 t -84.66 97.85 0.55 Allowed Pre-proline 0 N--CA 1.478 0.943 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.563 ' HD2' HD23 ' B' ' 220' ' ' LEU . 27.4 Cg_endo -57.57 -25.57 67.82 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 123.332 2.688 . . . . 0.0 113.563 -171.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.59 -52.39 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 O-C-N 123.692 0.62 . . . . 0.0 111.275 -172.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.2 p -107.41 -4.01 18.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.53 45.82 35.04 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 115.18 0.832 . . . . 0.0 115.18 169.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 34.5 m -119.82 139.44 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.536 0.734 . . . . 0.0 110.677 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -89.28 115.83 27.05 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.458 HD11 ' HB2' ' B' ' 204' ' ' CYS . 12.3 pt -145.14 156.16 54.59 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.939 1.296 . . . . 0.0 109.815 -171.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.95 165.45 23.74 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.852 2.368 . . . . 0.0 113.946 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.587 ' O ' HG23 ' B' ' 216' ' ' ILE . 32.9 tt0 -56.79 -47.02 81.14 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 126.376 1.87 . . . . 0.0 114.318 -167.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 14.6 m -69.9 -37.87 76.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.13 -0.981 . . . . 0.0 110.391 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -67.16 -31.43 71.85 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.949 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.587 HG23 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -69.66 -46.46 75.0 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -176.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.47 -43.43 98.87 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.55 0.531 . . . . 0.0 110.73 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -59.91 -51.58 69.09 Favored 'General case' 0 C--O 1.253 1.245 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.487 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . 0.4 ' O ' ' SG ' ' B' ' 223' ' ' CYS . 0.2 OUTLIER -57.19 -41.7 79.84 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.864 -175.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.563 HD23 ' HD2' ' B' ' 205' ' ' PRO . 96.7 mt -58.92 -53.86 53.62 Favored 'General case' 0 C--O 1.202 -1.398 0 O-C-N 124.399 1.062 . . . . 0.0 111.075 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.52 -30.18 60.22 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.767 1.292 . . . . 0.0 111.43 -171.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.8 t -83.44 -45.02 14.13 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.317 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' B' ' 219' ' ' HIS . 88.0 m -68.94 -29.02 67.17 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.63 1.172 . . . . 0.0 112.642 -173.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' A' ' 49' ' ' GLN . 4.2 pp . . . . . 0 N--CA 1.483 1.185 0 C-N-CA 123.6 0.76 . . . . 0.0 109.936 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -120.5 142.95 48.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.737 0.415 . . . . 0.0 110.744 176.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 155.15 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.702 1.201 . . . . 0.0 109.385 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 66' ' ' THR . 92.2 m-85 -112.99 108.45 17.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.694 0.797 . . . . 0.0 109.648 -174.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 69' ' ' LEU . 69.6 t -105.86 119.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -106.87 125.66 51.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.806 0.842 . . . . 0.0 110.281 -171.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.664 HG21 HD12 ' A' ' 69' ' ' LEU . 77.2 p -76.45 168.61 19.77 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.367 0.531 . . . . 0.0 111.793 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.5 mt -70.62 -22.93 62.47 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.256 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -80.18 -5.6 56.35 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.277 0.631 . . . . 0.0 111.056 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.78 20.65 46.33 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.352 -0.385 . . . . 0.0 113.999 167.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.14 153.21 18.23 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.5 m -104.11 134.37 47.49 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.239 0.616 . . . . 0.0 110.791 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.411 HD12 HG23 ' A' ' 7' ' ' THR . 5.3 mp -118.61 109.59 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.326 1.05 . . . . 0.0 108.44 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.0 m -91.21 119.26 31.15 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.136 0.575 . . . . 0.0 109.494 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.9 mm? -104.98 155.73 18.68 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.446 0.698 . . . . 0.0 109.631 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -121.9 72.55 1.03 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.957 0.903 . . . . 0.0 108.695 -174.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.798 HG22 HG22 ' A' ' 26' ' ' VAL . 31.3 m -138.57 -176.23 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.945 0.898 . . . . 0.0 109.382 -174.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -108.43 158.03 34.93 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 122.966 0.506 . . . . 0.0 110.592 -172.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 38.0 Cg_endo -63.18 -28.15 73.19 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.504 2.136 . . . . 0.0 111.925 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 t -109.14 25.21 12.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.508 0.723 . . . . 0.0 109.633 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.02 -99.71 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.267 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.473 ' O ' HG21 ' A' ' 26' ' ' VAL . 10.1 t 173.55 140.44 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.275 1.43 . . . . 0.0 108.812 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mm -58.67 -37.43 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.583 1.153 . . . . 0.0 111.984 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 43.5 tt0 -58.32 -38.22 76.68 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.508 0.723 . . . . 0.0 111.062 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.508 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 9.7 t30 -74.06 -41.92 61.0 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.043 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.798 HG22 HG22 ' A' ' 17' ' ' VAL . 48.5 t -58.74 -45.71 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 124.231 0.957 . . . . 0.0 110.623 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HA ' HD13 ' A' ' 30' ' ' ILE . 18.4 ptpt -73.92 -27.49 61.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.271 0.628 . . . . 0.0 111.602 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.94 79.16 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.397 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 67.9 mmtt -74.12 -27.52 60.9 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.753 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 27' ' ' LYS . 91.9 mt -67.0 -36.09 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 120.999 0.428 . . . . 0.0 110.028 175.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -65.39 -33.62 76.38 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.657 169.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.44 -23.01 62.65 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.435 0.694 . . . . 0.0 111.581 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 73.0 mmtt -98.66 -67.66 0.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.92 0.327 . . . . 0.0 110.984 -177.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.09 -24.37 30.38 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.03 7.82 55.95 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 120.013 -0.326 . . . . 0.0 113.846 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.22 124.92 43.28 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.442 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 73.3 Cg_endo -68.33 154.7 71.48 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.232 2.621 . . . . 0.0 112.773 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.42 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 13.7 Cg_endo -53.99 -15.66 7.8 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.961 3.107 . . . . 0.0 114.134 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.45 -41.96 37.79 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.852 0.861 . . . . 0.0 110.702 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -92.43 -19.02 22.47 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.91 0.884 . . . . 0.0 113.071 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.491 HE22 HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -103.14 149.73 24.34 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 173.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.484 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 38.5 ttt180 -134.68 129.99 35.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.26 0.624 . . . . 0.0 109.723 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.491 HD21 HE22 ' A' ' 41' ' ' GLN . 4.6 mm? -95.48 123.66 39.13 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.583 0.753 . . . . 0.0 110.549 -172.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.6 mt -141.93 124.71 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.672 0.789 . . . . 0.0 109.873 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.534 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 87.0 t80 -124.79 123.01 39.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.332 1.053 . . . . 0.0 108.191 175.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.422 ' HB1' ' HE3' ' A' ' 48' ' ' LYS . . . 60.02 25.92 15.19 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.837 0.855 . . . . 0.0 112.461 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.36 -21.5 45.16 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 122.956 0.313 . . . . 0.0 113.671 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 5.1 ptpt -91.11 134.47 34.49 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 117.362 0.581 . . . . 0.0 109.603 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.7 139.65 39.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 43' ' ' LEU . 24.3 mt -92.07 121.77 33.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.945 0.498 . . . . 0.0 110.96 -171.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.24 138.02 38.41 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.471 1.108 . . . . 0.0 109.973 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.0 m-20 -61.59 -42.49 98.94 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.3 1.04 . . . . 0.0 112.042 -172.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.84 -25.55 75.16 Favored Glycine 0 C--N 1.343 0.941 0 O-C-N 124.184 0.927 . . . . 0.0 113.467 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -78.86 177.24 8.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.997 0.519 . . . . 0.0 111.973 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.5 p -114.68 167.11 11.04 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.979 0.912 . . . . 0.0 110.228 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -55.58 -56.23 22.77 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.704 0.628 . . . . 0.0 110.518 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 31.1 t -65.48 -18.35 65.25 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.981 0.912 . . . . 0.0 112.013 -174.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.0 -46.01 83.21 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.485 0.66 . . . . 0.0 109.34 173.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -86.21 18.66 3.02 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.094 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.6 OUTLIER 70.54 18.61 6.46 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.422 1.089 . . . . 0.0 111.802 176.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.4 mt -92.57 110.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -98.71 -174.7 2.86 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -65.14 135.59 55.68 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.95 0.405 . . . . 0.0 110.514 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 68.75 17.21 8.87 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.241 1.416 . . . . 0.0 111.811 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -72.27 139.08 47.88 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 168.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 41.1 m -101.36 128.38 47.56 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.529 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -133.48 168.09 19.26 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.27 1.028 . . . . 0.0 109.044 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -93.87 153.02 18.48 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.496 0.718 . . . . 0.0 111.406 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.664 HD12 HG21 ' A' ' 7' ' ' THR . 2.4 tm? -134.21 129.45 35.75 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.555 HG21 HD13 ' B' ' 220' ' ' LEU . 95.4 t -112.09 117.56 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 123.424 0.69 . . . . 0.0 109.76 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.94 150.88 28.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.332 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -121.62 -49.86 2.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.816 0.847 . . . . 0.0 109.599 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.49 1.525 0 C-N-CA 124.664 1.185 . . . . 0.0 112.017 -177.115 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 9.7 m -140.74 -176.73 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.063 1.345 . . . . 0.0 108.858 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -120.21 147.03 45.46 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.652 0.381 . . . . 0.0 110.244 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.572 ' HA ' HD13 ' B' ' 216' ' ' ILE . 43.5 t -86.87 101.34 2.05 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.995 0.918 . . . . 0.0 109.087 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.495 ' HD2' HD21 ' B' ' 220' ' ' LEU . 96.6 Cg_endo -72.13 11.4 0.74 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.834 2.356 . . . . 0.0 115.126 -166.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 19.5 t -103.54 -52.78 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.562 0.745 . . . . 0.0 110.24 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.9 p -106.87 -6.3 17.74 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.126 0.57 . . . . 0.0 111.628 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 59.79 59.19 10.95 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 124.467 1.032 . . . . 0.0 115.405 176.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.89 134.78 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.228 0.611 . . . . 0.0 110.007 173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -76.87 120.49 22.07 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.531 HD13 ' HB2' ' B' ' 204' ' ' CYS . 5.4 pt -148.97 162.15 30.17 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 125.443 1.497 . . . . 0.0 109.112 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -65.85 161.19 40.36 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.545 2.164 . . . . 0.0 112.184 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.49 ' O ' HG23 ' B' ' 216' ' ' ILE . 41.2 tt0 -65.47 -28.23 69.06 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.268 1.027 . . . . 0.0 112.063 -174.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 39.5 t -67.88 -46.36 71.91 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.381 0.61 . . . . 0.0 110.38 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -80.87 -14.44 58.02 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.643 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.9 -42.94 53.37 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -58.2 7.47 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 124.134 0.896 . . . . 0.0 109.111 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -57.69 -44.73 86.04 Favored 'General case' 0 C--O 1.255 1.364 0 O-C-N 124.456 1.098 . . . . 0.0 111.069 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -39.4 83.47 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.388 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 70' ' ' VAL . 88.9 mt -69.8 -36.45 75.7 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 124.029 0.831 . . . . 0.0 111.72 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -57.02 -33.64 67.37 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.799 0.687 . . . . 0.0 110.513 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.8 t -86.28 -38.05 17.93 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.402 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 65.4 m -81.33 -19.63 42.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.82 0.848 . . . . 0.0 112.986 -169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.487 1.404 0 C-N-CA 122.598 0.359 . . . . 0.0 110.564 -178.56 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.973 0.415 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.5 mp0 -109.65 144.35 38.13 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.649 0.78 . . . . 0.0 109.856 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.48 149.61 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.881 0.873 . . . . 0.0 109.154 169.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 66' ' ' THR . 64.4 m-85 -106.25 100.16 9.71 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.24 -173.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 69' ' ' LEU . 79.0 t -97.2 114.69 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -101.11 122.16 43.1 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.55 1.14 . . . . 0.0 110.337 -172.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.65 HG23 HD13 ' A' ' 69' ' ' LEU . 51.5 p -71.07 162.47 29.37 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.669 0.668 . . . . 0.0 111.069 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.506 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 84.1 mt -70.73 -20.24 62.67 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.047 171.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -80.34 -5.4 56.29 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.504 0.722 . . . . 0.0 111.206 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.47 15.28 51.1 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 114.457 0.543 . . . . 0.0 114.457 166.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HZ3' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -95.32 152.22 18.58 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.4 m -100.6 141.45 33.45 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.469 HD11 HG22 ' A' ' 7' ' ' THR . 5.4 mp -123.31 116.34 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.309 1.043 . . . . 0.0 108.297 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -101.38 117.16 34.4 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.518 0.727 . . . . 0.0 109.594 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -104.62 151.47 23.62 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.665 0.786 . . . . 0.0 109.515 -175.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -108.94 76.95 1.04 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 124.095 0.872 . . . . 0.0 109.338 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.684 HG22 HG21 ' A' ' 26' ' ' VAL . 3.6 m -140.7 170.38 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -91.8 157.88 40.88 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.491 0.716 . . . . 0.0 109.185 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 25.1 Cg_endo -61.24 -29.37 86.36 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.539 1.493 . . . . 0.0 111.206 168.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 t -99.28 19.86 14.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.731 0.812 . . . . 0.0 110.583 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.73 -94.74 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.2 t 177.05 143.87 0.09 Allowed 'General case' 0 C--N 1.364 1.238 0 C-N-CA 124.889 1.276 . . . . 0.0 109.734 173.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -61.62 -38.01 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.539 1.136 . . . . 0.0 111.298 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -52.92 -40.45 63.59 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.968 0.907 . . . . 0.0 111.013 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.437 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.2 t-20 -72.72 -44.71 61.35 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.116 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.684 HG21 HG22 ' A' ' 17' ' ' VAL . 53.1 t -54.91 -47.68 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 124.479 1.112 . . . . 0.0 111.086 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -69.88 -34.06 73.05 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 122.879 0.472 . . . . 0.0 111.552 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -25.1 65.2 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.888 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 8.8 mmpt? -77.69 -32.35 52.97 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.58 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.468 HG13 HG23 ' A' ' 13' ' ' ILE . 1.9 mp -57.01 -43.13 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 119.078 0.854 . . . . 0.0 109.967 169.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -62.42 -30.67 71.39 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.635 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -73.76 -29.61 62.31 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.582 0.753 . . . . 0.0 111.833 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 69.8 mmtt -95.23 -67.98 0.82 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.38 -23.87 32.25 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.248 0.219 . . . . 0.0 110.923 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.6 40.8 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.195 174.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.53 125.08 35.02 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 72.5 Cg_endo -70.4 158.39 56.25 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.205 2.603 . . . . 0.0 112.698 -173.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.0 -16.27 20.16 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 123.804 3.003 . . . . 0.0 114.052 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.44 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 23.0 t70 -74.46 -28.07 60.87 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.874 0.87 . . . . 0.0 110.797 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -108.13 -17.59 13.99 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.823 1.249 . . . . 0.0 113.244 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.432 ' HB2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -110.56 155.6 22.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.019 0.528 . . . . 0.0 110.218 176.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.49 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 41.7 ttt180 -139.54 125.0 19.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.94 0.496 . . . . 0.0 110.234 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.69 124.24 37.55 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.517 0.727 . . . . 0.0 110.032 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -142.45 130.56 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.152 0.981 . . . . 0.0 109.526 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.518 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 89.8 t80 -128.56 135.37 49.28 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 171.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.447 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 66.62 16.7 10.47 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.18 0.992 . . . . 0.0 112.378 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.23 21.82 58.09 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.234 0.334 . . . . 0.0 113.846 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 11.4 ptpt -130.8 145.27 51.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.29 0.636 . . . . 0.0 109.352 174.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -74.58 140.13 44.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.815 0.446 . . . . 0.0 110.104 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.4 mt -91.6 125.05 36.19 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.205 0.602 . . . . 0.0 110.647 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.41 138.46 32.83 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.826 0.85 . . . . 0.0 110.309 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.65 -46.56 84.05 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.653 1.181 . . . . 0.0 112.387 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.7 -26.41 72.04 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 124.142 0.902 . . . . 0.0 113.641 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 55.9 mtt180 -77.54 177.09 8.32 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.303 0.641 . . . . 0.0 111.582 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.7 p -116.1 169.07 9.55 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.652 0.781 . . . . 0.0 109.777 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.0 mt -55.99 -53.07 61.36 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.698 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 t -61.34 -24.89 66.78 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.567 1.147 . . . . 0.0 111.648 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 12.4 t70 -65.7 -41.83 91.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -91.47 20.77 5.03 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.812 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 72.6 8.01 5.61 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 124.745 1.218 . . . . 0.0 112.789 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 10.6 mt -84.61 116.91 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -106.48 -172.15 2.03 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -58.71 146.95 34.73 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.105 0.479 . . . . 0.0 110.557 172.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 62.9 5.57 1.86 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.636 1.574 . . . . 0.0 113.711 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.6 m -70.6 143.71 51.43 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 118.664 0.665 . . . . 0.0 111.198 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 27.2 m -108.54 134.3 51.49 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.15 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.509 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -144.77 173.13 12.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.988 1.315 . . . . 0.0 108.536 -176.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -102.97 153.43 20.23 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.701 0.762 . . . . 0.0 112.677 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.65 HD13 HG23 ' A' ' 7' ' ' THR . 2.3 tm? -130.52 126.07 35.9 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.495 HG22 HD11 ' A' ' 8' ' ' LEU . 73.8 t -110.79 124.61 67.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 123.275 0.63 . . . . 0.0 109.742 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -85.42 147.13 26.64 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.681 0.792 . . . . 0.0 110.355 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.44 ' HD2' ' O ' ' A' ' 39' ' ' ASP . 40.1 mtt180 -122.33 -44.18 2.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.703 0.801 . . . . 0.0 110.451 -173.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.487 1.423 0 C-N-CA 124.733 1.213 . . . . 0.0 112.081 -179.273 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 3.4 m -140.58 151.58 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.144 1.378 . . . . 0.0 110.047 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' B' ' 210' ' ' ASN . 4.8 m-20 -78.89 147.19 33.19 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.731 -175.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.568 ' HA ' HD13 ' B' ' 216' ' ' ILE . 24.8 t -89.77 98.33 1.3 Allowed Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.522 ' HD2' HD13 ' B' ' 220' ' ' LEU . 74.1 Cg_endo -68.45 9.01 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.521 2.814 . . . . 0.0 115.887 -163.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 29.9 t -104.61 -48.62 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 122.833 0.453 . . . . 0.0 110.654 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . 0.491 ' SG ' HG21 ' B' ' 209' ' ' VAL . 18.0 p -107.48 -7.95 16.4 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.901 0.48 . . . . 0.0 112.185 -173.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.63 41.55 64.66 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . 0.491 HG21 ' SG ' ' B' ' 207' ' ' CYS . 27.9 m -118.62 132.83 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 117.647 0.724 . . . . 0.0 110.072 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' B' ' 203' ' ' ASP . 25.3 t-20 -86.23 126.49 34.31 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 4.9 pt -148.92 159.45 37.54 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 125.865 1.666 . . . . 0.0 108.991 -169.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' B' ' 215' ' ' HIS . 17.8 Cg_endo -58.74 156.25 33.48 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.41 2.073 . . . . 0.0 111.964 174.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.521 ' O ' HG21 ' B' ' 216' ' ' ILE . 26.7 tt0 -66.32 -30.21 70.57 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.02 0.928 . . . . 0.0 112.033 -170.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 51.2 p -63.92 -49.98 70.51 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.581 0.705 . . . . 0.0 109.558 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . 0.491 ' HB2' ' HG2' ' B' ' 212' ' ' PRO . 47.1 m80 -76.11 -12.2 60.07 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.871 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -72.85 -51.6 26.45 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.274 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -63.87 -31.23 72.34 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.181 0.446 . . . . 0.0 111.727 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -66.13 -63.58 1.05 Allowed 'General case' 0 C--O 1.251 1.178 0 O-C-N 123.885 0.741 . . . . 0.0 111.556 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -43.27 69.79 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.319 1.048 . . . . 0.0 109.863 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.522 HD13 ' HD2' ' B' ' 205' ' ' PRO . 30.7 tp -63.31 -46.04 88.54 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 113.654 -1.612 . . . . 0.0 111.808 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.17 -35.28 64.63 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 124.316 1.01 . . . . 0.0 110.358 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.3 t -79.77 -38.31 33.46 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.995 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 93.9 m -74.24 -35.11 63.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.448 1.099 . . . . 0.0 112.633 -172.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . 0.409 HD23 ' HG ' ' B' ' 220' ' ' LEU . 4.0 pp . . . . . 0 N--CA 1.49 1.557 0 C-N-CA 123.559 0.743 . . . . 0.0 111.846 -168.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.85 0.357 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.531 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 17.4 mp0 -90.12 134.43 34.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.929 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.477 HD13 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -130.53 157.96 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.126 1.37 . . . . 0.0 108.586 172.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 66' ' ' THR . 72.8 m-85 -116.55 120.5 38.91 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.305 0.642 . . . . 0.0 109.783 -173.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.559 HG21 HD13 ' A' ' 30' ' ' ILE . 68.9 t -109.9 130.89 62.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -118.16 117.02 28.01 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.551 HG22 HD11 ' A' ' 69' ' ' LEU . 43.5 p -70.15 165.68 21.53 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.286 0.565 . . . . 0.0 111.697 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.412 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 57.5 mt -68.92 -22.0 64.18 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.005 173.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.0 p -79.64 -15.89 56.78 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.387 0.675 . . . . 0.0 110.782 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.96 21.21 16.31 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.539 -0.59 . . . . 0.0 114.476 170.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.618 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.39 153.71 17.83 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.496 0.648 . . . . 0.0 109.599 174.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.9 m -100.53 144.22 29.77 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.324 0.65 . . . . 0.0 109.869 172.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.517 HD13 HG21 ' A' ' 7' ' ' THR . 5.3 mp -128.79 114.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.808 1.243 . . . . 0.0 108.408 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.1 m -99.58 121.85 41.79 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.504 0.722 . . . . 0.0 110.119 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -112.21 153.16 27.5 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -116.43 76.9 1.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.657 HG23 HG21 ' A' ' 26' ' ' VAL . 20.5 m -140.04 177.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.375 0.67 . . . . 0.0 110.386 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -91.99 157.08 41.74 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 123.642 0.777 . . . . 0.0 109.75 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.466 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 24.3 Cg_endo -61.95 -34.68 80.6 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.536 1.491 . . . . 0.0 110.836 165.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -94.13 13.88 21.76 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.1 0.56 . . . . 0.0 110.67 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.42 -96.15 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.393 0.677 . . . . 0.0 110.867 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.1 t 169.52 138.26 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.6 1.56 . . . . 0.0 108.307 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.15 -34.33 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.759 0.824 . . . . 0.0 110.956 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 16.8 tp10 -60.25 -35.42 75.44 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.557 0.694 . . . . 0.0 111.399 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 12.2 t30 -76.47 -44.04 37.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.923 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.657 HG21 HG23 ' A' ' 17' ' ' VAL . 62.6 t -57.0 -43.88 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 124.316 1.01 . . . . 0.0 110.488 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HB2' ' OE1' ' A' ' 41' ' ' GLN . 17.6 ptpt -71.08 -33.89 70.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.261 0.624 . . . . 0.0 110.576 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.63 -31.77 73.04 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.848 171.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 9.7 mmpt? -72.62 -35.49 67.84 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 5' ' ' VAL . 1.8 mp -55.65 -43.64 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.486 0.585 . . . . 0.0 110.167 171.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -65.48 -29.26 69.9 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.317 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.1 -25.92 62.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.169 0.588 . . . . 0.0 111.234 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 68.5 mmtt -99.28 -69.03 0.78 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.733 0.242 . . . . 0.0 111.168 -175.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -85.18 -21.2 29.27 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.73 14.1 51.05 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 114.298 0.479 . . . . 0.0 114.298 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.1 127.71 32.69 Favored Pre-proline 0 N--CA 1.481 1.113 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.29 154.27 72.51 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.06 2.507 . . . . 0.0 112.976 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 15.6 Cg_endo -54.64 -14.84 8.09 Favored 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 124.295 3.33 . . . . 0.0 114.94 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -72.36 -48.53 41.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.962 0.505 . . . . 0.0 110.309 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.82 -22.7 23.1 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.968 0.907 . . . . 0.0 113.109 -171.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.634 HE21 HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -101.21 124.64 47.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.813 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 34.1 ttt180 -112.91 130.27 56.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.177 0.991 . . . . 0.0 108.826 -172.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.03 119.0 32.8 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.44 0.696 . . . . 0.0 110.533 -170.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.7 mt -140.95 127.73 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.562 0.745 . . . . 0.0 109.796 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.671 ' HB3' HD21 ' A' ' 50' ' ' LEU . 75.6 t80 -129.23 126.01 38.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.76 1.224 . . . . 0.0 108.448 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.417 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . . . 61.8 18.45 9.73 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.107 0.963 . . . . 0.0 113.343 173.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.5 5.14 56.99 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.914 -0.381 . . . . 0.0 113.821 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.0 ptpt -118.02 146.98 43.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.367 0.667 . . . . 0.0 109.396 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -80.51 140.61 35.78 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.945 0.498 . . . . 0.0 109.98 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 45' ' ' PHE . 23.5 mt -94.96 114.93 26.82 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 122.931 0.493 . . . . 0.0 110.825 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -77.82 139.07 39.27 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.684 0.793 . . . . 0.0 110.199 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 11.2 p-10 -58.84 -39.54 81.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.522 1.129 . . . . 0.0 112.448 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.25 -18.25 80.06 Favored Glycine 0 C--N 1.354 1.536 0 O-C-N 124.126 0.891 . . . . 0.0 113.351 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.424 ' HD3' ' OD2' ' A' ' 58' ' ' ASP . 99.6 mtt180 -86.13 177.11 7.64 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.46 0.704 . . . . 0.0 111.275 175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 p -116.19 168.44 10.11 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 123.864 0.865 . . . . 0.0 109.668 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 89.4 mt -56.23 -49.87 72.91 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 124.195 0.934 . . . . 0.0 109.65 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 35.7 t -63.67 -26.14 68.53 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.541 1.137 . . . . 0.0 111.548 -175.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD2' ' HD3' ' A' ' 54' ' ' ARG . 20.2 t70 -65.18 -41.61 94.42 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 121.544 0.688 . . . . 0.0 109.637 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -89.87 15.07 10.49 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.944 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 71.37 14.85 6.38 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.072 1.349 . . . . 0.0 112.399 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 8.8 mt -86.52 121.68 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -115.01 -172.53 2.14 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -57.44 143.56 39.88 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.293 0.37 . . . . 0.0 110.815 172.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 72.25 1.11 3.82 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.295 1.438 . . . . 0.0 112.31 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -75.62 135.57 40.48 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 118.09 0.404 . . . . 0.0 110.223 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.4 m -99.9 131.23 46.0 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.117 0.484 . . . . 0.0 110.603 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.507 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -124.57 175.7 7.0 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.866 1.266 . . . . 0.0 108.667 174.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -108.68 153.09 23.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.349 0.66 . . . . 0.0 111.423 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.634 HD23 HE21 ' A' ' 41' ' ' GLN . 2.1 tm? -131.21 126.25 35.07 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -175.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.813 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.4 t -105.28 109.2 26.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.802 0.841 . . . . 0.0 109.828 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -81.63 138.96 35.25 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.305 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -113.07 -47.48 3.03 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.898 0.879 . . . . 0.0 110.676 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.492 1.66 0 C-N-CA 123.939 0.896 . . . . 0.0 112.131 -178.176 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.628 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . 0.529 HG22 HG13 ' B' ' 216' ' ' ILE . 0.9 OUTLIER -147.61 146.18 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.033 0.933 . . . . 0.0 111.036 -162.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -74.2 147.73 42.26 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.383 0.673 . . . . 0.0 111.492 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.471 ' HA ' HD12 ' B' ' 216' ' ' ILE . 20.0 t -91.7 97.59 1.51 Allowed Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.166 0.986 . . . . 0.0 108.902 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.406 ' HD2' HD12 ' B' ' 220' ' ' LEU . 32.3 Cg_endo -58.52 -5.45 2.41 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.679 2.919 . . . . 0.0 116.364 -166.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . 0.413 HG11 ' O ' ' B' ' 223' ' ' CYS . 41.0 t -94.67 -57.48 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 173.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . 0.484 ' SG ' HG21 ' B' ' 209' ' ' VAL . 11.7 p -106.12 9.45 32.31 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.56 -37.55 2.78 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.865 1.106 . . . . 0.0 115.865 171.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . 0.484 HG21 ' SG ' ' B' ' 207' ' ' CYS . 20.6 m -60.2 134.73 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -165.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -84.7 125.35 32.44 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.695 HG13 HG12 ' B' ' 216' ' ' ILE . 5.2 pt -148.56 156.08 41.98 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.464 1.506 . . . . 0.0 109.166 -171.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.04 151.55 77.61 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.698 2.266 . . . . 0.0 112.196 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.423 ' HA ' ' HB ' ' B' ' 216' ' ' ILE . 3.9 tm-20 -58.53 -43.65 89.3 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -166.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 27.1 t -65.71 -36.75 84.5 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.583 -0.698 . . . . 0.0 110.381 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -82.43 -11.47 58.51 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.107 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.695 HG12 HG13 ' B' ' 211' ' ' ILE . 0.4 OUTLIER -68.8 -45.94 80.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 172.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -74.21 -30.36 62.16 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.519 0.512 . . . . 0.0 111.974 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -68.4 -50.72 50.87 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.31 0.381 . . . . 0.0 110.888 172.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.13 -45.37 83.56 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.08 0.552 . . . . 0.0 109.543 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.529 HD13 HG22 ' A' ' 70' ' ' VAL . 60.7 mt -68.96 -34.36 75.21 Favored 'General case' 0 C--O 1.209 -1.078 0 O-C-N 124.528 1.142 . . . . 0.0 112.439 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.57 -31.23 65.94 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.907 0.754 . . . . 0.0 109.882 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 t -91.33 -36.24 13.97 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.782 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . 0.509 ' HB2' ' HA ' ' B' ' 220' ' ' LEU . 84.9 m -75.01 -28.25 60.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.675 0.79 . . . . 0.0 112.271 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 123.042 0.537 . . . . 0.0 110.903 -176.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 20.7 mp0 -98.48 136.74 38.17 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.723 0.409 . . . . 0.0 110.713 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.4 155.94 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.678 1.191 . . . . 0.0 108.568 173.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 66' ' ' THR . 90.2 m-85 -113.53 99.66 7.92 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.277 -170.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 69' ' ' LEU . 93.6 t -99.45 100.01 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -94.65 123.49 38.12 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.899 0.88 . . . . 0.0 110.737 -171.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.721 HG21 HD11 ' A' ' 69' ' ' LEU . 39.5 p -70.59 166.94 19.58 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.715 0.769 . . . . 0.0 111.922 176.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.13 -19.64 65.65 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.721 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -79.59 -3.85 48.88 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.569 0.747 . . . . 0.0 111.309 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.15 5.78 67.37 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.054 0.359 . . . . 0.0 112.378 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -90.4 137.83 32.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.206 1.003 . . . . 0.0 109.621 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.7 m -107.05 129.1 54.86 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.252 0.621 . . . . 0.0 110.369 -176.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -108.06 113.27 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.024 0.93 . . . . 0.0 109.327 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 m -87.45 117.0 25.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.723 0.809 . . . . 0.0 109.123 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.8 mm? -104.54 160.24 15.1 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.655 0.782 . . . . 0.0 109.022 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.07 80.99 1.99 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.858 0.863 . . . . 0.0 108.795 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.74 HG23 HG21 ' A' ' 26' ' ' VAL . 3.1 m -138.19 175.52 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.612 1.165 . . . . 0.0 108.657 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 12.9 mt-10 -92.28 140.71 24.41 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.452 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 9.7 Cg_endo -55.57 -29.1 68.34 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.857 2.372 . . . . 0.0 112.038 167.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -92.92 4.19 54.37 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.85 0.86 . . . . 0.0 110.797 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 22.6 t70 -82.27 -87.52 0.09 Allowed 'General case' 0 C--N 1.358 0.955 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.275 -174.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' VAL . 10.0 t 179.02 149.98 0.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.75 0.82 . . . . 0.0 110.956 176.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.28 -34.0 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.754 1.222 . . . . 0.0 110.685 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.506 ' HG2' ' HB2' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -58.49 -38.46 77.67 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.068 0.947 . . . . 0.0 109.821 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.509 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.6 t30 -71.66 -44.76 63.73 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.078 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.74 HG21 HG23 ' A' ' 17' ' ' VAL . 61.4 t -55.06 -48.17 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 124.437 1.085 . . . . 0.0 110.825 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -69.1 -31.83 70.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.298 0.639 . . . . 0.0 111.429 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.61 74.38 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.797 0.685 . . . . 0.0 111.141 170.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 65.3 mmtt -78.09 -31.57 50.19 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.932 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -58.85 -44.08 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.351 0.978 . . . . 0.0 109.291 170.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.75 -31.28 72.19 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.539 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 8.6 t70 -71.54 -35.21 70.59 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.639 0.776 . . . . 0.0 111.564 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.4 mmtt -88.72 -67.02 0.86 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.575 0.35 . . . . 0.0 110.968 -171.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -88.06 -22.33 24.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.301 0.24 . . . . 0.0 111.512 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.96 12.38 46.64 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.993 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -98.62 122.19 54.06 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -69.82 155.86 64.67 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.524 2.816 . . . . 0.0 113.059 -172.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.94 -13.1 10.8 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 124.482 3.455 . . . . 0.0 114.621 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.21 -47.33 14.81 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -77.64 -27.99 51.18 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.304 0.641 . . . . 0.0 111.286 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.46 HE22 HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -96.65 147.68 23.64 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.648 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 42.9 ttt180 -137.66 129.25 28.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.46 HD22 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -92.2 125.73 36.99 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -173.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.403 HD12 ' HG ' ' B' ' 220' ' ' LEU . 97.6 mt -142.78 131.54 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.911 0.884 . . . . 0.0 110.071 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.538 ' HB3' HD23 ' A' ' 50' ' ' LEU . 86.0 t80 -135.81 128.36 30.63 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.499 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . . . 65.45 21.3 11.84 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.834 0.854 . . . . 0.0 111.938 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.56 2.33 82.34 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.448 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 9.9 ptpt -108.99 142.16 40.05 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -76.86 126.47 31.04 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.028 0.531 . . . . 0.0 110.081 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 45' ' ' PHE . 17.7 mt -77.83 119.6 21.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.173 0.589 . . . . 0.0 110.352 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.0 138.37 42.18 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.742 0.651 . . . . 0.0 109.562 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.506 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 10.4 p-10 -61.1 -40.03 92.19 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 124.126 0.891 . . . . 0.0 112.037 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.57 -27.24 73.94 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.624 0.578 . . . . 0.0 113.374 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -77.48 176.77 8.58 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.214 0.606 . . . . 0.0 111.919 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.5 p -110.07 167.22 10.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.437 0.695 . . . . 0.0 109.765 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 81.4 mt -58.3 -51.46 69.69 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 56.2 m -59.6 -25.98 65.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.932 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.53 -34.25 73.98 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.074 0.464 . . . . 0.0 110.044 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -92.6 15.94 13.21 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.754 0.822 . . . . 0.0 111.768 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 66.67 30.04 8.43 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.239 1.016 . . . . 0.0 111.639 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -101.16 118.01 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -102.89 -175.99 2.96 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -58.18 141.5 50.33 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.125 171.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 72.49 0.34 3.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.509 1.523 . . . . 0.0 112.669 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.8 m -73.46 137.35 44.47 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 118.236 0.471 . . . . 0.0 110.705 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 15.0 m -95.53 137.04 35.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.875 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.73 174.54 10.41 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.945 1.298 . . . . 0.0 108.454 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -101.76 158.56 16.02 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.849 0.833 . . . . 0.0 112.185 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.721 HD11 HG21 ' A' ' 7' ' ' THR . 2.7 tm? -138.35 125.82 21.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.215 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 91.0 t -99.93 120.61 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 123.301 0.64 . . . . 0.0 110.224 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.436 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 93.0 mt -89.29 140.41 29.52 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.349 1.031 . . . . 0.0 109.883 174.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -119.14 -28.34 5.49 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.002 0.921 . . . . 0.0 111.476 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' ' 71' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.496 1.829 0 C-N-CA 125.657 1.583 . . . . 0.0 113.978 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.8 m -138.01 172.08 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 125.505 1.522 . . . . 0.0 108.441 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.47 146.52 31.64 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 122.373 -0.204 . . . . 0.0 110.624 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.547 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.9 t -83.7 105.72 6.17 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.711 0.805 . . . . 0.0 109.019 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.54 ' HD2' HD11 ' B' ' 220' ' ' LEU . 40.5 Cg_endo -63.12 -1.0 2.52 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 124.087 3.191 . . . . 0.0 115.401 -171.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.95 -51.08 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.377 0.671 . . . . 0.0 111.427 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.9 p -113.88 1.07 14.64 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.009 0.523 . . . . 0.0 111.8 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 56.28 55.3 30.21 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 124.48 1.038 . . . . 0.0 115.195 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.72 127.2 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.166 0.586 . . . . 0.0 109.512 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.96 110.47 15.37 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 8.6 pt -138.6 160.87 61.66 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 125.715 1.606 . . . . 0.0 109.721 -173.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.75 159.77 23.54 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.841 2.361 . . . . 0.0 113.124 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.496 ' O ' HG22 ' B' ' 216' ' ' ILE . 34.4 tt0 -63.14 -33.49 75.58 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.993 1.317 . . . . 0.0 112.686 -172.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.0 t -66.23 -46.35 77.47 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.508 0.67 . . . . 0.0 110.594 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.19 -13.0 57.8 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.891 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.47 -44.82 53.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 174.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -55.07 28.44 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 124.502 1.126 . . . . 0.0 109.152 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -61.62 -39.18 90.34 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 124.446 1.091 . . . . 0.0 112.145 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -36.26 80.05 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.297 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.54 HD11 ' HD2' ' B' ' 205' ' ' PRO . 0.0 OUTLIER -63.71 -50.44 69.13 Favored 'General case' 0 C--O 1.21 -1.009 0 O-C-N 123.789 0.681 . . . . 0.0 110.249 177.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -54.49 -27.33 37.12 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 123.924 0.765 . . . . 0.0 112.048 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.1 t -89.1 -39.77 13.39 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.589 0.756 . . . . 0.0 111.217 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.55 -18.96 43.12 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.393 1.077 . . . . 0.0 113.511 -171.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' B' ' 220' ' ' LEU . 4.4 pp . . . . . 0 N--CA 1.494 1.728 0 CA-C-N 118.625 0.648 . . . . 0.0 110.105 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 75.8 mt-30 -119.42 132.63 55.85 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.3 0.64 . . . . 0.0 110.78 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.539 HD13 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -128.24 156.4 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.133 1.373 . . . . 0.0 108.951 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 66' ' ' THR . 50.1 m-85 -115.2 112.2 22.13 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.401 0.619 . . . . 0.0 110.073 -173.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.7 t -104.06 120.88 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -111.11 125.11 53.42 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.554 0.741 . . . . 0.0 109.82 -173.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.65 HG23 HD12 ' A' ' 69' ' ' LEU . 66.7 p -78.33 168.81 19.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.303 0.573 . . . . 0.0 112.067 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.434 HD13 HG23 ' A' ' 70' ' ' VAL . 60.7 mt -67.32 -27.68 67.35 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.345 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -79.34 -9.4 59.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.651 0.78 . . . . 0.0 110.987 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.69 22.98 37.58 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 114.17 0.428 . . . . 0.0 114.17 168.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.544 ' HZ3' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.64 152.42 18.51 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.7 m -101.54 139.51 37.1 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.121 0.568 . . . . 0.0 109.994 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.87 105.59 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.443 1.097 . . . . 0.0 108.181 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.1 m -86.96 122.97 31.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -105.8 156.29 18.46 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -120.34 69.66 0.87 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.442 1.097 . . . . 0.0 109.023 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.737 HG23 HG22 ' A' ' 26' ' ' VAL . 7.1 m -136.95 175.05 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -90.96 149.8 40.77 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HB2' ' OG ' ' A' ' 57' ' ' SER . 12.1 Cg_endo -58.96 -31.71 96.14 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.62 1.546 . . . . 0.0 111.733 164.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 t -97.36 18.09 15.98 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.905 0.482 . . . . 0.0 110.548 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.73 -96.73 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.827 0.851 . . . . 0.0 109.975 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.497 ' O ' HG21 ' A' ' 26' ' ' VAL . 5.2 t 174.36 140.37 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.2 1.4 . . . . 0.0 109.244 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.92 -37.11 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.879 0.871 . . . . 0.0 111.486 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 35.5 tt0 -54.92 -40.54 69.97 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.805 0.812 . . . . 0.0 110.792 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 11.5 t30 -73.54 -43.32 60.19 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.417 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.737 HG22 HG23 ' A' ' 17' ' ' VAL . 60.5 t -55.95 -48.63 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 124.311 1.007 . . . . 0.0 110.6 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.7 ptpt -68.41 -33.66 74.62 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.014 0.526 . . . . 0.0 111.602 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.64 -33.65 70.3 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.98 170.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 34.7 mmtm -76.64 -31.01 57.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.436 -0.793 . . . . 0.0 112.464 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 27' ' ' LYS . 2.8 mp -60.49 -39.63 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 119.682 1.128 . . . . 0.0 109.129 170.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.64 -34.18 77.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.311 0.644 . . . . 0.0 111.207 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.05 -36.55 75.08 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.479 0.712 . . . . 0.0 111.5 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.6 mmtt -88.23 -65.7 0.99 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.83 0.452 . . . . 0.0 111.243 -170.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -84.18 -24.04 30.32 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.923 0.328 . . . . 0.0 111.272 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.0 17.84 31.18 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.173 0.295 . . . . 0.0 113.554 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.82 127.36 27.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.482 0.713 . . . . 0.0 109.36 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.403 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 58.8 Cg_endo -67.09 154.53 74.18 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.057 2.504 . . . . 0.0 112.697 -173.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 37.3 Cg_endo -61.14 -13.79 30.0 Favored 'Trans proline' 0 C--N 1.388 2.634 0 C-N-CA 123.666 2.911 . . . . 0.0 113.88 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.96 -32.18 51.3 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.742 0.817 . . . . 0.0 110.703 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -96.53 -18.33 19.88 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.855 1.262 . . . . 0.0 112.437 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.56 ' HB2' HD13 ' A' ' 69' ' ' LEU . 3.5 pp0? -118.96 133.57 55.74 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.165 0.507 . . . . 0.0 110.82 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.634 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 56.1 ttt180 -120.95 128.71 52.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.26 1.024 . . . . 0.0 109.788 -169.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.01 126.98 38.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.697 0.799 . . . . 0.0 109.656 -171.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.7 mt -142.15 132.03 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.292 0.637 . . . . 0.0 109.952 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.56 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 72.4 t80 -137.9 131.58 31.17 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 171.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.12 19.32 10.44 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.031 0.932 . . . . 0.0 112.013 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 6.53 79.57 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.975 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 13.8 ptpt -118.81 145.06 45.93 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.648 0.724 . . . . 0.0 109.998 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.521 ' HB2' HD23 ' B' ' 224' ' ' LEU . 0.4 OUTLIER -77.67 122.91 25.98 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -175.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 45' ' ' PHE . 27.6 mt -72.11 119.52 16.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.405 0.682 . . . . 0.0 111.187 -175.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -81.54 138.77 35.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.233 1.013 . . . . 0.0 110.288 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 1.7 m-20 -60.22 -43.05 96.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.472 1.109 . . . . 0.0 112.613 -173.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.02 -8.77 74.7 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 124.36 1.037 . . . . 0.0 114.112 -177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 86.0 mtt-85 -95.1 177.33 5.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.99 0.916 . . . . 0.0 111.416 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -114.82 170.65 8.17 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.044 0.938 . . . . 0.0 109.509 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.9 mt -60.28 -52.16 66.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 40.7 m -54.62 -29.47 52.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.189 1.396 . . . . 0.0 112.633 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 12.7 t70 -65.67 -43.57 88.9 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 123.759 0.662 . . . . 0.0 109.761 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -87.93 21.23 2.76 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.916 0.887 . . . . 0.0 111.395 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 70.93 13.57 7.0 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.503 1.121 . . . . 0.0 111.982 176.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 14.6 mt -88.18 118.23 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.695 0.798 . . . . 0.0 109.001 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -102.5 -174.94 2.68 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -58.2 140.52 52.88 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.192 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 70.09 7.45 6.23 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.919 1.288 . . . . 0.0 112.954 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -69.46 135.88 50.78 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 117.901 0.319 . . . . 0.0 110.649 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.5 m -93.99 125.65 38.74 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.432 0.693 . . . . 0.0 109.617 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.56 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -127.46 167.92 15.61 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.347 1.059 . . . . 0.0 109.393 177.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -94.63 150.48 20.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.49 0.662 . . . . 0.0 110.93 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.65 HD12 HG23 ' A' ' 7' ' ' THR . 2.4 tm? -133.85 126.68 31.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.65 HG21 HD11 ' B' ' 220' ' ' LEU . 69.8 t -101.9 109.07 25.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.441 0.697 . . . . 0.0 110.12 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.509 ' HB3' HD22 ' A' ' 73' ' ' LEU . 67.1 mt -80.73 144.9 31.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.241 173.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -121.08 -48.14 2.24 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.062 0.945 . . . . 0.0 109.249 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 71' ' ' LEU . 4.6 mm? . . . . . 0 N--CA 1.486 1.353 0 C-N-CA 124.678 1.191 . . . . 0.0 112.109 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.89 -176.29 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.919 1.288 . . . . 0.0 109.319 -170.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -113.07 144.26 42.92 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.787 0.435 . . . . 0.0 110.326 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.525 ' HA ' HD13 ' B' ' 216' ' ' ILE . 53.5 t -86.14 98.03 0.71 Allowed Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.496 ' HD2' HD23 ' B' ' 220' ' ' LEU . 20.7 Cg_endo -55.22 -24.67 42.8 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.122 2.548 . . . . 0.0 114.413 -164.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 10.8 t -74.48 -63.42 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 122.861 0.464 . . . . 0.0 110.608 -173.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 22.7 p -91.6 -9.76 42.95 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.025 0.53 . . . . 0.0 111.24 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.92 58.77 12.03 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 124.073 0.844 . . . . 0.0 114.203 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 33.2 m -118.98 135.66 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.586 0.754 . . . . 0.0 109.553 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -83.44 104.81 13.88 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.091 0.472 . . . . 0.0 110.095 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' B' ' 204' ' ' CYS . 15.9 pt -137.01 152.21 73.52 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 125.308 1.443 . . . . 0.0 110.057 -174.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.09 163.36 16.93 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.012 2.475 . . . . 0.0 113.339 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.582 ' O ' HG22 ' B' ' 216' ' ' ILE . 5.6 tm-20 -62.64 -39.93 95.42 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -167.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 52.3 m -65.53 -39.87 92.29 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.7 -1.25 . . . . 0.0 110.295 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . 0.411 ' O ' ' HB2' ' B' ' 219' ' ' HIS . 8.0 m80 -68.24 -28.14 66.96 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.815 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.582 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -69.09 -48.41 69.51 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -176.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -67.13 -37.66 84.24 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.472 0.482 . . . . 0.0 111.387 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -42.22 83.53 Favored 'General case' 0 C--O 1.255 1.366 0 O-C-N 123.533 0.521 . . . . 0.0 111.212 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' B' ' 215' ' ' HIS . 0.1 OUTLIER -59.93 -37.52 79.75 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.41 177.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.65 HD11 HG21 ' A' ' 70' ' ' VAL . 96.7 mt -63.03 -45.39 92.49 Favored 'General case' 0 C--O 1.206 -1.218 0 O-C-N 124.014 0.821 . . . . 0.0 110.935 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -56.53 -28.37 59.86 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.445 0.466 . . . . 0.0 111.516 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.8 t -89.21 -41.18 12.37 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.312 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.2 m -79.04 -28.21 43.21 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.959 0.904 . . . . 0.0 112.971 -167.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . 0.521 HD23 ' HB2' ' A' ' 49' ' ' GLN . 3.7 pp . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 123.383 0.673 . . . . 0.0 109.3 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 mmt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 88.7 mt-30 -120.1 151.57 38.86 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.854 0.462 . . . . 0.0 111.388 172.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -141.13 159.54 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.223 1.409 . . . . 0.0 109.701 177.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 66' ' ' THR . 86.7 m-85 -107.58 109.8 21.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.032 0.933 . . . . 0.0 109.68 -176.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.451 HG22 HD11 ' A' ' 30' ' ' ILE . 19.4 t -101.51 111.42 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 tptt -110.93 117.15 32.58 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.511 0.725 . . . . 0.0 109.981 -171.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.57 HG23 HD13 ' A' ' 69' ' ' LEU . 80.4 p -69.51 161.29 29.82 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.165 0.507 . . . . 0.0 111.716 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.491 HD13 HG21 ' A' ' 70' ' ' VAL . 87.0 mt -66.36 -17.54 64.83 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.853 175.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -83.16 -26.88 30.5 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.975 0.51 . . . . 0.0 110.714 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.05 9.59 11.91 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.123 0.409 . . . . 0.0 114.123 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 147.35 35.97 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -108.77 139.35 43.71 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.93 106.54 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.7 m -88.97 120.49 30.43 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.477 ' HB2' HD11 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -105.45 155.63 18.96 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.95 75.48 1.0 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.489 0.716 . . . . 0.0 109.423 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.801 HG23 HG21 ' A' ' 26' ' ' VAL . 11.3 m -137.96 167.38 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.097 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -86.74 155.34 56.09 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.156 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.471 ' HB2' ' OG ' ' A' ' 57' ' ' SER . 13.0 Cg_endo -57.48 -35.58 98.83 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 121.968 1.779 . . . . 0.0 111.198 165.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 t -97.66 19.36 13.68 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.027 0.931 . . . . 0.0 110.875 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.14 -94.82 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.366 0.666 . . . . 0.0 109.692 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 26' ' ' VAL . 10.1 t 176.23 141.14 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.135 1.374 . . . . 0.0 109.57 172.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.53 HG22 ' HE3' ' A' ' 27' ' ' LYS . 45.1 mm -61.63 -37.69 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.527 1.131 . . . . 0.0 111.571 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -50.09 -44.64 52.07 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.239 1.016 . . . . 0.0 110.686 177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.473 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 7.9 t30 -71.78 -43.62 65.39 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.035 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.801 HG21 HG23 ' A' ' 17' ' ' VAL . 60.9 t -54.76 -50.78 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 124.207 0.942 . . . . 0.0 110.953 -177.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HE3' HG22 ' A' ' 23' ' ' ILE . 16.5 ptpt -68.6 -35.56 77.5 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.678 0.391 . . . . 0.0 111.257 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.0 -28.08 68.77 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.118 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 9.5 mmpt? -74.06 -37.42 64.25 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 118.765 -0.635 . . . . 0.0 111.134 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.451 HD11 HG22 ' A' ' 5' ' ' VAL . 3.5 mp -60.86 -40.4 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-N 118.865 0.757 . . . . 0.0 109.131 173.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.99 -25.65 67.95 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.365 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -81.21 -32.47 33.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.189 0.595 . . . . 0.0 111.117 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.0 mmtt -88.24 -69.06 0.72 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.608 0.363 . . . . 0.0 110.895 -172.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.89 -26.1 34.44 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 120.481 0.181 . . . . 0.0 110.819 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.4 24.15 19.64 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.908 171.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.31 131.71 21.69 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.178 0.591 . . . . 0.0 109.476 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.74 149.87 89.04 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.34 2.693 . . . . 0.0 113.135 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 37.2 Cg_endo -61.27 -12.26 22.8 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.784 2.989 . . . . 0.0 113.724 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.35 -43.0 61.57 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.424 0.69 . . . . 0.0 110.535 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.5 mp0 -85.11 -28.9 25.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.051 0.94 . . . . 0.0 111.772 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.53 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 3.5 pp0? -109.0 123.22 48.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.306 0.642 . . . . 0.0 109.921 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.52 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 55.2 ttt180 -112.31 128.02 56.16 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.143 0.977 . . . . 0.0 110.184 -168.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.64 120.03 33.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.311 0.644 . . . . 0.0 110.486 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.2 mt -141.98 135.55 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.417 1.087 . . . . 0.0 109.88 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.51 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 88.3 t80 -131.69 123.46 27.81 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.36 1.064 . . . . 0.0 108.133 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.44 20.0 9.68 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.645 0.778 . . . . 0.0 112.608 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' HA2' HG23 ' B' ' 206' ' ' VAL . . . 101.23 -18.8 53.53 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 114.499 0.559 . . . . 0.0 114.499 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.1 ptpt -86.46 137.64 32.38 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.57 0.685 . . . . 0.0 109.709 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.556 ' HB2' HD22 ' B' ' 224' ' ' LEU . 27.4 tt0 -81.64 135.53 35.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.58 117.16 26.2 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 122.737 0.415 . . . . 0.0 111.298 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.65 138.86 31.85 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.581 1.152 . . . . 0.0 109.639 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.88 -47.55 64.49 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.78 1.232 . . . . 0.0 112.968 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.68 -30.97 78.42 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.905 0.753 . . . . 0.0 113.76 -174.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.461 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 97.2 mtt180 -80.04 177.77 8.7 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.516 0.726 . . . . 0.0 112.037 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -112.51 168.28 9.77 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.785 0.834 . . . . 0.0 109.915 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.6 mt -59.0 -50.48 73.94 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 21.9 m -54.93 -31.13 60.01 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.971 1.309 . . . . 0.0 112.778 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.92 -41.39 91.44 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.201 0.525 . . . . 0.0 109.826 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.461 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 34.8 m-85 -86.41 13.02 8.91 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.436 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.8 OUTLIER 70.11 27.79 4.19 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.55 1.14 . . . . 0.0 111.122 178.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 10.4 mt -99.44 144.95 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -135.27 -173.81 3.44 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -62.88 146.81 51.96 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 120.681 0.276 . . . . 0.0 110.637 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 68.57 5.51 4.89 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.268 1.427 . . . . 0.0 112.174 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -71.86 139.01 48.67 Favored 'General case' 0 C--N 1.362 1.126 0 CA-C-N 117.963 0.347 . . . . 0.0 110.118 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 21.4 m -100.52 117.05 33.89 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.51 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -121.6 142.14 50.41 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.183 0.993 . . . . 0.0 109.484 -177.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -77.91 130.01 36.06 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.648 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.57 HD13 HG23 ' A' ' 7' ' ' THR . 2.5 tm? -103.73 129.34 51.08 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.3 t -111.67 121.04 63.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.238 0.615 . . . . 0.0 109.922 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.86 156.84 23.38 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.523 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 51.6 mtt180 -128.57 -47.24 1.29 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.701 0.8 . . . . 0.0 110.385 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.49 1.57 0 C-N-CA 124.763 1.225 . . . . 0.0 112.433 -178.073 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 57.9 mttm . . . . . 0 C--O 1.239 0.52 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 7.0 m -143.08 179.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.466 1.106 . . . . 0.0 109.595 -169.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.94 142.26 47.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.954 0.502 . . . . 0.0 110.739 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.535 ' HA ' HD13 ' B' ' 216' ' ' ILE . 49.0 t -76.01 104.76 1.67 Allowed Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 124.327 1.051 . . . . 0.0 108.648 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.526 ' HD2' HD22 ' B' ' 220' ' ' LEU . 38.2 Cg_endo -61.79 -12.96 27.79 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.559 2.839 . . . . 0.0 114.808 -168.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . 0.526 HG23 ' HA2' ' A' ' 47' ' ' GLY . 5.6 t -85.8 -61.28 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.133 0.573 . . . . 0.0 110.257 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 21.1 p -99.74 -5.54 28.56 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 112.224 0.454 . . . . 0.0 112.224 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 68.07 45.17 73.95 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 115.023 0.769 . . . . 0.0 115.023 173.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.24 133.44 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 117.342 0.571 . . . . 0.0 110.321 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -81.78 122.52 27.79 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.011 0.524 . . . . 0.0 110.17 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' B' ' 204' ' ' CYS . 3.4 pt -150.23 159.66 34.7 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.757 1.623 . . . . 0.0 108.924 -172.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.35 157.75 43.98 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.199 1.932 . . . . 0.0 112.061 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.562 ' O ' HG22 ' B' ' 216' ' ' ILE . 43.1 tt0 -60.9 -31.35 70.85 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.743 1.217 . . . . 0.0 112.093 -174.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 23.5 p -64.0 -50.95 66.5 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 121.653 0.739 . . . . 0.0 110.277 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -80.15 -10.96 59.79 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.16 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.562 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.1 OUTLIER -73.78 -48.36 39.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . 0.509 ' HA ' HD13 ' B' ' 220' ' ' LEU . 52.3 m-80 -63.39 -36.52 83.98 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.407 0.442 . . . . 0.0 110.843 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -57.57 -52.76 64.11 Favored 'General case' 0 C--O 1.254 1.3 0 O-C-N 123.96 0.788 . . . . 0.0 111.212 172.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -30.66 70.68 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.731 -176.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.526 HD22 ' HD2' ' B' ' 205' ' ' PRO . 96.3 mt -64.52 -50.48 67.21 Favored 'General case' 0 C--O 1.206 -1.186 0 O-C-N 123.887 0.742 . . . . 0.0 111.181 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -57.38 -27.79 62.63 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 123.87 0.731 . . . . 0.0 111.69 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.1 t -80.03 -45.74 17.83 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.552 173.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 67.0 m -81.12 -22.94 38.71 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.626 1.17 . . . . 0.0 113.811 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . 0.556 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.2 pp . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 120.851 0.358 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 21.6 mp0 -98.52 152.85 19.11 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.497 0.319 . . . . 0.0 110.512 173.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.18 150.6 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.345 1.058 . . . . 0.0 108.728 171.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.0 101.75 11.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.4 0.68 . . . . 0.0 109.787 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 69' ' ' LEU . 88.4 t -98.76 103.16 14.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -101.39 124.93 47.87 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.439 0.696 . . . . 0.0 110.901 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.706 HG22 HD11 ' A' ' 69' ' ' LEU . 60.2 p -65.53 157.74 28.86 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.316 0.647 . . . . 0.0 111.765 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.516 HD11 HG22 ' A' ' 70' ' ' VAL . 81.0 mt -66.47 -17.78 64.99 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.686 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -79.63 -11.31 59.87 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.342 0.657 . . . . 0.0 110.928 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.49 7.34 39.94 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 123.25 0.452 . . . . 0.0 113.863 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HZ1' ' HB3' ' A' ' 34' ' ' GLU . 1.0 OUTLIER -93.43 143.02 26.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.626 0.77 . . . . 0.0 109.193 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 m -103.51 141.19 36.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.857 0.463 . . . . 0.0 110.684 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.81 113.27 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.431 1.092 . . . . 0.0 108.504 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.3 m -91.57 120.34 32.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.922 0.489 . . . . 0.0 109.716 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -106.19 163.9 12.43 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.018 0.927 . . . . 0.0 109.261 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -130.82 82.47 2.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.376 0.67 . . . . 0.0 109.562 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.781 HG21 HG23 ' A' ' 26' ' ' VAL . 16.7 m -140.9 172.03 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.242 1.017 . . . . 0.0 109.085 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -86.02 150.71 53.24 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.742 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -60.79 -25.14 80.59 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.998 1.799 . . . . 0.0 111.332 166.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 t -95.12 5.65 51.24 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.038 0.935 . . . . 0.0 111.449 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.01 -96.62 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.139 0.576 . . . . 0.0 110.123 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.465 ' O ' HG22 ' A' ' 26' ' ' VAL . 11.1 t 177.85 146.13 0.13 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.676 1.191 . . . . 0.0 109.31 172.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -62.63 -36.26 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.598 1.159 . . . . 0.0 111.56 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.31 -36.51 71.17 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.712 0.767 . . . . 0.0 110.878 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.0 t-20 -76.07 -42.02 48.71 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.341 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.781 HG23 HG21 ' A' ' 17' ' ' VAL . 58.4 t -55.75 -48.16 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 124.342 1.026 . . . . 0.0 110.371 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.9 ptpt -69.93 -35.15 74.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.977 0.511 . . . . 0.0 110.945 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.05 -36.03 70.01 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.613 0.365 . . . . 0.0 110.921 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 74.0 mmtt -69.58 -33.92 73.41 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 118.59 -0.719 . . . . 0.0 112.394 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' A' ' 27' ' ' LYS . 2.7 mp -60.0 -41.22 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 119.404 1.002 . . . . 0.0 109.662 172.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -67.98 -24.71 65.18 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.526 0.731 . . . . 0.0 111.311 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -77.7 -30.26 51.77 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.849 0.859 . . . . 0.0 111.021 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -94.58 -67.63 0.84 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.828 0.451 . . . . 0.0 111.093 -173.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' HB3' ' HZ1' ' A' ' 11' ' ' LYS . 14.4 pt-20 -84.41 -26.62 28.19 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.201 0.2 . . . . 0.0 111.115 -178.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.75 23.68 22.68 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 116.547 -0.297 . . . . 0.0 112.851 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.79 129.04 25.59 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.436 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 73.9 Cg_endo -68.39 155.24 69.88 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.166 2.577 . . . . 0.0 112.766 -174.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 38.3 Cg_endo -61.16 -16.21 44.73 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.675 2.917 . . . . 0.0 114.082 -176.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.0 -24.71 43.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.829 0.852 . . . . 0.0 110.664 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.45 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.7 mp0 -99.9 -31.69 11.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.218 1.007 . . . . 0.0 111.954 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 3.1 pp0? -103.94 123.8 47.82 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.236 0.541 . . . . 0.0 110.419 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.703 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 67.2 ttt180 -115.06 128.58 56.33 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.393 1.077 . . . . 0.0 109.86 -169.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.6 mm? -94.16 121.18 35.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.552 0.741 . . . . 0.0 110.577 -171.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.0 mt -142.62 125.96 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.023 0.929 . . . . 0.0 109.988 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.627 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 85.0 t80 -121.73 122.72 40.18 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.47 1.108 . . . . 0.0 108.962 177.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.66 22.84 10.35 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.699 0.8 . . . . 0.0 112.754 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.17 -13.02 60.4 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.343 0.497 . . . . 0.0 114.343 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.9 ptpt -93.34 133.1 36.93 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.623 0.711 . . . . 0.0 109.298 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -76.08 136.81 39.89 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.441 HD12 ' HB3' ' A' ' 43' ' ' LEU . 22.7 mt -92.34 119.39 31.86 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 121.117 0.484 . . . . 0.0 111.164 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -86.87 139.46 30.63 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.252 1.421 . . . . 0.0 110.892 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.84 -45.37 82.43 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.802 1.241 . . . . 0.0 112.838 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.82 -27.03 73.69 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 124.072 0.857 . . . . 0.0 113.481 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -80.84 177.59 8.94 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.826 0.851 . . . . 0.0 111.93 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.7 p -113.99 167.83 10.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.817 0.847 . . . . 0.0 110.159 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 93.7 mt -56.72 -52.33 65.37 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.615 173.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.4 t -63.9 -22.78 67.08 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.283 1.033 . . . . 0.0 111.543 -176.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.03 -42.63 89.35 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.46 0.647 . . . . 0.0 109.488 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -89.25 15.64 8.65 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.887 -1.052 . . . . 0.0 112.147 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER 73.49 14.08 4.41 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.027 1.331 . . . . 0.0 112.175 175.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 7.9 mt -84.29 137.79 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -130.7 -173.93 3.22 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -56.53 141.24 43.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 122.866 0.466 . . . . 0.0 111.364 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 67.3 5.83 4.47 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.591 1.556 . . . . 0.0 113.268 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.3 m -70.48 133.19 46.59 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 118.204 0.457 . . . . 0.0 110.708 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.8 m -97.16 121.22 38.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.35 0.66 . . . . 0.0 109.278 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.627 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -123.24 175.05 6.9 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.897 1.279 . . . . 0.0 109.424 176.137 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -105.61 149.29 26.44 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.667 0.787 . . . . 0.0 110.665 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.706 HD11 HG22 ' A' ' 7' ' ' THR . 3.0 tm? -127.82 122.23 32.15 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.703 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 60.3 t -101.02 112.82 35.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 123.384 0.674 . . . . 0.0 109.779 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.85 145.89 36.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.728 173.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 67.2 mtp85 -122.25 -28.15 4.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.666 0.786 . . . . 0.0 111.124 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 N--CA 1.493 1.71 0 C-N-CA 124.532 1.133 . . . . 0.0 113.235 176.918 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.93 -177.41 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.833 1.253 . . . . 0.0 109.536 -169.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -112.86 147.34 37.21 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.679 0.391 . . . . 0.0 110.971 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.53 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.4 t -87.31 101.95 2.78 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 124.379 1.072 . . . . 0.0 108.692 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.547 ' HD2' HD23 ' B' ' 220' ' ' LEU . 55.2 Cg_endo -65.55 2.71 1.43 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.272 2.648 . . . . 0.0 115.335 -172.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.13 -51.8 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.691 0.396 . . . . 0.0 110.901 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 14.6 p -114.59 9.0 16.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 58.56 42.17 95.91 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 115.907 1.123 . . . . 0.0 115.907 169.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.1 141.26 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 117.331 0.566 . . . . 0.0 110.644 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -88.17 112.55 22.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.006 0.522 . . . . 0.0 110.078 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.519 HD13 ' HB2' ' B' ' 204' ' ' CYS . 6.9 pt -141.66 156.26 66.33 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.489 1.515 . . . . 0.0 109.641 -173.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.75 162.6 33.93 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.704 2.269 . . . . 0.0 111.965 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.536 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.9 tm-20 -66.69 -38.69 87.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.979 0.911 . . . . 0.0 112.934 -166.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 43.1 t -56.39 -44.97 80.75 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.762 0.791 . . . . 0.0 109.868 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -80.33 -16.22 55.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.935 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.548 ' O ' ' HG ' ' B' ' 220' ' ' LEU . 0.2 OUTLIER -73.21 -50.34 32.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -67.14 -36.91 82.88 Favored 'General case' 0 C--N 1.347 0.461 0 O-C-N 123.645 0.591 . . . . 0.0 111.075 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -60.82 -46.99 88.37 Favored 'General case' 0 C--O 1.253 1.266 0 O-C-N 123.675 0.609 . . . . 0.0 110.905 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -40.32 82.62 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.167 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 216' ' ' ILE . 96.0 mt -60.75 -49.71 76.4 Favored 'General case' 0 C--O 1.211 -0.948 0 O-C-N 123.958 0.786 . . . . 0.0 111.584 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.65 -24.5 67.81 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 123.93 0.769 . . . . 0.0 112.072 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 30.1 t -81.89 -41.8 20.44 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.16 0.505 . . . . 0.0 110.564 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 94.2 m -81.49 -27.45 34.54 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.292 1.037 . . . . 0.0 113.179 -167.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.486 1.35 0 C-N-CA 123.032 0.533 . . . . 0.0 110.828 -173.187 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.998 0.428 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -106.5 144.74 32.74 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.621 0.368 . . . . 0.0 111.237 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.75 157.65 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.991 1.316 . . . . 0.0 108.964 175.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 66' ' ' THR . 72.2 m-85 -110.84 101.33 9.94 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.493 0.717 . . . . 0.0 110.026 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' A' ' 69' ' ' LEU . 74.6 t -97.44 106.77 19.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -107.11 129.13 54.87 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.325 0.65 . . . . 0.0 110.499 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.678 HG22 HD13 ' A' ' 69' ' ' LEU . 71.8 p -72.25 165.28 24.75 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.362 0.601 . . . . 0.0 111.841 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.492 HD12 HG21 ' A' ' 70' ' ' VAL . 70.0 mt -67.17 -25.79 66.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.924 172.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -78.09 -14.14 59.6 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.34 0.656 . . . . 0.0 110.553 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.99 14.47 39.49 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 114.884 0.714 . . . . 0.0 114.884 165.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.429 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -84.31 151.65 24.62 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 m -107.61 132.0 53.77 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.95 112.44 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 m -92.16 116.09 28.65 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.424 0.69 . . . . 0.0 109.424 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.5 mm? -104.79 157.19 17.37 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.635 0.774 . . . . 0.0 109.483 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.09 86.76 2.63 Favored 'General case' 0 C--O 1.244 0.784 0 O-C-N 124.248 0.968 . . . . 0.0 108.436 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.779 HG21 HG21 ' A' ' 26' ' ' VAL . 13.7 m -140.71 176.65 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 124.374 1.07 . . . . 0.0 108.345 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -92.72 148.68 36.55 Favored Pre-proline 0 N--CA 1.475 0.782 0 O-C-N 121.69 -0.631 . . . . 0.0 109.379 172.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 19.5 Cg_endo -58.45 -28.32 84.88 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.171 1.914 . . . . 0.0 111.71 169.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.7 t -101.93 16.09 27.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.909 0.484 . . . . 0.0 110.979 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.98 -92.08 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -178.85 145.61 0.29 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.503 1.121 . . . . 0.0 109.825 173.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.54 -37.81 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.451 1.1 . . . . 0.0 111.359 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -58.55 -35.17 71.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.397 0.679 . . . . 0.0 110.807 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 16.2 t-20 -72.39 -44.95 61.78 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.331 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.779 HG21 HG21 ' A' ' 17' ' ' VAL . 45.3 t -54.2 -50.32 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 124.372 1.045 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.2 ptpt -68.94 -31.35 70.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.075 0.55 . . . . 0.0 111.802 -175.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.31 -39.61 79.86 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.978 0.418 . . . . 0.0 110.662 170.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 35.6 mmtm -68.88 -36.83 78.55 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.531 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.9 mp -59.13 -41.78 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 119.473 1.033 . . . . 0.0 110.17 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -62.97 -33.15 74.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.56 -26.01 57.59 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.278 0.631 . . . . 0.0 111.319 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.8 mmtt -94.5 -66.38 0.92 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.866 0.466 . . . . 0.0 110.889 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.89 -16.01 32.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.74 20.24 51.44 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 170.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.67 127.83 27.71 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.31 152.01 82.04 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.244 2.629 . . . . 0.0 112.989 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.598 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 43.6 Cg_endo -61.83 -17.14 53.56 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.983 3.122 . . . . 0.0 113.932 -174.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.22 -37.66 63.78 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.832 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -89.29 -32.2 17.48 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.276 1.03 . . . . 0.0 112.091 -174.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.598 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 3.0 pp0? -99.77 128.95 45.84 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.499 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 55.7 ttt180 -117.18 128.88 55.55 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.4 1.08 . . . . 0.0 109.174 -168.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.48 125.42 38.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 109.892 -172.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -142.22 133.96 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.087 0.955 . . . . 0.0 110.135 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.597 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 79.0 t80 -132.87 129.52 38.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 172.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.48 19.33 11.77 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.985 0.914 . . . . 0.0 113.073 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.33 17.07 54.24 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 114.282 0.473 . . . . 0.0 114.282 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 4.0 ptpt -130.01 148.64 51.89 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.731 0.766 . . . . 0.0 109.982 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -74.11 140.57 45.36 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.779 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.428 HD22 ' HB3' ' A' ' 45' ' ' PHE . 24.7 mt -88.64 119.22 28.91 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.015 0.526 . . . . 0.0 109.76 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.05 138.77 38.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.689 0.796 . . . . 0.0 109.989 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.88 -40.93 85.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.002 0.921 . . . . 0.0 111.616 -173.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.04 -23.95 77.59 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.256 0.972 . . . . 0.0 113.923 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 61.6 mtt180 -80.3 177.48 8.94 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.485 0.714 . . . . 0.0 112.268 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.1 p -113.21 168.46 9.71 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.774 0.829 . . . . 0.0 109.795 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 92.0 mt -59.56 -50.09 75.26 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 t -59.72 -26.71 65.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.927 1.291 . . . . 0.0 111.317 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.405 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 14.8 t70 -64.7 -43.16 94.37 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.224 0.61 . . . . 0.0 109.968 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.81 19.51 4.01 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.769 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 69.54 18.66 7.7 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.353 1.061 . . . . 0.0 111.744 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 14.5 mt -91.88 117.45 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -102.82 -178.29 3.63 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -61.67 142.97 56.85 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.137 170.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 74.2 3.31 4.35 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.612 1.565 . . . . 0.0 112.126 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -71.94 134.32 45.91 Favored 'General case' 0 C--N 1.363 1.155 0 CA-C-N 118.322 0.51 . . . . 0.0 110.513 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 52.3 m -95.13 126.27 40.35 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.597 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -128.26 174.41 9.31 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.528 1.131 . . . . 0.0 109.313 177.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -100.02 149.6 23.31 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.177 0.591 . . . . 0.0 111.629 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.678 HD13 HG22 ' A' ' 7' ' ' THR . 2.9 tm? -129.61 130.44 45.65 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.503 HG22 HD13 ' B' ' 220' ' ' LEU . 64.8 t -114.11 128.68 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 123.406 0.682 . . . . 0.0 110.153 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.583 ' HB3' HD22 ' A' ' 73' ' ' LEU . 77.6 mt -89.94 149.17 22.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.619 0.768 . . . . 0.0 110.793 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -118.99 -59.9 1.81 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.843 0.857 . . . . 0.0 109.298 172.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.583 HD22 ' HB3' ' A' ' 71' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.494 1.727 0 C-N-CA 124.343 1.057 . . . . 0.0 111.384 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.73 -176.46 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.869 0.868 . . . . 0.0 110.751 -168.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.84 147.76 43.6 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.682 0.793 . . . . 0.0 110.225 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.564 ' HA ' HD13 ' B' ' 216' ' ' ILE . 46.2 t -89.63 101.56 3.42 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.095 0.958 . . . . 0.0 108.635 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.585 ' HD2' HD22 ' B' ' 220' ' ' LEU . 89.3 Cg_exo -49.09 -27.52 12.39 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 124.277 3.318 . . . . 0.0 115.006 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 6.3 t -80.66 -64.5 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.381 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 18.1 p -96.56 1.04 50.93 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.73 45.46 95.7 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 115.061 0.784 . . . . 0.0 115.061 171.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.71 138.11 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.052 0.541 . . . . 0.0 110.223 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -87.54 117.47 26.36 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.441 HD11 ' HB2' ' B' ' 204' ' ' CYS . 7.4 pt -145.59 162.17 37.65 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.157 1.383 . . . . 0.0 110.17 -170.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.35 162.43 33.57 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.64 2.227 . . . . 0.0 112.98 174.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.596 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.9 tt0 -65.07 -39.45 93.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.61 1.164 . . . . 0.0 113.665 -169.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 14.9 m -65.76 -43.44 88.89 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.361 -0.837 . . . . 0.0 109.901 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -75.6 -18.58 59.67 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.831 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.596 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -71.21 -47.62 59.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -68.43 -36.12 78.6 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.313 0.383 . . . . 0.0 111.859 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -63.34 -44.56 94.52 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.157 0.286 . . . . 0.0 110.353 172.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -43.48 86.66 Favored 'General case' 0 C--O 1.211 -0.963 0 O-C-N 123.836 0.71 . . . . 0.0 109.841 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.585 HD22 ' HD2' ' B' ' 205' ' ' PRO . 93.0 mt -60.69 -46.5 90.14 Favored 'General case' 0 C--O 1.21 -1.02 0 O-C-N 124.059 0.849 . . . . 0.0 110.876 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -60.25 -31.22 70.0 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.842 1.339 . . . . 0.0 110.464 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 t -86.49 -37.43 18.26 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.127 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 88.2 m -79.51 -22.15 44.34 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.002 0.921 . . . . 0.0 112.282 -171.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 123.026 0.53 . . . . 0.0 110.462 -176.668 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 21.9 mp0 -108.85 142.13 39.88 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.926 -0.484 . . . . 0.0 111.212 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.01 159.44 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.735 1.214 . . . . 0.0 108.874 174.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 66' ' ' THR . 94.0 m-85 -109.36 105.92 15.5 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.443 0.697 . . . . 0.0 109.953 -175.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 69' ' ' LEU . 2.6 t -95.59 114.88 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -102.3 113.1 26.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.668 0.787 . . . . 0.0 109.326 -174.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.634 HG21 HD13 ' A' ' 69' ' ' LEU . 23.5 p -68.91 157.93 35.62 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.849 0.356 . . . . 0.0 110.4 174.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.409 HD11 HG23 ' A' ' 70' ' ' VAL . 96.2 mt -58.73 -25.2 62.71 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.941 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.3 p -79.08 3.05 18.59 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.562 0.745 . . . . 0.0 111.799 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 12.39 74.84 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 116.42 -0.355 . . . . 0.0 113.124 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -95.54 147.73 23.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.014 0.926 . . . . 0.0 110.207 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 m -108.02 140.98 40.38 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.561 0.744 . . . . 0.0 109.75 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -125.7 115.6 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.683 1.193 . . . . 0.0 107.978 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 m -92.1 117.64 30.05 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -104.04 156.18 18.07 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -123.85 82.45 2.02 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.906 0.753 . . . . 0.0 109.155 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.721 HG23 HG23 ' A' ' 26' ' ' VAL . 9.6 m -139.63 178.96 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 124.773 1.229 . . . . 0.0 107.969 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 10.1 mt-10 -96.29 152.82 39.0 Favored Pre-proline 0 N--CA 1.482 1.166 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.8 Cg_endo -61.63 -30.61 85.9 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.098 1.865 . . . . 0.0 111.168 171.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t -102.5 18.97 19.87 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.057 0.543 . . . . 0.0 110.026 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 16.1 t70 -81.04 -88.5 0.08 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.128 0.571 . . . . 0.0 109.49 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 26' ' ' VAL . 7.1 t 177.37 147.53 0.13 Allowed 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.539 1.136 . . . . 0.0 110.183 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -66.03 -34.39 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.251 1.02 . . . . 0.0 111.031 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 36.2 tt0 -62.59 -31.45 72.28 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.311 0.576 . . . . 0.0 110.858 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 12.7 t-20 -75.17 -42.07 56.69 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.862 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.721 HG23 HG23 ' A' ' 17' ' ' VAL . 59.0 t -55.57 -46.93 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 124.283 0.989 . . . . 0.0 110.3 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HA ' HD13 ' A' ' 30' ' ' ILE . 17.9 ptpt -71.22 -29.36 65.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.266 0.626 . . . . 0.0 111.592 -176.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -33.29 75.68 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.519 169.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 68.1 mmtt -75.62 -27.56 58.49 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.229 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.9 mp -58.14 -45.66 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 119.348 0.976 . . . . 0.0 109.281 166.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.404 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.2 tt0 -67.21 -20.81 65.75 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.579 177.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 23.0 t70 -81.42 -37.0 28.79 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.742 0.817 . . . . 0.0 111.369 174.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.8 mmtt -91.78 -61.92 1.53 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.794 0.437 . . . . 0.0 111.024 -170.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -92.55 -25.12 18.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.422 0.289 . . . . 0.0 111.184 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 97.2 13.83 44.14 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 116.546 -0.297 . . . . 0.0 113.83 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.87 125.88 55.57 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -63.55 152.59 79.52 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.745 2.297 . . . . 0.0 112.097 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -62.01 -16.47 50.2 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.469 2.78 . . . . 0.0 113.694 -173.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -75.4 -42.58 53.4 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.249 0.62 . . . . 0.0 110.616 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -81.74 -22.04 37.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.158 0.983 . . . . 0.0 112.52 -173.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.426 ' NE2' ' HB2' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -102.39 148.01 26.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.428 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.574 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 52.2 ttt180 -132.31 129.73 39.89 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.426 0.69 . . . . 0.0 109.556 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.64 125.69 37.38 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.373 0.669 . . . . 0.0 109.303 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.9 mt -142.6 130.99 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.158 0.983 . . . . 0.0 109.749 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' HB3' HD21 ' A' ' 50' ' ' LEU . 92.5 t80 -129.84 124.12 32.52 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.13 19.85 11.87 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.31 1.044 . . . . 0.0 112.651 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.78 -12.09 60.98 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-O 120.005 -0.33 . . . . 0.0 113.891 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.8 ptpt -99.87 142.28 31.56 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -75.4 140.82 43.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.352 0.261 . . . . 0.0 110.34 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.6 mt -88.15 134.05 33.86 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.137 0.575 . . . . 0.0 109.905 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 27.8 tt0 -85.16 137.37 33.06 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 9.2 p-10 -61.46 -33.49 73.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.112 0.965 . . . . 0.0 111.892 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.48 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -72.82 -29.5 65.13 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.856 0.723 . . . . 0.0 113.409 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -80.04 177.18 9.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.381 0.672 . . . . 0.0 111.548 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -111.06 167.46 10.24 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.738 0.815 . . . . 0.0 110.254 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 90.4 mt -56.22 -49.82 73.02 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.924 0.765 . . . . 0.0 109.135 172.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -61.3 -27.56 68.56 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.896 1.278 . . . . 0.0 111.572 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.85 -39.2 83.82 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -91.99 20.65 5.6 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.367 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 65.74 25.96 11.39 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.512 1.125 . . . . 0.0 112.194 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.88 118.27 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -106.84 -175.09 2.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -56.38 138.21 51.42 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.381 171.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 71.34 9.67 6.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.211 1.404 . . . . 0.0 112.501 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.1 m -78.57 138.55 38.42 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.147 0.43 . . . . 0.0 110.604 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 46.8 m -95.49 130.37 42.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.23 0.612 . . . . 0.0 109.928 175.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.66 159.32 37.57 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.781 1.232 . . . . 0.0 108.66 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -87.33 152.61 22.13 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.451 0.643 . . . . 0.0 111.299 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.634 HD13 HG21 ' A' ' 7' ' ' THR . 2.8 tm? -134.89 131.53 37.43 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 73.8 t -110.23 113.7 44.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.029 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.38 152.48 32.24 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.993 174.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.434 ' HA ' ' HG2' ' B' ' 213' ' ' GLU . 53.7 mtp180 -129.79 -40.17 1.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.026 0.93 . . . . 0.0 109.883 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 125.035 1.334 . . . . 0.0 112.914 177.71 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.8 m -143.1 163.52 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.375 1.07 . . . . 0.0 110.736 -167.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -96.29 147.34 23.89 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.808 0.843 . . . . 0.0 111.409 -172.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.574 ' HA ' HD13 ' B' ' 216' ' ' ILE . 43.5 t -88.2 103.92 6.02 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.538 ' HD2' HD22 ' B' ' 220' ' ' LEU . 36.2 Cg_endo -60.52 -12.54 21.26 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.478 2.785 . . . . 0.0 114.816 -168.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 t -88.47 -54.27 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.032 0.533 . . . . 0.0 110.755 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 15.8 p -108.48 1.74 21.79 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -174.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 63.01 46.58 93.22 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 115.632 1.013 . . . . 0.0 115.632 170.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.5 m -119.0 132.84 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.265 0.626 . . . . 0.0 110.764 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -84.76 119.23 25.05 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 5.2 pt -142.91 161.06 50.68 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.71 1.604 . . . . 0.0 108.875 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.46 153.08 56.82 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.229 1.953 . . . . 0.0 112.249 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.552 ' O ' HG23 ' B' ' 216' ' ' ILE . 33.5 tt0 -64.79 -32.64 74.43 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.384 1.474 . . . . 0.0 113.156 -168.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 38.6 t -64.33 -44.3 91.94 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.661 0.743 . . . . 0.0 109.924 172.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -77.0 -19.34 57.4 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.374 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -71.1 -46.5 66.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -60.68 -45.18 95.13 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.477 0.486 . . . . 0.0 110.121 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -56.62 -46.64 80.83 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 124.373 1.046 . . . . 0.0 111.945 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -36.91 81.21 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.246 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.538 HD22 ' HD2' ' B' ' 205' ' ' PRO . 93.4 mt -63.58 -46.48 85.64 Favored 'General case' 0 C--O 1.21 -0.986 0 O-C-N 124.186 0.929 . . . . 0.0 111.481 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -54.22 -34.13 59.93 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.251 0.97 . . . . 0.0 111.009 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 34.5 t -82.91 -39.52 21.4 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.268 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 81.3 m -80.05 -18.0 51.24 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.12 0.968 . . . . 0.0 112.612 -170.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 122.857 0.463 . . . . 0.0 110.499 -179.831 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 121.045 0.45 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 93.0 mt-30 -103.47 122.65 45.34 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.626 0.77 . . . . 0.0 109.972 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.529 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -125.39 152.13 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.732 1.213 . . . . 0.0 108.559 177.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.7 m-85 -111.9 113.11 25.23 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.563 0.697 . . . . 0.0 110.204 -170.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.9 t -105.84 119.74 55.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -111.76 119.12 37.55 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.622 0.769 . . . . 0.0 109.535 -174.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.62 HG23 HD12 ' A' ' 69' ' ' LEU . 68.1 p -70.58 167.11 19.21 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.212 0.53 . . . . 0.0 111.628 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.509 HD11 HG23 ' A' ' 70' ' ' VAL . 84.0 mt -73.33 -19.35 61.04 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.936 173.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.1 p -79.05 -12.99 60.03 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.132 0.573 . . . . 0.0 110.39 171.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 26.29 19.79 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.712 -0.677 . . . . 0.0 114.144 169.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.608 ' HZ1' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.4 152.57 18.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.6 m -97.72 141.11 31.14 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.893 0.477 . . . . 0.0 110.492 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.476 HD12 HG22 ' A' ' 7' ' ' THR . 5.2 mp -127.68 109.82 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.902 1.281 . . . . 0.0 107.68 174.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.1 m -91.5 123.58 35.02 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.7 mm? -106.97 156.02 19.16 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.172 0.589 . . . . 0.0 109.617 -177.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -118.96 76.88 1.14 Allowed 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.371 1.044 . . . . 0.0 109.301 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.68 HG23 HG22 ' A' ' 26' ' ' VAL . 28.9 m -147.43 173.14 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 123.733 0.813 . . . . 0.0 110.236 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.491 ' O ' HD12 ' A' ' 56' ' ' LEU . 9.6 mt-10 -95.72 160.02 31.2 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.139 0.576 . . . . 0.0 109.864 -169.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.91 -17.05 55.01 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 121.758 1.638 . . . . 0.0 111.89 169.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 t -103.41 3.11 34.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.45 157.91 28.81 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 168.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 26' ' ' VAL . 9.3 t -102.04 150.23 23.44 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.291 -165.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.1 -36.26 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.624 0.77 . . . . 0.0 112.156 -171.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.03 -34.63 75.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.455 0.645 . . . . 0.0 110.934 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.2 t30 -73.36 -45.17 56.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.866 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.68 HG22 HG23 ' A' ' 17' ' ' VAL . 65.7 t -55.93 -43.68 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 124.144 0.978 . . . . 0.0 111.361 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -71.74 -33.17 68.47 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.867 0.467 . . . . 0.0 111.473 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.91 68.96 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.143 169.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 10.3 mmpt? -76.51 -32.57 58.36 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.188 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.25 -42.93 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 118.404 0.547 . . . . 0.0 110.057 170.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.31 -35.38 78.86 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.154 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.72 -24.66 63.59 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.961 0.904 . . . . 0.0 111.689 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 72.1 mmtt -101.03 -69.51 0.77 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.01 -19.47 31.97 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.665 0.211 . . . . 0.0 111.44 -175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.95 17.76 46.44 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.028 0.205 . . . . 0.0 113.062 173.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.62 125.86 34.64 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 123.394 0.678 . . . . 0.0 109.567 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -71.82 159.1 51.52 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.102 2.535 . . . . 0.0 112.095 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 29.3 Cg_endo -58.84 -15.26 25.93 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.549 2.832 . . . . 0.0 113.689 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.58 -44.71 70.23 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.366 1.066 . . . . 0.0 110.653 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.81 -33.2 19.95 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.817 0.847 . . . . 0.0 111.963 -175.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -94.2 150.39 20.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.648 0.379 . . . . 0.0 110.408 -179.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.588 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 44.9 ttt180 -140.17 129.98 24.55 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.233 0.613 . . . . 0.0 109.666 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.449 ' HB3' HD11 ' A' ' 50' ' ' LEU . 4.6 mm? -93.45 123.02 36.47 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.522 0.729 . . . . 0.0 109.721 -173.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -141.73 121.73 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.071 0.948 . . . . 0.0 109.716 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.616 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 91.1 t80 -119.51 121.32 39.13 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.492 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . . . 66.27 17.88 10.8 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.263 1.025 . . . . 0.0 113.5 173.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.95 14.05 47.45 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 113.983 0.353 . . . . 0.0 113.983 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.492 ' HE3' ' HB2' ' A' ' 46' ' ' ALA . 1.6 ptpt -124.27 139.24 54.11 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.79 132.08 41.29 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.514 HD22 ' HB3' ' A' ' 45' ' ' PHE . 32.0 mt -78.37 118.77 20.86 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.036 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.78 138.46 42.66 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.992 0.917 . . . . 0.0 110.357 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.15 -44.81 83.79 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.886 1.275 . . . . 0.0 112.116 -172.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 -28.22 73.5 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 124.574 1.171 . . . . 0.0 113.747 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -77.65 175.23 10.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.087 0.555 . . . . 0.0 111.813 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 26.2 p -115.85 165.26 13.28 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.486 0.715 . . . . 0.0 109.746 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 18' ' ' GLU . 83.8 mt -55.51 -56.29 21.96 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 123.635 0.584 . . . . 0.0 110.495 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 t -61.91 -22.16 65.34 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.122 0.969 . . . . 0.0 112.057 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.1 -39.25 79.09 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.763 0.425 . . . . 0.0 110.096 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -87.26 13.53 9.5 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.342 172.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 67.63 25.45 8.22 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.912 1.285 . . . . 0.0 111.691 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 mt -91.12 112.96 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.408 1.083 . . . . 0.0 108.472 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -101.45 -172.76 2.21 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -61.65 140.28 58.18 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 70.65 3.22 4.45 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.809 1.244 . . . . 0.0 113.306 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -64.74 130.23 42.77 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 20.6 m -99.68 131.23 45.8 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.763 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.616 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -134.19 174.18 10.79 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.07 0.948 . . . . 0.0 110.107 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -98.55 148.21 24.0 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.332 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.62 HD12 HG23 ' A' ' 7' ' ' THR . 2.6 tm? -127.32 130.63 49.85 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 67.1 t -108.68 111.55 36.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.21 0.604 . . . . 0.0 109.833 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.2 mt -79.2 149.75 31.85 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 124.191 0.932 . . . . 0.0 109.011 171.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -118.98 -39.43 2.94 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.445 0.698 . . . . 0.0 110.72 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.485 1.298 0 C-N-CA 124.645 1.178 . . . . 0.0 111.89 -178.012 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 m -144.46 -178.04 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.382 1.073 . . . . 0.0 110.072 -165.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -113.57 148.06 36.84 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.219 0.608 . . . . 0.0 110.314 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.57 ' HA ' HD11 ' B' ' 216' ' ' ILE . 46.2 t -85.4 100.81 1.35 Allowed Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.079 0.952 . . . . 0.0 109.501 176.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.557 ' HD2' HD23 ' B' ' 220' ' ' LEU . 65.3 Cg_endo -68.0 8.29 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.392 2.728 . . . . 0.0 115.361 -168.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.07 -50.63 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 122.971 0.509 . . . . 0.0 110.716 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.9 p -114.03 -4.61 13.17 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 122.746 0.418 . . . . 0.0 111.945 -172.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.36 58.25 14.95 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 124.288 0.947 . . . . 0.0 114.956 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.07 129.83 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.201 0.601 . . . . 0.0 109.57 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -82.59 115.42 21.55 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.8 pt -143.95 160.77 48.61 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.491 1.516 . . . . 0.0 109.746 -170.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' B' ' 215' ' ' HIS . 28.4 Cg_endo -60.92 155.92 46.92 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.704 2.27 . . . . 0.0 112.199 172.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.507 ' O ' HG21 ' B' ' 216' ' ' ILE . 35.7 tt0 -68.51 -28.32 66.9 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.69 1.196 . . . . 0.0 113.466 -170.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 40.9 t -65.78 -44.22 86.42 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.657 0.741 . . . . 0.0 109.724 171.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . 0.425 ' HB2' ' HG2' ' B' ' 212' ' ' PRO . 70.6 m-70 -80.35 -16.51 54.38 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.046 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.57 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -72.55 -44.5 61.06 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 175.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -54.38 -54.47 40.15 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.023 0.827 . . . . 0.0 109.999 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -57.24 -44.84 84.19 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 124.48 1.113 . . . . 0.0 112.558 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -33.93 74.87 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.105 -177.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.557 HD23 ' HD2' ' B' ' 205' ' ' PRO . 78.8 mt -68.49 -42.95 77.9 Favored 'General case' 0 C--O 1.212 -0.901 0 O-C-N 123.557 0.536 . . . . 0.0 111.521 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -57.58 -28.4 63.56 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 124.027 0.829 . . . . 0.0 111.259 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 43.4 t -86.38 -42.27 13.8 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.692 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.9 m -80.7 -26.54 37.42 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -167.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.489 1.519 0 C-N-CA 123.053 0.541 . . . . 0.0 110.222 -175.313 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 65.8 mt-30 -111.13 147.72 34.27 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.273 0.629 . . . . 0.0 110.641 176.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -138.93 155.29 26.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 125.396 1.478 . . . . 0.0 107.841 174.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 66' ' ' THR . 89.8 m-85 -112.34 116.78 30.9 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.734 -174.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 55.6 t -105.32 131.96 53.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tpmt? -123.26 124.57 43.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.242 0.617 . . . . 0.0 109.972 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.64 HG23 HD13 ' A' ' 69' ' ' LEU . 42.8 p -73.27 169.49 16.99 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.259 0.552 . . . . 0.0 111.495 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.4 mt -65.59 -26.41 67.84 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.036 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.9 p -80.55 -15.9 55.53 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.637 0.775 . . . . 0.0 111.189 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.23 11.64 38.59 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 114.781 0.673 . . . . 0.0 114.781 167.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.508 ' HZ1' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -78.91 152.27 31.25 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.743 0.771 . . . . 0.0 109.609 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.4 m -95.26 141.78 28.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.177 0.591 . . . . 0.0 109.693 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 7' ' ' THR . 4.4 mp -132.37 100.9 4.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.7 m -95.06 121.36 36.61 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -105.65 152.77 22.71 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -117.45 82.73 1.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.739 HG21 HG22 ' A' ' 26' ' ' VAL . 24.6 m -141.74 177.32 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.72 1.208 . . . . 0.0 108.509 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -92.61 153.42 42.44 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 24.0 Cg_endo -61.98 -28.61 80.88 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.829 1.686 . . . . 0.0 110.742 164.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -94.13 13.54 22.82 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.019 0.928 . . . . 0.0 111.24 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.71 -99.19 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.163 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.509 ' O ' HG21 ' A' ' 26' ' ' VAL . 6.0 t 171.86 140.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.967 1.307 . . . . 0.0 109.324 177.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 50' ' ' LEU . 39.9 mm -60.54 -36.81 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.578 1.151 . . . . 0.0 112.034 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.01 -34.84 76.94 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.564 0.697 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.5 t30 -75.82 -41.0 53.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.107 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.739 HG22 HG21 ' A' ' 17' ' ' VAL . 58.4 t -57.97 -45.86 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 124.441 1.088 . . . . 0.0 110.042 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.1 ptpt -72.39 -28.68 63.14 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.026 0.53 . . . . 0.0 111.313 -176.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.33 75.13 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.218 0.324 . . . . 0.0 110.434 169.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 71.6 mmtt -74.03 -36.13 64.41 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.95 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.479 HD11 ' HA ' ' A' ' 27' ' ' LYS . 2.9 mp -57.23 -41.57 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.532 1.06 . . . . 0.0 109.511 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -60.4 -39.09 86.08 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.447 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.43 -32.09 73.52 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.207 0.603 . . . . 0.0 111.481 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 70.4 mmtt -91.4 -67.97 0.82 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.626 0.37 . . . . 0.0 111.624 -171.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -80.39 -22.95 40.77 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.768 0.258 . . . . 0.0 111.06 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.86 18.67 39.62 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.222 0.326 . . . . 0.0 113.037 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.581 HG13 HD11 ' A' ' 73' ' ' LEU . 1.9 mp -108.79 127.52 27.21 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.68 156.13 67.25 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.907 2.404 . . . . 0.0 112.287 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.615 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 46.3 Cg_endo -62.17 -13.32 31.27 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 123.636 2.891 . . . . 0.0 113.967 -173.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 7.4 t70 -76.23 -46.13 29.61 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.893 0.746 . . . . 0.0 109.943 174.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.427 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.9 mp0 -83.8 -23.09 31.59 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.521 0.728 . . . . 0.0 112.366 -172.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.615 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 2.9 pp0? -104.74 133.27 49.85 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.973 0.509 . . . . 0.0 109.857 173.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.573 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.2 ttt180 -120.26 130.74 54.63 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.975 0.91 . . . . 0.0 110.238 -170.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.428 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -94.28 117.42 30.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.634 0.774 . . . . 0.0 110.546 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -141.85 127.54 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 124.27 1.028 . . . . 0.0 109.547 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.52 ' HB3' HD21 ' A' ' 50' ' ' LEU . 81.2 t80 -123.17 124.08 42.25 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.142 0.977 . . . . 0.0 109.236 177.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.94 16.06 9.61 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.031 1.332 . . . . 0.0 112.972 176.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.09 -8.48 60.97 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.929 -0.373 . . . . 0.0 113.171 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.5 ptpt -96.03 135.79 37.33 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -76.39 131.58 39.21 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 45' ' ' PHE . 30.5 mt -74.34 153.84 39.13 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.436 0.294 . . . . 0.0 110.466 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.34 137.35 52.22 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.397 0.679 . . . . 0.0 109.194 -176.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.92 -44.18 86.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.673 1.189 . . . . 0.0 112.075 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.27 -25.04 75.8 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 124.43 1.081 . . . . 0.0 113.478 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -81.31 177.57 8.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.301 0.64 . . . . 0.0 111.789 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 73.1 p -110.36 169.68 8.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.663 0.785 . . . . 0.0 109.795 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 95.4 mt -57.32 -54.8 42.7 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.893 0.746 . . . . 0.0 109.46 172.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 24.3 t -62.59 -19.28 63.57 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.733 1.213 . . . . 0.0 111.971 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -66.91 -41.4 87.17 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -90.98 17.87 7.38 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.09 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 68.39 16.69 9.23 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.18 1.392 . . . . 0.0 112.17 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.1 mt -85.16 102.01 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -86.48 -177.23 6.13 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -62.34 144.95 55.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 76.6 -3.34 2.55 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.61 1.564 . . . . 0.0 111.81 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -68.72 133.69 48.75 Favored 'General case' 0 C--N 1.366 1.306 0 CA-C-N 117.971 0.351 . . . . 0.0 110.713 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 18.0 m -99.43 140.21 33.95 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.796 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.79 173.35 11.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.939 0.896 . . . . 0.0 109.699 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -97.32 147.16 24.44 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.371 0.668 . . . . 0.0 110.88 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 7' ' ' THR . 2.5 tm? -129.19 127.74 41.94 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 96.0 t -108.78 126.77 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 123.282 0.633 . . . . 0.0 110.109 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.52 ' HB3' HD21 ' A' ' 73' ' ' LEU . 66.4 mt -86.25 147.04 26.27 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.771 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.427 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 37.3 mtp-105 -136.29 6.4 3.05 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.475 1.11 . . . . 0.0 110.243 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.581 HD11 HG13 ' A' ' 36' ' ' ILE . 4.2 mm? . . . . . 0 N--CA 1.489 1.516 0 C-N-CA 126.467 1.907 . . . . 0.0 114.27 -169.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' B' ' 212' ' ' PRO . 11.6 mptt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.13 -176.91 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.87 1.668 . . . . 0.0 109.093 -172.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -111.23 146.08 37.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.936 -0.478 . . . . 0.0 110.915 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.613 ' HA ' HD13 ' B' ' 216' ' ' ILE . 35.1 t -94.72 101.12 6.31 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.43 ' HD2' HD21 ' B' ' 220' ' ' LEU . 66.3 Cg_endo -67.49 -4.65 12.35 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.173 2.582 . . . . 0.0 114.765 -164.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . 0.44 HG12 ' O ' ' B' ' 223' ' ' CYS . 11.6 t -95.25 -58.01 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 122.793 0.437 . . . . 0.0 110.661 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.3 p -99.19 -4.63 31.65 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 66.85 47.01 69.11 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 172.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.25 144.22 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 117.514 0.657 . . . . 0.0 110.842 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -90.26 108.75 19.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.078 0.951 . . . . 0.0 110.026 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' B' ' 204' ' ' CYS . 10.0 pt -144.25 153.42 56.12 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.864 1.266 . . . . 0.0 110.419 -172.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' B' ' 201' ' ' LYS . 54.6 Cg_endo -65.17 165.3 22.37 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.439 2.76 . . . . 0.0 114.366 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.577 ' O ' HG23 ' B' ' 216' ' ' ILE . 31.6 tt0 -62.25 -41.83 98.78 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 125.341 1.456 . . . . 0.0 114.31 -164.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.0 m -76.11 -29.7 57.98 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.812 -1.18 . . . . 0.0 110.712 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -81.63 -23.96 36.66 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.047 0.539 . . . . 0.0 109.997 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.613 HD13 ' HA ' ' B' ' 204' ' ' CYS . 0.1 OUTLIER -72.64 -42.79 62.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -65.11 -42.93 93.49 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.851 0.719 . . . . 0.0 110.923 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -64.09 -37.62 88.12 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.654 0.596 . . . . 0.0 110.969 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -39.88 88.58 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.401 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.532 HD13 HG21 ' A' ' 70' ' ' VAL . 80.0 mt -71.19 -32.38 68.78 Favored 'General case' 0 C--O 1.214 -0.763 0 O-C-N 124.201 0.938 . . . . 0.0 111.581 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -58.65 -27.29 64.61 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 123.847 0.717 . . . . 0.0 109.892 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.3 t -95.51 -36.03 11.45 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 123.473 0.709 . . . . 0.0 112.4 172.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . 0.495 ' HB2' ' HA ' ' B' ' 220' ' ' LEU . 91.6 m -81.96 -17.79 45.76 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.142 0.977 . . . . 0.0 112.614 -168.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 N--CA 1.488 1.442 0 C-N-CA 122.582 0.353 . . . . 0.0 111.052 177.962 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 mmt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.4 mp0 -95.06 131.03 41.49 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.791 0.436 . . . . 0.0 111.456 -173.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.24 147.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.013 1.325 . . . . 0.0 108.539 172.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' THR . 96.1 m-85 -111.49 103.63 11.99 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.316 0.647 . . . . 0.0 110.211 -169.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.565 HG12 ' HB2' ' A' ' 69' ' ' LEU . 84.0 t -103.01 106.06 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.896 0.878 . . . . 0.0 108.978 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -89.22 118.29 28.8 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.816 1.246 . . . . 0.0 110.426 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.599 HG23 HD12 ' A' ' 69' ' ' LEU . 7.8 p -70.95 167.36 19.27 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.61 0.719 . . . . 0.0 112.131 175.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.52 HD12 HG22 ' A' ' 70' ' ' VAL . 89.2 mt -70.2 -11.23 60.75 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.675 172.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.7 p -86.47 -4.43 59.17 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.478 0.711 . . . . 0.0 111.504 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.49 15.63 73.23 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.262 0.352 . . . . 0.0 112.868 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -93.53 151.59 19.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.472 1.109 . . . . 0.0 109.923 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -109.51 128.74 55.4 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.141 0.576 . . . . 0.0 110.288 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.96 106.71 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.685 0.794 . . . . 0.0 108.949 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.7 m -88.78 118.03 28.18 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.069 0.947 . . . . 0.0 109.834 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.2 mm? -105.53 159.67 15.76 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.491 0.716 . . . . 0.0 109.458 178.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -126.7 83.19 2.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.775 0.83 . . . . 0.0 108.839 -174.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.694 HG23 HG21 ' A' ' 26' ' ' VAL . 32.2 m -147.73 -177.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 124.168 0.987 . . . . 0.0 110.056 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -96.21 155.95 37.54 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 123.253 0.621 . . . . 0.0 110.247 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 28.9 Cg_endo -61.52 -31.64 87.66 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 121.984 1.789 . . . . 0.0 111.322 167.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -95.65 10.59 36.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.585 0.754 . . . . 0.0 110.939 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.47 -96.36 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.924 0.889 . . . . 0.0 110.334 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.6 t 172.72 144.63 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.327 1.451 . . . . 0.0 108.98 173.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.06 -35.98 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.806 0.843 . . . . 0.0 111.616 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.09 -35.54 75.42 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.606 0.717 . . . . 0.0 110.777 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 6.2 t30 -74.57 -42.32 58.95 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.712 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.694 HG21 HG23 ' A' ' 17' ' ' VAL . 72.8 t -56.75 -44.05 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 124.367 1.042 . . . . 0.0 110.479 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 17.9 ptpt -74.32 -26.45 60.17 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.653 0.381 . . . . 0.0 111.498 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.6 -32.03 72.47 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.635 168.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -68.96 -38.65 79.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.152 0.581 . . . . 0.0 111.134 175.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.16 -43.7 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 118.249 0.477 . . . . 0.0 109.99 173.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.437 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.3 tt0 -65.73 -24.97 67.09 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.236 0.541 . . . . 0.0 111.542 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.92 -31.81 59.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.852 0.461 . . . . 0.0 110.76 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.7 mmtt -91.12 -67.2 0.87 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.611 0.364 . . . . 0.0 110.526 -172.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -86.44 -26.59 24.61 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.384 0.274 . . . . 0.0 111.547 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 93.24 17.4 43.18 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 120.048 -0.307 . . . . 0.0 113.619 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.05 126.77 47.64 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.76 152.46 78.36 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.954 2.436 . . . . 0.0 112.109 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -58.73 -15.76 27.73 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.324 2.682 . . . . 0.0 113.509 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.27 -36.12 63.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.827 0.851 . . . . 0.0 111.432 175.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -97.05 -28.64 14.05 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.158 0.983 . . . . 0.0 112.81 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.412 ' NE2' ' HB2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -90.69 149.86 21.89 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.031 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.46 ' HD3' HD22 ' B' ' 220' ' ' LEU . 10.4 ttt180 -140.85 127.01 19.6 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.481 ' HB3' HD13 ' A' ' 50' ' ' LEU . 4.5 mm? -92.38 126.22 37.37 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.919 0.888 . . . . 0.0 109.337 -171.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.503 HD11 HD21 ' B' ' 220' ' ' LEU . 90.5 mt -140.78 118.62 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.097 0.559 . . . . 0.0 110.704 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.558 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 71.8 t80 -122.01 129.28 52.32 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.28 20.65 12.39 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.708 0.803 . . . . 0.0 112.605 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.77 22.5 55.54 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 119.881 -0.4 . . . . 0.0 113.692 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.5 ptpt -128.96 146.09 51.06 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 173.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.6 ' HB2' ' HB2' ' B' ' 224' ' ' LEU . 0.3 OUTLIER -82.83 138.5 33.92 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 43' ' ' LEU . 26.6 mt -90.82 120.14 31.61 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.56 -172.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -75.53 138.85 41.8 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.4 1.08 . . . . 0.0 110.51 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.17 -49.7 63.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.636 1.174 . . . . 0.0 111.919 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.69 -29.77 76.12 Favored Glycine 0 C--N 1.352 1.471 0 O-C-N 124.367 1.042 . . . . 0.0 113.962 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -79.31 177.46 8.82 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.568 0.747 . . . . 0.0 111.402 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -118.72 166.59 12.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.604 0.762 . . . . 0.0 110.234 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 93.2 mt -55.76 -54.2 47.35 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 124.104 0.877 . . . . 0.0 109.677 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 15.7 t -60.89 -26.02 67.13 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.591 1.156 . . . . 0.0 111.514 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -68.6 -41.22 79.87 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 122.867 0.467 . . . . 0.0 109.834 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -85.86 15.11 5.13 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.631 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 68.36 25.8 6.92 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.69 1.196 . . . . 0.0 111.69 176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.1 mt -93.42 127.89 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.394 1.078 . . . . 0.0 108.256 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -110.08 -178.21 3.46 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 172.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -60.1 137.03 58.19 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.044 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 73.15 10.04 5.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.277 1.431 . . . . 0.0 112.467 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -68.11 138.89 56.09 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 170.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 24.9 m -101.29 129.57 47.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.384 0.674 . . . . 0.0 109.613 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.558 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -143.96 154.35 43.21 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.006 0.923 . . . . 0.0 109.909 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -80.58 154.59 27.37 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.462 0.648 . . . . 0.0 112.455 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.599 HD12 HG23 ' A' ' 7' ' ' THR . 2.2 tm? -131.58 121.67 24.79 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.634 HG23 HD23 ' B' ' 220' ' ' LEU . 57.1 t -98.25 119.36 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.53 0.732 . . . . 0.0 110.397 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -85.97 147.65 26.12 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.853 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -121.41 -40.64 2.56 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.497 0.719 . . . . 0.0 110.874 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.5 2.044 0 C-N-CA 125.022 1.329 . . . . 0.0 113.017 -178.969 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 8.3 m -148.25 -177.58 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.666 1.186 . . . . 0.0 109.326 -167.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -120.95 138.59 54.06 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.722 0.409 . . . . 0.0 111.134 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 204' ' ' CYS . . . . . 0.485 ' HA ' HD13 ' B' ' 216' ' ' ILE . 37.1 t -78.73 100.25 0.52 Allowed Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 124.303 1.041 . . . . 0.0 108.263 174.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . 0.475 ' HD3' HD13 ' B' ' 216' ' ' ILE . 44.5 Cg_endo -81.99 20.49 1.07 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.071 2.514 . . . . 0.0 114.116 -159.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 53.9 t -105.32 -58.24 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.333 0.653 . . . . 0.0 109.691 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 28.8 p -91.97 -23.84 19.43 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.072 0.549 . . . . 0.0 111.22 -175.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.89 52.52 3.83 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 114.299 0.48 . . . . 0.0 114.299 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.76 134.76 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.264 0.626 . . . . 0.0 110.172 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -87.92 114.06 24.17 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' ILE . . . . . 0.439 HD13 ' HB2' ' B' ' 204' ' ' CYS . 8.9 pt -143.89 160.41 50.08 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 124.866 1.266 . . . . 0.0 110.376 -171.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.4 156.19 32.11 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.153 2.569 . . . . 0.0 112.774 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' GLU . . . . . 0.491 ' O ' HG21 ' B' ' 216' ' ' ILE . 33.2 tt0 -66.18 -29.39 69.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.522 1.129 . . . . 0.0 113.499 -171.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 15.7 m -64.11 -43.68 94.58 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.882 0.849 . . . . 0.0 110.057 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -81.17 -21.53 39.62 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.304 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . 0.491 HG21 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -69.82 -41.13 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -58.97 -51.68 69.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.15 0.906 . . . . 0.0 109.973 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -64.95 -47.93 75.88 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.966 -174.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -33.76 76.73 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.505 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.634 HD23 HG23 ' A' ' 70' ' ' VAL . 46.6 tp -68.23 -39.34 82.37 Favored 'General case' 0 C--O 1.214 -0.777 0 O-C-N 124.249 0.968 . . . . 0.0 111.447 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.14 -36.32 63.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.044 0.538 . . . . 0.0 110.822 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.4 t -77.93 -43.92 28.49 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.668 174.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 75.1 m -77.38 -21.09 53.75 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 3.9 pp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.094 0 N-CA-C 112.694 -0.162 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 19.8 m -87.08 -177.04 5.93 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.577 0.751 . . . . 0.0 109.875 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 19.3 p80 -141.36 116.03 9.66 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt -105.32 150.09 25.48 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.2 mp0 -99.47 130.39 45.73 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.041 -174.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.7 146.81 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.636 1.174 . . . . 0.0 109.355 176.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 66' ' ' THR . 73.7 m-85 -103.19 100.11 10.0 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.761 0.824 . . . . 0.0 109.89 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 69' ' ' LEU . 93.6 t -101.67 99.91 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -98.89 123.49 43.19 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.587 -169.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.745 HG21 HD13 ' A' ' 69' ' ' LEU . 41.3 p -67.84 166.75 14.85 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.822 0.849 . . . . 0.0 112.927 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.51 -17.03 64.51 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.073 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.4 p -85.87 2.96 43.84 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.335 0.654 . . . . 0.0 111.113 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.05 85.61 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 113.888 0.315 . . . . 0.0 113.888 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.5 135.98 34.22 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.84 0.856 . . . . 0.0 109.841 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.6 m -101.34 124.58 47.24 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.035 0.534 . . . . 0.0 110.683 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.7 mp -107.53 110.54 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.9 0.88 . . . . 0.0 109.495 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -87.03 118.69 26.58 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.568 0.747 . . . . 0.0 109.755 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.6 mm? -103.78 162.37 13.15 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.491 0.716 . . . . 0.0 109.217 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 0' ' ' HIS . 45.7 mt-10 -125.25 72.0 1.23 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.223 -175.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.685 HG22 HG22 ' A' ' 26' ' ' VAL . 2.4 m -134.11 174.16 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.313 0.645 . . . . 0.0 109.572 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 2.7 mm-40 -85.96 148.68 48.7 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.132 0.573 . . . . 0.0 109.61 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.19 -31.38 89.93 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 121.687 1.592 . . . . 0.0 111.287 167.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.6 t -98.52 17.92 17.89 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.397 0.679 . . . . 0.0 110.563 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 12.1 t0 -74.89 -94.96 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 26' ' ' VAL . 12.0 t 176.95 149.28 0.14 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 125.027 1.331 . . . . 0.0 108.828 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.49 -36.09 76.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.856 0.862 . . . . 0.0 110.848 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.15 -40.71 64.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.902 0.881 . . . . 0.0 110.847 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.3 t30 -70.95 -46.03 63.09 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.126 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.685 HG22 HG22 ' A' ' 17' ' ' VAL . 61.1 t -55.19 -49.52 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 124.173 0.921 . . . . 0.0 111.022 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -67.21 -33.71 75.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.318 0.647 . . . . 0.0 111.929 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.25 -30.1 70.87 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.236 171.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 68.8 mmtt -80.79 -28.15 36.41 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.94 -40.44 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-N 119.577 1.08 . . . . 0.0 108.805 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.76 -35.25 75.93 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.304 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.14 -26.4 62.99 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.778 0.831 . . . . 0.0 112.065 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -95.1 -70.1 0.73 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.415 0.286 . . . . 0.0 111.381 -175.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -83.4 -24.36 31.98 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.23 26.79 13.2 Favored Glycine 0 C--N 1.349 1.259 0 O-C-N 123.224 0.327 . . . . 0.0 113.036 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.8 125.79 29.31 Favored Pre-proline 0 N--CA 1.481 1.115 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.95 155.8 68.32 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.888 2.392 . . . . 0.0 112.686 -171.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.26 -11.57 19.75 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.672 2.915 . . . . 0.0 113.918 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.59 -42.53 58.52 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.205 0.602 . . . . 0.0 110.333 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -89.44 -12.54 39.92 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.829 0.852 . . . . 0.0 112.709 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.459 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.86 152.75 31.67 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 123.127 0.571 . . . . 0.0 109.956 173.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.497 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 41.8 ttt180 -136.09 134.56 38.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.117 0.567 . . . . 0.0 110.3 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.445 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -94.66 123.35 38.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.873 0.869 . . . . 0.0 110.452 -173.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.5 mt -142.91 126.7 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.078 0.951 . . . . 0.0 109.915 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 84.8 t80 -121.96 124.84 44.98 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.271 1.029 . . . . 0.0 108.9 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.6 17.96 7.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.07 0.948 . . . . 0.0 112.964 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.79 -7.14 59.05 Favored Glycine 0 C--N 1.351 1.385 0 C-N-CA 122.992 0.329 . . . . 0.0 113.88 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.8 ptpt -95.43 135.21 37.35 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -73.69 138.98 45.05 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.445 HD12 ' HB3' ' A' ' 43' ' ' LEU . 18.5 mt -92.03 110.22 21.58 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.876 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.89 139.44 43.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.285 1.034 . . . . 0.0 110.524 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.38 -47.06 69.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.696 1.198 . . . . 0.0 112.362 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.01 -26.11 73.29 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 124.123 0.889 . . . . 0.0 114.019 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 80.0 mtt180 -83.24 176.34 9.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.28 0.632 . . . . 0.0 111.794 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.8 p -111.13 167.13 10.51 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.607 0.763 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.75 -51.33 69.99 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.0 t -57.59 -29.95 64.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.727 1.211 . . . . 0.0 111.733 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 10.4 t70 -61.06 -48.26 82.54 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.778 0.799 . . . . 0.0 109.645 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.483 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 29.9 m-85 -87.29 18.85 3.49 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.628 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER 72.0 22.2 3.83 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.303 1.041 . . . . 0.0 111.805 177.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -98.94 118.64 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.83 -179.56 4.21 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 10.8 ptmm? -62.97 140.87 58.9 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.618 170.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 64.2 23.57 13.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.164 1.386 . . . . 0.0 112.678 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -75.72 142.12 42.52 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 166.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 61.3 m -101.15 125.76 47.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.501 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -130.84 173.36 11.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.987 1.315 . . . . 0.0 108.876 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -100.45 151.07 21.98 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.762 0.792 . . . . 0.0 111.726 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.745 HD13 HG21 ' A' ' 7' ' ' THR . 3.1 tm? -129.86 123.74 31.55 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 90.9 t -98.73 112.09 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.324 0.65 . . . . 0.0 110.5 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt -78.22 143.72 36.89 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.961 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.567 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 72.4 mtp180 -124.98 -42.35 2.04 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.724 0.81 . . . . 0.0 110.062 -175.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 48.53 35.25 5.74 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.565 0.746 . . . . 0.0 111.89 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.567 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 4.0 mmp_? -64.08 -29.41 70.54 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.944 -175.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.37 -28.84 67.83 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.824 0.703 . . . . 0.0 113.456 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.307 0 C-N-CA 123.241 0.448 . . . . 0.0 113.89 174.974 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.814 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 39.2 m -88.81 101.18 13.78 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.642 0.777 . . . . 0.0 109.532 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -82.88 73.96 9.88 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.545 0.688 . . . . 0.0 109.584 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -164.95 153.12 11.84 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.55 -1.204 . . . . 0.0 108.961 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.84 119.64 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 169.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' THR . . . . . 0.478 HG22 HG11 ' B' ' 202' ' ' VAL . 34.6 m -77.07 127.7 33.14 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.882 0.873 . . . . 0.0 110.655 -175.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.71 123.45 39.28 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . 0.478 HG11 HG22 ' B' ' 200' ' ' THR . 5.9 m -143.64 167.33 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.193 1.397 . . . . 0.0 110.023 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -94.38 146.48 24.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.171 0.588 . . . . 0.0 111.685 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.57 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.5 t -90.22 102.49 4.96 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.511 ' HD2' HD22 ' B' ' 220' ' ' LEU . 61.2 Cg_endo -66.62 -2.89 8.21 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.115 2.543 . . . . 0.0 114.599 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.24 -64.09 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.003 0.521 . . . . 0.0 110.338 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.2 p -98.84 4.32 47.53 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.67 0.388 . . . . 0.0 111.835 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.06 44.51 97.67 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 115.181 0.832 . . . . 0.0 115.181 169.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.13 136.57 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 117.472 0.636 . . . . 0.0 110.973 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -87.38 123.4 32.29 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.445 HD13 ' HB2' ' B' ' 204' ' ' CYS . 3.9 pt -148.79 162.98 27.79 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.543 1.537 . . . . 0.0 109.013 -169.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.55 153.98 71.6 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.049 1.833 . . . . 0.0 111.333 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.548 ' O ' HG23 ' B' ' 216' ' ' ILE . 2.6 tm-20 -66.97 -36.22 81.72 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.34 1.056 . . . . 0.0 113.217 -168.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 16.7 p -58.82 -41.12 86.08 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.88 0.848 . . . . 0.0 110.14 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -81.03 -19.16 44.48 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.464 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.57 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -71.48 -44.75 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -59.3 -52.65 64.74 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.952 0.901 . . . . 0.0 109.967 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -60.61 -40.13 90.74 Favored 'General case' 0 C--O 1.254 1.296 0 O-C-N 124.401 1.063 . . . . 0.0 111.608 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -43.62 80.4 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.92 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 216' ' ' ILE . 83.4 mt -62.23 -47.04 86.19 Favored 'General case' 0 C--O 1.213 -0.847 0 O-C-N 124.167 0.917 . . . . 0.0 111.144 -177.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -53.83 -32.21 52.06 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 124.112 0.882 . . . . 0.0 111.636 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.3 t -85.06 -39.35 18.09 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.442 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 92.9 m -79.8 -24.84 41.14 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.24 1.016 . . . . 0.0 112.462 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.09 -12.89 42.86 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.072 0.549 . . . . 0.0 110.223 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 46.4 m -68.24 86.15 0.27 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -105.22 169.94 8.16 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.461 1.104 . . . . 0.0 110.522 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.561 1.368 0 C-N-CA 124.693 1.197 . . . . 0.0 110.676 -173.008 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.941 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 83.4 p 54.6 -164.34 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.863 1.265 . . . . 0.0 111.825 -176.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -161.6 141.12 10.15 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.886 0.474 . . . . 0.0 110.415 171.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt -106.19 154.14 21.13 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 14.9 mp0 -102.85 124.97 49.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.181 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -121.91 159.36 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.475 1.11 . . . . 0.0 108.605 175.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' THR . 61.3 m-85 -114.23 116.3 28.82 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.367 0.603 . . . . 0.0 110.463 -172.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.709 HG12 ' HB2' ' A' ' 69' ' ' LEU . 2.1 t -104.26 117.79 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -109.58 110.31 21.34 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.73 0.812 . . . . 0.0 108.822 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.618 HG23 HD13 ' A' ' 69' ' ' LEU . 40.7 p -66.64 163.16 19.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.481 0.313 . . . . 0.0 111.136 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.36 -19.6 65.58 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.894 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.5 p -78.72 -9.86 59.56 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.959 0.504 . . . . 0.0 110.908 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.44 8.84 62.23 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.683 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -84.32 146.76 27.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.428 0.691 . . . . 0.0 110.267 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -108.27 140.03 42.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.271 0.628 . . . . 0.0 109.903 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -129.99 116.6 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.082 1.353 . . . . 0.0 107.72 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -93.63 120.8 34.35 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -104.64 156.47 17.95 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -127.25 83.02 2.13 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.696 HG23 HG21 ' A' ' 26' ' ' VAL . 33.7 m -146.07 178.75 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.967 0.907 . . . . 0.0 110.25 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -95.4 155.38 38.8 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.485 0.714 . . . . 0.0 109.801 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 21.3 Cg_endo -62.43 -26.97 76.86 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 121.774 1.649 . . . . 0.0 111.833 166.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -93.2 5.16 52.47 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.726 0.81 . . . . 0.0 111.321 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.82 -98.32 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.923 0.889 . . . . 0.0 110.734 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 9.5 t 170.11 143.54 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.353 1.461 . . . . 0.0 109.246 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.99 -32.82 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.602 0.761 . . . . 0.0 110.54 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -54.98 -41.42 71.16 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.361 1.064 . . . . 0.0 110.091 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 9.4 t30 -79.26 -40.68 29.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.136 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.696 HG21 HG23 ' A' ' 17' ' ' VAL . 85.6 t -56.35 -44.43 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 124.112 0.883 . . . . 0.0 110.856 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HZ1' ' HB3' ' A' ' 52' ' ' ASP . 17.6 ptpt -73.45 -29.61 62.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.93 0.492 . . . . 0.0 111.231 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.78 71.84 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.731 168.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 10.0 mmpt? -72.16 -37.88 69.28 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-O 119.181 -0.437 . . . . 0.0 110.785 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.547 HD12 HG22 ' A' ' 5' ' ' VAL . 2.0 mp -55.22 -45.99 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.006 0.431 . . . . 0.0 110.054 172.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -61.9 -33.43 74.22 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.49 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -72.12 -32.31 66.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.543 0.737 . . . . 0.0 111.646 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.3 mmtt -90.65 -66.31 0.94 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.613 0.365 . . . . 0.0 110.975 -172.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -87.91 -26.84 22.52 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.92 29.35 10.63 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.06 126.02 30.25 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.7 154.05 75.82 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.841 2.361 . . . . 0.0 112.473 -173.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 20.7 Cg_endo -56.94 -19.43 32.07 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.557 2.838 . . . . 0.0 113.251 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.61 -35.74 70.57 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.876 0.87 . . . . 0.0 111.024 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -95.2 -27.92 15.29 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 123.486 0.714 . . . . 0.0 112.198 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.491 ' HB2' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -92.5 140.63 29.37 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.637 0.653 . . . . 0.0 109.809 178.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.432 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 19.7 ttt180 -127.8 127.89 44.32 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -96.28 123.21 39.83 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.595 0.758 . . . . 0.0 110.371 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -141.5 129.42 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.017 0.527 . . . . 0.0 109.864 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.551 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 93.7 t80 -130.81 121.98 26.31 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.19 20.81 11.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.718 0.807 . . . . 0.0 113.122 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.09 -16.96 57.77 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.0 ptpt -90.34 135.15 33.86 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.09 135.42 35.32 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD22 ' HB3' ' A' ' 45' ' ' PHE . 20.2 mt -89.29 114.21 25.57 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.689 -172.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 31.0 tt0 -76.95 138.24 39.55 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 123.603 0.761 . . . . 0.0 109.637 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.427 ' HB3' ' HZ1' ' A' ' 27' ' ' LYS . 5.5 p-10 -60.5 -37.79 82.23 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.124 0.89 . . . . 0.0 111.93 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.416 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -67.27 -22.07 72.54 Favored Glycine 0 C--N 1.348 1.235 0 O-C-N 123.675 0.609 . . . . 0.0 114.183 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.543 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 78.7 mtt180 -89.59 177.22 6.6 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.393 0.677 . . . . 0.0 111.511 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 55.6 p -109.9 169.78 8.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.522 0.729 . . . . 0.0 110.43 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 87.1 mt -55.83 -54.86 39.34 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.59 0.556 . . . . 0.0 109.705 173.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 22.8 t -61.73 -22.73 65.62 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.333 1.053 . . . . 0.0 111.798 -176.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.1 -47.39 83.04 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.543 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 36.2 m-85 -86.33 17.02 3.95 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.148 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.442 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER 72.96 9.76 5.39 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.144 1.378 . . . . 0.0 112.404 176.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.1 mt -81.66 123.09 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.7 0.8 . . . . 0.0 108.958 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -110.0 -174.18 2.43 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.181 0.592 . . . . 0.0 109.712 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.44 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 10.2 ptmm? -58.7 144.34 43.84 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.713 172.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 62.33 10.82 4.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.937 1.295 . . . . 0.0 113.644 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -70.06 132.57 46.07 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 118.17 0.441 . . . . 0.0 110.223 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 29.0 m -93.89 130.97 39.75 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.08 160.46 38.89 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.973 0.909 . . . . 0.0 109.416 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -88.7 138.69 31.19 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.203 0.525 . . . . 0.0 111.423 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.709 ' HB2' HG12 ' A' ' 5' ' ' VAL . 2.7 tm? -119.62 135.26 54.88 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.604 HG21 HD13 ' B' ' 220' ' ' LEU . 90.8 t -115.6 115.54 49.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.591 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.505 ' HB3' HD23 ' A' ' 73' ' ' LEU . 67.2 mt -81.27 99.44 8.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.128 173.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -67.69 -40.52 84.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.67 1.188 . . . . 0.0 109.144 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 71' ' ' LEU . 0.2 OUTLIER 58.37 29.93 18.87 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.037 1.335 . . . . 0.0 112.082 172.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -79.74 -7.24 58.51 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.066 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.3 36.58 1.64 Allowed Glycine 0 C--N 1.341 0.849 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.337 0 O-C-N 124.02 0.482 . . . . 0.0 113.816 174.744 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.736 0 CA-C-O 120.93 0.184 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 35.0 p -98.94 87.19 3.65 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.35 1.06 . . . . 0.0 108.967 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -116.67 -56.28 2.29 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.918 0.887 . . . . 0.0 109.641 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -94.17 165.08 12.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.694 0.798 . . . . 0.0 109.912 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' B' ' 213' ' ' GLU . 5.6 p -61.17 118.78 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.154 0.502 . . . . 0.0 110.072 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 20.1 m -76.68 146.75 37.88 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.958 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' B' ' 201' ' ' LYS . 9.4 mptt -97.7 122.22 40.54 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 172.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.27 -178.5 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.72 0.808 . . . . 0.0 110.314 -165.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -124.95 144.72 50.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.72 0.808 . . . . 0.0 109.352 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.581 ' HA ' HD13 ' B' ' 216' ' ' ILE . 42.0 t -91.09 100.46 2.99 Favored Pre-proline 0 N--CA 1.481 1.093 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.507 ' HD2' HD23 ' B' ' 220' ' ' LEU . 30.1 Cg_endo -58.56 -23.65 65.98 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.983 2.456 . . . . 0.0 114.137 -169.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.37 -53.59 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 C-N-CA 122.22 0.208 . . . . 0.0 111.555 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 17.8 p -103.34 -6.72 21.69 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.7 50.86 39.45 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.527 0.517 . . . . 0.0 114.286 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.0 m -119.09 138.97 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 123.232 0.613 . . . . 0.0 110.271 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -87.44 125.27 34.19 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' B' ' 204' ' ' CYS . 6.5 pt -153.47 157.04 32.8 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 125.136 1.375 . . . . 0.0 109.371 -169.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.19 165.0 31.81 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.417 2.078 . . . . 0.0 112.974 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.521 ' O ' HG23 ' B' ' 216' ' ' ILE . 39.8 tt0 -60.03 -42.1 93.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.69 1.596 . . . . 0.0 115.006 -166.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 35.9 t -70.5 -33.58 71.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.369 -0.832 . . . . 0.0 109.976 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -71.35 -29.34 64.86 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.327 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.581 HD13 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -71.8 -37.0 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -57.49 -54.21 49.4 Favored 'General case' 0 C--O 1.244 0.806 0 O-C-N 123.803 0.689 . . . . 0.0 110.365 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -69.54 -33.3 72.59 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.973 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -46.46 90.52 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 70' ' ' VAL . 91.2 mt -67.91 -37.43 81.7 Favored 'General case' 0 C--O 1.208 -1.09 0 O-C-N 124.129 0.893 . . . . 0.0 111.232 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.04 -32.31 63.91 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 124.538 1.149 . . . . 0.0 110.675 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 33.2 t -93.49 -36.36 12.48 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.513 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 96.9 m -77.8 -24.13 48.91 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.607 0.763 . . . . 0.0 112.802 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.4 -21.16 63.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.928 0.491 . . . . 0.0 110.459 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 14.0 m -69.14 111.04 4.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.295 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -144.56 37.69 1.22 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.275 1.03 . . . . 0.0 109.043 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.558 1.283 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.864 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 CA-C-O 120.683 0.046 . . . . 0.0 113.081 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 71.3 m -72.55 119.97 17.52 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.914 0.486 . . . . 0.0 109.862 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -153.44 -73.65 0.13 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.453 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.9 mmt -81.41 166.9 19.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.06 0.544 . . . . 0.0 110.356 -175.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.6 mp0 -114.07 136.91 52.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.262 0.625 . . . . 0.0 110.552 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -128.82 164.14 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 124.811 1.244 . . . . 0.0 108.721 172.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 66' ' ' THR . 69.4 m-85 -119.72 110.18 16.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.137 -174.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.477 HG21 HD12 ' A' ' 30' ' ' ILE . 50.8 t -97.03 135.22 31.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -122.09 123.77 42.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.837 0.455 . . . . 0.0 110.214 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.618 HG23 HD13 ' A' ' 69' ' ' LEU . 57.0 p -81.18 165.37 21.59 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.974 0.416 . . . . 0.0 111.728 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 70' ' ' VAL . 85.8 mt -71.38 -19.53 62.26 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.459 172.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.0 p -78.57 -17.88 55.45 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.724 0.41 . . . . 0.0 109.967 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.86 23.9 14.42 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 167.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.21 153.01 18.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 172.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -100.4 144.56 29.26 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 170.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.527 HD11 HG22 ' A' ' 7' ' ' THR . 5.1 mp -124.97 113.44 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.826 1.251 . . . . 0.0 107.911 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.0 m -89.45 122.04 32.26 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.3 mm? -111.19 152.36 27.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.561 0.744 . . . . 0.0 109.156 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 1' ' ' MET . 3.0 mp0 -112.81 95.32 5.35 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 26' ' ' VAL . 33.5 m -146.34 -174.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -102.09 155.77 36.05 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 19.7 Cg_endo -57.98 -32.29 94.94 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.018 1.812 . . . . 0.0 111.118 167.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -98.1 18.62 15.7 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.312 0.645 . . . . 0.0 110.808 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -82.13 -92.57 0.06 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.046 0.538 . . . . 0.0 109.808 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.466 HG21 ' H ' ' A' ' 25' ' ' ASN . 15.3 t 177.81 149.49 0.18 Allowed 'General case' 0 C--N 1.367 1.361 0 C-N-CA 124.526 1.13 . . . . 0.0 110.762 174.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.0 mm -65.83 -37.19 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.591 1.157 . . . . 0.0 110.81 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -55.6 -38.57 69.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.181 0.992 . . . . 0.0 111.056 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.497 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 4.9 t-20 -76.64 -39.14 53.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.277 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.595 HG22 HG22 ' A' ' 17' ' ' VAL . 64.4 t -57.67 -46.9 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 124.471 1.107 . . . . 0.0 110.759 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HA ' HD11 ' A' ' 30' ' ' ILE . 17.2 ptpt -71.3 -27.56 63.49 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.944 0.498 . . . . 0.0 111.795 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.27 -39.43 89.41 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.505 0.503 . . . . 0.0 110.911 169.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 4.4 mmtm -66.15 -37.27 85.25 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.652 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 27' ' ' LYS . 94.3 mt -64.05 -38.42 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.649 0.78 . . . . 0.0 110.915 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.404 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.8 tt0 -64.92 -31.1 72.18 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.036 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.31 -38.91 78.48 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.398 0.279 . . . . 0.0 110.984 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.5 mmtt -85.31 -69.43 0.66 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.078 0.237 . . . . 0.0 110.699 -168.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.7 -20.49 31.12 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 122.087 0.155 . . . . 0.0 111.08 -176.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 88.06 25.96 30.15 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.451 0.469 . . . . 0.0 113.359 171.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.11 125.88 30.15 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -65.47 149.83 87.47 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.939 2.426 . . . . 0.0 112.438 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.05 -17.6 11.56 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 124.325 3.35 . . . . 0.0 114.339 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -74.49 -41.91 59.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.302 0.641 . . . . 0.0 111.2 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.12 -33.56 22.36 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.731 0.812 . . . . 0.0 111.489 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.433 HE22 HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -89.78 149.34 22.75 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 44.3 ttt180 -132.75 131.12 40.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.941 0.496 . . . . 0.0 110.207 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.433 HD21 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -94.84 124.84 39.11 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.687 0.795 . . . . 0.0 110.122 -174.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.7 mt -142.52 132.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.003 0.921 . . . . 0.0 109.139 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 86.6 t80 -135.21 132.31 37.75 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 171.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.49 23.28 12.93 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.889 0.876 . . . . 0.0 112.197 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.33 -7.97 75.29 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 114.516 0.566 . . . . 0.0 114.516 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.8 ptpt -103.28 141.34 36.08 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 117.494 0.647 . . . . 0.0 109.448 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.476 ' NE2' HD23 ' B' ' 224' ' ' LEU . 8.0 tt0 -74.43 131.41 41.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD23 ' HB3' ' A' ' 45' ' ' PHE . 20.3 mt -83.25 117.97 23.31 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.407 0.283 . . . . 0.0 110.245 -176.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.76 137.96 38.0 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 123.945 0.898 . . . . 0.0 109.674 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.3 -50.26 67.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.726 1.211 . . . . 0.0 111.843 -174.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.64 -27.39 70.93 Favored Glycine 0 C--N 1.35 1.32 0 O-C-N 124.273 0.983 . . . . 0.0 114.072 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.446 ' HD3' ' OD2' ' A' ' 58' ' ' ASP . 54.5 mtt180 -77.3 175.73 9.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.316 0.646 . . . . 0.0 112.013 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 65.8 p -111.27 164.08 13.27 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.013 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.9 mt -55.44 -53.33 57.59 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.807 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 9.4 t -66.56 -20.64 66.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.263 1.025 . . . . 0.0 111.339 -173.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.446 ' OD2' ' HD3' ' A' ' 54' ' ' ARG . 12.2 t70 -67.26 -42.18 84.31 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -86.78 16.18 5.05 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.813 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.94 17.43 6.28 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.033 1.333 . . . . 0.0 112.301 176.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.1 mt -90.45 103.66 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -84.97 -178.97 6.97 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -59.4 143.47 49.62 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 64.28 11.83 6.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.13 1.372 . . . . 0.0 113.573 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.9 m -75.25 149.57 38.82 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.275 0.489 . . . . 0.0 110.614 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.7 m -101.02 130.12 46.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.974 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.61 154.85 48.46 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.95 1.3 . . . . 0.0 108.181 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -87.85 158.7 18.66 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.44 0.638 . . . . 0.0 111.888 -174.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.618 HD13 HG23 ' A' ' 7' ' ' THR . 2.4 tm? -141.94 129.47 21.38 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.545 -1.207 . . . . 0.0 107.829 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.511 HG23 HD11 ' B' ' 220' ' ' LEU . 98.4 t -111.0 117.18 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.755 0.822 . . . . 0.0 110.112 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.68 139.86 30.36 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.123 0.969 . . . . 0.0 110.673 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.506 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 18.6 mtm180 -118.18 -44.92 2.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.748 0.819 . . . . 0.0 111.583 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.49 32.4 20.69 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.201 1.0 . . . . 0.0 112.425 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.506 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 88.0 mmt-85 -61.09 -58.04 10.04 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.725 0.81 . . . . 0.0 109.951 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.27 32.24 6.9 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 114.768 -1.106 . . . . 0.0 112.135 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.609 0 CA-C-N 116.514 0.157 . . . . 0.0 113.439 179.057 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.764 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 28.0 p -70.28 90.78 0.7 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.429 0.692 . . . . 0.0 110.124 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . 0.4 HH22 ' HD3' ' A' ' 74' ' ' ARG . 56.9 ttt180 -75.56 124.98 28.12 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.121 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.26 175.34 8.24 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.269 1.027 . . . . 0.0 109.232 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 6.3 p -70.71 83.63 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 CA-C-O 122.422 1.106 . . . . 0.0 109.264 171.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 42.3 m -78.4 136.73 37.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.856 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.52 ' HB2' ' HZ2' ' B' ' 201' ' ' LYS . 0.2 OUTLIER -98.53 123.68 42.83 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 6.6 m -134.12 -178.86 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 125.379 1.472 . . . . 0.0 109.173 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -109.64 146.18 35.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.19 0.596 . . . . 0.0 111.097 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.531 ' HA ' HD13 ' B' ' 216' ' ' ILE . 49.7 t -89.46 102.36 4.32 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.322 1.049 . . . . 0.0 109.236 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.52 ' HD2' HD22 ' B' ' 220' ' ' LEU . 45.8 Cg_endo -62.28 -10.09 17.34 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.776 2.984 . . . . 0.0 114.984 -166.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 42.4 t -84.07 -60.47 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 123.054 0.542 . . . . 0.0 110.769 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 22.3 p -101.3 -6.99 23.42 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.804 0.441 . . . . 0.0 112.038 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.66 51.05 38.36 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.435 0.54 . . . . 0.0 114.207 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.12 142.22 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 123.008 0.523 . . . . 0.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -92.47 122.36 34.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.491 0.717 . . . . 0.0 109.903 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.49 HD13 ' HB2' ' B' ' 204' ' ' CYS . 3.8 pt -152.67 160.99 30.39 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.767 1.627 . . . . 0.0 109.387 -169.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.26 158.8 46.67 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.156 1.904 . . . . 0.0 111.629 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.525 ' O ' HG23 ' B' ' 216' ' ' ILE . 2.9 tm-20 -69.75 -28.41 65.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.055 0.942 . . . . 0.0 112.104 -169.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 37.2 p -60.79 -45.82 92.9 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.657 0.741 . . . . 0.0 110.058 169.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -76.8 -18.3 58.5 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.815 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.548 ' O ' ' HG ' ' B' ' 220' ' ' LEU . 0.2 OUTLIER -72.21 -50.16 38.26 Favored 'Isoleucine or valine' 0 C--N 1.364 1.214 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -67.75 -35.61 79.04 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.205 0.316 . . . . 0.0 110.467 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -45.47 94.03 Favored 'General case' 0 C--O 1.254 1.313 0 O-C-N 123.886 0.741 . . . . 0.0 110.967 172.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . 0.422 ' HB3' ' SG ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -59.57 -38.58 81.53 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.78 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 216' ' ' ILE . 79.4 mt -66.21 -39.56 89.7 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 123.972 0.795 . . . . 0.0 111.295 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -55.56 -38.71 69.68 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.945 0.778 . . . . 0.0 110.88 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.2 t -88.24 -31.54 18.98 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.829 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 63.6 m -82.47 -19.73 38.29 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.645 0.778 . . . . 0.0 112.967 -173.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . 0.476 HD23 ' NE2' ' A' ' 49' ' ' GLN . 4.6 pp -76.42 -8.65 57.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.676 0.39 . . . . 0.0 110.928 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 17.0 m -63.7 2.38 0.47 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.031 1.333 . . . . 0.0 113.185 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -57.14 98.5 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.284 1.034 . . . . 0.0 109.776 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--O 1.248 1.006 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -174.549 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 28.9 t -93.74 -46.17 7.35 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.376 0.67 . . . . 0.0 111.807 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.549 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 2.9 m80 70.57 132.61 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.62 1.168 . . . . 0.0 111.634 -170.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt -132.11 -174.39 3.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.679 1.191 . . . . 0.0 109.769 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.1 mp0 -112.35 155.61 23.85 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.469 0.708 . . . . 0.0 110.201 174.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.45 HD11 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -142.8 157.08 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 124.793 1.237 . . . . 0.0 109.218 167.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' THR . 39.0 m-85 -112.57 100.49 8.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.372 0.669 . . . . 0.0 110.322 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 69' ' ' LEU . 95.2 t -101.77 104.84 16.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -102.16 127.3 49.15 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.732 0.813 . . . . 0.0 111.137 -172.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.65 HG23 HD11 ' A' ' 69' ' ' LEU . 49.2 p -70.85 166.46 21.02 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-O 121.599 0.714 . . . . 0.0 112.782 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 70' ' ' VAL . 68.4 mt -67.82 -23.52 65.19 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.297 171.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.7 p -78.63 -16.54 57.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.308 0.643 . . . . 0.0 110.397 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.41 5.71 39.54 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-O 119.182 -0.788 . . . . 0.0 114.856 167.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HZ1' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -84.47 151.13 24.82 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.063 0.932 . . . . 0.0 108.586 177.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.1 m -107.01 126.04 51.81 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.013 0.525 . . . . 0.0 110.3 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 7' ' ' THR . 4.7 mp -107.27 110.75 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.797 0.839 . . . . 0.0 109.006 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.9 m -90.31 120.44 31.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.278 0.631 . . . . 0.0 109.446 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.5 mm? -106.9 151.75 24.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.01 0.524 . . . . 0.0 109.833 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -110.69 78.29 1.11 Allowed 'General case' 0 C--O 1.239 0.53 0 O-C-N 124.205 0.941 . . . . 0.0 108.618 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.719 HG21 HG21 ' A' ' 26' ' ' VAL . 3.4 m -144.77 172.07 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.702 0.801 . . . . 0.0 108.981 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 0' ' ' HIS . 8.1 mt-10 -93.11 158.0 38.08 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.65 -34.16 97.73 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.139 1.893 . . . . 0.0 112.074 169.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.2 t -102.03 21.35 14.93 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.881 0.472 . . . . 0.0 110.611 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -73.03 -87.33 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 26' ' ' VAL . 7.4 t 173.65 148.86 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.461 1.504 . . . . 0.0 109.081 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.478 HG22 ' HE3' ' A' ' 27' ' ' LYS . 44.3 mm -63.19 -38.53 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.322 1.049 . . . . 0.0 110.42 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -60.03 -33.06 71.5 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.374 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.2 t-20 -74.53 -43.26 56.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.719 HG21 HG21 ' A' ' 17' ' ' VAL . 60.6 t -56.35 -47.31 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 124.387 1.054 . . . . 0.0 110.093 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.492 ' HB3' HD22 ' A' ' 43' ' ' LEU . 17.6 ptpt -74.18 -25.93 59.99 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.37 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.62 -34.26 77.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.28 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 73.6 mmtt -72.52 -32.59 66.25 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.557 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 27' ' ' LYS . 1.4 mp -53.42 -45.0 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 119.05 0.841 . . . . 0.0 110.076 168.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.97 -32.99 74.72 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.507 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.99 -34.88 66.71 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.099 0.56 . . . . 0.0 111.328 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.76 -68.7 0.78 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.046 0.539 . . . . 0.0 110.952 -171.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -83.35 -21.74 33.03 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.78 20.8 35.76 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.753 -0.203 . . . . 0.0 112.942 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -107.98 122.72 39.88 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.35 153.43 78.25 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.645 2.23 . . . . 0.0 112.333 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.421 ' HA ' ' HG3' ' A' ' 41' ' ' GLN . 18.4 Cg_endo -56.32 -14.38 12.17 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.715 2.943 . . . . 0.0 113.761 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -75.07 -48.78 22.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.033 0.933 . . . . 0.0 110.628 173.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -80.84 -23.83 38.86 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.511 0.724 . . . . 0.0 111.911 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.501 ' NE2' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.43 153.71 18.34 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.592 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 32.9 ttt180 -134.89 126.48 28.81 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.714 ' HG ' HD11 ' A' ' 50' ' ' LEU . 5.3 tp -100.84 122.61 43.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.839 -166.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.1 mt -139.32 133.05 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.727 0.811 . . . . 0.0 109.954 -173.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.598 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 82.6 t80 -135.32 131.97 37.11 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.78 21.62 12.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.857 0.863 . . . . 0.0 112.468 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.58 10.4 79.58 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.449 -0.341 . . . . 0.0 113.819 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 12.7 ptpt -118.39 147.57 43.41 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.286 0.634 . . . . 0.0 109.373 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.496 ' HB2' HD22 ' B' ' 224' ' ' LEU . 8.0 tt0 -75.94 127.2 32.48 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.127 0.571 . . . . 0.0 109.779 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.714 HD11 ' HG ' ' A' ' 43' ' ' LEU . 25.0 mt -80.75 123.65 28.39 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.039 0.536 . . . . 0.0 109.998 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.75 138.44 32.09 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.152 0.981 . . . . 0.0 109.707 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.53 -39.2 92.82 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.627 1.171 . . . . 0.0 112.28 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.14 -18.57 76.64 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.218 0.949 . . . . 0.0 113.816 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -88.35 178.1 6.66 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.823 0.849 . . . . 0.0 111.563 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.6 p -116.59 168.67 9.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.717 0.807 . . . . 0.0 109.874 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.5 mt -57.54 -50.73 72.13 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.1 t -61.55 -25.64 67.43 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.379 1.072 . . . . 0.0 111.554 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.64 -45.98 84.49 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 121.127 0.489 . . . . 0.0 109.688 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -85.59 17.23 3.36 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.473 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 65.73 19.98 11.45 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.402 1.081 . . . . 0.0 111.776 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.6 mt -85.58 132.68 31.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -115.8 -175.2 2.68 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -61.96 130.41 45.49 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.238 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 72.58 18.18 4.42 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.258 1.423 . . . . 0.0 111.965 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.4 m -71.05 139.92 50.58 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 53.1 m -93.72 129.66 39.98 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.456 0.473 . . . . 0.0 109.986 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.598 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -137.84 166.07 24.92 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.696 1.198 . . . . 0.0 108.891 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -96.65 148.3 23.01 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.349 0.595 . . . . 0.0 111.267 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.65 HD11 HG23 ' A' ' 7' ' ' THR . 2.4 tm? -127.12 130.85 50.6 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 94.0 t -114.02 130.42 68.25 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 124.207 1.003 . . . . 0.0 109.936 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.34 146.29 25.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.317 0.647 . . . . 0.0 110.95 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.602 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 65.2 mtp180 -117.18 -40.46 3.09 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.28 1.032 . . . . 0.0 110.627 177.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 48.19 34.31 4.32 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.989 1.316 . . . . 0.0 113.191 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.602 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 26.1 mmm180 -74.09 -42.47 60.09 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.586 0.707 . . . . 0.0 109.271 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.74 64.67 0.49 Allowed Glycine 0 C--N 1.34 0.805 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.13 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.046 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 175.69 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.728 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 23.5 m -69.27 146.69 52.07 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.771 0.828 . . . . 0.0 111.369 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -162.46 -33.65 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.661 0.784 . . . . 0.0 109.802 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -85.92 156.8 20.35 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.8 0.84 . . . . 0.0 109.165 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.47 117.17 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 121.253 0.549 . . . . 0.0 110.543 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' THR . . . . . 0.51 HG21 HG13 ' B' ' 202' ' ' VAL . 29.5 m -72.49 131.86 43.09 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.096 -173.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -83.94 122.68 29.07 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . 0.51 HG13 HG21 ' B' ' 200' ' ' THR . 3.6 m -145.59 -177.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.902 0.881 . . . . 0.0 110.179 -168.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -125.81 146.7 49.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.58 0.752 . . . . 0.0 110.907 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.574 ' HA ' HD13 ' B' ' 216' ' ' ILE . 48.7 t -92.95 96.09 1.29 Allowed Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 124.651 1.18 . . . . 0.0 107.998 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.537 ' HD2' HD23 ' B' ' 220' ' ' LEU . 34.2 Cg_endo -59.79 -17.36 42.76 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.234 2.622 . . . . 0.0 114.483 -168.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.16 -56.93 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 122.789 0.436 . . . . 0.0 110.851 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 14.9 p -103.65 -0.65 29.26 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.435 0.294 . . . . 0.0 111.555 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 69.05 42.11 78.47 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 115.153 0.821 . . . . 0.0 115.153 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.01 137.51 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.318 0.559 . . . . 0.0 110.894 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -89.13 123.77 33.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.211 0.604 . . . . 0.0 109.684 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.403 HD13 ' HB2' ' B' ' 204' ' ' CYS . 6.2 pt -153.55 160.11 31.32 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.845 1.258 . . . . 0.0 110.434 -168.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.18 161.22 16.83 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.172 2.581 . . . . 0.0 113.563 171.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.554 ' O ' HG21 ' B' ' 216' ' ' ILE . 40.3 tt0 -62.79 -44.72 95.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.412 1.485 . . . . 0.0 113.096 -172.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 20.3 m -62.66 -40.99 98.78 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-O 121.978 0.894 . . . . 0.0 110.347 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -73.58 -26.3 60.75 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.249 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -69.54 -43.68 80.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -67.29 -37.42 83.38 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 123.394 0.434 . . . . 0.0 110.421 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -69.59 -40.59 76.61 Favored 'General case' 0 C--O 1.247 0.945 0 O-C-N 123.226 0.329 . . . . 0.0 111.57 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -45.45 93.15 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.48 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.537 HD23 ' HD2' ' B' ' 205' ' ' PRO . 96.3 mt -61.82 -43.62 98.48 Favored 'General case' 0 C--O 1.206 -1.196 0 O-C-N 124.431 1.082 . . . . 0.0 111.153 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.45 -27.21 56.2 Favored 'General case' 0 CA--C 1.553 1.094 0 O-C-N 124.578 1.173 . . . . 0.0 110.767 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.4 t -91.57 -39.8 11.7 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.642 0.777 . . . . 0.0 111.454 172.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 91.4 m -75.04 -23.0 58.07 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.333 1.053 . . . . 0.0 112.899 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . 0.496 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.5 pp -85.92 -23.9 26.81 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 32.1 m -71.49 84.37 0.83 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.697 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . 0.515 ' HG3' ' HG3' ' B' ' 227' ' ' GLU . 6.6 ptm180 -99.59 -36.02 9.66 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.979 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . 0.515 ' HG3' ' HG3' ' B' ' 226' ' ' ARG . 42.7 mt-10 . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.05 0.94 . . . . 0.0 108.484 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.038 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.8 m -84.09 115.84 22.58 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.692 0.797 . . . . 0.0 111.076 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -72.17 106.77 4.51 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.806 0.842 . . . . 0.0 109.67 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt -86.52 171.67 10.9 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.071 0.949 . . . . 0.0 111.044 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 54.9 mt-30 -107.2 138.5 43.27 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.678 0.791 . . . . 0.0 110.635 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.544 HD13 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -137.57 153.59 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.299 1.04 . . . . 0.0 109.746 176.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' THR . 81.8 m-85 -105.79 107.78 18.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.033 0.933 . . . . 0.0 109.445 -175.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 30' ' ' ILE . 56.1 t -103.67 117.58 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -108.11 119.6 39.95 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.844 0.857 . . . . 0.0 109.615 -171.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.618 HG21 HD13 ' A' ' 69' ' ' LEU . 38.5 p -72.1 165.0 25.19 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.296 0.569 . . . . 0.0 111.461 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.439 HD11 HG21 ' A' ' 70' ' ' VAL . 88.4 mt -70.37 -18.7 63.06 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.165 171.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -79.64 -12.86 59.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.908 0.483 . . . . 0.0 110.809 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.54 18.78 37.19 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.908 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.05 153.44 18.16 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.7 m -100.58 134.28 43.78 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.585 0.754 . . . . 0.0 110.022 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -120.41 109.93 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.96 1.304 . . . . 0.0 107.53 174.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.2 m -94.78 130.35 41.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -112.62 154.48 25.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.72 0.808 . . . . 0.0 109.28 -177.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -110.6 71.87 0.77 Allowed 'General case' 0 C--O 1.242 0.706 0 O-C-N 124.512 1.132 . . . . 0.0 108.887 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.791 HG23 HG21 ' A' ' 26' ' ' VAL . 20.3 m -140.47 172.63 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.514 0.726 . . . . 0.0 110.169 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -102.87 161.88 21.83 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 123.639 0.775 . . . . 0.0 109.95 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.5 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 29.1 Cg_endo -59.41 -37.05 92.22 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 121.868 1.712 . . . . 0.0 111.03 171.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 p -96.64 15.72 20.93 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.872 0.869 . . . . 0.0 111.092 -174.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.75 -98.97 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.771 0.828 . . . . 0.0 109.576 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.1 t 174.75 142.45 0.05 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.989 1.316 . . . . 0.0 109.091 173.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -61.0 -38.84 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.208 1.003 . . . . 0.0 111.848 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 42.7 tt0 -57.47 -35.22 69.89 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.563 0.697 . . . . 0.0 111.483 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.433 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.4 t30 -75.99 -42.23 48.86 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.213 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.791 HG21 HG23 ' A' ' 17' ' ' VAL . 61.8 t -55.27 -47.3 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 124.606 1.191 . . . . 0.0 110.367 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -69.45 -32.2 70.99 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.079 0.551 . . . . 0.0 111.696 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.48 70.44 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.387 0.429 . . . . 0.0 110.838 170.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 8.8 mmpt? -75.96 -35.81 59.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.906 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 5' ' ' VAL . 2.2 mp -57.09 -43.4 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 118.915 0.78 . . . . 0.0 109.666 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.11 -31.76 72.26 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.353 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.36 -30.77 66.56 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.42 0.688 . . . . 0.0 111.541 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 72.2 mmtt -93.55 -70.37 0.71 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 117.624 0.193 . . . . 0.0 110.715 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -80.38 -25.93 38.85 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.24 0.216 . . . . 0.0 111.274 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.32 18.55 30.68 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.311 0.382 . . . . 0.0 113.928 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.75 123.83 41.07 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -70.29 156.64 61.52 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.112 2.541 . . . . 0.0 112.375 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.23 -16.43 17.36 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.713 2.942 . . . . 0.0 114.072 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -71.8 -47.09 55.75 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 120.949 0.404 . . . . 0.0 110.197 173.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -83.2 -21.3 33.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.895 0.878 . . . . 0.0 112.216 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.437 HE22 HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -109.18 153.0 24.39 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.105 0.562 . . . . 0.0 110.515 177.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -138.72 138.08 37.37 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.119 0.567 . . . . 0.0 110.263 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.437 HD23 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -98.06 125.08 42.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.788 0.835 . . . . 0.0 110.373 -174.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -142.86 125.04 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.015 0.926 . . . . 0.0 109.586 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.625 ' HB3' HD21 ' A' ' 50' ' ' LEU . 79.4 t80 -124.67 124.96 43.31 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.43 1.092 . . . . 0.0 108.148 177.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.498 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 60.44 27.0 16.6 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.893 0.877 . . . . 0.0 112.812 175.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.52 -15.89 61.99 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 2.5 ptpt -98.73 142.32 30.43 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -83.18 132.96 35.04 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.7 mt -82.51 116.64 22.04 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.426 0.691 . . . . 0.0 110.996 -175.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 54' ' ' ARG . 32.8 tt0 -83.87 139.45 32.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.485 1.114 . . . . 0.0 110.466 -175.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.5 m-20 -56.25 -47.92 77.57 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.603 1.161 . . . . 0.0 112.795 -172.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.49 -18.2 71.5 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 124.758 1.286 . . . . 0.0 113.893 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 62.5 mtt180 -84.96 177.53 7.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.69 0.796 . . . . 0.0 111.04 175.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.9 p -116.71 170.78 8.33 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.343 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 94.9 mt -57.35 -47.97 80.21 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 47.4 t -62.18 -26.49 68.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.755 1.222 . . . . 0.0 111.6 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 7.7 t70 -61.25 -45.47 94.4 Favored 'General case' 0 C--N 1.357 0.932 0 CA-C-O 121.532 0.682 . . . . 0.0 109.654 177.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.4 15.95 7.11 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.589 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 71.22 8.06 6.3 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.475 1.51 . . . . 0.0 112.309 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mt -77.91 129.56 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -122.83 -176.63 3.45 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -59.16 143.5 48.66 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 68.19 13.3 9.05 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.885 1.274 . . . . 0.0 112.239 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.5 m -84.91 138.76 32.32 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 57.9 m -99.27 127.31 45.25 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 110.187 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.58 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -124.13 173.67 8.15 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.25 1.42 . . . . 0.0 108.585 176.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -108.97 154.96 21.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.496 0.718 . . . . 0.0 110.97 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.618 HD13 HG21 ' A' ' 7' ' ' THR . 2.6 tm? -133.79 126.17 30.02 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.586 HG11 HD13 ' B' ' 220' ' ' LEU . 90.2 t -104.95 115.85 47.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 123.518 0.727 . . . . 0.0 109.993 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.458 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 86.8 mt -85.67 147.79 26.2 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.519 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 54.9 mtp180 -121.98 -45.64 2.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.249 1.02 . . . . 0.0 110.127 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.61 ' HB3' ' HD2' ' B' ' 197' ' ' ARG . 3.9 mm? 52.46 29.27 6.8 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.501 1.121 . . . . 0.0 112.976 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.584 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 4.8 mmp_? -64.7 -43.67 92.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.577 0.751 . . . . 0.0 110.545 -176.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.95 35.85 4.47 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.831 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.453 0 CA-C-O 120.169 -0.24 . . . . 0.0 112.786 -178.192 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.08 0 CA-C-O 120.121 -0.266 . . . . 0.0 113.183 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 22.6 p -72.13 119.55 16.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.487 0.715 . . . . 0.0 110.108 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . 0.61 ' HD2' ' HB3' ' A' ' 73' ' ' LEU . 34.7 mmt180 -85.65 73.63 10.4 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.216 0.532 . . . . 0.0 110.307 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.17 149.91 28.9 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.352 170.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 4.8 p -61.06 104.1 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-O 121.472 0.653 . . . . 0.0 109.614 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 22.8 m -68.46 143.59 54.96 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.886 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' B' ' 201' ' ' LYS . 11.2 mptt -94.94 122.29 37.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 m -142.6 -178.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.289 1.036 . . . . 0.0 109.761 -166.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -118.73 146.31 44.86 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.256 0.622 . . . . 0.0 110.599 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.528 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.7 t -83.08 102.64 1.9 Allowed Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.505 ' HD2' HD21 ' B' ' 220' ' ' LEU . 43.7 Cg_endo -62.38 -9.6 15.96 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.319 2.679 . . . . 0.0 114.052 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.78 -65.09 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.311 0.644 . . . . 0.0 110.611 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 18.1 p -100.3 2.46 42.63 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.704 0.401 . . . . 0.0 112.061 -172.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 63.23 38.85 97.14 Favored Glycine 0 N--CA 1.477 1.388 0 N-CA-C 115.494 0.957 . . . . 0.0 115.494 170.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.65 134.41 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.077 0.551 . . . . 0.0 110.482 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -84.74 122.62 29.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.611 0.365 . . . . 0.0 110.029 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 6.0 pt -149.44 158.7 37.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 125.825 1.65 . . . . 0.0 109.484 -171.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.8 162.99 20.07 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.618 2.212 . . . . 0.0 112.839 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.536 ' O ' HG21 ' B' ' 216' ' ' ILE . 39.5 tt0 -65.36 -36.18 83.24 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.459 1.504 . . . . 0.0 113.23 -169.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 34.2 t -69.0 -38.0 79.04 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.098 0.475 . . . . 0.0 110.04 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -76.26 -23.45 54.45 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.2 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.542 ' O ' ' HG ' ' B' ' 220' ' ' LEU . 0.3 OUTLIER -70.91 -43.0 77.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -55.78 -52.87 62.49 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.016 0.823 . . . . 0.0 110.346 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -54.26 -47.48 72.25 Favored 'General case' 0 C--O 1.252 1.221 0 O-C-N 124.307 1.004 . . . . 0.0 111.82 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -35.06 79.13 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.991 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.586 HD13 HG11 ' A' ' 70' ' ' VAL . 71.3 mt -64.62 -51.95 60.01 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 123.529 0.518 . . . . 0.0 110.882 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -58.25 -29.41 65.75 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.569 1.168 . . . . 0.0 111.684 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 46.7 t -81.88 -43.5 18.11 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.435 0.694 . . . . 0.0 110.921 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 69.6 m -81.59 -19.03 42.77 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.251 1.02 . . . . 0.0 113.383 -170.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp -83.82 2.16 39.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.482 0.583 . . . . 0.0 111.182 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 32.1 t -51.62 103.93 0.07 Allowed 'General case' 0 C--N 1.357 0.901 0 C-N-CA 124.58 1.152 . . . . 0.0 111.107 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 -67.79 127.49 32.97 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.565 175.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 124.372 1.069 . . . . 0.0 109.611 177.446 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.145 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 60.0 m -138.76 26.4 2.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.805 0.842 . . . . 0.0 111.201 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -75.68 97.81 3.91 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 mmt -84.99 155.98 21.34 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.991 0.916 . . . . 0.0 111.065 -172.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 18.5 mp0 -92.91 124.57 36.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.488 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.463 HD13 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -122.5 157.56 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.338 1.455 . . . . 0.0 108.212 175.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 64.7 m-85 -116.81 105.51 12.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.431 -172.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.538 HG21 HD13 ' A' ' 30' ' ' ILE . 40.3 t -95.08 122.26 46.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -108.9 120.04 41.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.309 0.644 . . . . 0.0 110.144 -173.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.64 HG22 HD11 ' A' ' 69' ' ' LEU . 31.6 p -77.77 167.08 22.12 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.465 0.65 . . . . 0.0 111.939 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.468 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 82.6 mt -71.28 -20.22 62.24 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.724 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -78.67 -16.94 56.7 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.954 0.502 . . . . 0.0 110.282 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.58 14.8 26.61 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HG2' ' HG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -93.22 152.83 18.96 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.469 0.635 . . . . 0.0 109.436 176.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.9 m -96.29 143.25 27.53 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.1 102.44 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.0 m -84.49 117.39 23.65 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -104.3 153.49 20.96 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.417 ' HG3' ' HG3' ' A' ' 2' ' ' GLN . 4.7 mp0 -114.37 90.63 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.762 HG23 HG22 ' A' ' 26' ' ' VAL . 9.2 m -139.32 169.04 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -90.13 153.13 46.73 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 42.5 Cg_endo -64.13 -26.32 65.29 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 121.975 1.783 . . . . 0.0 111.14 172.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.9 t -100.18 14.33 31.2 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.057 0.943 . . . . 0.0 110.365 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.73 -94.78 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.112 0.565 . . . . 0.0 109.57 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.43 ' O ' HG21 ' A' ' 26' ' ' VAL . 9.2 t 179.58 145.65 0.19 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.521 1.128 . . . . 0.0 109.678 173.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.414 HG22 HD23 ' A' ' 43' ' ' LEU . 46.1 mm -61.8 -36.23 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.168 0.987 . . . . 0.0 111.196 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -57.71 -34.93 69.98 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.428 0.691 . . . . 0.0 111.009 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.7 t-20 -73.95 -43.29 58.73 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.152 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.762 HG22 HG23 ' A' ' 17' ' ' VAL . 38.6 t -57.71 -50.06 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 124.256 0.973 . . . . 0.0 110.735 -178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -67.41 -30.19 69.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.179 0.592 . . . . 0.0 111.232 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.62 78.84 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.653 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 7.2 mmpt? -73.82 -31.63 63.33 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 118.801 -0.618 . . . . 0.0 110.896 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.538 HD13 HG21 ' A' ' 5' ' ' VAL . 1.7 mp -54.26 -47.87 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.638 0.654 . . . . 0.0 110.113 169.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -66.03 -30.81 71.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.395 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.24 -27.74 64.7 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.344 0.658 . . . . 0.0 111.627 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.6 mmtt -100.61 -68.84 0.79 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.711 0.404 . . . . 0.0 110.912 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -83.42 -22.36 32.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.412 0.285 . . . . 0.0 111.311 -175.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.73 6.98 57.0 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 113.883 0.313 . . . . 0.0 113.883 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -95.54 124.07 54.26 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.071 0.549 . . . . 0.0 109.764 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HG2' ' HB2' ' A' ' 40' ' ' GLN . 53.1 Cg_endo -64.31 155.91 62.87 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.525 2.817 . . . . 0.0 113.152 -174.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -56.5 -18.29 24.94 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 124.237 3.291 . . . . 0.0 113.94 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.53 -47.14 16.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.26 0.624 . . . . 0.0 110.748 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.478 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -78.59 -23.8 45.82 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.3 0.64 . . . . 0.0 111.056 -173.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.467 ' HB2' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.06 152.7 19.13 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.586 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 35.4 ttt180 -140.54 116.87 10.68 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 121.844 0.831 . . . . 0.0 109.032 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.715 ' HG ' HD13 ' A' ' 50' ' ' LEU . 10.6 tp -93.84 123.75 37.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.654 -162.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 96.2 mt -140.49 135.45 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 123.291 0.637 . . . . 0.0 110.775 -169.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.526 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 78.6 t80 -136.13 132.85 36.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . . . 66.72 18.15 10.67 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.523 1.129 . . . . 0.0 112.61 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.67 15.48 65.71 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.86 -0.411 . . . . 0.0 113.593 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 13.6 ptpt -124.2 143.9 50.25 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.505 0.722 . . . . 0.0 109.148 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -75.5 130.67 39.27 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.779 0.431 . . . . 0.0 110.349 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.715 HD13 ' HG ' ' A' ' 43' ' ' LEU . 24.9 mt -78.49 122.03 25.33 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 123.21 0.604 . . . . 0.0 110.465 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -77.74 136.29 38.13 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.689 0.796 . . . . 0.0 108.91 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -61.62 -36.97 82.26 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.105 0.878 . . . . 0.0 112.521 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.25 -27.83 69.25 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.98 0.8 . . . . 0.0 113.166 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -76.04 176.83 7.58 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.127 0.571 . . . . 0.0 111.44 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.0 p -114.75 168.75 9.61 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.707 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 85.4 mt -55.71 -52.1 65.05 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.948 0.78 . . . . 0.0 109.532 172.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -59.13 -27.52 65.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.529 1.132 . . . . 0.0 111.83 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.13 -40.05 86.72 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.027 0.531 . . . . 0.0 110.017 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -90.39 21.37 3.91 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.918 0.887 . . . . 0.0 111.41 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 67.17 15.36 10.03 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.451 1.101 . . . . 0.0 111.884 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -88.11 134.36 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -122.9 -173.59 2.74 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.453 0.701 . . . . 0.0 109.266 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 11.7 ptmm? -59.04 144.0 46.7 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.918 170.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 65.05 7.6 4.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.614 1.566 . . . . 0.0 112.968 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -72.4 129.86 39.35 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 118.112 0.414 . . . . 0.0 109.897 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 20.0 m -99.43 140.91 32.91 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.526 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -143.58 173.87 11.27 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.09 0.956 . . . . 0.0 109.344 -175.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -97.54 154.63 17.39 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.691 0.758 . . . . 0.0 111.601 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.64 HD11 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -137.49 119.33 15.22 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.484 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.655 HG22 HD22 ' B' ' 220' ' ' LEU . 53.1 t -93.31 110.31 23.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.581 0.752 . . . . 0.0 110.368 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.6 mt -78.25 137.78 38.29 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.748 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -115.54 -48.62 2.77 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.19 0.996 . . . . 0.0 109.641 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 48.75 45.83 21.77 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.185 1.394 . . . . 0.0 112.196 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -68.74 -36.09 77.95 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.316 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.13 14.83 56.47 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.274 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.586 0 CA-C-N 117.195 0.497 . . . . 0.0 112.185 178.392 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.101 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 60.8 p -78.04 79.31 4.51 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.531 0.681 . . . . 0.0 109.944 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -64.71 -35.01 79.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.162 0.985 . . . . 0.0 110.17 175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -128.32 158.39 38.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.793 1.237 . . . . 0.0 107.794 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . 0.449 HG13 ' HZ2' ' B' ' 201' ' ' LYS . 2.4 p -58.06 108.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 CA-C-O 121.377 0.608 . . . . 0.0 110.678 173.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 5.6 m -69.6 138.03 52.79 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.0 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.449 ' HZ2' HG13 ' B' ' 199' ' ' VAL . 13.2 mptt -95.54 127.32 41.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 171.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 6.0 m -145.38 -177.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.135 1.374 . . . . 0.0 109.28 -162.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -115.18 137.2 52.29 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 122.464 0.306 . . . . 0.0 111.522 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.464 ' HA ' HD13 ' B' ' 216' ' ' ILE . 48.8 t -79.91 101.43 0.84 Allowed Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.0 -1.09 8.95 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.796 2.33 . . . . 0.0 114.592 -159.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 23.3 t -93.88 -62.95 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.2 p -89.47 -10.51 46.09 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.745 0.418 . . . . 0.0 111.52 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.14 57.7 17.2 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 124.321 0.962 . . . . 0.0 114.195 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 32.6 m -117.94 135.62 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.399 0.68 . . . . 0.0 109.263 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -83.85 113.03 20.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' B' ' 204' ' ' CYS . 7.9 pt -142.5 156.04 63.73 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.808 1.243 . . . . 0.0 110.287 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.92 163.34 14.04 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.946 2.431 . . . . 0.0 113.186 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.558 ' O ' HG23 ' B' ' 216' ' ' ILE . 43.8 tt0 -65.47 -37.04 85.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.176 1.39 . . . . 0.0 113.131 -166.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 23.3 t -65.48 -43.6 89.72 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.369 0.605 . . . . 0.0 109.743 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -69.81 -25.01 63.57 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.402 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.558 HG23 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -70.24 -44.03 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.324 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -61.88 -46.43 89.46 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 123.686 0.616 . . . . 0.0 110.508 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -47.79 78.9 Favored 'General case' 0 C--O 1.25 1.093 0 O-C-N 124.0 0.813 . . . . 0.0 112.469 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.53 -37.75 88.49 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.569 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.655 HD22 HG22 ' A' ' 70' ' ' VAL . 62.6 tp -62.48 -42.59 99.59 Favored 'General case' 0 C--O 1.215 -0.723 0 O-C-N 124.28 0.988 . . . . 0.0 111.452 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -53.23 -40.35 64.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.856 0.722 . . . . 0.0 110.342 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.2 t -75.53 -41.87 53.99 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.324 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 96.0 m -77.9 -19.04 55.44 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.169 0.987 . . . . 0.0 112.878 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . 0.606 HD21 ' HG ' ' B' ' 220' ' ' LEU . 4.2 pp -90.15 -5.22 56.7 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.647 0.379 . . . . 0.0 110.73 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 20.8 t -71.52 87.52 0.9 Allowed 'General case' 0 C--N 1.356 0.878 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -113.59 138.68 49.82 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.185 0.994 . . . . 0.0 110.427 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 CA--C 1.559 1.318 0 C-N-CA 124.002 0.921 . . . . 0.0 109.93 -176.26 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 22.7 t -69.73 122.51 19.32 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -81.11 119.04 23.06 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.035 0.934 . . . . 0.0 110.421 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt -80.0 158.48 26.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.487 1.115 . . . . 0.0 110.338 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 77.7 mt-30 -104.72 123.22 47.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.516 0.726 . . . . 0.0 110.572 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.464 HD13 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -123.85 155.27 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.538 1.135 . . . . 0.0 109.623 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -108.28 103.88 13.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.921 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.604 HG13 ' HB2' ' A' ' 69' ' ' LEU . 92.3 t -104.65 100.17 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.99 122.52 43.01 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.595 0.758 . . . . 0.0 111.129 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.636 HG22 HD12 ' A' ' 69' ' ' LEU . 37.4 p -67.71 162.97 22.57 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.608 0.763 . . . . 0.0 112.219 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.33 -15.69 63.39 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.138 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.5 p -80.21 0.01 34.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.47 0.708 . . . . 0.0 111.202 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.53 9.3 75.71 Favored Glycine 0 C--N 1.351 1.39 0 C-N-CA 123.235 0.445 . . . . 0.0 113.376 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -94.23 141.6 28.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.036 0.934 . . . . 0.0 109.237 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 m -105.22 136.6 44.44 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.831 0.452 . . . . 0.0 110.534 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.34 109.84 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.086 0.954 . . . . 0.0 109.021 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.0 m -84.72 122.49 29.17 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.6 mm? -108.95 159.05 17.13 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -124.02 82.25 2.01 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.669 HG23 HG22 ' A' ' 26' ' ' VAL . 15.4 m -140.84 172.6 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.999 0.92 . . . . 0.0 109.775 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.93 149.15 35.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 30.1 Cg_endo -61.79 -27.06 80.18 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.085 1.856 . . . . 0.0 111.904 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.4 t -99.87 16.62 23.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.776 0.43 . . . . 0.0 110.308 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.79 -98.58 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 119.108 -0.472 . . . . 0.0 109.797 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.466 ' O ' HG21 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -170.5 143.85 2.32 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 125.447 1.499 . . . . 0.0 108.786 175.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.37 -37.38 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.885 0.874 . . . . 0.0 110.639 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.98 -36.19 72.27 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.039 0.936 . . . . 0.0 110.849 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 24.3 t-20 -70.84 -46.42 62.76 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.397 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.669 HG22 HG23 ' A' ' 17' ' ' VAL . 67.0 t -55.87 -44.51 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 124.158 0.911 . . . . 0.0 110.85 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -71.93 -30.12 65.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.797 0.439 . . . . 0.0 111.748 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.68 -32.6 74.34 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.809 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 10.3 mmpt? -71.36 -35.21 71.04 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.526 0.516 . . . . 0.0 110.607 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.28 -46.04 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 122.877 0.471 . . . . 0.0 110.47 169.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -65.87 -23.3 66.63 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.3 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.08 -31.03 27.53 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.163 0.985 . . . . 0.0 111.327 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.85 -70.43 0.69 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.621 0.368 . . . . 0.0 110.95 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -86.72 -24.33 25.2 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.724 0.41 . . . . 0.0 111.236 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.48 35.71 8.47 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.436 0.46 . . . . 0.0 112.777 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -111.75 126.11 29.11 Favored Pre-proline 0 CA--C 1.556 1.188 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.49 151.49 79.86 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.221 2.614 . . . . 0.0 112.766 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.26 -13.94 26.82 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.137 3.225 . . . . 0.0 114.25 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.42 -43.66 39.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.377 0.671 . . . . 0.0 110.183 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.46 -35.59 30.37 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.629 0.772 . . . . 0.0 111.124 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.483 HE22 HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -88.76 148.73 23.79 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.806 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 39.8 ttt180 -135.47 130.96 35.52 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.333 0.653 . . . . 0.0 109.432 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.483 HD23 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -95.02 122.69 37.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.498 0.719 . . . . 0.0 110.232 -174.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -141.42 117.74 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.671 0.789 . . . . 0.0 110.027 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.52 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 88.5 t80 -117.38 126.98 53.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.307 1.043 . . . . 0.0 108.644 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.24 23.03 13.29 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.008 0.923 . . . . 0.0 112.691 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.79 1.64 65.5 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 114.274 0.47 . . . . 0.0 114.274 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.5 ptpt -112.56 145.81 39.66 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -80.76 140.97 35.22 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 45' ' ' PHE . 19.8 mt -94.11 122.91 37.12 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.143 0.577 . . . . 0.0 110.538 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.49 140.31 29.66 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.346 1.058 . . . . 0.0 110.186 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.54 -52.04 56.78 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.57 1.548 . . . . 0.0 113.251 -173.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.67 -20.36 70.07 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 124.573 1.171 . . . . 0.0 113.922 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 -82.75 177.33 8.72 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.016 0.526 . . . . 0.0 110.681 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.8 p -116.82 168.79 9.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.317 0.647 . . . . 0.0 109.877 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 98.1 mt -57.21 -52.07 66.79 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -62.75 -25.16 68.06 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.302 1.041 . . . . 0.0 111.445 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.82 -40.95 96.02 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -91.16 17.03 8.68 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.153 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 69.54 17.16 8.01 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.578 1.151 . . . . 0.0 112.215 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.9 mt -87.52 139.78 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -137.6 -167.85 2.21 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -55.66 142.39 34.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.234 0.614 . . . . 0.0 112.031 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 56.24 14.62 1.6 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.248 1.419 . . . . 0.0 114.157 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 m -75.72 132.84 40.77 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.1 m -97.2 124.76 41.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.361 0.6 . . . . 0.0 110.012 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.52 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -127.42 174.67 8.82 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.178 1.391 . . . . 0.0 108.507 176.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -109.08 146.67 33.63 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.505 0.722 . . . . 0.0 111.102 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.636 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -122.28 125.71 46.59 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.806 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 79.5 t -105.26 124.27 59.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 123.62 0.768 . . . . 0.0 110.009 -175.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.518 ' HB3' HD23 ' A' ' 73' ' ' LEU . 83.1 mt -96.64 115.37 27.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.101 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -85.81 -46.06 11.01 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 169.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 71' ' ' LEU . 2.8 mm? 50.44 45.84 25.95 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.42 1.488 . . . . 0.0 113.511 172.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -67.64 87.06 0.21 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.227 166.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.48 -39.79 0.74 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.855 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.281 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 -177.822 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.637 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 36.7 t -75.6 133.73 40.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.113 0.565 . . . . 0.0 110.43 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -117.07 11.24 14.17 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.965 0.906 . . . . 0.0 108.99 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -121.9 175.02 6.52 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.743 0.817 . . . . 0.0 110.773 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . 0.481 HG13 ' HZ3' ' B' ' 201' ' ' LYS . 2.8 p -70.82 99.02 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.397 174.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' THR . . . . . 0.415 HG21 HG11 ' B' ' 202' ' ' VAL . 18.1 m -71.2 135.43 47.54 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.578 0.751 . . . . 0.0 110.096 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.481 ' HZ3' HG13 ' B' ' 199' ' ' VAL . 12.2 mptt -95.76 123.88 39.53 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 174.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . 0.415 HG11 HG21 ' B' ' 200' ' ' THR . 2.9 m -146.59 152.56 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.841 1.256 . . . . 0.0 109.58 -171.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -90.67 146.78 23.74 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.121 0.568 . . . . 0.0 111.584 -173.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.561 ' HA ' HD11 ' B' ' 216' ' ' ILE . 37.4 t -88.69 97.91 0.98 Allowed Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.716 1.206 . . . . 0.0 108.184 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.565 ' HD2' HD23 ' B' ' 220' ' ' LEU . 33.2 Cg_endo -59.62 -14.96 28.56 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.37 2.713 . . . . 0.0 114.777 -168.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 33.4 t -84.37 -46.88 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 122.686 0.395 . . . . 0.0 111.245 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . 0.418 ' SG ' HG21 ' B' ' 209' ' ' VAL . 20.5 p -111.56 -3.36 15.14 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.93 42.75 84.92 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . 0.418 HG21 ' SG ' ' B' ' 207' ' ' CYS . 22.8 m -117.86 133.43 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 117.448 0.624 . . . . 0.0 110.418 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -86.63 121.88 29.76 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 5.9 pt -146.6 162.87 32.29 Favored Pre-proline 0 N--CA 1.484 1.264 0 C-N-CA 124.878 1.271 . . . . 0.0 110.673 -169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -58.33 161.58 13.77 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.678 2.252 . . . . 0.0 113.505 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.542 ' O ' HG21 ' B' ' 216' ' ' ILE . 33.8 tt0 -65.62 -42.56 91.41 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.079 1.351 . . . . 0.0 112.788 -169.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 21.2 m -72.24 -35.89 68.95 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.623 -0.673 . . . . 0.0 110.432 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -74.5 -22.0 59.28 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.331 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.561 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.4 OUTLIER -69.09 -47.17 76.45 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -62.4 -39.2 92.46 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 123.77 0.669 . . . . 0.0 110.862 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -70.65 -42.91 70.2 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.104 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -36.69 84.08 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.565 HD23 ' HD2' ' B' ' 205' ' ' PRO . 87.3 mt -69.74 -42.46 73.89 Favored 'General case' 0 C--O 1.21 -0.995 0 O-C-N 124.321 1.013 . . . . 0.0 111.138 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -58.21 -25.54 61.76 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.505 1.128 . . . . 0.0 110.682 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 30.5 t -89.8 -44.08 10.21 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.056 170.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.8 m -70.19 -20.46 63.12 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.327 1.051 . . . . 0.0 113.062 -171.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.99 -1.3 57.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.909 0.484 . . . . 0.0 112.168 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 70.5 p -69.49 83.75 0.41 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.811 0.815 . . . . 0.0 109.86 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 19.4 mmm-85 -110.77 -20.45 12.49 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.377 1.071 . . . . 0.0 110.86 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 123.829 0.851 . . . . 0.0 112.126 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.6 m -69.28 106.05 2.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.864 0.866 . . . . 0.0 109.38 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.646 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 6.3 p80 -71.76 96.89 1.68 Allowed 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.762 0.792 . . . . 0.0 110.566 -171.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt -101.43 146.76 27.18 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.3 mp0 -95.92 128.56 42.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.693 -172.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.09 147.76 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.793 1.237 . . . . 0.0 108.425 173.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 66' ' ' THR . 31.2 m-85 -103.29 101.58 11.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.283 0.633 . . . . 0.0 109.778 -172.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.43 HG12 ' HB2' ' A' ' 69' ' ' LEU . 11.5 t -96.99 117.93 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -108.28 124.94 51.08 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.442 0.697 . . . . 0.0 109.445 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.617 HG23 HD11 ' A' ' 69' ' ' LEU . 35.3 p -73.16 167.24 21.57 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.489 0.661 . . . . 0.0 111.314 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.474 HD11 HG23 ' A' ' 70' ' ' VAL . 43.2 mt -68.81 -24.05 64.34 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.79 172.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p -78.69 -14.24 59.4 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.6 0.76 . . . . 0.0 110.758 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.99 18.9 32.68 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.033 0.373 . . . . 0.0 114.033 170.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.17 153.16 18.8 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 m -102.0 145.9 28.63 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.042 0.449 . . . . 0.0 110.053 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.498 HD13 HG22 ' A' ' 7' ' ' THR . 5.3 mp -128.88 108.68 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 m -87.91 115.44 25.38 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -103.35 152.2 21.86 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.646 ' HB3' ' HB2' ' A' ' 0' ' ' HIS . 37.1 mt-10 -128.29 79.42 1.9 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -171.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.619 HG23 HG21 ' A' ' 26' ' ' VAL . 30.0 m -146.07 179.02 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.673 1.189 . . . . 0.0 109.081 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -85.31 153.12 59.01 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.2 Cg_endo -59.09 -32.82 98.02 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 121.827 1.685 . . . . 0.0 110.85 164.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -91.96 8.88 35.49 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.018 0.927 . . . . 0.0 111.479 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -74.46 -92.3 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.342 0.657 . . . . 0.0 110.074 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 26' ' ' VAL . 8.9 t 177.08 145.5 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.48 1.112 . . . . 0.0 109.84 171.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.75 -34.25 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.177 0.991 . . . . 0.0 110.684 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.68 -40.77 66.24 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.953 0.901 . . . . 0.0 110.66 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.45 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.5 t-20 -77.31 -43.39 33.27 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.031 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.619 HG21 HG23 ' A' ' 17' ' ' VAL . 99.4 t -56.86 -44.25 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 124.361 1.038 . . . . 0.0 110.442 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HB2' ' OE1' ' A' ' 41' ' ' GLN . 16.6 ptpt -71.78 -32.58 67.8 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.947 0.499 . . . . 0.0 110.609 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.09 -28.41 68.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.858 0.463 . . . . 0.0 111.164 169.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.51 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 9.8 mmpt? -72.78 -37.06 67.73 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 122.9 0.48 . . . . 0.0 110.247 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.448 HG13 HG23 ' A' ' 13' ' ' ILE . 2.2 mp -58.53 -42.58 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 118.413 0.551 . . . . 0.0 109.838 172.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.05 -27.98 69.77 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.326 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.33 -27.87 47.21 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.614 0.766 . . . . 0.0 111.622 174.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.3 mmtt -95.69 -68.02 0.82 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.986 -0.446 . . . . 0.0 111.025 -174.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.424 ' HG2' HG23 ' A' ' 30' ' ' ILE . 15.1 pt-20 -85.51 -20.09 30.2 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.703 0.229 . . . . 0.0 111.549 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 24.76 35.68 Favored Glycine 0 C--N 1.347 1.17 0 O-C-N 122.946 0.154 . . . . 0.0 113.231 171.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.47 127.44 27.83 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.8 151.69 74.17 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.975 2.45 . . . . 0.0 112.486 -174.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.519 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 18.6 Cg_endo -57.43 -14.1 15.27 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.976 3.117 . . . . 0.0 114.782 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.21 -44.64 68.23 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 123.486 0.492 . . . . 0.0 110.202 172.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.11 -35.65 20.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.022 0.929 . . . . 0.0 111.882 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.637 HE21 HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -94.16 120.29 34.19 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.014 0.435 . . . . 0.0 109.849 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.602 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.1 ttt180 -106.86 128.7 54.51 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.048 0.939 . . . . 0.0 109.544 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.481 HD21 HE22 ' A' ' 41' ' ' GLN . 4.6 mm? -94.09 127.76 40.09 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.837 0.855 . . . . 0.0 109.653 -174.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -141.54 131.54 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.676 0.79 . . . . 0.0 110.199 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.572 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 74.2 t80 -136.79 128.4 28.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.68 21.79 11.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.512 1.125 . . . . 0.0 112.164 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.66 -0.03 73.18 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.446 -0.641 . . . . 0.0 114.047 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.7 ptpt -112.42 151.51 29.76 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 117.711 0.755 . . . . 0.0 110.394 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' HB2' HD21 ' B' ' 224' ' ' LEU . 29.5 tt0 -77.32 133.04 38.88 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.171 0.589 . . . . 0.0 110.343 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 45' ' ' PHE . 24.2 mt -85.95 120.47 27.38 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 122.764 0.426 . . . . 0.0 110.258 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.74 136.1 36.68 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 123.731 0.813 . . . . 0.0 109.102 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.42 -38.08 82.9 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.142 0.902 . . . . 0.0 111.591 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.61 -38.52 96.53 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.844 0.715 . . . . 0.0 112.867 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -75.07 177.57 6.3 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.733 0.813 . . . . 0.0 112.034 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 52.7 p -110.43 167.52 10.15 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.66 0.784 . . . . 0.0 110.093 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.1 mt -55.78 -51.4 67.57 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 t -63.19 -24.02 67.69 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.47 1.108 . . . . 0.0 111.771 -175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.13 -31.65 66.2 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.182 0.515 . . . . 0.0 109.909 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -94.53 17.5 13.08 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.626 0.77 . . . . 0.0 111.747 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 68.75 16.65 8.92 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.447 1.099 . . . . 0.0 112.038 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.6 mt -88.05 119.48 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -99.36 179.77 4.47 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -60.3 142.78 54.2 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 68.33 9.5 7.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.918 1.287 . . . . 0.0 113.424 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -70.73 137.59 49.81 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 26.2 m -97.88 126.14 43.11 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.572 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -133.11 172.58 12.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.569 1.147 . . . . 0.0 108.854 -178.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -101.48 154.86 18.46 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.522 0.677 . . . . 0.0 111.68 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.637 HD22 HE21 ' A' ' 41' ' ' GLN . 2.2 tm? -135.88 132.81 37.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.206 -1.361 . . . . 0.0 107.936 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 99.5 t -117.0 124.04 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.929 0.892 . . . . 0.0 110.575 -175.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.443 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 86.5 mt -92.49 120.71 33.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.095 0.558 . . . . 0.0 109.685 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -90.72 -37.21 13.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.095 0.958 . . . . 0.0 109.612 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 71' ' ' LEU . 92.8 mt 47.89 35.93 5.46 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.357 1.463 . . . . 0.0 113.154 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -58.4 -26.2 62.97 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.754 1.222 . . . . 0.0 112.013 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.53 45.24 0.66 Allowed Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 171.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.235 0 N-CA-C 112.309 -0.316 . . . . 0.0 112.309 -175.206 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.764 0 N-CA-C 112.096 -0.401 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 20.5 m -82.32 92.54 6.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.491 0.716 . . . . 0.0 110.569 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -94.25 -6.21 45.08 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.519 0.728 . . . . 0.0 109.454 170.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -123.46 162.62 22.47 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.213 1.405 . . . . 0.0 108.732 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.49 115.03 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.267 0.556 . . . . 0.0 109.66 175.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' THR . . . . . 0.554 HG23 HG13 ' B' ' 202' ' ' VAL . 25.0 m -71.51 133.76 46.05 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.236 -168.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -87.76 123.24 32.36 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . 0.554 HG13 HG23 ' B' ' 200' ' ' THR . 4.0 m -141.38 -176.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.388 1.075 . . . . 0.0 109.48 -170.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -123.67 143.37 50.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.283 0.633 . . . . 0.0 110.042 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.563 ' HA ' HD13 ' B' ' 216' ' ' ILE . 49.7 t -84.66 97.85 0.55 Allowed Pre-proline 0 N--CA 1.478 0.943 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.563 ' HD2' HD23 ' B' ' 220' ' ' LEU . 27.4 Cg_endo -57.57 -25.57 67.82 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 123.332 2.688 . . . . 0.0 113.563 -171.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.59 -52.39 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 O-C-N 123.692 0.62 . . . . 0.0 111.275 -172.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.2 p -107.41 -4.01 18.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.53 45.82 35.04 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 115.18 0.832 . . . . 0.0 115.18 169.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 34.5 m -119.82 139.44 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.536 0.734 . . . . 0.0 110.677 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -89.28 115.83 27.05 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.458 HD11 ' HB2' ' B' ' 204' ' ' CYS . 12.3 pt -145.14 156.16 54.59 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.939 1.296 . . . . 0.0 109.815 -171.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.95 165.45 23.74 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.852 2.368 . . . . 0.0 113.946 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.587 ' O ' HG23 ' B' ' 216' ' ' ILE . 32.9 tt0 -56.79 -47.02 81.14 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 126.376 1.87 . . . . 0.0 114.318 -167.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 14.6 m -69.9 -37.87 76.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.13 -0.981 . . . . 0.0 110.391 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -67.16 -31.43 71.85 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.949 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.587 HG23 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -69.66 -46.46 75.0 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -176.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.47 -43.43 98.87 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.55 0.531 . . . . 0.0 110.73 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -59.91 -51.58 69.09 Favored 'General case' 0 C--O 1.253 1.245 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.487 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . 0.4 ' O ' ' SG ' ' B' ' 223' ' ' CYS . 0.2 OUTLIER -57.19 -41.7 79.84 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.864 -175.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.563 HD23 ' HD2' ' B' ' 205' ' ' PRO . 96.7 mt -58.92 -53.86 53.62 Favored 'General case' 0 C--O 1.202 -1.398 0 O-C-N 124.399 1.062 . . . . 0.0 111.075 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.52 -30.18 60.22 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.767 1.292 . . . . 0.0 111.43 -171.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.8 t -83.44 -45.02 14.13 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.317 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' B' ' 219' ' ' HIS . 88.0 m -68.94 -29.02 67.17 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.63 1.172 . . . . 0.0 112.642 -173.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' A' ' 49' ' ' GLN . 4.2 pp -94.4 -23.64 17.68 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.6 0.76 . . . . 0.0 109.936 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 27.0 t -67.44 -30.38 70.09 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.537 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.16 77.6 3.7 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 167.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.494 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 23.2 p -70.98 113.95 8.54 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.594 0.757 . . . . 0.0 111.128 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -107.89 178.19 4.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.366 0.666 . . . . 0.0 109.888 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt -113.42 167.45 10.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.568 0.747 . . . . 0.0 109.651 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -120.5 142.95 48.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.737 0.415 . . . . 0.0 110.744 176.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.29 155.15 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.702 1.201 . . . . 0.0 109.385 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 66' ' ' THR . 92.2 m-85 -112.99 108.45 17.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.694 0.797 . . . . 0.0 109.648 -174.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 69' ' ' LEU . 69.6 t -105.86 119.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -106.87 125.66 51.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.806 0.842 . . . . 0.0 110.281 -171.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.664 HG21 HD12 ' A' ' 69' ' ' LEU . 77.2 p -76.45 168.61 19.77 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.367 0.531 . . . . 0.0 111.793 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.5 mt -70.62 -22.93 62.47 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.256 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -80.18 -5.6 56.35 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.277 0.631 . . . . 0.0 111.056 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.78 20.65 46.33 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.352 -0.385 . . . . 0.0 113.999 167.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.14 153.21 18.23 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.5 m -104.11 134.37 47.49 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.239 0.616 . . . . 0.0 110.791 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.411 HD12 HG23 ' A' ' 7' ' ' THR . 5.3 mp -118.61 109.59 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.326 1.05 . . . . 0.0 108.44 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.0 m -91.21 119.26 31.15 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.136 0.575 . . . . 0.0 109.494 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.9 mm? -104.98 155.73 18.68 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.446 0.698 . . . . 0.0 109.631 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -121.9 72.55 1.03 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.957 0.903 . . . . 0.0 108.695 -174.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.798 HG22 HG22 ' A' ' 26' ' ' VAL . 31.3 m -138.57 -176.23 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.945 0.898 . . . . 0.0 109.382 -174.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -108.43 158.03 34.93 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 122.966 0.506 . . . . 0.0 110.592 -172.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 38.0 Cg_endo -63.18 -28.15 73.19 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.504 2.136 . . . . 0.0 111.925 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 t -109.14 25.21 12.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.508 0.723 . . . . 0.0 109.633 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.02 -99.71 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.267 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.473 ' O ' HG21 ' A' ' 26' ' ' VAL . 10.1 t 173.55 140.44 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.275 1.43 . . . . 0.0 108.812 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mm -58.67 -37.43 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.583 1.153 . . . . 0.0 111.984 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 43.5 tt0 -58.32 -38.22 76.68 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.508 0.723 . . . . 0.0 111.062 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.508 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 9.7 t30 -74.06 -41.92 61.0 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.043 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.798 HG22 HG22 ' A' ' 17' ' ' VAL . 48.5 t -58.74 -45.71 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 124.231 0.957 . . . . 0.0 110.623 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HA ' HD13 ' A' ' 30' ' ' ILE . 18.4 ptpt -73.92 -27.49 61.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.271 0.628 . . . . 0.0 111.602 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.94 79.16 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.397 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 67.9 mmtt -74.12 -27.52 60.9 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.753 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 27' ' ' LYS . 91.9 mt -67.0 -36.09 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 120.999 0.428 . . . . 0.0 110.028 175.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -65.39 -33.62 76.38 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.657 169.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.44 -23.01 62.65 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.435 0.694 . . . . 0.0 111.581 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 73.0 mmtt -98.66 -67.66 0.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.92 0.327 . . . . 0.0 110.984 -177.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.09 -24.37 30.38 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.03 7.82 55.95 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 120.013 -0.326 . . . . 0.0 113.846 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.22 124.92 43.28 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.442 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 73.3 Cg_endo -68.33 154.7 71.48 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.232 2.621 . . . . 0.0 112.773 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.42 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 13.7 Cg_endo -53.99 -15.66 7.8 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.961 3.107 . . . . 0.0 114.134 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.45 -41.96 37.79 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.852 0.861 . . . . 0.0 110.702 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -92.43 -19.02 22.47 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.91 0.884 . . . . 0.0 113.071 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.491 HE22 HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -103.14 149.73 24.34 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 173.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.484 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 38.5 ttt180 -134.68 129.99 35.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.26 0.624 . . . . 0.0 109.723 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.491 HD21 HE22 ' A' ' 41' ' ' GLN . 4.6 mm? -95.48 123.66 39.13 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.583 0.753 . . . . 0.0 110.549 -172.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.6 mt -141.93 124.71 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.672 0.789 . . . . 0.0 109.873 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.534 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 87.0 t80 -124.79 123.01 39.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.332 1.053 . . . . 0.0 108.191 175.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' HB1' ' HE3' ' A' ' 48' ' ' LYS . . . 60.02 25.92 15.19 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.837 0.855 . . . . 0.0 112.461 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.36 -21.5 45.16 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 122.956 0.313 . . . . 0.0 113.671 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 5.1 ptpt -91.11 134.47 34.49 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 117.362 0.581 . . . . 0.0 109.603 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.7 139.65 39.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 43' ' ' LEU . 24.3 mt -92.07 121.77 33.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.945 0.498 . . . . 0.0 110.96 -171.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.24 138.02 38.41 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.471 1.108 . . . . 0.0 109.973 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.0 m-20 -61.59 -42.49 98.94 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.3 1.04 . . . . 0.0 112.042 -172.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.84 -25.55 75.16 Favored Glycine 0 C--N 1.343 0.941 0 O-C-N 124.184 0.927 . . . . 0.0 113.467 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -78.86 177.24 8.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.997 0.519 . . . . 0.0 111.973 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.5 p -114.68 167.11 11.04 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.979 0.912 . . . . 0.0 110.228 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.9 mt -55.58 -56.23 22.77 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.704 0.628 . . . . 0.0 110.518 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 31.1 t -65.48 -18.35 65.25 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.981 0.912 . . . . 0.0 112.013 -174.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.0 -46.01 83.21 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.485 0.66 . . . . 0.0 109.34 173.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -86.21 18.66 3.02 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.094 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.6 OUTLIER 70.54 18.61 6.46 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.422 1.089 . . . . 0.0 111.802 176.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.4 mt -92.57 110.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -98.71 -174.7 2.86 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -65.14 135.59 55.68 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.95 0.405 . . . . 0.0 110.514 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 68.75 17.21 8.87 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.241 1.416 . . . . 0.0 111.811 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -72.27 139.08 47.88 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 168.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 41.1 m -101.36 128.38 47.56 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.529 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -133.48 168.09 19.26 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.27 1.028 . . . . 0.0 109.044 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -93.87 153.02 18.48 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.496 0.718 . . . . 0.0 111.406 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.664 HD12 HG21 ' A' ' 7' ' ' THR . 2.4 tm? -134.21 129.45 35.75 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.555 HG21 HD13 ' B' ' 220' ' ' LEU . 95.4 t -112.09 117.56 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 123.424 0.69 . . . . 0.0 109.76 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.94 150.88 28.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.332 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.719 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 80.0 mtp180 -121.62 -49.86 2.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.816 0.847 . . . . 0.0 109.599 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 55.51 30.93 16.07 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.664 1.185 . . . . 0.0 112.017 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.719 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 27.4 mmm180 -75.48 -24.43 56.93 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.251 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.63 15.76 56.92 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.973 172.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.524 0 CA-C-O 120.169 -0.239 . . . . 0.0 112.564 -176.012 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.785 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 25.8 m -80.36 98.72 7.59 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.954 0.502 . . . . 0.0 110.204 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -76.83 -16.37 59.45 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.697 0.799 . . . . 0.0 111.27 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -70.72 174.22 6.25 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.86 0.864 . . . . 0.0 111.874 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.1 p -55.34 101.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.36 0 C-N-CA 124.33 1.052 . . . . 0.0 111.759 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 70.3 m -85.87 128.3 34.79 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.871 0.868 . . . . 0.0 110.555 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -86.33 124.43 32.68 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 9.7 m -140.74 -176.73 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.063 1.345 . . . . 0.0 108.858 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -120.21 147.03 45.46 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.652 0.381 . . . . 0.0 110.244 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.572 ' HA ' HD13 ' B' ' 216' ' ' ILE . 43.5 t -86.87 101.34 2.05 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.995 0.918 . . . . 0.0 109.087 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.495 ' HD2' HD21 ' B' ' 220' ' ' LEU . 96.6 Cg_endo -72.13 11.4 0.74 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.834 2.356 . . . . 0.0 115.126 -166.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 19.5 t -103.54 -52.78 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.562 0.745 . . . . 0.0 110.24 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.9 p -106.87 -6.3 17.74 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.126 0.57 . . . . 0.0 111.628 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 59.79 59.19 10.95 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 124.467 1.032 . . . . 0.0 115.405 176.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.89 134.78 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.228 0.611 . . . . 0.0 110.007 173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -76.87 120.49 22.07 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.531 HD13 ' HB2' ' B' ' 204' ' ' CYS . 5.4 pt -148.97 162.15 30.17 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 125.443 1.497 . . . . 0.0 109.112 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -65.85 161.19 40.36 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.545 2.164 . . . . 0.0 112.184 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.49 ' O ' HG23 ' B' ' 216' ' ' ILE . 41.2 tt0 -65.47 -28.23 69.06 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.268 1.027 . . . . 0.0 112.063 -174.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 39.5 t -67.88 -46.36 71.91 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.381 0.61 . . . . 0.0 110.38 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -80.87 -14.44 58.02 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.643 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.9 -42.94 53.37 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -58.2 7.47 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 124.134 0.896 . . . . 0.0 109.111 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -57.69 -44.73 86.04 Favored 'General case' 0 C--O 1.255 1.364 0 O-C-N 124.456 1.098 . . . . 0.0 111.069 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -39.4 83.47 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.388 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 70' ' ' VAL . 88.9 mt -69.8 -36.45 75.7 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 124.029 0.831 . . . . 0.0 111.72 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -57.02 -33.64 67.37 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.799 0.687 . . . . 0.0 110.513 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.8 t -86.28 -38.05 17.93 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.402 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 65.4 m -81.33 -19.63 42.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.82 0.848 . . . . 0.0 112.986 -169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp -76.44 -19.38 58.13 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.598 0.359 . . . . 0.0 110.564 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 32.7 t -64.57 115.46 5.21 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -124.63 165.32 18.1 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.978 0.911 . . . . 0.0 109.664 -169.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 . . . . . 0 C--O 1.254 1.32 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.334 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.995 0 CA-C-O 119.447 -0.641 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 37.0 m -65.93 97.84 0.38 Allowed 'General case' 0 C--N 1.354 0.799 0 C-N-CA 123.809 0.844 . . . . 0.0 110.373 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -116.89 152.9 33.53 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.177 0.991 . . . . 0.0 110.484 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -101.45 178.6 4.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.08 0.952 . . . . 0.0 110.242 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.5 mp0 -109.65 144.35 38.13 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.649 0.78 . . . . 0.0 109.856 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.424 HD11 ' N ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.48 149.61 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.881 0.873 . . . . 0.0 109.154 169.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 66' ' ' THR . 64.4 m-85 -106.25 100.16 9.71 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.24 -173.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 69' ' ' LEU . 79.0 t -97.2 114.69 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -101.11 122.16 43.1 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.55 1.14 . . . . 0.0 110.337 -172.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.65 HG23 HD13 ' A' ' 69' ' ' LEU . 51.5 p -71.07 162.47 29.37 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.669 0.668 . . . . 0.0 111.069 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.506 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 84.1 mt -70.73 -20.24 62.67 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.047 171.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -80.34 -5.4 56.29 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.504 0.722 . . . . 0.0 111.206 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.47 15.28 51.1 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 114.457 0.543 . . . . 0.0 114.457 166.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HZ3' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -95.32 152.22 18.58 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.4 m -100.6 141.45 33.45 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.469 HD11 HG22 ' A' ' 7' ' ' THR . 5.4 mp -123.31 116.34 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.309 1.043 . . . . 0.0 108.297 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -101.38 117.16 34.4 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.518 0.727 . . . . 0.0 109.594 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -104.62 151.47 23.62 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.665 0.786 . . . . 0.0 109.515 -175.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -108.94 76.95 1.04 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 124.095 0.872 . . . . 0.0 109.338 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.684 HG22 HG21 ' A' ' 26' ' ' VAL . 3.6 m -140.7 170.38 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -91.8 157.88 40.88 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.491 0.716 . . . . 0.0 109.185 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 25.1 Cg_endo -61.24 -29.37 86.36 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.539 1.493 . . . . 0.0 111.206 168.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 t -99.28 19.86 14.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.731 0.812 . . . . 0.0 110.583 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -80.73 -94.74 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.2 t 177.05 143.87 0.09 Allowed 'General case' 0 C--N 1.364 1.238 0 C-N-CA 124.889 1.276 . . . . 0.0 109.734 173.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -61.62 -38.01 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.539 1.136 . . . . 0.0 111.298 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -52.92 -40.45 63.59 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.968 0.907 . . . . 0.0 111.013 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.437 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.2 t-20 -72.72 -44.71 61.35 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.116 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.684 HG21 HG22 ' A' ' 17' ' ' VAL . 53.1 t -54.91 -47.68 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 124.479 1.112 . . . . 0.0 111.086 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -69.88 -34.06 73.05 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 122.879 0.472 . . . . 0.0 111.552 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -25.1 65.2 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.888 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 8.8 mmpt? -77.69 -32.35 52.97 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.58 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.468 HG13 HG23 ' A' ' 13' ' ' ILE . 1.9 mp -57.01 -43.13 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 119.078 0.854 . . . . 0.0 109.967 169.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -62.42 -30.67 71.39 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.635 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -73.76 -29.61 62.31 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.582 0.753 . . . . 0.0 111.833 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 69.8 mmtt -95.23 -67.98 0.82 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.38 -23.87 32.25 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.248 0.219 . . . . 0.0 110.923 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.6 40.8 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.195 174.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.53 125.08 35.02 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 72.5 Cg_endo -70.4 158.39 56.25 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.205 2.603 . . . . 0.0 112.698 -173.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.0 -16.27 20.16 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 123.804 3.003 . . . . 0.0 114.052 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.44 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 23.0 t70 -74.46 -28.07 60.87 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.874 0.87 . . . . 0.0 110.797 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.405 ' OE1' ' HB2' ' A' ' 74' ' ' ARG . 2.7 mp0 -108.13 -17.59 13.99 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.823 1.249 . . . . 0.0 113.244 -175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.432 ' HB2' HD22 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -110.56 155.6 22.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.019 0.528 . . . . 0.0 110.218 176.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.49 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 41.7 ttt180 -139.54 125.0 19.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.94 0.496 . . . . 0.0 110.234 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.69 124.24 37.55 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.517 0.727 . . . . 0.0 110.032 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -142.45 130.56 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.152 0.981 . . . . 0.0 109.526 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.518 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 89.8 t80 -128.56 135.37 49.28 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 171.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.447 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 66.62 16.7 10.47 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.18 0.992 . . . . 0.0 112.378 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.23 21.82 58.09 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.234 0.334 . . . . 0.0 113.846 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 11.4 ptpt -130.8 145.27 51.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.29 0.636 . . . . 0.0 109.352 174.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -74.58 140.13 44.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.815 0.446 . . . . 0.0 110.104 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.4 mt -91.6 125.05 36.19 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.205 0.602 . . . . 0.0 110.647 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.41 138.46 32.83 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.826 0.85 . . . . 0.0 110.309 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.65 -46.56 84.05 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.653 1.181 . . . . 0.0 112.387 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.7 -26.41 72.04 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 124.142 0.902 . . . . 0.0 113.641 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 55.9 mtt180 -77.54 177.09 8.32 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.303 0.641 . . . . 0.0 111.582 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.7 p -116.1 169.07 9.55 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.652 0.781 . . . . 0.0 109.777 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.0 mt -55.99 -53.07 61.36 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.698 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 t -61.34 -24.89 66.78 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.567 1.147 . . . . 0.0 111.648 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 12.4 t70 -65.7 -41.83 91.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -91.47 20.77 5.03 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.812 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 72.6 8.01 5.61 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 124.745 1.218 . . . . 0.0 112.789 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 10.6 mt -84.61 116.91 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -106.48 -172.15 2.03 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -58.71 146.95 34.73 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.105 0.479 . . . . 0.0 110.557 172.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 62.9 5.57 1.86 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.636 1.574 . . . . 0.0 113.711 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.6 m -70.6 143.71 51.43 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 118.664 0.665 . . . . 0.0 111.198 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 27.2 m -108.54 134.3 51.49 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.15 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.509 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -144.77 173.13 12.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.988 1.315 . . . . 0.0 108.536 -176.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -102.97 153.43 20.23 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.701 0.762 . . . . 0.0 112.677 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.65 HD13 HG23 ' A' ' 7' ' ' THR . 2.3 tm? -130.52 126.07 35.9 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.495 HG22 HD11 ' A' ' 8' ' ' LEU . 73.8 t -110.79 124.61 67.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 123.275 0.63 . . . . 0.0 109.742 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -85.42 147.13 26.64 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.681 0.792 . . . . 0.0 110.355 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.44 ' HD2' ' O ' ' A' ' 39' ' ' ASP . 40.1 mtt180 -122.33 -44.18 2.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.703 0.801 . . . . 0.0 110.451 -173.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' B' ' 196' ' ' SER . 4.1 mm? 57.26 40.01 28.2 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.733 1.213 . . . . 0.0 112.081 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HB2' ' OE1' ' A' ' 40' ' ' GLN . 18.8 mmm180 -68.97 -58.8 3.63 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.861 0.864 . . . . 0.0 110.355 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.48 14.41 39.12 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.994 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.737 0 CA-C-N 117.034 0.417 . . . . 0.0 113.692 178.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.693 0 N-CA-C 112.119 -0.393 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' SER . . . . . 0.448 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 38.7 p -79.01 75.82 5.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.703 0.763 . . . . 0.0 110.374 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -102.61 10.7 38.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.904 0.882 . . . . 0.0 110.771 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -163.27 171.77 15.68 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.97 0.908 . . . . 0.0 110.075 -172.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.26 92.77 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 163.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' THR . . . . . 0.493 HG21 HG12 ' B' ' 202' ' ' VAL . 8.2 m -66.7 130.83 44.46 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.984 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -93.94 123.99 37.65 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 3.4 m -140.58 151.58 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.144 1.378 . . . . 0.0 110.047 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' B' ' 210' ' ' ASN . 4.8 m-20 -78.89 147.19 33.19 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.731 -175.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.568 ' HA ' HD13 ' B' ' 216' ' ' ILE . 24.8 t -89.77 98.33 1.3 Allowed Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.522 ' HD2' HD13 ' B' ' 220' ' ' LEU . 74.1 Cg_endo -68.45 9.01 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.521 2.814 . . . . 0.0 115.887 -163.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 29.9 t -104.61 -48.62 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 122.833 0.453 . . . . 0.0 110.654 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . 0.491 ' SG ' HG21 ' B' ' 209' ' ' VAL . 18.0 p -107.48 -7.95 16.4 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.901 0.48 . . . . 0.0 112.185 -173.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.63 41.55 64.66 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . 0.491 HG21 ' SG ' ' B' ' 207' ' ' CYS . 27.9 m -118.62 132.83 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 117.647 0.724 . . . . 0.0 110.072 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' B' ' 203' ' ' ASP . 25.3 t-20 -86.23 126.49 34.31 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 4.9 pt -148.92 159.45 37.54 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 125.865 1.666 . . . . 0.0 108.991 -169.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' B' ' 215' ' ' HIS . 17.8 Cg_endo -58.74 156.25 33.48 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.41 2.073 . . . . 0.0 111.964 174.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.521 ' O ' HG21 ' B' ' 216' ' ' ILE . 26.7 tt0 -66.32 -30.21 70.57 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.02 0.928 . . . . 0.0 112.033 -170.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 51.2 p -63.92 -49.98 70.51 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.581 0.705 . . . . 0.0 109.558 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . 0.491 ' HB2' ' HG2' ' B' ' 212' ' ' PRO . 47.1 m80 -76.11 -12.2 60.07 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.871 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -72.85 -51.6 26.45 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.274 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -63.87 -31.23 72.34 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.181 0.446 . . . . 0.0 111.727 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -66.13 -63.58 1.05 Allowed 'General case' 0 C--O 1.251 1.178 0 O-C-N 123.885 0.741 . . . . 0.0 111.556 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -43.27 69.79 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.319 1.048 . . . . 0.0 109.863 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.522 HD13 ' HD2' ' B' ' 205' ' ' PRO . 30.7 tp -63.31 -46.04 88.54 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 113.654 -1.612 . . . . 0.0 111.808 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.17 -35.28 64.63 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 124.316 1.01 . . . . 0.0 110.358 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.3 t -79.77 -38.31 33.46 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.995 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 93.9 m -74.24 -35.11 63.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.448 1.099 . . . . 0.0 112.633 -172.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . 0.409 HD23 ' HG ' ' B' ' 220' ' ' LEU . 4.0 pp -73.4 -9.08 58.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.559 0.743 . . . . 0.0 111.846 -168.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 40.5 m -72.65 87.03 1.22 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -125.91 122.96 37.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.084 0.953 . . . . 0.0 109.586 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.255 1.389 0 C-N-CA 123.669 0.788 . . . . 0.0 109.907 179.321 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.429 0 N-CA-C 112.312 -0.315 . . . . 0.0 112.312 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' SER . . . . . 0.45 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 60.9 m -153.94 177.26 11.23 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.695 1.198 . . . . 0.0 109.909 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -152.71 114.56 4.35 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 164.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' HE2' ' HB3' ' A' ' -1' ' ' SER . 20.9 mmt -123.39 160.22 27.26 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.163 0.985 . . . . 0.0 110.147 -173.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.531 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 17.4 mp0 -90.12 134.43 34.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.929 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.477 HD13 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -130.53 157.96 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.126 1.37 . . . . 0.0 108.586 172.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 66' ' ' THR . 72.8 m-85 -116.55 120.5 38.91 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.305 0.642 . . . . 0.0 109.783 -173.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.559 HG21 HD13 ' A' ' 30' ' ' ILE . 68.9 t -109.9 130.89 62.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -118.16 117.02 28.01 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.551 HG22 HD11 ' A' ' 69' ' ' LEU . 43.5 p -70.15 165.68 21.53 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.286 0.565 . . . . 0.0 111.697 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.412 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 57.5 mt -68.92 -22.0 64.18 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.005 173.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.0 p -79.64 -15.89 56.78 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.387 0.675 . . . . 0.0 110.782 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.96 21.21 16.31 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.539 -0.59 . . . . 0.0 114.476 170.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.618 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.39 153.71 17.83 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.496 0.648 . . . . 0.0 109.599 174.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.9 m -100.53 144.22 29.77 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.324 0.65 . . . . 0.0 109.869 172.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.517 HD13 HG21 ' A' ' 7' ' ' THR . 5.3 mp -128.79 114.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.808 1.243 . . . . 0.0 108.408 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.1 m -99.58 121.85 41.79 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.504 0.722 . . . . 0.0 110.119 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -112.21 153.16 27.5 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -116.43 76.9 1.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.657 HG23 HG21 ' A' ' 26' ' ' VAL . 20.5 m -140.04 177.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.375 0.67 . . . . 0.0 110.386 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -91.99 157.08 41.74 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 123.642 0.777 . . . . 0.0 109.75 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.466 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 24.3 Cg_endo -61.95 -34.68 80.6 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.536 1.491 . . . . 0.0 110.836 165.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -94.13 13.88 21.76 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.1 0.56 . . . . 0.0 110.67 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.42 -96.15 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.393 0.677 . . . . 0.0 110.867 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.1 t 169.52 138.26 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.6 1.56 . . . . 0.0 108.307 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.15 -34.33 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.759 0.824 . . . . 0.0 110.956 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 16.8 tp10 -60.25 -35.42 75.44 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.557 0.694 . . . . 0.0 111.399 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 12.2 t30 -76.47 -44.04 37.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.923 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.657 HG21 HG23 ' A' ' 17' ' ' VAL . 62.6 t -57.0 -43.88 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 124.316 1.01 . . . . 0.0 110.488 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HB2' ' OE1' ' A' ' 41' ' ' GLN . 17.6 ptpt -71.08 -33.89 70.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.261 0.624 . . . . 0.0 110.576 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.63 -31.77 73.04 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.848 171.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 9.7 mmpt? -72.62 -35.49 67.84 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 5' ' ' VAL . 1.8 mp -55.65 -43.64 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.486 0.585 . . . . 0.0 110.167 171.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -65.48 -29.26 69.9 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.317 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.1 -25.92 62.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.169 0.588 . . . . 0.0 111.234 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 68.5 mmtt -99.28 -69.03 0.78 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.733 0.242 . . . . 0.0 111.168 -175.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -85.18 -21.2 29.27 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.73 14.1 51.05 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 114.298 0.479 . . . . 0.0 114.298 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.1 127.71 32.69 Favored Pre-proline 0 N--CA 1.481 1.113 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.29 154.27 72.51 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.06 2.507 . . . . 0.0 112.976 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 15.6 Cg_endo -54.64 -14.84 8.09 Favored 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 124.295 3.33 . . . . 0.0 114.94 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -72.36 -48.53 41.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.962 0.505 . . . . 0.0 110.309 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 2.9 mp0 -88.82 -22.7 23.1 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.968 0.907 . . . . 0.0 113.109 -171.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.634 HE21 HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -101.21 124.64 47.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.813 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 34.1 ttt180 -112.91 130.27 56.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.177 0.991 . . . . 0.0 108.826 -172.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.03 119.0 32.8 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.44 0.696 . . . . 0.0 110.533 -170.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.7 mt -140.95 127.73 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.562 0.745 . . . . 0.0 109.796 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.671 ' HB3' HD21 ' A' ' 50' ' ' LEU . 75.6 t80 -129.23 126.01 38.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.76 1.224 . . . . 0.0 108.448 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . . . 61.8 18.45 9.73 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.107 0.963 . . . . 0.0 113.343 173.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.5 5.14 56.99 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.914 -0.381 . . . . 0.0 113.821 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.0 ptpt -118.02 146.98 43.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.367 0.667 . . . . 0.0 109.396 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -80.51 140.61 35.78 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.945 0.498 . . . . 0.0 109.98 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 45' ' ' PHE . 23.5 mt -94.96 114.93 26.82 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 122.931 0.493 . . . . 0.0 110.825 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -77.82 139.07 39.27 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.684 0.793 . . . . 0.0 110.199 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 11.2 p-10 -58.84 -39.54 81.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.522 1.129 . . . . 0.0 112.448 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.25 -18.25 80.06 Favored Glycine 0 C--N 1.354 1.536 0 O-C-N 124.126 0.891 . . . . 0.0 113.351 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.424 ' HD3' ' OD2' ' A' ' 58' ' ' ASP . 99.6 mtt180 -86.13 177.11 7.64 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.46 0.704 . . . . 0.0 111.275 175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 p -116.19 168.44 10.11 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 123.864 0.865 . . . . 0.0 109.668 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 89.4 mt -56.23 -49.87 72.91 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 124.195 0.934 . . . . 0.0 109.65 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 35.7 t -63.67 -26.14 68.53 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.541 1.137 . . . . 0.0 111.548 -175.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' OD2' ' HD3' ' A' ' 54' ' ' ARG . 20.2 t70 -65.18 -41.61 94.42 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 121.544 0.688 . . . . 0.0 109.637 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -89.87 15.07 10.49 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.944 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 71.37 14.85 6.38 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.072 1.349 . . . . 0.0 112.399 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 8.8 mt -86.52 121.68 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -115.01 -172.53 2.14 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -57.44 143.56 39.88 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.293 0.37 . . . . 0.0 110.815 172.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 72.25 1.11 3.82 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.295 1.438 . . . . 0.0 112.31 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -75.62 135.57 40.48 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 118.09 0.404 . . . . 0.0 110.223 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.4 m -99.9 131.23 46.0 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.117 0.484 . . . . 0.0 110.603 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.507 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -124.57 175.7 7.0 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.866 1.266 . . . . 0.0 108.667 174.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -108.68 153.09 23.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.349 0.66 . . . . 0.0 111.423 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.634 HD23 HE21 ' A' ' 41' ' ' GLN . 2.1 tm? -131.21 126.25 35.07 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -175.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.813 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.4 t -105.28 109.2 26.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.802 0.841 . . . . 0.0 109.828 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -81.63 138.96 35.25 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.305 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.691 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 61.2 mtp180 -113.07 -47.48 3.03 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.898 0.879 . . . . 0.0 110.676 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.93 21.98 8.25 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.939 0.896 . . . . 0.0 112.131 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.691 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 3.5 mmp_? -65.41 -49.84 67.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.48 0.712 . . . . 0.0 110.319 -174.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.3 -21.77 37.07 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.979 172.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--N 1.35 1.354 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.503 0 N-CA-C 112.296 -0.321 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 46.0 t -154.39 133.95 12.78 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.543 0.737 . . . . 0.0 109.871 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -174.44 90.89 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.244 1.018 . . . . 0.0 109.324 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -114.79 160.33 19.56 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.9 p -53.69 99.83 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 124.246 1.018 . . . . 0.0 111.926 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 200' ' ' THR . . . . . 0.548 HG23 HG11 ' B' ' 202' ' ' VAL . 38.5 m -84.06 133.55 34.65 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.805 0.842 . . . . 0.0 110.723 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.67 123.6 37.11 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . 0.548 HG11 HG23 ' B' ' 200' ' ' THR . 0.9 OUTLIER -147.61 146.18 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.033 0.933 . . . . 0.0 111.036 -162.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -74.2 147.73 42.26 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.383 0.673 . . . . 0.0 111.492 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.471 ' HA ' HD12 ' B' ' 216' ' ' ILE . 20.0 t -91.7 97.59 1.51 Allowed Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.166 0.986 . . . . 0.0 108.902 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.406 ' HD2' HD12 ' B' ' 220' ' ' LEU . 32.3 Cg_endo -58.52 -5.45 2.41 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.679 2.919 . . . . 0.0 116.364 -166.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . 0.413 HG11 ' O ' ' B' ' 223' ' ' CYS . 41.0 t -94.67 -57.48 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 173.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . 0.484 ' SG ' HG21 ' B' ' 209' ' ' VAL . 11.7 p -106.12 9.45 32.31 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.56 -37.55 2.78 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.865 1.106 . . . . 0.0 115.865 171.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . 0.484 HG21 ' SG ' ' B' ' 207' ' ' CYS . 20.6 m -60.2 134.73 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -165.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -84.7 125.35 32.44 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.695 HG13 HG12 ' B' ' 216' ' ' ILE . 5.2 pt -148.56 156.08 41.98 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.464 1.506 . . . . 0.0 109.166 -171.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.04 151.55 77.61 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.698 2.266 . . . . 0.0 112.196 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.423 ' HA ' ' HB ' ' B' ' 216' ' ' ILE . 3.9 tm-20 -58.53 -43.65 89.3 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -166.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 27.1 t -65.71 -36.75 84.5 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.583 -0.698 . . . . 0.0 110.381 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -82.43 -11.47 58.51 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.107 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.695 HG12 HG13 ' B' ' 211' ' ' ILE . 0.4 OUTLIER -68.8 -45.94 80.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 172.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -74.21 -30.36 62.16 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.519 0.512 . . . . 0.0 111.974 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -68.4 -50.72 50.87 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.31 0.381 . . . . 0.0 110.888 172.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.13 -45.37 83.56 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.08 0.552 . . . . 0.0 109.543 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.529 HD13 HG22 ' A' ' 70' ' ' VAL . 60.7 mt -68.96 -34.36 75.21 Favored 'General case' 0 C--O 1.209 -1.078 0 O-C-N 124.528 1.142 . . . . 0.0 112.439 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.57 -31.23 65.94 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.907 0.754 . . . . 0.0 109.882 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 t -91.33 -36.24 13.97 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.782 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . 0.509 ' HB2' ' HA ' ' B' ' 220' ' ' LEU . 84.9 m -75.01 -28.25 60.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.675 0.79 . . . . 0.0 112.271 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.79 -9.51 58.62 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.042 0.537 . . . . 0.0 110.903 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 36.0 t -65.15 83.03 0.05 OUTLIER 'General case' 0 C--N 1.36 1.026 0 C-N-CA 123.819 0.848 . . . . 0.0 109.62 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -75.58 -29.12 59.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.107 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 C--O 1.248 1.0 0 C-N-CA 124.711 1.204 . . . . 0.0 108.461 177.292 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.459 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.2 p -96.01 104.54 16.49 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.25 1.02 . . . . 0.0 109.905 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 37.7 p-80 -73.65 98.52 2.88 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.797 0.808 . . . . 0.0 111.345 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt -89.2 156.79 18.55 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.291 174.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 20.7 mp0 -98.48 136.74 38.17 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.723 0.409 . . . . 0.0 110.713 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.4 155.94 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.678 1.191 . . . . 0.0 108.568 173.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 66' ' ' THR . 90.2 m-85 -113.53 99.66 7.92 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.277 -170.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 69' ' ' LEU . 93.6 t -99.45 100.01 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -94.65 123.49 38.12 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.899 0.88 . . . . 0.0 110.737 -171.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.721 HG21 HD11 ' A' ' 69' ' ' LEU . 39.5 p -70.59 166.94 19.58 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.715 0.769 . . . . 0.0 111.922 176.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.13 -19.64 65.65 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.721 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -79.59 -3.85 48.88 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.569 0.747 . . . . 0.0 111.309 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.15 5.78 67.37 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.054 0.359 . . . . 0.0 112.378 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -90.4 137.83 32.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.206 1.003 . . . . 0.0 109.621 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.7 m -107.05 129.1 54.86 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.252 0.621 . . . . 0.0 110.369 -176.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -108.06 113.27 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.024 0.93 . . . . 0.0 109.327 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 m -87.45 117.0 25.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.723 0.809 . . . . 0.0 109.123 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.8 mm? -104.54 160.24 15.1 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.655 0.782 . . . . 0.0 109.022 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 0' ' ' HIS . 33.9 mt-10 -127.07 80.99 1.99 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.858 0.863 . . . . 0.0 108.795 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.74 HG23 HG21 ' A' ' 26' ' ' VAL . 3.1 m -138.19 175.52 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.612 1.165 . . . . 0.0 108.657 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 12.9 mt-10 -92.28 140.71 24.41 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.452 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 9.7 Cg_endo -55.57 -29.1 68.34 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.857 2.372 . . . . 0.0 112.038 167.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -92.92 4.19 54.37 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.85 0.86 . . . . 0.0 110.797 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 22.6 t70 -82.27 -87.52 0.09 Allowed 'General case' 0 C--N 1.358 0.955 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.275 -174.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' VAL . 10.0 t 179.02 149.98 0.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.75 0.82 . . . . 0.0 110.956 176.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.28 -34.0 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.754 1.222 . . . . 0.0 110.685 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.506 ' HG2' ' HB2' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -58.49 -38.46 77.67 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.068 0.947 . . . . 0.0 109.821 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.509 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.6 t30 -71.66 -44.76 63.73 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.078 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.74 HG21 HG23 ' A' ' 17' ' ' VAL . 61.4 t -55.06 -48.17 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 124.437 1.085 . . . . 0.0 110.825 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -69.1 -31.83 70.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.298 0.639 . . . . 0.0 111.429 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.61 74.38 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.797 0.685 . . . . 0.0 111.141 170.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 65.3 mmtt -78.09 -31.57 50.19 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.932 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -58.85 -44.08 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.351 0.978 . . . . 0.0 109.291 170.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.75 -31.28 72.19 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.539 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 8.6 t70 -71.54 -35.21 70.59 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.639 0.776 . . . . 0.0 111.564 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.4 mmtt -88.72 -67.02 0.86 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.575 0.35 . . . . 0.0 110.968 -171.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -88.06 -22.33 24.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.301 0.24 . . . . 0.0 111.512 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.96 12.38 46.64 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.993 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -98.62 122.19 54.06 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -69.82 155.86 64.67 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.524 2.816 . . . . 0.0 113.059 -172.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.94 -13.1 10.8 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 124.482 3.455 . . . . 0.0 114.621 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.21 -47.33 14.81 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -77.64 -27.99 51.18 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.304 0.641 . . . . 0.0 111.286 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.46 HE22 HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -96.65 147.68 23.64 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.648 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 42.9 ttt180 -137.66 129.25 28.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.46 HD22 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -92.2 125.73 36.99 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -173.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.403 HD12 ' HG ' ' B' ' 220' ' ' LEU . 97.6 mt -142.78 131.54 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.911 0.884 . . . . 0.0 110.071 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.538 ' HB3' HD23 ' A' ' 50' ' ' LEU . 86.0 t80 -135.81 128.36 30.63 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.499 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . . . 65.45 21.3 11.84 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.834 0.854 . . . . 0.0 111.938 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.56 2.33 82.34 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.448 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 9.9 ptpt -108.99 142.16 40.05 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -76.86 126.47 31.04 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.028 0.531 . . . . 0.0 110.081 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 45' ' ' PHE . 17.7 mt -77.83 119.6 21.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.173 0.589 . . . . 0.0 110.352 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.0 138.37 42.18 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.742 0.651 . . . . 0.0 109.562 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.506 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 10.4 p-10 -61.1 -40.03 92.19 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 124.126 0.891 . . . . 0.0 112.037 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.57 -27.24 73.94 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.624 0.578 . . . . 0.0 113.374 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -77.48 176.77 8.58 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.214 0.606 . . . . 0.0 111.919 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.5 p -110.07 167.22 10.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.437 0.695 . . . . 0.0 109.765 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 81.4 mt -58.3 -51.46 69.69 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 56.2 m -59.6 -25.98 65.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.932 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.53 -34.25 73.98 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.074 0.464 . . . . 0.0 110.044 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -92.6 15.94 13.21 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.754 0.822 . . . . 0.0 111.768 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 66.67 30.04 8.43 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.239 1.016 . . . . 0.0 111.639 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -101.16 118.01 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -102.89 -175.99 2.96 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -58.18 141.5 50.33 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.125 171.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 72.49 0.34 3.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.509 1.523 . . . . 0.0 112.669 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.8 m -73.46 137.35 44.47 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 118.236 0.471 . . . . 0.0 110.705 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 15.0 m -95.53 137.04 35.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.875 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.73 174.54 10.41 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.945 1.298 . . . . 0.0 108.454 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -101.76 158.56 16.02 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.849 0.833 . . . . 0.0 112.185 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.721 HD11 HG21 ' A' ' 7' ' ' THR . 2.7 tm? -138.35 125.82 21.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.215 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 91.0 t -99.93 120.61 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 123.301 0.64 . . . . 0.0 110.224 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.436 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 93.0 mt -89.29 140.41 29.52 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.349 1.031 . . . . 0.0 109.883 174.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -119.14 -28.34 5.49 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.002 0.921 . . . . 0.0 111.476 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' ' 71' ' ' LEU . 3.6 mm? 44.3 46.45 7.64 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 125.657 1.583 . . . . 0.0 113.978 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -65.66 -23.11 66.72 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.704 174.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.48 -11.49 38.38 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.778 174.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.479 0 C-N-CA 123.191 0.424 . . . . 0.0 112.965 -176.884 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.851 0 CA-C-O 120.035 -0.314 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 196' ' ' SER . . . . . 0.403 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 66.6 m -75.72 78.19 2.68 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.559 0.744 . . . . 0.0 109.929 174.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -134.71 6.21 3.44 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.035 1.334 . . . . 0.0 110.03 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -133.61 175.09 9.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.702 0.801 . . . . 0.0 110.495 -172.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.4 p -69.19 95.13 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 121.665 0.745 . . . . 0.0 110.44 175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 200' ' ' THR . . . . . 0.469 HG22 HG13 ' B' ' 202' ' ' VAL . 50.4 m -80.05 120.11 23.77 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.69 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -83.25 123.27 29.42 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . 0.469 HG13 HG22 ' B' ' 200' ' ' THR . 3.8 m -138.01 172.08 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 125.505 1.522 . . . . 0.0 108.441 -173.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.47 146.52 31.64 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 122.373 -0.204 . . . . 0.0 110.624 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.547 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.9 t -83.7 105.72 6.17 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.711 0.805 . . . . 0.0 109.019 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.54 ' HD2' HD11 ' B' ' 220' ' ' LEU . 40.5 Cg_endo -63.12 -1.0 2.52 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 124.087 3.191 . . . . 0.0 115.401 -171.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.95 -51.08 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.377 0.671 . . . . 0.0 111.427 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.9 p -113.88 1.07 14.64 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.009 0.523 . . . . 0.0 111.8 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 56.28 55.3 30.21 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 124.48 1.038 . . . . 0.0 115.195 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.72 127.2 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.166 0.586 . . . . 0.0 109.512 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.96 110.47 15.37 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 8.6 pt -138.6 160.87 61.66 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 125.715 1.606 . . . . 0.0 109.721 -173.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.75 159.77 23.54 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.841 2.361 . . . . 0.0 113.124 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.496 ' O ' HG22 ' B' ' 216' ' ' ILE . 34.4 tt0 -63.14 -33.49 75.58 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.993 1.317 . . . . 0.0 112.686 -172.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.0 t -66.23 -46.35 77.47 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.508 0.67 . . . . 0.0 110.594 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.19 -13.0 57.8 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.891 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.47 -44.82 53.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 174.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -55.07 28.44 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 124.502 1.126 . . . . 0.0 109.152 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -61.62 -39.18 90.34 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 124.446 1.091 . . . . 0.0 112.145 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -36.26 80.05 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.297 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.54 HD11 ' HD2' ' B' ' 205' ' ' PRO . 0.0 OUTLIER -63.71 -50.44 69.13 Favored 'General case' 0 C--O 1.21 -1.009 0 O-C-N 123.789 0.681 . . . . 0.0 110.249 177.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -54.49 -27.33 37.12 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 123.924 0.765 . . . . 0.0 112.048 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.1 t -89.1 -39.77 13.39 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.589 0.756 . . . . 0.0 111.217 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.55 -18.96 43.12 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.393 1.077 . . . . 0.0 113.511 -171.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' B' ' 220' ' ' LEU . 4.4 pp -94.93 13.81 23.69 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.625 0.648 . . . . 0.0 110.105 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 30.0 m -75.0 20.1 0.14 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.46 1.104 . . . . 0.0 112.665 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -149.48 151.49 34.03 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.07 0.948 . . . . 0.0 108.864 170.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.287 0 C-N-CA 124.367 1.067 . . . . 0.0 109.232 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.427 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.7 t -130.48 79.72 1.91 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.486 0.715 . . . . 0.0 109.921 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -84.58 152.18 24.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.88 174.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt -108.6 178.71 4.4 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.85 0.86 . . . . 0.0 110.209 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 75.8 mt-30 -119.42 132.63 55.85 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.3 0.64 . . . . 0.0 110.78 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.539 HD13 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -128.24 156.4 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.133 1.373 . . . . 0.0 108.951 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 66' ' ' THR . 50.1 m-85 -115.2 112.2 22.13 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.401 0.619 . . . . 0.0 110.073 -173.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.7 t -104.06 120.88 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -111.11 125.11 53.42 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.554 0.741 . . . . 0.0 109.82 -173.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.65 HG23 HD12 ' A' ' 69' ' ' LEU . 66.7 p -78.33 168.81 19.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.303 0.573 . . . . 0.0 112.067 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.434 HD13 HG23 ' A' ' 70' ' ' VAL . 60.7 mt -67.32 -27.68 67.35 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.345 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -79.34 -9.4 59.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.651 0.78 . . . . 0.0 110.987 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.69 22.98 37.58 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 114.17 0.428 . . . . 0.0 114.17 168.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.544 ' HZ3' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.64 152.42 18.51 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.7 m -101.54 139.51 37.1 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.121 0.568 . . . . 0.0 109.994 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.87 105.59 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.443 1.097 . . . . 0.0 108.181 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.1 m -86.96 122.97 31.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -105.8 156.29 18.46 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -120.34 69.66 0.87 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.442 1.097 . . . . 0.0 109.023 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.737 HG23 HG22 ' A' ' 26' ' ' VAL . 7.1 m -136.95 175.05 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -90.96 149.8 40.77 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HB2' ' OG ' ' A' ' 57' ' ' SER . 12.1 Cg_endo -58.96 -31.71 96.14 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.62 1.546 . . . . 0.0 111.733 164.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 t -97.36 18.09 15.98 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.905 0.482 . . . . 0.0 110.548 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.73 -96.73 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.827 0.851 . . . . 0.0 109.975 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.497 ' O ' HG21 ' A' ' 26' ' ' VAL . 5.2 t 174.36 140.37 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.2 1.4 . . . . 0.0 109.244 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.92 -37.11 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.879 0.871 . . . . 0.0 111.486 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 35.5 tt0 -54.92 -40.54 69.97 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.805 0.812 . . . . 0.0 110.792 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 11.5 t30 -73.54 -43.32 60.19 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.417 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.737 HG22 HG23 ' A' ' 17' ' ' VAL . 60.5 t -55.95 -48.63 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 124.311 1.007 . . . . 0.0 110.6 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.7 ptpt -68.41 -33.66 74.62 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.014 0.526 . . . . 0.0 111.602 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.64 -33.65 70.3 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.98 170.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 34.7 mmtm -76.64 -31.01 57.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.436 -0.793 . . . . 0.0 112.464 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 27' ' ' LYS . 2.8 mp -60.49 -39.63 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 119.682 1.128 . . . . 0.0 109.129 170.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.64 -34.18 77.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.311 0.644 . . . . 0.0 111.207 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.05 -36.55 75.08 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.479 0.712 . . . . 0.0 111.5 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.6 mmtt -88.23 -65.7 0.99 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.83 0.452 . . . . 0.0 111.243 -170.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -84.18 -24.04 30.32 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.923 0.328 . . . . 0.0 111.272 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.0 17.84 31.18 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.173 0.295 . . . . 0.0 113.554 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.82 127.36 27.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.482 0.713 . . . . 0.0 109.36 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.403 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 58.8 Cg_endo -67.09 154.53 74.18 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.057 2.504 . . . . 0.0 112.697 -173.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 37.3 Cg_endo -61.14 -13.79 30.0 Favored 'Trans proline' 0 C--N 1.388 2.634 0 C-N-CA 123.666 2.911 . . . . 0.0 113.88 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.96 -32.18 51.3 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.742 0.817 . . . . 0.0 110.703 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -96.53 -18.33 19.88 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.855 1.262 . . . . 0.0 112.437 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.56 ' HB2' HD13 ' A' ' 69' ' ' LEU . 3.5 pp0? -118.96 133.57 55.74 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.165 0.507 . . . . 0.0 110.82 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.634 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 56.1 ttt180 -120.95 128.71 52.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.26 1.024 . . . . 0.0 109.788 -169.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.01 126.98 38.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.697 0.799 . . . . 0.0 109.656 -171.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.7 mt -142.15 132.03 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.292 0.637 . . . . 0.0 109.952 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.56 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 72.4 t80 -137.9 131.58 31.17 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 171.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.12 19.32 10.44 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.031 0.932 . . . . 0.0 112.013 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 6.53 79.57 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.975 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 13.8 ptpt -118.81 145.06 45.93 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.648 0.724 . . . . 0.0 109.998 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.521 ' HB2' HD23 ' B' ' 224' ' ' LEU . 0.4 OUTLIER -77.67 122.91 25.98 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -175.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 45' ' ' PHE . 27.6 mt -72.11 119.52 16.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.405 0.682 . . . . 0.0 111.187 -175.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -81.54 138.77 35.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.233 1.013 . . . . 0.0 110.288 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 1.7 m-20 -60.22 -43.05 96.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.472 1.109 . . . . 0.0 112.613 -173.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.02 -8.77 74.7 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 124.36 1.037 . . . . 0.0 114.112 -177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 86.0 mtt-85 -95.1 177.33 5.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.99 0.916 . . . . 0.0 111.416 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -114.82 170.65 8.17 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.044 0.938 . . . . 0.0 109.509 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.9 mt -60.28 -52.16 66.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 40.7 m -54.62 -29.47 52.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.189 1.396 . . . . 0.0 112.633 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 12.7 t70 -65.67 -43.57 88.9 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 123.759 0.662 . . . . 0.0 109.761 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -87.93 21.23 2.76 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.916 0.887 . . . . 0.0 111.395 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 70.93 13.57 7.0 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.503 1.121 . . . . 0.0 111.982 176.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 14.6 mt -88.18 118.23 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.695 0.798 . . . . 0.0 109.001 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -102.5 -174.94 2.68 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -58.2 140.52 52.88 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.192 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 70.09 7.45 6.23 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.919 1.288 . . . . 0.0 112.954 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -69.46 135.88 50.78 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 117.901 0.319 . . . . 0.0 110.649 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.5 m -93.99 125.65 38.74 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.432 0.693 . . . . 0.0 109.617 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.56 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -127.46 167.92 15.61 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.347 1.059 . . . . 0.0 109.393 177.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -94.63 150.48 20.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.49 0.662 . . . . 0.0 110.93 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.65 HD12 HG23 ' A' ' 7' ' ' THR . 2.4 tm? -133.85 126.68 31.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.65 HG21 HD11 ' B' ' 220' ' ' LEU . 69.8 t -101.9 109.07 25.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.441 0.697 . . . . 0.0 110.12 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.509 ' HB3' HD22 ' A' ' 73' ' ' LEU . 67.1 mt -80.73 144.9 31.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.241 173.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -121.08 -48.14 2.24 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.062 0.945 . . . . 0.0 109.249 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 71' ' ' LEU . 4.6 mm? 51.72 45.5 28.05 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.678 1.191 . . . . 0.0 112.109 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -70.04 -17.72 63.27 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.025 175.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.91 5.45 84.87 Favored Glycine 0 C--N 1.35 1.307 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.337 172.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.396 0 C-N-CA 123.302 0.477 . . . . 0.0 112.536 179.324 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.828 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 29.3 t -151.9 103.03 2.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.264 0.626 . . . . 0.0 109.464 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -78.9 -28.96 44.05 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.941 0.896 . . . . 0.0 110.151 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -66.87 157.71 32.42 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.854 0.862 . . . . 0.0 111.015 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.25 101.89 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 O-C-N 124.047 0.842 . . . . 0.0 108.814 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 200' ' ' THR . . . . . 0.406 HG23 HG12 ' B' ' 202' ' ' VAL . 20.8 m -81.27 114.07 19.82 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.794 -172.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.68 124.61 28.17 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . 0.406 HG12 HG23 ' B' ' 200' ' ' THR . 6.1 m -140.89 -176.29 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.919 1.288 . . . . 0.0 109.319 -170.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -113.07 144.26 42.92 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.787 0.435 . . . . 0.0 110.326 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.525 ' HA ' HD13 ' B' ' 216' ' ' ILE . 53.5 t -86.14 98.03 0.71 Allowed Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.496 ' HD2' HD23 ' B' ' 220' ' ' LEU . 20.7 Cg_endo -55.22 -24.67 42.8 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.122 2.548 . . . . 0.0 114.413 -164.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 10.8 t -74.48 -63.42 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 122.861 0.464 . . . . 0.0 110.608 -173.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 22.7 p -91.6 -9.76 42.95 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.025 0.53 . . . . 0.0 111.24 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.92 58.77 12.03 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 124.073 0.844 . . . . 0.0 114.203 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 33.2 m -118.98 135.66 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.586 0.754 . . . . 0.0 109.553 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -83.44 104.81 13.88 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.091 0.472 . . . . 0.0 110.095 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' B' ' 204' ' ' CYS . 15.9 pt -137.01 152.21 73.52 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 125.308 1.443 . . . . 0.0 110.057 -174.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.09 163.36 16.93 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.012 2.475 . . . . 0.0 113.339 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.582 ' O ' HG22 ' B' ' 216' ' ' ILE . 5.6 tm-20 -62.64 -39.93 95.42 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -167.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 52.3 m -65.53 -39.87 92.29 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.7 -1.25 . . . . 0.0 110.295 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . 0.411 ' O ' ' HB2' ' B' ' 219' ' ' HIS . 8.0 m80 -68.24 -28.14 66.96 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.815 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.582 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -69.09 -48.41 69.51 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -176.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -67.13 -37.66 84.24 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.472 0.482 . . . . 0.0 111.387 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -42.22 83.53 Favored 'General case' 0 C--O 1.255 1.366 0 O-C-N 123.533 0.521 . . . . 0.0 111.212 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' B' ' 215' ' ' HIS . 0.1 OUTLIER -59.93 -37.52 79.75 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.41 177.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.65 HD11 HG21 ' A' ' 70' ' ' VAL . 96.7 mt -63.03 -45.39 92.49 Favored 'General case' 0 C--O 1.206 -1.218 0 O-C-N 124.014 0.821 . . . . 0.0 110.935 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -56.53 -28.37 59.86 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.445 0.466 . . . . 0.0 111.516 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.8 t -89.21 -41.18 12.37 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.312 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.2 m -79.04 -28.21 43.21 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.959 0.904 . . . . 0.0 112.971 -167.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . 0.521 HD23 ' HB2' ' A' ' 49' ' ' GLN . 3.7 pp -82.29 -16.56 48.98 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.383 0.673 . . . . 0.0 109.3 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 23.0 t -75.72 74.45 2.69 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 123.993 0.917 . . . . 0.0 109.142 176.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 34.1 ttt-85 -93.9 -45.39 7.65 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.62 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 CA--C 1.555 1.16 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.274 -167.447 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 33.3 t -162.38 -51.7 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.776 0.83 . . . . 0.0 109.914 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.619 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 80.6 m80 68.54 116.46 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.051 1.34 . . . . 0.0 111.599 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 mmt -106.11 -170.22 1.7 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.6 1.16 . . . . 0.0 109.32 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 88.7 mt-30 -120.1 151.57 38.86 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.854 0.462 . . . . 0.0 111.388 172.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -141.13 159.54 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.223 1.409 . . . . 0.0 109.701 177.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 66' ' ' THR . 86.7 m-85 -107.58 109.8 21.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.032 0.933 . . . . 0.0 109.68 -176.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.451 HG22 HD11 ' A' ' 30' ' ' ILE . 19.4 t -101.51 111.42 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 tptt -110.93 117.15 32.58 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.511 0.725 . . . . 0.0 109.981 -171.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.57 HG23 HD13 ' A' ' 69' ' ' LEU . 80.4 p -69.51 161.29 29.82 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.165 0.507 . . . . 0.0 111.716 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.491 HD13 HG21 ' A' ' 70' ' ' VAL . 87.0 mt -66.36 -17.54 64.83 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.853 175.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -83.16 -26.88 30.5 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.975 0.51 . . . . 0.0 110.714 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.05 9.59 11.91 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.123 0.409 . . . . 0.0 114.123 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 147.35 35.97 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -108.77 139.35 43.71 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.93 106.54 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.7 m -88.97 120.49 30.43 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.477 ' HB2' HD11 ' A' ' 3' ' ' ILE . 1.0 OUTLIER -105.45 155.63 18.96 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.95 75.48 1.0 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.489 0.716 . . . . 0.0 109.423 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.801 HG23 HG21 ' A' ' 26' ' ' VAL . 11.3 m -137.96 167.38 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.097 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' A' ' 0' ' ' HIS . 2.4 mt-10 -86.74 155.34 56.09 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.156 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.471 ' HB2' ' OG ' ' A' ' 57' ' ' SER . 13.0 Cg_endo -57.48 -35.58 98.83 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 121.968 1.779 . . . . 0.0 111.198 165.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 t -97.66 19.36 13.68 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.027 0.931 . . . . 0.0 110.875 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.14 -94.82 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.366 0.666 . . . . 0.0 109.692 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 26' ' ' VAL . 10.1 t 176.23 141.14 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.135 1.374 . . . . 0.0 109.57 172.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.53 HG22 ' HE3' ' A' ' 27' ' ' LYS . 45.1 mm -61.63 -37.69 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.527 1.131 . . . . 0.0 111.571 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -50.09 -44.64 52.07 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.239 1.016 . . . . 0.0 110.686 177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.473 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 7.9 t30 -71.78 -43.62 65.39 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.035 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.801 HG21 HG23 ' A' ' 17' ' ' VAL . 60.9 t -54.76 -50.78 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 124.207 0.942 . . . . 0.0 110.953 -177.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HE3' HG22 ' A' ' 23' ' ' ILE . 16.5 ptpt -68.6 -35.56 77.5 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.678 0.391 . . . . 0.0 111.257 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.0 -28.08 68.77 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.118 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 9.5 mmpt? -74.06 -37.42 64.25 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 118.765 -0.635 . . . . 0.0 111.134 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.451 HD11 HG22 ' A' ' 5' ' ' VAL . 3.5 mp -60.86 -40.4 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-N 118.865 0.757 . . . . 0.0 109.131 173.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.99 -25.65 67.95 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.365 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -81.21 -32.47 33.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.189 0.595 . . . . 0.0 111.117 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.0 mmtt -88.24 -69.06 0.72 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.608 0.363 . . . . 0.0 110.895 -172.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.89 -26.1 34.44 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 120.481 0.181 . . . . 0.0 110.819 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.4 24.15 19.64 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.908 171.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.31 131.71 21.69 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.178 0.591 . . . . 0.0 109.476 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -64.74 149.87 89.04 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.34 2.693 . . . . 0.0 113.135 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 37.2 Cg_endo -61.27 -12.26 22.8 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.784 2.989 . . . . 0.0 113.724 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.35 -43.0 61.57 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.424 0.69 . . . . 0.0 110.535 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.5 mp0 -85.11 -28.9 25.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.051 0.94 . . . . 0.0 111.772 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.53 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 3.5 pp0? -109.0 123.22 48.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.306 0.642 . . . . 0.0 109.921 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.52 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 55.2 ttt180 -112.31 128.02 56.16 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.143 0.977 . . . . 0.0 110.184 -168.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.64 120.03 33.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.311 0.644 . . . . 0.0 110.486 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.2 mt -141.98 135.55 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.417 1.087 . . . . 0.0 109.88 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.51 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 88.3 t80 -131.69 123.46 27.81 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.36 1.064 . . . . 0.0 108.133 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.44 20.0 9.68 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.645 0.778 . . . . 0.0 112.608 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' HA2' HG23 ' B' ' 206' ' ' VAL . . . 101.23 -18.8 53.53 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 114.499 0.559 . . . . 0.0 114.499 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.1 ptpt -86.46 137.64 32.38 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.57 0.685 . . . . 0.0 109.709 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.556 ' HB2' HD22 ' B' ' 224' ' ' LEU . 27.4 tt0 -81.64 135.53 35.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.58 117.16 26.2 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 122.737 0.415 . . . . 0.0 111.298 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.65 138.86 31.85 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.581 1.152 . . . . 0.0 109.639 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.88 -47.55 64.49 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.78 1.232 . . . . 0.0 112.968 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.68 -30.97 78.42 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.905 0.753 . . . . 0.0 113.76 -174.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.461 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 97.2 mtt180 -80.04 177.77 8.7 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.516 0.726 . . . . 0.0 112.037 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -112.51 168.28 9.77 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.785 0.834 . . . . 0.0 109.915 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.6 mt -59.0 -50.48 73.94 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 21.9 m -54.93 -31.13 60.01 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.971 1.309 . . . . 0.0 112.778 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.92 -41.39 91.44 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.201 0.525 . . . . 0.0 109.826 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.461 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 34.8 m-85 -86.41 13.02 8.91 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.436 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.8 OUTLIER 70.11 27.79 4.19 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.55 1.14 . . . . 0.0 111.122 178.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 10.4 mt -99.44 144.95 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -135.27 -173.81 3.44 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -62.88 146.81 51.96 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 120.681 0.276 . . . . 0.0 110.637 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 68.57 5.51 4.89 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.268 1.427 . . . . 0.0 112.174 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -71.86 139.01 48.67 Favored 'General case' 0 C--N 1.362 1.126 0 CA-C-N 117.963 0.347 . . . . 0.0 110.118 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 21.4 m -100.52 117.05 33.89 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.51 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -121.6 142.14 50.41 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.183 0.993 . . . . 0.0 109.484 -177.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -77.91 130.01 36.06 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.648 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.57 HD13 HG23 ' A' ' 7' ' ' THR . 2.5 tm? -103.73 129.34 51.08 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.3 t -111.67 121.04 63.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.238 0.615 . . . . 0.0 109.922 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.86 156.84 23.38 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.523 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.468 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 51.6 mtt180 -128.57 -47.24 1.29 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.701 0.8 . . . . 0.0 110.385 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 51.18 36.03 14.79 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.763 1.225 . . . . 0.0 112.433 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.468 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 26.5 mmm180 -73.33 -23.57 60.26 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.856 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.43 0.1 77.21 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.628 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.263 0 C-N-CA 123.074 0.369 . . . . 0.0 112.431 -173.597 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.84 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 29.3 t -168.43 153.43 6.38 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.428 1.091 . . . . 0.0 109.647 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -148.49 24.28 1.0 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.039 0.936 . . . . 0.0 109.36 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -149.99 164.68 34.84 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.13 0.972 . . . . 0.0 109.634 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.23 126.31 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 28.6 m -87.81 138.32 31.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.103 0.561 . . . . 0.0 110.509 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -85.73 122.07 29.29 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 7.0 m -143.08 179.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.466 1.106 . . . . 0.0 109.595 -169.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.94 142.26 47.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.954 0.502 . . . . 0.0 110.739 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.535 ' HA ' HD13 ' B' ' 216' ' ' ILE . 49.0 t -76.01 104.76 1.67 Allowed Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 124.327 1.051 . . . . 0.0 108.648 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.526 ' HD2' HD22 ' B' ' 220' ' ' LEU . 38.2 Cg_endo -61.79 -12.96 27.79 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.559 2.839 . . . . 0.0 114.808 -168.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . 0.526 HG23 ' HA2' ' A' ' 47' ' ' GLY . 5.6 t -85.8 -61.28 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.133 0.573 . . . . 0.0 110.257 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 21.1 p -99.74 -5.54 28.56 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 112.224 0.454 . . . . 0.0 112.224 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 68.07 45.17 73.95 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 115.023 0.769 . . . . 0.0 115.023 173.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.24 133.44 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 117.342 0.571 . . . . 0.0 110.321 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -81.78 122.52 27.79 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.011 0.524 . . . . 0.0 110.17 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' B' ' 204' ' ' CYS . 3.4 pt -150.23 159.66 34.7 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.757 1.623 . . . . 0.0 108.924 -172.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.35 157.75 43.98 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.199 1.932 . . . . 0.0 112.061 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.562 ' O ' HG22 ' B' ' 216' ' ' ILE . 43.1 tt0 -60.9 -31.35 70.85 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.743 1.217 . . . . 0.0 112.093 -174.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 23.5 p -64.0 -50.95 66.5 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 121.653 0.739 . . . . 0.0 110.277 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -80.15 -10.96 59.79 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.16 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.562 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.1 OUTLIER -73.78 -48.36 39.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . 0.509 ' HA ' HD13 ' B' ' 220' ' ' LEU . 52.3 m-80 -63.39 -36.52 83.98 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.407 0.442 . . . . 0.0 110.843 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -57.57 -52.76 64.11 Favored 'General case' 0 C--O 1.254 1.3 0 O-C-N 123.96 0.788 . . . . 0.0 111.212 172.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -30.66 70.68 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.731 -176.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.526 HD22 ' HD2' ' B' ' 205' ' ' PRO . 96.3 mt -64.52 -50.48 67.21 Favored 'General case' 0 C--O 1.206 -1.186 0 O-C-N 123.887 0.742 . . . . 0.0 111.181 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -57.38 -27.79 62.63 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 123.87 0.731 . . . . 0.0 111.69 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.1 t -80.03 -45.74 17.83 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.552 173.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 67.0 m -81.12 -22.94 38.71 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.626 1.17 . . . . 0.0 113.811 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . 0.556 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.2 pp -88.3 -23.09 23.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 47.7 t -71.82 74.67 0.86 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.228 1.011 . . . . 0.0 108.625 172.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.54 96.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 -172.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.198 0 C-N-CA 124.504 1.121 . . . . 0.0 108.622 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.5 m -76.46 109.27 10.04 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.456 0.703 . . . . 0.0 110.828 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -81.37 100.78 9.42 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.697 0.799 . . . . 0.0 109.526 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt -78.44 170.13 17.13 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.393 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 21.6 mp0 -98.52 152.85 19.11 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.497 0.319 . . . . 0.0 110.512 173.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.18 150.6 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.345 1.058 . . . . 0.0 108.728 171.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.0 101.75 11.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.4 0.68 . . . . 0.0 109.787 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 69' ' ' LEU . 88.4 t -98.76 103.16 14.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -101.39 124.93 47.87 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.439 0.696 . . . . 0.0 110.901 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.706 HG22 HD11 ' A' ' 69' ' ' LEU . 60.2 p -65.53 157.74 28.86 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.316 0.647 . . . . 0.0 111.765 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.516 HD11 HG22 ' A' ' 70' ' ' VAL . 81.0 mt -66.47 -17.78 64.99 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.686 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -79.63 -11.31 59.87 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.342 0.657 . . . . 0.0 110.928 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.49 7.34 39.94 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 123.25 0.452 . . . . 0.0 113.863 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HZ1' ' HB3' ' A' ' 34' ' ' GLU . 1.0 OUTLIER -93.43 143.02 26.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.626 0.77 . . . . 0.0 109.193 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 m -103.51 141.19 36.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.857 0.463 . . . . 0.0 110.684 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.81 113.27 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.431 1.092 . . . . 0.0 108.504 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.3 m -91.57 120.34 32.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.922 0.489 . . . . 0.0 109.716 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -106.19 163.9 12.43 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.018 0.927 . . . . 0.0 109.261 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -130.82 82.47 2.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.376 0.67 . . . . 0.0 109.562 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.781 HG21 HG23 ' A' ' 26' ' ' VAL . 16.7 m -140.9 172.03 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.242 1.017 . . . . 0.0 109.085 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -86.02 150.71 53.24 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.742 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -60.79 -25.14 80.59 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.998 1.799 . . . . 0.0 111.332 166.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 t -95.12 5.65 51.24 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.038 0.935 . . . . 0.0 111.449 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.01 -96.62 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.139 0.576 . . . . 0.0 110.123 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.465 ' O ' HG22 ' A' ' 26' ' ' VAL . 11.1 t 177.85 146.13 0.13 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.676 1.191 . . . . 0.0 109.31 172.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -62.63 -36.26 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.598 1.159 . . . . 0.0 111.56 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.31 -36.51 71.17 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.712 0.767 . . . . 0.0 110.878 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.0 t-20 -76.07 -42.02 48.71 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.341 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.781 HG23 HG21 ' A' ' 17' ' ' VAL . 58.4 t -55.75 -48.16 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 124.342 1.026 . . . . 0.0 110.371 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.537 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.9 ptpt -69.93 -35.15 74.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.977 0.511 . . . . 0.0 110.945 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.05 -36.03 70.01 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.613 0.365 . . . . 0.0 110.921 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 74.0 mmtt -69.58 -33.92 73.41 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 118.59 -0.719 . . . . 0.0 112.394 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' A' ' 27' ' ' LYS . 2.7 mp -60.0 -41.22 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 119.404 1.002 . . . . 0.0 109.662 172.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -67.98 -24.71 65.18 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.526 0.731 . . . . 0.0 111.311 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -77.7 -30.26 51.77 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.849 0.859 . . . . 0.0 111.021 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -94.58 -67.63 0.84 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.828 0.451 . . . . 0.0 111.093 -173.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' HB3' ' HZ1' ' A' ' 11' ' ' LYS . 14.4 pt-20 -84.41 -26.62 28.19 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.201 0.2 . . . . 0.0 111.115 -178.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.75 23.68 22.68 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 116.547 -0.297 . . . . 0.0 112.851 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.79 129.04 25.59 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.436 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 73.9 Cg_endo -68.39 155.24 69.88 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.166 2.577 . . . . 0.0 112.766 -174.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 38.3 Cg_endo -61.16 -16.21 44.73 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.675 2.917 . . . . 0.0 114.082 -176.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.0 -24.71 43.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.829 0.852 . . . . 0.0 110.664 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.45 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.7 mp0 -99.9 -31.69 11.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.218 1.007 . . . . 0.0 111.954 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 3.1 pp0? -103.94 123.8 47.82 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.236 0.541 . . . . 0.0 110.419 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.703 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 67.2 ttt180 -115.06 128.58 56.33 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.393 1.077 . . . . 0.0 109.86 -169.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.6 mm? -94.16 121.18 35.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.552 0.741 . . . . 0.0 110.577 -171.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.0 mt -142.62 125.96 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.023 0.929 . . . . 0.0 109.988 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.627 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 85.0 t80 -121.73 122.72 40.18 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.47 1.108 . . . . 0.0 108.962 177.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.66 22.84 10.35 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.699 0.8 . . . . 0.0 112.754 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.17 -13.02 60.4 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.343 0.497 . . . . 0.0 114.343 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.9 ptpt -93.34 133.1 36.93 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.623 0.711 . . . . 0.0 109.298 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -76.08 136.81 39.89 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.441 HD12 ' HB3' ' A' ' 43' ' ' LEU . 22.7 mt -92.34 119.39 31.86 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 121.117 0.484 . . . . 0.0 111.164 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -86.87 139.46 30.63 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.252 1.421 . . . . 0.0 110.892 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.84 -45.37 82.43 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.802 1.241 . . . . 0.0 112.838 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.82 -27.03 73.69 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 124.072 0.857 . . . . 0.0 113.481 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -80.84 177.59 8.94 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.826 0.851 . . . . 0.0 111.93 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.7 p -113.99 167.83 10.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.817 0.847 . . . . 0.0 110.159 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 93.7 mt -56.72 -52.33 65.37 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.615 173.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.4 t -63.9 -22.78 67.08 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.283 1.033 . . . . 0.0 111.543 -176.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.03 -42.63 89.35 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.46 0.647 . . . . 0.0 109.488 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -89.25 15.64 8.65 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.887 -1.052 . . . . 0.0 112.147 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER 73.49 14.08 4.41 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.027 1.331 . . . . 0.0 112.175 175.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 7.9 mt -84.29 137.79 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -130.7 -173.93 3.22 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -56.53 141.24 43.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 122.866 0.466 . . . . 0.0 111.364 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 67.3 5.83 4.47 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.591 1.556 . . . . 0.0 113.268 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.3 m -70.48 133.19 46.59 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 118.204 0.457 . . . . 0.0 110.708 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.8 m -97.16 121.22 38.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.35 0.66 . . . . 0.0 109.278 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.627 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -123.24 175.05 6.9 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.897 1.279 . . . . 0.0 109.424 176.137 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -105.61 149.29 26.44 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.667 0.787 . . . . 0.0 110.665 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.706 HD11 HG22 ' A' ' 7' ' ' THR . 3.0 tm? -127.82 122.23 32.15 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.703 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 60.3 t -101.02 112.82 35.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 123.384 0.674 . . . . 0.0 109.779 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.85 145.89 36.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.728 173.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 67.2 mtp85 -122.25 -28.15 4.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.666 0.786 . . . . 0.0 111.124 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 50.94 28.86 4.02 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.532 1.133 . . . . 0.0 113.235 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.4 mmt-85 -73.19 -14.68 61.4 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.243 0.544 . . . . 0.0 109.997 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.65 26.52 1.49 Allowed Glycine 0 C--N 1.343 0.933 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.634 0 C-N-CA 123.631 0.634 . . . . 0.0 113.43 -178.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 36.1 t -158.94 144.73 16.5 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.952 0.901 . . . . 0.0 109.151 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -113.77 -51.22 2.8 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.047 0.939 . . . . 0.0 110.472 -176.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -86.03 175.4 8.6 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.815 0.846 . . . . 0.0 111.554 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.7 p -55.56 115.02 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 124.104 0.961 . . . . 0.0 110.824 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 200' ' ' THR . . . . . 0.481 HG23 HG13 ' B' ' 202' ' ' VAL . 4.4 m -97.07 111.86 23.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.084 0.554 . . . . 0.0 110.157 -171.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -85.3 123.13 30.43 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . 0.481 HG13 HG23 ' B' ' 200' ' ' THR . 4.0 m -144.93 -177.41 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.833 1.253 . . . . 0.0 109.536 -169.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -112.86 147.34 37.21 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.679 0.391 . . . . 0.0 110.971 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.53 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.4 t -87.31 101.95 2.78 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 124.379 1.072 . . . . 0.0 108.692 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.547 ' HD2' HD23 ' B' ' 220' ' ' LEU . 55.2 Cg_endo -65.55 2.71 1.43 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.272 2.648 . . . . 0.0 115.335 -172.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.13 -51.8 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.691 0.396 . . . . 0.0 110.901 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 14.6 p -114.59 9.0 16.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 58.56 42.17 95.91 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 115.907 1.123 . . . . 0.0 115.907 169.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.1 141.26 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 117.331 0.566 . . . . 0.0 110.644 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -88.17 112.55 22.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.006 0.522 . . . . 0.0 110.078 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.519 HD13 ' HB2' ' B' ' 204' ' ' CYS . 6.9 pt -141.66 156.26 66.33 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.489 1.515 . . . . 0.0 109.641 -173.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.75 162.6 33.93 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.704 2.269 . . . . 0.0 111.965 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.536 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.9 tm-20 -66.69 -38.69 87.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.979 0.911 . . . . 0.0 112.934 -166.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 43.1 t -56.39 -44.97 80.75 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.762 0.791 . . . . 0.0 109.868 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -80.33 -16.22 55.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.935 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.548 ' O ' ' HG ' ' B' ' 220' ' ' LEU . 0.2 OUTLIER -73.21 -50.34 32.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -67.14 -36.91 82.88 Favored 'General case' 0 C--N 1.347 0.461 0 O-C-N 123.645 0.591 . . . . 0.0 111.075 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -60.82 -46.99 88.37 Favored 'General case' 0 C--O 1.253 1.266 0 O-C-N 123.675 0.609 . . . . 0.0 110.905 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -40.32 82.62 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.167 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 216' ' ' ILE . 96.0 mt -60.75 -49.71 76.4 Favored 'General case' 0 C--O 1.211 -0.948 0 O-C-N 123.958 0.786 . . . . 0.0 111.584 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.65 -24.5 67.81 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 123.93 0.769 . . . . 0.0 112.072 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 30.1 t -81.89 -41.8 20.44 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.16 0.505 . . . . 0.0 110.564 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 94.2 m -81.49 -27.45 34.54 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.292 1.037 . . . . 0.0 113.179 -167.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp -79.45 -1.22 36.37 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.032 0.533 . . . . 0.0 110.828 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 18.4 m -66.09 83.41 0.08 Allowed 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.362 1.065 . . . . 0.0 110.199 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -64.62 -37.14 86.55 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.268 173.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 . . . . . 0 C--O 1.25 1.131 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.221 -177.176 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 59.7 m -140.96 146.39 37.27 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.826 0.85 . . . . 0.0 109.77 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -81.5 109.4 15.93 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt -74.9 163.11 28.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.477 0.711 . . . . 0.0 110.345 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -106.5 144.74 32.74 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.621 0.368 . . . . 0.0 111.237 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.75 157.65 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.991 1.316 . . . . 0.0 108.964 175.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 66' ' ' THR . 72.2 m-85 -110.84 101.33 9.94 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.493 0.717 . . . . 0.0 110.026 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' A' ' 69' ' ' LEU . 74.6 t -97.44 106.77 19.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -107.11 129.13 54.87 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.325 0.65 . . . . 0.0 110.499 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.678 HG22 HD13 ' A' ' 69' ' ' LEU . 71.8 p -72.25 165.28 24.75 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.362 0.601 . . . . 0.0 111.841 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.492 HD12 HG21 ' A' ' 70' ' ' VAL . 70.0 mt -67.17 -25.79 66.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.924 172.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -78.09 -14.14 59.6 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.34 0.656 . . . . 0.0 110.553 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.99 14.47 39.49 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 114.884 0.714 . . . . 0.0 114.884 165.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -84.31 151.65 24.62 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 m -107.61 132.0 53.77 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.95 112.44 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 m -92.16 116.09 28.65 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.424 0.69 . . . . 0.0 109.424 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.5 mm? -104.79 157.19 17.37 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.635 0.774 . . . . 0.0 109.483 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.09 86.76 2.63 Favored 'General case' 0 C--O 1.244 0.784 0 O-C-N 124.248 0.968 . . . . 0.0 108.436 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.779 HG21 HG21 ' A' ' 26' ' ' VAL . 13.7 m -140.71 176.65 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 124.374 1.07 . . . . 0.0 108.345 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -92.72 148.68 36.55 Favored Pre-proline 0 N--CA 1.475 0.782 0 O-C-N 121.69 -0.631 . . . . 0.0 109.379 172.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 19.5 Cg_endo -58.45 -28.32 84.88 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.171 1.914 . . . . 0.0 111.71 169.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.7 t -101.93 16.09 27.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.909 0.484 . . . . 0.0 110.979 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.98 -92.08 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -178.85 145.61 0.29 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.503 1.121 . . . . 0.0 109.825 173.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.54 -37.81 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.451 1.1 . . . . 0.0 111.359 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -58.55 -35.17 71.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.397 0.679 . . . . 0.0 110.807 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 16.2 t-20 -72.39 -44.95 61.78 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.331 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.779 HG21 HG21 ' A' ' 17' ' ' VAL . 45.3 t -54.2 -50.32 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 124.372 1.045 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.2 ptpt -68.94 -31.35 70.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.075 0.55 . . . . 0.0 111.802 -175.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.31 -39.61 79.86 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.978 0.418 . . . . 0.0 110.662 170.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 35.6 mmtm -68.88 -36.83 78.55 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.531 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.9 mp -59.13 -41.78 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 119.473 1.033 . . . . 0.0 110.17 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -62.97 -33.15 74.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.56 -26.01 57.59 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.278 0.631 . . . . 0.0 111.319 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.8 mmtt -94.5 -66.38 0.92 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.866 0.466 . . . . 0.0 110.889 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.89 -16.01 32.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.74 20.24 51.44 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 170.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.67 127.83 27.71 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.31 152.01 82.04 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.244 2.629 . . . . 0.0 112.989 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.598 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 43.6 Cg_endo -61.83 -17.14 53.56 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.983 3.122 . . . . 0.0 113.932 -174.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.22 -37.66 63.78 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.832 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -89.29 -32.2 17.48 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.276 1.03 . . . . 0.0 112.091 -174.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.598 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 3.0 pp0? -99.77 128.95 45.84 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.499 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 55.7 ttt180 -117.18 128.88 55.55 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.4 1.08 . . . . 0.0 109.174 -168.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.48 125.42 38.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 109.892 -172.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -142.22 133.96 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.087 0.955 . . . . 0.0 110.135 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.597 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 79.0 t80 -132.87 129.52 38.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 172.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.48 19.33 11.77 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.985 0.914 . . . . 0.0 113.073 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.33 17.07 54.24 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 114.282 0.473 . . . . 0.0 114.282 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 4.0 ptpt -130.01 148.64 51.89 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.731 0.766 . . . . 0.0 109.982 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -74.11 140.57 45.36 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.779 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.428 HD22 ' HB3' ' A' ' 45' ' ' PHE . 24.7 mt -88.64 119.22 28.91 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.015 0.526 . . . . 0.0 109.76 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.05 138.77 38.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.689 0.796 . . . . 0.0 109.989 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.88 -40.93 85.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.002 0.921 . . . . 0.0 111.616 -173.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.04 -23.95 77.59 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.256 0.972 . . . . 0.0 113.923 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 61.6 mtt180 -80.3 177.48 8.94 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.485 0.714 . . . . 0.0 112.268 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.1 p -113.21 168.46 9.71 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.774 0.829 . . . . 0.0 109.795 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 92.0 mt -59.56 -50.09 75.26 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 t -59.72 -26.71 65.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.927 1.291 . . . . 0.0 111.317 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 14.8 t70 -64.7 -43.16 94.37 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.224 0.61 . . . . 0.0 109.968 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.81 19.51 4.01 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.769 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 69.54 18.66 7.7 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.353 1.061 . . . . 0.0 111.744 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 14.5 mt -91.88 117.45 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -102.82 -178.29 3.63 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -61.67 142.97 56.85 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.137 170.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 74.2 3.31 4.35 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.612 1.565 . . . . 0.0 112.126 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -71.94 134.32 45.91 Favored 'General case' 0 C--N 1.363 1.155 0 CA-C-N 118.322 0.51 . . . . 0.0 110.513 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 52.3 m -95.13 126.27 40.35 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.597 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -128.26 174.41 9.31 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.528 1.131 . . . . 0.0 109.313 177.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -100.02 149.6 23.31 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.177 0.591 . . . . 0.0 111.629 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.678 HD13 HG22 ' A' ' 7' ' ' THR . 2.9 tm? -129.61 130.44 45.65 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.503 HG22 HD13 ' B' ' 220' ' ' LEU . 64.8 t -114.11 128.68 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 123.406 0.682 . . . . 0.0 110.153 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.583 ' HB3' HD22 ' A' ' 73' ' ' LEU . 77.6 mt -89.94 149.17 22.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.619 0.768 . . . . 0.0 110.793 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.474 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 72.6 mtp180 -118.99 -59.9 1.81 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.843 0.857 . . . . 0.0 109.298 172.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.583 HD22 ' HB3' ' A' ' 71' ' ' LEU . 3.7 mm? 53.75 40.18 31.17 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.343 1.057 . . . . 0.0 111.384 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.474 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 6.0 mmp_? -62.97 -49.81 73.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.804 0.842 . . . . 0.0 112.433 -169.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.67 -19.45 37.57 Favored Glycine 0 N--CA 1.47 0.908 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.331 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.434 0 C-N-CA 123.005 0.336 . . . . 0.0 112.314 -175.918 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 N-CA-C 113.481 0.152 . . . . 0.0 113.481 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 48.1 t -164.56 -44.06 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.884 0.874 . . . . 0.0 109.383 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -149.37 112.6 4.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.207 0.603 . . . . 0.0 109.921 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -137.0 158.13 45.17 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.271 1.028 . . . . 0.0 109.636 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 5.7 p -101.23 106.49 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 165.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 200' ' ' THR . . . . . 0.479 HG22 HG13 ' B' ' 202' ' ' VAL . 13.6 m -75.22 141.03 43.61 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.238 -172.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -99.75 124.95 45.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . 0.479 HG13 HG22 ' B' ' 200' ' ' THR . 4.0 m -142.73 -176.46 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.869 0.868 . . . . 0.0 110.751 -168.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.84 147.76 43.6 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.682 0.793 . . . . 0.0 110.225 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.564 ' HA ' HD13 ' B' ' 216' ' ' ILE . 46.2 t -89.63 101.56 3.42 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.095 0.958 . . . . 0.0 108.635 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.585 ' HD2' HD22 ' B' ' 220' ' ' LEU . 89.3 Cg_exo -49.09 -27.52 12.39 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 124.277 3.318 . . . . 0.0 115.006 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 6.3 t -80.66 -64.5 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.381 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 18.1 p -96.56 1.04 50.93 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.73 45.46 95.7 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 115.061 0.784 . . . . 0.0 115.061 171.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.71 138.11 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.052 0.541 . . . . 0.0 110.223 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -87.54 117.47 26.36 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.441 HD11 ' HB2' ' B' ' 204' ' ' CYS . 7.4 pt -145.59 162.17 37.65 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.157 1.383 . . . . 0.0 110.17 -170.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.35 162.43 33.57 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.64 2.227 . . . . 0.0 112.98 174.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.596 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.9 tt0 -65.07 -39.45 93.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.61 1.164 . . . . 0.0 113.665 -169.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 14.9 m -65.76 -43.44 88.89 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.361 -0.837 . . . . 0.0 109.901 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -75.6 -18.58 59.67 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.831 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.596 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -71.21 -47.62 59.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -68.43 -36.12 78.6 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.313 0.383 . . . . 0.0 111.859 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -63.34 -44.56 94.52 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.157 0.286 . . . . 0.0 110.353 172.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -43.48 86.66 Favored 'General case' 0 C--O 1.211 -0.963 0 O-C-N 123.836 0.71 . . . . 0.0 109.841 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.585 HD22 ' HD2' ' B' ' 205' ' ' PRO . 93.0 mt -60.69 -46.5 90.14 Favored 'General case' 0 C--O 1.21 -1.02 0 O-C-N 124.059 0.849 . . . . 0.0 110.876 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -60.25 -31.22 70.0 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.842 1.339 . . . . 0.0 110.464 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 t -86.49 -37.43 18.26 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.127 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 88.2 m -79.51 -22.15 44.34 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.002 0.921 . . . . 0.0 112.282 -171.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp -79.64 -4.63 52.52 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.026 0.53 . . . . 0.0 110.462 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 34.9 t -64.49 84.91 0.04 OUTLIER 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.957 0.903 . . . . 0.0 109.34 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.04 159.16 34.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.294 1.037 . . . . 0.0 111.254 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 123.917 0.887 . . . . 0.0 109.248 172.669 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.101 0 N-CA-C 112.254 -0.338 . . . . 0.0 112.254 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 22.7 p -71.31 107.67 4.4 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.708 0.803 . . . . 0.0 111.237 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.619 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 17.9 p80 -75.84 91.75 3.01 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.636 0.731 . . . . 0.0 110.921 -175.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt -79.63 158.31 27.09 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 21.9 mp0 -108.85 142.13 39.88 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.926 -0.484 . . . . 0.0 111.212 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.01 159.44 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.735 1.214 . . . . 0.0 108.874 174.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 66' ' ' THR . 94.0 m-85 -109.36 105.92 15.5 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.443 0.697 . . . . 0.0 109.953 -175.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 69' ' ' LEU . 2.6 t -95.59 114.88 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -102.3 113.1 26.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.668 0.787 . . . . 0.0 109.326 -174.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.634 HG21 HD13 ' A' ' 69' ' ' LEU . 23.5 p -68.91 157.93 35.62 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.849 0.356 . . . . 0.0 110.4 174.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.409 HD11 HG23 ' A' ' 70' ' ' VAL . 96.2 mt -58.73 -25.2 62.71 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.941 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.3 p -79.08 3.05 18.59 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.562 0.745 . . . . 0.0 111.799 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 12.39 74.84 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 116.42 -0.355 . . . . 0.0 113.124 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -95.54 147.73 23.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.014 0.926 . . . . 0.0 110.207 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 m -108.02 140.98 40.38 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.561 0.744 . . . . 0.0 109.75 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -125.7 115.6 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.683 1.193 . . . . 0.0 107.978 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 m -92.1 117.64 30.05 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -104.04 156.18 18.07 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.619 ' HB3' ' HB2' ' A' ' 0' ' ' HIS . 47.0 mt-10 -123.85 82.45 2.02 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.906 0.753 . . . . 0.0 109.155 -177.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.721 HG23 HG23 ' A' ' 26' ' ' VAL . 9.6 m -139.63 178.96 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 124.773 1.229 . . . . 0.0 107.969 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 10.1 mt-10 -96.29 152.82 39.0 Favored Pre-proline 0 N--CA 1.482 1.166 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.8 Cg_endo -61.63 -30.61 85.9 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.098 1.865 . . . . 0.0 111.168 171.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t -102.5 18.97 19.87 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.057 0.543 . . . . 0.0 110.026 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 16.1 t70 -81.04 -88.5 0.08 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.128 0.571 . . . . 0.0 109.49 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 26' ' ' VAL . 7.1 t 177.37 147.53 0.13 Allowed 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.539 1.136 . . . . 0.0 110.183 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -66.03 -34.39 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.251 1.02 . . . . 0.0 111.031 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 36.2 tt0 -62.59 -31.45 72.28 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.311 0.576 . . . . 0.0 110.858 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 12.7 t-20 -75.17 -42.07 56.69 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.862 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.721 HG23 HG23 ' A' ' 17' ' ' VAL . 59.0 t -55.57 -46.93 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 124.283 0.989 . . . . 0.0 110.3 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HA ' HD13 ' A' ' 30' ' ' ILE . 17.9 ptpt -71.22 -29.36 65.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.266 0.626 . . . . 0.0 111.592 -176.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -33.29 75.68 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.519 169.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 68.1 mmtt -75.62 -27.56 58.49 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.229 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.9 mp -58.14 -45.66 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 119.348 0.976 . . . . 0.0 109.281 166.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.404 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.2 tt0 -67.21 -20.81 65.75 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.579 177.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 23.0 t70 -81.42 -37.0 28.79 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.742 0.817 . . . . 0.0 111.369 174.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.8 mmtt -91.78 -61.92 1.53 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.794 0.437 . . . . 0.0 111.024 -170.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -92.55 -25.12 18.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.422 0.289 . . . . 0.0 111.184 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 97.2 13.83 44.14 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 116.546 -0.297 . . . . 0.0 113.83 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.87 125.88 55.57 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -63.55 152.59 79.52 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.745 2.297 . . . . 0.0 112.097 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -62.01 -16.47 50.2 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.469 2.78 . . . . 0.0 113.694 -173.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -75.4 -42.58 53.4 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.249 0.62 . . . . 0.0 110.616 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -81.74 -22.04 37.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.158 0.983 . . . . 0.0 112.52 -173.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.426 ' NE2' ' HB2' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -102.39 148.01 26.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.428 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.574 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 52.2 ttt180 -132.31 129.73 39.89 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.426 0.69 . . . . 0.0 109.556 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.64 125.69 37.38 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.373 0.669 . . . . 0.0 109.303 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.9 mt -142.6 130.99 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.158 0.983 . . . . 0.0 109.749 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' HB3' HD21 ' A' ' 50' ' ' LEU . 92.5 t80 -129.84 124.12 32.52 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.13 19.85 11.87 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.31 1.044 . . . . 0.0 112.651 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.78 -12.09 60.98 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-O 120.005 -0.33 . . . . 0.0 113.891 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.8 ptpt -99.87 142.28 31.56 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -75.4 140.82 43.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.352 0.261 . . . . 0.0 110.34 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.6 mt -88.15 134.05 33.86 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.137 0.575 . . . . 0.0 109.905 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 27.8 tt0 -85.16 137.37 33.06 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 9.2 p-10 -61.46 -33.49 73.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.112 0.965 . . . . 0.0 111.892 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.48 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -72.82 -29.5 65.13 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.856 0.723 . . . . 0.0 113.409 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -80.04 177.18 9.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.381 0.672 . . . . 0.0 111.548 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -111.06 167.46 10.24 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.738 0.815 . . . . 0.0 110.254 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 90.4 mt -56.22 -49.82 73.02 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.924 0.765 . . . . 0.0 109.135 172.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -61.3 -27.56 68.56 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.896 1.278 . . . . 0.0 111.572 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.85 -39.2 83.82 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -91.99 20.65 5.6 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.367 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 65.74 25.96 11.39 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.512 1.125 . . . . 0.0 112.194 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.88 118.27 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -106.84 -175.09 2.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -56.38 138.21 51.42 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.381 171.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 71.34 9.67 6.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.211 1.404 . . . . 0.0 112.501 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.1 m -78.57 138.55 38.42 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.147 0.43 . . . . 0.0 110.604 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 46.8 m -95.49 130.37 42.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.23 0.612 . . . . 0.0 109.928 175.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.66 159.32 37.57 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.781 1.232 . . . . 0.0 108.66 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -87.33 152.61 22.13 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.451 0.643 . . . . 0.0 111.299 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.634 HD13 HG21 ' A' ' 7' ' ' THR . 2.8 tm? -134.89 131.53 37.43 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 73.8 t -110.23 113.7 44.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.029 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.38 152.48 32.24 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.993 174.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.434 ' HA ' ' HG2' ' B' ' 213' ' ' GLU . 53.7 mtp180 -129.79 -40.17 1.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.026 0.93 . . . . 0.0 109.883 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 53.41 32.2 13.47 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.035 1.334 . . . . 0.0 112.914 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -75.67 80.53 2.64 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.18 -11.2 0.26 Allowed Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.356 -173.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 1.786 0 C-N-CA 123.042 0.353 . . . . 0.0 113.406 177.033 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 CA-C-O 119.949 -0.361 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 55.8 p -157.41 154.39 28.75 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.117 0.567 . . . . 0.0 110.689 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -74.33 -22.04 59.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.182 0.993 . . . . 0.0 111.109 172.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -93.57 167.82 11.43 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.479 0.712 . . . . 0.0 110.825 177.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 14.0 p -78.02 135.93 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.76 0.824 . . . . 0.0 110.071 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 15.4 m -88.2 155.08 19.95 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.279 0.632 . . . . 0.0 109.421 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.86 120.92 43.64 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 171.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.8 m -143.1 163.52 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.375 1.07 . . . . 0.0 110.736 -167.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -96.29 147.34 23.89 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.808 0.843 . . . . 0.0 111.409 -172.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.574 ' HA ' HD13 ' B' ' 216' ' ' ILE . 43.5 t -88.2 103.92 6.02 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.538 ' HD2' HD22 ' B' ' 220' ' ' LEU . 36.2 Cg_endo -60.52 -12.54 21.26 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.478 2.785 . . . . 0.0 114.816 -168.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 t -88.47 -54.27 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.032 0.533 . . . . 0.0 110.755 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 15.8 p -108.48 1.74 21.79 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -174.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 63.01 46.58 93.22 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 115.632 1.013 . . . . 0.0 115.632 170.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.5 m -119.0 132.84 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.265 0.626 . . . . 0.0 110.764 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -84.76 119.23 25.05 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 5.2 pt -142.91 161.06 50.68 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.71 1.604 . . . . 0.0 108.875 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.46 153.08 56.82 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.229 1.953 . . . . 0.0 112.249 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.552 ' O ' HG23 ' B' ' 216' ' ' ILE . 33.5 tt0 -64.79 -32.64 74.43 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.384 1.474 . . . . 0.0 113.156 -168.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 38.6 t -64.33 -44.3 91.94 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.661 0.743 . . . . 0.0 109.924 172.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -77.0 -19.34 57.4 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.374 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -71.1 -46.5 66.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -60.68 -45.18 95.13 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.477 0.486 . . . . 0.0 110.121 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -56.62 -46.64 80.83 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 124.373 1.046 . . . . 0.0 111.945 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -36.91 81.21 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.246 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.538 HD22 ' HD2' ' B' ' 205' ' ' PRO . 93.4 mt -63.58 -46.48 85.64 Favored 'General case' 0 C--O 1.21 -0.986 0 O-C-N 124.186 0.929 . . . . 0.0 111.481 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -54.22 -34.13 59.93 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.251 0.97 . . . . 0.0 111.009 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 34.5 t -82.91 -39.52 21.4 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.268 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 81.3 m -80.05 -18.0 51.24 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.12 0.968 . . . . 0.0 112.612 -170.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 pp -95.27 -2.78 48.73 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.857 0.463 . . . . 0.0 110.499 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 34.0 m -71.94 81.47 0.92 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.653 0.781 . . . . 0.0 110.402 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -80.03 148.22 31.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.584 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.441 0.696 . . . . 0.0 109.475 -175.876 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.873 0 CA-C-O 119.584 -0.564 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 55.6 p -63.25 100.46 0.24 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.755 0.822 . . . . 0.0 110.904 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -75.11 134.18 41.37 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.499 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt -103.89 162.82 12.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.597 0.759 . . . . 0.0 110.09 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 93.0 mt-30 -103.47 122.65 45.34 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.626 0.77 . . . . 0.0 109.972 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.529 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -125.39 152.13 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.732 1.213 . . . . 0.0 108.559 177.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.509 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.7 m-85 -111.9 113.11 25.23 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.563 0.697 . . . . 0.0 110.204 -170.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.9 t -105.84 119.74 55.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -111.76 119.12 37.55 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.622 0.769 . . . . 0.0 109.535 -174.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.62 HG23 HD12 ' A' ' 69' ' ' LEU . 68.1 p -70.58 167.11 19.21 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.212 0.53 . . . . 0.0 111.628 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.509 HD11 HG23 ' A' ' 70' ' ' VAL . 84.0 mt -73.33 -19.35 61.04 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.936 173.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.462 HG22 HG23 ' B' ' 200' ' ' THR . 44.1 p -79.05 -12.99 60.03 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.132 0.573 . . . . 0.0 110.39 171.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 26.29 19.79 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.712 -0.677 . . . . 0.0 114.144 169.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.608 ' HZ1' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -94.4 152.57 18.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.6 m -97.72 141.11 31.14 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.893 0.477 . . . . 0.0 110.492 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.476 HD12 HG22 ' A' ' 7' ' ' THR . 5.2 mp -127.68 109.82 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.902 1.281 . . . . 0.0 107.68 174.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.1 m -91.5 123.58 35.02 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.7 mm? -106.97 156.02 19.16 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.172 0.589 . . . . 0.0 109.617 -177.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -118.96 76.88 1.14 Allowed 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.371 1.044 . . . . 0.0 109.301 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.68 HG23 HG22 ' A' ' 26' ' ' VAL . 28.9 m -147.43 173.14 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 123.733 0.813 . . . . 0.0 110.236 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.491 ' O ' HD12 ' A' ' 56' ' ' LEU . 9.6 mt-10 -95.72 160.02 31.2 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.139 0.576 . . . . 0.0 109.864 -169.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.91 -17.05 55.01 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 121.758 1.638 . . . . 0.0 111.89 169.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 t -103.41 3.11 34.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.45 157.91 28.81 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 168.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 26' ' ' VAL . 9.3 t -102.04 150.23 23.44 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.291 -165.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.1 -36.26 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.624 0.77 . . . . 0.0 112.156 -171.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.03 -34.63 75.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.455 0.645 . . . . 0.0 110.934 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.415 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.2 t30 -73.36 -45.17 56.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.866 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.68 HG22 HG23 ' A' ' 17' ' ' VAL . 65.7 t -55.93 -43.68 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 124.144 0.978 . . . . 0.0 111.361 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -71.74 -33.17 68.47 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.867 0.467 . . . . 0.0 111.473 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.91 68.96 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.143 169.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 10.3 mmpt? -76.51 -32.57 58.36 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.188 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.25 -42.93 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 118.404 0.547 . . . . 0.0 110.057 170.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.31 -35.38 78.86 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.154 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.72 -24.66 63.59 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.961 0.904 . . . . 0.0 111.689 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 72.1 mmtt -101.03 -69.51 0.77 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.01 -19.47 31.97 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.665 0.211 . . . . 0.0 111.44 -175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.95 17.76 46.44 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.028 0.205 . . . . 0.0 113.062 173.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.62 125.86 34.64 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 123.394 0.678 . . . . 0.0 109.567 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -71.82 159.1 51.52 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.102 2.535 . . . . 0.0 112.095 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 29.3 Cg_endo -58.84 -15.26 25.93 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.549 2.832 . . . . 0.0 113.689 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.58 -44.71 70.23 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.366 1.066 . . . . 0.0 110.653 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.81 -33.2 19.95 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.817 0.847 . . . . 0.0 111.963 -175.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -94.2 150.39 20.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.648 0.379 . . . . 0.0 110.408 -179.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.588 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 44.9 ttt180 -140.17 129.98 24.55 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.233 0.613 . . . . 0.0 109.666 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.449 ' HB3' HD11 ' A' ' 50' ' ' LEU . 4.6 mm? -93.45 123.02 36.47 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.522 0.729 . . . . 0.0 109.721 -173.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -141.73 121.73 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.071 0.948 . . . . 0.0 109.716 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.616 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 91.1 t80 -119.51 121.32 39.13 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.492 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . . . 66.27 17.88 10.8 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.263 1.025 . . . . 0.0 113.5 173.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.95 14.05 47.45 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 113.983 0.353 . . . . 0.0 113.983 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.492 ' HE3' ' HB2' ' A' ' 46' ' ' ALA . 1.6 ptpt -124.27 139.24 54.11 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -74.79 132.08 41.29 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.514 HD22 ' HB3' ' A' ' 45' ' ' PHE . 32.0 mt -78.37 118.77 20.86 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.036 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.78 138.46 42.66 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.992 0.917 . . . . 0.0 110.357 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.15 -44.81 83.79 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.886 1.275 . . . . 0.0 112.116 -172.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 -28.22 73.5 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 124.574 1.171 . . . . 0.0 113.747 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -77.65 175.23 10.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.087 0.555 . . . . 0.0 111.813 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 26.2 p -115.85 165.26 13.28 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.486 0.715 . . . . 0.0 109.746 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 18' ' ' GLU . 83.8 mt -55.51 -56.29 21.96 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 123.635 0.584 . . . . 0.0 110.495 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 t -61.91 -22.16 65.34 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.122 0.969 . . . . 0.0 112.057 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.1 -39.25 79.09 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.763 0.425 . . . . 0.0 110.096 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -87.26 13.53 9.5 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.342 172.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 67.63 25.45 8.22 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.912 1.285 . . . . 0.0 111.691 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 mt -91.12 112.96 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.408 1.083 . . . . 0.0 108.472 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -101.45 -172.76 2.21 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -61.65 140.28 58.18 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 70.65 3.22 4.45 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.809 1.244 . . . . 0.0 113.306 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -64.74 130.23 42.77 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 20.6 m -99.68 131.23 45.8 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.763 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.616 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -134.19 174.18 10.79 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.07 0.948 . . . . 0.0 110.107 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -98.55 148.21 24.0 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.332 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.62 HD12 HG23 ' A' ' 7' ' ' THR . 2.6 tm? -127.32 130.63 49.85 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 67.1 t -108.68 111.55 36.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.21 0.604 . . . . 0.0 109.833 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.2 mt -79.2 149.75 31.85 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 124.191 0.932 . . . . 0.0 109.011 171.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -118.98 -39.43 2.94 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.445 0.698 . . . . 0.0 110.72 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 52.68 49.94 19.24 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.645 1.178 . . . . 0.0 111.89 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -57.56 -40.94 80.05 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.363 0.665 . . . . 0.0 111.286 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.63 12.92 50.68 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.087 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.37 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 -174.379 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.546 0 CA-C-O 119.139 -0.812 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 20.1 m 62.36 15.87 8.05 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.098 1.359 . . . . 0.0 113.12 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -96.39 -33.91 11.74 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.602 0.761 . . . . 0.0 111.138 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -103.39 179.8 4.17 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.185 0.594 . . . . 0.0 110.915 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 4.8 p -72.92 116.84 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 200' ' ' THR . . . . . 0.462 HG23 HG22 ' A' ' 9' ' ' THR . 9.0 m -78.48 153.85 31.05 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.236 0.615 . . . . 0.0 110.692 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.79 123.52 44.12 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 168.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 m -144.46 -178.04 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.382 1.073 . . . . 0.0 110.072 -165.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -113.57 148.06 36.84 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.219 0.608 . . . . 0.0 110.314 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.57 ' HA ' HD11 ' B' ' 216' ' ' ILE . 46.2 t -85.4 100.81 1.35 Allowed Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.079 0.952 . . . . 0.0 109.501 176.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.557 ' HD2' HD23 ' B' ' 220' ' ' LEU . 65.3 Cg_endo -68.0 8.29 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.392 2.728 . . . . 0.0 115.361 -168.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.07 -50.63 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 122.971 0.509 . . . . 0.0 110.716 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.9 p -114.03 -4.61 13.17 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 122.746 0.418 . . . . 0.0 111.945 -172.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.36 58.25 14.95 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 124.288 0.947 . . . . 0.0 114.956 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.07 129.83 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.201 0.601 . . . . 0.0 109.57 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -82.59 115.42 21.55 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.8 pt -143.95 160.77 48.61 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.491 1.516 . . . . 0.0 109.746 -170.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' B' ' 215' ' ' HIS . 28.4 Cg_endo -60.92 155.92 46.92 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.704 2.27 . . . . 0.0 112.199 172.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.507 ' O ' HG21 ' B' ' 216' ' ' ILE . 35.7 tt0 -68.51 -28.32 66.9 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.69 1.196 . . . . 0.0 113.466 -170.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 40.9 t -65.78 -44.22 86.42 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.657 0.741 . . . . 0.0 109.724 171.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . 0.425 ' HB2' ' HG2' ' B' ' 212' ' ' PRO . 70.6 m-70 -80.35 -16.51 54.38 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.046 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.57 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -72.55 -44.5 61.06 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 175.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -54.38 -54.47 40.15 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.023 0.827 . . . . 0.0 109.999 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -57.24 -44.84 84.19 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 124.48 1.113 . . . . 0.0 112.558 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -33.93 74.87 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.105 -177.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.557 HD23 ' HD2' ' B' ' 205' ' ' PRO . 78.8 mt -68.49 -42.95 77.9 Favored 'General case' 0 C--O 1.212 -0.901 0 O-C-N 123.557 0.536 . . . . 0.0 111.521 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -57.58 -28.4 63.56 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 124.027 0.829 . . . . 0.0 111.259 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 43.4 t -86.38 -42.27 13.8 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.692 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.9 m -80.7 -26.54 37.42 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -167.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.5 -25.33 63.09 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.053 0.541 . . . . 0.0 110.222 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 22.7 t -73.08 82.94 1.28 Allowed 'General case' 0 C--N 1.348 0.535 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -86.13 79.46 9.12 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.573 -176.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 C--O 1.248 1.009 0 CA-C-N 114.204 -1.362 . . . . 0.0 107.994 179.134 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.357 0 N-CA-C 112.202 -0.359 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.7 t -158.93 -33.72 0.06 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.702 0.801 . . . . 0.0 110.237 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -75.09 130.16 38.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.878 0.871 . . . . 0.0 110.989 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt -98.53 178.65 4.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.791 0.837 . . . . 0.0 110.052 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 65.8 mt-30 -111.13 147.72 34.27 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.273 0.629 . . . . 0.0 110.641 176.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -138.93 155.29 26.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 125.396 1.478 . . . . 0.0 107.841 174.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 66' ' ' THR . 89.8 m-85 -112.34 116.78 30.9 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.734 -174.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 55.6 t -105.32 131.96 53.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tpmt? -123.26 124.57 43.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.242 0.617 . . . . 0.0 109.972 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.64 HG23 HD13 ' A' ' 69' ' ' LEU . 42.8 p -73.27 169.49 16.99 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.259 0.552 . . . . 0.0 111.495 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.4 mt -65.59 -26.41 67.84 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.036 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.9 p -80.55 -15.9 55.53 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.637 0.775 . . . . 0.0 111.189 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.23 11.64 38.59 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 114.781 0.673 . . . . 0.0 114.781 167.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.508 ' HZ1' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -78.91 152.27 31.25 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.743 0.771 . . . . 0.0 109.609 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.4 m -95.26 141.78 28.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.177 0.591 . . . . 0.0 109.693 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 7' ' ' THR . 4.4 mp -132.37 100.9 4.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.7 m -95.06 121.36 36.61 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -105.65 152.77 22.71 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -117.45 82.73 1.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.739 HG21 HG22 ' A' ' 26' ' ' VAL . 24.6 m -141.74 177.32 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.72 1.208 . . . . 0.0 108.509 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -92.61 153.42 42.44 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 24.0 Cg_endo -61.98 -28.61 80.88 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.829 1.686 . . . . 0.0 110.742 164.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -94.13 13.54 22.82 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.019 0.928 . . . . 0.0 111.24 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.71 -99.19 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.163 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.509 ' O ' HG21 ' A' ' 26' ' ' VAL . 6.0 t 171.86 140.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.967 1.307 . . . . 0.0 109.324 177.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 50' ' ' LEU . 39.9 mm -60.54 -36.81 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.578 1.151 . . . . 0.0 112.034 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.01 -34.84 76.94 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.564 0.697 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.5 t30 -75.82 -41.0 53.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.107 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.739 HG22 HG21 ' A' ' 17' ' ' VAL . 58.4 t -57.97 -45.86 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 124.441 1.088 . . . . 0.0 110.042 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.1 ptpt -72.39 -28.68 63.14 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.026 0.53 . . . . 0.0 111.313 -176.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.33 75.13 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.218 0.324 . . . . 0.0 110.434 169.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 71.6 mmtt -74.03 -36.13 64.41 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.95 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.479 HD11 ' HA ' ' A' ' 27' ' ' LYS . 2.9 mp -57.23 -41.57 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.532 1.06 . . . . 0.0 109.511 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -60.4 -39.09 86.08 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.447 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.43 -32.09 73.52 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.207 0.603 . . . . 0.0 111.481 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 70.4 mmtt -91.4 -67.97 0.82 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.626 0.37 . . . . 0.0 111.624 -171.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -80.39 -22.95 40.77 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.768 0.258 . . . . 0.0 111.06 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.86 18.67 39.62 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.222 0.326 . . . . 0.0 113.037 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.581 HG13 HD11 ' A' ' 73' ' ' LEU . 1.9 mp -108.79 127.52 27.21 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.68 156.13 67.25 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.907 2.404 . . . . 0.0 112.287 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.615 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 46.3 Cg_endo -62.17 -13.32 31.27 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 123.636 2.891 . . . . 0.0 113.967 -173.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 7.4 t70 -76.23 -46.13 29.61 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.893 0.746 . . . . 0.0 109.943 174.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.427 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.9 mp0 -83.8 -23.09 31.59 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.521 0.728 . . . . 0.0 112.366 -172.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.615 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 2.9 pp0? -104.74 133.27 49.85 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.973 0.509 . . . . 0.0 109.857 173.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.573 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.2 ttt180 -120.26 130.74 54.63 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.975 0.91 . . . . 0.0 110.238 -170.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.428 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -94.28 117.42 30.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.634 0.774 . . . . 0.0 110.546 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -141.85 127.54 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 124.27 1.028 . . . . 0.0 109.547 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.52 ' HB3' HD21 ' A' ' 50' ' ' LEU . 81.2 t80 -123.17 124.08 42.25 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.142 0.977 . . . . 0.0 109.236 177.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.94 16.06 9.61 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.031 1.332 . . . . 0.0 112.972 176.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.09 -8.48 60.97 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.929 -0.373 . . . . 0.0 113.171 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.5 ptpt -96.03 135.79 37.33 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -76.39 131.58 39.21 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 45' ' ' PHE . 30.5 mt -74.34 153.84 39.13 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.436 0.294 . . . . 0.0 110.466 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.34 137.35 52.22 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.397 0.679 . . . . 0.0 109.194 -176.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.92 -44.18 86.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.673 1.189 . . . . 0.0 112.075 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.27 -25.04 75.8 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 124.43 1.081 . . . . 0.0 113.478 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -81.31 177.57 8.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.301 0.64 . . . . 0.0 111.789 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 73.1 p -110.36 169.68 8.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.663 0.785 . . . . 0.0 109.795 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 95.4 mt -57.32 -54.8 42.7 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.893 0.746 . . . . 0.0 109.46 172.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 24.3 t -62.59 -19.28 63.57 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.733 1.213 . . . . 0.0 111.971 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -66.91 -41.4 87.17 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -90.98 17.87 7.38 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.09 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 68.39 16.69 9.23 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.18 1.392 . . . . 0.0 112.17 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.1 mt -85.16 102.01 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -86.48 -177.23 6.13 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -62.34 144.95 55.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 76.6 -3.34 2.55 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.61 1.564 . . . . 0.0 111.81 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -68.72 133.69 48.75 Favored 'General case' 0 C--N 1.366 1.306 0 CA-C-N 117.971 0.351 . . . . 0.0 110.713 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 18.0 m -99.43 140.21 33.95 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.796 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.79 173.35 11.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.939 0.896 . . . . 0.0 109.699 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -97.32 147.16 24.44 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.371 0.668 . . . . 0.0 110.88 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 7' ' ' THR . 2.5 tm? -129.19 127.74 41.94 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 96.0 t -108.78 126.77 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 123.282 0.633 . . . . 0.0 110.109 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.52 ' HB3' HD21 ' A' ' 73' ' ' LEU . 66.4 mt -86.25 147.04 26.27 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.771 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.427 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 37.3 mtp-105 -136.29 6.4 3.05 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.475 1.11 . . . . 0.0 110.243 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.581 HD11 HG13 ' A' ' 36' ' ' ILE . 4.2 mm? -33.04 104.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 126.467 1.907 . . . . 0.0 114.27 -169.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -75.71 -59.16 2.87 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.967 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.99 14.52 63.21 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.065 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.502 0 CA-C-N 116.795 0.297 . . . . 0.0 113.28 179.784 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.675 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 31.4 m -70.31 94.75 0.96 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.993 0.917 . . . . 0.0 109.809 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -65.83 123.55 20.08 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.804 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -154.49 169.36 23.98 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.92 0.888 . . . . 0.0 109.671 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . 0.435 HG11 ' HZ2' ' B' ' 201' ' ' LYS . 7.2 p -72.36 77.42 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 124.098 0.959 . . . . 0.0 110.575 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 95.7 m -72.26 124.96 26.15 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.251 1.021 . . . . 0.0 111.867 -171.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' B' ' 212' ' ' PRO . 11.6 mptt -82.57 124.72 30.4 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.321 0.649 . . . . 0.0 109.368 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.13 -176.91 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.87 1.668 . . . . 0.0 109.093 -172.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -111.23 146.08 37.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.936 -0.478 . . . . 0.0 110.915 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.613 ' HA ' HD13 ' B' ' 216' ' ' ILE . 35.1 t -94.72 101.12 6.31 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.43 ' HD2' HD21 ' B' ' 220' ' ' LEU . 66.3 Cg_endo -67.49 -4.65 12.35 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.173 2.582 . . . . 0.0 114.765 -164.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . 0.44 HG12 ' O ' ' B' ' 223' ' ' CYS . 11.6 t -95.25 -58.01 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 122.793 0.437 . . . . 0.0 110.661 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.3 p -99.19 -4.63 31.65 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 66.85 47.01 69.11 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 172.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.25 144.22 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 117.514 0.657 . . . . 0.0 110.842 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -90.26 108.75 19.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.078 0.951 . . . . 0.0 110.026 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.463 HD11 ' HB2' ' B' ' 204' ' ' CYS . 10.0 pt -144.25 153.42 56.12 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.864 1.266 . . . . 0.0 110.419 -172.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' B' ' 201' ' ' LYS . 54.6 Cg_endo -65.17 165.3 22.37 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.439 2.76 . . . . 0.0 114.366 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.577 ' O ' HG23 ' B' ' 216' ' ' ILE . 31.6 tt0 -62.25 -41.83 98.78 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 125.341 1.456 . . . . 0.0 114.31 -164.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.0 m -76.11 -29.7 57.98 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.812 -1.18 . . . . 0.0 110.712 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -81.63 -23.96 36.66 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.047 0.539 . . . . 0.0 109.997 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.613 HD13 ' HA ' ' B' ' 204' ' ' CYS . 0.1 OUTLIER -72.64 -42.79 62.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -65.11 -42.93 93.49 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.851 0.719 . . . . 0.0 110.923 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -64.09 -37.62 88.12 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.654 0.596 . . . . 0.0 110.969 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -39.88 88.58 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.401 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.532 HD13 HG21 ' A' ' 70' ' ' VAL . 80.0 mt -71.19 -32.38 68.78 Favored 'General case' 0 C--O 1.214 -0.763 0 O-C-N 124.201 0.938 . . . . 0.0 111.581 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -58.65 -27.29 64.61 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 123.847 0.717 . . . . 0.0 109.892 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.3 t -95.51 -36.03 11.45 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 123.473 0.709 . . . . 0.0 112.4 172.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . 0.495 ' HB2' ' HA ' ' B' ' 220' ' ' LEU . 91.6 m -81.96 -17.79 45.76 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.142 0.977 . . . . 0.0 112.614 -168.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.98 -7.97 51.82 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.582 0.353 . . . . 0.0 111.052 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 11.2 m -78.68 47.51 0.74 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.55 1.14 . . . . 0.0 110.645 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -73.65 87.05 1.65 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.814 0.846 . . . . 0.0 108.889 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 124.23 1.012 . . . . 0.0 109.506 -174.463 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.372 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 22.7 t -87.42 175.32 8.03 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.175 0.59 . . . . 0.0 110.788 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 3.9 m-70 -130.69 101.19 5.57 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.633 0.773 . . . . 0.0 110.804 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 mmt -101.24 152.03 21.16 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.606 0.762 . . . . 0.0 109.037 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.4 mp0 -95.06 131.03 41.49 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.791 0.436 . . . . 0.0 111.456 -173.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.24 147.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.013 1.325 . . . . 0.0 108.539 172.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' THR . 96.1 m-85 -111.49 103.63 11.99 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.316 0.647 . . . . 0.0 110.211 -169.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.565 HG12 ' HB2' ' A' ' 69' ' ' LEU . 84.0 t -103.01 106.06 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.896 0.878 . . . . 0.0 108.978 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -89.22 118.29 28.8 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.816 1.246 . . . . 0.0 110.426 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.599 HG23 HD12 ' A' ' 69' ' ' LEU . 7.8 p -70.95 167.36 19.27 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.61 0.719 . . . . 0.0 112.131 175.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.52 HD12 HG22 ' A' ' 70' ' ' VAL . 89.2 mt -70.2 -11.23 60.75 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.675 172.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.7 p -86.47 -4.43 59.17 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.478 0.711 . . . . 0.0 111.504 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.49 15.63 73.23 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.262 0.352 . . . . 0.0 112.868 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -93.53 151.59 19.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.472 1.109 . . . . 0.0 109.923 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -109.51 128.74 55.4 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.141 0.576 . . . . 0.0 110.288 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.96 106.71 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.685 0.794 . . . . 0.0 108.949 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.7 m -88.78 118.03 28.18 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.069 0.947 . . . . 0.0 109.834 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.2 mm? -105.53 159.67 15.76 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.491 0.716 . . . . 0.0 109.458 178.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.599 ' HB3' ' HB3' ' A' ' 0' ' ' HIS . 38.1 mt-10 -126.7 83.19 2.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.775 0.83 . . . . 0.0 108.839 -174.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.694 HG23 HG21 ' A' ' 26' ' ' VAL . 32.2 m -147.73 -177.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 124.168 0.987 . . . . 0.0 110.056 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -96.21 155.95 37.54 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 123.253 0.621 . . . . 0.0 110.247 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 28.9 Cg_endo -61.52 -31.64 87.66 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 121.984 1.789 . . . . 0.0 111.322 167.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -95.65 10.59 36.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.585 0.754 . . . . 0.0 110.939 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.47 -96.36 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.924 0.889 . . . . 0.0 110.334 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.6 t 172.72 144.63 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.327 1.451 . . . . 0.0 108.98 173.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.06 -35.98 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.806 0.843 . . . . 0.0 111.616 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.09 -35.54 75.42 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.606 0.717 . . . . 0.0 110.777 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 6.2 t30 -74.57 -42.32 58.95 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.712 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.694 HG21 HG23 ' A' ' 17' ' ' VAL . 72.8 t -56.75 -44.05 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 124.367 1.042 . . . . 0.0 110.479 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 17.9 ptpt -74.32 -26.45 60.17 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.653 0.381 . . . . 0.0 111.498 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.6 -32.03 72.47 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.635 168.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -68.96 -38.65 79.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.152 0.581 . . . . 0.0 111.134 175.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.16 -43.7 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 118.249 0.477 . . . . 0.0 109.99 173.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.437 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.3 tt0 -65.73 -24.97 67.09 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.236 0.541 . . . . 0.0 111.542 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.92 -31.81 59.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.852 0.461 . . . . 0.0 110.76 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.7 mmtt -91.12 -67.2 0.87 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.611 0.364 . . . . 0.0 110.526 -172.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -86.44 -26.59 24.61 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.384 0.274 . . . . 0.0 111.547 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 93.24 17.4 43.18 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 120.048 -0.307 . . . . 0.0 113.619 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.05 126.77 47.64 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.76 152.46 78.36 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.954 2.436 . . . . 0.0 112.109 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -58.73 -15.76 27.73 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.324 2.682 . . . . 0.0 113.509 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.27 -36.12 63.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.827 0.851 . . . . 0.0 111.432 175.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -97.05 -28.64 14.05 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.158 0.983 . . . . 0.0 112.81 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.412 ' NE2' ' HB2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -90.69 149.86 21.89 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.031 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.46 ' HD3' HD22 ' B' ' 220' ' ' LEU . 10.4 ttt180 -140.85 127.01 19.6 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.481 ' HB3' HD13 ' A' ' 50' ' ' LEU . 4.5 mm? -92.38 126.22 37.37 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.919 0.888 . . . . 0.0 109.337 -171.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.503 HD11 HD21 ' B' ' 220' ' ' LEU . 90.5 mt -140.78 118.62 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.097 0.559 . . . . 0.0 110.704 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.558 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 71.8 t80 -122.01 129.28 52.32 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.28 20.65 12.39 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.708 0.803 . . . . 0.0 112.605 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.77 22.5 55.54 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 119.881 -0.4 . . . . 0.0 113.692 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.5 ptpt -128.96 146.09 51.06 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 173.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.6 ' HB2' ' HB2' ' B' ' 224' ' ' LEU . 0.3 OUTLIER -82.83 138.5 33.92 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 43' ' ' LEU . 26.6 mt -90.82 120.14 31.61 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.56 -172.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -75.53 138.85 41.8 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.4 1.08 . . . . 0.0 110.51 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.17 -49.7 63.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.636 1.174 . . . . 0.0 111.919 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.69 -29.77 76.12 Favored Glycine 0 C--N 1.352 1.471 0 O-C-N 124.367 1.042 . . . . 0.0 113.962 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -79.31 177.46 8.82 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.568 0.747 . . . . 0.0 111.402 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -118.72 166.59 12.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.604 0.762 . . . . 0.0 110.234 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 93.2 mt -55.76 -54.2 47.35 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 124.104 0.877 . . . . 0.0 109.677 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 15.7 t -60.89 -26.02 67.13 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.591 1.156 . . . . 0.0 111.514 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -68.6 -41.22 79.87 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 122.867 0.467 . . . . 0.0 109.834 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -85.86 15.11 5.13 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.631 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 68.36 25.8 6.92 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.69 1.196 . . . . 0.0 111.69 176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.1 mt -93.42 127.89 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.394 1.078 . . . . 0.0 108.256 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -110.08 -178.21 3.46 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 172.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -60.1 137.03 58.19 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.044 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 73.15 10.04 5.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.277 1.431 . . . . 0.0 112.467 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -68.11 138.89 56.09 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 170.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 24.9 m -101.29 129.57 47.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.384 0.674 . . . . 0.0 109.613 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.558 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -143.96 154.35 43.21 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.006 0.923 . . . . 0.0 109.909 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -80.58 154.59 27.37 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.462 0.648 . . . . 0.0 112.455 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.599 HD12 HG23 ' A' ' 7' ' ' THR . 2.2 tm? -131.58 121.67 24.79 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.634 HG23 HD23 ' B' ' 220' ' ' LEU . 57.1 t -98.25 119.36 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.53 0.732 . . . . 0.0 110.397 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -85.97 147.65 26.12 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.853 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -121.41 -40.64 2.56 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.497 0.719 . . . . 0.0 110.874 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 52.34 30.86 8.62 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 125.022 1.329 . . . . 0.0 113.017 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -68.96 -56.58 7.4 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.821 0.848 . . . . 0.0 109.472 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.44 35.56 4.89 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.682 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.486 0 N-CA-C 114.051 0.38 . . . . 0.0 114.051 175.884 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 56.0 p -83.72 121.81 27.78 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.366 0.666 . . . . 0.0 110.616 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -101.78 -5.55 24.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.86 0.864 . . . . 0.0 111.119 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.86 169.48 8.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.674 0.789 . . . . 0.0 110.467 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.06 110.67 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 11.5 m -79.89 134.65 36.31 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.718 0.807 . . . . 0.0 111.072 -170.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -79.11 122.87 26.78 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 8.3 m -148.25 -177.58 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.666 1.186 . . . . 0.0 109.326 -167.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -120.95 138.59 54.06 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.722 0.409 . . . . 0.0 111.134 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' CYS . . . . . 0.485 ' HA ' HD13 ' B' ' 216' ' ' ILE . 37.1 t -78.73 100.25 0.52 Allowed Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 124.303 1.041 . . . . 0.0 108.263 174.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . 0.475 ' HD3' HD13 ' B' ' 216' ' ' ILE . 44.5 Cg_endo -81.99 20.49 1.07 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.071 2.514 . . . . 0.0 114.116 -159.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 53.9 t -105.32 -58.24 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.333 0.653 . . . . 0.0 109.691 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 28.8 p -91.97 -23.84 19.43 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.072 0.549 . . . . 0.0 111.22 -175.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.89 52.52 3.83 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 114.299 0.48 . . . . 0.0 114.299 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.76 134.76 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.264 0.626 . . . . 0.0 110.172 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -87.92 114.06 24.17 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' ILE . . . . . 0.439 HD13 ' HB2' ' B' ' 204' ' ' CYS . 8.9 pt -143.89 160.41 50.08 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 124.866 1.266 . . . . 0.0 110.376 -171.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.4 156.19 32.11 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.153 2.569 . . . . 0.0 112.774 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . 0.491 ' O ' HG21 ' B' ' 216' ' ' ILE . 33.2 tt0 -66.18 -29.39 69.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.522 1.129 . . . . 0.0 113.499 -171.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 15.7 m -64.11 -43.68 94.58 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.882 0.849 . . . . 0.0 110.057 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -81.17 -21.53 39.62 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.304 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . 0.491 HG21 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -69.82 -41.13 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -58.97 -51.68 69.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.15 0.906 . . . . 0.0 109.973 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -64.95 -47.93 75.88 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.966 -174.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -33.76 76.73 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.505 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.634 HD23 HG23 ' A' ' 70' ' ' VAL . 46.6 tp -68.23 -39.34 82.37 Favored 'General case' 0 C--O 1.214 -0.777 0 O-C-N 124.249 0.968 . . . . 0.0 111.447 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.14 -36.32 63.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.044 0.538 . . . . 0.0 110.822 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.4 t -77.93 -43.92 28.49 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.668 174.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 75.1 m -77.38 -21.09 53.75 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 3.9 pp -87.4 -31.54 20.03 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -176.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 21.6 t -80.77 79.18 7.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.446 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -73.82 -22.5 59.77 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.727 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 CA--C 1.567 1.609 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.494 168.105 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.2 mp0 -99.47 130.39 45.73 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.041 -174.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.422 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -128.7 146.81 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.636 1.174 . . . . 0.0 109.355 176.016 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 66' ' ' THR . 73.7 m-85 -103.19 100.11 10.0 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.761 0.824 . . . . 0.0 109.89 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 69' ' ' LEU . 93.6 t -101.67 99.91 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -98.89 123.49 43.19 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.587 -169.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.757 HG22 HD12 ' A' ' 69' ' ' LEU . 41.3 p -67.84 166.75 14.85 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.822 0.849 . . . . 0.0 112.927 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.51 -17.03 64.51 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.073 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.4 p -85.87 2.96 43.84 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.335 0.654 . . . . 0.0 111.113 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.05 85.61 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 113.888 0.315 . . . . 0.0 113.888 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.5 135.98 34.22 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.84 0.856 . . . . 0.0 109.841 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.6 m -101.34 124.58 47.24 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.035 0.534 . . . . 0.0 110.683 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.7 mp -107.53 110.54 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.9 0.88 . . . . 0.0 109.495 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -87.03 118.69 26.58 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.568 0.747 . . . . 0.0 109.755 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.6 mm? -103.78 162.37 13.15 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.491 0.716 . . . . 0.0 109.217 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -125.25 72.0 1.23 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.223 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.686 HG21 HG22 ' A' ' 26' ' ' VAL . 2.4 m -134.11 174.16 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.313 0.645 . . . . 0.0 109.572 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 2.7 mm-40 -85.96 148.68 48.7 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.132 0.573 . . . . 0.0 109.61 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 20.5 Cg_endo -61.19 -31.38 89.93 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 121.687 1.592 . . . . 0.0 111.287 167.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.6 t -98.52 17.92 17.89 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.397 0.679 . . . . 0.0 110.563 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 12.1 t0 -74.89 -94.96 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 25' ' ' ASN . 12.0 t 176.95 149.28 0.14 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 125.027 1.331 . . . . 0.0 108.828 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.431 HG22 ' HE3' ' A' ' 27' ' ' LYS . 50.3 mm -65.49 -36.09 76.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.856 0.862 . . . . 0.0 110.848 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.15 -40.71 64.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.902 0.881 . . . . 0.0 110.847 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.516 ' H ' HG23 ' A' ' 22' ' ' THR . 10.3 t30 -70.95 -46.03 63.09 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.126 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.686 HG22 HG21 ' A' ' 17' ' ' VAL . 61.1 t -55.19 -49.52 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 124.173 0.921 . . . . 0.0 111.022 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 16.7 ptpt -67.21 -33.71 75.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.318 0.647 . . . . 0.0 111.929 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.25 -30.1 70.87 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.236 171.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 68.8 mmtt -80.79 -28.15 36.41 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.94 -40.44 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-N 119.577 1.08 . . . . 0.0 108.805 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -60.76 -35.25 75.93 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.304 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 27.1 t70 -71.14 -26.4 62.99 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.778 0.831 . . . . 0.0 112.065 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -95.1 -70.1 0.73 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.415 0.286 . . . . 0.0 111.381 -175.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -83.4 -24.36 31.98 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.23 26.79 13.2 Favored Glycine 0 C--N 1.349 1.259 0 O-C-N 123.224 0.327 . . . . 0.0 113.036 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.8 125.79 29.31 Favored Pre-proline 0 N--CA 1.481 1.115 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.95 155.8 68.32 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.888 2.392 . . . . 0.0 112.686 -171.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.471 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 33.3 Cg_endo -61.26 -11.57 19.75 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.672 2.915 . . . . 0.0 113.918 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.59 -42.53 58.52 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.205 0.602 . . . . 0.0 110.333 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -89.44 -12.54 39.92 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.829 0.852 . . . . 0.0 112.709 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.566 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.1 pp0? -114.86 152.75 31.67 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 123.127 0.571 . . . . 0.0 109.956 173.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.503 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 41.8 ttt180 -136.09 134.56 38.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.117 0.567 . . . . 0.0 110.3 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -94.66 123.35 38.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.873 0.869 . . . . 0.0 110.452 -173.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.5 mt -142.91 126.7 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.078 0.951 . . . . 0.0 109.915 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.5 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 84.8 t80 -121.96 124.84 44.98 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.271 1.029 . . . . 0.0 108.9 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.6 17.96 7.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.07 0.948 . . . . 0.0 112.964 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.79 -7.14 59.05 Favored Glycine 0 C--N 1.351 1.385 0 C-N-CA 122.992 0.329 . . . . 0.0 113.88 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.8 ptpt -95.43 135.21 37.35 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -73.69 138.98 45.05 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.457 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 18.5 mt -92.03 110.22 21.58 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.876 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.89 139.44 43.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.285 1.034 . . . . 0.0 110.524 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.38 -47.06 69.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.696 1.198 . . . . 0.0 112.362 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.01 -26.11 73.29 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 124.123 0.889 . . . . 0.0 114.019 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 80.0 mtt180 -83.24 176.34 9.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.28 0.632 . . . . 0.0 111.794 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.8 p -111.13 167.13 10.51 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.607 0.763 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 91.3 mt -57.75 -51.33 69.99 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.0 t -57.59 -29.95 64.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.727 1.211 . . . . 0.0 111.733 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 10.4 t70 -61.06 -48.26 82.54 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.778 0.799 . . . . 0.0 109.645 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 29.9 m-85 -87.29 18.85 3.49 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.628 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 72.0 22.2 3.83 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.303 1.041 . . . . 0.0 111.805 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -98.94 118.64 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.83 -179.56 4.21 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 10.8 ptmm? -62.97 140.87 58.9 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.618 170.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 64.2 23.57 13.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.164 1.386 . . . . 0.0 112.678 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -75.72 142.12 42.52 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 166.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 61.3 m -101.15 125.76 47.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.5 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -130.84 173.36 11.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.987 1.315 . . . . 0.0 108.876 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -100.45 151.07 21.98 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.762 0.792 . . . . 0.0 111.726 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.757 HD12 HG22 ' A' ' 7' ' ' THR . 3.1 tm? -129.86 123.74 31.55 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.521 HG21 HD11 ' B' ' 220' ' ' LEU . 90.9 t -98.73 112.09 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.324 0.65 . . . . 0.0 110.5 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt -78.22 143.72 36.89 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.961 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -124.98 -42.35 2.04 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.724 0.81 . . . . 0.0 110.062 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.49 1.554 0 C-N-CA 123.565 0.746 . . . . 0.0 111.89 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 5.9 m -143.64 167.33 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.193 1.397 . . . . 0.0 110.023 -172.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -94.38 146.48 24.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.171 0.588 . . . . 0.0 111.685 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.63 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.5 t -90.22 102.49 4.96 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.525 ' HD2' HD21 ' B' ' 220' ' ' LEU . 61.2 Cg_endo -66.62 -2.89 8.21 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.115 2.543 . . . . 0.0 114.599 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.24 -64.09 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.003 0.521 . . . . 0.0 110.338 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.2 p -98.84 4.32 47.53 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.67 0.388 . . . . 0.0 111.835 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.06 44.51 97.67 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 115.181 0.832 . . . . 0.0 115.181 169.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.13 136.57 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 117.472 0.636 . . . . 0.0 110.973 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -87.38 123.4 32.29 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' B' ' 204' ' ' CYS . 3.9 pt -148.79 162.98 27.79 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.543 1.537 . . . . 0.0 109.013 -169.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.55 153.98 71.6 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.049 1.833 . . . . 0.0 111.333 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.563 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.6 tm-20 -66.97 -36.22 81.72 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.34 1.056 . . . . 0.0 113.217 -168.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 16.7 p -58.82 -41.12 86.08 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.88 0.848 . . . . 0.0 110.14 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -81.03 -19.16 44.48 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.464 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -71.48 -44.75 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.67 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -59.3 -52.65 64.74 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.952 0.901 . . . . 0.0 109.967 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -60.61 -40.13 90.74 Favored 'General case' 0 C--O 1.254 1.296 0 O-C-N 124.401 1.063 . . . . 0.0 111.608 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -43.62 80.4 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.92 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' B' ' 216' ' ' ILE . 83.4 mt -62.23 -47.04 86.19 Favored 'General case' 0 C--O 1.213 -0.847 0 O-C-N 124.167 0.917 . . . . 0.0 111.144 -177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -53.83 -32.21 52.06 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 124.112 0.882 . . . . 0.0 111.636 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.3 t -85.06 -39.35 18.09 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.442 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 92.9 m -79.8 -24.84 41.14 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.24 1.016 . . . . 0.0 112.462 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 N--CA 1.479 0.986 0 C-N-CA 123.072 0.549 . . . . 0.0 110.223 -178.062 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 14.9 mp0 -102.85 124.97 49.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.181 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -121.91 159.36 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.475 1.11 . . . . 0.0 108.605 175.479 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' THR . 61.3 m-85 -114.23 116.3 28.82 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.367 0.603 . . . . 0.0 110.463 -172.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.723 HG13 ' HB2' ' A' ' 69' ' ' LEU . 2.1 t -104.26 117.79 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -109.58 110.31 21.34 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.73 0.812 . . . . 0.0 108.822 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.605 HG22 HD12 ' A' ' 69' ' ' LEU . 40.7 p -66.64 163.16 19.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.481 0.313 . . . . 0.0 111.136 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.36 -19.6 65.58 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.894 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.5 p -78.72 -9.86 59.56 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.959 0.504 . . . . 0.0 110.908 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.44 8.84 62.23 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.683 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -84.32 146.76 27.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.428 0.691 . . . . 0.0 110.267 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -108.27 140.03 42.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.271 0.628 . . . . 0.0 109.903 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -129.99 116.6 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.082 1.353 . . . . 0.0 107.72 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -93.63 120.8 34.35 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -104.64 156.47 17.95 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -127.25 83.02 2.13 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.702 HG21 HG22 ' A' ' 26' ' ' VAL . 33.7 m -146.07 178.75 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.967 0.907 . . . . 0.0 110.25 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -95.4 155.38 38.8 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.485 0.714 . . . . 0.0 109.801 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.526 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 21.3 Cg_endo -62.43 -26.97 76.86 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 121.774 1.649 . . . . 0.0 111.833 166.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -93.2 5.16 52.47 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.726 0.81 . . . . 0.0 111.321 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.82 -98.32 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.923 0.889 . . . . 0.0 110.734 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.5 t 170.11 143.54 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.353 1.461 . . . . 0.0 109.246 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.99 -32.82 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.602 0.761 . . . . 0.0 110.54 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -54.98 -41.42 71.16 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.361 1.064 . . . . 0.0 110.091 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 16.4 t-20 -79.26 -40.68 29.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.136 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.702 HG22 HG21 ' A' ' 17' ' ' VAL . 85.6 t -56.35 -44.43 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 124.112 0.883 . . . . 0.0 110.856 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 17.6 ptpt -73.45 -29.61 62.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.93 0.492 . . . . 0.0 111.231 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.78 71.84 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.731 168.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 10.0 mmpt? -72.16 -37.88 69.28 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-O 119.181 -0.437 . . . . 0.0 110.785 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.568 HD11 HG21 ' A' ' 5' ' ' VAL . 2.0 mp -55.22 -45.99 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.006 0.431 . . . . 0.0 110.054 172.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -61.9 -33.43 74.22 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.49 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -72.12 -32.31 66.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.543 0.737 . . . . 0.0 111.646 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.3 mmtt -90.65 -66.31 0.94 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.613 0.365 . . . . 0.0 110.975 -172.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -87.91 -26.84 22.52 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.92 29.35 10.63 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.06 126.02 30.25 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.7 154.05 75.82 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.841 2.361 . . . . 0.0 112.473 -173.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 20.7 Cg_endo -56.94 -19.43 32.07 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.557 2.838 . . . . 0.0 113.251 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.61 -35.74 70.57 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.876 0.87 . . . . 0.0 111.024 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -95.2 -27.92 15.29 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 123.486 0.714 . . . . 0.0 112.198 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.537 ' HB2' HD21 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -92.5 140.63 29.37 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.637 0.653 . . . . 0.0 109.809 178.084 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.444 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 19.7 ttt180 -127.8 127.89 44.32 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -96.28 123.21 39.83 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.595 0.758 . . . . 0.0 110.371 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -141.5 129.42 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.017 0.527 . . . . 0.0 109.864 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.56 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 93.7 t80 -130.81 121.98 26.31 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.19 20.81 11.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.718 0.807 . . . . 0.0 113.122 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.09 -16.96 57.77 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.0 ptpt -90.34 135.15 33.86 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.09 135.42 35.32 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.2 mt -89.29 114.21 25.57 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.689 -172.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 31.0 tt0 -76.95 138.24 39.55 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 123.603 0.761 . . . . 0.0 109.637 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.5 -37.79 82.23 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.124 0.89 . . . . 0.0 111.93 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -67.27 -22.07 72.54 Favored Glycine 0 C--N 1.348 1.235 0 O-C-N 123.675 0.609 . . . . 0.0 114.183 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.565 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 78.7 mtt180 -89.59 177.22 6.6 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.393 0.677 . . . . 0.0 111.511 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 55.6 p -109.9 169.78 8.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.522 0.729 . . . . 0.0 110.43 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 87.1 mt -55.83 -54.86 39.34 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.59 0.556 . . . . 0.0 109.705 173.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 22.8 t -61.73 -22.73 65.62 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.333 1.053 . . . . 0.0 111.798 -176.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.1 -47.39 83.04 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.565 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 36.2 m-85 -86.33 17.02 3.95 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.148 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 m120 72.96 9.76 5.39 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.144 1.378 . . . . 0.0 112.404 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.1 mt -81.66 123.09 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.7 0.8 . . . . 0.0 108.958 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -110.0 -174.18 2.43 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.181 0.592 . . . . 0.0 109.712 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 10.2 ptmm? -58.7 144.34 43.84 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.713 172.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 62.33 10.82 4.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.937 1.295 . . . . 0.0 113.644 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -70.06 132.57 46.07 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 118.17 0.441 . . . . 0.0 110.223 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 29.0 m -93.89 130.97 39.75 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.08 160.46 38.89 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.973 0.909 . . . . 0.0 109.416 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -88.7 138.69 31.19 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.203 0.525 . . . . 0.0 111.423 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.723 ' HB2' HG13 ' A' ' 5' ' ' VAL . 2.7 tm? -119.62 135.26 54.88 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.641 HG21 HD11 ' B' ' 220' ' ' LEU . 90.8 t -115.6 115.54 49.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.591 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.517 ' HB3' HD23 ' A' ' 73' ' ' LEU . 67.2 mt -81.27 99.44 8.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.128 173.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -67.69 -40.52 84.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.67 1.188 . . . . 0.0 109.144 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 71' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 125.037 1.335 . . . . 0.0 112.082 172.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' B' ' 201' ' ' LYS . 9.4 mptt . . . . . 0 C--O 1.243 0.73 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.27 -178.5 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.72 0.808 . . . . 0.0 110.314 -165.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -124.95 144.72 50.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.72 0.808 . . . . 0.0 109.352 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.642 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.0 t -91.09 100.46 2.99 Favored Pre-proline 0 N--CA 1.481 1.093 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.514 ' HD2' HD21 ' B' ' 220' ' ' LEU . 30.1 Cg_endo -58.56 -23.65 65.98 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.983 2.456 . . . . 0.0 114.137 -169.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.37 -53.59 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 C-N-CA 122.22 0.208 . . . . 0.0 111.555 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 17.8 p -103.34 -6.72 21.69 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.7 50.86 39.45 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.527 0.517 . . . . 0.0 114.286 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.0 m -119.09 138.97 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 123.232 0.613 . . . . 0.0 110.271 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -87.44 125.27 34.19 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.5 pt -153.47 157.04 32.8 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 125.136 1.375 . . . . 0.0 109.371 -169.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.19 165.0 31.81 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.417 2.078 . . . . 0.0 112.974 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.537 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.8 tt0 -60.03 -42.1 93.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.69 1.596 . . . . 0.0 115.006 -166.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 35.9 t -70.5 -33.58 71.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.369 -0.832 . . . . 0.0 109.976 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -71.35 -29.34 64.86 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.327 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -71.8 -37.0 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -57.49 -54.21 49.4 Favored 'General case' 0 C--O 1.244 0.806 0 O-C-N 123.803 0.689 . . . . 0.0 110.365 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -69.54 -33.3 72.59 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.973 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -46.46 90.52 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.641 HD11 HG21 ' A' ' 70' ' ' VAL . 91.2 mt -67.91 -37.43 81.7 Favored 'General case' 0 C--O 1.208 -1.09 0 O-C-N 124.129 0.893 . . . . 0.0 111.232 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.04 -32.31 63.91 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 124.538 1.149 . . . . 0.0 110.675 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 33.2 t -93.49 -36.36 12.48 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.513 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 96.9 m -77.8 -24.13 48.91 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.607 0.763 . . . . 0.0 112.802 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 N--CA 1.485 1.308 0 C-N-CA 122.928 0.491 . . . . 0.0 110.459 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.9 mmt . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.762 0.315 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.6 mp0 -114.07 136.91 52.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.262 0.625 . . . . 0.0 110.552 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -128.82 164.14 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 124.811 1.244 . . . . 0.0 108.721 172.31 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 66' ' ' THR . 69.4 m-85 -119.72 110.18 16.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.137 -174.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.502 HG21 HD11 ' A' ' 30' ' ' ILE . 50.8 t -97.03 135.22 31.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -122.09 123.77 42.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.837 0.455 . . . . 0.0 110.214 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.637 HG22 HD12 ' A' ' 69' ' ' LEU . 57.0 p -81.18 165.37 21.59 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.974 0.416 . . . . 0.0 111.728 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 70' ' ' VAL . 85.8 mt -71.38 -19.53 62.26 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.459 172.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.0 p -78.57 -17.88 55.45 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.724 0.41 . . . . 0.0 109.967 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.86 23.9 14.42 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 167.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 153.01 18.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 172.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -100.4 144.56 29.26 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 170.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.567 HD11 HG23 ' A' ' 7' ' ' THR . 5.1 mp -124.97 113.44 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.826 1.251 . . . . 0.0 107.911 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.0 m -89.45 122.04 32.26 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.3 mm? -111.19 152.36 27.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.561 0.744 . . . . 0.0 109.156 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 1' ' ' MET . 3.0 mp0 -112.81 95.32 5.35 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.626 HG21 HG22 ' A' ' 26' ' ' VAL . 33.5 m -146.34 -174.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.434 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 16.0 mt-10 -102.09 155.77 36.05 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 19.7 Cg_endo -57.98 -32.29 94.94 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.018 1.812 . . . . 0.0 111.118 167.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -98.1 18.62 15.7 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.312 0.645 . . . . 0.0 110.808 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 14.7 t70 -82.13 -92.57 0.06 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.046 0.538 . . . . 0.0 109.808 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.518 HG23 ' H ' ' A' ' 25' ' ' ASN . 15.3 t 177.81 149.49 0.18 Allowed 'General case' 0 C--N 1.367 1.361 0 C-N-CA 124.526 1.13 . . . . 0.0 110.762 174.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.0 mm -65.83 -37.19 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.591 1.157 . . . . 0.0 110.81 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -55.6 -38.57 69.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.181 0.992 . . . . 0.0 111.056 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.518 ' H ' HG23 ' A' ' 22' ' ' THR . 4.9 t-20 -76.64 -39.14 53.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.277 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 17' ' ' VAL . 64.4 t -57.67 -46.9 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 124.471 1.107 . . . . 0.0 110.759 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HA ' HD12 ' A' ' 30' ' ' ILE . 17.2 ptpt -71.3 -27.56 63.49 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.944 0.498 . . . . 0.0 111.795 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.27 -39.43 89.41 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.505 0.503 . . . . 0.0 110.911 169.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 4.4 mmtm -66.15 -37.27 85.25 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.652 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.502 HD11 HG21 ' A' ' 5' ' ' VAL . 94.3 mt -64.05 -38.42 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.649 0.78 . . . . 0.0 110.915 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.8 tt0 -64.92 -31.1 72.18 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.036 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.31 -38.91 78.48 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.398 0.279 . . . . 0.0 110.984 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.5 mmtt -85.31 -69.43 0.66 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.078 0.237 . . . . 0.0 110.699 -168.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.7 -20.49 31.12 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 122.087 0.155 . . . . 0.0 111.08 -176.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 88.06 25.96 30.15 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.451 0.469 . . . . 0.0 113.359 171.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.11 125.88 30.15 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -65.47 149.83 87.47 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.939 2.426 . . . . 0.0 112.438 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 11.6 Cg_endo -54.05 -17.6 11.56 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 124.325 3.35 . . . . 0.0 114.339 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -74.49 -41.91 59.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.302 0.641 . . . . 0.0 111.2 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -85.12 -33.56 22.36 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.731 0.812 . . . . 0.0 111.489 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.457 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -89.78 149.34 22.75 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.43 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 44.3 ttt180 -132.75 131.12 40.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.941 0.496 . . . . 0.0 110.207 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.84 124.84 39.11 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.687 0.795 . . . . 0.0 110.122 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.7 mt -142.52 132.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.003 0.921 . . . . 0.0 109.139 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.552 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 86.6 t80 -135.21 132.31 37.75 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 171.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.49 23.28 12.93 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.889 0.876 . . . . 0.0 112.197 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.33 -7.97 75.29 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 114.516 0.566 . . . . 0.0 114.516 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.8 ptpt -103.28 141.34 36.08 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 117.494 0.647 . . . . 0.0 109.448 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.48 ' NE2' HD22 ' B' ' 224' ' ' LEU . 8.0 tt0 -74.43 131.41 41.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.3 mt -83.25 117.97 23.31 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.407 0.283 . . . . 0.0 110.245 -176.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.76 137.96 38.0 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 123.945 0.898 . . . . 0.0 109.674 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.3 -50.26 67.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.726 1.211 . . . . 0.0 111.843 -174.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.64 -27.39 70.93 Favored Glycine 0 C--N 1.35 1.32 0 O-C-N 124.273 0.983 . . . . 0.0 114.072 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.445 ' HD3' ' OD2' ' A' ' 58' ' ' ASP . 54.5 mtt180 -77.3 175.73 9.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.316 0.646 . . . . 0.0 112.013 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 65.8 p -111.27 164.08 13.27 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.013 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 90.9 mt -55.44 -53.33 57.59 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.807 174.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 9.4 t -66.56 -20.64 66.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.263 1.025 . . . . 0.0 111.339 -173.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' OD2' ' HD3' ' A' ' 54' ' ' ARG . 12.2 t70 -67.26 -42.18 84.31 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -86.78 16.18 5.05 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.813 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m120 70.94 17.43 6.28 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.033 1.333 . . . . 0.0 112.301 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 11.1 mt -90.45 103.66 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -84.97 -178.97 6.97 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -59.4 143.47 49.62 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 64.28 11.83 6.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.13 1.372 . . . . 0.0 113.573 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.9 m -75.25 149.57 38.82 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.275 0.489 . . . . 0.0 110.614 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.7 m -101.02 130.12 46.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.974 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.61 154.85 48.46 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.95 1.3 . . . . 0.0 108.181 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -87.85 158.7 18.66 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.44 0.638 . . . . 0.0 111.888 -174.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.637 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -141.94 129.47 21.38 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.545 -1.207 . . . . 0.0 107.829 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.577 HG21 HD11 ' B' ' 220' ' ' LEU . 98.4 t -111.0 117.18 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.755 0.822 . . . . 0.0 110.112 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.68 139.86 30.36 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.123 0.969 . . . . 0.0 110.673 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -118.18 -44.92 2.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.748 0.819 . . . . 0.0 111.583 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 N--CA 1.491 1.599 0 C-N-CA 124.201 1.0 . . . . 0.0 112.425 -178.873 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 202' ' ' VAL . . . . . 0.441 HG23 HG13 ' B' ' 216' ' ' ILE . 6.6 m -134.12 -178.86 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 125.379 1.472 . . . . 0.0 109.173 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -109.64 146.18 35.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.19 0.596 . . . . 0.0 111.097 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.567 ' HA ' HD11 ' B' ' 216' ' ' ILE . 49.7 t -89.46 102.36 4.32 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.322 1.049 . . . . 0.0 109.236 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.531 ' HD2' HD21 ' B' ' 220' ' ' LEU . 45.8 Cg_endo -62.28 -10.09 17.34 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.776 2.984 . . . . 0.0 114.984 -166.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 42.4 t -84.07 -60.47 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 123.054 0.542 . . . . 0.0 110.769 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 22.3 p -101.3 -6.99 23.42 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.804 0.441 . . . . 0.0 112.038 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.66 51.05 38.36 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.435 0.54 . . . . 0.0 114.207 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.12 142.22 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 123.008 0.523 . . . . 0.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -92.47 122.36 34.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.491 0.717 . . . . 0.0 109.903 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.534 HD11 ' HB2' ' B' ' 204' ' ' CYS . 3.8 pt -152.67 160.99 30.39 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.767 1.627 . . . . 0.0 109.387 -169.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.26 158.8 46.67 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.156 1.904 . . . . 0.0 111.629 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.537 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.9 tm-20 -69.75 -28.41 65.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.055 0.942 . . . . 0.0 112.104 -169.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 37.2 p -60.79 -45.82 92.9 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.657 0.741 . . . . 0.0 110.058 169.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -76.8 -18.3 58.5 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.815 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -72.21 -50.16 38.26 Favored 'Isoleucine or valine' 0 C--N 1.364 1.214 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -67.75 -35.61 79.04 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.205 0.316 . . . . 0.0 110.467 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -45.47 94.03 Favored 'General case' 0 C--O 1.254 1.313 0 O-C-N 123.886 0.741 . . . . 0.0 110.967 172.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 219' ' ' HIS . . . . . 0.414 ' HB3' ' SG ' ' B' ' 204' ' ' CYS . 0.1 OUTLIER -59.57 -38.58 81.53 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.78 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 70' ' ' VAL . 79.4 mt -66.21 -39.56 89.7 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 123.972 0.795 . . . . 0.0 111.295 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -55.56 -38.71 69.68 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.945 0.778 . . . . 0.0 110.88 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.2 t -88.24 -31.54 18.98 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.829 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 63.6 m -82.47 -19.73 38.29 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.645 0.778 . . . . 0.0 112.967 -173.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' LEU . . . . . 0.48 HD22 ' NE2' ' A' ' 49' ' ' GLN . 4.6 pp . . . . . 0 N--CA 1.489 1.498 0 C-N-CA 122.676 0.39 . . . . 0.0 110.928 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.1 mp0 -112.35 155.61 23.85 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.469 0.708 . . . . 0.0 110.201 174.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.436 HD11 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -142.8 157.08 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 124.793 1.237 . . . . 0.0 109.218 167.226 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 66' ' ' THR . 39.0 m-85 -112.57 100.49 8.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.372 0.669 . . . . 0.0 110.322 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 69' ' ' LEU . 95.2 t -101.77 104.84 16.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -102.16 127.3 49.15 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.732 0.813 . . . . 0.0 111.137 -172.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.655 HG22 HD12 ' A' ' 69' ' ' LEU . 49.2 p -70.85 166.46 21.02 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-O 121.599 0.714 . . . . 0.0 112.782 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.421 HD11 HG22 ' A' ' 70' ' ' VAL . 68.4 mt -67.82 -23.52 65.19 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.297 171.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.7 p -78.63 -16.54 57.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.308 0.643 . . . . 0.0 110.397 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.41 5.71 39.54 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-O 119.182 -0.788 . . . . 0.0 114.856 167.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.47 151.13 24.82 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.063 0.932 . . . . 0.0 108.586 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.1 m -107.01 126.04 51.81 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.013 0.525 . . . . 0.0 110.3 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.414 HD11 HG23 ' A' ' 7' ' ' THR . 4.7 mp -107.27 110.75 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.797 0.839 . . . . 0.0 109.006 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.9 m -90.31 120.44 31.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.278 0.631 . . . . 0.0 109.446 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.5 mm? -106.9 151.75 24.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.01 0.524 . . . . 0.0 109.833 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -110.69 78.29 1.11 Allowed 'General case' 0 C--O 1.239 0.53 0 O-C-N 124.205 0.941 . . . . 0.0 108.618 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.734 HG21 HG22 ' A' ' 26' ' ' VAL . 3.4 m -144.77 172.07 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.702 0.801 . . . . 0.0 108.981 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.428 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 8.1 mt-10 -93.11 158.0 38.08 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -57.65 -34.16 97.73 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.139 1.893 . . . . 0.0 112.074 169.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.2 t -102.03 21.35 14.93 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.881 0.472 . . . . 0.0 110.611 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 6.2 t70 -73.03 -87.33 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 25' ' ' ASN . 7.4 t 173.65 148.86 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.461 1.504 . . . . 0.0 109.081 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.508 HG22 ' HE3' ' A' ' 27' ' ' LYS . 44.3 mm -63.19 -38.53 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.322 1.049 . . . . 0.0 110.42 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -60.03 -33.06 71.5 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.374 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.2 t-20 -74.53 -43.26 56.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.734 HG22 HG21 ' A' ' 17' ' ' VAL . 60.6 t -56.35 -47.31 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 124.387 1.054 . . . . 0.0 110.093 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HE3' HG22 ' A' ' 23' ' ' ILE . 17.6 ptpt -74.18 -25.93 59.99 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.37 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.62 -34.26 77.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.28 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 73.6 mmtt -72.52 -32.59 66.25 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.557 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.4 mp -53.42 -45.0 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 119.05 0.841 . . . . 0.0 110.076 168.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.97 -32.99 74.72 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.507 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.99 -34.88 66.71 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.099 0.56 . . . . 0.0 111.328 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.76 -68.7 0.78 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.046 0.539 . . . . 0.0 110.952 -171.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -83.35 -21.74 33.03 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.78 20.8 35.76 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.753 -0.203 . . . . 0.0 112.942 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -107.98 122.72 39.88 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.35 153.43 78.25 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.645 2.23 . . . . 0.0 112.333 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HA ' ' HG3' ' A' ' 41' ' ' GLN . 18.4 Cg_endo -56.32 -14.38 12.17 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.715 2.943 . . . . 0.0 113.761 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -75.07 -48.78 22.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.033 0.933 . . . . 0.0 110.628 173.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -80.84 -23.83 38.86 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.511 0.724 . . . . 0.0 111.911 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.506 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -93.43 153.71 18.34 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.601 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 32.9 ttt180 -134.89 126.48 28.81 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.726 ' HG ' HD12 ' A' ' 50' ' ' LEU . 5.3 tp -100.84 122.61 43.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.839 -166.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.1 mt -139.32 133.05 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.727 0.811 . . . . 0.0 109.954 -173.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.601 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 82.6 t80 -135.32 131.97 37.11 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.78 21.62 12.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.857 0.863 . . . . 0.0 112.468 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.58 10.4 79.58 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.449 -0.341 . . . . 0.0 113.819 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 12.7 ptpt -118.39 147.57 43.41 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.286 0.634 . . . . 0.0 109.373 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.529 ' HB2' HD22 ' B' ' 224' ' ' LEU . 8.0 tt0 -75.94 127.2 32.48 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.127 0.571 . . . . 0.0 109.779 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.726 HD12 ' HG ' ' A' ' 43' ' ' LEU . 25.0 mt -80.75 123.65 28.39 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.039 0.536 . . . . 0.0 109.998 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.75 138.44 32.09 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.152 0.981 . . . . 0.0 109.707 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.53 -39.2 92.82 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.627 1.171 . . . . 0.0 112.28 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.14 -18.57 76.64 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.218 0.949 . . . . 0.0 113.816 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -88.35 178.1 6.66 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.823 0.849 . . . . 0.0 111.563 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.6 p -116.59 168.67 9.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.717 0.807 . . . . 0.0 109.874 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.5 mt -57.54 -50.73 72.13 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.1 t -61.55 -25.64 67.43 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.379 1.072 . . . . 0.0 111.554 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.64 -45.98 84.49 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 121.127 0.489 . . . . 0.0 109.688 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -85.59 17.23 3.36 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.473 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 65.73 19.98 11.45 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.402 1.081 . . . . 0.0 111.776 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.6 mt -85.58 132.68 31.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -115.8 -175.2 2.68 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -61.96 130.41 45.49 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.238 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 72.58 18.18 4.42 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.258 1.423 . . . . 0.0 111.965 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.4 m -71.05 139.92 50.58 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 53.1 m -93.72 129.66 39.98 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.456 0.473 . . . . 0.0 109.986 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.601 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -137.84 166.07 24.92 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.696 1.198 . . . . 0.0 108.891 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -96.65 148.3 23.01 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.349 0.595 . . . . 0.0 111.267 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.655 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -127.12 130.85 50.6 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 94.0 t -114.02 130.42 68.25 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 124.207 1.003 . . . . 0.0 109.936 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 92.1 mt -98.34 146.29 25.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.317 0.647 . . . . 0.0 110.95 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -117.18 -40.46 3.09 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.28 1.032 . . . . 0.0 110.627 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 71' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.494 1.764 0 C-N-CA 124.989 1.316 . . . . 0.0 113.191 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 11.2 mptt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.6 m -145.59 -177.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.902 0.881 . . . . 0.0 110.179 -168.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -125.81 146.7 49.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.58 0.752 . . . . 0.0 110.907 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.627 ' HA ' HD11 ' B' ' 216' ' ' ILE . 48.7 t -92.95 96.09 1.29 Allowed Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 124.651 1.18 . . . . 0.0 107.998 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.56 ' HD2' HD21 ' B' ' 220' ' ' LEU . 34.2 Cg_endo -59.79 -17.36 42.76 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.234 2.622 . . . . 0.0 114.483 -168.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.16 -56.93 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 122.789 0.436 . . . . 0.0 110.851 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 14.9 p -103.65 -0.65 29.26 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.435 0.294 . . . . 0.0 111.555 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 69.05 42.11 78.47 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 115.153 0.821 . . . . 0.0 115.153 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.01 137.51 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.318 0.559 . . . . 0.0 110.894 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -89.13 123.77 33.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.211 0.604 . . . . 0.0 109.684 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.2 pt -153.55 160.11 31.32 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.845 1.258 . . . . 0.0 110.434 -168.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.18 161.22 16.83 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.172 2.581 . . . . 0.0 113.563 171.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.571 ' O ' HG22 ' B' ' 216' ' ' ILE . 40.3 tt0 -62.79 -44.72 95.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.412 1.485 . . . . 0.0 113.096 -172.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 20.3 m -62.66 -40.99 98.78 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-O 121.978 0.894 . . . . 0.0 110.347 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -73.58 -26.3 60.75 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.249 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -69.54 -43.68 80.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.143 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -67.29 -37.42 83.38 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 123.394 0.434 . . . . 0.0 110.421 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -69.59 -40.59 76.61 Favored 'General case' 0 C--O 1.247 0.945 0 O-C-N 123.226 0.329 . . . . 0.0 111.57 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.32 -45.45 93.15 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.48 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.56 HD21 ' HD2' ' B' ' 205' ' ' PRO . 96.3 mt -61.82 -43.62 98.48 Favored 'General case' 0 C--O 1.206 -1.196 0 O-C-N 124.431 1.082 . . . . 0.0 111.153 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.45 -27.21 56.2 Favored 'General case' 0 CA--C 1.553 1.094 0 O-C-N 124.578 1.173 . . . . 0.0 110.767 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.4 t -91.57 -39.8 11.7 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.642 0.777 . . . . 0.0 111.454 172.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 91.4 m -75.04 -23.0 58.07 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.333 1.053 . . . . 0.0 112.899 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.5 pp . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.753 0.311 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 40.4 mt-30 -107.2 138.5 43.27 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.678 0.791 . . . . 0.0 110.635 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.585 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -137.57 153.59 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.299 1.04 . . . . 0.0 109.746 176.064 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 66' ' ' THR . 81.8 m-85 -105.79 107.78 18.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.033 0.933 . . . . 0.0 109.445 -175.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.451 HG21 HD11 ' A' ' 30' ' ' ILE . 56.1 t -103.67 117.58 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -108.11 119.6 39.95 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.844 0.857 . . . . 0.0 109.615 -171.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.635 HG22 HD12 ' A' ' 69' ' ' LEU . 38.5 p -72.1 165.0 25.19 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.296 0.569 . . . . 0.0 111.461 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 70' ' ' VAL . 88.4 mt -70.37 -18.7 63.06 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.165 171.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -79.64 -12.86 59.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.908 0.483 . . . . 0.0 110.809 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.54 18.78 37.19 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.908 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 153.44 18.16 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.7 m -100.58 134.28 43.78 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.585 0.754 . . . . 0.0 110.022 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 7' ' ' THR . 5.2 mp -120.41 109.93 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.96 1.304 . . . . 0.0 107.53 174.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.2 m -94.78 130.35 41.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -112.62 154.48 25.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.72 0.808 . . . . 0.0 109.28 -177.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -110.6 71.87 0.77 Allowed 'General case' 0 C--O 1.242 0.706 0 O-C-N 124.512 1.132 . . . . 0.0 108.887 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.794 HG21 HG22 ' A' ' 26' ' ' VAL . 20.3 m -140.47 172.63 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.514 0.726 . . . . 0.0 110.169 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -102.87 161.88 21.83 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 123.639 0.775 . . . . 0.0 109.95 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 29.1 Cg_endo -59.41 -37.05 92.22 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 121.868 1.712 . . . . 0.0 111.03 171.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 p -96.64 15.72 20.93 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.872 0.869 . . . . 0.0 111.092 -174.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.75 -98.97 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.771 0.828 . . . . 0.0 109.576 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.1 t 174.75 142.45 0.05 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.989 1.316 . . . . 0.0 109.091 173.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -61.0 -38.84 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.208 1.003 . . . . 0.0 111.848 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 42.7 tt0 -57.47 -35.22 69.89 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.563 0.697 . . . . 0.0 111.483 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 16.0 t-20 -75.99 -42.23 48.86 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.213 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.794 HG22 HG21 ' A' ' 17' ' ' VAL . 61.8 t -55.27 -47.3 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 124.606 1.191 . . . . 0.0 110.367 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.408 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 16.3 ptpt -69.45 -32.2 70.99 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.079 0.551 . . . . 0.0 111.696 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.48 70.44 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.387 0.429 . . . . 0.0 110.838 170.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 8.8 mmpt? -75.96 -35.81 59.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.906 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 5' ' ' VAL . 2.2 mp -57.09 -43.4 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 118.915 0.78 . . . . 0.0 109.666 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -62.11 -31.76 72.26 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.353 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.36 -30.77 66.56 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.42 0.688 . . . . 0.0 111.541 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 72.2 mmtt -93.55 -70.37 0.71 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 117.624 0.193 . . . . 0.0 110.715 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -80.38 -25.93 38.85 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.24 0.216 . . . . 0.0 111.274 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.32 18.55 30.68 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.311 0.382 . . . . 0.0 113.928 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.75 123.83 41.07 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -70.29 156.64 61.52 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.112 2.541 . . . . 0.0 112.375 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 18.5 Cg_endo -56.23 -16.43 17.36 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.713 2.942 . . . . 0.0 114.072 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -71.8 -47.09 55.75 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 120.949 0.404 . . . . 0.0 110.197 173.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -83.2 -21.3 33.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.895 0.878 . . . . 0.0 112.216 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.47 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.1 pp0? -109.18 153.0 24.39 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.105 0.562 . . . . 0.0 110.515 177.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -138.72 138.08 37.37 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.119 0.567 . . . . 0.0 110.263 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.06 125.08 42.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.788 0.835 . . . . 0.0 110.373 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -142.86 125.04 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.015 0.926 . . . . 0.0 109.586 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.643 ' HB3' HD21 ' A' ' 50' ' ' LEU . 79.4 t80 -124.67 124.96 43.31 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.43 1.092 . . . . 0.0 108.148 177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.447 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 60.44 27.0 16.6 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.893 0.877 . . . . 0.0 112.812 175.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.52 -15.89 61.99 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 2.5 ptpt -98.73 142.32 30.43 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -83.18 132.96 35.04 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.643 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.7 mt -82.51 116.64 22.04 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.426 0.691 . . . . 0.0 110.996 -175.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -83.87 139.45 32.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.485 1.114 . . . . 0.0 110.466 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.5 m-20 -56.25 -47.92 77.57 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.603 1.161 . . . . 0.0 112.795 -172.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.49 -18.2 71.5 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 124.758 1.286 . . . . 0.0 113.893 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 62.5 mtt180 -84.96 177.53 7.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.69 0.796 . . . . 0.0 111.04 175.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.9 p -116.71 170.78 8.33 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.343 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 94.9 mt -57.35 -47.97 80.21 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 47.4 t -62.18 -26.49 68.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.755 1.222 . . . . 0.0 111.6 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.432 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 7.7 t70 -61.25 -45.47 94.4 Favored 'General case' 0 C--N 1.357 0.932 0 CA-C-O 121.532 0.682 . . . . 0.0 109.654 177.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.4 15.95 7.11 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.589 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 71.22 8.06 6.3 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.475 1.51 . . . . 0.0 112.309 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mt -77.91 129.56 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -122.83 -176.63 3.45 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -59.16 143.5 48.66 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 68.19 13.3 9.05 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.885 1.274 . . . . 0.0 112.239 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.5 m -84.91 138.76 32.32 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 57.9 m -99.27 127.31 45.25 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 110.187 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.587 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -124.13 173.67 8.15 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.25 1.42 . . . . 0.0 108.585 176.125 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -108.97 154.96 21.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.496 0.718 . . . . 0.0 110.97 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD12 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -133.79 126.17 30.02 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.589 HG11 HD11 ' B' ' 220' ' ' LEU . 90.2 t -104.95 115.85 47.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 123.518 0.727 . . . . 0.0 109.993 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.471 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 86.8 mt -85.67 147.79 26.2 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.519 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -121.98 -45.64 2.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.249 1.02 . . . . 0.0 110.127 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 71' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.499 2.006 0 C-N-CA 124.501 1.121 . . . . 0.0 112.976 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' B' ' 201' ' ' LYS . 11.2 mptt . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 m -142.6 -178.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.289 1.036 . . . . 0.0 109.761 -166.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -118.73 146.31 44.86 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.256 0.622 . . . . 0.0 110.599 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.523 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.7 t -83.08 102.64 1.9 Allowed Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.518 ' HD2' HD21 ' B' ' 220' ' ' LEU . 43.7 Cg_endo -62.38 -9.6 15.96 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.319 2.679 . . . . 0.0 114.052 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.78 -65.09 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.311 0.644 . . . . 0.0 110.611 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 18.1 p -100.3 2.46 42.63 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.704 0.401 . . . . 0.0 112.061 -172.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 63.23 38.85 97.14 Favored Glycine 0 N--CA 1.477 1.388 0 N-CA-C 115.494 0.957 . . . . 0.0 115.494 170.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.65 134.41 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.077 0.551 . . . . 0.0 110.482 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -84.74 122.62 29.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.611 0.365 . . . . 0.0 110.029 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 6.0 pt -149.44 158.7 37.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 125.825 1.65 . . . . 0.0 109.484 -171.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.8 162.99 20.07 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.618 2.212 . . . . 0.0 112.839 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.546 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.5 tt0 -65.36 -36.18 83.24 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.459 1.504 . . . . 0.0 113.23 -169.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 34.2 t -69.0 -38.0 79.04 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.098 0.475 . . . . 0.0 110.04 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -76.26 -23.45 54.45 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.2 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' B' ' 220' ' ' LEU . 0.3 OUTLIER -70.91 -43.0 77.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -55.78 -52.87 62.49 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.016 0.823 . . . . 0.0 110.346 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -54.26 -47.48 72.25 Favored 'General case' 0 C--O 1.252 1.221 0 O-C-N 124.307 1.004 . . . . 0.0 111.82 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -35.06 79.13 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.991 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.589 HD11 HG11 ' A' ' 70' ' ' VAL . 71.3 mt -64.62 -51.95 60.01 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 123.529 0.518 . . . . 0.0 110.882 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -58.25 -29.41 65.75 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.569 1.168 . . . . 0.0 111.684 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 46.7 t -81.88 -43.5 18.11 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.435 0.694 . . . . 0.0 110.921 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 69.6 m -81.59 -19.03 42.77 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.251 1.02 . . . . 0.0 113.383 -170.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.491 1.595 0 CA-C-N 118.482 0.583 . . . . 0.0 111.182 -176.768 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 N--CA 1.476 0.825 0 CA-C-O 121.216 0.532 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 18.5 mp0 -92.91 124.57 36.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.488 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -122.5 157.56 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.338 1.455 . . . . 0.0 108.212 175.418 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 66' ' ' THR . 64.7 m-85 -116.81 105.51 12.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.431 -172.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 30' ' ' ILE . 40.3 t -95.08 122.26 46.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -108.9 120.04 41.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.309 0.644 . . . . 0.0 110.144 -173.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.652 HG22 HD12 ' A' ' 69' ' ' LEU . 31.6 p -77.77 167.08 22.12 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.465 0.65 . . . . 0.0 111.939 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 82.6 mt -71.28 -20.22 62.24 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.724 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -78.67 -16.94 56.7 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.954 0.502 . . . . 0.0 110.282 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.58 14.8 26.61 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -93.22 152.83 18.96 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.469 0.635 . . . . 0.0 109.436 176.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.9 m -96.29 143.25 27.53 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 7' ' ' THR . 5.0 mp -125.1 102.44 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.0 m -84.49 117.39 23.65 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -104.3 153.49 20.96 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.42 ' HG3' ' HG3' ' A' ' 2' ' ' GLN . 4.7 mp0 -114.37 90.63 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.777 HG21 HG22 ' A' ' 26' ' ' VAL . 9.2 m -139.32 169.04 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -90.13 153.13 46.73 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 42.5 Cg_endo -64.13 -26.32 65.29 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 121.975 1.783 . . . . 0.0 111.14 172.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.9 t -100.18 14.33 31.2 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.057 0.943 . . . . 0.0 110.365 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.73 -94.78 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.112 0.565 . . . . 0.0 109.57 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.2 t 179.58 145.65 0.19 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.521 1.128 . . . . 0.0 109.678 173.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.416 HG23 HD23 ' A' ' 43' ' ' LEU . 46.1 mm -61.8 -36.23 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.168 0.987 . . . . 0.0 111.196 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -57.71 -34.93 69.98 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.428 0.691 . . . . 0.0 111.009 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.416 ' H ' HG23 ' A' ' 22' ' ' THR . 15.7 t-20 -73.95 -43.29 58.73 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.152 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.777 HG22 HG21 ' A' ' 17' ' ' VAL . 38.6 t -57.71 -50.06 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 124.256 0.973 . . . . 0.0 110.735 -178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HE3' HG22 ' A' ' 23' ' ' ILE . 18.0 ptpt -67.41 -30.19 69.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.179 0.592 . . . . 0.0 111.232 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.62 78.84 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.653 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 7.2 mmpt? -73.82 -31.63 63.33 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 118.801 -0.618 . . . . 0.0 110.896 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 5' ' ' VAL . 1.7 mp -54.26 -47.87 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.638 0.654 . . . . 0.0 110.113 169.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -66.03 -30.81 71.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.395 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.24 -27.74 64.7 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.344 0.658 . . . . 0.0 111.627 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.6 mmtt -100.61 -68.84 0.79 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.711 0.404 . . . . 0.0 110.912 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -83.42 -22.36 32.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.412 0.285 . . . . 0.0 111.311 -175.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.73 6.98 57.0 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 113.883 0.313 . . . . 0.0 113.883 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -95.54 124.07 54.26 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.071 0.549 . . . . 0.0 109.764 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 40' ' ' GLN . 53.1 Cg_endo -64.31 155.91 62.87 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.525 2.817 . . . . 0.0 113.152 -174.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -56.5 -18.29 24.94 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 124.237 3.291 . . . . 0.0 113.94 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.53 -47.14 16.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.26 0.624 . . . . 0.0 110.748 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 4.0 mp0 -78.59 -23.8 45.82 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.3 0.64 . . . . 0.0 111.056 -173.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.548 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.06 152.7 19.13 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.59 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 35.4 ttt180 -140.54 116.87 10.68 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 121.844 0.831 . . . . 0.0 109.032 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.729 ' HG ' HD12 ' A' ' 50' ' ' LEU . 10.6 tp -93.84 123.75 37.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.654 -162.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.533 HD11 HD21 ' B' ' 220' ' ' LEU . 96.2 mt -140.49 135.45 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 123.291 0.637 . . . . 0.0 110.775 -169.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 78.6 t80 -136.13 132.85 36.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.72 18.15 10.67 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.523 1.129 . . . . 0.0 112.61 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.67 15.48 65.71 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.86 -0.411 . . . . 0.0 113.593 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 13.6 ptpt -124.2 143.9 50.25 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.505 0.722 . . . . 0.0 109.148 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -75.5 130.67 39.27 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.779 0.431 . . . . 0.0 110.349 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.729 HD12 ' HG ' ' A' ' 43' ' ' LEU . 24.9 mt -78.49 122.03 25.33 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 123.21 0.604 . . . . 0.0 110.465 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -77.74 136.29 38.13 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.689 0.796 . . . . 0.0 108.91 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -61.62 -36.97 82.26 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.105 0.878 . . . . 0.0 112.521 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.25 -27.83 69.25 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.98 0.8 . . . . 0.0 113.166 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -76.04 176.83 7.58 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.127 0.571 . . . . 0.0 111.44 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.0 p -114.75 168.75 9.61 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.707 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 85.4 mt -55.71 -52.1 65.05 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.948 0.78 . . . . 0.0 109.532 172.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -59.13 -27.52 65.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.529 1.132 . . . . 0.0 111.83 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.13 -40.05 86.72 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.027 0.531 . . . . 0.0 110.017 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -90.39 21.37 3.91 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.918 0.887 . . . . 0.0 111.41 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 67.17 15.36 10.03 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.451 1.101 . . . . 0.0 111.884 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -88.11 134.36 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -122.9 -173.59 2.74 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.453 0.701 . . . . 0.0 109.266 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 11.7 ptmm? -59.04 144.0 46.7 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.918 170.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 65.05 7.6 4.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.614 1.566 . . . . 0.0 112.968 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -72.4 129.86 39.35 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 118.112 0.414 . . . . 0.0 109.897 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 20.0 m -99.43 140.91 32.91 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.531 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -143.58 173.87 11.27 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.09 0.956 . . . . 0.0 109.344 -175.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -97.54 154.63 17.39 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.691 0.758 . . . . 0.0 111.601 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.652 HD12 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -137.49 119.33 15.22 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.484 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.638 HG21 HD22 ' B' ' 220' ' ' LEU . 53.1 t -93.31 110.31 23.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.581 0.752 . . . . 0.0 110.368 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.6 mt -78.25 137.78 38.29 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.748 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -115.54 -48.62 2.77 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.19 0.996 . . . . 0.0 109.641 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.489 1.497 0 C-N-CA 125.185 1.394 . . . . 0.0 112.196 179.673 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 13.2 mptt . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 202' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 6.0 m -145.38 -177.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.135 1.374 . . . . 0.0 109.28 -162.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -115.18 137.2 52.29 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 122.464 0.306 . . . . 0.0 111.522 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.524 ' HA ' HD11 ' B' ' 216' ' ' ILE . 48.8 t -79.91 101.43 0.84 Allowed Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.406 ' HD3' HD11 ' B' ' 216' ' ' ILE . 91.9 Cg_endo -71.0 -1.09 8.95 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.796 2.33 . . . . 0.0 114.592 -159.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 23.3 t -93.88 -62.95 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.2 p -89.47 -10.51 46.09 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.745 0.418 . . . . 0.0 111.52 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.14 57.7 17.2 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 124.321 0.962 . . . . 0.0 114.195 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 32.6 m -117.94 135.62 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.399 0.68 . . . . 0.0 109.263 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -83.85 113.03 20.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.497 HD11 ' HB2' ' B' ' 204' ' ' CYS . 7.9 pt -142.5 156.04 63.73 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.808 1.243 . . . . 0.0 110.287 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.92 163.34 14.04 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.946 2.431 . . . . 0.0 113.186 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.576 ' O ' HG22 ' B' ' 216' ' ' ILE . 43.8 tt0 -65.47 -37.04 85.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.176 1.39 . . . . 0.0 113.131 -166.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 23.3 t -65.48 -43.6 89.72 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.369 0.605 . . . . 0.0 109.743 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -69.81 -25.01 63.57 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.402 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.576 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -70.24 -44.03 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.324 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -61.88 -46.43 89.46 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 123.686 0.616 . . . . 0.0 110.508 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -47.79 78.9 Favored 'General case' 0 C--O 1.25 1.093 0 O-C-N 124.0 0.813 . . . . 0.0 112.469 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.53 -37.75 88.49 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.569 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.638 HD22 HG21 ' A' ' 70' ' ' VAL . 62.6 tp -62.48 -42.59 99.59 Favored 'General case' 0 C--O 1.215 -0.723 0 O-C-N 124.28 0.988 . . . . 0.0 111.452 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -53.23 -40.35 64.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.856 0.722 . . . . 0.0 110.342 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.2 t -75.53 -41.87 53.99 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.324 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 96.0 m -77.9 -19.04 55.44 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.169 0.987 . . . . 0.0 112.878 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' LEU . . . . . 0.625 HD23 ' HG ' ' B' ' 220' ' ' LEU . 4.2 pp . . . . . 0 N--CA 1.482 1.17 0 C-N-CA 122.647 0.379 . . . . 0.0 110.73 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.928 0.394 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 77.7 mt-30 -104.72 123.22 47.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.516 0.726 . . . . 0.0 110.572 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -123.85 155.27 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.538 1.135 . . . . 0.0 109.623 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -108.28 103.88 13.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.921 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.614 HG12 ' HB2' ' A' ' 69' ' ' LEU . 92.3 t -104.65 100.17 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.99 122.52 43.01 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.595 0.758 . . . . 0.0 111.129 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.622 HG22 HD12 ' A' ' 69' ' ' LEU . 37.4 p -67.71 162.97 22.57 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.608 0.763 . . . . 0.0 112.219 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.33 -15.69 63.39 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.138 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.5 p -80.21 0.01 34.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.47 0.708 . . . . 0.0 111.202 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.53 9.3 75.71 Favored Glycine 0 C--N 1.351 1.39 0 C-N-CA 123.235 0.445 . . . . 0.0 113.376 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -94.23 141.6 28.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.036 0.934 . . . . 0.0 109.237 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 m -105.22 136.6 44.44 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.831 0.452 . . . . 0.0 110.534 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.34 109.84 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.086 0.954 . . . . 0.0 109.021 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.0 m -84.72 122.49 29.17 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.6 mm? -108.95 159.05 17.13 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -124.02 82.25 2.01 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.677 HG21 HG22 ' A' ' 26' ' ' VAL . 15.4 m -140.84 172.6 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.999 0.92 . . . . 0.0 109.775 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.93 149.15 35.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 30.1 Cg_endo -61.79 -27.06 80.18 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.085 1.856 . . . . 0.0 111.904 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.4 t -99.87 16.62 23.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.776 0.43 . . . . 0.0 110.308 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.79 -98.58 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 119.108 -0.472 . . . . 0.0 109.797 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -170.5 143.85 2.32 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 125.447 1.499 . . . . 0.0 108.786 175.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.37 -37.38 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.885 0.874 . . . . 0.0 110.639 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.98 -36.19 72.27 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.039 0.936 . . . . 0.0 110.849 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.475 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 24.3 t-20 -70.84 -46.42 62.76 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.397 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.677 HG22 HG21 ' A' ' 17' ' ' VAL . 67.0 t -55.87 -44.51 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 124.158 0.911 . . . . 0.0 110.85 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -71.93 -30.12 65.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.797 0.439 . . . . 0.0 111.748 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.68 -32.6 74.34 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.809 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 10.3 mmpt? -71.36 -35.21 71.04 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.526 0.516 . . . . 0.0 110.607 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.28 -46.04 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 122.877 0.471 . . . . 0.0 110.47 169.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -65.87 -23.3 66.63 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.3 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.08 -31.03 27.53 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.163 0.985 . . . . 0.0 111.327 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.1 mmtt -91.85 -70.43 0.69 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.621 0.368 . . . . 0.0 110.95 -174.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -86.72 -24.33 25.2 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.724 0.41 . . . . 0.0 111.236 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.48 35.71 8.47 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.436 0.46 . . . . 0.0 112.777 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -111.75 126.11 29.11 Favored Pre-proline 0 CA--C 1.556 1.188 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.49 151.49 79.86 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.221 2.614 . . . . 0.0 112.766 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.26 -13.94 26.82 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.137 3.225 . . . . 0.0 114.25 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.42 -43.66 39.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.377 0.671 . . . . 0.0 110.183 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.46 -35.59 30.37 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.629 0.772 . . . . 0.0 111.124 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.48 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.3 pp0? -88.76 148.73 23.79 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.813 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 39.8 ttt180 -135.47 130.96 35.52 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.333 0.653 . . . . 0.0 109.432 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.02 122.69 37.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.498 0.719 . . . . 0.0 110.232 -174.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -141.42 117.74 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.671 0.789 . . . . 0.0 110.027 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.52 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 88.5 t80 -117.38 126.98 53.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.307 1.043 . . . . 0.0 108.644 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.24 23.03 13.29 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.008 0.923 . . . . 0.0 112.691 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.79 1.64 65.5 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 114.274 0.47 . . . . 0.0 114.274 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.5 ptpt -112.56 145.81 39.66 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -80.76 140.97 35.22 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.513 HD21 ' HB3' ' A' ' 45' ' ' PHE . 19.8 mt -94.11 122.91 37.12 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.143 0.577 . . . . 0.0 110.538 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.49 140.31 29.66 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.346 1.058 . . . . 0.0 110.186 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.54 -52.04 56.78 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.57 1.548 . . . . 0.0 113.251 -173.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.67 -20.36 70.07 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 124.573 1.171 . . . . 0.0 113.922 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 -82.75 177.33 8.72 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.016 0.526 . . . . 0.0 110.681 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.8 p -116.82 168.79 9.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.317 0.647 . . . . 0.0 109.877 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 98.1 mt -57.21 -52.07 66.79 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -62.75 -25.16 68.06 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.302 1.041 . . . . 0.0 111.445 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.82 -40.95 96.02 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -91.16 17.03 8.68 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.153 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 69.54 17.16 8.01 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.578 1.151 . . . . 0.0 112.215 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.9 mt -87.52 139.78 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -137.6 -167.85 2.21 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -55.66 142.39 34.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.234 0.614 . . . . 0.0 112.031 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 56.24 14.62 1.6 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.248 1.419 . . . . 0.0 114.157 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 m -75.72 132.84 40.77 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.1 m -97.2 124.76 41.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.361 0.6 . . . . 0.0 110.012 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.52 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -127.42 174.67 8.82 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.178 1.391 . . . . 0.0 108.507 176.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -109.08 146.67 33.63 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.505 0.722 . . . . 0.0 111.102 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.622 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -122.28 125.71 46.59 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.813 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 79.5 t -105.26 124.27 59.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 123.62 0.768 . . . . 0.0 110.009 -175.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.556 ' HB3' HD23 ' A' ' 73' ' ' LEU . 83.1 mt -96.64 115.37 27.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.101 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -85.81 -46.06 11.01 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 169.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 71' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 125.42 1.488 . . . . 0.0 113.511 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 12.2 mptt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 202' ' ' VAL . . . . . 0.402 HG23 HG13 ' B' ' 216' ' ' ILE . 2.9 m -146.59 152.56 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.841 1.256 . . . . 0.0 109.58 -171.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -90.67 146.78 23.74 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.121 0.568 . . . . 0.0 111.584 -173.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.658 ' HA ' HD11 ' B' ' 216' ' ' ILE . 37.4 t -88.69 97.91 0.98 Allowed Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.716 1.206 . . . . 0.0 108.184 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.608 ' HD2' HD21 ' B' ' 220' ' ' LEU . 33.2 Cg_endo -59.62 -14.96 28.56 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.37 2.713 . . . . 0.0 114.777 -168.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 33.4 t -84.37 -46.88 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 122.686 0.395 . . . . 0.0 111.245 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 207' ' ' CYS . . . . . 0.428 ' SG ' HG22 ' B' ' 209' ' ' VAL . 20.5 p -111.56 -3.36 15.14 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.93 42.75 84.92 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 209' ' ' VAL . . . . . 0.428 HG22 ' SG ' ' B' ' 207' ' ' CYS . 22.8 m -117.86 133.43 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 117.448 0.624 . . . . 0.0 110.418 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -86.63 121.88 29.76 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' B' ' 204' ' ' CYS . 5.9 pt -146.6 162.87 32.29 Favored Pre-proline 0 N--CA 1.484 1.264 0 C-N-CA 124.878 1.271 . . . . 0.0 110.673 -169.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -58.33 161.58 13.77 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.678 2.252 . . . . 0.0 113.505 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.569 ' O ' HG22 ' B' ' 216' ' ' ILE . 33.8 tt0 -65.62 -42.56 91.41 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.079 1.351 . . . . 0.0 112.788 -169.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 21.2 m -72.24 -35.89 68.95 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.623 -0.673 . . . . 0.0 110.432 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -74.5 -22.0 59.28 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.331 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.4 OUTLIER -69.09 -47.17 76.45 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -62.4 -39.2 92.46 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 123.77 0.669 . . . . 0.0 110.862 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -70.65 -42.91 70.2 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.104 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -36.69 84.08 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.608 HD21 ' HD2' ' B' ' 205' ' ' PRO . 87.3 mt -69.74 -42.46 73.89 Favored 'General case' 0 C--O 1.21 -0.995 0 O-C-N 124.321 1.013 . . . . 0.0 111.138 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -58.21 -25.54 61.76 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.505 1.128 . . . . 0.0 110.682 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 30.5 t -89.8 -44.08 10.21 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.056 170.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.8 m -70.19 -20.46 63.12 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.327 1.051 . . . . 0.0 113.062 -171.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.491 1.608 0 C-N-CA 122.909 0.484 . . . . 0.0 112.168 -173.564 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' HE3' ' A' ' 63' ' ' LYS . 21.2 mmt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.3 mp0 -95.92 128.56 42.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.693 -172.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.09 147.76 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.793 1.237 . . . . 0.0 108.425 173.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' THR . 31.2 m-85 -103.29 101.58 11.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.283 0.633 . . . . 0.0 109.778 -172.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 69' ' ' LEU . 11.5 t -96.99 117.93 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -108.28 124.94 51.08 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.442 0.697 . . . . 0.0 109.445 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.597 HG22 HD12 ' A' ' 69' ' ' LEU . 35.3 p -73.16 167.24 21.57 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.489 0.661 . . . . 0.0 111.314 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.456 HD11 HG22 ' A' ' 70' ' ' VAL . 43.2 mt -68.81 -24.05 64.34 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.79 172.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p -78.69 -14.24 59.4 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.6 0.76 . . . . 0.0 110.758 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.99 18.9 32.68 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.033 0.373 . . . . 0.0 114.033 170.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.17 153.16 18.8 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 m -102.0 145.9 28.63 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.042 0.449 . . . . 0.0 110.053 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.537 HD11 HG23 ' A' ' 7' ' ' THR . 5.3 mp -128.88 108.68 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 m -87.91 115.44 25.38 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -103.35 152.2 21.86 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -128.29 79.42 1.9 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -171.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.645 HG21 HG22 ' A' ' 26' ' ' VAL . 30.0 m -146.07 179.02 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.673 1.189 . . . . 0.0 109.081 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -85.31 153.12 59.01 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.2 Cg_endo -59.09 -32.82 98.02 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 121.827 1.685 . . . . 0.0 110.85 164.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -91.96 8.88 35.49 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.018 0.927 . . . . 0.0 111.479 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -74.46 -92.3 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.342 0.657 . . . . 0.0 110.074 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 26' ' ' VAL . 8.9 t 177.08 145.5 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.48 1.112 . . . . 0.0 109.84 171.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.75 -34.25 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.177 0.991 . . . . 0.0 110.684 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.68 -40.77 66.24 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.953 0.901 . . . . 0.0 110.66 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.477 ' H ' HG23 ' A' ' 22' ' ' THR . 10.5 t-20 -77.31 -43.39 33.27 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.031 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.645 HG22 HG21 ' A' ' 17' ' ' VAL . 99.4 t -56.86 -44.25 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 124.361 1.038 . . . . 0.0 110.442 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HB2' ' OE1' ' A' ' 41' ' ' GLN . 16.6 ptpt -71.78 -32.58 67.8 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.947 0.499 . . . . 0.0 110.609 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.09 -28.41 68.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.858 0.463 . . . . 0.0 111.164 169.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 9.8 mmpt? -72.78 -37.06 67.73 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 122.9 0.48 . . . . 0.0 110.247 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.442 HG13 HG21 ' A' ' 13' ' ' ILE . 2.2 mp -58.53 -42.58 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 118.413 0.551 . . . . 0.0 109.838 172.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.05 -27.98 69.77 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.326 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.33 -27.87 47.21 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.614 0.766 . . . . 0.0 111.622 174.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.3 mmtt -95.69 -68.02 0.82 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.986 -0.446 . . . . 0.0 111.025 -174.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 30' ' ' ILE . 15.1 pt-20 -85.51 -20.09 30.2 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.703 0.229 . . . . 0.0 111.549 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 24.76 35.68 Favored Glycine 0 C--N 1.347 1.17 0 O-C-N 122.946 0.154 . . . . 0.0 113.231 171.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.47 127.44 27.83 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.8 151.69 74.17 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.975 2.45 . . . . 0.0 112.486 -174.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 18.6 Cg_endo -57.43 -14.1 15.27 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.976 3.117 . . . . 0.0 114.782 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.21 -44.64 68.23 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 123.486 0.492 . . . . 0.0 110.202 172.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -86.11 -35.65 20.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.022 0.929 . . . . 0.0 111.882 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.715 HE21 HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -94.16 120.29 34.19 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.014 0.435 . . . . 0.0 109.849 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.604 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.1 ttt180 -106.86 128.7 54.51 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.048 0.939 . . . . 0.0 109.544 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.496 HD21 HE22 ' A' ' 41' ' ' GLN . 4.6 mm? -94.09 127.76 40.09 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.837 0.855 . . . . 0.0 109.653 -174.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -141.54 131.54 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.676 0.79 . . . . 0.0 110.199 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.577 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 74.2 t80 -136.79 128.4 28.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.68 21.79 11.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.512 1.125 . . . . 0.0 112.164 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.66 -0.03 73.18 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.446 -0.641 . . . . 0.0 114.047 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.7 ptpt -112.42 151.51 29.76 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 117.711 0.755 . . . . 0.0 110.394 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' HD22 ' B' ' 224' ' ' LEU . 29.5 tt0 -77.32 133.04 38.88 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.171 0.589 . . . . 0.0 110.343 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 45' ' ' PHE . 24.2 mt -85.95 120.47 27.38 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 122.764 0.426 . . . . 0.0 110.258 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.74 136.1 36.68 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 123.731 0.813 . . . . 0.0 109.102 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.42 -38.08 82.9 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.142 0.902 . . . . 0.0 111.591 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.61 -38.52 96.53 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.844 0.715 . . . . 0.0 112.867 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -75.07 177.57 6.3 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.733 0.813 . . . . 0.0 112.034 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.7 p -110.43 167.52 10.15 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.66 0.784 . . . . 0.0 110.093 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.1 mt -55.78 -51.4 67.57 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 t -63.19 -24.02 67.69 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.47 1.108 . . . . 0.0 111.771 -175.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.13 -31.65 66.2 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.182 0.515 . . . . 0.0 109.909 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -94.53 17.5 13.08 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.626 0.77 . . . . 0.0 111.747 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 68.75 16.65 8.92 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.447 1.099 . . . . 0.0 112.038 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.6 mt -88.05 119.48 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -99.36 179.77 4.47 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HE3' ' SD ' ' A' ' 1' ' ' MET . 8.7 ptmm? -60.3 142.78 54.2 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 170.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 68.33 9.5 7.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.918 1.287 . . . . 0.0 113.424 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -70.73 137.59 49.81 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 26.2 m -97.88 126.14 43.11 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.577 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -133.11 172.58 12.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.569 1.147 . . . . 0.0 108.854 -178.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -101.48 154.86 18.46 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.522 0.677 . . . . 0.0 111.68 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.715 HD21 HE21 ' A' ' 41' ' ' GLN . 2.2 tm? -135.88 132.81 37.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.206 -1.361 . . . . 0.0 107.936 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 99.5 t -117.0 124.04 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.929 0.892 . . . . 0.0 110.575 -175.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.434 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 86.5 mt -92.49 120.71 33.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.095 0.558 . . . . 0.0 109.685 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -90.72 -37.21 13.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.095 0.958 . . . . 0.0 109.612 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.434 ' HG ' ' HB3' ' A' ' 71' ' ' LEU . 92.8 mt . . . . . 0 N--CA 1.487 1.379 0 C-N-CA 125.357 1.463 . . . . 0.0 113.154 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.0 m -141.38 -176.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.388 1.075 . . . . 0.0 109.48 -170.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -123.67 143.37 50.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.283 0.633 . . . . 0.0 110.042 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.628 ' HA ' HD11 ' B' ' 216' ' ' ILE . 49.7 t -84.66 97.85 0.55 Allowed Pre-proline 0 N--CA 1.478 0.943 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.576 ' HD2' HD21 ' B' ' 220' ' ' LEU . 27.4 Cg_endo -57.57 -25.57 67.82 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 123.332 2.688 . . . . 0.0 113.563 -171.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.59 -52.39 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 O-C-N 123.692 0.62 . . . . 0.0 111.275 -172.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.2 p -107.41 -4.01 18.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.53 45.82 35.04 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 115.18 0.832 . . . . 0.0 115.18 169.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 34.5 m -119.82 139.44 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.536 0.734 . . . . 0.0 110.677 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -89.28 115.83 27.05 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.502 HD11 ' HB2' ' B' ' 204' ' ' CYS . 12.3 pt -145.14 156.16 54.59 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.939 1.296 . . . . 0.0 109.815 -171.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.95 165.45 23.74 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.852 2.368 . . . . 0.0 113.946 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.6 ' O ' HG22 ' B' ' 216' ' ' ILE . 32.9 tt0 -56.79 -47.02 81.14 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 126.376 1.87 . . . . 0.0 114.318 -167.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 14.6 m -69.9 -37.87 76.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.13 -0.981 . . . . 0.0 110.391 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -67.16 -31.43 71.85 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.949 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.628 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -69.66 -46.46 75.0 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -176.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.47 -43.43 98.87 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.55 0.531 . . . . 0.0 110.73 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -59.91 -51.58 69.09 Favored 'General case' 0 C--O 1.253 1.245 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.487 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -41.7 79.84 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.864 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 70' ' ' VAL . 96.7 mt -58.92 -53.86 53.62 Favored 'General case' 0 C--O 1.202 -1.398 0 O-C-N 124.399 1.062 . . . . 0.0 111.075 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.52 -30.18 60.22 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.767 1.292 . . . . 0.0 111.43 -171.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.8 t -83.44 -45.02 14.13 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.317 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 88.0 m -68.94 -29.02 67.17 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.63 1.172 . . . . 0.0 112.642 -173.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.2 pp . . . . . 0 N--CA 1.483 1.185 0 C-N-CA 123.6 0.76 . . . . 0.0 109.936 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -120.5 142.95 48.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.737 0.415 . . . . 0.0 110.744 176.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -132.29 155.15 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.702 1.201 . . . . 0.0 109.385 175.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' THR . 92.2 m-85 -112.99 108.45 17.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.694 0.797 . . . . 0.0 109.648 -174.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' A' ' 69' ' ' LEU . 69.6 t -105.86 119.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -106.87 125.66 51.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.806 0.842 . . . . 0.0 110.281 -171.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.703 HG22 HD12 ' A' ' 69' ' ' LEU . 77.2 p -76.45 168.61 19.77 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.367 0.531 . . . . 0.0 111.793 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.5 mt -70.62 -22.93 62.47 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.256 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -80.18 -5.6 56.35 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.277 0.631 . . . . 0.0 111.056 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.78 20.65 46.33 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.352 -0.385 . . . . 0.0 113.999 167.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.14 153.21 18.23 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.5 m -104.11 134.37 47.49 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.239 0.616 . . . . 0.0 110.791 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 7' ' ' THR . 5.3 mp -118.61 109.59 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.326 1.05 . . . . 0.0 108.44 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.0 m -91.21 119.26 31.15 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.136 0.575 . . . . 0.0 109.494 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.9 mm? -104.98 155.73 18.68 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.446 0.698 . . . . 0.0 109.631 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -121.9 72.55 1.03 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.957 0.903 . . . . 0.0 108.695 -174.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.81 HG21 HG22 ' A' ' 26' ' ' VAL . 31.3 m -138.57 -176.23 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.945 0.898 . . . . 0.0 109.382 -174.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -108.43 158.03 34.93 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 122.966 0.506 . . . . 0.0 110.592 -172.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 38.0 Cg_endo -63.18 -28.15 73.19 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.504 2.136 . . . . 0.0 111.925 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 t -109.14 25.21 12.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.508 0.723 . . . . 0.0 109.633 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.02 -99.71 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.267 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 26' ' ' VAL . 10.1 t 173.55 140.44 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.275 1.43 . . . . 0.0 108.812 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mm -58.67 -37.43 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.583 1.153 . . . . 0.0 111.984 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 43.5 tt0 -58.32 -38.22 76.68 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.508 0.723 . . . . 0.0 111.062 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.509 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 9.7 t30 -74.06 -41.92 61.0 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.043 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.81 HG22 HG21 ' A' ' 17' ' ' VAL . 48.5 t -58.74 -45.71 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 124.231 0.957 . . . . 0.0 110.623 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 30' ' ' ILE . 18.4 ptpt -73.92 -27.49 61.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.271 0.628 . . . . 0.0 111.602 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.94 79.16 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.397 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 67.9 mmtt -74.12 -27.52 60.9 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.753 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 27' ' ' LYS . 91.9 mt -67.0 -36.09 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 120.999 0.428 . . . . 0.0 110.028 175.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -65.39 -33.62 76.38 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.657 169.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.44 -23.01 62.65 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.435 0.694 . . . . 0.0 111.581 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 73.0 mmtt -98.66 -67.66 0.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.92 0.327 . . . . 0.0 110.984 -177.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.09 -24.37 30.38 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.03 7.82 55.95 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 120.013 -0.326 . . . . 0.0 113.846 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.22 124.92 43.28 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 73.3 Cg_endo -68.33 154.7 71.48 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.232 2.621 . . . . 0.0 112.773 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 13.7 Cg_endo -53.99 -15.66 7.8 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.961 3.107 . . . . 0.0 114.134 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.45 -41.96 37.79 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.852 0.861 . . . . 0.0 110.702 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -92.43 -19.02 22.47 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.91 0.884 . . . . 0.0 113.071 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.483 HE22 ' HB2' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -103.14 149.73 24.34 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 173.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.488 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 38.5 ttt180 -134.68 129.99 35.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.26 0.624 . . . . 0.0 109.723 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.451 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.6 mm? -95.48 123.66 39.13 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.583 0.753 . . . . 0.0 110.549 -172.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.6 mt -141.93 124.71 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.672 0.789 . . . . 0.0 109.873 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 87.0 t80 -124.79 123.01 39.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.332 1.053 . . . . 0.0 108.191 175.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.02 25.92 15.19 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.837 0.855 . . . . 0.0 112.461 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.36 -21.5 45.16 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 122.956 0.313 . . . . 0.0 113.671 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 5.1 ptpt -91.11 134.47 34.49 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 117.362 0.581 . . . . 0.0 109.603 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.7 139.65 39.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 43' ' ' LEU . 24.3 mt -92.07 121.77 33.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.945 0.498 . . . . 0.0 110.96 -171.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.24 138.02 38.41 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.471 1.108 . . . . 0.0 109.973 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.0 m-20 -61.59 -42.49 98.94 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.3 1.04 . . . . 0.0 112.042 -172.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.84 -25.55 75.16 Favored Glycine 0 C--N 1.343 0.941 0 O-C-N 124.184 0.927 . . . . 0.0 113.467 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -78.86 177.24 8.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.997 0.519 . . . . 0.0 111.973 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.5 p -114.68 167.11 11.04 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.979 0.912 . . . . 0.0 110.228 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 87.9 mt -55.58 -56.23 22.77 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.704 0.628 . . . . 0.0 110.518 176.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 31.1 t -65.48 -18.35 65.25 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.981 0.912 . . . . 0.0 112.013 -174.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.0 -46.01 83.21 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.485 0.66 . . . . 0.0 109.34 173.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -86.21 18.66 3.02 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.094 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m120 70.54 18.61 6.46 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.422 1.089 . . . . 0.0 111.802 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.4 mt -92.57 110.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -98.71 -174.7 2.86 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -65.14 135.59 55.68 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.95 0.405 . . . . 0.0 110.514 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 68.75 17.21 8.87 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.241 1.416 . . . . 0.0 111.811 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -72.27 139.08 47.88 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 168.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 41.1 m -101.36 128.38 47.56 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.531 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -133.48 168.09 19.26 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.27 1.028 . . . . 0.0 109.044 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -93.87 153.02 18.48 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.496 0.718 . . . . 0.0 111.406 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -134.21 129.45 35.75 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.587 HG21 HD11 ' B' ' 220' ' ' LEU . 95.4 t -112.09 117.56 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 123.424 0.69 . . . . 0.0 109.76 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.94 150.88 28.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.332 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -121.62 -49.86 2.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.816 0.847 . . . . 0.0 109.599 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.49 1.525 0 C-N-CA 124.664 1.185 . . . . 0.0 112.017 -177.115 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 9.7 m -140.74 -176.73 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.063 1.345 . . . . 0.0 108.858 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -120.21 147.03 45.46 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.652 0.381 . . . . 0.0 110.244 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.631 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.5 t -86.87 101.34 2.05 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.995 0.918 . . . . 0.0 109.087 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.503 ' HD2' HD21 ' B' ' 220' ' ' LEU . 96.6 Cg_endo -72.13 11.4 0.74 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.834 2.356 . . . . 0.0 115.126 -166.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 19.5 t -103.54 -52.78 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.562 0.745 . . . . 0.0 110.24 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.9 p -106.87 -6.3 17.74 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.126 0.57 . . . . 0.0 111.628 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 59.79 59.19 10.95 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 124.467 1.032 . . . . 0.0 115.405 176.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.89 134.78 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.228 0.611 . . . . 0.0 110.007 173.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -76.87 120.49 22.07 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.573 HD11 ' HB2' ' B' ' 204' ' ' CYS . 5.4 pt -148.97 162.15 30.17 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 125.443 1.497 . . . . 0.0 109.112 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -65.85 161.19 40.36 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.545 2.164 . . . . 0.0 112.184 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.502 ' O ' HG22 ' B' ' 216' ' ' ILE . 41.2 tt0 -65.47 -28.23 69.06 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.268 1.027 . . . . 0.0 112.063 -174.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 39.5 t -67.88 -46.36 71.91 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.381 0.61 . . . . 0.0 110.38 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -80.87 -14.44 58.02 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.643 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.631 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.9 -42.94 53.37 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -58.2 7.47 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 124.134 0.896 . . . . 0.0 109.111 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -57.69 -44.73 86.04 Favored 'General case' 0 C--O 1.255 1.364 0 O-C-N 124.456 1.098 . . . . 0.0 111.069 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -39.4 83.47 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.388 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 70' ' ' VAL . 88.9 mt -69.8 -36.45 75.7 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 124.029 0.831 . . . . 0.0 111.72 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -57.02 -33.64 67.37 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.799 0.687 . . . . 0.0 110.513 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.8 t -86.28 -38.05 17.93 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.402 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 65.4 m -81.33 -19.63 42.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.82 0.848 . . . . 0.0 112.986 -169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.487 1.404 0 C-N-CA 122.598 0.359 . . . . 0.0 110.564 -178.56 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.973 0.415 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.5 mp0 -109.65 144.35 38.13 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.649 0.78 . . . . 0.0 109.856 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.48 149.61 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.881 0.873 . . . . 0.0 109.154 169.682 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 66' ' ' THR . 64.4 m-85 -106.25 100.16 9.71 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.24 -173.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 69' ' ' LEU . 79.0 t -97.2 114.69 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -101.11 122.16 43.1 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.55 1.14 . . . . 0.0 110.337 -172.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.679 HG22 HD12 ' A' ' 69' ' ' LEU . 51.5 p -71.07 162.47 29.37 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.669 0.668 . . . . 0.0 111.069 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.517 HD11 HG22 ' A' ' 70' ' ' VAL . 84.1 mt -70.73 -20.24 62.67 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.047 171.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -80.34 -5.4 56.29 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.504 0.722 . . . . 0.0 111.206 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.47 15.28 51.1 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 114.457 0.543 . . . . 0.0 114.457 166.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.32 152.22 18.58 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.4 m -100.6 141.45 33.45 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.503 HD11 HG23 ' A' ' 7' ' ' THR . 5.4 mp -123.31 116.34 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.309 1.043 . . . . 0.0 108.297 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -101.38 117.16 34.4 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.518 0.727 . . . . 0.0 109.594 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -104.62 151.47 23.62 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.665 0.786 . . . . 0.0 109.515 -175.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -108.94 76.95 1.04 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 124.095 0.872 . . . . 0.0 109.338 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.719 HG21 HG22 ' A' ' 26' ' ' VAL . 3.6 m -140.7 170.38 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.429 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 15.9 mt-10 -91.8 157.88 40.88 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.491 0.716 . . . . 0.0 109.185 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 25.1 Cg_endo -61.24 -29.37 86.36 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.539 1.493 . . . . 0.0 111.206 168.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 t -99.28 19.86 14.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.731 0.812 . . . . 0.0 110.583 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 10.8 t70 -80.73 -94.74 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.2 t 177.05 143.87 0.09 Allowed 'General case' 0 C--N 1.364 1.238 0 C-N-CA 124.889 1.276 . . . . 0.0 109.734 173.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.415 HG22 ' HE3' ' A' ' 27' ' ' LYS . 47.8 mm -61.62 -38.01 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.539 1.136 . . . . 0.0 111.298 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -52.92 -40.45 63.59 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.968 0.907 . . . . 0.0 111.013 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.2 t-20 -72.72 -44.71 61.35 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.116 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.719 HG22 HG21 ' A' ' 17' ' ' VAL . 53.1 t -54.91 -47.68 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 124.479 1.112 . . . . 0.0 111.086 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 17.7 ptpt -69.88 -34.06 73.05 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 122.879 0.472 . . . . 0.0 111.552 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -25.1 65.2 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.888 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 8.8 mmpt? -77.69 -32.35 52.97 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.58 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.472 HG13 HG21 ' A' ' 13' ' ' ILE . 1.9 mp -57.01 -43.13 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 119.078 0.854 . . . . 0.0 109.967 169.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -62.42 -30.67 71.39 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.635 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -73.76 -29.61 62.31 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.582 0.753 . . . . 0.0 111.833 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 69.8 mmtt -95.23 -67.98 0.82 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.38 -23.87 32.25 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.248 0.219 . . . . 0.0 110.923 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.6 40.8 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.195 174.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.53 125.08 35.02 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 72.5 Cg_endo -70.4 158.39 56.25 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.205 2.603 . . . . 0.0 112.698 -173.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HA ' HE21 ' A' ' 41' ' ' GLN . 18.8 Cg_endo -57.0 -16.27 20.16 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 123.804 3.003 . . . . 0.0 114.052 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.439 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 23.0 t70 -74.46 -28.07 60.87 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.874 0.87 . . . . 0.0 110.797 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -108.13 -17.59 13.99 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.823 1.249 . . . . 0.0 113.244 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB2' HD21 ' A' ' 69' ' ' LEU . 1.1 pp0? -110.56 155.6 22.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.019 0.528 . . . . 0.0 110.218 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.469 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 41.7 ttt180 -139.54 125.0 19.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.94 0.496 . . . . 0.0 110.234 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.69 124.24 37.55 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.517 0.727 . . . . 0.0 110.032 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -142.45 130.56 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.152 0.981 . . . . 0.0 109.526 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.528 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 89.8 t80 -128.56 135.37 49.28 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 171.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.62 16.7 10.47 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.18 0.992 . . . . 0.0 112.378 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.23 21.82 58.09 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.234 0.334 . . . . 0.0 113.846 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 11.4 ptpt -130.8 145.27 51.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.29 0.636 . . . . 0.0 109.352 174.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -74.58 140.13 44.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.815 0.446 . . . . 0.0 110.104 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 45' ' ' PHE . 27.4 mt -91.6 125.05 36.19 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.205 0.602 . . . . 0.0 110.647 -176.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.41 138.46 32.83 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.826 0.85 . . . . 0.0 110.309 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.65 -46.56 84.05 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.653 1.181 . . . . 0.0 112.387 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.7 -26.41 72.04 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 124.142 0.902 . . . . 0.0 113.641 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.401 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 55.9 mtt180 -77.54 177.09 8.32 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.303 0.641 . . . . 0.0 111.582 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.7 p -116.1 169.07 9.55 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.652 0.781 . . . . 0.0 109.777 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.497 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.0 mt -55.99 -53.07 61.36 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.698 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 t -61.34 -24.89 66.78 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.567 1.147 . . . . 0.0 111.648 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 12.4 t70 -65.7 -41.83 91.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -91.47 20.77 5.03 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.812 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 72.6 8.01 5.61 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 124.745 1.218 . . . . 0.0 112.789 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 10.6 mt -84.61 116.91 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -106.48 -172.15 2.03 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -58.71 146.95 34.73 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.105 0.479 . . . . 0.0 110.557 172.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 62.9 5.57 1.86 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.636 1.574 . . . . 0.0 113.711 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.6 m -70.6 143.71 51.43 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 118.664 0.665 . . . . 0.0 111.198 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 27.2 m -108.54 134.3 51.49 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.15 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.517 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -144.77 173.13 12.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.988 1.315 . . . . 0.0 108.536 -176.528 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -102.97 153.43 20.23 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.701 0.762 . . . . 0.0 112.677 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.679 HD12 HG22 ' A' ' 7' ' ' THR . 2.3 tm? -130.52 126.07 35.9 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.517 HG22 HD11 ' A' ' 8' ' ' LEU . 73.8 t -110.79 124.61 67.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 123.275 0.63 . . . . 0.0 109.742 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -85.42 147.13 26.64 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.681 0.792 . . . . 0.0 110.355 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 39' ' ' ASP . 40.1 mtt180 -122.33 -44.18 2.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.703 0.801 . . . . 0.0 110.451 -173.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.487 1.423 0 C-N-CA 124.733 1.213 . . . . 0.0 112.081 -179.273 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 202' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 3.4 m -140.58 151.58 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.144 1.378 . . . . 0.0 110.047 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 203' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' B' ' 210' ' ' ASN . 4.8 m-20 -78.89 147.19 33.19 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.731 -175.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.658 ' HA ' HD11 ' B' ' 216' ' ' ILE . 24.8 t -89.77 98.33 1.3 Allowed Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.519 ' HD2' HD13 ' B' ' 220' ' ' LEU . 74.1 Cg_endo -68.45 9.01 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.521 2.814 . . . . 0.0 115.887 -163.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 206' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' B' ' 223' ' ' CYS . 29.9 t -104.61 -48.62 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 122.833 0.453 . . . . 0.0 110.654 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 207' ' ' CYS . . . . . 0.484 ' SG ' HG22 ' B' ' 209' ' ' VAL . 18.0 p -107.48 -7.95 16.4 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.901 0.48 . . . . 0.0 112.185 -173.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.63 41.55 64.66 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 209' ' ' VAL . . . . . 0.484 HG22 ' SG ' ' B' ' 207' ' ' CYS . 27.9 m -118.62 132.83 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 117.647 0.724 . . . . 0.0 110.072 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 210' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' B' ' 203' ' ' ASP . 25.3 t-20 -86.23 126.49 34.31 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 4.9 pt -148.92 159.45 37.54 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 125.865 1.666 . . . . 0.0 108.991 -169.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.473 ' HG2' ' HB2' ' B' ' 215' ' ' HIS . 17.8 Cg_endo -58.74 156.25 33.48 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.41 2.073 . . . . 0.0 111.964 174.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.54 ' O ' HG22 ' B' ' 216' ' ' ILE . 26.7 tt0 -66.32 -30.21 70.57 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.02 0.928 . . . . 0.0 112.033 -170.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 51.2 p -63.92 -49.98 70.51 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.581 0.705 . . . . 0.0 109.558 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' HIS . . . . . 0.473 ' HB2' ' HG2' ' B' ' 212' ' ' PRO . 47.1 m80 -76.11 -12.2 60.07 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.871 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -72.85 -51.6 26.45 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.274 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -63.87 -31.23 72.34 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.181 0.446 . . . . 0.0 111.727 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -66.13 -63.58 1.05 Allowed 'General case' 0 C--O 1.251 1.178 0 O-C-N 123.885 0.741 . . . . 0.0 111.556 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -43.27 69.79 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.319 1.048 . . . . 0.0 109.863 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.519 HD13 ' HD2' ' B' ' 205' ' ' PRO . 30.7 tp -63.31 -46.04 88.54 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 113.654 -1.612 . . . . 0.0 111.808 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.17 -35.28 64.63 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 124.316 1.01 . . . . 0.0 110.358 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.3 t -79.77 -38.31 33.46 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.995 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' B' ' 206' ' ' VAL . 93.9 m -74.24 -35.11 63.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.448 1.099 . . . . 0.0 112.633 -172.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 224' ' ' LEU . . . . . 0.422 HD23 ' HG ' ' B' ' 220' ' ' LEU . 4.0 pp . . . . . 0 N--CA 1.49 1.557 0 C-N-CA 123.559 0.743 . . . . 0.0 111.846 -168.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.85 0.357 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 17.4 mp0 -90.12 134.43 34.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.929 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.518 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -130.53 157.96 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.126 1.37 . . . . 0.0 108.586 172.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 72.8 m-85 -116.55 120.5 38.91 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.305 0.642 . . . . 0.0 109.783 -173.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 30' ' ' ILE . 68.9 t -109.9 130.89 62.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -118.16 117.02 28.01 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.573 HG23 HD11 ' A' ' 13' ' ' ILE . 43.5 p -70.15 165.68 21.53 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.286 0.565 . . . . 0.0 111.697 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.415 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 57.5 mt -68.92 -22.0 64.18 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.005 173.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.0 p -79.64 -15.89 56.78 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.387 0.675 . . . . 0.0 110.782 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.96 21.21 16.31 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.539 -0.59 . . . . 0.0 114.476 170.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -94.39 153.71 17.83 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.496 0.648 . . . . 0.0 109.599 174.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.9 m -100.53 144.22 29.77 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.324 0.65 . . . . 0.0 109.869 172.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.573 HD11 HG23 ' A' ' 7' ' ' THR . 5.3 mp -128.79 114.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.808 1.243 . . . . 0.0 108.408 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.1 m -99.58 121.85 41.79 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.504 0.722 . . . . 0.0 110.119 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -112.21 153.16 27.5 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -116.43 76.9 1.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 26' ' ' VAL . 20.5 m -140.04 177.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.375 0.67 . . . . 0.0 110.386 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -91.99 157.08 41.74 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 123.642 0.777 . . . . 0.0 109.75 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 24.3 Cg_endo -61.95 -34.68 80.6 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.536 1.491 . . . . 0.0 110.836 165.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -94.13 13.88 21.76 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.1 0.56 . . . . 0.0 110.67 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.42 -96.15 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.393 0.677 . . . . 0.0 110.867 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.1 t 169.52 138.26 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.6 1.56 . . . . 0.0 108.307 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.15 -34.33 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.759 0.824 . . . . 0.0 110.956 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 16.8 tp10 -60.25 -35.42 75.44 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.557 0.694 . . . . 0.0 111.399 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 19.1 t-20 -76.47 -44.04 37.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.923 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.674 HG22 HG21 ' A' ' 17' ' ' VAL . 62.6 t -57.0 -43.88 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 124.316 1.01 . . . . 0.0 110.488 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.544 ' HB2' ' OE1' ' A' ' 41' ' ' GLN . 17.6 ptpt -71.08 -33.89 70.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.261 0.624 . . . . 0.0 110.576 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.63 -31.77 73.04 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.848 171.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 9.7 mmpt? -72.62 -35.49 67.84 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.578 HD11 HG21 ' A' ' 5' ' ' VAL . 1.8 mp -55.65 -43.64 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.486 0.585 . . . . 0.0 110.167 171.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -65.48 -29.26 69.9 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.317 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.1 -25.92 62.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.169 0.588 . . . . 0.0 111.234 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 68.5 mmtt -99.28 -69.03 0.78 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.733 0.242 . . . . 0.0 111.168 -175.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -85.18 -21.2 29.27 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.73 14.1 51.05 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 114.298 0.479 . . . . 0.0 114.298 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.1 127.71 32.69 Favored Pre-proline 0 N--CA 1.481 1.113 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.29 154.27 72.51 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.06 2.507 . . . . 0.0 112.976 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 15.6 Cg_endo -54.64 -14.84 8.09 Favored 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 124.295 3.33 . . . . 0.0 114.94 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -72.36 -48.53 41.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.962 0.505 . . . . 0.0 110.309 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.82 -22.7 23.1 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.968 0.907 . . . . 0.0 113.109 -171.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.694 HE21 HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -101.21 124.64 47.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.816 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 34.1 ttt180 -112.91 130.27 56.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.177 0.991 . . . . 0.0 108.826 -172.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 4.4 mm? -95.03 119.0 32.8 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.44 0.696 . . . . 0.0 110.533 -170.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.7 mt -140.95 127.73 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.562 0.745 . . . . 0.0 109.796 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.686 ' HB3' HD21 ' A' ' 50' ' ' LEU . 75.6 t80 -129.23 126.01 38.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.76 1.224 . . . . 0.0 108.448 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.41 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 61.8 18.45 9.73 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.107 0.963 . . . . 0.0 113.343 173.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.5 5.14 56.99 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.914 -0.381 . . . . 0.0 113.821 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.0 ptpt -118.02 146.98 43.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.367 0.667 . . . . 0.0 109.396 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -80.51 140.61 35.78 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.945 0.498 . . . . 0.0 109.98 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 45' ' ' PHE . 23.5 mt -94.96 114.93 26.82 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 122.931 0.493 . . . . 0.0 110.825 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -77.82 139.07 39.27 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.684 0.793 . . . . 0.0 110.199 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 11.2 p-10 -58.84 -39.54 81.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.522 1.129 . . . . 0.0 112.448 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.25 -18.25 80.06 Favored Glycine 0 C--N 1.354 1.536 0 O-C-N 124.126 0.891 . . . . 0.0 113.351 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HD3' ' OD2' ' A' ' 58' ' ' ASP . 99.6 mtt180 -86.13 177.11 7.64 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.46 0.704 . . . . 0.0 111.275 175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 p -116.19 168.44 10.11 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 123.864 0.865 . . . . 0.0 109.668 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.4 mt -56.23 -49.87 72.91 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 124.195 0.934 . . . . 0.0 109.65 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 35.7 t -63.67 -26.14 68.53 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.541 1.137 . . . . 0.0 111.548 -175.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.418 ' OD2' ' HD3' ' A' ' 54' ' ' ARG . 20.2 t70 -65.18 -41.61 94.42 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 121.544 0.688 . . . . 0.0 109.637 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -89.87 15.07 10.49 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.944 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 71.37 14.85 6.38 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.072 1.349 . . . . 0.0 112.399 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 8.8 mt -86.52 121.68 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -115.01 -172.53 2.14 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -57.44 143.56 39.88 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.293 0.37 . . . . 0.0 110.815 172.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 72.25 1.11 3.82 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.295 1.438 . . . . 0.0 112.31 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -75.62 135.57 40.48 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 118.09 0.404 . . . . 0.0 110.223 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.4 m -99.9 131.23 46.0 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.117 0.484 . . . . 0.0 110.603 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.511 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -124.57 175.7 7.0 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.866 1.266 . . . . 0.0 108.667 174.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -108.68 153.09 23.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.349 0.66 . . . . 0.0 111.423 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.694 HD21 HE21 ' A' ' 41' ' ' GLN . 2.1 tm? -131.21 126.25 35.07 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -175.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.816 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.4 t -105.28 109.2 26.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.802 0.841 . . . . 0.0 109.828 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -81.63 138.96 35.25 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.305 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -113.07 -47.48 3.03 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.898 0.879 . . . . 0.0 110.676 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.492 1.66 0 C-N-CA 123.939 0.896 . . . . 0.0 112.131 -178.176 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' B' ' 201' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.628 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 202' ' ' VAL . . . . . 0.665 HG23 HG13 ' B' ' 216' ' ' ILE . 0.9 OUTLIER -147.61 146.18 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.033 0.933 . . . . 0.0 111.036 -162.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -74.2 147.73 42.26 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.383 0.673 . . . . 0.0 111.492 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.457 ' HA ' HD11 ' B' ' 216' ' ' ILE . 20.0 t -91.7 97.59 1.51 Allowed Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.166 0.986 . . . . 0.0 108.902 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.453 ' HD2' HD11 ' B' ' 220' ' ' LEU . 32.3 Cg_endo -58.52 -5.45 2.41 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.679 2.919 . . . . 0.0 116.364 -166.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 206' ' ' VAL . . . . . 0.427 HG11 ' O ' ' B' ' 223' ' ' CYS . 41.0 t -94.67 -57.48 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 173.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 207' ' ' CYS . . . . . 0.505 ' SG ' HG22 ' B' ' 209' ' ' VAL . 11.7 p -106.12 9.45 32.31 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.56 -37.55 2.78 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.865 1.106 . . . . 0.0 115.865 171.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 209' ' ' VAL . . . . . 0.505 HG22 ' SG ' ' B' ' 207' ' ' CYS . 20.6 m -60.2 134.73 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -165.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -84.7 125.35 32.44 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.699 HG13 HG12 ' B' ' 216' ' ' ILE . 5.2 pt -148.56 156.08 41.98 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.464 1.506 . . . . 0.0 109.166 -171.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.04 151.55 77.61 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.698 2.266 . . . . 0.0 112.196 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.457 ' HA ' ' HB ' ' B' ' 216' ' ' ILE . 3.9 tm-20 -58.53 -43.65 89.3 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -166.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 27.1 t -65.71 -36.75 84.5 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.583 -0.698 . . . . 0.0 110.381 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -82.43 -11.47 58.51 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.107 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.699 HG12 HG13 ' B' ' 211' ' ' ILE . 0.4 OUTLIER -68.8 -45.94 80.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 172.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -74.21 -30.36 62.16 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.519 0.512 . . . . 0.0 111.974 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -68.4 -50.72 50.87 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.31 0.381 . . . . 0.0 110.888 172.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.13 -45.37 83.56 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.08 0.552 . . . . 0.0 109.543 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.548 HD13 HG21 ' A' ' 70' ' ' VAL . 60.7 mt -68.96 -34.36 75.21 Favored 'General case' 0 C--O 1.209 -1.078 0 O-C-N 124.528 1.142 . . . . 0.0 112.439 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.57 -31.23 65.94 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.907 0.754 . . . . 0.0 109.882 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 t -91.33 -36.24 13.97 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.782 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 223' ' ' CYS . . . . . 0.53 ' HB2' ' HA ' ' B' ' 220' ' ' LEU . 84.9 m -75.01 -28.25 60.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.675 0.79 . . . . 0.0 112.271 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 123.042 0.537 . . . . 0.0 110.903 -176.956 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 20.7 mp0 -98.48 136.74 38.17 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.723 0.409 . . . . 0.0 110.713 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.4 155.94 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.678 1.191 . . . . 0.0 108.568 173.351 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 66' ' ' THR . 90.2 m-85 -113.53 99.66 7.92 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.277 -170.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.525 HG12 ' HB2' ' A' ' 69' ' ' LEU . 93.6 t -99.45 100.01 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -94.65 123.49 38.12 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.899 0.88 . . . . 0.0 110.737 -171.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.689 HG22 HD12 ' A' ' 69' ' ' LEU . 39.5 p -70.59 166.94 19.58 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.715 0.769 . . . . 0.0 111.922 176.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.13 -19.64 65.65 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.721 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -79.59 -3.85 48.88 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.569 0.747 . . . . 0.0 111.309 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.15 5.78 67.37 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.054 0.359 . . . . 0.0 112.378 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -90.4 137.83 32.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.206 1.003 . . . . 0.0 109.621 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.7 m -107.05 129.1 54.86 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.252 0.621 . . . . 0.0 110.369 -176.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -108.06 113.27 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.024 0.93 . . . . 0.0 109.327 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 m -87.45 117.0 25.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.723 0.809 . . . . 0.0 109.123 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.8 mm? -104.54 160.24 15.1 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.655 0.782 . . . . 0.0 109.022 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.07 80.99 1.99 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.858 0.863 . . . . 0.0 108.795 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.756 HG21 HG22 ' A' ' 26' ' ' VAL . 3.1 m -138.19 175.52 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.612 1.165 . . . . 0.0 108.657 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 12.9 mt-10 -92.28 140.71 24.41 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 9.7 Cg_endo -55.57 -29.1 68.34 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.857 2.372 . . . . 0.0 112.038 167.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -92.92 4.19 54.37 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.85 0.86 . . . . 0.0 110.797 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 22.6 t70 -82.27 -87.52 0.09 Allowed 'General case' 0 C--N 1.358 0.955 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.275 -174.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 25' ' ' ASN . 10.0 t 179.02 149.98 0.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.75 0.82 . . . . 0.0 110.956 176.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.28 -34.0 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.754 1.222 . . . . 0.0 110.685 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -58.49 -38.46 77.67 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.068 0.947 . . . . 0.0 109.821 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.6 t30 -71.66 -44.76 63.73 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.078 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.756 HG22 HG21 ' A' ' 17' ' ' VAL . 61.4 t -55.06 -48.17 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 124.437 1.085 . . . . 0.0 110.825 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -69.1 -31.83 70.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.298 0.639 . . . . 0.0 111.429 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.61 74.38 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.797 0.685 . . . . 0.0 111.141 170.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 65.3 mmtt -78.09 -31.57 50.19 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.932 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -58.85 -44.08 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.351 0.978 . . . . 0.0 109.291 170.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.75 -31.28 72.19 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.539 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 8.6 t70 -71.54 -35.21 70.59 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.639 0.776 . . . . 0.0 111.564 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.4 mmtt -88.72 -67.02 0.86 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.575 0.35 . . . . 0.0 110.968 -171.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -88.06 -22.33 24.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.301 0.24 . . . . 0.0 111.512 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.96 12.38 46.64 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.993 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -98.62 122.19 54.06 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -69.82 155.86 64.67 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.524 2.816 . . . . 0.0 113.059 -172.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.94 -13.1 10.8 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 124.482 3.455 . . . . 0.0 114.621 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.21 -47.33 14.81 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -77.64 -27.99 51.18 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.304 0.641 . . . . 0.0 111.286 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.2 pp0? -96.65 147.68 23.64 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.643 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 42.9 ttt180 -137.66 129.25 28.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.2 125.73 36.99 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -173.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.422 HD11 ' HG ' ' B' ' 220' ' ' LEU . 97.6 mt -142.78 131.54 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.911 0.884 . . . . 0.0 110.071 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.559 ' HB3' HD21 ' A' ' 50' ' ' LEU . 86.0 t80 -135.81 128.36 30.63 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 65.45 21.3 11.84 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.834 0.854 . . . . 0.0 111.938 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.56 2.33 82.34 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.448 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 9.9 ptpt -108.99 142.16 40.05 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB2' HD22 ' B' ' 224' ' ' LEU . 9.7 tt0 -76.86 126.47 31.04 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.028 0.531 . . . . 0.0 110.081 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.7 mt -77.83 119.6 21.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.173 0.589 . . . . 0.0 110.352 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.0 138.37 42.18 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.742 0.651 . . . . 0.0 109.562 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.511 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 10.4 p-10 -61.1 -40.03 92.19 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 124.126 0.891 . . . . 0.0 112.037 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.57 -27.24 73.94 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.624 0.578 . . . . 0.0 113.374 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -77.48 176.77 8.58 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.214 0.606 . . . . 0.0 111.919 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.5 p -110.07 167.22 10.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.437 0.695 . . . . 0.0 109.765 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 81.4 mt -58.3 -51.46 69.69 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 56.2 m -59.6 -25.98 65.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.932 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.53 -34.25 73.98 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.074 0.464 . . . . 0.0 110.044 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -92.6 15.94 13.21 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.754 0.822 . . . . 0.0 111.768 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 66.67 30.04 8.43 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.239 1.016 . . . . 0.0 111.639 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -101.16 118.01 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -102.89 -175.99 2.96 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -58.18 141.5 50.33 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.125 171.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 72.49 0.34 3.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.509 1.523 . . . . 0.0 112.669 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.8 m -73.46 137.35 44.47 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 118.236 0.471 . . . . 0.0 110.705 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 15.0 m -95.53 137.04 35.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.875 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.73 174.54 10.41 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.945 1.298 . . . . 0.0 108.454 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -101.76 158.56 16.02 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.849 0.833 . . . . 0.0 112.185 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.689 HD12 HG22 ' A' ' 7' ' ' THR . 2.7 tm? -138.35 125.82 21.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.215 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.643 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 91.0 t -99.93 120.61 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 123.301 0.64 . . . . 0.0 110.224 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 93.0 mt -89.29 140.41 29.52 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.349 1.031 . . . . 0.0 109.883 174.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -119.14 -28.34 5.49 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.002 0.921 . . . . 0.0 111.476 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 71' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.496 1.829 0 C-N-CA 125.657 1.583 . . . . 0.0 113.978 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.8 m -138.01 172.08 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 125.505 1.522 . . . . 0.0 108.441 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.47 146.52 31.64 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 122.373 -0.204 . . . . 0.0 110.624 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.583 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.9 t -83.7 105.72 6.17 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.711 0.805 . . . . 0.0 109.019 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.549 ' HD2' HD11 ' B' ' 220' ' ' LEU . 40.5 Cg_endo -63.12 -1.0 2.52 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 124.087 3.191 . . . . 0.0 115.401 -171.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.95 -51.08 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.377 0.671 . . . . 0.0 111.427 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.9 p -113.88 1.07 14.64 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.009 0.523 . . . . 0.0 111.8 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 56.28 55.3 30.21 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 124.48 1.038 . . . . 0.0 115.195 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.72 127.2 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.166 0.586 . . . . 0.0 109.512 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.96 110.47 15.37 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 8.6 pt -138.6 160.87 61.66 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 125.715 1.606 . . . . 0.0 109.721 -173.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.75 159.77 23.54 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.841 2.361 . . . . 0.0 113.124 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.509 ' O ' HG22 ' B' ' 216' ' ' ILE . 34.4 tt0 -63.14 -33.49 75.58 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.993 1.317 . . . . 0.0 112.686 -172.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.0 t -66.23 -46.35 77.47 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.508 0.67 . . . . 0.0 110.594 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.19 -13.0 57.8 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.891 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.47 -44.82 53.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 174.386 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -55.07 28.44 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 124.502 1.126 . . . . 0.0 109.152 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -61.62 -39.18 90.34 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 124.446 1.091 . . . . 0.0 112.145 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -36.26 80.05 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.297 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.549 HD11 ' HD2' ' B' ' 205' ' ' PRO . 0.0 OUTLIER -63.71 -50.44 69.13 Favored 'General case' 0 C--O 1.21 -1.009 0 O-C-N 123.789 0.681 . . . . 0.0 110.249 177.478 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -54.49 -27.33 37.12 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 123.924 0.765 . . . . 0.0 112.048 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.1 t -89.1 -39.77 13.39 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.589 0.756 . . . . 0.0 111.217 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.55 -18.96 43.12 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.393 1.077 . . . . 0.0 113.511 -171.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 224' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' B' ' 220' ' ' LEU . 4.4 pp . . . . . 0 N--CA 1.494 1.728 0 CA-C-N 118.625 0.648 . . . . 0.0 110.105 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 75.8 mt-30 -119.42 132.63 55.85 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.3 0.64 . . . . 0.0 110.78 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.562 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -128.24 156.4 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.133 1.373 . . . . 0.0 108.951 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 66' ' ' THR . 50.1 m-85 -115.2 112.2 22.13 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.401 0.619 . . . . 0.0 110.073 -173.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.7 t -104.06 120.88 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -111.11 125.11 53.42 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.554 0.741 . . . . 0.0 109.82 -173.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.649 HG22 HD12 ' A' ' 69' ' ' LEU . 66.7 p -78.33 168.81 19.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.303 0.573 . . . . 0.0 112.067 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.43 HD11 HG22 ' A' ' 70' ' ' VAL . 60.7 mt -67.32 -27.68 67.35 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.345 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -79.34 -9.4 59.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.651 0.78 . . . . 0.0 110.987 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.69 22.98 37.58 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 114.17 0.428 . . . . 0.0 114.17 168.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 152.42 18.51 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.7 m -101.54 139.51 37.1 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.121 0.568 . . . . 0.0 109.994 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 7' ' ' THR . 5.2 mp -124.87 105.59 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.443 1.097 . . . . 0.0 108.181 176.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.1 m -86.96 122.97 31.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -105.8 156.29 18.46 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -120.34 69.66 0.87 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.442 1.097 . . . . 0.0 109.023 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.744 HG21 HG22 ' A' ' 26' ' ' VAL . 7.1 m -136.95 175.05 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -90.96 149.8 40.77 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.549 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 12.1 Cg_endo -58.96 -31.71 96.14 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.62 1.546 . . . . 0.0 111.733 164.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 t -97.36 18.09 15.98 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.905 0.482 . . . . 0.0 110.548 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.73 -96.73 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.827 0.851 . . . . 0.0 109.975 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 26' ' ' VAL . 5.2 t 174.36 140.37 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.2 1.4 . . . . 0.0 109.244 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.92 -37.11 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.879 0.871 . . . . 0.0 111.486 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 35.5 tt0 -54.92 -40.54 69.97 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.805 0.812 . . . . 0.0 110.792 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 11.5 t30 -73.54 -43.32 60.19 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.417 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.744 HG22 HG21 ' A' ' 17' ' ' VAL . 60.5 t -55.95 -48.63 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 124.311 1.007 . . . . 0.0 110.6 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.474 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.7 ptpt -68.41 -33.66 74.62 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.014 0.526 . . . . 0.0 111.602 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.64 -33.65 70.3 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.98 170.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 34.7 mmtm -76.64 -31.01 57.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.436 -0.793 . . . . 0.0 112.464 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.8 mp -60.49 -39.63 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 119.682 1.128 . . . . 0.0 109.129 170.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.64 -34.18 77.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.311 0.644 . . . . 0.0 111.207 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.05 -36.55 75.08 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.479 0.712 . . . . 0.0 111.5 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.6 mmtt -88.23 -65.7 0.99 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.83 0.452 . . . . 0.0 111.243 -170.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -84.18 -24.04 30.32 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.923 0.328 . . . . 0.0 111.272 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.0 17.84 31.18 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.173 0.295 . . . . 0.0 113.554 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.82 127.36 27.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.482 0.713 . . . . 0.0 109.36 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 58.8 Cg_endo -67.09 154.53 74.18 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.057 2.504 . . . . 0.0 112.697 -173.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 37.3 Cg_endo -61.14 -13.79 30.0 Favored 'Trans proline' 0 C--N 1.388 2.634 0 C-N-CA 123.666 2.911 . . . . 0.0 113.88 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.96 -32.18 51.3 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.742 0.817 . . . . 0.0 110.703 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -96.53 -18.33 19.88 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.855 1.262 . . . . 0.0 112.437 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.641 ' HB2' HD11 ' A' ' 69' ' ' LEU . 3.5 pp0? -118.96 133.57 55.74 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.165 0.507 . . . . 0.0 110.82 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.644 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 56.1 ttt180 -120.95 128.71 52.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.26 1.024 . . . . 0.0 109.788 -169.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.01 126.98 38.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.697 0.799 . . . . 0.0 109.656 -171.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.7 mt -142.15 132.03 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.292 0.637 . . . . 0.0 109.952 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.563 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 72.4 t80 -137.9 131.58 31.17 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 171.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.12 19.32 10.44 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.031 0.932 . . . . 0.0 112.013 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 6.53 79.57 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.975 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 13.8 ptpt -118.81 145.06 45.93 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.648 0.724 . . . . 0.0 109.998 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.538 ' HB2' HD22 ' B' ' 224' ' ' LEU . 0.4 OUTLIER -77.67 122.91 25.98 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -175.663 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' A' ' 45' ' ' PHE . 27.6 mt -72.11 119.52 16.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.405 0.682 . . . . 0.0 111.187 -175.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -81.54 138.77 35.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.233 1.013 . . . . 0.0 110.288 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 1.7 m-20 -60.22 -43.05 96.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.472 1.109 . . . . 0.0 112.613 -173.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.02 -8.77 74.7 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 124.36 1.037 . . . . 0.0 114.112 -177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 86.0 mtt-85 -95.1 177.33 5.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.99 0.916 . . . . 0.0 111.416 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -114.82 170.65 8.17 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.044 0.938 . . . . 0.0 109.509 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.9 mt -60.28 -52.16 66.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 40.7 m -54.62 -29.47 52.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.189 1.396 . . . . 0.0 112.633 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 12.7 t70 -65.67 -43.57 88.9 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 123.759 0.662 . . . . 0.0 109.761 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -87.93 21.23 2.76 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.916 0.887 . . . . 0.0 111.395 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 70.93 13.57 7.0 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.503 1.121 . . . . 0.0 111.982 176.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 14.6 mt -88.18 118.23 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.695 0.798 . . . . 0.0 109.001 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -102.5 -174.94 2.68 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -58.2 140.52 52.88 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.192 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 70.09 7.45 6.23 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.919 1.288 . . . . 0.0 112.954 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -69.46 135.88 50.78 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 117.901 0.319 . . . . 0.0 110.649 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.5 m -93.99 125.65 38.74 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.432 0.693 . . . . 0.0 109.617 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -127.46 167.92 15.61 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.347 1.059 . . . . 0.0 109.393 177.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -94.63 150.48 20.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.49 0.662 . . . . 0.0 110.93 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.649 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -133.85 126.68 31.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.696 HG21 HD11 ' B' ' 220' ' ' LEU . 69.8 t -101.9 109.07 25.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.441 0.697 . . . . 0.0 110.12 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.518 ' HB3' HD23 ' A' ' 73' ' ' LEU . 67.1 mt -80.73 144.9 31.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.241 173.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -121.08 -48.14 2.24 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.062 0.945 . . . . 0.0 109.249 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 71' ' ' LEU . 4.6 mm? . . . . . 0 N--CA 1.486 1.353 0 C-N-CA 124.678 1.191 . . . . 0.0 112.109 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.89 -176.29 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.919 1.288 . . . . 0.0 109.319 -170.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -113.07 144.26 42.92 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.787 0.435 . . . . 0.0 110.326 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.546 ' HA ' HD11 ' B' ' 216' ' ' ILE . 53.5 t -86.14 98.03 0.71 Allowed Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.489 ' HD2' HD21 ' B' ' 220' ' ' LEU . 20.7 Cg_endo -55.22 -24.67 42.8 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.122 2.548 . . . . 0.0 114.413 -164.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 10.8 t -74.48 -63.42 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 122.861 0.464 . . . . 0.0 110.608 -173.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 22.7 p -91.6 -9.76 42.95 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.025 0.53 . . . . 0.0 111.24 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.92 58.77 12.03 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 124.073 0.844 . . . . 0.0 114.203 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 33.2 m -118.98 135.66 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.586 0.754 . . . . 0.0 109.553 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -83.44 104.81 13.88 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.091 0.472 . . . . 0.0 110.095 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' B' ' 204' ' ' CYS . 15.9 pt -137.01 152.21 73.52 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 125.308 1.443 . . . . 0.0 110.057 -174.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.09 163.36 16.93 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.012 2.475 . . . . 0.0 113.339 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.599 ' O ' HG22 ' B' ' 216' ' ' ILE . 5.6 tm-20 -62.64 -39.93 95.42 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -167.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 52.3 m -65.53 -39.87 92.29 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.7 -1.25 . . . . 0.0 110.295 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 215' ' ' HIS . . . . . 0.414 ' O ' ' HB2' ' B' ' 219' ' ' HIS . 8.0 m80 -68.24 -28.14 66.96 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.815 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.599 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -69.09 -48.41 69.51 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -176.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -67.13 -37.66 84.24 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.472 0.482 . . . . 0.0 111.387 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -42.22 83.53 Favored 'General case' 0 C--O 1.255 1.366 0 O-C-N 123.533 0.521 . . . . 0.0 111.212 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 219' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' B' ' 215' ' ' HIS . 0.1 OUTLIER -59.93 -37.52 79.75 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.41 177.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.696 HD11 HG21 ' A' ' 70' ' ' VAL . 96.7 mt -63.03 -45.39 92.49 Favored 'General case' 0 C--O 1.206 -1.218 0 O-C-N 124.014 0.821 . . . . 0.0 110.935 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -56.53 -28.37 59.86 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.445 0.466 . . . . 0.0 111.516 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.8 t -89.21 -41.18 12.37 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.312 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.2 m -79.04 -28.21 43.21 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.959 0.904 . . . . 0.0 112.971 -167.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 224' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 49' ' ' GLN . 3.7 pp . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 123.383 0.673 . . . . 0.0 109.3 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 mmt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 88.7 mt-30 -120.1 151.57 38.86 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.854 0.462 . . . . 0.0 111.388 172.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -141.13 159.54 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.223 1.409 . . . . 0.0 109.701 177.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' THR . 86.7 m-85 -107.58 109.8 21.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.032 0.933 . . . . 0.0 109.68 -176.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 30' ' ' ILE . 19.4 t -101.51 111.42 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 tptt -110.93 117.15 32.58 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.511 0.725 . . . . 0.0 109.981 -171.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.606 HG22 HD12 ' A' ' 69' ' ' LEU . 80.4 p -69.51 161.29 29.82 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.165 0.507 . . . . 0.0 111.716 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.49 HD11 HG22 ' A' ' 70' ' ' VAL . 87.0 mt -66.36 -17.54 64.83 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.853 175.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -83.16 -26.88 30.5 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.975 0.51 . . . . 0.0 110.714 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.05 9.59 11.91 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.123 0.409 . . . . 0.0 114.123 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 147.35 35.97 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -108.77 139.35 43.71 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.93 106.54 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.7 m -88.97 120.49 30.43 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -105.45 155.63 18.96 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.95 75.48 1.0 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.489 0.716 . . . . 0.0 109.423 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.821 HG21 HG22 ' A' ' 26' ' ' VAL . 11.3 m -137.96 167.38 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.097 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.423 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 2.4 mt-10 -86.74 155.34 56.09 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.156 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.53 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 13.0 Cg_endo -57.48 -35.58 98.83 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 121.968 1.779 . . . . 0.0 111.198 165.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 t -97.66 19.36 13.68 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.027 0.931 . . . . 0.0 110.875 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 15.8 t70 -77.14 -94.82 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.366 0.666 . . . . 0.0 109.692 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 26' ' ' VAL . 10.1 t 176.23 141.14 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.135 1.374 . . . . 0.0 109.57 172.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.567 HG22 ' HE3' ' A' ' 27' ' ' LYS . 45.1 mm -61.63 -37.69 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.527 1.131 . . . . 0.0 111.571 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -50.09 -44.64 52.07 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.239 1.016 . . . . 0.0 110.686 177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 14.2 t-20 -71.78 -43.62 65.39 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.035 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.821 HG22 HG21 ' A' ' 17' ' ' VAL . 60.9 t -54.76 -50.78 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 124.207 0.942 . . . . 0.0 110.953 -177.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HE3' HG22 ' A' ' 23' ' ' ILE . 16.5 ptpt -68.6 -35.56 77.5 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.678 0.391 . . . . 0.0 111.257 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.0 -28.08 68.77 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.118 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 9.5 mmpt? -74.06 -37.42 64.25 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 118.765 -0.635 . . . . 0.0 111.134 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 5' ' ' VAL . 3.5 mp -60.86 -40.4 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-N 118.865 0.757 . . . . 0.0 109.131 173.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.99 -25.65 67.95 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.365 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -81.21 -32.47 33.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.189 0.595 . . . . 0.0 111.117 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.0 mmtt -88.24 -69.06 0.72 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.608 0.363 . . . . 0.0 110.895 -172.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.89 -26.1 34.44 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 120.481 0.181 . . . . 0.0 110.819 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.4 24.15 19.64 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.908 171.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.31 131.71 21.69 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.178 0.591 . . . . 0.0 109.476 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 53.9 Cg_endo -64.74 149.87 89.04 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.34 2.693 . . . . 0.0 113.135 -173.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 37.2 Cg_endo -61.27 -12.26 22.8 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.784 2.989 . . . . 0.0 113.724 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.35 -43.0 61.57 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.424 0.69 . . . . 0.0 110.535 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.5 mp0 -85.11 -28.9 25.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.051 0.94 . . . . 0.0 111.772 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' HB2' HD11 ' A' ' 69' ' ' LEU . 3.5 pp0? -109.0 123.22 48.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.306 0.642 . . . . 0.0 109.921 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.516 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 55.2 ttt180 -112.31 128.02 56.16 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.143 0.977 . . . . 0.0 110.184 -168.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.64 120.03 33.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.311 0.644 . . . . 0.0 110.486 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.2 mt -141.98 135.55 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.417 1.087 . . . . 0.0 109.88 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.515 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 88.3 t80 -131.69 123.46 27.81 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.36 1.064 . . . . 0.0 108.133 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 60.44 20.0 9.68 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.645 0.778 . . . . 0.0 112.608 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.558 ' HA2' HG22 ' B' ' 206' ' ' VAL . . . 101.23 -18.8 53.53 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 114.499 0.559 . . . . 0.0 114.499 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.1 ptpt -86.46 137.64 32.38 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.57 0.685 . . . . 0.0 109.709 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.585 ' HB2' HD22 ' B' ' 224' ' ' LEU . 27.4 tt0 -81.64 135.53 35.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.58 117.16 26.2 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 122.737 0.415 . . . . 0.0 111.298 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.65 138.86 31.85 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.581 1.152 . . . . 0.0 109.639 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.88 -47.55 64.49 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.78 1.232 . . . . 0.0 112.968 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.68 -30.97 78.42 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.905 0.753 . . . . 0.0 113.76 -174.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.488 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 97.2 mtt180 -80.04 177.77 8.7 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.516 0.726 . . . . 0.0 112.037 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -112.51 168.28 9.77 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.785 0.834 . . . . 0.0 109.915 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.6 mt -59.0 -50.48 73.94 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 21.9 m -54.93 -31.13 60.01 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.971 1.309 . . . . 0.0 112.778 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.92 -41.39 91.44 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.201 0.525 . . . . 0.0 109.826 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 34.8 m-85 -86.41 13.02 8.91 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.436 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 70.11 27.79 4.19 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.55 1.14 . . . . 0.0 111.122 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 10.4 mt -99.44 144.95 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -135.27 -173.81 3.44 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -62.88 146.81 51.96 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 120.681 0.276 . . . . 0.0 110.637 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 68.57 5.51 4.89 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.268 1.427 . . . . 0.0 112.174 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -71.86 139.01 48.67 Favored 'General case' 0 C--N 1.362 1.126 0 CA-C-N 117.963 0.347 . . . . 0.0 110.118 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 21.4 m -100.52 117.05 33.89 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.515 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -121.6 142.14 50.41 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.183 0.993 . . . . 0.0 109.484 -177.379 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -77.91 130.01 36.06 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.648 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.606 HD12 HG22 ' A' ' 7' ' ' THR . 2.5 tm? -103.73 129.34 51.08 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.54 HG21 HD11 ' B' ' 220' ' ' LEU . 84.3 t -111.67 121.04 63.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.238 0.615 . . . . 0.0 109.922 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.86 156.84 23.38 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.523 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.406 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 51.6 mtt180 -128.57 -47.24 1.29 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.701 0.8 . . . . 0.0 110.385 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.49 1.57 0 C-N-CA 124.763 1.225 . . . . 0.0 112.433 -178.073 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 57.9 mttm . . . . . 0 C--O 1.239 0.52 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 7.0 m -143.08 179.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.466 1.106 . . . . 0.0 109.595 -169.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.94 142.26 47.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.954 0.502 . . . . 0.0 110.739 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.598 ' HA ' HD11 ' B' ' 216' ' ' ILE . 49.0 t -76.01 104.76 1.67 Allowed Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 124.327 1.051 . . . . 0.0 108.648 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.559 ' HD2' HD21 ' B' ' 220' ' ' LEU . 38.2 Cg_endo -61.79 -12.96 27.79 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.559 2.839 . . . . 0.0 114.808 -168.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 206' ' ' VAL . . . . . 0.558 HG22 ' HA2' ' A' ' 47' ' ' GLY . 5.6 t -85.8 -61.28 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.133 0.573 . . . . 0.0 110.257 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 21.1 p -99.74 -5.54 28.56 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 112.224 0.454 . . . . 0.0 112.224 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 68.07 45.17 73.95 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 115.023 0.769 . . . . 0.0 115.023 173.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.24 133.44 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 117.342 0.571 . . . . 0.0 110.321 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -81.78 122.52 27.79 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.011 0.524 . . . . 0.0 110.17 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' B' ' 204' ' ' CYS . 3.4 pt -150.23 159.66 34.7 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.757 1.623 . . . . 0.0 108.924 -172.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.35 157.75 43.98 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.199 1.932 . . . . 0.0 112.061 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.573 ' O ' HG22 ' B' ' 216' ' ' ILE . 43.1 tt0 -60.9 -31.35 70.85 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.743 1.217 . . . . 0.0 112.093 -174.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 23.5 p -64.0 -50.95 66.5 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 121.653 0.739 . . . . 0.0 110.277 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -80.15 -10.96 59.79 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.16 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.1 OUTLIER -73.78 -48.36 39.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 217' ' ' ASN . . . . . 0.523 ' HA ' HD12 ' B' ' 220' ' ' LEU . 52.3 m-80 -63.39 -36.52 83.98 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.407 0.442 . . . . 0.0 110.843 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -57.57 -52.76 64.11 Favored 'General case' 0 C--O 1.254 1.3 0 O-C-N 123.96 0.788 . . . . 0.0 111.212 172.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -30.66 70.68 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.731 -176.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.559 HD21 ' HD2' ' B' ' 205' ' ' PRO . 96.3 mt -64.52 -50.48 67.21 Favored 'General case' 0 C--O 1.206 -1.186 0 O-C-N 123.887 0.742 . . . . 0.0 111.181 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -57.38 -27.79 62.63 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 123.87 0.731 . . . . 0.0 111.69 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.1 t -80.03 -45.74 17.83 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.552 173.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 67.0 m -81.12 -22.94 38.71 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.626 1.17 . . . . 0.0 113.811 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 224' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.2 pp . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 120.851 0.358 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 21.6 mp0 -98.52 152.85 19.11 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.497 0.319 . . . . 0.0 110.512 173.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.18 150.6 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.345 1.058 . . . . 0.0 108.728 171.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.0 101.75 11.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.4 0.68 . . . . 0.0 109.787 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 69' ' ' LEU . 88.4 t -98.76 103.16 14.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -101.39 124.93 47.87 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.439 0.696 . . . . 0.0 110.901 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.734 HG22 HD12 ' A' ' 69' ' ' LEU . 60.2 p -65.53 157.74 28.86 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.316 0.647 . . . . 0.0 111.765 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.527 HD11 HG22 ' A' ' 70' ' ' VAL . 81.0 mt -66.47 -17.78 64.99 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.686 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -79.63 -11.31 59.87 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.342 0.657 . . . . 0.0 110.928 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.49 7.34 39.94 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 123.25 0.452 . . . . 0.0 113.863 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.43 143.02 26.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.626 0.77 . . . . 0.0 109.193 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 m -103.51 141.19 36.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.857 0.463 . . . . 0.0 110.684 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.81 113.27 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.431 1.092 . . . . 0.0 108.504 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.3 m -91.57 120.34 32.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.922 0.489 . . . . 0.0 109.716 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -106.19 163.9 12.43 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.018 0.927 . . . . 0.0 109.261 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -130.82 82.47 2.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.376 0.67 . . . . 0.0 109.562 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.803 HG21 HG22 ' A' ' 26' ' ' VAL . 16.7 m -140.9 172.03 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.242 1.017 . . . . 0.0 109.085 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -86.02 150.71 53.24 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.742 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -60.79 -25.14 80.59 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.998 1.799 . . . . 0.0 111.332 166.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 t -95.12 5.65 51.24 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.038 0.935 . . . . 0.0 111.449 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.01 -96.62 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.139 0.576 . . . . 0.0 110.123 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 26' ' ' VAL . 11.1 t 177.85 146.13 0.13 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.676 1.191 . . . . 0.0 109.31 172.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -62.63 -36.26 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.598 1.159 . . . . 0.0 111.56 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.31 -36.51 71.17 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.712 0.767 . . . . 0.0 110.878 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.0 t-20 -76.07 -42.02 48.71 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.341 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.803 HG22 HG21 ' A' ' 17' ' ' VAL . 58.4 t -55.75 -48.16 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 124.342 1.026 . . . . 0.0 110.371 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.9 ptpt -69.93 -35.15 74.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.977 0.511 . . . . 0.0 110.945 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.05 -36.03 70.01 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.613 0.365 . . . . 0.0 110.921 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 74.0 mmtt -69.58 -33.92 73.41 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 118.59 -0.719 . . . . 0.0 112.394 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.7 mp -60.0 -41.22 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 119.404 1.002 . . . . 0.0 109.662 172.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -67.98 -24.71 65.18 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.526 0.731 . . . . 0.0 111.311 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -77.7 -30.26 51.77 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.849 0.859 . . . . 0.0 111.021 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.5 mmtt -94.58 -67.63 0.84 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.828 0.451 . . . . 0.0 111.093 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -84.41 -26.62 28.19 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.201 0.2 . . . . 0.0 111.115 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.75 23.68 22.68 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 116.547 -0.297 . . . . 0.0 112.851 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.79 129.04 25.59 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 73.9 Cg_endo -68.39 155.24 69.88 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.166 2.577 . . . . 0.0 112.766 -174.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 38.3 Cg_endo -61.16 -16.21 44.73 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.675 2.917 . . . . 0.0 114.082 -176.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.0 -24.71 43.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.829 0.852 . . . . 0.0 110.664 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.453 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 1.3 mp0 -99.9 -31.69 11.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.218 1.007 . . . . 0.0 111.954 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.521 ' HB2' HD21 ' A' ' 69' ' ' LEU . 3.1 pp0? -103.94 123.8 47.82 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.236 0.541 . . . . 0.0 110.419 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.701 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 67.2 ttt180 -115.06 128.58 56.33 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.393 1.077 . . . . 0.0 109.86 -169.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.6 mm? -94.16 121.18 35.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.552 0.741 . . . . 0.0 110.577 -171.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.0 mt -142.62 125.96 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.023 0.929 . . . . 0.0 109.988 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.633 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 85.0 t80 -121.73 122.72 40.18 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.47 1.108 . . . . 0.0 108.962 177.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.66 22.84 10.35 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.699 0.8 . . . . 0.0 112.754 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.17 -13.02 60.4 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.343 0.497 . . . . 0.0 114.343 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.9 ptpt -93.34 133.1 36.93 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.623 0.711 . . . . 0.0 109.298 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -76.08 136.81 39.89 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 43' ' ' LEU . 22.7 mt -92.34 119.39 31.86 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 121.117 0.484 . . . . 0.0 111.164 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.441 ' H ' ' HE2' ' A' ' 59' ' ' TYR . 36.0 tt0 -86.87 139.46 30.63 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.252 1.421 . . . . 0.0 110.892 -176.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.84 -45.37 82.43 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.802 1.241 . . . . 0.0 112.838 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.82 -27.03 73.69 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 124.072 0.857 . . . . 0.0 113.481 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 78.2 mtt180 -80.84 177.59 8.94 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.826 0.851 . . . . 0.0 111.93 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.7 p -113.99 167.83 10.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.817 0.847 . . . . 0.0 110.159 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 93.7 mt -56.72 -52.33 65.37 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.615 173.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.4 t -63.9 -22.78 67.08 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.283 1.033 . . . . 0.0 111.543 -176.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.03 -42.63 89.35 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.46 0.647 . . . . 0.0 109.488 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.441 ' HE2' ' H ' ' A' ' 51' ' ' GLU . 30.0 m-85 -89.25 15.64 8.65 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.887 -1.052 . . . . 0.0 112.147 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 73.49 14.08 4.41 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.027 1.331 . . . . 0.0 112.175 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 7.9 mt -84.29 137.79 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -130.7 -173.93 3.22 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -56.53 141.24 43.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 122.866 0.466 . . . . 0.0 111.364 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 67.3 5.83 4.47 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.591 1.556 . . . . 0.0 113.268 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.3 m -70.48 133.19 46.59 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 118.204 0.457 . . . . 0.0 110.708 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.8 m -97.16 121.22 38.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.35 0.66 . . . . 0.0 109.278 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.633 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -123.24 175.05 6.9 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.897 1.279 . . . . 0.0 109.424 176.137 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -105.61 149.29 26.44 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.667 0.787 . . . . 0.0 110.665 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.734 HD12 HG22 ' A' ' 7' ' ' THR . 3.0 tm? -127.82 122.23 32.15 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.701 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 60.3 t -101.02 112.82 35.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 123.384 0.674 . . . . 0.0 109.779 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.85 145.89 36.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.728 173.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 67.2 mtp85 -122.25 -28.15 4.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.666 0.786 . . . . 0.0 111.124 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 N--CA 1.493 1.71 0 C-N-CA 124.532 1.133 . . . . 0.0 113.235 176.918 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.93 -177.41 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.833 1.253 . . . . 0.0 109.536 -169.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -112.86 147.34 37.21 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.679 0.391 . . . . 0.0 110.971 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.579 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.4 t -87.31 101.95 2.78 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 124.379 1.072 . . . . 0.0 108.692 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.562 ' HD2' HD21 ' B' ' 220' ' ' LEU . 55.2 Cg_endo -65.55 2.71 1.43 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.272 2.648 . . . . 0.0 115.335 -172.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.13 -51.8 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.691 0.396 . . . . 0.0 110.901 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 14.6 p -114.59 9.0 16.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 58.56 42.17 95.91 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 115.907 1.123 . . . . 0.0 115.907 169.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.1 141.26 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 117.331 0.566 . . . . 0.0 110.644 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -88.17 112.55 22.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.006 0.522 . . . . 0.0 110.078 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.9 pt -141.66 156.26 66.33 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.489 1.515 . . . . 0.0 109.641 -173.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.75 162.6 33.93 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.704 2.269 . . . . 0.0 111.965 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.548 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.9 tm-20 -66.69 -38.69 87.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.979 0.911 . . . . 0.0 112.934 -166.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 43.1 t -56.39 -44.97 80.75 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.762 0.791 . . . . 0.0 109.868 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -80.33 -16.22 55.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.935 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.579 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.21 -50.34 32.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 217' ' ' ASN . . . . . 0.418 ' HA ' HD12 ' B' ' 220' ' ' LEU . 44.9 m-80 -67.14 -36.91 82.88 Favored 'General case' 0 C--N 1.347 0.461 0 O-C-N 123.645 0.591 . . . . 0.0 111.075 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -60.82 -46.99 88.37 Favored 'General case' 0 C--O 1.253 1.266 0 O-C-N 123.675 0.609 . . . . 0.0 110.905 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -40.32 82.62 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.167 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.562 HD21 ' HD2' ' B' ' 205' ' ' PRO . 96.0 mt -60.75 -49.71 76.4 Favored 'General case' 0 C--O 1.211 -0.948 0 O-C-N 123.958 0.786 . . . . 0.0 111.584 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.65 -24.5 67.81 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 123.93 0.769 . . . . 0.0 112.072 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 30.1 t -81.89 -41.8 20.44 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.16 0.505 . . . . 0.0 110.564 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 94.2 m -81.49 -27.45 34.54 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.292 1.037 . . . . 0.0 113.179 -167.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.486 1.35 0 C-N-CA 123.032 0.533 . . . . 0.0 110.828 -173.187 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.998 0.428 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -106.5 144.74 32.74 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.621 0.368 . . . . 0.0 111.237 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.4 HD13 ' N ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -137.75 157.65 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.991 1.316 . . . . 0.0 108.964 175.166 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 66' ' ' THR . 72.2 m-85 -110.84 101.33 9.94 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.493 0.717 . . . . 0.0 110.026 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 69' ' ' LEU . 74.6 t -97.44 106.77 19.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -107.11 129.13 54.87 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.325 0.65 . . . . 0.0 110.499 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.704 HG22 HD12 ' A' ' 69' ' ' LEU . 71.8 p -72.25 165.28 24.75 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.362 0.601 . . . . 0.0 111.841 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.504 HD11 HG22 ' A' ' 70' ' ' VAL . 70.0 mt -67.17 -25.79 66.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.924 172.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -78.09 -14.14 59.6 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.34 0.656 . . . . 0.0 110.553 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.99 14.47 39.49 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 114.884 0.714 . . . . 0.0 114.884 165.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.31 151.65 24.62 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 m -107.61 132.0 53.77 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.95 112.44 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 m -92.16 116.09 28.65 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.424 0.69 . . . . 0.0 109.424 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.5 mm? -104.79 157.19 17.37 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.635 0.774 . . . . 0.0 109.483 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.09 86.76 2.63 Favored 'General case' 0 C--O 1.244 0.784 0 O-C-N 124.248 0.968 . . . . 0.0 108.436 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.792 HG21 HG22 ' A' ' 26' ' ' VAL . 13.7 m -140.71 176.65 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 124.374 1.07 . . . . 0.0 108.345 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -92.72 148.68 36.55 Favored Pre-proline 0 N--CA 1.475 0.782 0 O-C-N 121.69 -0.631 . . . . 0.0 109.379 172.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 19.5 Cg_endo -58.45 -28.32 84.88 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.171 1.914 . . . . 0.0 111.71 169.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.7 t -101.93 16.09 27.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.909 0.484 . . . . 0.0 110.979 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.98 -92.08 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -178.85 145.61 0.29 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.503 1.121 . . . . 0.0 109.825 173.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.54 -37.81 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.451 1.1 . . . . 0.0 111.359 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -58.55 -35.17 71.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.397 0.679 . . . . 0.0 110.807 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 16.2 t-20 -72.39 -44.95 61.78 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.331 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.792 HG22 HG21 ' A' ' 17' ' ' VAL . 45.3 t -54.2 -50.32 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 124.372 1.045 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.2 ptpt -68.94 -31.35 70.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.075 0.55 . . . . 0.0 111.802 -175.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.31 -39.61 79.86 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.978 0.418 . . . . 0.0 110.662 170.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 35.6 mmtm -68.88 -36.83 78.55 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.531 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.9 mp -59.13 -41.78 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 119.473 1.033 . . . . 0.0 110.17 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -62.97 -33.15 74.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.56 -26.01 57.59 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.278 0.631 . . . . 0.0 111.319 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.8 mmtt -94.5 -66.38 0.92 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.866 0.466 . . . . 0.0 110.889 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.89 -16.01 32.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.74 20.24 51.44 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 170.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.67 127.83 27.71 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 43.2 Cg_endo -63.31 152.01 82.04 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.244 2.629 . . . . 0.0 112.989 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 43.6 Cg_endo -61.83 -17.14 53.56 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.983 3.122 . . . . 0.0 113.932 -174.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.22 -37.66 63.78 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.832 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HG3' ' H ' ' A' ' 73' ' ' LEU . 2.6 mp0 -89.29 -32.2 17.48 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.276 1.03 . . . . 0.0 112.091 -174.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.538 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 3.0 pp0? -99.77 128.95 45.84 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 55.7 ttt180 -117.18 128.88 55.55 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.4 1.08 . . . . 0.0 109.174 -168.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.48 125.42 38.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 109.892 -172.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -142.22 133.96 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.087 0.955 . . . . 0.0 110.135 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.602 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 79.0 t80 -132.87 129.52 38.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 172.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.48 19.33 11.77 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.985 0.914 . . . . 0.0 113.073 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.33 17.07 54.24 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 114.282 0.473 . . . . 0.0 114.282 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 4.0 ptpt -130.01 148.64 51.89 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.731 0.766 . . . . 0.0 109.982 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -74.11 140.57 45.36 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.779 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 45' ' ' PHE . 24.7 mt -88.64 119.22 28.91 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.015 0.526 . . . . 0.0 109.76 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.05 138.77 38.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.689 0.796 . . . . 0.0 109.989 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.88 -40.93 85.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.002 0.921 . . . . 0.0 111.616 -173.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.04 -23.95 77.59 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.256 0.972 . . . . 0.0 113.923 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.408 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 61.6 mtt180 -80.3 177.48 8.94 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.485 0.714 . . . . 0.0 112.268 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.1 p -113.21 168.46 9.71 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.774 0.829 . . . . 0.0 109.795 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 92.0 mt -59.56 -50.09 75.26 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 t -59.72 -26.71 65.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.927 1.291 . . . . 0.0 111.317 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 14.8 t70 -64.7 -43.16 94.37 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.224 0.61 . . . . 0.0 109.968 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.81 19.51 4.01 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.769 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 69.54 18.66 7.7 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.353 1.061 . . . . 0.0 111.744 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.44 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 14.5 mt -91.88 117.45 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -102.82 -178.29 3.63 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -61.67 142.97 56.85 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.137 170.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 74.2 3.31 4.35 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.612 1.565 . . . . 0.0 112.126 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -71.94 134.32 45.91 Favored 'General case' 0 C--N 1.363 1.155 0 CA-C-N 118.322 0.51 . . . . 0.0 110.513 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 52.3 m -95.13 126.27 40.35 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.602 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -128.26 174.41 9.31 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.528 1.131 . . . . 0.0 109.313 177.181 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -100.02 149.6 23.31 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.177 0.591 . . . . 0.0 111.629 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.704 HD12 HG22 ' A' ' 7' ' ' THR . 2.9 tm? -129.61 130.44 45.65 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.536 HG21 HD11 ' B' ' 220' ' ' LEU . 64.8 t -114.11 128.68 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 123.406 0.682 . . . . 0.0 110.153 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.631 ' HB3' HD23 ' A' ' 73' ' ' LEU . 77.6 mt -89.94 149.17 22.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.619 0.768 . . . . 0.0 110.793 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -118.99 -59.9 1.81 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.843 0.857 . . . . 0.0 109.298 172.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 71' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.494 1.727 0 C-N-CA 124.343 1.057 . . . . 0.0 111.384 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.73 -176.46 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.869 0.868 . . . . 0.0 110.751 -168.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.84 147.76 43.6 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.682 0.793 . . . . 0.0 110.225 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.596 ' HA ' HD11 ' B' ' 216' ' ' ILE . 46.2 t -89.63 101.56 3.42 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.095 0.958 . . . . 0.0 108.635 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.639 ' HD2' HD21 ' B' ' 220' ' ' LEU . 89.3 Cg_exo -49.09 -27.52 12.39 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 124.277 3.318 . . . . 0.0 115.006 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 206' ' ' VAL . . . . . 0.406 HG11 ' O ' ' B' ' 223' ' ' CYS . 6.3 t -80.66 -64.5 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.381 -173.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 18.1 p -96.56 1.04 50.93 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.73 45.46 95.7 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 115.061 0.784 . . . . 0.0 115.061 171.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.71 138.11 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.052 0.541 . . . . 0.0 110.223 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -87.54 117.47 26.36 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.479 HD11 ' HB2' ' B' ' 204' ' ' CYS . 7.4 pt -145.59 162.17 37.65 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.157 1.383 . . . . 0.0 110.17 -170.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.35 162.43 33.57 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.64 2.227 . . . . 0.0 112.98 174.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.616 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.9 tt0 -65.07 -39.45 93.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.61 1.164 . . . . 0.0 113.665 -169.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 14.9 m -65.76 -43.44 88.89 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.361 -0.837 . . . . 0.0 109.901 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -75.6 -18.58 59.67 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.831 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.616 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -71.21 -47.62 59.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -68.43 -36.12 78.6 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.313 0.383 . . . . 0.0 111.859 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -63.34 -44.56 94.52 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.157 0.286 . . . . 0.0 110.353 172.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -43.48 86.66 Favored 'General case' 0 C--O 1.211 -0.963 0 O-C-N 123.836 0.71 . . . . 0.0 109.841 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.639 HD21 ' HD2' ' B' ' 205' ' ' PRO . 93.0 mt -60.69 -46.5 90.14 Favored 'General case' 0 C--O 1.21 -1.02 0 O-C-N 124.059 0.849 . . . . 0.0 110.876 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -60.25 -31.22 70.0 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.842 1.339 . . . . 0.0 110.464 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 t -86.49 -37.43 18.26 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.127 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 223' ' ' CYS . . . . . 0.406 ' O ' HG11 ' B' ' 206' ' ' VAL . 88.2 m -79.51 -22.15 44.34 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.002 0.921 . . . . 0.0 112.282 -171.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 123.026 0.53 . . . . 0.0 110.462 -176.668 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 21.9 mp0 -108.85 142.13 39.88 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.926 -0.484 . . . . 0.0 111.212 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.01 159.44 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.735 1.214 . . . . 0.0 108.874 174.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 66' ' ' THR . 94.0 m-85 -109.36 105.92 15.5 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.443 0.697 . . . . 0.0 109.953 -175.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 69' ' ' LEU . 2.6 t -95.59 114.88 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -102.3 113.1 26.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.668 0.787 . . . . 0.0 109.326 -174.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.66 HG22 HD12 ' A' ' 69' ' ' LEU . 23.5 p -68.91 157.93 35.62 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.849 0.356 . . . . 0.0 110.4 174.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.423 HD11 HG22 ' A' ' 70' ' ' VAL . 96.2 mt -58.73 -25.2 62.71 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.941 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.3 p -79.08 3.05 18.59 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.562 0.745 . . . . 0.0 111.799 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 12.39 74.84 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 116.42 -0.355 . . . . 0.0 113.124 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -95.54 147.73 23.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.014 0.926 . . . . 0.0 110.207 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 m -108.02 140.98 40.38 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.561 0.744 . . . . 0.0 109.75 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -125.7 115.6 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.683 1.193 . . . . 0.0 107.978 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 m -92.1 117.64 30.05 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -104.04 156.18 18.07 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -123.85 82.45 2.02 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.906 0.753 . . . . 0.0 109.155 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.75 HG21 HG22 ' A' ' 26' ' ' VAL . 9.6 m -139.63 178.96 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 124.773 1.229 . . . . 0.0 107.969 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 10.1 mt-10 -96.29 152.82 39.0 Favored Pre-proline 0 N--CA 1.482 1.166 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.483 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.8 Cg_endo -61.63 -30.61 85.9 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.098 1.865 . . . . 0.0 111.168 171.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t -102.5 18.97 19.87 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.057 0.543 . . . . 0.0 110.026 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 16.1 t70 -81.04 -88.5 0.08 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.128 0.571 . . . . 0.0 109.49 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 26' ' ' VAL . 7.1 t 177.37 147.53 0.13 Allowed 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.539 1.136 . . . . 0.0 110.183 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -66.03 -34.39 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.251 1.02 . . . . 0.0 111.031 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 36.2 tt0 -62.59 -31.45 72.28 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.311 0.576 . . . . 0.0 110.858 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 12.7 t-20 -75.17 -42.07 56.69 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.862 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.75 HG22 HG21 ' A' ' 17' ' ' VAL . 59.0 t -55.57 -46.93 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 124.283 0.989 . . . . 0.0 110.3 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HA ' HD13 ' A' ' 30' ' ' ILE . 17.9 ptpt -71.22 -29.36 65.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.266 0.626 . . . . 0.0 111.592 -176.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -33.29 75.68 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.519 169.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 68.1 mmtt -75.62 -27.56 58.49 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.229 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.9 mp -58.14 -45.66 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 119.348 0.976 . . . . 0.0 109.281 166.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 59.5 tt0 -67.21 -20.81 65.75 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.579 177.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 23.0 t70 -81.42 -37.0 28.79 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.742 0.817 . . . . 0.0 111.369 174.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.8 mmtt -91.78 -61.92 1.53 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.794 0.437 . . . . 0.0 111.024 -170.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -92.55 -25.12 18.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.422 0.289 . . . . 0.0 111.184 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 97.2 13.83 44.14 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 116.546 -0.297 . . . . 0.0 113.83 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.87 125.88 55.57 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -63.55 152.59 79.52 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.745 2.297 . . . . 0.0 112.097 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -62.01 -16.47 50.2 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.469 2.78 . . . . 0.0 113.694 -173.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -75.4 -42.58 53.4 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.249 0.62 . . . . 0.0 110.616 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -81.74 -22.04 37.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.158 0.983 . . . . 0.0 112.52 -173.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -102.39 148.01 26.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.428 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.576 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 52.2 ttt180 -132.31 129.73 39.89 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.426 0.69 . . . . 0.0 109.556 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.64 125.69 37.38 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.373 0.669 . . . . 0.0 109.303 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.9 mt -142.6 130.99 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.158 0.983 . . . . 0.0 109.749 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.476 ' HB3' HD21 ' A' ' 50' ' ' LEU . 92.5 t80 -129.84 124.12 32.52 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.13 19.85 11.87 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.31 1.044 . . . . 0.0 112.651 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.78 -12.09 60.98 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-O 120.005 -0.33 . . . . 0.0 113.891 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.8 ptpt -99.87 142.28 31.56 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -75.4 140.82 43.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.352 0.261 . . . . 0.0 110.34 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.6 mt -88.15 134.05 33.86 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.137 0.575 . . . . 0.0 109.905 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.529 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 27.8 tt0 -85.16 137.37 33.06 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 9.2 p-10 -61.46 -33.49 73.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.112 0.965 . . . . 0.0 111.892 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.529 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -72.82 -29.5 65.13 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.856 0.723 . . . . 0.0 113.409 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -80.04 177.18 9.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.381 0.672 . . . . 0.0 111.548 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -111.06 167.46 10.24 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.738 0.815 . . . . 0.0 110.254 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 90.4 mt -56.22 -49.82 73.02 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.924 0.765 . . . . 0.0 109.135 172.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -61.3 -27.56 68.56 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.896 1.278 . . . . 0.0 111.572 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.85 -39.2 83.82 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -91.99 20.65 5.6 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.367 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 65.74 25.96 11.39 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.512 1.125 . . . . 0.0 112.194 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.88 118.27 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -106.84 -175.09 2.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -56.38 138.21 51.42 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.381 171.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 71.34 9.67 6.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.211 1.404 . . . . 0.0 112.501 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.1 m -78.57 138.55 38.42 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.147 0.43 . . . . 0.0 110.604 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 46.8 m -95.49 130.37 42.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.23 0.612 . . . . 0.0 109.928 175.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.66 159.32 37.57 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.781 1.232 . . . . 0.0 108.66 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -87.33 152.61 22.13 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.451 0.643 . . . . 0.0 111.299 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.66 HD12 HG22 ' A' ' 7' ' ' THR . 2.8 tm? -134.89 131.53 37.43 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 73.8 t -110.23 113.7 44.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.029 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.38 152.48 32.24 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.993 174.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.434 ' HA ' ' HG2' ' B' ' 213' ' ' GLU . 53.7 mtp180 -129.79 -40.17 1.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.026 0.93 . . . . 0.0 109.883 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 125.035 1.334 . . . . 0.0 112.914 177.71 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.8 m -143.1 163.52 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.375 1.07 . . . . 0.0 110.736 -167.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -96.29 147.34 23.89 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.808 0.843 . . . . 0.0 111.409 -172.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.614 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.5 t -88.2 103.92 6.02 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.553 ' HD2' HD21 ' B' ' 220' ' ' LEU . 36.2 Cg_endo -60.52 -12.54 21.26 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.478 2.785 . . . . 0.0 114.816 -168.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 t -88.47 -54.27 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.032 0.533 . . . . 0.0 110.755 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 15.8 p -108.48 1.74 21.79 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -174.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 63.01 46.58 93.22 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 115.632 1.013 . . . . 0.0 115.632 170.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.5 m -119.0 132.84 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.265 0.626 . . . . 0.0 110.764 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -84.76 119.23 25.05 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 5.2 pt -142.91 161.06 50.68 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.71 1.604 . . . . 0.0 108.875 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.46 153.08 56.82 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.229 1.953 . . . . 0.0 112.249 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.565 ' O ' HG22 ' B' ' 216' ' ' ILE . 33.5 tt0 -64.79 -32.64 74.43 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.384 1.474 . . . . 0.0 113.156 -168.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 38.6 t -64.33 -44.3 91.94 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.661 0.743 . . . . 0.0 109.924 172.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -77.0 -19.34 57.4 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.374 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -71.1 -46.5 66.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -60.68 -45.18 95.13 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.477 0.486 . . . . 0.0 110.121 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -56.62 -46.64 80.83 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 124.373 1.046 . . . . 0.0 111.945 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -36.91 81.21 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.246 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 70' ' ' VAL . 93.4 mt -63.58 -46.48 85.64 Favored 'General case' 0 C--O 1.21 -0.986 0 O-C-N 124.186 0.929 . . . . 0.0 111.481 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -54.22 -34.13 59.93 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.251 0.97 . . . . 0.0 111.009 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 34.5 t -82.91 -39.52 21.4 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.268 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 81.3 m -80.05 -18.0 51.24 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.12 0.968 . . . . 0.0 112.612 -170.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 122.857 0.463 . . . . 0.0 110.499 -179.831 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 121.045 0.45 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 93.0 mt-30 -103.47 122.65 45.34 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.626 0.77 . . . . 0.0 109.972 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.555 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -125.39 152.13 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.732 1.213 . . . . 0.0 108.559 177.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.7 m-85 -111.9 113.11 25.23 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.563 0.697 . . . . 0.0 110.204 -170.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.9 t -105.84 119.74 55.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -111.76 119.12 37.55 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.622 0.769 . . . . 0.0 109.535 -174.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.61 HG22 HD12 ' A' ' 69' ' ' LEU . 68.1 p -70.58 167.11 19.21 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.212 0.53 . . . . 0.0 111.628 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.527 HD11 HG22 ' A' ' 70' ' ' VAL . 84.0 mt -73.33 -19.35 61.04 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.936 173.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.1 p -79.05 -12.99 60.03 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.132 0.573 . . . . 0.0 110.39 171.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 26.29 19.79 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.712 -0.677 . . . . 0.0 114.144 169.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.4 152.57 18.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.6 m -97.72 141.11 31.14 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.893 0.477 . . . . 0.0 110.492 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.484 HD11 HG23 ' A' ' 7' ' ' THR . 5.2 mp -127.68 109.82 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.902 1.281 . . . . 0.0 107.68 174.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.1 m -91.5 123.58 35.02 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.7 mm? -106.97 156.02 19.16 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.172 0.589 . . . . 0.0 109.617 -177.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -118.96 76.88 1.14 Allowed 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.371 1.044 . . . . 0.0 109.301 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.707 HG21 HG22 ' A' ' 26' ' ' VAL . 28.9 m -147.43 173.14 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 123.733 0.813 . . . . 0.0 110.236 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.503 ' O ' HD12 ' A' ' 56' ' ' LEU . 9.6 mt-10 -95.72 160.02 31.2 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.139 0.576 . . . . 0.0 109.864 -169.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.91 -17.05 55.01 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 121.758 1.638 . . . . 0.0 111.89 169.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 t -103.41 3.11 34.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.45 157.91 28.81 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 168.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.3 t -102.04 150.23 23.44 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.291 -165.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.1 -36.26 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.624 0.77 . . . . 0.0 112.156 -171.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.03 -34.63 75.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.455 0.645 . . . . 0.0 110.934 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.423 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 18.5 t-20 -73.36 -45.17 56.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.866 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.707 HG22 HG21 ' A' ' 17' ' ' VAL . 65.7 t -55.93 -43.68 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 124.144 0.978 . . . . 0.0 111.361 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -71.74 -33.17 68.47 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.867 0.467 . . . . 0.0 111.473 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.91 68.96 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.143 169.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 10.3 mmpt? -76.51 -32.57 58.36 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.188 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.25 -42.93 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 118.404 0.547 . . . . 0.0 110.057 170.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -62.31 -35.38 78.86 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.154 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.72 -24.66 63.59 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.961 0.904 . . . . 0.0 111.689 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 72.1 mmtt -101.03 -69.51 0.77 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.01 -19.47 31.97 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.665 0.211 . . . . 0.0 111.44 -175.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.95 17.76 46.44 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.028 0.205 . . . . 0.0 113.062 173.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.62 125.86 34.64 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 123.394 0.678 . . . . 0.0 109.567 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -71.82 159.1 51.52 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.102 2.535 . . . . 0.0 112.095 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 29.3 Cg_endo -58.84 -15.26 25.93 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.549 2.832 . . . . 0.0 113.689 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.58 -44.71 70.23 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.366 1.066 . . . . 0.0 110.653 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.81 -33.2 19.95 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.817 0.847 . . . . 0.0 111.963 -175.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -94.2 150.39 20.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.648 0.379 . . . . 0.0 110.408 -179.305 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.585 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 44.9 ttt180 -140.17 129.98 24.55 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.233 0.613 . . . . 0.0 109.666 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.6 mm? -93.45 123.02 36.47 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.522 0.729 . . . . 0.0 109.721 -173.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -141.73 121.73 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.071 0.948 . . . . 0.0 109.716 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.622 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 91.1 t80 -119.51 121.32 39.13 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 66.27 17.88 10.8 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.263 1.025 . . . . 0.0 113.5 173.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.95 14.05 47.45 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 113.983 0.353 . . . . 0.0 113.983 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 1.6 ptpt -124.27 139.24 54.11 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' NE2' ' HE ' ' A' ' 42' ' ' ARG . 63.7 tt0 -74.79 132.08 41.29 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 45' ' ' PHE . 32.0 mt -78.37 118.77 20.86 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.036 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.78 138.46 42.66 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.992 0.917 . . . . 0.0 110.357 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.15 -44.81 83.79 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.886 1.275 . . . . 0.0 112.116 -172.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 -28.22 73.5 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 124.574 1.171 . . . . 0.0 113.747 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -77.65 175.23 10.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.087 0.555 . . . . 0.0 111.813 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 26.2 p -115.85 165.26 13.28 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.486 0.715 . . . . 0.0 109.746 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 18' ' ' GLU . 83.8 mt -55.51 -56.29 21.96 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 123.635 0.584 . . . . 0.0 110.495 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 t -61.91 -22.16 65.34 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.122 0.969 . . . . 0.0 112.057 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.1 -39.25 79.09 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.763 0.425 . . . . 0.0 110.096 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -87.26 13.53 9.5 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.342 172.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 67.63 25.45 8.22 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.912 1.285 . . . . 0.0 111.691 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 mt -91.12 112.96 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.408 1.083 . . . . 0.0 108.472 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -101.45 -172.76 2.21 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -61.65 140.28 58.18 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 70.65 3.22 4.45 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.809 1.244 . . . . 0.0 113.306 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -64.74 130.23 42.77 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 20.6 m -99.68 131.23 45.8 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.763 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.622 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -134.19 174.18 10.79 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.07 0.948 . . . . 0.0 110.107 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -98.55 148.21 24.0 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.332 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -127.32 130.63 49.85 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 67.1 t -108.68 111.55 36.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.21 0.604 . . . . 0.0 109.833 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.2 mt -79.2 149.75 31.85 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 124.191 0.932 . . . . 0.0 109.011 171.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -118.98 -39.43 2.94 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.445 0.698 . . . . 0.0 110.72 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.485 1.298 0 C-N-CA 124.645 1.178 . . . . 0.0 111.89 -178.012 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 m -144.46 -178.04 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.382 1.073 . . . . 0.0 110.072 -165.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -113.57 148.06 36.84 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.219 0.608 . . . . 0.0 110.314 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.627 ' HA ' HD11 ' B' ' 216' ' ' ILE . 46.2 t -85.4 100.81 1.35 Allowed Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.079 0.952 . . . . 0.0 109.501 176.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.58 ' HD2' HD21 ' B' ' 220' ' ' LEU . 65.3 Cg_endo -68.0 8.29 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.392 2.728 . . . . 0.0 115.361 -168.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.07 -50.63 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 122.971 0.509 . . . . 0.0 110.716 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.9 p -114.03 -4.61 13.17 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 122.746 0.418 . . . . 0.0 111.945 -172.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.36 58.25 14.95 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 124.288 0.947 . . . . 0.0 114.956 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.07 129.83 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.201 0.601 . . . . 0.0 109.57 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -82.59 115.42 21.55 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.8 pt -143.95 160.77 48.61 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.491 1.516 . . . . 0.0 109.746 -170.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' B' ' 215' ' ' HIS . 28.4 Cg_endo -60.92 155.92 46.92 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.704 2.27 . . . . 0.0 112.199 172.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.516 ' O ' HG22 ' B' ' 216' ' ' ILE . 35.7 tt0 -68.51 -28.32 66.9 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.69 1.196 . . . . 0.0 113.466 -170.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 40.9 t -65.78 -44.22 86.42 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.657 0.741 . . . . 0.0 109.724 171.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 215' ' ' HIS . . . . . 0.401 ' HB2' ' HG2' ' B' ' 212' ' ' PRO . 70.6 m-70 -80.35 -16.51 54.38 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.046 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -72.55 -44.5 61.06 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 175.727 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -54.38 -54.47 40.15 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.023 0.827 . . . . 0.0 109.999 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -57.24 -44.84 84.19 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 124.48 1.113 . . . . 0.0 112.558 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -33.93 74.87 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.105 -177.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.58 HD21 ' HD2' ' B' ' 205' ' ' PRO . 78.8 mt -68.49 -42.95 77.9 Favored 'General case' 0 C--O 1.212 -0.901 0 O-C-N 123.557 0.536 . . . . 0.0 111.521 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -57.58 -28.4 63.56 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 124.027 0.829 . . . . 0.0 111.259 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 43.4 t -86.38 -42.27 13.8 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.692 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.9 m -80.7 -26.54 37.42 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -167.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.489 1.519 0 C-N-CA 123.053 0.541 . . . . 0.0 110.222 -175.313 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 65.8 mt-30 -111.13 147.72 34.27 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.273 0.629 . . . . 0.0 110.641 176.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.506 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -138.93 155.29 26.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 125.396 1.478 . . . . 0.0 107.841 174.76 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 66' ' ' THR . 89.8 m-85 -112.34 116.78 30.9 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.734 -174.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 55.6 t -105.32 131.96 53.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tpmt? -123.26 124.57 43.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.242 0.617 . . . . 0.0 109.972 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.657 HG22 HD12 ' A' ' 69' ' ' LEU . 42.8 p -73.27 169.49 16.99 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.259 0.552 . . . . 0.0 111.495 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.4 mt -65.59 -26.41 67.84 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.036 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.9 p -80.55 -15.9 55.53 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.637 0.775 . . . . 0.0 111.189 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.23 11.64 38.59 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 114.781 0.673 . . . . 0.0 114.781 167.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 152.27 31.25 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.743 0.771 . . . . 0.0 109.609 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.4 m -95.26 141.78 28.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.177 0.591 . . . . 0.0 109.693 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.55 HD11 HG23 ' A' ' 7' ' ' THR . 4.4 mp -132.37 100.9 4.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.7 m -95.06 121.36 36.61 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -105.65 152.77 22.71 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -117.45 82.73 1.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.752 HG21 HG22 ' A' ' 26' ' ' VAL . 24.6 m -141.74 177.32 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.72 1.208 . . . . 0.0 108.509 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -92.61 153.42 42.44 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.55 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 24.0 Cg_endo -61.98 -28.61 80.88 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.829 1.686 . . . . 0.0 110.742 164.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -94.13 13.54 22.82 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.019 0.928 . . . . 0.0 111.24 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.71 -99.19 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.163 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.0 t 171.86 140.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.967 1.307 . . . . 0.0 109.324 177.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.415 HD12 HD13 ' A' ' 50' ' ' LEU . 39.9 mm -60.54 -36.81 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.578 1.151 . . . . 0.0 112.034 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.01 -34.84 76.94 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.564 0.697 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.5 t30 -75.82 -41.0 53.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.107 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.752 HG22 HG21 ' A' ' 17' ' ' VAL . 58.4 t -57.97 -45.86 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 124.441 1.088 . . . . 0.0 110.042 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.1 ptpt -72.39 -28.68 63.14 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.026 0.53 . . . . 0.0 111.313 -176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.33 75.13 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.218 0.324 . . . . 0.0 110.434 169.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 71.6 mmtt -74.03 -36.13 64.41 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.95 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.9 mp -57.23 -41.57 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.532 1.06 . . . . 0.0 109.511 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -60.4 -39.09 86.08 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.447 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.43 -32.09 73.52 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.207 0.603 . . . . 0.0 111.481 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 70.4 mmtt -91.4 -67.97 0.82 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.626 0.37 . . . . 0.0 111.624 -171.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -80.39 -22.95 40.77 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.768 0.258 . . . . 0.0 111.06 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.86 18.67 39.62 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.222 0.326 . . . . 0.0 113.037 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.598 HG13 HD11 ' A' ' 73' ' ' LEU . 1.9 mp -108.79 127.52 27.21 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.68 156.13 67.25 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.907 2.404 . . . . 0.0 112.287 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 46.3 Cg_endo -62.17 -13.32 31.27 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 123.636 2.891 . . . . 0.0 113.967 -173.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 7.4 t70 -76.23 -46.13 29.61 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.893 0.746 . . . . 0.0 109.943 174.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.9 mp0 -83.8 -23.09 31.59 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.521 0.728 . . . . 0.0 112.366 -172.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.568 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 2.9 pp0? -104.74 133.27 49.85 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.973 0.509 . . . . 0.0 109.857 173.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.562 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.2 ttt180 -120.26 130.74 54.63 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.975 0.91 . . . . 0.0 110.238 -170.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -94.28 117.42 30.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.634 0.774 . . . . 0.0 110.546 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -141.85 127.54 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 124.27 1.028 . . . . 0.0 109.547 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.538 ' HB3' HD21 ' A' ' 50' ' ' LEU . 81.2 t80 -123.17 124.08 42.25 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.142 0.977 . . . . 0.0 109.236 177.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.94 16.06 9.61 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.031 1.332 . . . . 0.0 112.972 176.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.09 -8.48 60.97 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.929 -0.373 . . . . 0.0 113.171 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.5 ptpt -96.03 135.79 37.33 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -76.39 131.58 39.21 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.538 HD21 ' HB3' ' A' ' 45' ' ' PHE . 30.5 mt -74.34 153.84 39.13 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.436 0.294 . . . . 0.0 110.466 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' H ' ' HE2' ' A' ' 59' ' ' TYR . 37.5 tt0 -116.34 137.35 52.22 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.397 0.679 . . . . 0.0 109.194 -176.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.92 -44.18 86.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.673 1.189 . . . . 0.0 112.075 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.27 -25.04 75.8 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 124.43 1.081 . . . . 0.0 113.478 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -81.31 177.57 8.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.301 0.64 . . . . 0.0 111.789 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 73.1 p -110.36 169.68 8.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.663 0.785 . . . . 0.0 109.795 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 95.4 mt -57.32 -54.8 42.7 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.893 0.746 . . . . 0.0 109.46 172.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.511 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 24.3 t -62.59 -19.28 63.57 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.733 1.213 . . . . 0.0 111.971 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -66.91 -41.4 87.17 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.451 ' HE2' ' H ' ' A' ' 51' ' ' GLU . 38.1 m-85 -90.98 17.87 7.38 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.09 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 68.39 16.69 9.23 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.18 1.392 . . . . 0.0 112.17 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.1 mt -85.16 102.01 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -86.48 -177.23 6.13 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -62.34 144.95 55.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 76.6 -3.34 2.55 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.61 1.564 . . . . 0.0 111.81 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -68.72 133.69 48.75 Favored 'General case' 0 C--N 1.366 1.306 0 CA-C-N 117.971 0.351 . . . . 0.0 110.713 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 18.0 m -99.43 140.21 33.95 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.796 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.404 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -140.79 173.35 11.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.939 0.896 . . . . 0.0 109.699 -178.699 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -97.32 147.16 24.44 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.371 0.668 . . . . 0.0 110.88 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.657 HD12 HG22 ' A' ' 7' ' ' THR . 2.5 tm? -129.19 127.74 41.94 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.574 HG21 HD11 ' B' ' 220' ' ' LEU . 96.0 t -108.78 126.77 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 123.282 0.633 . . . . 0.0 110.109 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.518 ' HB3' HD23 ' A' ' 73' ' ' LEU . 66.4 mt -86.25 147.04 26.27 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.771 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.428 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 37.3 mtp-105 -136.29 6.4 3.05 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.475 1.11 . . . . 0.0 110.243 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD11 HG13 ' A' ' 36' ' ' ILE . 4.2 mm? . . . . . 0 N--CA 1.489 1.516 0 C-N-CA 126.467 1.907 . . . . 0.0 114.27 -169.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' B' ' 212' ' ' PRO . 11.6 mptt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.13 -176.91 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.87 1.668 . . . . 0.0 109.093 -172.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -111.23 146.08 37.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.936 -0.478 . . . . 0.0 110.915 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.664 ' HA ' HD11 ' B' ' 216' ' ' ILE . 35.1 t -94.72 101.12 6.31 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.445 ' HD2' HD21 ' B' ' 220' ' ' LEU . 66.3 Cg_endo -67.49 -4.65 12.35 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.173 2.582 . . . . 0.0 114.765 -164.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 206' ' ' VAL . . . . . 0.451 HG11 ' O ' ' B' ' 223' ' ' CYS . 11.6 t -95.25 -58.01 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 122.793 0.437 . . . . 0.0 110.661 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.3 p -99.19 -4.63 31.65 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 66.85 47.01 69.11 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 172.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.25 144.22 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 117.514 0.657 . . . . 0.0 110.842 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -90.26 108.75 19.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.078 0.951 . . . . 0.0 110.026 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' B' ' 204' ' ' CYS . 10.0 pt -144.25 153.42 56.12 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.864 1.266 . . . . 0.0 110.419 -172.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' B' ' 201' ' ' LYS . 54.6 Cg_endo -65.17 165.3 22.37 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.439 2.76 . . . . 0.0 114.366 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.593 ' O ' HG22 ' B' ' 216' ' ' ILE . 31.6 tt0 -62.25 -41.83 98.78 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 125.341 1.456 . . . . 0.0 114.31 -164.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.0 m -76.11 -29.7 57.98 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.812 -1.18 . . . . 0.0 110.712 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -81.63 -23.96 36.66 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.047 0.539 . . . . 0.0 109.997 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.664 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.1 OUTLIER -72.64 -42.79 62.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -65.11 -42.93 93.49 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.851 0.719 . . . . 0.0 110.923 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -64.09 -37.62 88.12 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.654 0.596 . . . . 0.0 110.969 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -39.88 88.58 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.401 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.574 HD11 HG21 ' A' ' 70' ' ' VAL . 80.0 mt -71.19 -32.38 68.78 Favored 'General case' 0 C--O 1.214 -0.763 0 O-C-N 124.201 0.938 . . . . 0.0 111.581 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -58.65 -27.29 64.61 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 123.847 0.717 . . . . 0.0 109.892 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.3 t -95.51 -36.03 11.45 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 123.473 0.709 . . . . 0.0 112.4 172.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 223' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' B' ' 220' ' ' LEU . 91.6 m -81.96 -17.79 45.76 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.142 0.977 . . . . 0.0 112.614 -168.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 N--CA 1.488 1.442 0 C-N-CA 122.582 0.353 . . . . 0.0 111.052 177.962 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 mmt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.4 mp0 -95.06 131.03 41.49 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.791 0.436 . . . . 0.0 111.456 -173.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.24 147.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.013 1.325 . . . . 0.0 108.539 172.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' THR . 96.1 m-85 -111.49 103.63 11.99 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.316 0.647 . . . . 0.0 110.211 -169.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 69' ' ' LEU . 84.0 t -103.01 106.06 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.896 0.878 . . . . 0.0 108.978 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -89.22 118.29 28.8 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.816 1.246 . . . . 0.0 110.426 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.58 HG22 HD12 ' A' ' 69' ' ' LEU . 7.8 p -70.95 167.36 19.27 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.61 0.719 . . . . 0.0 112.131 175.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.539 HD11 HG22 ' A' ' 70' ' ' VAL . 89.2 mt -70.2 -11.23 60.75 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.675 172.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.7 p -86.47 -4.43 59.17 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.478 0.711 . . . . 0.0 111.504 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.49 15.63 73.23 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.262 0.352 . . . . 0.0 112.868 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -93.53 151.59 19.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.472 1.109 . . . . 0.0 109.923 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -109.51 128.74 55.4 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.141 0.576 . . . . 0.0 110.288 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.96 106.71 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.685 0.794 . . . . 0.0 108.949 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.7 m -88.78 118.03 28.18 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.069 0.947 . . . . 0.0 109.834 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.2 mm? -105.53 159.67 15.76 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.491 0.716 . . . . 0.0 109.458 178.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -126.7 83.19 2.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.775 0.83 . . . . 0.0 108.839 -174.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.702 HG21 HG22 ' A' ' 26' ' ' VAL . 32.2 m -147.73 -177.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 124.168 0.987 . . . . 0.0 110.056 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -96.21 155.95 37.54 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 123.253 0.621 . . . . 0.0 110.247 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 28.9 Cg_endo -61.52 -31.64 87.66 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 121.984 1.789 . . . . 0.0 111.322 167.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -95.65 10.59 36.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.585 0.754 . . . . 0.0 110.939 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.47 -96.36 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.924 0.889 . . . . 0.0 110.334 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.6 t 172.72 144.63 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.327 1.451 . . . . 0.0 108.98 173.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.06 -35.98 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.806 0.843 . . . . 0.0 111.616 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.09 -35.54 75.42 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.606 0.717 . . . . 0.0 110.777 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 16.8 t-20 -74.57 -42.32 58.95 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.712 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.702 HG22 HG21 ' A' ' 17' ' ' VAL . 72.8 t -56.75 -44.05 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 124.367 1.042 . . . . 0.0 110.479 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 17.9 ptpt -74.32 -26.45 60.17 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.653 0.381 . . . . 0.0 111.498 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.6 -32.03 72.47 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.635 168.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -68.96 -38.65 79.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.152 0.581 . . . . 0.0 111.134 175.379 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.16 -43.7 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 118.249 0.477 . . . . 0.0 109.99 173.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.433 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 62.7 tt0 -65.73 -24.97 67.09 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.236 0.541 . . . . 0.0 111.542 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.92 -31.81 59.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.852 0.461 . . . . 0.0 110.76 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.7 mmtt -91.12 -67.2 0.87 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.611 0.364 . . . . 0.0 110.526 -172.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -86.44 -26.59 24.61 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.384 0.274 . . . . 0.0 111.547 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 93.24 17.4 43.18 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 120.048 -0.307 . . . . 0.0 113.619 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.05 126.77 47.64 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.76 152.46 78.36 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.954 2.436 . . . . 0.0 112.109 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -58.73 -15.76 27.73 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.324 2.682 . . . . 0.0 113.509 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.27 -36.12 63.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.827 0.851 . . . . 0.0 111.432 175.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -97.05 -28.64 14.05 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.158 0.983 . . . . 0.0 112.81 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.486 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -90.69 149.86 21.89 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.031 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.602 ' HD3' HD23 ' B' ' 220' ' ' LEU . 10.4 ttt180 -140.85 127.01 19.6 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.48 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -92.38 126.22 37.37 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.919 0.888 . . . . 0.0 109.337 -171.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.614 HD11 HD21 ' B' ' 220' ' ' LEU . 90.5 mt -140.78 118.62 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.097 0.559 . . . . 0.0 110.704 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.556 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 71.8 t80 -122.01 129.28 52.32 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.28 20.65 12.39 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.708 0.803 . . . . 0.0 112.605 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.77 22.5 55.54 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 119.881 -0.4 . . . . 0.0 113.692 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.5 ptpt -128.96 146.09 51.06 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 173.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.616 ' HB2' ' HB2' ' B' ' 224' ' ' LEU . 0.3 OUTLIER -82.83 138.5 33.92 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.801 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 43' ' ' LEU . 26.6 mt -90.82 120.14 31.61 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.56 -172.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -75.53 138.85 41.8 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.4 1.08 . . . . 0.0 110.51 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.17 -49.7 63.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.636 1.174 . . . . 0.0 111.919 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.69 -29.77 76.12 Favored Glycine 0 C--N 1.352 1.471 0 O-C-N 124.367 1.042 . . . . 0.0 113.962 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -79.31 177.46 8.82 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.568 0.747 . . . . 0.0 111.402 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -118.72 166.59 12.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.604 0.762 . . . . 0.0 110.234 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 93.2 mt -55.76 -54.2 47.35 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 124.104 0.877 . . . . 0.0 109.677 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 15.7 t -60.89 -26.02 67.13 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.591 1.156 . . . . 0.0 111.514 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -68.6 -41.22 79.87 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 122.867 0.467 . . . . 0.0 109.834 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -85.86 15.11 5.13 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.631 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 68.36 25.8 6.92 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.69 1.196 . . . . 0.0 111.69 176.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 56' ' ' LEU . 14.1 mt -93.42 127.89 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.394 1.078 . . . . 0.0 108.256 175.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -110.08 -178.21 3.46 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 172.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -60.1 137.03 58.19 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.044 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 73.15 10.04 5.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.277 1.431 . . . . 0.0 112.467 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -68.11 138.89 56.09 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 170.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 24.9 m -101.29 129.57 47.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.384 0.674 . . . . 0.0 109.613 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.556 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -143.96 154.35 43.21 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.006 0.923 . . . . 0.0 109.909 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -80.58 154.59 27.37 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.462 0.648 . . . . 0.0 112.455 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.58 HD12 HG22 ' A' ' 7' ' ' THR . 2.2 tm? -131.58 121.67 24.79 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.576 HG21 HD22 ' B' ' 220' ' ' LEU . 57.1 t -98.25 119.36 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.53 0.732 . . . . 0.0 110.397 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -85.97 147.65 26.12 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.853 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -121.41 -40.64 2.56 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.497 0.719 . . . . 0.0 110.874 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.5 2.044 0 C-N-CA 125.022 1.329 . . . . 0.0 113.017 -178.969 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 8.3 m -148.25 -177.58 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.666 1.186 . . . . 0.0 109.326 -167.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -120.95 138.59 54.06 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.722 0.409 . . . . 0.0 111.134 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 204' ' ' CYS . . . . . 0.536 ' HA ' HD11 ' B' ' 216' ' ' ILE . 37.1 t -78.73 100.25 0.52 Allowed Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 124.303 1.041 . . . . 0.0 108.263 174.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 205' ' ' PRO . . . . . 0.507 ' HD3' HD11 ' B' ' 216' ' ' ILE . 44.5 Cg_endo -81.99 20.49 1.07 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.071 2.514 . . . . 0.0 114.116 -159.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 53.9 t -105.32 -58.24 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.333 0.653 . . . . 0.0 109.691 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 28.8 p -91.97 -23.84 19.43 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.072 0.549 . . . . 0.0 111.22 -175.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.89 52.52 3.83 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 114.299 0.48 . . . . 0.0 114.299 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.76 134.76 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.264 0.626 . . . . 0.0 110.172 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -87.92 114.06 24.17 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 211' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' B' ' 204' ' ' CYS . 8.9 pt -143.89 160.41 50.08 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 124.866 1.266 . . . . 0.0 110.376 -171.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.4 156.19 32.11 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.153 2.569 . . . . 0.0 112.774 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 213' ' ' GLU . . . . . 0.5 ' O ' HG22 ' B' ' 216' ' ' ILE . 33.2 tt0 -66.18 -29.39 69.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.522 1.129 . . . . 0.0 113.499 -171.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 15.7 m -64.11 -43.68 94.58 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.882 0.849 . . . . 0.0 110.057 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -81.17 -21.53 39.62 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.304 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -69.82 -41.13 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -58.97 -51.68 69.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.15 0.906 . . . . 0.0 109.973 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -64.95 -47.93 75.88 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.966 -174.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -33.76 76.73 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.505 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.614 HD21 HD11 ' A' ' 44' ' ' ILE . 46.6 tp -68.23 -39.34 82.37 Favored 'General case' 0 C--O 1.214 -0.777 0 O-C-N 124.249 0.968 . . . . 0.0 111.447 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.14 -36.32 63.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.044 0.538 . . . . 0.0 110.822 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.4 t -77.93 -43.92 28.49 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.668 174.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 75.1 m -77.38 -21.09 53.75 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 224' ' ' LEU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 3.9 pp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.094 0 N-CA-C 112.694 -0.162 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 19.8 m -87.08 -177.04 5.93 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.577 0.751 . . . . 0.0 109.875 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 19.3 p80 -141.36 116.03 9.66 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt -105.32 150.09 25.48 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.2 mp0 -99.47 130.39 45.73 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.041 -174.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.422 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -128.7 146.81 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.636 1.174 . . . . 0.0 109.355 176.016 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 66' ' ' THR . 73.7 m-85 -103.19 100.11 10.0 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.761 0.824 . . . . 0.0 109.89 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 69' ' ' LEU . 93.6 t -101.67 99.91 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -98.89 123.49 43.19 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.587 -169.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.757 HG22 HD12 ' A' ' 69' ' ' LEU . 41.3 p -67.84 166.75 14.85 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.822 0.849 . . . . 0.0 112.927 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.51 -17.03 64.51 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.073 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.4 p -85.87 2.96 43.84 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.335 0.654 . . . . 0.0 111.113 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.05 85.61 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 113.888 0.315 . . . . 0.0 113.888 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.5 135.98 34.22 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.84 0.856 . . . . 0.0 109.841 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.6 m -101.34 124.58 47.24 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.035 0.534 . . . . 0.0 110.683 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.7 mp -107.53 110.54 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.9 0.88 . . . . 0.0 109.495 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -87.03 118.69 26.58 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.568 0.747 . . . . 0.0 109.755 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.6 mm? -103.78 162.37 13.15 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.491 0.716 . . . . 0.0 109.217 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 0' ' ' HIS . 45.7 mt-10 -125.25 72.0 1.23 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.223 -175.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.686 HG21 HG22 ' A' ' 26' ' ' VAL . 2.4 m -134.11 174.16 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.313 0.645 . . . . 0.0 109.572 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 2.7 mm-40 -85.96 148.68 48.7 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.132 0.573 . . . . 0.0 109.61 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 20.5 Cg_endo -61.19 -31.38 89.93 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 121.687 1.592 . . . . 0.0 111.287 167.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.6 t -98.52 17.92 17.89 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.397 0.679 . . . . 0.0 110.563 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 12.1 t0 -74.89 -94.96 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 25' ' ' ASN . 12.0 t 176.95 149.28 0.14 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 125.027 1.331 . . . . 0.0 108.828 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.431 HG22 ' HE3' ' A' ' 27' ' ' LYS . 50.3 mm -65.49 -36.09 76.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.856 0.862 . . . . 0.0 110.848 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.15 -40.71 64.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.902 0.881 . . . . 0.0 110.847 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.516 ' H ' HG23 ' A' ' 22' ' ' THR . 10.3 t30 -70.95 -46.03 63.09 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.126 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.686 HG22 HG21 ' A' ' 17' ' ' VAL . 61.1 t -55.19 -49.52 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 124.173 0.921 . . . . 0.0 111.022 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 16.7 ptpt -67.21 -33.71 75.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.318 0.647 . . . . 0.0 111.929 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.25 -30.1 70.87 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.236 171.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 68.8 mmtt -80.79 -28.15 36.41 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.94 -40.44 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-N 119.577 1.08 . . . . 0.0 108.805 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -60.76 -35.25 75.93 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.304 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 27.1 t70 -71.14 -26.4 62.99 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.778 0.831 . . . . 0.0 112.065 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -95.1 -70.1 0.73 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.415 0.286 . . . . 0.0 111.381 -175.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -83.4 -24.36 31.98 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.23 26.79 13.2 Favored Glycine 0 C--N 1.349 1.259 0 O-C-N 123.224 0.327 . . . . 0.0 113.036 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.8 125.79 29.31 Favored Pre-proline 0 N--CA 1.481 1.115 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.95 155.8 68.32 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.888 2.392 . . . . 0.0 112.686 -171.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.471 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 33.3 Cg_endo -61.26 -11.57 19.75 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.672 2.915 . . . . 0.0 113.918 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.59 -42.53 58.52 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.205 0.602 . . . . 0.0 110.333 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -89.44 -12.54 39.92 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.829 0.852 . . . . 0.0 112.709 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.566 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.1 pp0? -114.86 152.75 31.67 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 123.127 0.571 . . . . 0.0 109.956 173.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.503 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 41.8 ttt180 -136.09 134.56 38.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.117 0.567 . . . . 0.0 110.3 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -94.66 123.35 38.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.873 0.869 . . . . 0.0 110.452 -173.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.5 mt -142.91 126.7 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.078 0.951 . . . . 0.0 109.915 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.5 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 84.8 t80 -121.96 124.84 44.98 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.271 1.029 . . . . 0.0 108.9 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.6 17.96 7.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.07 0.948 . . . . 0.0 112.964 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.79 -7.14 59.05 Favored Glycine 0 C--N 1.351 1.385 0 C-N-CA 122.992 0.329 . . . . 0.0 113.88 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.8 ptpt -95.43 135.21 37.35 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -73.69 138.98 45.05 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.457 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 18.5 mt -92.03 110.22 21.58 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.876 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.89 139.44 43.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.285 1.034 . . . . 0.0 110.524 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.38 -47.06 69.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.696 1.198 . . . . 0.0 112.362 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.01 -26.11 73.29 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 124.123 0.889 . . . . 0.0 114.019 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 80.0 mtt180 -83.24 176.34 9.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.28 0.632 . . . . 0.0 111.794 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.8 p -111.13 167.13 10.51 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.607 0.763 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 91.3 mt -57.75 -51.33 69.99 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.0 t -57.59 -29.95 64.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.727 1.211 . . . . 0.0 111.733 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 10.4 t70 -61.06 -48.26 82.54 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.778 0.799 . . . . 0.0 109.645 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 29.9 m-85 -87.29 18.85 3.49 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.628 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 72.0 22.2 3.83 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.303 1.041 . . . . 0.0 111.805 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -98.94 118.64 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.83 -179.56 4.21 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 10.8 ptmm? -62.97 140.87 58.9 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.618 170.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 64.2 23.57 13.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.164 1.386 . . . . 0.0 112.678 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -75.72 142.12 42.52 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 166.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 61.3 m -101.15 125.76 47.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.5 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -130.84 173.36 11.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.987 1.315 . . . . 0.0 108.876 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -100.45 151.07 21.98 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.762 0.792 . . . . 0.0 111.726 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.757 HD12 HG22 ' A' ' 7' ' ' THR . 3.1 tm? -129.86 123.74 31.55 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.521 HG21 HD11 ' B' ' 220' ' ' LEU . 90.9 t -98.73 112.09 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.324 0.65 . . . . 0.0 110.5 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt -78.22 143.72 36.89 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.961 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.589 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 72.4 mtp180 -124.98 -42.35 2.04 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.724 0.81 . . . . 0.0 110.062 -175.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 48.53 35.25 5.74 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.565 0.746 . . . . 0.0 111.89 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.589 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 4.0 mmp_? -64.08 -29.41 70.54 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.944 -175.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.37 -28.84 67.83 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.824 0.703 . . . . 0.0 113.456 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.307 0 C-N-CA 123.241 0.448 . . . . 0.0 113.89 174.974 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.814 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 39.2 m -88.81 101.18 13.78 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.642 0.777 . . . . 0.0 109.532 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -82.88 73.96 9.88 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.545 0.688 . . . . 0.0 109.584 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -164.95 153.12 11.84 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.55 -1.204 . . . . 0.0 108.961 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.84 119.64 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 169.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 200' ' ' THR . . . . . 0.477 HG22 HG13 ' B' ' 202' ' ' VAL . 34.6 m -77.07 127.7 33.14 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.882 0.873 . . . . 0.0 110.655 -175.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.71 123.45 39.28 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 202' ' ' VAL . . . . . 0.477 HG13 HG22 ' B' ' 200' ' ' THR . 5.9 m -143.64 167.33 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.193 1.397 . . . . 0.0 110.023 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -94.38 146.48 24.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.171 0.588 . . . . 0.0 111.685 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.63 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.5 t -90.22 102.49 4.96 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.525 ' HD2' HD21 ' B' ' 220' ' ' LEU . 61.2 Cg_endo -66.62 -2.89 8.21 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.115 2.543 . . . . 0.0 114.599 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.24 -64.09 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.003 0.521 . . . . 0.0 110.338 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.2 p -98.84 4.32 47.53 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.67 0.388 . . . . 0.0 111.835 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.06 44.51 97.67 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 115.181 0.832 . . . . 0.0 115.181 169.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.13 136.57 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 117.472 0.636 . . . . 0.0 110.973 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -87.38 123.4 32.29 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' B' ' 204' ' ' CYS . 3.9 pt -148.79 162.98 27.79 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.543 1.537 . . . . 0.0 109.013 -169.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.55 153.98 71.6 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.049 1.833 . . . . 0.0 111.333 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.563 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.6 tm-20 -66.97 -36.22 81.72 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.34 1.056 . . . . 0.0 113.217 -168.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 16.7 p -58.82 -41.12 86.08 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.88 0.848 . . . . 0.0 110.14 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -81.03 -19.16 44.48 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.464 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -71.48 -44.75 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -59.3 -52.65 64.74 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.952 0.901 . . . . 0.0 109.967 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -60.61 -40.13 90.74 Favored 'General case' 0 C--O 1.254 1.296 0 O-C-N 124.401 1.063 . . . . 0.0 111.608 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -43.62 80.4 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.92 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' B' ' 216' ' ' ILE . 83.4 mt -62.23 -47.04 86.19 Favored 'General case' 0 C--O 1.213 -0.847 0 O-C-N 124.167 0.917 . . . . 0.0 111.144 -177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -53.83 -32.21 52.06 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 124.112 0.882 . . . . 0.0 111.636 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.3 t -85.06 -39.35 18.09 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.442 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 92.9 m -79.8 -24.84 41.14 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.24 1.016 . . . . 0.0 112.462 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.09 -12.89 42.86 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.072 0.549 . . . . 0.0 110.223 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 46.4 m -68.24 86.15 0.27 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -105.22 169.94 8.16 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.461 1.104 . . . . 0.0 110.522 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.561 1.368 0 C-N-CA 124.693 1.197 . . . . 0.0 110.676 -173.008 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.941 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 83.4 p 54.6 -164.34 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.863 1.265 . . . . 0.0 111.825 -176.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -161.6 141.12 10.15 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.886 0.474 . . . . 0.0 110.415 171.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt -106.19 154.14 21.13 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 14.9 mp0 -102.85 124.97 49.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.181 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -121.91 159.36 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.475 1.11 . . . . 0.0 108.605 175.479 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' THR . 61.3 m-85 -114.23 116.3 28.82 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.367 0.603 . . . . 0.0 110.463 -172.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.723 HG13 ' HB2' ' A' ' 69' ' ' LEU . 2.1 t -104.26 117.79 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -109.58 110.31 21.34 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.73 0.812 . . . . 0.0 108.822 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.605 HG22 HD12 ' A' ' 69' ' ' LEU . 40.7 p -66.64 163.16 19.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.481 0.313 . . . . 0.0 111.136 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.36 -19.6 65.58 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.894 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.5 p -78.72 -9.86 59.56 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.959 0.504 . . . . 0.0 110.908 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.44 8.84 62.23 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.683 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -84.32 146.76 27.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.428 0.691 . . . . 0.0 110.267 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -108.27 140.03 42.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.271 0.628 . . . . 0.0 109.903 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -129.99 116.6 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.082 1.353 . . . . 0.0 107.72 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -93.63 120.8 34.35 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -104.64 156.47 17.95 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -127.25 83.02 2.13 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.702 HG21 HG22 ' A' ' 26' ' ' VAL . 33.7 m -146.07 178.75 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.967 0.907 . . . . 0.0 110.25 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -95.4 155.38 38.8 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.485 0.714 . . . . 0.0 109.801 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.526 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 21.3 Cg_endo -62.43 -26.97 76.86 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 121.774 1.649 . . . . 0.0 111.833 166.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -93.2 5.16 52.47 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.726 0.81 . . . . 0.0 111.321 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.82 -98.32 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.923 0.889 . . . . 0.0 110.734 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.5 t 170.11 143.54 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.353 1.461 . . . . 0.0 109.246 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.99 -32.82 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.602 0.761 . . . . 0.0 110.54 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -54.98 -41.42 71.16 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.361 1.064 . . . . 0.0 110.091 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 16.4 t-20 -79.26 -40.68 29.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.136 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.702 HG22 HG21 ' A' ' 17' ' ' VAL . 85.6 t -56.35 -44.43 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 124.112 0.883 . . . . 0.0 110.856 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 17.6 ptpt -73.45 -29.61 62.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.93 0.492 . . . . 0.0 111.231 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.78 71.84 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.731 168.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 10.0 mmpt? -72.16 -37.88 69.28 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-O 119.181 -0.437 . . . . 0.0 110.785 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.568 HD11 HG21 ' A' ' 5' ' ' VAL . 2.0 mp -55.22 -45.99 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.006 0.431 . . . . 0.0 110.054 172.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -61.9 -33.43 74.22 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.49 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -72.12 -32.31 66.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.543 0.737 . . . . 0.0 111.646 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.3 mmtt -90.65 -66.31 0.94 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.613 0.365 . . . . 0.0 110.975 -172.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -87.91 -26.84 22.52 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.92 29.35 10.63 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.06 126.02 30.25 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.7 154.05 75.82 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.841 2.361 . . . . 0.0 112.473 -173.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 20.7 Cg_endo -56.94 -19.43 32.07 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.557 2.838 . . . . 0.0 113.251 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.61 -35.74 70.57 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.876 0.87 . . . . 0.0 111.024 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -95.2 -27.92 15.29 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 123.486 0.714 . . . . 0.0 112.198 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.537 ' HB2' HD21 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -92.5 140.63 29.37 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.637 0.653 . . . . 0.0 109.809 178.084 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.444 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 19.7 ttt180 -127.8 127.89 44.32 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -96.28 123.21 39.83 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.595 0.758 . . . . 0.0 110.371 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -141.5 129.42 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.017 0.527 . . . . 0.0 109.864 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.56 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 93.7 t80 -130.81 121.98 26.31 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.19 20.81 11.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.718 0.807 . . . . 0.0 113.122 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.09 -16.96 57.77 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.0 ptpt -90.34 135.15 33.86 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.09 135.42 35.32 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.2 mt -89.29 114.21 25.57 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.689 -172.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 31.0 tt0 -76.95 138.24 39.55 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 123.603 0.761 . . . . 0.0 109.637 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.5 -37.79 82.23 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.124 0.89 . . . . 0.0 111.93 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -67.27 -22.07 72.54 Favored Glycine 0 C--N 1.348 1.235 0 O-C-N 123.675 0.609 . . . . 0.0 114.183 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.565 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 78.7 mtt180 -89.59 177.22 6.6 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.393 0.677 . . . . 0.0 111.511 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 55.6 p -109.9 169.78 8.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.522 0.729 . . . . 0.0 110.43 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 87.1 mt -55.83 -54.86 39.34 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.59 0.556 . . . . 0.0 109.705 173.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 22.8 t -61.73 -22.73 65.62 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.333 1.053 . . . . 0.0 111.798 -176.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.1 -47.39 83.04 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.565 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 36.2 m-85 -86.33 17.02 3.95 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.148 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 m120 72.96 9.76 5.39 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.144 1.378 . . . . 0.0 112.404 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.1 mt -81.66 123.09 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.7 0.8 . . . . 0.0 108.958 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -110.0 -174.18 2.43 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.181 0.592 . . . . 0.0 109.712 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 10.2 ptmm? -58.7 144.34 43.84 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.713 172.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 62.33 10.82 4.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.937 1.295 . . . . 0.0 113.644 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -70.06 132.57 46.07 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 118.17 0.441 . . . . 0.0 110.223 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 29.0 m -93.89 130.97 39.75 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.08 160.46 38.89 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.973 0.909 . . . . 0.0 109.416 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -88.7 138.69 31.19 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.203 0.525 . . . . 0.0 111.423 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.723 ' HB2' HG13 ' A' ' 5' ' ' VAL . 2.7 tm? -119.62 135.26 54.88 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.641 HG21 HD11 ' B' ' 220' ' ' LEU . 90.8 t -115.6 115.54 49.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.591 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.517 ' HB3' HD23 ' A' ' 73' ' ' LEU . 67.2 mt -81.27 99.44 8.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.128 173.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -67.69 -40.52 84.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.67 1.188 . . . . 0.0 109.144 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 71' ' ' LEU . 0.2 OUTLIER 58.37 29.93 18.87 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.037 1.335 . . . . 0.0 112.082 172.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -79.74 -7.24 58.51 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.066 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.3 36.58 1.64 Allowed Glycine 0 C--N 1.341 0.849 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.337 0 O-C-N 124.02 0.482 . . . . 0.0 113.816 174.744 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.736 0 CA-C-O 120.93 0.184 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 35.0 p -98.94 87.19 3.65 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.35 1.06 . . . . 0.0 108.967 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -116.67 -56.28 2.29 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.918 0.887 . . . . 0.0 109.641 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -94.17 165.08 12.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.694 0.798 . . . . 0.0 109.912 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 199' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' B' ' 213' ' ' GLU . 5.6 p -61.17 118.78 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.154 0.502 . . . . 0.0 110.072 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 20.1 m -76.68 146.75 37.88 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.958 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' B' ' 201' ' ' LYS . 9.4 mptt -97.7 122.22 40.54 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 172.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.27 -178.5 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.72 0.808 . . . . 0.0 110.314 -165.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -124.95 144.72 50.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.72 0.808 . . . . 0.0 109.352 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.642 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.0 t -91.09 100.46 2.99 Favored Pre-proline 0 N--CA 1.481 1.093 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.514 ' HD2' HD21 ' B' ' 220' ' ' LEU . 30.1 Cg_endo -58.56 -23.65 65.98 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.983 2.456 . . . . 0.0 114.137 -169.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.37 -53.59 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 C-N-CA 122.22 0.208 . . . . 0.0 111.555 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 17.8 p -103.34 -6.72 21.69 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.7 50.86 39.45 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.527 0.517 . . . . 0.0 114.286 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.0 m -119.09 138.97 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 123.232 0.613 . . . . 0.0 110.271 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -87.44 125.27 34.19 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.5 pt -153.47 157.04 32.8 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 125.136 1.375 . . . . 0.0 109.371 -169.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.19 165.0 31.81 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.417 2.078 . . . . 0.0 112.974 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.537 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.8 tt0 -60.03 -42.1 93.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.69 1.596 . . . . 0.0 115.006 -166.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 35.9 t -70.5 -33.58 71.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.369 -0.832 . . . . 0.0 109.976 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -71.35 -29.34 64.86 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.327 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -71.8 -37.0 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -57.49 -54.21 49.4 Favored 'General case' 0 C--O 1.244 0.806 0 O-C-N 123.803 0.689 . . . . 0.0 110.365 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -69.54 -33.3 72.59 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.973 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -46.46 90.52 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.641 HD11 HG21 ' A' ' 70' ' ' VAL . 91.2 mt -67.91 -37.43 81.7 Favored 'General case' 0 C--O 1.208 -1.09 0 O-C-N 124.129 0.893 . . . . 0.0 111.232 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.04 -32.31 63.91 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 124.538 1.149 . . . . 0.0 110.675 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 33.2 t -93.49 -36.36 12.48 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.513 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 96.9 m -77.8 -24.13 48.91 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.607 0.763 . . . . 0.0 112.802 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.4 -21.16 63.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.928 0.491 . . . . 0.0 110.459 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 14.0 m -69.14 111.04 4.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.295 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -144.56 37.69 1.22 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.275 1.03 . . . . 0.0 109.043 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.558 1.283 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.864 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 18' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.889 0 CA-C-O 120.683 0.046 . . . . 0.0 113.081 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 71.3 m -72.55 119.97 17.52 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.914 0.486 . . . . 0.0 109.862 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -153.44 -73.65 0.13 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.9 mmt -81.41 166.9 19.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.06 0.544 . . . . 0.0 110.356 -175.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.6 mp0 -114.07 136.91 52.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.262 0.625 . . . . 0.0 110.552 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -128.82 164.14 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 124.811 1.244 . . . . 0.0 108.721 172.31 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 66' ' ' THR . 69.4 m-85 -119.72 110.18 16.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.137 -174.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.502 HG21 HD11 ' A' ' 30' ' ' ILE . 50.8 t -97.03 135.22 31.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -122.09 123.77 42.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.837 0.455 . . . . 0.0 110.214 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.637 HG22 HD12 ' A' ' 69' ' ' LEU . 57.0 p -81.18 165.37 21.59 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.974 0.416 . . . . 0.0 111.728 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 70' ' ' VAL . 85.8 mt -71.38 -19.53 62.26 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.459 172.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.0 p -78.57 -17.88 55.45 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.724 0.41 . . . . 0.0 109.967 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.86 23.9 14.42 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 167.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 153.01 18.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 172.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -100.4 144.56 29.26 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 170.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.567 HD11 HG23 ' A' ' 7' ' ' THR . 5.1 mp -124.97 113.44 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.826 1.251 . . . . 0.0 107.911 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.0 m -89.45 122.04 32.26 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.3 mm? -111.19 152.36 27.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.561 0.744 . . . . 0.0 109.156 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 1' ' ' MET . 3.0 mp0 -112.81 95.32 5.35 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.626 HG21 HG22 ' A' ' 26' ' ' VAL . 33.5 m -146.34 -174.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.434 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 16.0 mt-10 -102.09 155.77 36.05 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 19.7 Cg_endo -57.98 -32.29 94.94 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.018 1.812 . . . . 0.0 111.118 167.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -98.1 18.62 15.7 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.312 0.645 . . . . 0.0 110.808 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 14.7 t70 -82.13 -92.57 0.06 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.046 0.538 . . . . 0.0 109.808 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.518 HG23 ' H ' ' A' ' 25' ' ' ASN . 15.3 t 177.81 149.49 0.18 Allowed 'General case' 0 C--N 1.367 1.361 0 C-N-CA 124.526 1.13 . . . . 0.0 110.762 174.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.0 mm -65.83 -37.19 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.591 1.157 . . . . 0.0 110.81 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -55.6 -38.57 69.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.181 0.992 . . . . 0.0 111.056 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.518 ' H ' HG23 ' A' ' 22' ' ' THR . 4.9 t-20 -76.64 -39.14 53.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.277 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 17' ' ' VAL . 64.4 t -57.67 -46.9 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 124.471 1.107 . . . . 0.0 110.759 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HA ' HD12 ' A' ' 30' ' ' ILE . 17.2 ptpt -71.3 -27.56 63.49 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.944 0.498 . . . . 0.0 111.795 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.27 -39.43 89.41 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.505 0.503 . . . . 0.0 110.911 169.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 4.4 mmtm -66.15 -37.27 85.25 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.652 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.502 HD11 HG21 ' A' ' 5' ' ' VAL . 94.3 mt -64.05 -38.42 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.649 0.78 . . . . 0.0 110.915 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.8 tt0 -64.92 -31.1 72.18 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.036 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.31 -38.91 78.48 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.398 0.279 . . . . 0.0 110.984 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.5 mmtt -85.31 -69.43 0.66 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.078 0.237 . . . . 0.0 110.699 -168.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.7 -20.49 31.12 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 122.087 0.155 . . . . 0.0 111.08 -176.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 88.06 25.96 30.15 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.451 0.469 . . . . 0.0 113.359 171.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.11 125.88 30.15 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -65.47 149.83 87.47 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.939 2.426 . . . . 0.0 112.438 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 11.6 Cg_endo -54.05 -17.6 11.56 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 124.325 3.35 . . . . 0.0 114.339 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -74.49 -41.91 59.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.302 0.641 . . . . 0.0 111.2 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.12 -33.56 22.36 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.731 0.812 . . . . 0.0 111.489 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.457 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -89.78 149.34 22.75 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.43 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 44.3 ttt180 -132.75 131.12 40.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.941 0.496 . . . . 0.0 110.207 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.84 124.84 39.11 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.687 0.795 . . . . 0.0 110.122 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.7 mt -142.52 132.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.003 0.921 . . . . 0.0 109.139 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.552 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 86.6 t80 -135.21 132.31 37.75 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 171.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.49 23.28 12.93 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.889 0.876 . . . . 0.0 112.197 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.33 -7.97 75.29 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 114.516 0.566 . . . . 0.0 114.516 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.8 ptpt -103.28 141.34 36.08 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 117.494 0.647 . . . . 0.0 109.448 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' NE2' HD22 ' B' ' 224' ' ' LEU . 8.0 tt0 -74.43 131.41 41.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.3 mt -83.25 117.97 23.31 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.407 0.283 . . . . 0.0 110.245 -176.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.76 137.96 38.0 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 123.945 0.898 . . . . 0.0 109.674 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.3 -50.26 67.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.726 1.211 . . . . 0.0 111.843 -174.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.64 -27.39 70.93 Favored Glycine 0 C--N 1.35 1.32 0 O-C-N 124.273 0.983 . . . . 0.0 114.072 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.445 ' HD3' ' OD2' ' A' ' 58' ' ' ASP . 54.5 mtt180 -77.3 175.73 9.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.316 0.646 . . . . 0.0 112.013 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 65.8 p -111.27 164.08 13.27 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.013 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 90.9 mt -55.44 -53.33 57.59 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.807 174.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 9.4 t -66.56 -20.64 66.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.263 1.025 . . . . 0.0 111.339 -173.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' OD2' ' HD3' ' A' ' 54' ' ' ARG . 12.2 t70 -67.26 -42.18 84.31 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -86.78 16.18 5.05 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.813 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m120 70.94 17.43 6.28 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.033 1.333 . . . . 0.0 112.301 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 11.1 mt -90.45 103.66 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -84.97 -178.97 6.97 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -59.4 143.47 49.62 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 64.28 11.83 6.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.13 1.372 . . . . 0.0 113.573 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.9 m -75.25 149.57 38.82 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.275 0.489 . . . . 0.0 110.614 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.7 m -101.02 130.12 46.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.974 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.61 154.85 48.46 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.95 1.3 . . . . 0.0 108.181 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -87.85 158.7 18.66 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.44 0.638 . . . . 0.0 111.888 -174.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.637 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -141.94 129.47 21.38 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.545 -1.207 . . . . 0.0 107.829 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.577 HG21 HD11 ' B' ' 220' ' ' LEU . 98.4 t -111.0 117.18 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.755 0.822 . . . . 0.0 110.112 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.68 139.86 30.36 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.123 0.969 . . . . 0.0 110.673 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.528 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 18.6 mtm180 -118.18 -44.92 2.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.748 0.819 . . . . 0.0 111.583 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.49 32.4 20.69 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.201 1.0 . . . . 0.0 112.425 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 88.0 mmt-85 -61.09 -58.04 10.04 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.725 0.81 . . . . 0.0 109.951 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.27 32.24 6.9 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 114.768 -1.106 . . . . 0.0 112.135 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.609 0 CA-C-N 116.514 0.157 . . . . 0.0 113.439 179.057 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.764 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 28.0 p -70.28 90.78 0.7 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.429 0.692 . . . . 0.0 110.124 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 197' ' ' ARG . . . . . 0.437 HH22 ' HD3' ' A' ' 74' ' ' ARG . 56.9 ttt180 -75.56 124.98 28.12 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.121 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -127.26 175.34 8.24 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.269 1.027 . . . . 0.0 109.232 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 6.3 p -70.71 83.63 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 CA-C-O 122.422 1.106 . . . . 0.0 109.264 171.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 42.3 m -78.4 136.73 37.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.856 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.53 123.68 42.83 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 202' ' ' VAL . . . . . 0.441 HG23 HG13 ' B' ' 216' ' ' ILE . 6.6 m -134.12 -178.86 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 125.379 1.472 . . . . 0.0 109.173 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -109.64 146.18 35.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.19 0.596 . . . . 0.0 111.097 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.567 ' HA ' HD11 ' B' ' 216' ' ' ILE . 49.7 t -89.46 102.36 4.32 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.322 1.049 . . . . 0.0 109.236 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.531 ' HD2' HD21 ' B' ' 220' ' ' LEU . 45.8 Cg_endo -62.28 -10.09 17.34 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.776 2.984 . . . . 0.0 114.984 -166.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 42.4 t -84.07 -60.47 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 123.054 0.542 . . . . 0.0 110.769 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 22.3 p -101.3 -6.99 23.42 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.804 0.441 . . . . 0.0 112.038 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.66 51.05 38.36 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.435 0.54 . . . . 0.0 114.207 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.12 142.22 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 123.008 0.523 . . . . 0.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -92.47 122.36 34.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.491 0.717 . . . . 0.0 109.903 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.534 HD11 ' HB2' ' B' ' 204' ' ' CYS . 3.8 pt -152.67 160.99 30.39 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.767 1.627 . . . . 0.0 109.387 -169.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.26 158.8 46.67 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.156 1.904 . . . . 0.0 111.629 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.537 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.9 tm-20 -69.75 -28.41 65.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.055 0.942 . . . . 0.0 112.104 -169.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 37.2 p -60.79 -45.82 92.9 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.657 0.741 . . . . 0.0 110.058 169.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -76.8 -18.3 58.5 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.815 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -72.21 -50.16 38.26 Favored 'Isoleucine or valine' 0 C--N 1.364 1.214 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -67.75 -35.61 79.04 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.205 0.316 . . . . 0.0 110.467 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -45.47 94.03 Favored 'General case' 0 C--O 1.254 1.313 0 O-C-N 123.886 0.741 . . . . 0.0 110.967 172.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' HIS . . . . . 0.414 ' HB3' ' SG ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -59.57 -38.58 81.53 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.78 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 70' ' ' VAL . 79.4 mt -66.21 -39.56 89.7 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 123.972 0.795 . . . . 0.0 111.295 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -55.56 -38.71 69.68 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.945 0.778 . . . . 0.0 110.88 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.2 t -88.24 -31.54 18.98 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.829 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 63.6 m -82.47 -19.73 38.29 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.645 0.778 . . . . 0.0 112.967 -173.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.48 HD22 ' NE2' ' A' ' 49' ' ' GLN . 4.6 pp -76.42 -8.65 57.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.676 0.39 . . . . 0.0 110.928 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 17.0 m -63.7 2.38 0.47 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.031 1.333 . . . . 0.0 113.185 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -57.14 98.5 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.284 1.034 . . . . 0.0 109.776 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--O 1.248 1.006 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -174.549 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 28.9 t -93.74 -46.17 7.35 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.376 0.67 . . . . 0.0 111.807 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.541 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 2.9 m80 70.57 132.61 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.62 1.168 . . . . 0.0 111.634 -170.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt -132.11 -174.39 3.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.679 1.191 . . . . 0.0 109.769 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.1 mp0 -112.35 155.61 23.85 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.469 0.708 . . . . 0.0 110.201 174.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.436 HD11 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -142.8 157.08 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 124.793 1.237 . . . . 0.0 109.218 167.226 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 66' ' ' THR . 39.0 m-85 -112.57 100.49 8.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.372 0.669 . . . . 0.0 110.322 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 69' ' ' LEU . 95.2 t -101.77 104.84 16.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -102.16 127.3 49.15 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.732 0.813 . . . . 0.0 111.137 -172.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.655 HG22 HD12 ' A' ' 69' ' ' LEU . 49.2 p -70.85 166.46 21.02 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-O 121.599 0.714 . . . . 0.0 112.782 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.421 HD11 HG22 ' A' ' 70' ' ' VAL . 68.4 mt -67.82 -23.52 65.19 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.297 171.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.7 p -78.63 -16.54 57.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.308 0.643 . . . . 0.0 110.397 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.41 5.71 39.54 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-O 119.182 -0.788 . . . . 0.0 114.856 167.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.47 151.13 24.82 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.063 0.932 . . . . 0.0 108.586 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.1 m -107.01 126.04 51.81 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.013 0.525 . . . . 0.0 110.3 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.414 HD11 HG23 ' A' ' 7' ' ' THR . 4.7 mp -107.27 110.75 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.797 0.839 . . . . 0.0 109.006 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.9 m -90.31 120.44 31.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.278 0.631 . . . . 0.0 109.446 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.5 mm? -106.9 151.75 24.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.01 0.524 . . . . 0.0 109.833 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -110.69 78.29 1.11 Allowed 'General case' 0 C--O 1.239 0.53 0 O-C-N 124.205 0.941 . . . . 0.0 108.618 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.734 HG21 HG22 ' A' ' 26' ' ' VAL . 3.4 m -144.77 172.07 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.702 0.801 . . . . 0.0 108.981 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 0' ' ' HIS . 8.1 mt-10 -93.11 158.0 38.08 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -57.65 -34.16 97.73 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.139 1.893 . . . . 0.0 112.074 169.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.2 t -102.03 21.35 14.93 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.881 0.472 . . . . 0.0 110.611 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 6.2 t70 -73.03 -87.33 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 25' ' ' ASN . 7.4 t 173.65 148.86 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.461 1.504 . . . . 0.0 109.081 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.508 HG22 ' HE3' ' A' ' 27' ' ' LYS . 44.3 mm -63.19 -38.53 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.322 1.049 . . . . 0.0 110.42 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -60.03 -33.06 71.5 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.374 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.2 t-20 -74.53 -43.26 56.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.734 HG22 HG21 ' A' ' 17' ' ' VAL . 60.6 t -56.35 -47.31 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 124.387 1.054 . . . . 0.0 110.093 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HE3' HG22 ' A' ' 23' ' ' ILE . 17.6 ptpt -74.18 -25.93 59.99 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.37 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.62 -34.26 77.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.28 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 73.6 mmtt -72.52 -32.59 66.25 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.557 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.4 mp -53.42 -45.0 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 119.05 0.841 . . . . 0.0 110.076 168.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.97 -32.99 74.72 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.507 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.99 -34.88 66.71 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.099 0.56 . . . . 0.0 111.328 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.76 -68.7 0.78 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.046 0.539 . . . . 0.0 110.952 -171.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -83.35 -21.74 33.03 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.78 20.8 35.76 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.753 -0.203 . . . . 0.0 112.942 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -107.98 122.72 39.88 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.35 153.43 78.25 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.645 2.23 . . . . 0.0 112.333 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HA ' ' HG3' ' A' ' 41' ' ' GLN . 18.4 Cg_endo -56.32 -14.38 12.17 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.715 2.943 . . . . 0.0 113.761 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -75.07 -48.78 22.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.033 0.933 . . . . 0.0 110.628 173.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -80.84 -23.83 38.86 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.511 0.724 . . . . 0.0 111.911 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.506 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -93.43 153.71 18.34 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.601 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 32.9 ttt180 -134.89 126.48 28.81 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.726 ' HG ' HD12 ' A' ' 50' ' ' LEU . 5.3 tp -100.84 122.61 43.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.839 -166.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.1 mt -139.32 133.05 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.727 0.811 . . . . 0.0 109.954 -173.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.601 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 82.6 t80 -135.32 131.97 37.11 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.78 21.62 12.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.857 0.863 . . . . 0.0 112.468 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.58 10.4 79.58 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.449 -0.341 . . . . 0.0 113.819 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 12.7 ptpt -118.39 147.57 43.41 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.286 0.634 . . . . 0.0 109.373 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.529 ' HB2' HD22 ' B' ' 224' ' ' LEU . 8.0 tt0 -75.94 127.2 32.48 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.127 0.571 . . . . 0.0 109.779 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.726 HD12 ' HG ' ' A' ' 43' ' ' LEU . 25.0 mt -80.75 123.65 28.39 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.039 0.536 . . . . 0.0 109.998 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.75 138.44 32.09 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.152 0.981 . . . . 0.0 109.707 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.53 -39.2 92.82 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.627 1.171 . . . . 0.0 112.28 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.14 -18.57 76.64 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.218 0.949 . . . . 0.0 113.816 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -88.35 178.1 6.66 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.823 0.849 . . . . 0.0 111.563 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.6 p -116.59 168.67 9.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.717 0.807 . . . . 0.0 109.874 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.5 mt -57.54 -50.73 72.13 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.1 t -61.55 -25.64 67.43 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.379 1.072 . . . . 0.0 111.554 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.64 -45.98 84.49 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 121.127 0.489 . . . . 0.0 109.688 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -85.59 17.23 3.36 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.473 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 65.73 19.98 11.45 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.402 1.081 . . . . 0.0 111.776 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.6 mt -85.58 132.68 31.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -115.8 -175.2 2.68 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -61.96 130.41 45.49 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.238 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 72.58 18.18 4.42 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.258 1.423 . . . . 0.0 111.965 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.4 m -71.05 139.92 50.58 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 53.1 m -93.72 129.66 39.98 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.456 0.473 . . . . 0.0 109.986 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.601 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -137.84 166.07 24.92 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.696 1.198 . . . . 0.0 108.891 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -96.65 148.3 23.01 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.349 0.595 . . . . 0.0 111.267 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.655 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -127.12 130.85 50.6 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 94.0 t -114.02 130.42 68.25 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 124.207 1.003 . . . . 0.0 109.936 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 92.1 mt -98.34 146.29 25.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.317 0.647 . . . . 0.0 110.95 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.623 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 65.2 mtp180 -117.18 -40.46 3.09 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.28 1.032 . . . . 0.0 110.627 177.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 71' ' ' LEU . 4.2 mm? 48.19 34.31 4.32 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.989 1.316 . . . . 0.0 113.191 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.623 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 26.1 mmm180 -74.09 -42.47 60.09 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.586 0.707 . . . . 0.0 109.271 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.74 64.67 0.49 Allowed Glycine 0 C--N 1.34 0.805 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.13 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.046 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 175.69 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.728 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 23.5 m -69.27 146.69 52.07 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.771 0.828 . . . . 0.0 111.369 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -162.46 -33.65 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.661 0.784 . . . . 0.0 109.802 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -85.92 156.8 20.35 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.8 0.84 . . . . 0.0 109.165 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.47 117.17 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 121.253 0.549 . . . . 0.0 110.543 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 200' ' ' THR . . . . . 0.531 HG22 HG13 ' B' ' 202' ' ' VAL . 29.5 m -72.49 131.86 43.09 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.096 -173.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -83.94 122.68 29.07 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' VAL . . . . . 0.531 HG13 HG22 ' B' ' 200' ' ' THR . 3.6 m -145.59 -177.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.902 0.881 . . . . 0.0 110.179 -168.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -125.81 146.7 49.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.58 0.752 . . . . 0.0 110.907 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.627 ' HA ' HD11 ' B' ' 216' ' ' ILE . 48.7 t -92.95 96.09 1.29 Allowed Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 124.651 1.18 . . . . 0.0 107.998 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.56 ' HD2' HD21 ' B' ' 220' ' ' LEU . 34.2 Cg_endo -59.79 -17.36 42.76 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.234 2.622 . . . . 0.0 114.483 -168.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.16 -56.93 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 122.789 0.436 . . . . 0.0 110.851 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 14.9 p -103.65 -0.65 29.26 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.435 0.294 . . . . 0.0 111.555 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 69.05 42.11 78.47 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 115.153 0.821 . . . . 0.0 115.153 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.01 137.51 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.318 0.559 . . . . 0.0 110.894 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -89.13 123.77 33.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.211 0.604 . . . . 0.0 109.684 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.2 pt -153.55 160.11 31.32 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.845 1.258 . . . . 0.0 110.434 -168.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.18 161.22 16.83 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.172 2.581 . . . . 0.0 113.563 171.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.571 ' O ' HG22 ' B' ' 216' ' ' ILE . 40.3 tt0 -62.79 -44.72 95.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.412 1.485 . . . . 0.0 113.096 -172.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 20.3 m -62.66 -40.99 98.78 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-O 121.978 0.894 . . . . 0.0 110.347 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -73.58 -26.3 60.75 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.249 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -69.54 -43.68 80.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -67.29 -37.42 83.38 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 123.394 0.434 . . . . 0.0 110.421 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -69.59 -40.59 76.61 Favored 'General case' 0 C--O 1.247 0.945 0 O-C-N 123.226 0.329 . . . . 0.0 111.57 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -45.45 93.15 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.48 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.56 HD21 ' HD2' ' B' ' 205' ' ' PRO . 96.3 mt -61.82 -43.62 98.48 Favored 'General case' 0 C--O 1.206 -1.196 0 O-C-N 124.431 1.082 . . . . 0.0 111.153 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.45 -27.21 56.2 Favored 'General case' 0 CA--C 1.553 1.094 0 O-C-N 124.578 1.173 . . . . 0.0 110.767 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.4 t -91.57 -39.8 11.7 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.642 0.777 . . . . 0.0 111.454 172.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 91.4 m -75.04 -23.0 58.07 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.333 1.053 . . . . 0.0 112.899 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.5 pp -85.92 -23.9 26.81 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 32.1 m -71.49 84.37 0.83 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.697 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ARG . . . . . 0.506 ' HG3' ' HG3' ' B' ' 227' ' ' GLU . 6.6 ptm180 -99.59 -36.02 9.66 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.979 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 227' ' ' GLU . . . . . 0.506 ' HG3' ' HG3' ' B' ' 226' ' ' ARG . 42.7 mt-10 . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.05 0.94 . . . . 0.0 108.484 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.038 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.8 m -84.09 115.84 22.58 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.692 0.797 . . . . 0.0 111.076 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -72.17 106.77 4.51 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.806 0.842 . . . . 0.0 109.67 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt -86.52 171.67 10.9 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.071 0.949 . . . . 0.0 111.044 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 40.4 mt-30 -107.2 138.5 43.27 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.678 0.791 . . . . 0.0 110.635 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.585 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -137.57 153.59 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.299 1.04 . . . . 0.0 109.746 176.064 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 66' ' ' THR . 81.8 m-85 -105.79 107.78 18.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.033 0.933 . . . . 0.0 109.445 -175.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.451 HG21 HD11 ' A' ' 30' ' ' ILE . 56.1 t -103.67 117.58 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -108.11 119.6 39.95 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.844 0.857 . . . . 0.0 109.615 -171.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.635 HG22 HD12 ' A' ' 69' ' ' LEU . 38.5 p -72.1 165.0 25.19 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.296 0.569 . . . . 0.0 111.461 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 70' ' ' VAL . 88.4 mt -70.37 -18.7 63.06 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.165 171.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -79.64 -12.86 59.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.908 0.483 . . . . 0.0 110.809 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.54 18.78 37.19 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.908 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 153.44 18.16 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.7 m -100.58 134.28 43.78 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.585 0.754 . . . . 0.0 110.022 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 7' ' ' THR . 5.2 mp -120.41 109.93 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.96 1.304 . . . . 0.0 107.53 174.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.2 m -94.78 130.35 41.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -112.62 154.48 25.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.72 0.808 . . . . 0.0 109.28 -177.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -110.6 71.87 0.77 Allowed 'General case' 0 C--O 1.242 0.706 0 O-C-N 124.512 1.132 . . . . 0.0 108.887 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.794 HG21 HG22 ' A' ' 26' ' ' VAL . 20.3 m -140.47 172.63 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.514 0.726 . . . . 0.0 110.169 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -102.87 161.88 21.83 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 123.639 0.775 . . . . 0.0 109.95 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 29.1 Cg_endo -59.41 -37.05 92.22 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 121.868 1.712 . . . . 0.0 111.03 171.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 p -96.64 15.72 20.93 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.872 0.869 . . . . 0.0 111.092 -174.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.75 -98.97 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.771 0.828 . . . . 0.0 109.576 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.1 t 174.75 142.45 0.05 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.989 1.316 . . . . 0.0 109.091 173.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -61.0 -38.84 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.208 1.003 . . . . 0.0 111.848 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 42.7 tt0 -57.47 -35.22 69.89 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.563 0.697 . . . . 0.0 111.483 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 16.0 t-20 -75.99 -42.23 48.86 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.213 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.794 HG22 HG21 ' A' ' 17' ' ' VAL . 61.8 t -55.27 -47.3 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 124.606 1.191 . . . . 0.0 110.367 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.408 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 16.3 ptpt -69.45 -32.2 70.99 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.079 0.551 . . . . 0.0 111.696 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.48 70.44 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.387 0.429 . . . . 0.0 110.838 170.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 8.8 mmpt? -75.96 -35.81 59.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.906 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 5' ' ' VAL . 2.2 mp -57.09 -43.4 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 118.915 0.78 . . . . 0.0 109.666 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -62.11 -31.76 72.26 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.353 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.36 -30.77 66.56 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.42 0.688 . . . . 0.0 111.541 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 72.2 mmtt -93.55 -70.37 0.71 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 117.624 0.193 . . . . 0.0 110.715 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -80.38 -25.93 38.85 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.24 0.216 . . . . 0.0 111.274 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.32 18.55 30.68 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.311 0.382 . . . . 0.0 113.928 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.75 123.83 41.07 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -70.29 156.64 61.52 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.112 2.541 . . . . 0.0 112.375 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 18.5 Cg_endo -56.23 -16.43 17.36 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.713 2.942 . . . . 0.0 114.072 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -71.8 -47.09 55.75 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 120.949 0.404 . . . . 0.0 110.197 173.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -83.2 -21.3 33.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.895 0.878 . . . . 0.0 112.216 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.47 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.1 pp0? -109.18 153.0 24.39 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.105 0.562 . . . . 0.0 110.515 177.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -138.72 138.08 37.37 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.119 0.567 . . . . 0.0 110.263 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.06 125.08 42.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.788 0.835 . . . . 0.0 110.373 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -142.86 125.04 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.015 0.926 . . . . 0.0 109.586 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.643 ' HB3' HD21 ' A' ' 50' ' ' LEU . 79.4 t80 -124.67 124.96 43.31 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.43 1.092 . . . . 0.0 108.148 177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.447 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 60.44 27.0 16.6 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.893 0.877 . . . . 0.0 112.812 175.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.52 -15.89 61.99 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 2.5 ptpt -98.73 142.32 30.43 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -83.18 132.96 35.04 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.643 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.7 mt -82.51 116.64 22.04 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.426 0.691 . . . . 0.0 110.996 -175.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -83.87 139.45 32.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.485 1.114 . . . . 0.0 110.466 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.5 m-20 -56.25 -47.92 77.57 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.603 1.161 . . . . 0.0 112.795 -172.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.49 -18.2 71.5 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 124.758 1.286 . . . . 0.0 113.893 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 62.5 mtt180 -84.96 177.53 7.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.69 0.796 . . . . 0.0 111.04 175.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.9 p -116.71 170.78 8.33 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.343 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 94.9 mt -57.35 -47.97 80.21 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 47.4 t -62.18 -26.49 68.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.755 1.222 . . . . 0.0 111.6 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 7.7 t70 -61.25 -45.47 94.4 Favored 'General case' 0 C--N 1.357 0.932 0 CA-C-O 121.532 0.682 . . . . 0.0 109.654 177.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.4 15.95 7.11 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.589 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 71.22 8.06 6.3 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.475 1.51 . . . . 0.0 112.309 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mt -77.91 129.56 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -122.83 -176.63 3.45 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -59.16 143.5 48.66 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 68.19 13.3 9.05 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.885 1.274 . . . . 0.0 112.239 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.5 m -84.91 138.76 32.32 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 57.9 m -99.27 127.31 45.25 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 110.187 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.587 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -124.13 173.67 8.15 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.25 1.42 . . . . 0.0 108.585 176.125 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -108.97 154.96 21.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.496 0.718 . . . . 0.0 110.97 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD12 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -133.79 126.17 30.02 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.589 HG11 HD11 ' B' ' 220' ' ' LEU . 90.2 t -104.95 115.85 47.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 123.518 0.727 . . . . 0.0 109.993 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.471 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 86.8 mt -85.67 147.79 26.2 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.519 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 54.9 mtp180 -121.98 -45.64 2.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.249 1.02 . . . . 0.0 110.127 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.611 ' HB3' ' HD2' ' B' ' 197' ' ' ARG . 3.9 mm? 52.46 29.27 6.8 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.501 1.121 . . . . 0.0 112.976 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.603 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 4.8 mmp_? -64.7 -43.67 92.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.577 0.751 . . . . 0.0 110.545 -176.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.95 35.85 4.47 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.831 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.453 0 CA-C-O 120.169 -0.24 . . . . 0.0 112.786 -178.192 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.08 0 CA-C-O 120.121 -0.266 . . . . 0.0 113.183 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 22.6 p -72.13 119.55 16.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.487 0.715 . . . . 0.0 110.108 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 197' ' ' ARG . . . . . 0.611 ' HD2' ' HB3' ' A' ' 73' ' ' LEU . 34.7 mmt180 -85.65 73.63 10.4 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.216 0.532 . . . . 0.0 110.307 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.17 149.91 28.9 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.352 170.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 4.8 p -61.06 104.1 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-O 121.472 0.653 . . . . 0.0 109.614 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 200' ' ' THR . . . . . 0.403 HG22 HG13 ' B' ' 202' ' ' VAL . 22.8 m -68.46 143.59 54.96 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.886 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' B' ' 201' ' ' LYS . 11.2 mptt -94.94 122.29 37.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 202' ' ' VAL . . . . . 0.403 HG13 HG22 ' B' ' 200' ' ' THR . 3.5 m -142.6 -178.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.289 1.036 . . . . 0.0 109.761 -166.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -118.73 146.31 44.86 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.256 0.622 . . . . 0.0 110.599 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.523 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.7 t -83.08 102.64 1.9 Allowed Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.518 ' HD2' HD21 ' B' ' 220' ' ' LEU . 43.7 Cg_endo -62.38 -9.6 15.96 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.319 2.679 . . . . 0.0 114.052 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.78 -65.09 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.311 0.644 . . . . 0.0 110.611 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 18.1 p -100.3 2.46 42.63 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.704 0.401 . . . . 0.0 112.061 -172.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 63.23 38.85 97.14 Favored Glycine 0 N--CA 1.477 1.388 0 N-CA-C 115.494 0.957 . . . . 0.0 115.494 170.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.65 134.41 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.077 0.551 . . . . 0.0 110.482 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -84.74 122.62 29.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.611 0.365 . . . . 0.0 110.029 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 6.0 pt -149.44 158.7 37.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 125.825 1.65 . . . . 0.0 109.484 -171.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.8 162.99 20.07 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.618 2.212 . . . . 0.0 112.839 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.546 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.5 tt0 -65.36 -36.18 83.24 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.459 1.504 . . . . 0.0 113.23 -169.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 34.2 t -69.0 -38.0 79.04 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.098 0.475 . . . . 0.0 110.04 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -76.26 -23.45 54.45 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.2 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' B' ' 220' ' ' LEU . 0.3 OUTLIER -70.91 -43.0 77.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -55.78 -52.87 62.49 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.016 0.823 . . . . 0.0 110.346 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -54.26 -47.48 72.25 Favored 'General case' 0 C--O 1.252 1.221 0 O-C-N 124.307 1.004 . . . . 0.0 111.82 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -35.06 79.13 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.991 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.589 HD11 HG11 ' A' ' 70' ' ' VAL . 71.3 mt -64.62 -51.95 60.01 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 123.529 0.518 . . . . 0.0 110.882 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -58.25 -29.41 65.75 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.569 1.168 . . . . 0.0 111.684 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 46.7 t -81.88 -43.5 18.11 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.435 0.694 . . . . 0.0 110.921 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 69.6 m -81.59 -19.03 42.77 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.251 1.02 . . . . 0.0 113.383 -170.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp -83.82 2.16 39.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.482 0.583 . . . . 0.0 111.182 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 32.1 t -51.62 103.93 0.07 Allowed 'General case' 0 C--N 1.357 0.901 0 C-N-CA 124.58 1.152 . . . . 0.0 111.107 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 -67.79 127.49 32.97 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.565 175.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 124.372 1.069 . . . . 0.0 109.611 177.446 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.145 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 60.0 m -138.76 26.4 2.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.805 0.842 . . . . 0.0 111.201 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -75.68 97.81 3.91 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 mmt -84.99 155.98 21.34 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.991 0.916 . . . . 0.0 111.065 -172.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 18.5 mp0 -92.91 124.57 36.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.488 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -122.5 157.56 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.338 1.455 . . . . 0.0 108.212 175.418 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 66' ' ' THR . 64.7 m-85 -116.81 105.51 12.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.431 -172.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 30' ' ' ILE . 40.3 t -95.08 122.26 46.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -108.9 120.04 41.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.309 0.644 . . . . 0.0 110.144 -173.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.652 HG22 HD12 ' A' ' 69' ' ' LEU . 31.6 p -77.77 167.08 22.12 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.465 0.65 . . . . 0.0 111.939 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 82.6 mt -71.28 -20.22 62.24 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.724 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -78.67 -16.94 56.7 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.954 0.502 . . . . 0.0 110.282 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.58 14.8 26.61 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -93.22 152.83 18.96 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.469 0.635 . . . . 0.0 109.436 176.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.9 m -96.29 143.25 27.53 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 7' ' ' THR . 5.0 mp -125.1 102.44 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.0 m -84.49 117.39 23.65 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -104.3 153.49 20.96 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.42 ' HG3' ' HG3' ' A' ' 2' ' ' GLN . 4.7 mp0 -114.37 90.63 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.777 HG21 HG22 ' A' ' 26' ' ' VAL . 9.2 m -139.32 169.04 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -90.13 153.13 46.73 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 42.5 Cg_endo -64.13 -26.32 65.29 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 121.975 1.783 . . . . 0.0 111.14 172.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.9 t -100.18 14.33 31.2 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.057 0.943 . . . . 0.0 110.365 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.73 -94.78 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.112 0.565 . . . . 0.0 109.57 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.2 t 179.58 145.65 0.19 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.521 1.128 . . . . 0.0 109.678 173.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.416 HG23 HD23 ' A' ' 43' ' ' LEU . 46.1 mm -61.8 -36.23 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.168 0.987 . . . . 0.0 111.196 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -57.71 -34.93 69.98 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.428 0.691 . . . . 0.0 111.009 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.416 ' H ' HG23 ' A' ' 22' ' ' THR . 15.7 t-20 -73.95 -43.29 58.73 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.152 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.777 HG22 HG21 ' A' ' 17' ' ' VAL . 38.6 t -57.71 -50.06 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 124.256 0.973 . . . . 0.0 110.735 -178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HE3' HG22 ' A' ' 23' ' ' ILE . 18.0 ptpt -67.41 -30.19 69.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.179 0.592 . . . . 0.0 111.232 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.62 78.84 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.653 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 7.2 mmpt? -73.82 -31.63 63.33 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 118.801 -0.618 . . . . 0.0 110.896 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 5' ' ' VAL . 1.7 mp -54.26 -47.87 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.638 0.654 . . . . 0.0 110.113 169.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -66.03 -30.81 71.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.395 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.24 -27.74 64.7 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.344 0.658 . . . . 0.0 111.627 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.6 mmtt -100.61 -68.84 0.79 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.711 0.404 . . . . 0.0 110.912 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -83.42 -22.36 32.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.412 0.285 . . . . 0.0 111.311 -175.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.73 6.98 57.0 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 113.883 0.313 . . . . 0.0 113.883 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -95.54 124.07 54.26 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.071 0.549 . . . . 0.0 109.764 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 40' ' ' GLN . 53.1 Cg_endo -64.31 155.91 62.87 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.525 2.817 . . . . 0.0 113.152 -174.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -56.5 -18.29 24.94 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 124.237 3.291 . . . . 0.0 113.94 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.53 -47.14 16.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.26 0.624 . . . . 0.0 110.748 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -78.59 -23.8 45.82 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.3 0.64 . . . . 0.0 111.056 -173.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.548 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.06 152.7 19.13 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.59 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 35.4 ttt180 -140.54 116.87 10.68 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 121.844 0.831 . . . . 0.0 109.032 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.729 ' HG ' HD12 ' A' ' 50' ' ' LEU . 10.6 tp -93.84 123.75 37.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.654 -162.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.533 HD11 HD21 ' B' ' 220' ' ' LEU . 96.2 mt -140.49 135.45 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 123.291 0.637 . . . . 0.0 110.775 -169.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 78.6 t80 -136.13 132.85 36.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.72 18.15 10.67 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.523 1.129 . . . . 0.0 112.61 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.67 15.48 65.71 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.86 -0.411 . . . . 0.0 113.593 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 13.6 ptpt -124.2 143.9 50.25 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.505 0.722 . . . . 0.0 109.148 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -75.5 130.67 39.27 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.779 0.431 . . . . 0.0 110.349 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.729 HD12 ' HG ' ' A' ' 43' ' ' LEU . 24.9 mt -78.49 122.03 25.33 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 123.21 0.604 . . . . 0.0 110.465 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -77.74 136.29 38.13 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.689 0.796 . . . . 0.0 108.91 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -61.62 -36.97 82.26 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.105 0.878 . . . . 0.0 112.521 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.25 -27.83 69.25 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.98 0.8 . . . . 0.0 113.166 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -76.04 176.83 7.58 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.127 0.571 . . . . 0.0 111.44 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.0 p -114.75 168.75 9.61 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.707 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 85.4 mt -55.71 -52.1 65.05 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.948 0.78 . . . . 0.0 109.532 172.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -59.13 -27.52 65.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.529 1.132 . . . . 0.0 111.83 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.13 -40.05 86.72 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.027 0.531 . . . . 0.0 110.017 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -90.39 21.37 3.91 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.918 0.887 . . . . 0.0 111.41 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 67.17 15.36 10.03 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.451 1.101 . . . . 0.0 111.884 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -88.11 134.36 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -122.9 -173.59 2.74 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.453 0.701 . . . . 0.0 109.266 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 11.7 ptmm? -59.04 144.0 46.7 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.918 170.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 65.05 7.6 4.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.614 1.566 . . . . 0.0 112.968 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -72.4 129.86 39.35 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 118.112 0.414 . . . . 0.0 109.897 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 20.0 m -99.43 140.91 32.91 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.531 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -143.58 173.87 11.27 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.09 0.956 . . . . 0.0 109.344 -175.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -97.54 154.63 17.39 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.691 0.758 . . . . 0.0 111.601 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.652 HD12 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -137.49 119.33 15.22 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.484 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.638 HG21 HD22 ' B' ' 220' ' ' LEU . 53.1 t -93.31 110.31 23.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.581 0.752 . . . . 0.0 110.368 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.6 mt -78.25 137.78 38.29 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.748 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -115.54 -48.62 2.77 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.19 0.996 . . . . 0.0 109.641 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 48.75 45.83 21.77 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.185 1.394 . . . . 0.0 112.196 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -68.74 -36.09 77.95 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.316 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.13 14.83 56.47 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.274 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.586 0 CA-C-N 117.195 0.497 . . . . 0.0 112.185 178.392 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.101 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 60.8 p -78.04 79.31 4.51 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.531 0.681 . . . . 0.0 109.944 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -64.71 -35.01 79.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.162 0.985 . . . . 0.0 110.17 175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -128.32 158.39 38.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.793 1.237 . . . . 0.0 107.794 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 2.4 p -58.06 108.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 CA-C-O 121.377 0.608 . . . . 0.0 110.678 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 5.6 m -69.6 138.03 52.79 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.0 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -95.54 127.32 41.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 171.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 6.0 m -145.38 -177.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.135 1.374 . . . . 0.0 109.28 -162.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -115.18 137.2 52.29 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 122.464 0.306 . . . . 0.0 111.522 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.524 ' HA ' HD11 ' B' ' 216' ' ' ILE . 48.8 t -79.91 101.43 0.84 Allowed Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.406 ' HD3' HD11 ' B' ' 216' ' ' ILE . 91.9 Cg_endo -71.0 -1.09 8.95 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.796 2.33 . . . . 0.0 114.592 -159.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 23.3 t -93.88 -62.95 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.2 p -89.47 -10.51 46.09 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.745 0.418 . . . . 0.0 111.52 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.14 57.7 17.2 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 124.321 0.962 . . . . 0.0 114.195 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 32.6 m -117.94 135.62 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.399 0.68 . . . . 0.0 109.263 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -83.85 113.03 20.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.497 HD11 ' HB2' ' B' ' 204' ' ' CYS . 7.9 pt -142.5 156.04 63.73 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.808 1.243 . . . . 0.0 110.287 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.92 163.34 14.04 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.946 2.431 . . . . 0.0 113.186 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.576 ' O ' HG22 ' B' ' 216' ' ' ILE . 43.8 tt0 -65.47 -37.04 85.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.176 1.39 . . . . 0.0 113.131 -166.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 23.3 t -65.48 -43.6 89.72 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.369 0.605 . . . . 0.0 109.743 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -69.81 -25.01 63.57 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.402 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.576 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -70.24 -44.03 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.324 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -61.88 -46.43 89.46 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 123.686 0.616 . . . . 0.0 110.508 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -47.79 78.9 Favored 'General case' 0 C--O 1.25 1.093 0 O-C-N 124.0 0.813 . . . . 0.0 112.469 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.53 -37.75 88.49 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.569 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.638 HD22 HG21 ' A' ' 70' ' ' VAL . 62.6 tp -62.48 -42.59 99.59 Favored 'General case' 0 C--O 1.215 -0.723 0 O-C-N 124.28 0.988 . . . . 0.0 111.452 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -53.23 -40.35 64.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.856 0.722 . . . . 0.0 110.342 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.2 t -75.53 -41.87 53.99 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.324 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 96.0 m -77.9 -19.04 55.44 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.169 0.987 . . . . 0.0 112.878 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.625 HD23 ' HG ' ' B' ' 220' ' ' LEU . 4.2 pp -90.15 -5.22 56.7 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.647 0.379 . . . . 0.0 110.73 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 20.8 t -71.52 87.52 0.9 Allowed 'General case' 0 C--N 1.356 0.878 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -113.59 138.68 49.82 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.185 0.994 . . . . 0.0 110.427 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 CA--C 1.559 1.318 0 C-N-CA 124.002 0.921 . . . . 0.0 109.93 -176.26 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 22.7 t -69.73 122.51 19.32 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -81.11 119.04 23.06 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.035 0.934 . . . . 0.0 110.421 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt -80.0 158.48 26.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.487 1.115 . . . . 0.0 110.338 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 77.7 mt-30 -104.72 123.22 47.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.516 0.726 . . . . 0.0 110.572 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -123.85 155.27 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.538 1.135 . . . . 0.0 109.623 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -108.28 103.88 13.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.921 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.614 HG12 ' HB2' ' A' ' 69' ' ' LEU . 92.3 t -104.65 100.17 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.99 122.52 43.01 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.595 0.758 . . . . 0.0 111.129 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.622 HG22 HD12 ' A' ' 69' ' ' LEU . 37.4 p -67.71 162.97 22.57 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.608 0.763 . . . . 0.0 112.219 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.33 -15.69 63.39 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.138 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.5 p -80.21 0.01 34.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.47 0.708 . . . . 0.0 111.202 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.53 9.3 75.71 Favored Glycine 0 C--N 1.351 1.39 0 C-N-CA 123.235 0.445 . . . . 0.0 113.376 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -94.23 141.6 28.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.036 0.934 . . . . 0.0 109.237 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 m -105.22 136.6 44.44 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.831 0.452 . . . . 0.0 110.534 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.34 109.84 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.086 0.954 . . . . 0.0 109.021 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.0 m -84.72 122.49 29.17 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.6 mm? -108.95 159.05 17.13 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -124.02 82.25 2.01 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.677 HG21 HG22 ' A' ' 26' ' ' VAL . 15.4 m -140.84 172.6 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.999 0.92 . . . . 0.0 109.775 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.93 149.15 35.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 30.1 Cg_endo -61.79 -27.06 80.18 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.085 1.856 . . . . 0.0 111.904 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.4 t -99.87 16.62 23.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.776 0.43 . . . . 0.0 110.308 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.79 -98.58 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 119.108 -0.472 . . . . 0.0 109.797 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -170.5 143.85 2.32 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 125.447 1.499 . . . . 0.0 108.786 175.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.37 -37.38 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.885 0.874 . . . . 0.0 110.639 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.98 -36.19 72.27 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.039 0.936 . . . . 0.0 110.849 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.475 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 24.3 t-20 -70.84 -46.42 62.76 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.397 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.677 HG22 HG21 ' A' ' 17' ' ' VAL . 67.0 t -55.87 -44.51 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 124.158 0.911 . . . . 0.0 110.85 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -71.93 -30.12 65.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.797 0.439 . . . . 0.0 111.748 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.68 -32.6 74.34 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.809 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 10.3 mmpt? -71.36 -35.21 71.04 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.526 0.516 . . . . 0.0 110.607 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.28 -46.04 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 122.877 0.471 . . . . 0.0 110.47 169.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -65.87 -23.3 66.63 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.3 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.08 -31.03 27.53 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.163 0.985 . . . . 0.0 111.327 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.1 mmtt -91.85 -70.43 0.69 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.621 0.368 . . . . 0.0 110.95 -174.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -86.72 -24.33 25.2 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.724 0.41 . . . . 0.0 111.236 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.48 35.71 8.47 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.436 0.46 . . . . 0.0 112.777 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -111.75 126.11 29.11 Favored Pre-proline 0 CA--C 1.556 1.188 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.49 151.49 79.86 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.221 2.614 . . . . 0.0 112.766 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.26 -13.94 26.82 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.137 3.225 . . . . 0.0 114.25 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.42 -43.66 39.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.377 0.671 . . . . 0.0 110.183 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.46 -35.59 30.37 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.629 0.772 . . . . 0.0 111.124 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.48 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.3 pp0? -88.76 148.73 23.79 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.813 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 39.8 ttt180 -135.47 130.96 35.52 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.333 0.653 . . . . 0.0 109.432 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -95.02 122.69 37.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.498 0.719 . . . . 0.0 110.232 -174.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -141.42 117.74 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.671 0.789 . . . . 0.0 110.027 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.52 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 88.5 t80 -117.38 126.98 53.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.307 1.043 . . . . 0.0 108.644 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.24 23.03 13.29 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.008 0.923 . . . . 0.0 112.691 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.79 1.64 65.5 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 114.274 0.47 . . . . 0.0 114.274 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.5 ptpt -112.56 145.81 39.66 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -80.76 140.97 35.22 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.513 HD21 ' HB3' ' A' ' 45' ' ' PHE . 19.8 mt -94.11 122.91 37.12 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.143 0.577 . . . . 0.0 110.538 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.49 140.31 29.66 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.346 1.058 . . . . 0.0 110.186 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.54 -52.04 56.78 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.57 1.548 . . . . 0.0 113.251 -173.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.67 -20.36 70.07 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 124.573 1.171 . . . . 0.0 113.922 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 -82.75 177.33 8.72 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.016 0.526 . . . . 0.0 110.681 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.8 p -116.82 168.79 9.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.317 0.647 . . . . 0.0 109.877 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 98.1 mt -57.21 -52.07 66.79 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -62.75 -25.16 68.06 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.302 1.041 . . . . 0.0 111.445 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.82 -40.95 96.02 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -91.16 17.03 8.68 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.153 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 69.54 17.16 8.01 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.578 1.151 . . . . 0.0 112.215 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.9 mt -87.52 139.78 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -137.6 -167.85 2.21 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -55.66 142.39 34.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.234 0.614 . . . . 0.0 112.031 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 56.24 14.62 1.6 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.248 1.419 . . . . 0.0 114.157 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 m -75.72 132.84 40.77 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.1 m -97.2 124.76 41.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.361 0.6 . . . . 0.0 110.012 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.52 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -127.42 174.67 8.82 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.178 1.391 . . . . 0.0 108.507 176.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -109.08 146.67 33.63 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.505 0.722 . . . . 0.0 111.102 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.622 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -122.28 125.71 46.59 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.813 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 79.5 t -105.26 124.27 59.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 123.62 0.768 . . . . 0.0 110.009 -175.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.556 ' HB3' HD23 ' A' ' 73' ' ' LEU . 83.1 mt -96.64 115.37 27.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.101 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -85.81 -46.06 11.01 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 169.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 71' ' ' LEU . 2.8 mm? 50.44 45.84 25.95 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.42 1.488 . . . . 0.0 113.511 172.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -67.64 87.06 0.21 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.227 166.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.48 -39.79 0.74 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.855 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.281 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 -177.822 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.637 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 36.7 t -75.6 133.73 40.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.113 0.565 . . . . 0.0 110.43 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -117.07 11.24 14.17 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.965 0.906 . . . . 0.0 108.99 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -121.9 175.02 6.52 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.743 0.817 . . . . 0.0 110.773 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.82 99.02 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.397 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 200' ' ' THR . . . . . 0.438 HG22 HG13 ' B' ' 202' ' ' VAL . 18.1 m -71.2 135.43 47.54 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.578 0.751 . . . . 0.0 110.096 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -95.76 123.88 39.53 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 202' ' ' VAL . . . . . 0.438 HG13 HG22 ' B' ' 200' ' ' THR . 2.9 m -146.59 152.56 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.841 1.256 . . . . 0.0 109.58 -171.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -90.67 146.78 23.74 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.121 0.568 . . . . 0.0 111.584 -173.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.658 ' HA ' HD11 ' B' ' 216' ' ' ILE . 37.4 t -88.69 97.91 0.98 Allowed Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.716 1.206 . . . . 0.0 108.184 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.608 ' HD2' HD21 ' B' ' 220' ' ' LEU . 33.2 Cg_endo -59.62 -14.96 28.56 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.37 2.713 . . . . 0.0 114.777 -168.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 33.4 t -84.37 -46.88 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 122.686 0.395 . . . . 0.0 111.245 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' CYS . . . . . 0.428 ' SG ' HG22 ' B' ' 209' ' ' VAL . 20.5 p -111.56 -3.36 15.14 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.93 42.75 84.92 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' VAL . . . . . 0.428 HG22 ' SG ' ' B' ' 207' ' ' CYS . 22.8 m -117.86 133.43 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 117.448 0.624 . . . . 0.0 110.418 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -86.63 121.88 29.76 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' B' ' 204' ' ' CYS . 5.9 pt -146.6 162.87 32.29 Favored Pre-proline 0 N--CA 1.484 1.264 0 C-N-CA 124.878 1.271 . . . . 0.0 110.673 -169.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -58.33 161.58 13.77 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.678 2.252 . . . . 0.0 113.505 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.569 ' O ' HG22 ' B' ' 216' ' ' ILE . 33.8 tt0 -65.62 -42.56 91.41 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.079 1.351 . . . . 0.0 112.788 -169.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 21.2 m -72.24 -35.89 68.95 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.623 -0.673 . . . . 0.0 110.432 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -74.5 -22.0 59.28 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.331 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.4 OUTLIER -69.09 -47.17 76.45 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -62.4 -39.2 92.46 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 123.77 0.669 . . . . 0.0 110.862 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -70.65 -42.91 70.2 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.104 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -36.69 84.08 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.608 HD21 ' HD2' ' B' ' 205' ' ' PRO . 87.3 mt -69.74 -42.46 73.89 Favored 'General case' 0 C--O 1.21 -0.995 0 O-C-N 124.321 1.013 . . . . 0.0 111.138 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -58.21 -25.54 61.76 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.505 1.128 . . . . 0.0 110.682 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 30.5 t -89.8 -44.08 10.21 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.056 170.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.8 m -70.19 -20.46 63.12 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.327 1.051 . . . . 0.0 113.062 -171.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.99 -1.3 57.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.909 0.484 . . . . 0.0 112.168 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 70.5 p -69.49 83.75 0.41 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.811 0.815 . . . . 0.0 109.86 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 19.4 mmm-85 -110.77 -20.45 12.49 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.377 1.071 . . . . 0.0 110.86 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 123.829 0.851 . . . . 0.0 112.126 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.6 m -69.28 106.05 2.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.864 0.866 . . . . 0.0 109.38 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 6.3 p80 -71.76 96.89 1.68 Allowed 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.762 0.792 . . . . 0.0 110.566 -171.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' HE3' ' A' ' 63' ' ' LYS . 21.2 mmt -101.43 146.76 27.18 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 172.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.3 mp0 -95.92 128.56 42.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.693 -172.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.09 147.76 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.793 1.237 . . . . 0.0 108.425 173.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' THR . 31.2 m-85 -103.29 101.58 11.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.283 0.633 . . . . 0.0 109.778 -172.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 69' ' ' LEU . 11.5 t -96.99 117.93 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -108.28 124.94 51.08 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.442 0.697 . . . . 0.0 109.445 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.597 HG22 HD12 ' A' ' 69' ' ' LEU . 35.3 p -73.16 167.24 21.57 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.489 0.661 . . . . 0.0 111.314 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.456 HD11 HG22 ' A' ' 70' ' ' VAL . 43.2 mt -68.81 -24.05 64.34 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.79 172.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p -78.69 -14.24 59.4 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.6 0.76 . . . . 0.0 110.758 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.99 18.9 32.68 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.033 0.373 . . . . 0.0 114.033 170.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.17 153.16 18.8 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 m -102.0 145.9 28.63 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.042 0.449 . . . . 0.0 110.053 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.537 HD11 HG23 ' A' ' 7' ' ' THR . 5.3 mp -128.88 108.68 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 m -87.91 115.44 25.38 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -103.35 152.2 21.86 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.66 ' HB3' ' HB2' ' A' ' 0' ' ' HIS . 37.1 mt-10 -128.29 79.42 1.9 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -171.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.645 HG21 HG22 ' A' ' 26' ' ' VAL . 30.0 m -146.07 179.02 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.673 1.189 . . . . 0.0 109.081 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -85.31 153.12 59.01 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.2 Cg_endo -59.09 -32.82 98.02 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 121.827 1.685 . . . . 0.0 110.85 164.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -91.96 8.88 35.49 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.018 0.927 . . . . 0.0 111.479 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -74.46 -92.3 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.342 0.657 . . . . 0.0 110.074 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 26' ' ' VAL . 8.9 t 177.08 145.5 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.48 1.112 . . . . 0.0 109.84 171.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.75 -34.25 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.177 0.991 . . . . 0.0 110.684 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.68 -40.77 66.24 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.953 0.901 . . . . 0.0 110.66 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.477 ' H ' HG23 ' A' ' 22' ' ' THR . 10.5 t-20 -77.31 -43.39 33.27 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.031 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.645 HG22 HG21 ' A' ' 17' ' ' VAL . 99.4 t -56.86 -44.25 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 124.361 1.038 . . . . 0.0 110.442 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HB2' ' OE1' ' A' ' 41' ' ' GLN . 16.6 ptpt -71.78 -32.58 67.8 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.947 0.499 . . . . 0.0 110.609 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.09 -28.41 68.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.858 0.463 . . . . 0.0 111.164 169.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 9.8 mmpt? -72.78 -37.06 67.73 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 122.9 0.48 . . . . 0.0 110.247 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.442 HG13 HG21 ' A' ' 13' ' ' ILE . 2.2 mp -58.53 -42.58 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 118.413 0.551 . . . . 0.0 109.838 172.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.05 -27.98 69.77 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.326 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.33 -27.87 47.21 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.614 0.766 . . . . 0.0 111.622 174.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.3 mmtt -95.69 -68.02 0.82 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.986 -0.446 . . . . 0.0 111.025 -174.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 30' ' ' ILE . 15.1 pt-20 -85.51 -20.09 30.2 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.703 0.229 . . . . 0.0 111.549 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 24.76 35.68 Favored Glycine 0 C--N 1.347 1.17 0 O-C-N 122.946 0.154 . . . . 0.0 113.231 171.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.47 127.44 27.83 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.8 151.69 74.17 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.975 2.45 . . . . 0.0 112.486 -174.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 18.6 Cg_endo -57.43 -14.1 15.27 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.976 3.117 . . . . 0.0 114.782 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.21 -44.64 68.23 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 123.486 0.492 . . . . 0.0 110.202 172.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.11 -35.65 20.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.022 0.929 . . . . 0.0 111.882 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.715 HE21 HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -94.16 120.29 34.19 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.014 0.435 . . . . 0.0 109.849 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.604 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.1 ttt180 -106.86 128.7 54.51 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.048 0.939 . . . . 0.0 109.544 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.496 HD21 HE22 ' A' ' 41' ' ' GLN . 4.6 mm? -94.09 127.76 40.09 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.837 0.855 . . . . 0.0 109.653 -174.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -141.54 131.54 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.676 0.79 . . . . 0.0 110.199 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.577 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 74.2 t80 -136.79 128.4 28.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.68 21.79 11.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.512 1.125 . . . . 0.0 112.164 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.66 -0.03 73.18 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.446 -0.641 . . . . 0.0 114.047 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.7 ptpt -112.42 151.51 29.76 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 117.711 0.755 . . . . 0.0 110.394 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' HD22 ' B' ' 224' ' ' LEU . 29.5 tt0 -77.32 133.04 38.88 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.171 0.589 . . . . 0.0 110.343 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 45' ' ' PHE . 24.2 mt -85.95 120.47 27.38 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 122.764 0.426 . . . . 0.0 110.258 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.74 136.1 36.68 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 123.731 0.813 . . . . 0.0 109.102 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.42 -38.08 82.9 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.142 0.902 . . . . 0.0 111.591 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.61 -38.52 96.53 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.844 0.715 . . . . 0.0 112.867 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -75.07 177.57 6.3 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.733 0.813 . . . . 0.0 112.034 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.7 p -110.43 167.52 10.15 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.66 0.784 . . . . 0.0 110.093 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.1 mt -55.78 -51.4 67.57 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 t -63.19 -24.02 67.69 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.47 1.108 . . . . 0.0 111.771 -175.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.13 -31.65 66.2 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.182 0.515 . . . . 0.0 109.909 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -94.53 17.5 13.08 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.626 0.77 . . . . 0.0 111.747 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 68.75 16.65 8.92 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.447 1.099 . . . . 0.0 112.038 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.6 mt -88.05 119.48 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -99.36 179.77 4.47 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HE3' ' SD ' ' A' ' 1' ' ' MET . 8.7 ptmm? -60.3 142.78 54.2 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 170.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 68.33 9.5 7.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.918 1.287 . . . . 0.0 113.424 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -70.73 137.59 49.81 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 26.2 m -97.88 126.14 43.11 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.577 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -133.11 172.58 12.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.569 1.147 . . . . 0.0 108.854 -178.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -101.48 154.86 18.46 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.522 0.677 . . . . 0.0 111.68 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.715 HD21 HE21 ' A' ' 41' ' ' GLN . 2.2 tm? -135.88 132.81 37.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.206 -1.361 . . . . 0.0 107.936 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 99.5 t -117.0 124.04 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.929 0.892 . . . . 0.0 110.575 -175.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.434 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 86.5 mt -92.49 120.71 33.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.095 0.558 . . . . 0.0 109.685 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -90.72 -37.21 13.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.095 0.958 . . . . 0.0 109.612 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.434 ' HG ' ' HB3' ' A' ' 71' ' ' LEU . 92.8 mt 47.89 35.93 5.46 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.357 1.463 . . . . 0.0 113.154 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -58.4 -26.2 62.97 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.754 1.222 . . . . 0.0 112.013 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.53 45.24 0.66 Allowed Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 171.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.235 0 N-CA-C 112.309 -0.316 . . . . 0.0 112.309 -175.206 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.764 0 N-CA-C 112.096 -0.401 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 20.5 m -82.32 92.54 6.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.491 0.716 . . . . 0.0 110.569 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -94.25 -6.21 45.08 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.519 0.728 . . . . 0.0 109.454 170.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -123.46 162.62 22.47 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.213 1.405 . . . . 0.0 108.732 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.49 115.03 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.267 0.556 . . . . 0.0 109.66 175.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 200' ' ' THR . . . . . 0.559 HG22 HG13 ' B' ' 202' ' ' VAL . 25.0 m -71.51 133.76 46.05 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.236 -168.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -87.76 123.24 32.36 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 202' ' ' VAL . . . . . 0.559 HG13 HG22 ' B' ' 200' ' ' THR . 4.0 m -141.38 -176.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.388 1.075 . . . . 0.0 109.48 -170.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -123.67 143.37 50.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.283 0.633 . . . . 0.0 110.042 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.628 ' HA ' HD11 ' B' ' 216' ' ' ILE . 49.7 t -84.66 97.85 0.55 Allowed Pre-proline 0 N--CA 1.478 0.943 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.576 ' HD2' HD21 ' B' ' 220' ' ' LEU . 27.4 Cg_endo -57.57 -25.57 67.82 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 123.332 2.688 . . . . 0.0 113.563 -171.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.59 -52.39 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 O-C-N 123.692 0.62 . . . . 0.0 111.275 -172.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.2 p -107.41 -4.01 18.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.53 45.82 35.04 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 115.18 0.832 . . . . 0.0 115.18 169.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 34.5 m -119.82 139.44 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.536 0.734 . . . . 0.0 110.677 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -89.28 115.83 27.05 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.502 HD11 ' HB2' ' B' ' 204' ' ' CYS . 12.3 pt -145.14 156.16 54.59 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.939 1.296 . . . . 0.0 109.815 -171.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.95 165.45 23.74 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.852 2.368 . . . . 0.0 113.946 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.6 ' O ' HG22 ' B' ' 216' ' ' ILE . 32.9 tt0 -56.79 -47.02 81.14 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 126.376 1.87 . . . . 0.0 114.318 -167.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 14.6 m -69.9 -37.87 76.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.13 -0.981 . . . . 0.0 110.391 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -67.16 -31.43 71.85 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.949 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.628 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -69.66 -46.46 75.0 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -176.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.47 -43.43 98.87 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.55 0.531 . . . . 0.0 110.73 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -59.91 -51.58 69.09 Favored 'General case' 0 C--O 1.253 1.245 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.487 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' HIS . . . . . 0.4 ' O ' ' SG ' ' B' ' 223' ' ' CYS . 0.2 OUTLIER -57.19 -41.7 79.84 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.864 -175.248 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 70' ' ' VAL . 96.7 mt -58.92 -53.86 53.62 Favored 'General case' 0 C--O 1.202 -1.398 0 O-C-N 124.399 1.062 . . . . 0.0 111.075 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.52 -30.18 60.22 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.767 1.292 . . . . 0.0 111.43 -171.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.8 t -83.44 -45.02 14.13 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.317 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' B' ' 219' ' ' HIS . 88.0 m -68.94 -29.02 67.17 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.63 1.172 . . . . 0.0 112.642 -173.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.2 pp -94.4 -23.64 17.68 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.6 0.76 . . . . 0.0 109.936 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 27.0 t -67.44 -30.38 70.09 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.537 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.16 77.6 3.7 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 167.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.494 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 23.2 p -70.98 113.95 8.54 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.594 0.757 . . . . 0.0 111.128 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -107.89 178.19 4.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.366 0.666 . . . . 0.0 109.888 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt -113.42 167.45 10.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.568 0.747 . . . . 0.0 109.651 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -120.5 142.95 48.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.737 0.415 . . . . 0.0 110.744 176.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -132.29 155.15 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.702 1.201 . . . . 0.0 109.385 175.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' THR . 92.2 m-85 -112.99 108.45 17.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.694 0.797 . . . . 0.0 109.648 -174.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' A' ' 69' ' ' LEU . 69.6 t -105.86 119.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -106.87 125.66 51.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.806 0.842 . . . . 0.0 110.281 -171.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.703 HG22 HD12 ' A' ' 69' ' ' LEU . 77.2 p -76.45 168.61 19.77 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.367 0.531 . . . . 0.0 111.793 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.5 mt -70.62 -22.93 62.47 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.256 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -80.18 -5.6 56.35 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.277 0.631 . . . . 0.0 111.056 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.78 20.65 46.33 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.352 -0.385 . . . . 0.0 113.999 167.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.14 153.21 18.23 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.5 m -104.11 134.37 47.49 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.239 0.616 . . . . 0.0 110.791 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 7' ' ' THR . 5.3 mp -118.61 109.59 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.326 1.05 . . . . 0.0 108.44 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.0 m -91.21 119.26 31.15 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.136 0.575 . . . . 0.0 109.494 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.9 mm? -104.98 155.73 18.68 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.446 0.698 . . . . 0.0 109.631 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -121.9 72.55 1.03 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.957 0.903 . . . . 0.0 108.695 -174.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.81 HG21 HG22 ' A' ' 26' ' ' VAL . 31.3 m -138.57 -176.23 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.945 0.898 . . . . 0.0 109.382 -174.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -108.43 158.03 34.93 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 122.966 0.506 . . . . 0.0 110.592 -172.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 38.0 Cg_endo -63.18 -28.15 73.19 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.504 2.136 . . . . 0.0 111.925 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 t -109.14 25.21 12.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.508 0.723 . . . . 0.0 109.633 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.02 -99.71 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.267 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 26' ' ' VAL . 10.1 t 173.55 140.44 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.275 1.43 . . . . 0.0 108.812 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mm -58.67 -37.43 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.583 1.153 . . . . 0.0 111.984 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 43.5 tt0 -58.32 -38.22 76.68 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.508 0.723 . . . . 0.0 111.062 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.509 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 9.7 t30 -74.06 -41.92 61.0 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.043 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.81 HG22 HG21 ' A' ' 17' ' ' VAL . 48.5 t -58.74 -45.71 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 124.231 0.957 . . . . 0.0 110.623 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 30' ' ' ILE . 18.4 ptpt -73.92 -27.49 61.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.271 0.628 . . . . 0.0 111.602 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.94 79.16 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.397 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 67.9 mmtt -74.12 -27.52 60.9 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.753 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 27' ' ' LYS . 91.9 mt -67.0 -36.09 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 120.999 0.428 . . . . 0.0 110.028 175.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -65.39 -33.62 76.38 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.657 169.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.44 -23.01 62.65 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.435 0.694 . . . . 0.0 111.581 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 73.0 mmtt -98.66 -67.66 0.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.92 0.327 . . . . 0.0 110.984 -177.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.09 -24.37 30.38 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.03 7.82 55.95 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 120.013 -0.326 . . . . 0.0 113.846 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.22 124.92 43.28 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 73.3 Cg_endo -68.33 154.7 71.48 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.232 2.621 . . . . 0.0 112.773 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 13.7 Cg_endo -53.99 -15.66 7.8 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.961 3.107 . . . . 0.0 114.134 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.45 -41.96 37.79 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.852 0.861 . . . . 0.0 110.702 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -92.43 -19.02 22.47 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.91 0.884 . . . . 0.0 113.071 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.483 HE22 ' HB2' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -103.14 149.73 24.34 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 173.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.488 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 38.5 ttt180 -134.68 129.99 35.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.26 0.624 . . . . 0.0 109.723 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.451 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.6 mm? -95.48 123.66 39.13 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.583 0.753 . . . . 0.0 110.549 -172.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.6 mt -141.93 124.71 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.672 0.789 . . . . 0.0 109.873 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 87.0 t80 -124.79 123.01 39.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.332 1.053 . . . . 0.0 108.191 175.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.02 25.92 15.19 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.837 0.855 . . . . 0.0 112.461 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.36 -21.5 45.16 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 122.956 0.313 . . . . 0.0 113.671 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 5.1 ptpt -91.11 134.47 34.49 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 117.362 0.581 . . . . 0.0 109.603 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.7 139.65 39.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 43' ' ' LEU . 24.3 mt -92.07 121.77 33.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.945 0.498 . . . . 0.0 110.96 -171.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.24 138.02 38.41 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.471 1.108 . . . . 0.0 109.973 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.0 m-20 -61.59 -42.49 98.94 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.3 1.04 . . . . 0.0 112.042 -172.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.84 -25.55 75.16 Favored Glycine 0 C--N 1.343 0.941 0 O-C-N 124.184 0.927 . . . . 0.0 113.467 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -78.86 177.24 8.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.997 0.519 . . . . 0.0 111.973 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.5 p -114.68 167.11 11.04 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.979 0.912 . . . . 0.0 110.228 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 87.9 mt -55.58 -56.23 22.77 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.704 0.628 . . . . 0.0 110.518 176.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 31.1 t -65.48 -18.35 65.25 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.981 0.912 . . . . 0.0 112.013 -174.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.0 -46.01 83.21 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.485 0.66 . . . . 0.0 109.34 173.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -86.21 18.66 3.02 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.094 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 m120 70.54 18.61 6.46 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.422 1.089 . . . . 0.0 111.802 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.4 mt -92.57 110.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -98.71 -174.7 2.86 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -65.14 135.59 55.68 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.95 0.405 . . . . 0.0 110.514 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 68.75 17.21 8.87 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.241 1.416 . . . . 0.0 111.811 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -72.27 139.08 47.88 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 168.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 41.1 m -101.36 128.38 47.56 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.531 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -133.48 168.09 19.26 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.27 1.028 . . . . 0.0 109.044 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -93.87 153.02 18.48 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.496 0.718 . . . . 0.0 111.406 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -134.21 129.45 35.75 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.587 HG21 HD11 ' B' ' 220' ' ' LEU . 95.4 t -112.09 117.56 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 123.424 0.69 . . . . 0.0 109.76 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.94 150.88 28.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.332 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.744 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 80.0 mtp180 -121.62 -49.86 2.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.816 0.847 . . . . 0.0 109.599 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 55.51 30.93 16.07 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.664 1.185 . . . . 0.0 112.017 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.744 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 27.4 mmm180 -75.48 -24.43 56.93 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.251 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.63 15.76 56.92 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.973 172.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.524 0 CA-C-O 120.169 -0.239 . . . . 0.0 112.564 -176.012 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.785 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 25.8 m -80.36 98.72 7.59 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.954 0.502 . . . . 0.0 110.204 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -76.83 -16.37 59.45 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.697 0.799 . . . . 0.0 111.27 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -70.72 174.22 6.25 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.86 0.864 . . . . 0.0 111.874 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.1 p -55.34 101.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.36 0 C-N-CA 124.33 1.052 . . . . 0.0 111.759 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 70.3 m -85.87 128.3 34.79 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.871 0.868 . . . . 0.0 110.555 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -86.33 124.43 32.68 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 9.7 m -140.74 -176.73 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.063 1.345 . . . . 0.0 108.858 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -120.21 147.03 45.46 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.652 0.381 . . . . 0.0 110.244 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.631 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.5 t -86.87 101.34 2.05 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.995 0.918 . . . . 0.0 109.087 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.503 ' HD2' HD21 ' B' ' 220' ' ' LEU . 96.6 Cg_endo -72.13 11.4 0.74 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.834 2.356 . . . . 0.0 115.126 -166.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 19.5 t -103.54 -52.78 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.562 0.745 . . . . 0.0 110.24 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.9 p -106.87 -6.3 17.74 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.126 0.57 . . . . 0.0 111.628 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 59.79 59.19 10.95 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 124.467 1.032 . . . . 0.0 115.405 176.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.89 134.78 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.228 0.611 . . . . 0.0 110.007 173.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -76.87 120.49 22.07 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.573 HD11 ' HB2' ' B' ' 204' ' ' CYS . 5.4 pt -148.97 162.15 30.17 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 125.443 1.497 . . . . 0.0 109.112 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -65.85 161.19 40.36 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.545 2.164 . . . . 0.0 112.184 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.502 ' O ' HG22 ' B' ' 216' ' ' ILE . 41.2 tt0 -65.47 -28.23 69.06 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.268 1.027 . . . . 0.0 112.063 -174.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 39.5 t -67.88 -46.36 71.91 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.381 0.61 . . . . 0.0 110.38 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -80.87 -14.44 58.02 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.643 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.631 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.9 -42.94 53.37 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -58.2 7.47 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 124.134 0.896 . . . . 0.0 109.111 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -57.69 -44.73 86.04 Favored 'General case' 0 C--O 1.255 1.364 0 O-C-N 124.456 1.098 . . . . 0.0 111.069 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -39.4 83.47 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.388 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 70' ' ' VAL . 88.9 mt -69.8 -36.45 75.7 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 124.029 0.831 . . . . 0.0 111.72 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -57.02 -33.64 67.37 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.799 0.687 . . . . 0.0 110.513 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.8 t -86.28 -38.05 17.93 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.402 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 65.4 m -81.33 -19.63 42.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.82 0.848 . . . . 0.0 112.986 -169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp -76.44 -19.38 58.13 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.598 0.359 . . . . 0.0 110.564 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 32.7 t -64.57 115.46 5.21 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -124.63 165.32 18.1 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.978 0.911 . . . . 0.0 109.664 -169.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 . . . . . 0 C--O 1.254 1.32 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.334 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.995 0 CA-C-O 119.447 -0.641 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 37.0 m -65.93 97.84 0.38 Allowed 'General case' 0 C--N 1.354 0.799 0 C-N-CA 123.809 0.844 . . . . 0.0 110.373 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -116.89 152.9 33.53 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.177 0.991 . . . . 0.0 110.484 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -101.45 178.6 4.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.08 0.952 . . . . 0.0 110.242 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.5 mp0 -109.65 144.35 38.13 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.649 0.78 . . . . 0.0 109.856 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.48 149.61 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.881 0.873 . . . . 0.0 109.154 169.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 66' ' ' THR . 64.4 m-85 -106.25 100.16 9.71 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.24 -173.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 69' ' ' LEU . 79.0 t -97.2 114.69 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -101.11 122.16 43.1 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.55 1.14 . . . . 0.0 110.337 -172.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.679 HG22 HD12 ' A' ' 69' ' ' LEU . 51.5 p -71.07 162.47 29.37 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.669 0.668 . . . . 0.0 111.069 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.517 HD11 HG22 ' A' ' 70' ' ' VAL . 84.1 mt -70.73 -20.24 62.67 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.047 171.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -80.34 -5.4 56.29 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.504 0.722 . . . . 0.0 111.206 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.47 15.28 51.1 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 114.457 0.543 . . . . 0.0 114.457 166.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.32 152.22 18.58 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.4 m -100.6 141.45 33.45 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.503 HD11 HG23 ' A' ' 7' ' ' THR . 5.4 mp -123.31 116.34 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.309 1.043 . . . . 0.0 108.297 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -101.38 117.16 34.4 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.518 0.727 . . . . 0.0 109.594 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -104.62 151.47 23.62 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.665 0.786 . . . . 0.0 109.515 -175.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -108.94 76.95 1.04 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 124.095 0.872 . . . . 0.0 109.338 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.719 HG21 HG22 ' A' ' 26' ' ' VAL . 3.6 m -140.7 170.38 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.429 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 15.9 mt-10 -91.8 157.88 40.88 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.491 0.716 . . . . 0.0 109.185 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 25.1 Cg_endo -61.24 -29.37 86.36 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.539 1.493 . . . . 0.0 111.206 168.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 t -99.28 19.86 14.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.731 0.812 . . . . 0.0 110.583 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 10.8 t70 -80.73 -94.74 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.2 t 177.05 143.87 0.09 Allowed 'General case' 0 C--N 1.364 1.238 0 C-N-CA 124.889 1.276 . . . . 0.0 109.734 173.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.415 HG22 ' HE3' ' A' ' 27' ' ' LYS . 47.8 mm -61.62 -38.01 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.539 1.136 . . . . 0.0 111.298 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -52.92 -40.45 63.59 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.968 0.907 . . . . 0.0 111.013 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.2 t-20 -72.72 -44.71 61.35 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.116 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.719 HG22 HG21 ' A' ' 17' ' ' VAL . 53.1 t -54.91 -47.68 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 124.479 1.112 . . . . 0.0 111.086 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 17.7 ptpt -69.88 -34.06 73.05 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 122.879 0.472 . . . . 0.0 111.552 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -25.1 65.2 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.888 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 8.8 mmpt? -77.69 -32.35 52.97 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.58 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.472 HG13 HG21 ' A' ' 13' ' ' ILE . 1.9 mp -57.01 -43.13 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 119.078 0.854 . . . . 0.0 109.967 169.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -62.42 -30.67 71.39 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.635 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -73.76 -29.61 62.31 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.582 0.753 . . . . 0.0 111.833 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 69.8 mmtt -95.23 -67.98 0.82 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.38 -23.87 32.25 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.248 0.219 . . . . 0.0 110.923 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.6 40.8 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.195 174.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.53 125.08 35.02 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 72.5 Cg_endo -70.4 158.39 56.25 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.205 2.603 . . . . 0.0 112.698 -173.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HA ' HE21 ' A' ' 41' ' ' GLN . 18.8 Cg_endo -57.0 -16.27 20.16 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 123.804 3.003 . . . . 0.0 114.052 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.439 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 23.0 t70 -74.46 -28.07 60.87 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.874 0.87 . . . . 0.0 110.797 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.402 ' OE1' ' HB2' ' A' ' 74' ' ' ARG . 2.7 mp0 -108.13 -17.59 13.99 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.823 1.249 . . . . 0.0 113.244 -175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB2' HD21 ' A' ' 69' ' ' LEU . 1.1 pp0? -110.56 155.6 22.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.019 0.528 . . . . 0.0 110.218 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.469 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 41.7 ttt180 -139.54 125.0 19.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.94 0.496 . . . . 0.0 110.234 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.69 124.24 37.55 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.517 0.727 . . . . 0.0 110.032 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -142.45 130.56 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.152 0.981 . . . . 0.0 109.526 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.528 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 89.8 t80 -128.56 135.37 49.28 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 171.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.62 16.7 10.47 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.18 0.992 . . . . 0.0 112.378 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.23 21.82 58.09 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.234 0.334 . . . . 0.0 113.846 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 11.4 ptpt -130.8 145.27 51.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.29 0.636 . . . . 0.0 109.352 174.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -74.58 140.13 44.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.815 0.446 . . . . 0.0 110.104 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 45' ' ' PHE . 27.4 mt -91.6 125.05 36.19 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.205 0.602 . . . . 0.0 110.647 -176.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.41 138.46 32.83 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.826 0.85 . . . . 0.0 110.309 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.65 -46.56 84.05 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.653 1.181 . . . . 0.0 112.387 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.7 -26.41 72.04 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 124.142 0.902 . . . . 0.0 113.641 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.401 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 55.9 mtt180 -77.54 177.09 8.32 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.303 0.641 . . . . 0.0 111.582 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.7 p -116.1 169.07 9.55 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.652 0.781 . . . . 0.0 109.777 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.497 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.0 mt -55.99 -53.07 61.36 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.698 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 t -61.34 -24.89 66.78 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.567 1.147 . . . . 0.0 111.648 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 12.4 t70 -65.7 -41.83 91.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -91.47 20.77 5.03 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.812 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 72.6 8.01 5.61 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 124.745 1.218 . . . . 0.0 112.789 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 10.6 mt -84.61 116.91 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -106.48 -172.15 2.03 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -58.71 146.95 34.73 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.105 0.479 . . . . 0.0 110.557 172.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 62.9 5.57 1.86 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.636 1.574 . . . . 0.0 113.711 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.6 m -70.6 143.71 51.43 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 118.664 0.665 . . . . 0.0 111.198 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 27.2 m -108.54 134.3 51.49 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.15 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.517 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -144.77 173.13 12.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.988 1.315 . . . . 0.0 108.536 -176.528 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -102.97 153.43 20.23 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.701 0.762 . . . . 0.0 112.677 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.679 HD12 HG22 ' A' ' 7' ' ' THR . 2.3 tm? -130.52 126.07 35.9 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.517 HG22 HD11 ' A' ' 8' ' ' LEU . 73.8 t -110.79 124.61 67.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 123.275 0.63 . . . . 0.0 109.742 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -85.42 147.13 26.64 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.681 0.792 . . . . 0.0 110.355 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 39' ' ' ASP . 40.1 mtt180 -122.33 -44.18 2.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.703 0.801 . . . . 0.0 110.451 -173.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' B' ' 196' ' ' SER . 4.1 mm? 57.26 40.01 28.2 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.733 1.213 . . . . 0.0 112.081 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.402 ' HB2' ' OE1' ' A' ' 40' ' ' GLN . 18.8 mmm180 -68.97 -58.8 3.63 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.861 0.864 . . . . 0.0 110.355 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.48 14.41 39.12 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.994 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.737 0 CA-C-N 117.034 0.417 . . . . 0.0 113.692 178.977 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.693 0 N-CA-C 112.119 -0.393 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 196' ' ' SER . . . . . 0.457 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 38.7 p -79.01 75.82 5.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.703 0.763 . . . . 0.0 110.374 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -102.61 10.7 38.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.904 0.882 . . . . 0.0 110.771 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -163.27 171.77 15.68 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.97 0.908 . . . . 0.0 110.075 -172.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.26 92.77 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 163.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 200' ' ' THR . . . . . 0.512 HG22 HG13 ' B' ' 202' ' ' VAL . 8.2 m -66.7 130.83 44.46 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.984 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -93.94 123.99 37.65 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 202' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 3.4 m -140.58 151.58 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.144 1.378 . . . . 0.0 110.047 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 203' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' B' ' 210' ' ' ASN . 4.8 m-20 -78.89 147.19 33.19 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.731 -175.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.658 ' HA ' HD11 ' B' ' 216' ' ' ILE . 24.8 t -89.77 98.33 1.3 Allowed Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.519 ' HD2' HD13 ' B' ' 220' ' ' LEU . 74.1 Cg_endo -68.45 9.01 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.521 2.814 . . . . 0.0 115.887 -163.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 206' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' B' ' 223' ' ' CYS . 29.9 t -104.61 -48.62 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 122.833 0.453 . . . . 0.0 110.654 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 207' ' ' CYS . . . . . 0.484 ' SG ' HG22 ' B' ' 209' ' ' VAL . 18.0 p -107.48 -7.95 16.4 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.901 0.48 . . . . 0.0 112.185 -173.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.63 41.55 64.66 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' VAL . . . . . 0.484 HG22 ' SG ' ' B' ' 207' ' ' CYS . 27.9 m -118.62 132.83 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 117.647 0.724 . . . . 0.0 110.072 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 210' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' B' ' 203' ' ' ASP . 25.3 t-20 -86.23 126.49 34.31 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 4.9 pt -148.92 159.45 37.54 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 125.865 1.666 . . . . 0.0 108.991 -169.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.473 ' HG2' ' HB2' ' B' ' 215' ' ' HIS . 17.8 Cg_endo -58.74 156.25 33.48 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.41 2.073 . . . . 0.0 111.964 174.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.54 ' O ' HG22 ' B' ' 216' ' ' ILE . 26.7 tt0 -66.32 -30.21 70.57 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.02 0.928 . . . . 0.0 112.033 -170.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 51.2 p -63.92 -49.98 70.51 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.581 0.705 . . . . 0.0 109.558 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' HIS . . . . . 0.473 ' HB2' ' HG2' ' B' ' 212' ' ' PRO . 47.1 m80 -76.11 -12.2 60.07 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.871 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -72.85 -51.6 26.45 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.274 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -63.87 -31.23 72.34 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.181 0.446 . . . . 0.0 111.727 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -66.13 -63.58 1.05 Allowed 'General case' 0 C--O 1.251 1.178 0 O-C-N 123.885 0.741 . . . . 0.0 111.556 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -43.27 69.79 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.319 1.048 . . . . 0.0 109.863 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.519 HD13 ' HD2' ' B' ' 205' ' ' PRO . 30.7 tp -63.31 -46.04 88.54 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 113.654 -1.612 . . . . 0.0 111.808 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.17 -35.28 64.63 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 124.316 1.01 . . . . 0.0 110.358 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.3 t -79.77 -38.31 33.46 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.995 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' B' ' 206' ' ' VAL . 93.9 m -74.24 -35.11 63.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.448 1.099 . . . . 0.0 112.633 -172.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.422 HD23 ' HG ' ' B' ' 220' ' ' LEU . 4.0 pp -73.4 -9.08 58.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.559 0.743 . . . . 0.0 111.846 -168.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 40.5 m -72.65 87.03 1.22 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -125.91 122.96 37.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.084 0.953 . . . . 0.0 109.586 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.255 1.389 0 C-N-CA 123.669 0.788 . . . . 0.0 109.907 179.321 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.429 0 N-CA-C 112.312 -0.315 . . . . 0.0 112.312 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 60.9 m -153.94 177.26 11.23 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.695 1.198 . . . . 0.0 109.909 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -152.71 114.56 4.35 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 164.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mmt -123.39 160.22 27.26 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.163 0.985 . . . . 0.0 110.147 -173.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 17.4 mp0 -90.12 134.43 34.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.929 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.518 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -130.53 157.96 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.126 1.37 . . . . 0.0 108.586 172.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 72.8 m-85 -116.55 120.5 38.91 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.305 0.642 . . . . 0.0 109.783 -173.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 30' ' ' ILE . 68.9 t -109.9 130.89 62.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -118.16 117.02 28.01 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.573 HG23 HD11 ' A' ' 13' ' ' ILE . 43.5 p -70.15 165.68 21.53 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.286 0.565 . . . . 0.0 111.697 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.415 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 57.5 mt -68.92 -22.0 64.18 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.005 173.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.0 p -79.64 -15.89 56.78 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.387 0.675 . . . . 0.0 110.782 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.96 21.21 16.31 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.539 -0.59 . . . . 0.0 114.476 170.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -94.39 153.71 17.83 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.496 0.648 . . . . 0.0 109.599 174.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.9 m -100.53 144.22 29.77 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.324 0.65 . . . . 0.0 109.869 172.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.573 HD11 HG23 ' A' ' 7' ' ' THR . 5.3 mp -128.79 114.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.808 1.243 . . . . 0.0 108.408 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.1 m -99.58 121.85 41.79 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.504 0.722 . . . . 0.0 110.119 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -112.21 153.16 27.5 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -116.43 76.9 1.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 26' ' ' VAL . 20.5 m -140.04 177.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.375 0.67 . . . . 0.0 110.386 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -91.99 157.08 41.74 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 123.642 0.777 . . . . 0.0 109.75 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 24.3 Cg_endo -61.95 -34.68 80.6 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.536 1.491 . . . . 0.0 110.836 165.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -94.13 13.88 21.76 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.1 0.56 . . . . 0.0 110.67 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.42 -96.15 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.393 0.677 . . . . 0.0 110.867 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.1 t 169.52 138.26 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.6 1.56 . . . . 0.0 108.307 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.15 -34.33 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.759 0.824 . . . . 0.0 110.956 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 16.8 tp10 -60.25 -35.42 75.44 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.557 0.694 . . . . 0.0 111.399 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 19.1 t-20 -76.47 -44.04 37.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.923 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.674 HG22 HG21 ' A' ' 17' ' ' VAL . 62.6 t -57.0 -43.88 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 124.316 1.01 . . . . 0.0 110.488 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.544 ' HB2' ' OE1' ' A' ' 41' ' ' GLN . 17.6 ptpt -71.08 -33.89 70.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.261 0.624 . . . . 0.0 110.576 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.63 -31.77 73.04 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.848 171.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 9.7 mmpt? -72.62 -35.49 67.84 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.578 HD11 HG21 ' A' ' 5' ' ' VAL . 1.8 mp -55.65 -43.64 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.486 0.585 . . . . 0.0 110.167 171.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -65.48 -29.26 69.9 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.317 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.1 -25.92 62.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.169 0.588 . . . . 0.0 111.234 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 68.5 mmtt -99.28 -69.03 0.78 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.733 0.242 . . . . 0.0 111.168 -175.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -85.18 -21.2 29.27 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.73 14.1 51.05 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 114.298 0.479 . . . . 0.0 114.298 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.1 127.71 32.69 Favored Pre-proline 0 N--CA 1.481 1.113 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.29 154.27 72.51 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.06 2.507 . . . . 0.0 112.976 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 15.6 Cg_endo -54.64 -14.84 8.09 Favored 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 124.295 3.33 . . . . 0.0 114.94 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -72.36 -48.53 41.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.962 0.505 . . . . 0.0 110.309 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 2.9 mp0 -88.82 -22.7 23.1 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.968 0.907 . . . . 0.0 113.109 -171.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.694 HE21 HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -101.21 124.64 47.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.816 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 34.1 ttt180 -112.91 130.27 56.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.177 0.991 . . . . 0.0 108.826 -172.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 4.4 mm? -95.03 119.0 32.8 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.44 0.696 . . . . 0.0 110.533 -170.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.7 mt -140.95 127.73 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.562 0.745 . . . . 0.0 109.796 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.686 ' HB3' HD21 ' A' ' 50' ' ' LEU . 75.6 t80 -129.23 126.01 38.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.76 1.224 . . . . 0.0 108.448 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.41 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 61.8 18.45 9.73 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.107 0.963 . . . . 0.0 113.343 173.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.5 5.14 56.99 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.914 -0.381 . . . . 0.0 113.821 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.0 ptpt -118.02 146.98 43.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.367 0.667 . . . . 0.0 109.396 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -80.51 140.61 35.78 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.945 0.498 . . . . 0.0 109.98 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 45' ' ' PHE . 23.5 mt -94.96 114.93 26.82 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 122.931 0.493 . . . . 0.0 110.825 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -77.82 139.07 39.27 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.684 0.793 . . . . 0.0 110.199 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 11.2 p-10 -58.84 -39.54 81.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.522 1.129 . . . . 0.0 112.448 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.25 -18.25 80.06 Favored Glycine 0 C--N 1.354 1.536 0 O-C-N 124.126 0.891 . . . . 0.0 113.351 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HD3' ' OD2' ' A' ' 58' ' ' ASP . 99.6 mtt180 -86.13 177.11 7.64 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.46 0.704 . . . . 0.0 111.275 175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 p -116.19 168.44 10.11 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 123.864 0.865 . . . . 0.0 109.668 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.4 mt -56.23 -49.87 72.91 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 124.195 0.934 . . . . 0.0 109.65 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 35.7 t -63.67 -26.14 68.53 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.541 1.137 . . . . 0.0 111.548 -175.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' OD2' ' HD3' ' A' ' 54' ' ' ARG . 20.2 t70 -65.18 -41.61 94.42 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 121.544 0.688 . . . . 0.0 109.637 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -89.87 15.07 10.49 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.944 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 71.37 14.85 6.38 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.072 1.349 . . . . 0.0 112.399 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 8.8 mt -86.52 121.68 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -115.01 -172.53 2.14 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -57.44 143.56 39.88 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.293 0.37 . . . . 0.0 110.815 172.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 72.25 1.11 3.82 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.295 1.438 . . . . 0.0 112.31 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -75.62 135.57 40.48 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 118.09 0.404 . . . . 0.0 110.223 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.4 m -99.9 131.23 46.0 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.117 0.484 . . . . 0.0 110.603 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.511 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -124.57 175.7 7.0 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.866 1.266 . . . . 0.0 108.667 174.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -108.68 153.09 23.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.349 0.66 . . . . 0.0 111.423 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.694 HD21 HE21 ' A' ' 41' ' ' GLN . 2.1 tm? -131.21 126.25 35.07 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -175.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.816 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.4 t -105.28 109.2 26.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.802 0.841 . . . . 0.0 109.828 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -81.63 138.96 35.25 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.305 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.717 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 61.2 mtp180 -113.07 -47.48 3.03 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.898 0.879 . . . . 0.0 110.676 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.93 21.98 8.25 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.939 0.896 . . . . 0.0 112.131 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.717 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 3.5 mmp_? -65.41 -49.84 67.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.48 0.712 . . . . 0.0 110.319 -174.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.3 -21.77 37.07 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.979 172.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--N 1.35 1.354 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.503 0 N-CA-C 112.296 -0.321 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 46.0 t -154.39 133.95 12.78 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.543 0.737 . . . . 0.0 109.871 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -174.44 90.89 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.244 1.018 . . . . 0.0 109.324 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -114.79 160.33 19.56 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.9 p -53.69 99.83 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 124.246 1.018 . . . . 0.0 111.926 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 200' ' ' THR . . . . . 0.563 HG22 HG13 ' B' ' 202' ' ' VAL . 38.5 m -84.06 133.55 34.65 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.805 0.842 . . . . 0.0 110.723 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' B' ' 201' ' ' LYS . 0.1 OUTLIER -93.67 123.6 37.11 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 202' ' ' VAL . . . . . 0.665 HG23 HG13 ' B' ' 216' ' ' ILE . 0.9 OUTLIER -147.61 146.18 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.033 0.933 . . . . 0.0 111.036 -162.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -74.2 147.73 42.26 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.383 0.673 . . . . 0.0 111.492 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.457 ' HA ' HD11 ' B' ' 216' ' ' ILE . 20.0 t -91.7 97.59 1.51 Allowed Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.166 0.986 . . . . 0.0 108.902 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.453 ' HD2' HD11 ' B' ' 220' ' ' LEU . 32.3 Cg_endo -58.52 -5.45 2.41 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.679 2.919 . . . . 0.0 116.364 -166.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 206' ' ' VAL . . . . . 0.427 HG11 ' O ' ' B' ' 223' ' ' CYS . 41.0 t -94.67 -57.48 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 173.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 207' ' ' CYS . . . . . 0.505 ' SG ' HG22 ' B' ' 209' ' ' VAL . 11.7 p -106.12 9.45 32.31 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.56 -37.55 2.78 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.865 1.106 . . . . 0.0 115.865 171.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 209' ' ' VAL . . . . . 0.505 HG22 ' SG ' ' B' ' 207' ' ' CYS . 20.6 m -60.2 134.73 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -165.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -84.7 125.35 32.44 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.699 HG13 HG12 ' B' ' 216' ' ' ILE . 5.2 pt -148.56 156.08 41.98 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.464 1.506 . . . . 0.0 109.166 -171.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.04 151.55 77.61 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.698 2.266 . . . . 0.0 112.196 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.457 ' HA ' ' HB ' ' B' ' 216' ' ' ILE . 3.9 tm-20 -58.53 -43.65 89.3 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -166.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 27.1 t -65.71 -36.75 84.5 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.583 -0.698 . . . . 0.0 110.381 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -82.43 -11.47 58.51 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.107 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.699 HG12 HG13 ' B' ' 211' ' ' ILE . 0.4 OUTLIER -68.8 -45.94 80.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 172.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -74.21 -30.36 62.16 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.519 0.512 . . . . 0.0 111.974 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -68.4 -50.72 50.87 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.31 0.381 . . . . 0.0 110.888 172.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.13 -45.37 83.56 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.08 0.552 . . . . 0.0 109.543 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.548 HD13 HG21 ' A' ' 70' ' ' VAL . 60.7 mt -68.96 -34.36 75.21 Favored 'General case' 0 C--O 1.209 -1.078 0 O-C-N 124.528 1.142 . . . . 0.0 112.439 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.57 -31.23 65.94 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.907 0.754 . . . . 0.0 109.882 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 t -91.33 -36.24 13.97 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.782 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 223' ' ' CYS . . . . . 0.53 ' HB2' ' HA ' ' B' ' 220' ' ' LEU . 84.9 m -75.01 -28.25 60.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.675 0.79 . . . . 0.0 112.271 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.79 -9.51 58.62 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.042 0.537 . . . . 0.0 110.903 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 36.0 t -65.15 83.03 0.05 OUTLIER 'General case' 0 C--N 1.36 1.026 0 C-N-CA 123.819 0.848 . . . . 0.0 109.62 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -75.58 -29.12 59.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.107 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 C--O 1.248 1.0 0 C-N-CA 124.711 1.204 . . . . 0.0 108.461 177.292 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.459 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.2 p -96.01 104.54 16.49 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.25 1.02 . . . . 0.0 109.905 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 37.7 p-80 -73.65 98.52 2.88 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.797 0.808 . . . . 0.0 111.345 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt -89.2 156.79 18.55 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.291 174.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 20.7 mp0 -98.48 136.74 38.17 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.723 0.409 . . . . 0.0 110.713 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.4 155.94 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.678 1.191 . . . . 0.0 108.568 173.351 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 66' ' ' THR . 90.2 m-85 -113.53 99.66 7.92 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.277 -170.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.525 HG12 ' HB2' ' A' ' 69' ' ' LEU . 93.6 t -99.45 100.01 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -94.65 123.49 38.12 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.899 0.88 . . . . 0.0 110.737 -171.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.689 HG22 HD12 ' A' ' 69' ' ' LEU . 39.5 p -70.59 166.94 19.58 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.715 0.769 . . . . 0.0 111.922 176.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.13 -19.64 65.65 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.721 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -79.59 -3.85 48.88 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.569 0.747 . . . . 0.0 111.309 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.15 5.78 67.37 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.054 0.359 . . . . 0.0 112.378 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -90.4 137.83 32.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.206 1.003 . . . . 0.0 109.621 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.7 m -107.05 129.1 54.86 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.252 0.621 . . . . 0.0 110.369 -176.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -108.06 113.27 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.024 0.93 . . . . 0.0 109.327 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 m -87.45 117.0 25.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.723 0.809 . . . . 0.0 109.123 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.8 mm? -104.54 160.24 15.1 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.655 0.782 . . . . 0.0 109.022 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 0' ' ' HIS . 33.9 mt-10 -127.07 80.99 1.99 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.858 0.863 . . . . 0.0 108.795 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.756 HG21 HG22 ' A' ' 26' ' ' VAL . 3.1 m -138.19 175.52 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.612 1.165 . . . . 0.0 108.657 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 12.9 mt-10 -92.28 140.71 24.41 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 9.7 Cg_endo -55.57 -29.1 68.34 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.857 2.372 . . . . 0.0 112.038 167.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -92.92 4.19 54.37 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.85 0.86 . . . . 0.0 110.797 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 22.6 t70 -82.27 -87.52 0.09 Allowed 'General case' 0 C--N 1.358 0.955 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.275 -174.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 25' ' ' ASN . 10.0 t 179.02 149.98 0.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.75 0.82 . . . . 0.0 110.956 176.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.28 -34.0 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.754 1.222 . . . . 0.0 110.685 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -58.49 -38.46 77.67 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.068 0.947 . . . . 0.0 109.821 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.6 t30 -71.66 -44.76 63.73 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.078 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.756 HG22 HG21 ' A' ' 17' ' ' VAL . 61.4 t -55.06 -48.17 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 124.437 1.085 . . . . 0.0 110.825 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -69.1 -31.83 70.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.298 0.639 . . . . 0.0 111.429 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.61 74.38 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.797 0.685 . . . . 0.0 111.141 170.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 65.3 mmtt -78.09 -31.57 50.19 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.932 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -58.85 -44.08 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.351 0.978 . . . . 0.0 109.291 170.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.75 -31.28 72.19 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.539 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 8.6 t70 -71.54 -35.21 70.59 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.639 0.776 . . . . 0.0 111.564 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.4 mmtt -88.72 -67.02 0.86 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.575 0.35 . . . . 0.0 110.968 -171.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -88.06 -22.33 24.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.301 0.24 . . . . 0.0 111.512 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.96 12.38 46.64 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.993 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -98.62 122.19 54.06 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -69.82 155.86 64.67 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.524 2.816 . . . . 0.0 113.059 -172.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.94 -13.1 10.8 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 124.482 3.455 . . . . 0.0 114.621 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.21 -47.33 14.81 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 74' ' ' ARG . 2.8 mp0 -77.64 -27.99 51.18 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.304 0.641 . . . . 0.0 111.286 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.2 pp0? -96.65 147.68 23.64 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.643 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 42.9 ttt180 -137.66 129.25 28.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.2 125.73 36.99 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -173.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.422 HD11 ' HG ' ' B' ' 220' ' ' LEU . 97.6 mt -142.78 131.54 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.911 0.884 . . . . 0.0 110.071 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.559 ' HB3' HD21 ' A' ' 50' ' ' LEU . 86.0 t80 -135.81 128.36 30.63 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 65.45 21.3 11.84 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.834 0.854 . . . . 0.0 111.938 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.56 2.33 82.34 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.448 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 9.9 ptpt -108.99 142.16 40.05 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB2' HD22 ' B' ' 224' ' ' LEU . 9.7 tt0 -76.86 126.47 31.04 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.028 0.531 . . . . 0.0 110.081 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.7 mt -77.83 119.6 21.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.173 0.589 . . . . 0.0 110.352 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.0 138.37 42.18 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.742 0.651 . . . . 0.0 109.562 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.511 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 10.4 p-10 -61.1 -40.03 92.19 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 124.126 0.891 . . . . 0.0 112.037 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.57 -27.24 73.94 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.624 0.578 . . . . 0.0 113.374 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -77.48 176.77 8.58 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.214 0.606 . . . . 0.0 111.919 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.5 p -110.07 167.22 10.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.437 0.695 . . . . 0.0 109.765 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 81.4 mt -58.3 -51.46 69.69 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 56.2 m -59.6 -25.98 65.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.932 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.53 -34.25 73.98 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.074 0.464 . . . . 0.0 110.044 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -92.6 15.94 13.21 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.754 0.822 . . . . 0.0 111.768 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 66.67 30.04 8.43 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.239 1.016 . . . . 0.0 111.639 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -101.16 118.01 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -102.89 -175.99 2.96 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -58.18 141.5 50.33 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.125 171.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 72.49 0.34 3.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.509 1.523 . . . . 0.0 112.669 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.8 m -73.46 137.35 44.47 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 118.236 0.471 . . . . 0.0 110.705 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 15.0 m -95.53 137.04 35.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.875 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.73 174.54 10.41 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.945 1.298 . . . . 0.0 108.454 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -101.76 158.56 16.02 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.849 0.833 . . . . 0.0 112.185 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.689 HD12 HG22 ' A' ' 7' ' ' THR . 2.7 tm? -138.35 125.82 21.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.215 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.643 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 91.0 t -99.93 120.61 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 123.301 0.64 . . . . 0.0 110.224 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 93.0 mt -89.29 140.41 29.52 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.349 1.031 . . . . 0.0 109.883 174.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -119.14 -28.34 5.49 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.002 0.921 . . . . 0.0 111.476 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 71' ' ' LEU . 3.6 mm? 44.3 46.45 7.64 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 125.657 1.583 . . . . 0.0 113.978 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.416 ' H ' ' HG3' ' A' ' 40' ' ' GLN . 24.5 mmt85 -65.66 -23.11 66.72 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.704 174.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.48 -11.49 38.38 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.778 174.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.479 0 C-N-CA 123.191 0.424 . . . . 0.0 112.965 -176.884 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.851 0 CA-C-O 120.035 -0.314 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 196' ' ' SER . . . . . 0.421 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 66.6 m -75.72 78.19 2.68 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.559 0.744 . . . . 0.0 109.929 174.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -134.71 6.21 3.44 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.035 1.334 . . . . 0.0 110.03 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -133.61 175.09 9.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.702 0.801 . . . . 0.0 110.495 -172.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.4 p -69.19 95.13 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 121.665 0.745 . . . . 0.0 110.44 175.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 200' ' ' THR . . . . . 0.482 HG22 HG13 ' B' ' 202' ' ' VAL . 50.4 m -80.05 120.11 23.77 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.69 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -83.25 123.27 29.42 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 202' ' ' VAL . . . . . 0.482 HG13 HG22 ' B' ' 200' ' ' THR . 3.8 m -138.01 172.08 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 125.505 1.522 . . . . 0.0 108.441 -173.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.47 146.52 31.64 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 122.373 -0.204 . . . . 0.0 110.624 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.583 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.9 t -83.7 105.72 6.17 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.711 0.805 . . . . 0.0 109.019 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.549 ' HD2' HD11 ' B' ' 220' ' ' LEU . 40.5 Cg_endo -63.12 -1.0 2.52 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 124.087 3.191 . . . . 0.0 115.401 -171.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.95 -51.08 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.377 0.671 . . . . 0.0 111.427 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.9 p -113.88 1.07 14.64 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.009 0.523 . . . . 0.0 111.8 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 56.28 55.3 30.21 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 124.48 1.038 . . . . 0.0 115.195 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.72 127.2 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.166 0.586 . . . . 0.0 109.512 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.96 110.47 15.37 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 8.6 pt -138.6 160.87 61.66 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 125.715 1.606 . . . . 0.0 109.721 -173.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.75 159.77 23.54 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.841 2.361 . . . . 0.0 113.124 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.509 ' O ' HG22 ' B' ' 216' ' ' ILE . 34.4 tt0 -63.14 -33.49 75.58 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.993 1.317 . . . . 0.0 112.686 -172.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.0 t -66.23 -46.35 77.47 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.508 0.67 . . . . 0.0 110.594 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.19 -13.0 57.8 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.891 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.47 -44.82 53.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 174.386 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -55.07 28.44 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 124.502 1.126 . . . . 0.0 109.152 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -61.62 -39.18 90.34 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 124.446 1.091 . . . . 0.0 112.145 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -36.26 80.05 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.297 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.549 HD11 ' HD2' ' B' ' 205' ' ' PRO . 0.0 OUTLIER -63.71 -50.44 69.13 Favored 'General case' 0 C--O 1.21 -1.009 0 O-C-N 123.789 0.681 . . . . 0.0 110.249 177.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -54.49 -27.33 37.12 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 123.924 0.765 . . . . 0.0 112.048 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.1 t -89.1 -39.77 13.39 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.589 0.756 . . . . 0.0 111.217 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.55 -18.96 43.12 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.393 1.077 . . . . 0.0 113.511 -171.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' B' ' 220' ' ' LEU . 4.4 pp -94.93 13.81 23.69 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.625 0.648 . . . . 0.0 110.105 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 30.0 m -75.0 20.1 0.14 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.46 1.104 . . . . 0.0 112.665 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -149.48 151.49 34.03 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.07 0.948 . . . . 0.0 108.864 170.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.287 0 C-N-CA 124.367 1.067 . . . . 0.0 109.232 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.427 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.7 t -130.48 79.72 1.91 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.486 0.715 . . . . 0.0 109.921 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -84.58 152.18 24.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.88 174.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt -108.6 178.71 4.4 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.85 0.86 . . . . 0.0 110.209 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 75.8 mt-30 -119.42 132.63 55.85 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.3 0.64 . . . . 0.0 110.78 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.562 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -128.24 156.4 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.133 1.373 . . . . 0.0 108.951 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 66' ' ' THR . 50.1 m-85 -115.2 112.2 22.13 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.401 0.619 . . . . 0.0 110.073 -173.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.7 t -104.06 120.88 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -111.11 125.11 53.42 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.554 0.741 . . . . 0.0 109.82 -173.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.649 HG22 HD12 ' A' ' 69' ' ' LEU . 66.7 p -78.33 168.81 19.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.303 0.573 . . . . 0.0 112.067 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.43 HD11 HG22 ' A' ' 70' ' ' VAL . 60.7 mt -67.32 -27.68 67.35 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.345 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -79.34 -9.4 59.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.651 0.78 . . . . 0.0 110.987 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.69 22.98 37.58 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 114.17 0.428 . . . . 0.0 114.17 168.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 152.42 18.51 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.7 m -101.54 139.51 37.1 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.121 0.568 . . . . 0.0 109.994 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 7' ' ' THR . 5.2 mp -124.87 105.59 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.443 1.097 . . . . 0.0 108.181 176.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.1 m -86.96 122.97 31.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -105.8 156.29 18.46 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -120.34 69.66 0.87 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.442 1.097 . . . . 0.0 109.023 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.744 HG21 HG22 ' A' ' 26' ' ' VAL . 7.1 m -136.95 175.05 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -90.96 149.8 40.77 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.549 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 12.1 Cg_endo -58.96 -31.71 96.14 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.62 1.546 . . . . 0.0 111.733 164.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 t -97.36 18.09 15.98 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.905 0.482 . . . . 0.0 110.548 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.73 -96.73 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.827 0.851 . . . . 0.0 109.975 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 26' ' ' VAL . 5.2 t 174.36 140.37 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.2 1.4 . . . . 0.0 109.244 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.92 -37.11 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.879 0.871 . . . . 0.0 111.486 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 35.5 tt0 -54.92 -40.54 69.97 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.805 0.812 . . . . 0.0 110.792 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 11.5 t30 -73.54 -43.32 60.19 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.417 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.744 HG22 HG21 ' A' ' 17' ' ' VAL . 60.5 t -55.95 -48.63 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 124.311 1.007 . . . . 0.0 110.6 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.474 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.7 ptpt -68.41 -33.66 74.62 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.014 0.526 . . . . 0.0 111.602 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.64 -33.65 70.3 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.98 170.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 34.7 mmtm -76.64 -31.01 57.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.436 -0.793 . . . . 0.0 112.464 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.8 mp -60.49 -39.63 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 119.682 1.128 . . . . 0.0 109.129 170.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.64 -34.18 77.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.311 0.644 . . . . 0.0 111.207 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.05 -36.55 75.08 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.479 0.712 . . . . 0.0 111.5 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.6 mmtt -88.23 -65.7 0.99 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.83 0.452 . . . . 0.0 111.243 -170.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -84.18 -24.04 30.32 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.923 0.328 . . . . 0.0 111.272 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.0 17.84 31.18 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.173 0.295 . . . . 0.0 113.554 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.82 127.36 27.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.482 0.713 . . . . 0.0 109.36 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 58.8 Cg_endo -67.09 154.53 74.18 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.057 2.504 . . . . 0.0 112.697 -173.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 37.3 Cg_endo -61.14 -13.79 30.0 Favored 'Trans proline' 0 C--N 1.388 2.634 0 C-N-CA 123.666 2.911 . . . . 0.0 113.88 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.96 -32.18 51.3 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.742 0.817 . . . . 0.0 110.703 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -96.53 -18.33 19.88 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.855 1.262 . . . . 0.0 112.437 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.641 ' HB2' HD11 ' A' ' 69' ' ' LEU . 3.5 pp0? -118.96 133.57 55.74 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.165 0.507 . . . . 0.0 110.82 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.644 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 56.1 ttt180 -120.95 128.71 52.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.26 1.024 . . . . 0.0 109.788 -169.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.01 126.98 38.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.697 0.799 . . . . 0.0 109.656 -171.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.7 mt -142.15 132.03 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.292 0.637 . . . . 0.0 109.952 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.563 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 72.4 t80 -137.9 131.58 31.17 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 171.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.12 19.32 10.44 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.031 0.932 . . . . 0.0 112.013 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 6.53 79.57 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.975 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 13.8 ptpt -118.81 145.06 45.93 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.648 0.724 . . . . 0.0 109.998 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.538 ' HB2' HD22 ' B' ' 224' ' ' LEU . 0.4 OUTLIER -77.67 122.91 25.98 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -175.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' A' ' 45' ' ' PHE . 27.6 mt -72.11 119.52 16.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.405 0.682 . . . . 0.0 111.187 -175.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -81.54 138.77 35.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.233 1.013 . . . . 0.0 110.288 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 1.7 m-20 -60.22 -43.05 96.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.472 1.109 . . . . 0.0 112.613 -173.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.02 -8.77 74.7 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 124.36 1.037 . . . . 0.0 114.112 -177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 86.0 mtt-85 -95.1 177.33 5.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.99 0.916 . . . . 0.0 111.416 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -114.82 170.65 8.17 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.044 0.938 . . . . 0.0 109.509 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.9 mt -60.28 -52.16 66.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 40.7 m -54.62 -29.47 52.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.189 1.396 . . . . 0.0 112.633 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 12.7 t70 -65.67 -43.57 88.9 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 123.759 0.662 . . . . 0.0 109.761 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -87.93 21.23 2.76 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.916 0.887 . . . . 0.0 111.395 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 70.93 13.57 7.0 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.503 1.121 . . . . 0.0 111.982 176.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 14.6 mt -88.18 118.23 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.695 0.798 . . . . 0.0 109.001 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -102.5 -174.94 2.68 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -58.2 140.52 52.88 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.192 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 70.09 7.45 6.23 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.919 1.288 . . . . 0.0 112.954 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -69.46 135.88 50.78 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 117.901 0.319 . . . . 0.0 110.649 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.5 m -93.99 125.65 38.74 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.432 0.693 . . . . 0.0 109.617 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -127.46 167.92 15.61 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.347 1.059 . . . . 0.0 109.393 177.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -94.63 150.48 20.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.49 0.662 . . . . 0.0 110.93 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.649 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -133.85 126.68 31.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.696 HG21 HD11 ' B' ' 220' ' ' LEU . 69.8 t -101.9 109.07 25.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.441 0.697 . . . . 0.0 110.12 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.518 ' HB3' HD23 ' A' ' 73' ' ' LEU . 67.1 mt -80.73 144.9 31.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.241 173.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -121.08 -48.14 2.24 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.062 0.945 . . . . 0.0 109.249 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 71' ' ' LEU . 4.6 mm? 51.72 45.5 28.05 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.678 1.191 . . . . 0.0 112.109 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -70.04 -17.72 63.27 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.025 175.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.91 5.45 84.87 Favored Glycine 0 C--N 1.35 1.307 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.337 172.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.396 0 C-N-CA 123.302 0.477 . . . . 0.0 112.536 179.324 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.828 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 29.3 t -151.9 103.03 2.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.264 0.626 . . . . 0.0 109.464 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -78.9 -28.96 44.05 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.941 0.896 . . . . 0.0 110.151 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.87 157.71 32.42 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.854 0.862 . . . . 0.0 111.015 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.25 101.89 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 O-C-N 124.047 0.842 . . . . 0.0 108.814 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 200' ' ' THR . . . . . 0.416 HG22 HG13 ' B' ' 202' ' ' VAL . 20.8 m -81.27 114.07 19.82 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.794 -172.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.68 124.61 28.17 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 202' ' ' VAL . . . . . 0.416 HG13 HG22 ' B' ' 200' ' ' THR . 6.1 m -140.89 -176.29 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.919 1.288 . . . . 0.0 109.319 -170.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -113.07 144.26 42.92 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.787 0.435 . . . . 0.0 110.326 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.546 ' HA ' HD11 ' B' ' 216' ' ' ILE . 53.5 t -86.14 98.03 0.71 Allowed Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.489 ' HD2' HD21 ' B' ' 220' ' ' LEU . 20.7 Cg_endo -55.22 -24.67 42.8 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.122 2.548 . . . . 0.0 114.413 -164.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 10.8 t -74.48 -63.42 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 122.861 0.464 . . . . 0.0 110.608 -173.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 22.7 p -91.6 -9.76 42.95 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.025 0.53 . . . . 0.0 111.24 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.92 58.77 12.03 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 124.073 0.844 . . . . 0.0 114.203 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 33.2 m -118.98 135.66 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.586 0.754 . . . . 0.0 109.553 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -83.44 104.81 13.88 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.091 0.472 . . . . 0.0 110.095 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' B' ' 204' ' ' CYS . 15.9 pt -137.01 152.21 73.52 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 125.308 1.443 . . . . 0.0 110.057 -174.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.09 163.36 16.93 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.012 2.475 . . . . 0.0 113.339 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.599 ' O ' HG22 ' B' ' 216' ' ' ILE . 5.6 tm-20 -62.64 -39.93 95.42 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -167.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 52.3 m -65.53 -39.87 92.29 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.7 -1.25 . . . . 0.0 110.295 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 215' ' ' HIS . . . . . 0.414 ' O ' ' HB2' ' B' ' 219' ' ' HIS . 8.0 m80 -68.24 -28.14 66.96 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.815 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.599 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -69.09 -48.41 69.51 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -176.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -67.13 -37.66 84.24 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.472 0.482 . . . . 0.0 111.387 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -42.22 83.53 Favored 'General case' 0 C--O 1.255 1.366 0 O-C-N 123.533 0.521 . . . . 0.0 111.212 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' B' ' 215' ' ' HIS . 0.1 OUTLIER -59.93 -37.52 79.75 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.41 177.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.696 HD11 HG21 ' A' ' 70' ' ' VAL . 96.7 mt -63.03 -45.39 92.49 Favored 'General case' 0 C--O 1.206 -1.218 0 O-C-N 124.014 0.821 . . . . 0.0 110.935 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -56.53 -28.37 59.86 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.445 0.466 . . . . 0.0 111.516 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.8 t -89.21 -41.18 12.37 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.312 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.2 m -79.04 -28.21 43.21 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.959 0.904 . . . . 0.0 112.971 -167.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 49' ' ' GLN . 3.7 pp -82.29 -16.56 48.98 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.383 0.673 . . . . 0.0 109.3 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 23.0 t -75.72 74.45 2.69 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 123.993 0.917 . . . . 0.0 109.142 176.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 34.1 ttt-85 -93.9 -45.39 7.65 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.62 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 CA--C 1.555 1.16 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.274 -167.447 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 33.3 t -162.38 -51.7 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.776 0.83 . . . . 0.0 109.914 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.613 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 90.6 m-70 68.54 116.46 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.051 1.34 . . . . 0.0 111.599 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 mmt -106.11 -170.22 1.7 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.6 1.16 . . . . 0.0 109.32 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 88.7 mt-30 -120.1 151.57 38.86 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.854 0.462 . . . . 0.0 111.388 172.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -141.13 159.54 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.223 1.409 . . . . 0.0 109.701 177.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' THR . 86.7 m-85 -107.58 109.8 21.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.032 0.933 . . . . 0.0 109.68 -176.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 30' ' ' ILE . 19.4 t -101.51 111.42 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 tptt -110.93 117.15 32.58 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.511 0.725 . . . . 0.0 109.981 -171.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.606 HG22 HD12 ' A' ' 69' ' ' LEU . 80.4 p -69.51 161.29 29.82 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.165 0.507 . . . . 0.0 111.716 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.49 HD11 HG22 ' A' ' 70' ' ' VAL . 87.0 mt -66.36 -17.54 64.83 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.853 175.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -83.16 -26.88 30.5 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.975 0.51 . . . . 0.0 110.714 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.05 9.59 11.91 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.123 0.409 . . . . 0.0 114.123 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 147.35 35.97 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -108.77 139.35 43.71 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.93 106.54 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.7 m -88.97 120.49 30.43 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -105.45 155.63 18.96 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.95 75.48 1.0 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.489 0.716 . . . . 0.0 109.423 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.821 HG21 HG22 ' A' ' 26' ' ' VAL . 11.3 m -137.96 167.38 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.097 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 0' ' ' HIS . 2.4 mt-10 -86.74 155.34 56.09 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.156 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 13.0 Cg_endo -57.48 -35.58 98.83 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 121.968 1.779 . . . . 0.0 111.198 165.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 t -97.66 19.36 13.68 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.027 0.931 . . . . 0.0 110.875 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 15.8 t70 -77.14 -94.82 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.366 0.666 . . . . 0.0 109.692 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 26' ' ' VAL . 10.1 t 176.23 141.14 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.135 1.374 . . . . 0.0 109.57 172.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.567 HG22 ' HE3' ' A' ' 27' ' ' LYS . 45.1 mm -61.63 -37.69 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.527 1.131 . . . . 0.0 111.571 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -50.09 -44.64 52.07 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.239 1.016 . . . . 0.0 110.686 177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 14.2 t-20 -71.78 -43.62 65.39 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.035 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.821 HG22 HG21 ' A' ' 17' ' ' VAL . 60.9 t -54.76 -50.78 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 124.207 0.942 . . . . 0.0 110.953 -177.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HE3' HG22 ' A' ' 23' ' ' ILE . 16.5 ptpt -68.6 -35.56 77.5 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.678 0.391 . . . . 0.0 111.257 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.0 -28.08 68.77 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.118 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 9.5 mmpt? -74.06 -37.42 64.25 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 118.765 -0.635 . . . . 0.0 111.134 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 5' ' ' VAL . 3.5 mp -60.86 -40.4 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-N 118.865 0.757 . . . . 0.0 109.131 173.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.99 -25.65 67.95 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.365 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -81.21 -32.47 33.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.189 0.595 . . . . 0.0 111.117 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.0 mmtt -88.24 -69.06 0.72 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.608 0.363 . . . . 0.0 110.895 -172.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.89 -26.1 34.44 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 120.481 0.181 . . . . 0.0 110.819 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.4 24.15 19.64 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.908 171.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.31 131.71 21.69 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.178 0.591 . . . . 0.0 109.476 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 53.9 Cg_endo -64.74 149.87 89.04 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.34 2.693 . . . . 0.0 113.135 -173.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 37.2 Cg_endo -61.27 -12.26 22.8 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.784 2.989 . . . . 0.0 113.724 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.35 -43.0 61.57 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.424 0.69 . . . . 0.0 110.535 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.5 mp0 -85.11 -28.9 25.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.051 0.94 . . . . 0.0 111.772 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' HB2' HD11 ' A' ' 69' ' ' LEU . 3.5 pp0? -109.0 123.22 48.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.306 0.642 . . . . 0.0 109.921 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.516 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 55.2 ttt180 -112.31 128.02 56.16 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.143 0.977 . . . . 0.0 110.184 -168.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.64 120.03 33.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.311 0.644 . . . . 0.0 110.486 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.2 mt -141.98 135.55 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.417 1.087 . . . . 0.0 109.88 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.515 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 88.3 t80 -131.69 123.46 27.81 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.36 1.064 . . . . 0.0 108.133 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 60.44 20.0 9.68 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.645 0.778 . . . . 0.0 112.608 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.558 ' HA2' HG22 ' B' ' 206' ' ' VAL . . . 101.23 -18.8 53.53 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 114.499 0.559 . . . . 0.0 114.499 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.1 ptpt -86.46 137.64 32.38 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.57 0.685 . . . . 0.0 109.709 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.585 ' HB2' HD22 ' B' ' 224' ' ' LEU . 27.4 tt0 -81.64 135.53 35.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.58 117.16 26.2 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 122.737 0.415 . . . . 0.0 111.298 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.65 138.86 31.85 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.581 1.152 . . . . 0.0 109.639 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.88 -47.55 64.49 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.78 1.232 . . . . 0.0 112.968 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.68 -30.97 78.42 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.905 0.753 . . . . 0.0 113.76 -174.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.488 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 97.2 mtt180 -80.04 177.77 8.7 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.516 0.726 . . . . 0.0 112.037 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -112.51 168.28 9.77 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.785 0.834 . . . . 0.0 109.915 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.6 mt -59.0 -50.48 73.94 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 21.9 m -54.93 -31.13 60.01 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.971 1.309 . . . . 0.0 112.778 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.92 -41.39 91.44 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.201 0.525 . . . . 0.0 109.826 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 34.8 m-85 -86.41 13.02 8.91 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.436 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 70.11 27.79 4.19 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.55 1.14 . . . . 0.0 111.122 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 10.4 mt -99.44 144.95 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -135.27 -173.81 3.44 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -62.88 146.81 51.96 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 120.681 0.276 . . . . 0.0 110.637 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 68.57 5.51 4.89 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.268 1.427 . . . . 0.0 112.174 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -71.86 139.01 48.67 Favored 'General case' 0 C--N 1.362 1.126 0 CA-C-N 117.963 0.347 . . . . 0.0 110.118 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 21.4 m -100.52 117.05 33.89 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.515 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -121.6 142.14 50.41 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.183 0.993 . . . . 0.0 109.484 -177.379 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -77.91 130.01 36.06 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.648 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.606 HD12 HG22 ' A' ' 7' ' ' THR . 2.5 tm? -103.73 129.34 51.08 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.54 HG21 HD11 ' B' ' 220' ' ' LEU . 84.3 t -111.67 121.04 63.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.238 0.615 . . . . 0.0 109.922 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.86 156.84 23.38 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.523 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.495 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 51.6 mtt180 -128.57 -47.24 1.29 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.701 0.8 . . . . 0.0 110.385 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 51.18 36.03 14.79 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.763 1.225 . . . . 0.0 112.433 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.495 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 26.5 mmm180 -73.33 -23.57 60.26 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.856 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.43 0.1 77.21 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.628 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.263 0 C-N-CA 123.074 0.369 . . . . 0.0 112.431 -173.597 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.84 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 29.3 t -168.43 153.43 6.38 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.428 1.091 . . . . 0.0 109.647 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -148.49 24.28 1.0 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.039 0.936 . . . . 0.0 109.36 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -149.99 164.68 34.84 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.13 0.972 . . . . 0.0 109.634 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.23 126.31 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 28.6 m -87.81 138.32 31.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.103 0.561 . . . . 0.0 110.509 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -85.73 122.07 29.29 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 7.0 m -143.08 179.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.466 1.106 . . . . 0.0 109.595 -169.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.94 142.26 47.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.954 0.502 . . . . 0.0 110.739 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.598 ' HA ' HD11 ' B' ' 216' ' ' ILE . 49.0 t -76.01 104.76 1.67 Allowed Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 124.327 1.051 . . . . 0.0 108.648 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.559 ' HD2' HD21 ' B' ' 220' ' ' LEU . 38.2 Cg_endo -61.79 -12.96 27.79 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.559 2.839 . . . . 0.0 114.808 -168.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 206' ' ' VAL . . . . . 0.558 HG22 ' HA2' ' A' ' 47' ' ' GLY . 5.6 t -85.8 -61.28 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.133 0.573 . . . . 0.0 110.257 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 21.1 p -99.74 -5.54 28.56 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 112.224 0.454 . . . . 0.0 112.224 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 68.07 45.17 73.95 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 115.023 0.769 . . . . 0.0 115.023 173.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.24 133.44 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 117.342 0.571 . . . . 0.0 110.321 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -81.78 122.52 27.79 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.011 0.524 . . . . 0.0 110.17 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' B' ' 204' ' ' CYS . 3.4 pt -150.23 159.66 34.7 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.757 1.623 . . . . 0.0 108.924 -172.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.35 157.75 43.98 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.199 1.932 . . . . 0.0 112.061 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.573 ' O ' HG22 ' B' ' 216' ' ' ILE . 43.1 tt0 -60.9 -31.35 70.85 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.743 1.217 . . . . 0.0 112.093 -174.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 23.5 p -64.0 -50.95 66.5 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 121.653 0.739 . . . . 0.0 110.277 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -80.15 -10.96 59.79 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.16 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.1 OUTLIER -73.78 -48.36 39.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 217' ' ' ASN . . . . . 0.523 ' HA ' HD12 ' B' ' 220' ' ' LEU . 52.3 m-80 -63.39 -36.52 83.98 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.407 0.442 . . . . 0.0 110.843 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -57.57 -52.76 64.11 Favored 'General case' 0 C--O 1.254 1.3 0 O-C-N 123.96 0.788 . . . . 0.0 111.212 172.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -30.66 70.68 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.731 -176.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.559 HD21 ' HD2' ' B' ' 205' ' ' PRO . 96.3 mt -64.52 -50.48 67.21 Favored 'General case' 0 C--O 1.206 -1.186 0 O-C-N 123.887 0.742 . . . . 0.0 111.181 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -57.38 -27.79 62.63 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 123.87 0.731 . . . . 0.0 111.69 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.1 t -80.03 -45.74 17.83 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.552 173.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 67.0 m -81.12 -22.94 38.71 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.626 1.17 . . . . 0.0 113.811 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.2 pp -88.3 -23.09 23.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 47.7 t -71.82 74.67 0.86 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.228 1.011 . . . . 0.0 108.625 172.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.54 96.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 -172.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.198 0 C-N-CA 124.504 1.121 . . . . 0.0 108.622 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.5 m -76.46 109.27 10.04 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.456 0.703 . . . . 0.0 110.828 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -81.37 100.78 9.42 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.697 0.799 . . . . 0.0 109.526 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt -78.44 170.13 17.13 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.393 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 21.6 mp0 -98.52 152.85 19.11 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.497 0.319 . . . . 0.0 110.512 173.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.18 150.6 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.345 1.058 . . . . 0.0 108.728 171.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.0 101.75 11.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.4 0.68 . . . . 0.0 109.787 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 69' ' ' LEU . 88.4 t -98.76 103.16 14.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -101.39 124.93 47.87 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.439 0.696 . . . . 0.0 110.901 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.734 HG22 HD12 ' A' ' 69' ' ' LEU . 60.2 p -65.53 157.74 28.86 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.316 0.647 . . . . 0.0 111.765 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.527 HD11 HG22 ' A' ' 70' ' ' VAL . 81.0 mt -66.47 -17.78 64.99 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.686 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -79.63 -11.31 59.87 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.342 0.657 . . . . 0.0 110.928 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.49 7.34 39.94 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 123.25 0.452 . . . . 0.0 113.863 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.43 143.02 26.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.626 0.77 . . . . 0.0 109.193 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 m -103.51 141.19 36.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.857 0.463 . . . . 0.0 110.684 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.81 113.27 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.431 1.092 . . . . 0.0 108.504 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.3 m -91.57 120.34 32.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.922 0.489 . . . . 0.0 109.716 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -106.19 163.9 12.43 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.018 0.927 . . . . 0.0 109.261 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -130.82 82.47 2.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.376 0.67 . . . . 0.0 109.562 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.803 HG21 HG22 ' A' ' 26' ' ' VAL . 16.7 m -140.9 172.03 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.242 1.017 . . . . 0.0 109.085 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -86.02 150.71 53.24 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.742 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -60.79 -25.14 80.59 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.998 1.799 . . . . 0.0 111.332 166.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 t -95.12 5.65 51.24 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.038 0.935 . . . . 0.0 111.449 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.01 -96.62 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.139 0.576 . . . . 0.0 110.123 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 26' ' ' VAL . 11.1 t 177.85 146.13 0.13 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.676 1.191 . . . . 0.0 109.31 172.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -62.63 -36.26 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.598 1.159 . . . . 0.0 111.56 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.31 -36.51 71.17 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.712 0.767 . . . . 0.0 110.878 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.0 t-20 -76.07 -42.02 48.71 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.341 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.803 HG22 HG21 ' A' ' 17' ' ' VAL . 58.4 t -55.75 -48.16 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 124.342 1.026 . . . . 0.0 110.371 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.9 ptpt -69.93 -35.15 74.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.977 0.511 . . . . 0.0 110.945 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.05 -36.03 70.01 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.613 0.365 . . . . 0.0 110.921 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 74.0 mmtt -69.58 -33.92 73.41 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 118.59 -0.719 . . . . 0.0 112.394 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.7 mp -60.0 -41.22 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 119.404 1.002 . . . . 0.0 109.662 172.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -67.98 -24.71 65.18 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.526 0.731 . . . . 0.0 111.311 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -77.7 -30.26 51.77 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.849 0.859 . . . . 0.0 111.021 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.5 mmtt -94.58 -67.63 0.84 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.828 0.451 . . . . 0.0 111.093 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -84.41 -26.62 28.19 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.201 0.2 . . . . 0.0 111.115 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.75 23.68 22.68 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 116.547 -0.297 . . . . 0.0 112.851 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.79 129.04 25.59 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 73.9 Cg_endo -68.39 155.24 69.88 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.166 2.577 . . . . 0.0 112.766 -174.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 38.3 Cg_endo -61.16 -16.21 44.73 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.675 2.917 . . . . 0.0 114.082 -176.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.0 -24.71 43.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.829 0.852 . . . . 0.0 110.664 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.453 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.7 mp0 -99.9 -31.69 11.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.218 1.007 . . . . 0.0 111.954 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' HB2' HD21 ' A' ' 69' ' ' LEU . 3.1 pp0? -103.94 123.8 47.82 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.236 0.541 . . . . 0.0 110.419 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.701 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 67.2 ttt180 -115.06 128.58 56.33 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.393 1.077 . . . . 0.0 109.86 -169.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.6 mm? -94.16 121.18 35.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.552 0.741 . . . . 0.0 110.577 -171.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.0 mt -142.62 125.96 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.023 0.929 . . . . 0.0 109.988 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.633 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 85.0 t80 -121.73 122.72 40.18 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.47 1.108 . . . . 0.0 108.962 177.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.66 22.84 10.35 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.699 0.8 . . . . 0.0 112.754 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.17 -13.02 60.4 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.343 0.497 . . . . 0.0 114.343 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.9 ptpt -93.34 133.1 36.93 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.623 0.711 . . . . 0.0 109.298 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -76.08 136.81 39.89 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 43' ' ' LEU . 22.7 mt -92.34 119.39 31.86 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 121.117 0.484 . . . . 0.0 111.164 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.441 ' H ' ' HE2' ' A' ' 59' ' ' TYR . 36.0 tt0 -86.87 139.46 30.63 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.252 1.421 . . . . 0.0 110.892 -176.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.84 -45.37 82.43 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.802 1.241 . . . . 0.0 112.838 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.82 -27.03 73.69 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 124.072 0.857 . . . . 0.0 113.481 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 78.2 mtt180 -80.84 177.59 8.94 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.826 0.851 . . . . 0.0 111.93 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.7 p -113.99 167.83 10.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.817 0.847 . . . . 0.0 110.159 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 93.7 mt -56.72 -52.33 65.37 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.615 173.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.4 t -63.9 -22.78 67.08 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.283 1.033 . . . . 0.0 111.543 -176.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.03 -42.63 89.35 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.46 0.647 . . . . 0.0 109.488 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.441 ' HE2' ' H ' ' A' ' 51' ' ' GLU . 30.0 m-85 -89.25 15.64 8.65 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.887 -1.052 . . . . 0.0 112.147 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 73.49 14.08 4.41 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.027 1.331 . . . . 0.0 112.175 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 7.9 mt -84.29 137.79 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -130.7 -173.93 3.22 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -56.53 141.24 43.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 122.866 0.466 . . . . 0.0 111.364 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 67.3 5.83 4.47 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.591 1.556 . . . . 0.0 113.268 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.3 m -70.48 133.19 46.59 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 118.204 0.457 . . . . 0.0 110.708 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.8 m -97.16 121.22 38.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.35 0.66 . . . . 0.0 109.278 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.633 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -123.24 175.05 6.9 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.897 1.279 . . . . 0.0 109.424 176.137 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -105.61 149.29 26.44 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.667 0.787 . . . . 0.0 110.665 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.734 HD12 HG22 ' A' ' 7' ' ' THR . 3.0 tm? -127.82 122.23 32.15 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.701 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 60.3 t -101.02 112.82 35.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 123.384 0.674 . . . . 0.0 109.779 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.85 145.89 36.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.728 173.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 67.2 mtp85 -122.25 -28.15 4.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.666 0.786 . . . . 0.0 111.124 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 50.94 28.86 4.02 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.532 1.133 . . . . 0.0 113.235 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.4 mmt-85 -73.19 -14.68 61.4 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.243 0.544 . . . . 0.0 109.997 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.65 26.52 1.49 Allowed Glycine 0 C--N 1.343 0.933 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.634 0 C-N-CA 123.631 0.634 . . . . 0.0 113.43 -178.967 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 36.1 t -158.94 144.73 16.5 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.952 0.901 . . . . 0.0 109.151 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -113.77 -51.22 2.8 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.047 0.939 . . . . 0.0 110.472 -176.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -86.03 175.4 8.6 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.815 0.846 . . . . 0.0 111.554 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.7 p -55.56 115.02 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 124.104 0.961 . . . . 0.0 110.824 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 200' ' ' THR . . . . . 0.487 HG22 HG13 ' B' ' 202' ' ' VAL . 4.4 m -97.07 111.86 23.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.084 0.554 . . . . 0.0 110.157 -171.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -85.3 123.13 30.43 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 202' ' ' VAL . . . . . 0.487 HG13 HG22 ' B' ' 200' ' ' THR . 4.0 m -144.93 -177.41 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.833 1.253 . . . . 0.0 109.536 -169.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -112.86 147.34 37.21 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.679 0.391 . . . . 0.0 110.971 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.579 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.4 t -87.31 101.95 2.78 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 124.379 1.072 . . . . 0.0 108.692 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.562 ' HD2' HD21 ' B' ' 220' ' ' LEU . 55.2 Cg_endo -65.55 2.71 1.43 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.272 2.648 . . . . 0.0 115.335 -172.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.13 -51.8 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.691 0.396 . . . . 0.0 110.901 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 14.6 p -114.59 9.0 16.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 58.56 42.17 95.91 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 115.907 1.123 . . . . 0.0 115.907 169.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.1 141.26 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 117.331 0.566 . . . . 0.0 110.644 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -88.17 112.55 22.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.006 0.522 . . . . 0.0 110.078 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.9 pt -141.66 156.26 66.33 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.489 1.515 . . . . 0.0 109.641 -173.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.75 162.6 33.93 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.704 2.269 . . . . 0.0 111.965 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.548 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.9 tm-20 -66.69 -38.69 87.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.979 0.911 . . . . 0.0 112.934 -166.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 43.1 t -56.39 -44.97 80.75 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.762 0.791 . . . . 0.0 109.868 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -80.33 -16.22 55.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.935 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.579 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.21 -50.34 32.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 217' ' ' ASN . . . . . 0.418 ' HA ' HD12 ' B' ' 220' ' ' LEU . 44.9 m-80 -67.14 -36.91 82.88 Favored 'General case' 0 C--N 1.347 0.461 0 O-C-N 123.645 0.591 . . . . 0.0 111.075 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -60.82 -46.99 88.37 Favored 'General case' 0 C--O 1.253 1.266 0 O-C-N 123.675 0.609 . . . . 0.0 110.905 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -40.32 82.62 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.167 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.562 HD21 ' HD2' ' B' ' 205' ' ' PRO . 96.0 mt -60.75 -49.71 76.4 Favored 'General case' 0 C--O 1.211 -0.948 0 O-C-N 123.958 0.786 . . . . 0.0 111.584 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.65 -24.5 67.81 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 123.93 0.769 . . . . 0.0 112.072 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 30.1 t -81.89 -41.8 20.44 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.16 0.505 . . . . 0.0 110.564 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 94.2 m -81.49 -27.45 34.54 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.292 1.037 . . . . 0.0 113.179 -167.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp -79.45 -1.22 36.37 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.032 0.533 . . . . 0.0 110.828 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 18.4 m -66.09 83.41 0.08 Allowed 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.362 1.065 . . . . 0.0 110.199 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -64.62 -37.14 86.55 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.268 173.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 . . . . . 0 C--O 1.25 1.131 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.221 -177.176 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 59.7 m -140.96 146.39 37.27 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.826 0.85 . . . . 0.0 109.77 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -81.5 109.4 15.93 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt -74.9 163.11 28.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.477 0.711 . . . . 0.0 110.345 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -106.5 144.74 32.74 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.621 0.368 . . . . 0.0 111.237 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.4 HD13 ' N ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -137.75 157.65 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.991 1.316 . . . . 0.0 108.964 175.166 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 66' ' ' THR . 72.2 m-85 -110.84 101.33 9.94 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.493 0.717 . . . . 0.0 110.026 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 69' ' ' LEU . 74.6 t -97.44 106.77 19.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -107.11 129.13 54.87 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.325 0.65 . . . . 0.0 110.499 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.704 HG22 HD12 ' A' ' 69' ' ' LEU . 71.8 p -72.25 165.28 24.75 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.362 0.601 . . . . 0.0 111.841 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.504 HD11 HG22 ' A' ' 70' ' ' VAL . 70.0 mt -67.17 -25.79 66.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.924 172.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -78.09 -14.14 59.6 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.34 0.656 . . . . 0.0 110.553 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.99 14.47 39.49 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 114.884 0.714 . . . . 0.0 114.884 165.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.31 151.65 24.62 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 m -107.61 132.0 53.77 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.95 112.44 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 m -92.16 116.09 28.65 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.424 0.69 . . . . 0.0 109.424 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.5 mm? -104.79 157.19 17.37 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.635 0.774 . . . . 0.0 109.483 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.09 86.76 2.63 Favored 'General case' 0 C--O 1.244 0.784 0 O-C-N 124.248 0.968 . . . . 0.0 108.436 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.792 HG21 HG22 ' A' ' 26' ' ' VAL . 13.7 m -140.71 176.65 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 124.374 1.07 . . . . 0.0 108.345 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -92.72 148.68 36.55 Favored Pre-proline 0 N--CA 1.475 0.782 0 O-C-N 121.69 -0.631 . . . . 0.0 109.379 172.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 19.5 Cg_endo -58.45 -28.32 84.88 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.171 1.914 . . . . 0.0 111.71 169.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.7 t -101.93 16.09 27.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.909 0.484 . . . . 0.0 110.979 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.98 -92.08 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -178.85 145.61 0.29 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.503 1.121 . . . . 0.0 109.825 173.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.54 -37.81 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.451 1.1 . . . . 0.0 111.359 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -58.55 -35.17 71.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.397 0.679 . . . . 0.0 110.807 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 16.2 t-20 -72.39 -44.95 61.78 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.331 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.792 HG22 HG21 ' A' ' 17' ' ' VAL . 45.3 t -54.2 -50.32 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 124.372 1.045 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.2 ptpt -68.94 -31.35 70.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.075 0.55 . . . . 0.0 111.802 -175.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.31 -39.61 79.86 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.978 0.418 . . . . 0.0 110.662 170.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 35.6 mmtm -68.88 -36.83 78.55 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.531 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.9 mp -59.13 -41.78 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 119.473 1.033 . . . . 0.0 110.17 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -62.97 -33.15 74.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.56 -26.01 57.59 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.278 0.631 . . . . 0.0 111.319 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.8 mmtt -94.5 -66.38 0.92 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.866 0.466 . . . . 0.0 110.889 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.89 -16.01 32.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.74 20.24 51.44 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 170.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.67 127.83 27.71 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 43.2 Cg_endo -63.31 152.01 82.04 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.244 2.629 . . . . 0.0 112.989 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 43.6 Cg_endo -61.83 -17.14 53.56 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.983 3.122 . . . . 0.0 113.932 -174.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.22 -37.66 63.78 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.832 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HG3' ' H ' ' A' ' 73' ' ' LEU . 2.6 mp0 -89.29 -32.2 17.48 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.276 1.03 . . . . 0.0 112.091 -174.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.538 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 3.0 pp0? -99.77 128.95 45.84 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 55.7 ttt180 -117.18 128.88 55.55 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.4 1.08 . . . . 0.0 109.174 -168.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.48 125.42 38.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 109.892 -172.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -142.22 133.96 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.087 0.955 . . . . 0.0 110.135 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.602 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 79.0 t80 -132.87 129.52 38.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 172.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.48 19.33 11.77 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.985 0.914 . . . . 0.0 113.073 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.33 17.07 54.24 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 114.282 0.473 . . . . 0.0 114.282 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 4.0 ptpt -130.01 148.64 51.89 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.731 0.766 . . . . 0.0 109.982 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -74.11 140.57 45.36 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.779 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 45' ' ' PHE . 24.7 mt -88.64 119.22 28.91 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.015 0.526 . . . . 0.0 109.76 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.05 138.77 38.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.689 0.796 . . . . 0.0 109.989 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.88 -40.93 85.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.002 0.921 . . . . 0.0 111.616 -173.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.04 -23.95 77.59 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.256 0.972 . . . . 0.0 113.923 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.408 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 61.6 mtt180 -80.3 177.48 8.94 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.485 0.714 . . . . 0.0 112.268 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.1 p -113.21 168.46 9.71 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.774 0.829 . . . . 0.0 109.795 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 92.0 mt -59.56 -50.09 75.26 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 t -59.72 -26.71 65.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.927 1.291 . . . . 0.0 111.317 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 14.8 t70 -64.7 -43.16 94.37 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.224 0.61 . . . . 0.0 109.968 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.81 19.51 4.01 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.769 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 69.54 18.66 7.7 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.353 1.061 . . . . 0.0 111.744 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.44 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 14.5 mt -91.88 117.45 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -102.82 -178.29 3.63 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -61.67 142.97 56.85 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.137 170.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 74.2 3.31 4.35 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.612 1.565 . . . . 0.0 112.126 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -71.94 134.32 45.91 Favored 'General case' 0 C--N 1.363 1.155 0 CA-C-N 118.322 0.51 . . . . 0.0 110.513 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 52.3 m -95.13 126.27 40.35 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.602 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -128.26 174.41 9.31 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.528 1.131 . . . . 0.0 109.313 177.181 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -100.02 149.6 23.31 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.177 0.591 . . . . 0.0 111.629 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.704 HD12 HG22 ' A' ' 7' ' ' THR . 2.9 tm? -129.61 130.44 45.65 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.536 HG21 HD11 ' B' ' 220' ' ' LEU . 64.8 t -114.11 128.68 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 123.406 0.682 . . . . 0.0 110.153 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.631 ' HB3' HD23 ' A' ' 73' ' ' LEU . 77.6 mt -89.94 149.17 22.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.619 0.768 . . . . 0.0 110.793 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 72.6 mtp180 -118.99 -59.9 1.81 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.843 0.857 . . . . 0.0 109.298 172.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 71' ' ' LEU . 3.7 mm? 53.75 40.18 31.17 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.343 1.057 . . . . 0.0 111.384 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.491 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 6.0 mmp_? -62.97 -49.81 73.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.804 0.842 . . . . 0.0 112.433 -169.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.67 -19.45 37.57 Favored Glycine 0 N--CA 1.47 0.908 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.331 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.434 0 C-N-CA 123.005 0.336 . . . . 0.0 112.314 -175.918 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 N-CA-C 113.481 0.152 . . . . 0.0 113.481 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 48.1 t -164.56 -44.06 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.884 0.874 . . . . 0.0 109.383 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -149.37 112.6 4.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.207 0.603 . . . . 0.0 109.921 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -137.0 158.13 45.17 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.271 1.028 . . . . 0.0 109.636 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 5.7 p -101.23 106.49 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 165.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 200' ' ' THR . . . . . 0.497 HG22 HG13 ' B' ' 202' ' ' VAL . 13.6 m -75.22 141.03 43.61 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.238 -172.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -99.75 124.95 45.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 202' ' ' VAL . . . . . 0.497 HG13 HG22 ' B' ' 200' ' ' THR . 4.0 m -142.73 -176.46 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.869 0.868 . . . . 0.0 110.751 -168.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.84 147.76 43.6 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.682 0.793 . . . . 0.0 110.225 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.596 ' HA ' HD11 ' B' ' 216' ' ' ILE . 46.2 t -89.63 101.56 3.42 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.095 0.958 . . . . 0.0 108.635 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.639 ' HD2' HD21 ' B' ' 220' ' ' LEU . 89.3 Cg_exo -49.09 -27.52 12.39 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 124.277 3.318 . . . . 0.0 115.006 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 206' ' ' VAL . . . . . 0.406 HG11 ' O ' ' B' ' 223' ' ' CYS . 6.3 t -80.66 -64.5 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.381 -173.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 18.1 p -96.56 1.04 50.93 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.73 45.46 95.7 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 115.061 0.784 . . . . 0.0 115.061 171.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.71 138.11 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.052 0.541 . . . . 0.0 110.223 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -87.54 117.47 26.36 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.479 HD11 ' HB2' ' B' ' 204' ' ' CYS . 7.4 pt -145.59 162.17 37.65 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.157 1.383 . . . . 0.0 110.17 -170.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.35 162.43 33.57 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.64 2.227 . . . . 0.0 112.98 174.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.616 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.9 tt0 -65.07 -39.45 93.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.61 1.164 . . . . 0.0 113.665 -169.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 14.9 m -65.76 -43.44 88.89 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.361 -0.837 . . . . 0.0 109.901 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -75.6 -18.58 59.67 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.831 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.616 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -71.21 -47.62 59.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -68.43 -36.12 78.6 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.313 0.383 . . . . 0.0 111.859 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -63.34 -44.56 94.52 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.157 0.286 . . . . 0.0 110.353 172.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -43.48 86.66 Favored 'General case' 0 C--O 1.211 -0.963 0 O-C-N 123.836 0.71 . . . . 0.0 109.841 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.639 HD21 ' HD2' ' B' ' 205' ' ' PRO . 93.0 mt -60.69 -46.5 90.14 Favored 'General case' 0 C--O 1.21 -1.02 0 O-C-N 124.059 0.849 . . . . 0.0 110.876 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -60.25 -31.22 70.0 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.842 1.339 . . . . 0.0 110.464 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 t -86.49 -37.43 18.26 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.127 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 223' ' ' CYS . . . . . 0.406 ' O ' HG11 ' B' ' 206' ' ' VAL . 88.2 m -79.51 -22.15 44.34 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.002 0.921 . . . . 0.0 112.282 -171.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp -79.64 -4.63 52.52 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.026 0.53 . . . . 0.0 110.462 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 34.9 t -64.49 84.91 0.04 OUTLIER 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.957 0.903 . . . . 0.0 109.34 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.04 159.16 34.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.294 1.037 . . . . 0.0 111.254 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 123.917 0.887 . . . . 0.0 109.248 172.669 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.101 0 N-CA-C 112.254 -0.338 . . . . 0.0 112.254 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 22.7 p -71.31 107.67 4.4 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.708 0.803 . . . . 0.0 111.237 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 17.9 p80 -75.84 91.75 3.01 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.636 0.731 . . . . 0.0 110.921 -175.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt -79.63 158.31 27.09 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 21.9 mp0 -108.85 142.13 39.88 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.926 -0.484 . . . . 0.0 111.212 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.01 159.44 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.735 1.214 . . . . 0.0 108.874 174.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 66' ' ' THR . 94.0 m-85 -109.36 105.92 15.5 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.443 0.697 . . . . 0.0 109.953 -175.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 69' ' ' LEU . 2.6 t -95.59 114.88 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -102.3 113.1 26.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.668 0.787 . . . . 0.0 109.326 -174.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.66 HG22 HD12 ' A' ' 69' ' ' LEU . 23.5 p -68.91 157.93 35.62 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.849 0.356 . . . . 0.0 110.4 174.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.423 HD11 HG22 ' A' ' 70' ' ' VAL . 96.2 mt -58.73 -25.2 62.71 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.941 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.3 p -79.08 3.05 18.59 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.562 0.745 . . . . 0.0 111.799 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 12.39 74.84 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 116.42 -0.355 . . . . 0.0 113.124 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -95.54 147.73 23.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.014 0.926 . . . . 0.0 110.207 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 m -108.02 140.98 40.38 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.561 0.744 . . . . 0.0 109.75 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -125.7 115.6 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.683 1.193 . . . . 0.0 107.978 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 m -92.1 117.64 30.05 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -104.04 156.18 18.07 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 0' ' ' HIS . 47.0 mt-10 -123.85 82.45 2.02 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.906 0.753 . . . . 0.0 109.155 -177.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.75 HG21 HG22 ' A' ' 26' ' ' VAL . 9.6 m -139.63 178.96 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 124.773 1.229 . . . . 0.0 107.969 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 10.1 mt-10 -96.29 152.82 39.0 Favored Pre-proline 0 N--CA 1.482 1.166 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.483 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.8 Cg_endo -61.63 -30.61 85.9 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.098 1.865 . . . . 0.0 111.168 171.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t -102.5 18.97 19.87 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.057 0.543 . . . . 0.0 110.026 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 16.1 t70 -81.04 -88.5 0.08 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.128 0.571 . . . . 0.0 109.49 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 26' ' ' VAL . 7.1 t 177.37 147.53 0.13 Allowed 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.539 1.136 . . . . 0.0 110.183 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -66.03 -34.39 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.251 1.02 . . . . 0.0 111.031 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 36.2 tt0 -62.59 -31.45 72.28 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.311 0.576 . . . . 0.0 110.858 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 12.7 t-20 -75.17 -42.07 56.69 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.862 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.75 HG22 HG21 ' A' ' 17' ' ' VAL . 59.0 t -55.57 -46.93 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 124.283 0.989 . . . . 0.0 110.3 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HA ' HD13 ' A' ' 30' ' ' ILE . 17.9 ptpt -71.22 -29.36 65.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.266 0.626 . . . . 0.0 111.592 -176.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -33.29 75.68 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.519 169.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 68.1 mmtt -75.62 -27.56 58.49 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.229 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.9 mp -58.14 -45.66 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 119.348 0.976 . . . . 0.0 109.281 166.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 59.5 tt0 -67.21 -20.81 65.75 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.579 177.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 23.0 t70 -81.42 -37.0 28.79 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.742 0.817 . . . . 0.0 111.369 174.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.8 mmtt -91.78 -61.92 1.53 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.794 0.437 . . . . 0.0 111.024 -170.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -92.55 -25.12 18.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.422 0.289 . . . . 0.0 111.184 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 97.2 13.83 44.14 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 116.546 -0.297 . . . . 0.0 113.83 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.87 125.88 55.57 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -63.55 152.59 79.52 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.745 2.297 . . . . 0.0 112.097 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -62.01 -16.47 50.2 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.469 2.78 . . . . 0.0 113.694 -173.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -75.4 -42.58 53.4 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.249 0.62 . . . . 0.0 110.616 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -81.74 -22.04 37.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.158 0.983 . . . . 0.0 112.52 -173.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -102.39 148.01 26.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.428 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.576 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 52.2 ttt180 -132.31 129.73 39.89 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.426 0.69 . . . . 0.0 109.556 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.64 125.69 37.38 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.373 0.669 . . . . 0.0 109.303 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.9 mt -142.6 130.99 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.158 0.983 . . . . 0.0 109.749 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.476 ' HB3' HD21 ' A' ' 50' ' ' LEU . 92.5 t80 -129.84 124.12 32.52 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.13 19.85 11.87 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.31 1.044 . . . . 0.0 112.651 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.78 -12.09 60.98 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-O 120.005 -0.33 . . . . 0.0 113.891 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.8 ptpt -99.87 142.28 31.56 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -75.4 140.82 43.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.352 0.261 . . . . 0.0 110.34 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.6 mt -88.15 134.05 33.86 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.137 0.575 . . . . 0.0 109.905 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.529 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 27.8 tt0 -85.16 137.37 33.06 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 9.2 p-10 -61.46 -33.49 73.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.112 0.965 . . . . 0.0 111.892 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.529 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -72.82 -29.5 65.13 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.856 0.723 . . . . 0.0 113.409 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -80.04 177.18 9.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.381 0.672 . . . . 0.0 111.548 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -111.06 167.46 10.24 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.738 0.815 . . . . 0.0 110.254 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 90.4 mt -56.22 -49.82 73.02 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.924 0.765 . . . . 0.0 109.135 172.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -61.3 -27.56 68.56 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.896 1.278 . . . . 0.0 111.572 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.85 -39.2 83.82 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -91.99 20.65 5.6 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.367 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 65.74 25.96 11.39 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.512 1.125 . . . . 0.0 112.194 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.88 118.27 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -106.84 -175.09 2.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -56.38 138.21 51.42 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.381 171.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 71.34 9.67 6.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.211 1.404 . . . . 0.0 112.501 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.1 m -78.57 138.55 38.42 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.147 0.43 . . . . 0.0 110.604 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 46.8 m -95.49 130.37 42.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.23 0.612 . . . . 0.0 109.928 175.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.66 159.32 37.57 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.781 1.232 . . . . 0.0 108.66 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -87.33 152.61 22.13 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.451 0.643 . . . . 0.0 111.299 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.66 HD12 HG22 ' A' ' 7' ' ' THR . 2.8 tm? -134.89 131.53 37.43 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 73.8 t -110.23 113.7 44.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.029 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.38 152.48 32.24 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.993 174.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.434 ' HA ' ' HG2' ' B' ' 213' ' ' GLU . 53.7 mtp180 -129.79 -40.17 1.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.026 0.93 . . . . 0.0 109.883 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 53.41 32.2 13.47 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.035 1.334 . . . . 0.0 112.914 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 25.3 mmm180 -75.67 80.53 2.64 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.18 -11.2 0.26 Allowed Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.356 -173.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 1.786 0 C-N-CA 123.042 0.353 . . . . 0.0 113.406 177.033 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 CA-C-O 119.949 -0.361 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 55.8 p -157.41 154.39 28.75 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.117 0.567 . . . . 0.0 110.689 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -74.33 -22.04 59.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.182 0.993 . . . . 0.0 111.109 172.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -93.57 167.82 11.43 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.479 0.712 . . . . 0.0 110.825 177.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 14.0 p -78.02 135.93 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.76 0.824 . . . . 0.0 110.071 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 15.4 m -88.2 155.08 19.95 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.279 0.632 . . . . 0.0 109.421 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.86 120.92 43.64 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 171.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.8 m -143.1 163.52 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.375 1.07 . . . . 0.0 110.736 -167.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -96.29 147.34 23.89 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.808 0.843 . . . . 0.0 111.409 -172.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.614 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.5 t -88.2 103.92 6.02 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.553 ' HD2' HD21 ' B' ' 220' ' ' LEU . 36.2 Cg_endo -60.52 -12.54 21.26 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.478 2.785 . . . . 0.0 114.816 -168.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 t -88.47 -54.27 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.032 0.533 . . . . 0.0 110.755 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 15.8 p -108.48 1.74 21.79 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -174.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 63.01 46.58 93.22 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 115.632 1.013 . . . . 0.0 115.632 170.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.5 m -119.0 132.84 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.265 0.626 . . . . 0.0 110.764 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -84.76 119.23 25.05 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 5.2 pt -142.91 161.06 50.68 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.71 1.604 . . . . 0.0 108.875 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.46 153.08 56.82 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.229 1.953 . . . . 0.0 112.249 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.565 ' O ' HG22 ' B' ' 216' ' ' ILE . 33.5 tt0 -64.79 -32.64 74.43 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.384 1.474 . . . . 0.0 113.156 -168.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 38.6 t -64.33 -44.3 91.94 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.661 0.743 . . . . 0.0 109.924 172.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -77.0 -19.34 57.4 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.374 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -71.1 -46.5 66.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -60.68 -45.18 95.13 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.477 0.486 . . . . 0.0 110.121 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -56.62 -46.64 80.83 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 124.373 1.046 . . . . 0.0 111.945 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -36.91 81.21 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.246 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 70' ' ' VAL . 93.4 mt -63.58 -46.48 85.64 Favored 'General case' 0 C--O 1.21 -0.986 0 O-C-N 124.186 0.929 . . . . 0.0 111.481 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -54.22 -34.13 59.93 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.251 0.97 . . . . 0.0 111.009 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 34.5 t -82.91 -39.52 21.4 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.268 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 81.3 m -80.05 -18.0 51.24 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.12 0.968 . . . . 0.0 112.612 -170.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 pp -95.27 -2.78 48.73 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.857 0.463 . . . . 0.0 110.499 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 34.0 m -71.94 81.47 0.92 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.653 0.781 . . . . 0.0 110.402 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -80.03 148.22 31.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.584 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.441 0.696 . . . . 0.0 109.475 -175.876 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.873 0 CA-C-O 119.584 -0.564 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 55.6 p -63.25 100.46 0.24 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.755 0.822 . . . . 0.0 110.904 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -75.11 134.18 41.37 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.499 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt -103.89 162.82 12.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.597 0.759 . . . . 0.0 110.09 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 93.0 mt-30 -103.47 122.65 45.34 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.626 0.77 . . . . 0.0 109.972 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.555 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -125.39 152.13 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.732 1.213 . . . . 0.0 108.559 177.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.7 m-85 -111.9 113.11 25.23 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.563 0.697 . . . . 0.0 110.204 -170.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.9 t -105.84 119.74 55.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -111.76 119.12 37.55 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.622 0.769 . . . . 0.0 109.535 -174.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.61 HG22 HD12 ' A' ' 69' ' ' LEU . 68.1 p -70.58 167.11 19.21 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.212 0.53 . . . . 0.0 111.628 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.527 HD11 HG22 ' A' ' 70' ' ' VAL . 84.0 mt -73.33 -19.35 61.04 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.936 173.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.476 HG22 HG21 ' B' ' 200' ' ' THR . 44.1 p -79.05 -12.99 60.03 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.132 0.573 . . . . 0.0 110.39 171.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 26.29 19.79 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.712 -0.677 . . . . 0.0 114.144 169.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.4 152.57 18.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.6 m -97.72 141.11 31.14 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.893 0.477 . . . . 0.0 110.492 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.484 HD11 HG23 ' A' ' 7' ' ' THR . 5.2 mp -127.68 109.82 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.902 1.281 . . . . 0.0 107.68 174.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.1 m -91.5 123.58 35.02 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.7 mm? -106.97 156.02 19.16 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.172 0.589 . . . . 0.0 109.617 -177.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -118.96 76.88 1.14 Allowed 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.371 1.044 . . . . 0.0 109.301 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.707 HG21 HG22 ' A' ' 26' ' ' VAL . 28.9 m -147.43 173.14 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 123.733 0.813 . . . . 0.0 110.236 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.503 ' O ' HD12 ' A' ' 56' ' ' LEU . 9.6 mt-10 -95.72 160.02 31.2 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.139 0.576 . . . . 0.0 109.864 -169.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.91 -17.05 55.01 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 121.758 1.638 . . . . 0.0 111.89 169.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 t -103.41 3.11 34.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.45 157.91 28.81 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 168.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.3 t -102.04 150.23 23.44 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.291 -165.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.1 -36.26 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.624 0.77 . . . . 0.0 112.156 -171.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.03 -34.63 75.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.455 0.645 . . . . 0.0 110.934 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.423 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 18.5 t-20 -73.36 -45.17 56.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.866 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.707 HG22 HG21 ' A' ' 17' ' ' VAL . 65.7 t -55.93 -43.68 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 124.144 0.978 . . . . 0.0 111.361 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -71.74 -33.17 68.47 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.867 0.467 . . . . 0.0 111.473 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.91 68.96 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.143 169.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 10.3 mmpt? -76.51 -32.57 58.36 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.188 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.25 -42.93 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 118.404 0.547 . . . . 0.0 110.057 170.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -62.31 -35.38 78.86 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.154 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.72 -24.66 63.59 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.961 0.904 . . . . 0.0 111.689 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 72.1 mmtt -101.03 -69.51 0.77 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.01 -19.47 31.97 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.665 0.211 . . . . 0.0 111.44 -175.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.95 17.76 46.44 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.028 0.205 . . . . 0.0 113.062 173.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.62 125.86 34.64 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 123.394 0.678 . . . . 0.0 109.567 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -71.82 159.1 51.52 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.102 2.535 . . . . 0.0 112.095 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 29.3 Cg_endo -58.84 -15.26 25.93 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.549 2.832 . . . . 0.0 113.689 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.58 -44.71 70.23 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.366 1.066 . . . . 0.0 110.653 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.81 -33.2 19.95 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.817 0.847 . . . . 0.0 111.963 -175.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -94.2 150.39 20.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.648 0.379 . . . . 0.0 110.408 -179.305 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.585 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 44.9 ttt180 -140.17 129.98 24.55 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.233 0.613 . . . . 0.0 109.666 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.6 mm? -93.45 123.02 36.47 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.522 0.729 . . . . 0.0 109.721 -173.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -141.73 121.73 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.071 0.948 . . . . 0.0 109.716 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.622 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 91.1 t80 -119.51 121.32 39.13 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 66.27 17.88 10.8 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.263 1.025 . . . . 0.0 113.5 173.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.95 14.05 47.45 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 113.983 0.353 . . . . 0.0 113.983 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 1.6 ptpt -124.27 139.24 54.11 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' NE2' ' HE ' ' A' ' 42' ' ' ARG . 63.7 tt0 -74.79 132.08 41.29 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 45' ' ' PHE . 32.0 mt -78.37 118.77 20.86 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.036 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.78 138.46 42.66 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.992 0.917 . . . . 0.0 110.357 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.15 -44.81 83.79 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.886 1.275 . . . . 0.0 112.116 -172.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 -28.22 73.5 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 124.574 1.171 . . . . 0.0 113.747 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -77.65 175.23 10.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.087 0.555 . . . . 0.0 111.813 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 26.2 p -115.85 165.26 13.28 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.486 0.715 . . . . 0.0 109.746 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 18' ' ' GLU . 83.8 mt -55.51 -56.29 21.96 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 123.635 0.584 . . . . 0.0 110.495 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 t -61.91 -22.16 65.34 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.122 0.969 . . . . 0.0 112.057 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.1 -39.25 79.09 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.763 0.425 . . . . 0.0 110.096 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -87.26 13.53 9.5 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.342 172.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 67.63 25.45 8.22 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.912 1.285 . . . . 0.0 111.691 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 mt -91.12 112.96 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.408 1.083 . . . . 0.0 108.472 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -101.45 -172.76 2.21 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -61.65 140.28 58.18 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 70.65 3.22 4.45 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.809 1.244 . . . . 0.0 113.306 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -64.74 130.23 42.77 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 20.6 m -99.68 131.23 45.8 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.763 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.622 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -134.19 174.18 10.79 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.07 0.948 . . . . 0.0 110.107 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -98.55 148.21 24.0 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.332 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -127.32 130.63 49.85 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 67.1 t -108.68 111.55 36.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.21 0.604 . . . . 0.0 109.833 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.2 mt -79.2 149.75 31.85 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 124.191 0.932 . . . . 0.0 109.011 171.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -118.98 -39.43 2.94 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.445 0.698 . . . . 0.0 110.72 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 52.68 49.94 19.24 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.645 1.178 . . . . 0.0 111.89 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -57.56 -40.94 80.05 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.363 0.665 . . . . 0.0 111.286 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.63 12.92 50.68 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.087 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.37 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 -174.379 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.546 0 CA-C-O 119.139 -0.812 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 20.1 m 62.36 15.87 8.05 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.098 1.359 . . . . 0.0 113.12 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -96.39 -33.91 11.74 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.602 0.761 . . . . 0.0 111.138 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -103.39 179.8 4.17 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.185 0.594 . . . . 0.0 110.915 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 4.8 p -72.92 116.84 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 200' ' ' THR . . . . . 0.476 HG21 HG22 ' A' ' 9' ' ' THR . 9.0 m -78.48 153.85 31.05 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.236 0.615 . . . . 0.0 110.692 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.79 123.52 44.12 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 168.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 m -144.46 -178.04 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.382 1.073 . . . . 0.0 110.072 -165.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -113.57 148.06 36.84 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.219 0.608 . . . . 0.0 110.314 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.627 ' HA ' HD11 ' B' ' 216' ' ' ILE . 46.2 t -85.4 100.81 1.35 Allowed Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.079 0.952 . . . . 0.0 109.501 176.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.58 ' HD2' HD21 ' B' ' 220' ' ' LEU . 65.3 Cg_endo -68.0 8.29 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.392 2.728 . . . . 0.0 115.361 -168.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.07 -50.63 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 122.971 0.509 . . . . 0.0 110.716 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.9 p -114.03 -4.61 13.17 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 122.746 0.418 . . . . 0.0 111.945 -172.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.36 58.25 14.95 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 124.288 0.947 . . . . 0.0 114.956 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.07 129.83 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.201 0.601 . . . . 0.0 109.57 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -82.59 115.42 21.55 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.8 pt -143.95 160.77 48.61 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.491 1.516 . . . . 0.0 109.746 -170.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' B' ' 215' ' ' HIS . 28.4 Cg_endo -60.92 155.92 46.92 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.704 2.27 . . . . 0.0 112.199 172.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.516 ' O ' HG22 ' B' ' 216' ' ' ILE . 35.7 tt0 -68.51 -28.32 66.9 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.69 1.196 . . . . 0.0 113.466 -170.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 40.9 t -65.78 -44.22 86.42 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.657 0.741 . . . . 0.0 109.724 171.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 215' ' ' HIS . . . . . 0.401 ' HB2' ' HG2' ' B' ' 212' ' ' PRO . 70.6 m-70 -80.35 -16.51 54.38 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.046 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -72.55 -44.5 61.06 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 175.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -54.38 -54.47 40.15 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.023 0.827 . . . . 0.0 109.999 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -57.24 -44.84 84.19 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 124.48 1.113 . . . . 0.0 112.558 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -33.93 74.87 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.105 -177.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.58 HD21 ' HD2' ' B' ' 205' ' ' PRO . 78.8 mt -68.49 -42.95 77.9 Favored 'General case' 0 C--O 1.212 -0.901 0 O-C-N 123.557 0.536 . . . . 0.0 111.521 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -57.58 -28.4 63.56 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 124.027 0.829 . . . . 0.0 111.259 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 43.4 t -86.38 -42.27 13.8 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.692 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.9 m -80.7 -26.54 37.42 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -167.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.5 -25.33 63.09 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.053 0.541 . . . . 0.0 110.222 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 22.7 t -73.08 82.94 1.28 Allowed 'General case' 0 C--N 1.348 0.535 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -86.13 79.46 9.12 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.573 -176.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 C--O 1.248 1.009 0 CA-C-N 114.204 -1.362 . . . . 0.0 107.994 179.134 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.357 0 N-CA-C 112.202 -0.359 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.7 t -158.93 -33.72 0.06 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.702 0.801 . . . . 0.0 110.237 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -75.09 130.16 38.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.878 0.871 . . . . 0.0 110.989 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt -98.53 178.65 4.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.791 0.837 . . . . 0.0 110.052 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 65.8 mt-30 -111.13 147.72 34.27 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.273 0.629 . . . . 0.0 110.641 176.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.506 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -138.93 155.29 26.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 125.396 1.478 . . . . 0.0 107.841 174.76 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 66' ' ' THR . 89.8 m-85 -112.34 116.78 30.9 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.734 -174.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 55.6 t -105.32 131.96 53.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tpmt? -123.26 124.57 43.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.242 0.617 . . . . 0.0 109.972 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.657 HG22 HD12 ' A' ' 69' ' ' LEU . 42.8 p -73.27 169.49 16.99 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.259 0.552 . . . . 0.0 111.495 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.4 mt -65.59 -26.41 67.84 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.036 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.9 p -80.55 -15.9 55.53 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.637 0.775 . . . . 0.0 111.189 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.23 11.64 38.59 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 114.781 0.673 . . . . 0.0 114.781 167.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 152.27 31.25 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.743 0.771 . . . . 0.0 109.609 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.4 m -95.26 141.78 28.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.177 0.591 . . . . 0.0 109.693 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.55 HD11 HG23 ' A' ' 7' ' ' THR . 4.4 mp -132.37 100.9 4.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.7 m -95.06 121.36 36.61 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -105.65 152.77 22.71 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -117.45 82.73 1.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.752 HG21 HG22 ' A' ' 26' ' ' VAL . 24.6 m -141.74 177.32 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.72 1.208 . . . . 0.0 108.509 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -92.61 153.42 42.44 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.55 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 24.0 Cg_endo -61.98 -28.61 80.88 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.829 1.686 . . . . 0.0 110.742 164.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -94.13 13.54 22.82 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.019 0.928 . . . . 0.0 111.24 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.71 -99.19 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.163 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.0 t 171.86 140.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.967 1.307 . . . . 0.0 109.324 177.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.415 HD12 HD13 ' A' ' 50' ' ' LEU . 39.9 mm -60.54 -36.81 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.578 1.151 . . . . 0.0 112.034 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.01 -34.84 76.94 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.564 0.697 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.5 t30 -75.82 -41.0 53.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.107 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.752 HG22 HG21 ' A' ' 17' ' ' VAL . 58.4 t -57.97 -45.86 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 124.441 1.088 . . . . 0.0 110.042 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.1 ptpt -72.39 -28.68 63.14 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.026 0.53 . . . . 0.0 111.313 -176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.33 75.13 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.218 0.324 . . . . 0.0 110.434 169.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 71.6 mmtt -74.03 -36.13 64.41 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.95 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.9 mp -57.23 -41.57 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.532 1.06 . . . . 0.0 109.511 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -60.4 -39.09 86.08 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.447 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.43 -32.09 73.52 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.207 0.603 . . . . 0.0 111.481 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 70.4 mmtt -91.4 -67.97 0.82 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.626 0.37 . . . . 0.0 111.624 -171.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -80.39 -22.95 40.77 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.768 0.258 . . . . 0.0 111.06 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.86 18.67 39.62 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.222 0.326 . . . . 0.0 113.037 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.598 HG13 HD11 ' A' ' 73' ' ' LEU . 1.9 mp -108.79 127.52 27.21 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.68 156.13 67.25 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.907 2.404 . . . . 0.0 112.287 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 46.3 Cg_endo -62.17 -13.32 31.27 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 123.636 2.891 . . . . 0.0 113.967 -173.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 7.4 t70 -76.23 -46.13 29.61 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.893 0.746 . . . . 0.0 109.943 174.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.9 mp0 -83.8 -23.09 31.59 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.521 0.728 . . . . 0.0 112.366 -172.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.568 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 2.9 pp0? -104.74 133.27 49.85 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.973 0.509 . . . . 0.0 109.857 173.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.562 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.2 ttt180 -120.26 130.74 54.63 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.975 0.91 . . . . 0.0 110.238 -170.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -94.28 117.42 30.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.634 0.774 . . . . 0.0 110.546 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -141.85 127.54 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 124.27 1.028 . . . . 0.0 109.547 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.538 ' HB3' HD21 ' A' ' 50' ' ' LEU . 81.2 t80 -123.17 124.08 42.25 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.142 0.977 . . . . 0.0 109.236 177.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.94 16.06 9.61 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.031 1.332 . . . . 0.0 112.972 176.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.09 -8.48 60.97 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.929 -0.373 . . . . 0.0 113.171 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.5 ptpt -96.03 135.79 37.33 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -76.39 131.58 39.21 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.538 HD21 ' HB3' ' A' ' 45' ' ' PHE . 30.5 mt -74.34 153.84 39.13 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.436 0.294 . . . . 0.0 110.466 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' H ' ' HE2' ' A' ' 59' ' ' TYR . 37.5 tt0 -116.34 137.35 52.22 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.397 0.679 . . . . 0.0 109.194 -176.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.92 -44.18 86.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.673 1.189 . . . . 0.0 112.075 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.27 -25.04 75.8 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 124.43 1.081 . . . . 0.0 113.478 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -81.31 177.57 8.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.301 0.64 . . . . 0.0 111.789 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 73.1 p -110.36 169.68 8.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.663 0.785 . . . . 0.0 109.795 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 95.4 mt -57.32 -54.8 42.7 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.893 0.746 . . . . 0.0 109.46 172.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.511 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 24.3 t -62.59 -19.28 63.57 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.733 1.213 . . . . 0.0 111.971 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -66.91 -41.4 87.17 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.451 ' HE2' ' H ' ' A' ' 51' ' ' GLU . 38.1 m-85 -90.98 17.87 7.38 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.09 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 68.39 16.69 9.23 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.18 1.392 . . . . 0.0 112.17 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.1 mt -85.16 102.01 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -86.48 -177.23 6.13 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -62.34 144.95 55.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 76.6 -3.34 2.55 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.61 1.564 . . . . 0.0 111.81 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -68.72 133.69 48.75 Favored 'General case' 0 C--N 1.366 1.306 0 CA-C-N 117.971 0.351 . . . . 0.0 110.713 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 18.0 m -99.43 140.21 33.95 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.796 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.404 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -140.79 173.35 11.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.939 0.896 . . . . 0.0 109.699 -178.699 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -97.32 147.16 24.44 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.371 0.668 . . . . 0.0 110.88 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.657 HD12 HG22 ' A' ' 7' ' ' THR . 2.5 tm? -129.19 127.74 41.94 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.574 HG21 HD11 ' B' ' 220' ' ' LEU . 96.0 t -108.78 126.77 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 123.282 0.633 . . . . 0.0 110.109 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.518 ' HB3' HD23 ' A' ' 73' ' ' LEU . 66.4 mt -86.25 147.04 26.27 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.771 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.428 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 37.3 mtp-105 -136.29 6.4 3.05 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.475 1.11 . . . . 0.0 110.243 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD11 HG13 ' A' ' 36' ' ' ILE . 4.2 mm? -33.04 104.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 126.467 1.907 . . . . 0.0 114.27 -169.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -75.71 -59.16 2.87 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.967 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.99 14.52 63.21 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.065 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.502 0 CA-C-N 116.795 0.297 . . . . 0.0 113.28 179.784 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.675 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 31.4 m -70.31 94.75 0.96 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.993 0.917 . . . . 0.0 109.809 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -65.83 123.55 20.08 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.804 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -154.49 169.36 23.98 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.92 0.888 . . . . 0.0 109.671 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.36 77.42 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 124.098 0.959 . . . . 0.0 110.575 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 95.7 m -72.26 124.96 26.15 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.251 1.021 . . . . 0.0 111.867 -171.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' B' ' 212' ' ' PRO . 11.6 mptt -82.57 124.72 30.4 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.321 0.649 . . . . 0.0 109.368 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.13 -176.91 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.87 1.668 . . . . 0.0 109.093 -172.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -111.23 146.08 37.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.936 -0.478 . . . . 0.0 110.915 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.664 ' HA ' HD11 ' B' ' 216' ' ' ILE . 35.1 t -94.72 101.12 6.31 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.445 ' HD2' HD21 ' B' ' 220' ' ' LEU . 66.3 Cg_endo -67.49 -4.65 12.35 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.173 2.582 . . . . 0.0 114.765 -164.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 206' ' ' VAL . . . . . 0.451 HG11 ' O ' ' B' ' 223' ' ' CYS . 11.6 t -95.25 -58.01 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 122.793 0.437 . . . . 0.0 110.661 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.3 p -99.19 -4.63 31.65 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 66.85 47.01 69.11 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 172.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.25 144.22 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 117.514 0.657 . . . . 0.0 110.842 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -90.26 108.75 19.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.078 0.951 . . . . 0.0 110.026 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' B' ' 204' ' ' CYS . 10.0 pt -144.25 153.42 56.12 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.864 1.266 . . . . 0.0 110.419 -172.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' B' ' 201' ' ' LYS . 54.6 Cg_endo -65.17 165.3 22.37 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.439 2.76 . . . . 0.0 114.366 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.593 ' O ' HG22 ' B' ' 216' ' ' ILE . 31.6 tt0 -62.25 -41.83 98.78 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 125.341 1.456 . . . . 0.0 114.31 -164.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.0 m -76.11 -29.7 57.98 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.812 -1.18 . . . . 0.0 110.712 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -81.63 -23.96 36.66 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.047 0.539 . . . . 0.0 109.997 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.664 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.1 OUTLIER -72.64 -42.79 62.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -65.11 -42.93 93.49 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.851 0.719 . . . . 0.0 110.923 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -64.09 -37.62 88.12 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.654 0.596 . . . . 0.0 110.969 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -39.88 88.58 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.401 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.574 HD11 HG21 ' A' ' 70' ' ' VAL . 80.0 mt -71.19 -32.38 68.78 Favored 'General case' 0 C--O 1.214 -0.763 0 O-C-N 124.201 0.938 . . . . 0.0 111.581 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -58.65 -27.29 64.61 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 123.847 0.717 . . . . 0.0 109.892 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.3 t -95.51 -36.03 11.45 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 123.473 0.709 . . . . 0.0 112.4 172.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 223' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' B' ' 220' ' ' LEU . 91.6 m -81.96 -17.79 45.76 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.142 0.977 . . . . 0.0 112.614 -168.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.98 -7.97 51.82 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.582 0.353 . . . . 0.0 111.052 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 11.2 m -78.68 47.51 0.74 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.55 1.14 . . . . 0.0 110.645 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -73.65 87.05 1.65 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.814 0.846 . . . . 0.0 108.889 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 124.23 1.012 . . . . 0.0 109.506 -174.463 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.372 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 22.7 t -87.42 175.32 8.03 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.175 0.59 . . . . 0.0 110.788 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.597 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 3.9 m-70 -130.69 101.19 5.57 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.633 0.773 . . . . 0.0 110.804 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 mmt -101.24 152.03 21.16 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.606 0.762 . . . . 0.0 109.037 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.4 mp0 -95.06 131.03 41.49 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.791 0.436 . . . . 0.0 111.456 -173.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.24 147.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.013 1.325 . . . . 0.0 108.539 172.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' THR . 96.1 m-85 -111.49 103.63 11.99 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.316 0.647 . . . . 0.0 110.211 -169.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 69' ' ' LEU . 84.0 t -103.01 106.06 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.896 0.878 . . . . 0.0 108.978 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -89.22 118.29 28.8 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.816 1.246 . . . . 0.0 110.426 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.58 HG22 HD12 ' A' ' 69' ' ' LEU . 7.8 p -70.95 167.36 19.27 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.61 0.719 . . . . 0.0 112.131 175.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.539 HD11 HG22 ' A' ' 70' ' ' VAL . 89.2 mt -70.2 -11.23 60.75 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.675 172.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.7 p -86.47 -4.43 59.17 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.478 0.711 . . . . 0.0 111.504 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.49 15.63 73.23 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.262 0.352 . . . . 0.0 112.868 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -93.53 151.59 19.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.472 1.109 . . . . 0.0 109.923 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -109.51 128.74 55.4 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.141 0.576 . . . . 0.0 110.288 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.96 106.71 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.685 0.794 . . . . 0.0 108.949 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.7 m -88.78 118.03 28.18 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.069 0.947 . . . . 0.0 109.834 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.2 mm? -105.53 159.67 15.76 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.491 0.716 . . . . 0.0 109.458 178.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 0' ' ' HIS . 38.1 mt-10 -126.7 83.19 2.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.775 0.83 . . . . 0.0 108.839 -174.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.702 HG21 HG22 ' A' ' 26' ' ' VAL . 32.2 m -147.73 -177.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 124.168 0.987 . . . . 0.0 110.056 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -96.21 155.95 37.54 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 123.253 0.621 . . . . 0.0 110.247 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 28.9 Cg_endo -61.52 -31.64 87.66 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 121.984 1.789 . . . . 0.0 111.322 167.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -95.65 10.59 36.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.585 0.754 . . . . 0.0 110.939 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.47 -96.36 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.924 0.889 . . . . 0.0 110.334 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.6 t 172.72 144.63 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.327 1.451 . . . . 0.0 108.98 173.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.06 -35.98 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.806 0.843 . . . . 0.0 111.616 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.09 -35.54 75.42 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.606 0.717 . . . . 0.0 110.777 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 16.8 t-20 -74.57 -42.32 58.95 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.712 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.702 HG22 HG21 ' A' ' 17' ' ' VAL . 72.8 t -56.75 -44.05 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 124.367 1.042 . . . . 0.0 110.479 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 17.9 ptpt -74.32 -26.45 60.17 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.653 0.381 . . . . 0.0 111.498 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.6 -32.03 72.47 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.635 168.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -68.96 -38.65 79.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.152 0.581 . . . . 0.0 111.134 175.379 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.16 -43.7 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 118.249 0.477 . . . . 0.0 109.99 173.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.433 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 62.7 tt0 -65.73 -24.97 67.09 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.236 0.541 . . . . 0.0 111.542 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.92 -31.81 59.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.852 0.461 . . . . 0.0 110.76 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.7 mmtt -91.12 -67.2 0.87 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.611 0.364 . . . . 0.0 110.526 -172.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -86.44 -26.59 24.61 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.384 0.274 . . . . 0.0 111.547 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 93.24 17.4 43.18 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 120.048 -0.307 . . . . 0.0 113.619 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.05 126.77 47.64 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.76 152.46 78.36 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.954 2.436 . . . . 0.0 112.109 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -58.73 -15.76 27.73 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.324 2.682 . . . . 0.0 113.509 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.27 -36.12 63.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.827 0.851 . . . . 0.0 111.432 175.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -97.05 -28.64 14.05 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.158 0.983 . . . . 0.0 112.81 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.486 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -90.69 149.86 21.89 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.031 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.602 ' HD3' HD23 ' B' ' 220' ' ' LEU . 10.4 ttt180 -140.85 127.01 19.6 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.48 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -92.38 126.22 37.37 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.919 0.888 . . . . 0.0 109.337 -171.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.614 HD11 HD21 ' B' ' 220' ' ' LEU . 90.5 mt -140.78 118.62 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.097 0.559 . . . . 0.0 110.704 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.556 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 71.8 t80 -122.01 129.28 52.32 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.28 20.65 12.39 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.708 0.803 . . . . 0.0 112.605 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.77 22.5 55.54 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 119.881 -0.4 . . . . 0.0 113.692 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.5 ptpt -128.96 146.09 51.06 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 173.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.616 ' HB2' ' HB2' ' B' ' 224' ' ' LEU . 0.3 OUTLIER -82.83 138.5 33.92 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.801 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 43' ' ' LEU . 26.6 mt -90.82 120.14 31.61 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.56 -172.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -75.53 138.85 41.8 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.4 1.08 . . . . 0.0 110.51 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.17 -49.7 63.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.636 1.174 . . . . 0.0 111.919 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.69 -29.77 76.12 Favored Glycine 0 C--N 1.352 1.471 0 O-C-N 124.367 1.042 . . . . 0.0 113.962 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -79.31 177.46 8.82 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.568 0.747 . . . . 0.0 111.402 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -118.72 166.59 12.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.604 0.762 . . . . 0.0 110.234 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 93.2 mt -55.76 -54.2 47.35 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 124.104 0.877 . . . . 0.0 109.677 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 15.7 t -60.89 -26.02 67.13 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.591 1.156 . . . . 0.0 111.514 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -68.6 -41.22 79.87 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 122.867 0.467 . . . . 0.0 109.834 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -85.86 15.11 5.13 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.631 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 68.36 25.8 6.92 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.69 1.196 . . . . 0.0 111.69 176.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 56' ' ' LEU . 14.1 mt -93.42 127.89 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.394 1.078 . . . . 0.0 108.256 175.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -110.08 -178.21 3.46 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 172.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -60.1 137.03 58.19 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.044 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 73.15 10.04 5.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.277 1.431 . . . . 0.0 112.467 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -68.11 138.89 56.09 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 170.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 24.9 m -101.29 129.57 47.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.384 0.674 . . . . 0.0 109.613 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.556 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -143.96 154.35 43.21 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.006 0.923 . . . . 0.0 109.909 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -80.58 154.59 27.37 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.462 0.648 . . . . 0.0 112.455 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.58 HD12 HG22 ' A' ' 7' ' ' THR . 2.2 tm? -131.58 121.67 24.79 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.576 HG21 HD22 ' B' ' 220' ' ' LEU . 57.1 t -98.25 119.36 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.53 0.732 . . . . 0.0 110.397 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -85.97 147.65 26.12 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.853 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -121.41 -40.64 2.56 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.497 0.719 . . . . 0.0 110.874 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 52.34 30.86 8.62 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 125.022 1.329 . . . . 0.0 113.017 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -68.96 -56.58 7.4 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.821 0.848 . . . . 0.0 109.472 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.44 35.56 4.89 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.682 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.486 0 N-CA-C 114.051 0.38 . . . . 0.0 114.051 175.884 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 56.0 p -83.72 121.81 27.78 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.366 0.666 . . . . 0.0 110.616 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -101.78 -5.55 24.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.86 0.864 . . . . 0.0 111.119 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.86 169.48 8.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.674 0.789 . . . . 0.0 110.467 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.06 110.67 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 11.5 m -79.89 134.65 36.31 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.718 0.807 . . . . 0.0 111.072 -170.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -79.11 122.87 26.78 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 8.3 m -148.25 -177.58 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.666 1.186 . . . . 0.0 109.326 -167.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -120.95 138.59 54.06 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.722 0.409 . . . . 0.0 111.134 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 204' ' ' CYS . . . . . 0.536 ' HA ' HD11 ' B' ' 216' ' ' ILE . 37.1 t -78.73 100.25 0.52 Allowed Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 124.303 1.041 . . . . 0.0 108.263 174.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 205' ' ' PRO . . . . . 0.507 ' HD3' HD11 ' B' ' 216' ' ' ILE . 44.5 Cg_endo -81.99 20.49 1.07 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.071 2.514 . . . . 0.0 114.116 -159.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 53.9 t -105.32 -58.24 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.333 0.653 . . . . 0.0 109.691 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 28.8 p -91.97 -23.84 19.43 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.072 0.549 . . . . 0.0 111.22 -175.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.89 52.52 3.83 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 114.299 0.48 . . . . 0.0 114.299 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.76 134.76 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.264 0.626 . . . . 0.0 110.172 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -87.92 114.06 24.17 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 211' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' B' ' 204' ' ' CYS . 8.9 pt -143.89 160.41 50.08 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 124.866 1.266 . . . . 0.0 110.376 -171.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.4 156.19 32.11 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.153 2.569 . . . . 0.0 112.774 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 213' ' ' GLU . . . . . 0.5 ' O ' HG22 ' B' ' 216' ' ' ILE . 33.2 tt0 -66.18 -29.39 69.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.522 1.129 . . . . 0.0 113.499 -171.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 15.7 m -64.11 -43.68 94.58 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.882 0.849 . . . . 0.0 110.057 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -81.17 -21.53 39.62 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.304 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -69.82 -41.13 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -58.97 -51.68 69.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.15 0.906 . . . . 0.0 109.973 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -64.95 -47.93 75.88 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.966 -174.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -33.76 76.73 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.505 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.614 HD21 HD11 ' A' ' 44' ' ' ILE . 46.6 tp -68.23 -39.34 82.37 Favored 'General case' 0 C--O 1.214 -0.777 0 O-C-N 124.249 0.968 . . . . 0.0 111.447 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.14 -36.32 63.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.044 0.538 . . . . 0.0 110.822 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.4 t -77.93 -43.92 28.49 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.668 174.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 75.1 m -77.38 -21.09 53.75 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 3.9 pp -87.4 -31.54 20.03 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -176.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 21.6 t -80.77 79.18 7.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.446 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -73.82 -22.5 59.77 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.727 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 CA--C 1.567 1.609 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.494 168.105 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.2 mp0 -99.47 130.39 45.73 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.041 -174.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.422 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -128.7 146.81 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.636 1.174 . . . . 0.0 109.355 176.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 66' ' ' THR . 73.7 m-85 -103.19 100.11 10.0 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.761 0.824 . . . . 0.0 109.89 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 69' ' ' LEU . 93.6 t -101.67 99.91 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -98.89 123.49 43.19 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.587 -169.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.757 HG22 HD12 ' A' ' 69' ' ' LEU . 41.3 p -67.84 166.75 14.85 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.822 0.849 . . . . 0.0 112.927 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.51 -17.03 64.51 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.073 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.4 p -85.87 2.96 43.84 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.335 0.654 . . . . 0.0 111.113 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.05 85.61 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 113.888 0.315 . . . . 0.0 113.888 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.5 135.98 34.22 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.84 0.856 . . . . 0.0 109.841 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.6 m -101.34 124.58 47.24 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.035 0.534 . . . . 0.0 110.683 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.7 mp -107.53 110.54 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.9 0.88 . . . . 0.0 109.495 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -87.03 118.69 26.58 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.568 0.747 . . . . 0.0 109.755 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.6 mm? -103.78 162.37 13.15 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.491 0.716 . . . . 0.0 109.217 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -125.25 72.0 1.23 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.223 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.686 HG21 HG22 ' A' ' 26' ' ' VAL . 2.4 m -134.11 174.16 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.313 0.645 . . . . 0.0 109.572 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 2.7 mm-40 -85.96 148.68 48.7 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.132 0.573 . . . . 0.0 109.61 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 20.5 Cg_endo -61.19 -31.38 89.93 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 121.687 1.592 . . . . 0.0 111.287 167.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.6 t -98.52 17.92 17.89 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.397 0.679 . . . . 0.0 110.563 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 12.1 t0 -74.89 -94.96 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 25' ' ' ASN . 12.0 t 176.95 149.28 0.14 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 125.027 1.331 . . . . 0.0 108.828 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.431 HG22 ' HE3' ' A' ' 27' ' ' LYS . 50.3 mm -65.49 -36.09 76.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.856 0.862 . . . . 0.0 110.848 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.15 -40.71 64.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.902 0.881 . . . . 0.0 110.847 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.516 ' H ' HG23 ' A' ' 22' ' ' THR . 10.3 t30 -70.95 -46.03 63.09 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.126 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.686 HG22 HG21 ' A' ' 17' ' ' VAL . 61.1 t -55.19 -49.52 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 124.173 0.921 . . . . 0.0 111.022 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HE3' HG22 ' A' ' 23' ' ' ILE . 16.7 ptpt -67.21 -33.71 75.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.318 0.647 . . . . 0.0 111.929 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.25 -30.1 70.87 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.236 171.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 68.8 mmtt -80.79 -28.15 36.41 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.94 -40.44 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-N 119.577 1.08 . . . . 0.0 108.805 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.76 -35.25 75.93 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.304 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 27.1 t70 -71.14 -26.4 62.99 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.778 0.831 . . . . 0.0 112.065 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -95.1 -70.1 0.73 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.415 0.286 . . . . 0.0 111.381 -175.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -83.4 -24.36 31.98 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.23 26.79 13.2 Favored Glycine 0 C--N 1.349 1.259 0 O-C-N 123.224 0.327 . . . . 0.0 113.036 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.8 125.79 29.31 Favored Pre-proline 0 N--CA 1.481 1.115 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.95 155.8 68.32 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.888 2.392 . . . . 0.0 112.686 -171.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.26 -11.57 19.75 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.672 2.915 . . . . 0.0 113.918 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.59 -42.53 58.52 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.205 0.602 . . . . 0.0 110.333 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -89.44 -12.54 39.92 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.829 0.852 . . . . 0.0 112.709 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.566 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.86 152.75 31.67 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 123.127 0.571 . . . . 0.0 109.956 173.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.503 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 41.8 ttt180 -136.09 134.56 38.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.117 0.567 . . . . 0.0 110.3 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.503 HD21 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -94.66 123.35 38.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.873 0.869 . . . . 0.0 110.452 -173.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.5 mt -142.91 126.7 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.078 0.951 . . . . 0.0 109.915 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.5 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 84.8 t80 -121.96 124.84 44.98 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.271 1.029 . . . . 0.0 108.9 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.6 17.96 7.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.07 0.948 . . . . 0.0 112.964 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.79 -7.14 59.05 Favored Glycine 0 C--N 1.351 1.385 0 C-N-CA 122.992 0.329 . . . . 0.0 113.88 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.8 ptpt -95.43 135.21 37.35 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -73.69 138.98 45.05 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.457 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 18.5 mt -92.03 110.22 21.58 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.876 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.89 139.44 43.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.285 1.034 . . . . 0.0 110.524 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.38 -47.06 69.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.696 1.198 . . . . 0.0 112.362 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.01 -26.11 73.29 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 124.123 0.889 . . . . 0.0 114.019 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 80.0 mtt180 -83.24 176.34 9.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.28 0.632 . . . . 0.0 111.794 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.8 p -111.13 167.13 10.51 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.607 0.763 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 91.3 mt -57.75 -51.33 69.99 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.0 t -57.59 -29.95 64.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.727 1.211 . . . . 0.0 111.733 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 10.4 t70 -61.06 -48.26 82.54 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.778 0.799 . . . . 0.0 109.645 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 29.9 m-85 -87.29 18.85 3.49 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.628 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.438 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.7 OUTLIER 72.0 22.2 3.83 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.303 1.041 . . . . 0.0 111.805 177.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -98.94 118.64 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.83 -179.56 4.21 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 10.8 ptmm? -62.97 140.87 58.9 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.618 170.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 64.2 23.57 13.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.164 1.386 . . . . 0.0 112.678 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -75.72 142.12 42.52 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 166.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 61.3 m -101.15 125.76 47.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.5 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -130.84 173.36 11.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.987 1.315 . . . . 0.0 108.876 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -100.45 151.07 21.98 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.762 0.792 . . . . 0.0 111.726 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.757 HD12 HG22 ' A' ' 7' ' ' THR . 3.1 tm? -129.86 123.74 31.55 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.521 HG21 HD11 ' B' ' 220' ' ' LEU . 90.9 t -98.73 112.09 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.324 0.65 . . . . 0.0 110.5 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt -78.22 143.72 36.89 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.961 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -124.98 -42.35 2.04 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.724 0.81 . . . . 0.0 110.062 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.49 1.554 0 C-N-CA 123.565 0.746 . . . . 0.0 111.89 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 5.9 m -143.64 167.33 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.193 1.397 . . . . 0.0 110.023 -172.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -94.38 146.48 24.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.171 0.588 . . . . 0.0 111.685 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.63 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.5 t -90.22 102.49 4.96 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.525 ' HD2' HD21 ' B' ' 220' ' ' LEU . 61.2 Cg_endo -66.62 -2.89 8.21 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.115 2.543 . . . . 0.0 114.599 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.24 -64.09 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.003 0.521 . . . . 0.0 110.338 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.2 p -98.84 4.32 47.53 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.67 0.388 . . . . 0.0 111.835 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.06 44.51 97.67 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 115.181 0.832 . . . . 0.0 115.181 169.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.13 136.57 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 117.472 0.636 . . . . 0.0 110.973 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -87.38 123.4 32.29 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' B' ' 204' ' ' CYS . 3.9 pt -148.79 162.98 27.79 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.543 1.537 . . . . 0.0 109.013 -169.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.55 153.98 71.6 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.049 1.833 . . . . 0.0 111.333 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.563 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.6 tm-20 -66.97 -36.22 81.72 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.34 1.056 . . . . 0.0 113.217 -168.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 16.7 p -58.82 -41.12 86.08 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.88 0.848 . . . . 0.0 110.14 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -81.03 -19.16 44.48 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.464 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -71.48 -44.75 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -59.3 -52.65 64.74 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.952 0.901 . . . . 0.0 109.967 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -60.61 -40.13 90.74 Favored 'General case' 0 C--O 1.254 1.296 0 O-C-N 124.401 1.063 . . . . 0.0 111.608 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -43.62 80.4 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.92 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' B' ' 216' ' ' ILE . 83.4 mt -62.23 -47.04 86.19 Favored 'General case' 0 C--O 1.213 -0.847 0 O-C-N 124.167 0.917 . . . . 0.0 111.144 -177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -53.83 -32.21 52.06 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 124.112 0.882 . . . . 0.0 111.636 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.3 t -85.06 -39.35 18.09 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.442 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 92.9 m -79.8 -24.84 41.14 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.24 1.016 . . . . 0.0 112.462 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 N--CA 1.479 0.986 0 C-N-CA 123.072 0.549 . . . . 0.0 110.223 -178.062 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 14.9 mp0 -102.85 124.97 49.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.181 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -121.91 159.36 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.475 1.11 . . . . 0.0 108.605 175.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' THR . 61.3 m-85 -114.23 116.3 28.82 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.367 0.603 . . . . 0.0 110.463 -172.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.723 HG13 ' HB2' ' A' ' 69' ' ' LEU . 2.1 t -104.26 117.79 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -109.58 110.31 21.34 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.73 0.812 . . . . 0.0 108.822 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.605 HG22 HD12 ' A' ' 69' ' ' LEU . 40.7 p -66.64 163.16 19.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.481 0.313 . . . . 0.0 111.136 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.36 -19.6 65.58 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.894 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.5 p -78.72 -9.86 59.56 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.959 0.504 . . . . 0.0 110.908 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.44 8.84 62.23 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.683 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -84.32 146.76 27.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.428 0.691 . . . . 0.0 110.267 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -108.27 140.03 42.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.271 0.628 . . . . 0.0 109.903 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -129.99 116.6 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.082 1.353 . . . . 0.0 107.72 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -93.63 120.8 34.35 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -104.64 156.47 17.95 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -127.25 83.02 2.13 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.702 HG21 HG22 ' A' ' 26' ' ' VAL . 33.7 m -146.07 178.75 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.967 0.907 . . . . 0.0 110.25 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -95.4 155.38 38.8 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.485 0.714 . . . . 0.0 109.801 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.526 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 21.3 Cg_endo -62.43 -26.97 76.86 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 121.774 1.649 . . . . 0.0 111.833 166.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -93.2 5.16 52.47 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.726 0.81 . . . . 0.0 111.321 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.82 -98.32 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.923 0.889 . . . . 0.0 110.734 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.5 t 170.11 143.54 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.353 1.461 . . . . 0.0 109.246 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.99 -32.82 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.602 0.761 . . . . 0.0 110.54 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -54.98 -41.42 71.16 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.361 1.064 . . . . 0.0 110.091 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 9.4 t30 -79.26 -40.68 29.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.136 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.702 HG22 HG21 ' A' ' 17' ' ' VAL . 85.6 t -56.35 -44.43 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 124.112 0.883 . . . . 0.0 110.856 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 17.6 ptpt -73.45 -29.61 62.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.93 0.492 . . . . 0.0 111.231 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.78 71.84 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.731 168.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 10.0 mmpt? -72.16 -37.88 69.28 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-O 119.181 -0.437 . . . . 0.0 110.785 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.568 HD11 HG21 ' A' ' 5' ' ' VAL . 2.0 mp -55.22 -45.99 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.006 0.431 . . . . 0.0 110.054 172.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -61.9 -33.43 74.22 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.49 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -72.12 -32.31 66.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.543 0.737 . . . . 0.0 111.646 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.3 mmtt -90.65 -66.31 0.94 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.613 0.365 . . . . 0.0 110.975 -172.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -87.91 -26.84 22.52 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.92 29.35 10.63 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.06 126.02 30.25 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.7 154.05 75.82 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.841 2.361 . . . . 0.0 112.473 -173.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 20.7 Cg_endo -56.94 -19.43 32.07 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.557 2.838 . . . . 0.0 113.251 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.61 -35.74 70.57 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.876 0.87 . . . . 0.0 111.024 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -95.2 -27.92 15.29 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 123.486 0.714 . . . . 0.0 112.198 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.537 ' HB2' HD21 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -92.5 140.63 29.37 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.637 0.653 . . . . 0.0 109.809 178.084 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.444 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 19.7 ttt180 -127.8 127.89 44.32 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -96.28 123.21 39.83 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.595 0.758 . . . . 0.0 110.371 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -141.5 129.42 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.017 0.527 . . . . 0.0 109.864 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.56 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 93.7 t80 -130.81 121.98 26.31 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.19 20.81 11.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.718 0.807 . . . . 0.0 113.122 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.09 -16.96 57.77 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.0 ptpt -90.34 135.15 33.86 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.09 135.42 35.32 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.2 mt -89.29 114.21 25.57 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.689 -172.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 31.0 tt0 -76.95 138.24 39.55 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 123.603 0.761 . . . . 0.0 109.637 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.5 -37.79 82.23 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.124 0.89 . . . . 0.0 111.93 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -67.27 -22.07 72.54 Favored Glycine 0 C--N 1.348 1.235 0 O-C-N 123.675 0.609 . . . . 0.0 114.183 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.565 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 78.7 mtt180 -89.59 177.22 6.6 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.393 0.677 . . . . 0.0 111.511 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 55.6 p -109.9 169.78 8.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.522 0.729 . . . . 0.0 110.43 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 87.1 mt -55.83 -54.86 39.34 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.59 0.556 . . . . 0.0 109.705 173.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 22.8 t -61.73 -22.73 65.62 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.333 1.053 . . . . 0.0 111.798 -176.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.1 -47.39 83.04 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.565 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 36.2 m-85 -86.33 17.02 3.95 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.148 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.7 OUTLIER 72.96 9.76 5.39 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.144 1.378 . . . . 0.0 112.404 176.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.1 mt -81.66 123.09 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.7 0.8 . . . . 0.0 108.958 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -110.0 -174.18 2.43 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.181 0.592 . . . . 0.0 109.712 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 10.2 ptmm? -58.7 144.34 43.84 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.713 172.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 62.33 10.82 4.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.937 1.295 . . . . 0.0 113.644 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -70.06 132.57 46.07 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 118.17 0.441 . . . . 0.0 110.223 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 29.0 m -93.89 130.97 39.75 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.08 160.46 38.89 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.973 0.909 . . . . 0.0 109.416 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -88.7 138.69 31.19 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.203 0.525 . . . . 0.0 111.423 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.723 ' HB2' HG13 ' A' ' 5' ' ' VAL . 2.7 tm? -119.62 135.26 54.88 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.641 HG21 HD11 ' B' ' 220' ' ' LEU . 90.8 t -115.6 115.54 49.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.591 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.517 ' HB3' HD23 ' A' ' 73' ' ' LEU . 67.2 mt -81.27 99.44 8.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.128 173.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -67.69 -40.52 84.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.67 1.188 . . . . 0.0 109.144 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 71' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 C-N-CA 125.037 1.335 . . . . 0.0 112.082 172.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' B' ' 201' ' ' LYS . 9.4 mptt . . . . . 0 C--O 1.243 0.73 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.27 -178.5 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.72 0.808 . . . . 0.0 110.314 -165.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -124.95 144.72 50.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.72 0.808 . . . . 0.0 109.352 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.642 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.0 t -91.09 100.46 2.99 Favored Pre-proline 0 N--CA 1.481 1.093 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.514 ' HD2' HD21 ' B' ' 220' ' ' LEU . 30.1 Cg_endo -58.56 -23.65 65.98 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.983 2.456 . . . . 0.0 114.137 -169.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.37 -53.59 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 C-N-CA 122.22 0.208 . . . . 0.0 111.555 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 17.8 p -103.34 -6.72 21.69 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.7 50.86 39.45 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.527 0.517 . . . . 0.0 114.286 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.0 m -119.09 138.97 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 123.232 0.613 . . . . 0.0 110.271 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -87.44 125.27 34.19 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.5 pt -153.47 157.04 32.8 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 125.136 1.375 . . . . 0.0 109.371 -169.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.19 165.0 31.81 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.417 2.078 . . . . 0.0 112.974 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.537 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.8 tt0 -60.03 -42.1 93.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.69 1.596 . . . . 0.0 115.006 -166.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 35.9 t -70.5 -33.58 71.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.369 -0.832 . . . . 0.0 109.976 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -71.35 -29.34 64.86 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.327 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -71.8 -37.0 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -57.49 -54.21 49.4 Favored 'General case' 0 C--O 1.244 0.806 0 O-C-N 123.803 0.689 . . . . 0.0 110.365 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -69.54 -33.3 72.59 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.973 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -46.46 90.52 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.641 HD11 HG21 ' A' ' 70' ' ' VAL . 91.2 mt -67.91 -37.43 81.7 Favored 'General case' 0 C--O 1.208 -1.09 0 O-C-N 124.129 0.893 . . . . 0.0 111.232 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.04 -32.31 63.91 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 124.538 1.149 . . . . 0.0 110.675 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 33.2 t -93.49 -36.36 12.48 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.513 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 96.9 m -77.8 -24.13 48.91 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.607 0.763 . . . . 0.0 112.802 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 N--CA 1.485 1.308 0 C-N-CA 122.928 0.491 . . . . 0.0 110.459 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.9 mmt . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.762 0.315 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.6 mp0 -114.07 136.91 52.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.262 0.625 . . . . 0.0 110.552 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -128.82 164.14 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 124.811 1.244 . . . . 0.0 108.721 172.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 66' ' ' THR . 69.4 m-85 -119.72 110.18 16.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.137 -174.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.502 HG21 HD11 ' A' ' 30' ' ' ILE . 50.8 t -97.03 135.22 31.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -122.09 123.77 42.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.837 0.455 . . . . 0.0 110.214 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.637 HG22 HD12 ' A' ' 69' ' ' LEU . 57.0 p -81.18 165.37 21.59 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.974 0.416 . . . . 0.0 111.728 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 70' ' ' VAL . 85.8 mt -71.38 -19.53 62.26 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.459 172.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.0 p -78.57 -17.88 55.45 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.724 0.41 . . . . 0.0 109.967 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.86 23.9 14.42 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 167.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 153.01 18.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 172.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -100.4 144.56 29.26 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 170.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.567 HD11 HG23 ' A' ' 7' ' ' THR . 5.1 mp -124.97 113.44 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.826 1.251 . . . . 0.0 107.911 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.0 m -89.45 122.04 32.26 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.3 mm? -111.19 152.36 27.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.561 0.744 . . . . 0.0 109.156 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 1' ' ' MET . 3.0 mp0 -112.81 95.32 5.35 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.626 HG21 HG22 ' A' ' 26' ' ' VAL . 33.5 m -146.34 -174.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.434 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 16.0 mt-10 -102.09 155.77 36.05 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 19.7 Cg_endo -57.98 -32.29 94.94 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.018 1.812 . . . . 0.0 111.118 167.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -98.1 18.62 15.7 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.312 0.645 . . . . 0.0 110.808 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 14.7 t70 -82.13 -92.57 0.06 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.046 0.538 . . . . 0.0 109.808 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.518 HG23 ' H ' ' A' ' 25' ' ' ASN . 15.3 t 177.81 149.49 0.18 Allowed 'General case' 0 C--N 1.367 1.361 0 C-N-CA 124.526 1.13 . . . . 0.0 110.762 174.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.0 mm -65.83 -37.19 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.591 1.157 . . . . 0.0 110.81 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -55.6 -38.57 69.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.181 0.992 . . . . 0.0 111.056 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.518 ' H ' HG23 ' A' ' 22' ' ' THR . 4.9 t-20 -76.64 -39.14 53.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.277 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 17' ' ' VAL . 64.4 t -57.67 -46.9 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 124.471 1.107 . . . . 0.0 110.759 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HA ' HD12 ' A' ' 30' ' ' ILE . 17.2 ptpt -71.3 -27.56 63.49 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.944 0.498 . . . . 0.0 111.795 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.27 -39.43 89.41 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.505 0.503 . . . . 0.0 110.911 169.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 4.4 mmtm -66.15 -37.27 85.25 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.652 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.502 HD11 HG21 ' A' ' 5' ' ' VAL . 94.3 mt -64.05 -38.42 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.649 0.78 . . . . 0.0 110.915 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.8 tt0 -64.92 -31.1 72.18 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.036 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.31 -38.91 78.48 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.398 0.279 . . . . 0.0 110.984 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.5 mmtt -85.31 -69.43 0.66 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.078 0.237 . . . . 0.0 110.699 -168.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.7 -20.49 31.12 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 122.087 0.155 . . . . 0.0 111.08 -176.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 88.06 25.96 30.15 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.451 0.469 . . . . 0.0 113.359 171.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.11 125.88 30.15 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -65.47 149.83 87.47 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.939 2.426 . . . . 0.0 112.438 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.05 -17.6 11.56 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 124.325 3.35 . . . . 0.0 114.339 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -74.49 -41.91 59.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.302 0.641 . . . . 0.0 111.2 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.12 -33.56 22.36 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.731 0.812 . . . . 0.0 111.489 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.479 HE22 HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -89.78 149.34 22.75 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.43 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 44.3 ttt180 -132.75 131.12 40.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.941 0.496 . . . . 0.0 110.207 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.479 HD21 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -94.84 124.84 39.11 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.687 0.795 . . . . 0.0 110.122 -174.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.7 mt -142.52 132.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.003 0.921 . . . . 0.0 109.139 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.552 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 86.6 t80 -135.21 132.31 37.75 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 171.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.49 23.28 12.93 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.889 0.876 . . . . 0.0 112.197 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.33 -7.97 75.29 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 114.516 0.566 . . . . 0.0 114.516 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.8 ptpt -103.28 141.34 36.08 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 117.494 0.647 . . . . 0.0 109.448 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.48 ' NE2' HD22 ' B' ' 224' ' ' LEU . 8.0 tt0 -74.43 131.41 41.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.3 mt -83.25 117.97 23.31 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.407 0.283 . . . . 0.0 110.245 -176.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.76 137.96 38.0 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 123.945 0.898 . . . . 0.0 109.674 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.3 -50.26 67.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.726 1.211 . . . . 0.0 111.843 -174.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.64 -27.39 70.93 Favored Glycine 0 C--N 1.35 1.32 0 O-C-N 124.273 0.983 . . . . 0.0 114.072 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.445 ' HD3' ' OD2' ' A' ' 58' ' ' ASP . 54.5 mtt180 -77.3 175.73 9.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.316 0.646 . . . . 0.0 112.013 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 65.8 p -111.27 164.08 13.27 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.013 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 90.9 mt -55.44 -53.33 57.59 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.807 174.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 9.4 t -66.56 -20.64 66.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.263 1.025 . . . . 0.0 111.339 -173.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' OD2' ' HD3' ' A' ' 54' ' ' ARG . 12.2 t70 -67.26 -42.18 84.31 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -86.78 16.18 5.05 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.813 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.429 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 70.94 17.43 6.28 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.033 1.333 . . . . 0.0 112.301 176.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 11.1 mt -90.45 103.66 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -84.97 -178.97 6.97 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -59.4 143.47 49.62 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 64.28 11.83 6.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.13 1.372 . . . . 0.0 113.573 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.9 m -75.25 149.57 38.82 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.275 0.489 . . . . 0.0 110.614 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.7 m -101.02 130.12 46.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.974 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.61 154.85 48.46 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.95 1.3 . . . . 0.0 108.181 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -87.85 158.7 18.66 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.44 0.638 . . . . 0.0 111.888 -174.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.637 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -141.94 129.47 21.38 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.545 -1.207 . . . . 0.0 107.829 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.577 HG21 HD11 ' B' ' 220' ' ' LEU . 98.4 t -111.0 117.18 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.755 0.822 . . . . 0.0 110.112 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.68 139.86 30.36 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.123 0.969 . . . . 0.0 110.673 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -118.18 -44.92 2.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.748 0.819 . . . . 0.0 111.583 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 N--CA 1.491 1.599 0 C-N-CA 124.201 1.0 . . . . 0.0 112.425 -178.873 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . 0.441 HG23 HG13 ' B' ' 216' ' ' ILE . 6.6 m -134.12 -178.86 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 125.379 1.472 . . . . 0.0 109.173 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -109.64 146.18 35.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.19 0.596 . . . . 0.0 111.097 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.567 ' HA ' HD11 ' B' ' 216' ' ' ILE . 49.7 t -89.46 102.36 4.32 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.322 1.049 . . . . 0.0 109.236 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.531 ' HD2' HD21 ' B' ' 220' ' ' LEU . 45.8 Cg_endo -62.28 -10.09 17.34 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.776 2.984 . . . . 0.0 114.984 -166.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 42.4 t -84.07 -60.47 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 123.054 0.542 . . . . 0.0 110.769 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 22.3 p -101.3 -6.99 23.42 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.804 0.441 . . . . 0.0 112.038 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.66 51.05 38.36 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.435 0.54 . . . . 0.0 114.207 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.12 142.22 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 123.008 0.523 . . . . 0.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -92.47 122.36 34.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.491 0.717 . . . . 0.0 109.903 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.534 HD11 ' HB2' ' B' ' 204' ' ' CYS . 3.8 pt -152.67 160.99 30.39 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.767 1.627 . . . . 0.0 109.387 -169.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.26 158.8 46.67 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.156 1.904 . . . . 0.0 111.629 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.537 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.9 tm-20 -69.75 -28.41 65.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.055 0.942 . . . . 0.0 112.104 -169.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 37.2 p -60.79 -45.82 92.9 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.657 0.741 . . . . 0.0 110.058 169.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -76.8 -18.3 58.5 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.815 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -72.21 -50.16 38.26 Favored 'Isoleucine or valine' 0 C--N 1.364 1.214 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -67.75 -35.61 79.04 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.205 0.316 . . . . 0.0 110.467 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -45.47 94.03 Favored 'General case' 0 C--O 1.254 1.313 0 O-C-N 123.886 0.741 . . . . 0.0 110.967 172.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . 0.414 ' HB3' ' SG ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -59.57 -38.58 81.53 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.78 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 70' ' ' VAL . 79.4 mt -66.21 -39.56 89.7 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 123.972 0.795 . . . . 0.0 111.295 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -55.56 -38.71 69.68 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.945 0.778 . . . . 0.0 110.88 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.2 t -88.24 -31.54 18.98 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.829 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 63.6 m -82.47 -19.73 38.29 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.645 0.778 . . . . 0.0 112.967 -173.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . 0.48 HD22 ' NE2' ' A' ' 49' ' ' GLN . 4.6 pp . . . . . 0 N--CA 1.489 1.498 0 C-N-CA 122.676 0.39 . . . . 0.0 110.928 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.1 mp0 -112.35 155.61 23.85 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.469 0.708 . . . . 0.0 110.201 174.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.436 HD11 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -142.8 157.08 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 124.793 1.237 . . . . 0.0 109.218 167.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 66' ' ' THR . 39.0 m-85 -112.57 100.49 8.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.372 0.669 . . . . 0.0 110.322 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 69' ' ' LEU . 95.2 t -101.77 104.84 16.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -102.16 127.3 49.15 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.732 0.813 . . . . 0.0 111.137 -172.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.655 HG22 HD12 ' A' ' 69' ' ' LEU . 49.2 p -70.85 166.46 21.02 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-O 121.599 0.714 . . . . 0.0 112.782 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.421 HD11 HG22 ' A' ' 70' ' ' VAL . 68.4 mt -67.82 -23.52 65.19 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.297 171.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.7 p -78.63 -16.54 57.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.308 0.643 . . . . 0.0 110.397 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.41 5.71 39.54 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-O 119.182 -0.788 . . . . 0.0 114.856 167.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.47 151.13 24.82 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.063 0.932 . . . . 0.0 108.586 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.1 m -107.01 126.04 51.81 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.013 0.525 . . . . 0.0 110.3 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.414 HD11 HG23 ' A' ' 7' ' ' THR . 4.7 mp -107.27 110.75 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.797 0.839 . . . . 0.0 109.006 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.9 m -90.31 120.44 31.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.278 0.631 . . . . 0.0 109.446 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.5 mm? -106.9 151.75 24.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.01 0.524 . . . . 0.0 109.833 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -110.69 78.29 1.11 Allowed 'General case' 0 C--O 1.239 0.53 0 O-C-N 124.205 0.941 . . . . 0.0 108.618 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.734 HG21 HG22 ' A' ' 26' ' ' VAL . 3.4 m -144.77 172.07 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.702 0.801 . . . . 0.0 108.981 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.428 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 8.1 mt-10 -93.11 158.0 38.08 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -57.65 -34.16 97.73 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.139 1.893 . . . . 0.0 112.074 169.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.2 t -102.03 21.35 14.93 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.881 0.472 . . . . 0.0 110.611 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 6.2 t70 -73.03 -87.33 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 25' ' ' ASN . 7.4 t 173.65 148.86 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.461 1.504 . . . . 0.0 109.081 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.508 HG22 ' HE3' ' A' ' 27' ' ' LYS . 44.3 mm -63.19 -38.53 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.322 1.049 . . . . 0.0 110.42 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -60.03 -33.06 71.5 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.374 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.2 t-20 -74.53 -43.26 56.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.734 HG22 HG21 ' A' ' 17' ' ' VAL . 60.6 t -56.35 -47.31 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 124.387 1.054 . . . . 0.0 110.093 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HE3' HG22 ' A' ' 23' ' ' ILE . 17.6 ptpt -74.18 -25.93 59.99 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.37 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.62 -34.26 77.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.28 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 73.6 mmtt -72.52 -32.59 66.25 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.557 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.4 mp -53.42 -45.0 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 119.05 0.841 . . . . 0.0 110.076 168.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.97 -32.99 74.72 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.507 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.99 -34.88 66.71 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.099 0.56 . . . . 0.0 111.328 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.76 -68.7 0.78 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.046 0.539 . . . . 0.0 110.952 -171.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -83.35 -21.74 33.03 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.78 20.8 35.76 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.753 -0.203 . . . . 0.0 112.942 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -107.98 122.72 39.88 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.35 153.43 78.25 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.645 2.23 . . . . 0.0 112.333 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HA ' ' HG3' ' A' ' 41' ' ' GLN . 18.4 Cg_endo -56.32 -14.38 12.17 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.715 2.943 . . . . 0.0 113.761 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -75.07 -48.78 22.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.033 0.933 . . . . 0.0 110.628 173.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -80.84 -23.83 38.86 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.511 0.724 . . . . 0.0 111.911 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.506 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -93.43 153.71 18.34 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.601 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 32.9 ttt180 -134.89 126.48 28.81 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.726 ' HG ' HD12 ' A' ' 50' ' ' LEU . 5.3 tp -100.84 122.61 43.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.839 -166.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.1 mt -139.32 133.05 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.727 0.811 . . . . 0.0 109.954 -173.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.601 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 82.6 t80 -135.32 131.97 37.11 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.78 21.62 12.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.857 0.863 . . . . 0.0 112.468 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.58 10.4 79.58 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.449 -0.341 . . . . 0.0 113.819 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 12.7 ptpt -118.39 147.57 43.41 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.286 0.634 . . . . 0.0 109.373 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.529 ' HB2' HD22 ' B' ' 224' ' ' LEU . 8.0 tt0 -75.94 127.2 32.48 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.127 0.571 . . . . 0.0 109.779 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.726 HD12 ' HG ' ' A' ' 43' ' ' LEU . 25.0 mt -80.75 123.65 28.39 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.039 0.536 . . . . 0.0 109.998 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.75 138.44 32.09 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.152 0.981 . . . . 0.0 109.707 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.53 -39.2 92.82 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.627 1.171 . . . . 0.0 112.28 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.14 -18.57 76.64 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.218 0.949 . . . . 0.0 113.816 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -88.35 178.1 6.66 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.823 0.849 . . . . 0.0 111.563 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.6 p -116.59 168.67 9.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.717 0.807 . . . . 0.0 109.874 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.5 mt -57.54 -50.73 72.13 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.1 t -61.55 -25.64 67.43 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.379 1.072 . . . . 0.0 111.554 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.64 -45.98 84.49 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 121.127 0.489 . . . . 0.0 109.688 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -85.59 17.23 3.36 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.473 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 65.73 19.98 11.45 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.402 1.081 . . . . 0.0 111.776 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.6 mt -85.58 132.68 31.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -115.8 -175.2 2.68 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -61.96 130.41 45.49 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.238 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 72.58 18.18 4.42 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.258 1.423 . . . . 0.0 111.965 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.4 m -71.05 139.92 50.58 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 53.1 m -93.72 129.66 39.98 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.456 0.473 . . . . 0.0 109.986 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.601 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -137.84 166.07 24.92 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.696 1.198 . . . . 0.0 108.891 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -96.65 148.3 23.01 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.349 0.595 . . . . 0.0 111.267 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.655 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -127.12 130.85 50.6 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 94.0 t -114.02 130.42 68.25 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 124.207 1.003 . . . . 0.0 109.936 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 92.1 mt -98.34 146.29 25.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.317 0.647 . . . . 0.0 110.95 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -117.18 -40.46 3.09 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.28 1.032 . . . . 0.0 110.627 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 71' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.494 1.764 0 C-N-CA 124.989 1.316 . . . . 0.0 113.191 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 11.2 mptt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.6 m -145.59 -177.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.902 0.881 . . . . 0.0 110.179 -168.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -125.81 146.7 49.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.58 0.752 . . . . 0.0 110.907 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.627 ' HA ' HD11 ' B' ' 216' ' ' ILE . 48.7 t -92.95 96.09 1.29 Allowed Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 124.651 1.18 . . . . 0.0 107.998 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.56 ' HD2' HD21 ' B' ' 220' ' ' LEU . 34.2 Cg_endo -59.79 -17.36 42.76 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.234 2.622 . . . . 0.0 114.483 -168.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.16 -56.93 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 122.789 0.436 . . . . 0.0 110.851 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 14.9 p -103.65 -0.65 29.26 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.435 0.294 . . . . 0.0 111.555 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 69.05 42.11 78.47 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 115.153 0.821 . . . . 0.0 115.153 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.01 137.51 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.318 0.559 . . . . 0.0 110.894 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -89.13 123.77 33.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.211 0.604 . . . . 0.0 109.684 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.2 pt -153.55 160.11 31.32 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.845 1.258 . . . . 0.0 110.434 -168.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.18 161.22 16.83 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.172 2.581 . . . . 0.0 113.563 171.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.571 ' O ' HG22 ' B' ' 216' ' ' ILE . 40.3 tt0 -62.79 -44.72 95.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.412 1.485 . . . . 0.0 113.096 -172.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 20.3 m -62.66 -40.99 98.78 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-O 121.978 0.894 . . . . 0.0 110.347 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -73.58 -26.3 60.75 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.249 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -69.54 -43.68 80.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -67.29 -37.42 83.38 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 123.394 0.434 . . . . 0.0 110.421 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -69.59 -40.59 76.61 Favored 'General case' 0 C--O 1.247 0.945 0 O-C-N 123.226 0.329 . . . . 0.0 111.57 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -45.45 93.15 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.48 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.56 HD21 ' HD2' ' B' ' 205' ' ' PRO . 96.3 mt -61.82 -43.62 98.48 Favored 'General case' 0 C--O 1.206 -1.196 0 O-C-N 124.431 1.082 . . . . 0.0 111.153 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.45 -27.21 56.2 Favored 'General case' 0 CA--C 1.553 1.094 0 O-C-N 124.578 1.173 . . . . 0.0 110.767 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.4 t -91.57 -39.8 11.7 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.642 0.777 . . . . 0.0 111.454 172.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 91.4 m -75.04 -23.0 58.07 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.333 1.053 . . . . 0.0 112.899 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.5 pp . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.753 0.311 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.475 HE21 HG21 ' A' ' 14' ' ' THR . 54.9 mt-30 -107.2 138.5 43.27 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.678 0.791 . . . . 0.0 110.635 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.585 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -137.57 153.59 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.299 1.04 . . . . 0.0 109.746 176.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 66' ' ' THR . 81.8 m-85 -105.79 107.78 18.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.033 0.933 . . . . 0.0 109.445 -175.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.451 HG21 HD11 ' A' ' 30' ' ' ILE . 56.1 t -103.67 117.58 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -108.11 119.6 39.95 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.844 0.857 . . . . 0.0 109.615 -171.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.635 HG22 HD12 ' A' ' 69' ' ' LEU . 38.5 p -72.1 165.0 25.19 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.296 0.569 . . . . 0.0 111.461 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 70' ' ' VAL . 88.4 mt -70.37 -18.7 63.06 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.165 171.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -79.64 -12.86 59.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.908 0.483 . . . . 0.0 110.809 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.54 18.78 37.19 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.908 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 153.44 18.16 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.7 m -100.58 134.28 43.78 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.585 0.754 . . . . 0.0 110.022 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 7' ' ' THR . 5.2 mp -120.41 109.93 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.96 1.304 . . . . 0.0 107.53 174.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.475 HG21 HE21 ' A' ' 2' ' ' GLN . 76.2 m -94.78 130.35 41.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -112.62 154.48 25.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.72 0.808 . . . . 0.0 109.28 -177.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -110.6 71.87 0.77 Allowed 'General case' 0 C--O 1.242 0.706 0 O-C-N 124.512 1.132 . . . . 0.0 108.887 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.794 HG21 HG22 ' A' ' 26' ' ' VAL . 20.3 m -140.47 172.63 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.514 0.726 . . . . 0.0 110.169 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -102.87 161.88 21.83 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 123.639 0.775 . . . . 0.0 109.95 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 29.1 Cg_endo -59.41 -37.05 92.22 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 121.868 1.712 . . . . 0.0 111.03 171.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 p -96.64 15.72 20.93 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.872 0.869 . . . . 0.0 111.092 -174.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.75 -98.97 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.771 0.828 . . . . 0.0 109.576 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.1 t 174.75 142.45 0.05 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.989 1.316 . . . . 0.0 109.091 173.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -61.0 -38.84 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.208 1.003 . . . . 0.0 111.848 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 42.7 tt0 -57.47 -35.22 69.89 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.563 0.697 . . . . 0.0 111.483 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.4 t30 -75.99 -42.23 48.86 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.213 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.794 HG22 HG21 ' A' ' 17' ' ' VAL . 61.8 t -55.27 -47.3 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 124.606 1.191 . . . . 0.0 110.367 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -69.45 -32.2 70.99 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.079 0.551 . . . . 0.0 111.696 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.48 70.44 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.387 0.429 . . . . 0.0 110.838 170.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 8.8 mmpt? -75.96 -35.81 59.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.906 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 5' ' ' VAL . 2.2 mp -57.09 -43.4 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 118.915 0.78 . . . . 0.0 109.666 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.11 -31.76 72.26 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.353 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.36 -30.77 66.56 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.42 0.688 . . . . 0.0 111.541 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 72.2 mmtt -93.55 -70.37 0.71 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 117.624 0.193 . . . . 0.0 110.715 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -80.38 -25.93 38.85 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.24 0.216 . . . . 0.0 111.274 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.32 18.55 30.68 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.311 0.382 . . . . 0.0 113.928 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.75 123.83 41.07 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -70.29 156.64 61.52 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.112 2.541 . . . . 0.0 112.375 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.23 -16.43 17.36 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.713 2.942 . . . . 0.0 114.072 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -71.8 -47.09 55.75 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 120.949 0.404 . . . . 0.0 110.197 173.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -83.2 -21.3 33.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.895 0.878 . . . . 0.0 112.216 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.502 HE22 HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -109.18 153.0 24.39 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.105 0.562 . . . . 0.0 110.515 177.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -138.72 138.08 37.37 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.119 0.567 . . . . 0.0 110.263 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.502 HD21 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -98.06 125.08 42.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.788 0.835 . . . . 0.0 110.373 -174.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -142.86 125.04 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.015 0.926 . . . . 0.0 109.586 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.643 ' HB3' HD21 ' A' ' 50' ' ' LEU . 79.4 t80 -124.67 124.96 43.31 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.43 1.092 . . . . 0.0 108.148 177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.447 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 60.44 27.0 16.6 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.893 0.877 . . . . 0.0 112.812 175.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.52 -15.89 61.99 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 2.5 ptpt -98.73 142.32 30.43 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -83.18 132.96 35.04 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.643 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.7 mt -82.51 116.64 22.04 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.426 0.691 . . . . 0.0 110.996 -175.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -83.87 139.45 32.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.485 1.114 . . . . 0.0 110.466 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.5 m-20 -56.25 -47.92 77.57 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.603 1.161 . . . . 0.0 112.795 -172.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.49 -18.2 71.5 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 124.758 1.286 . . . . 0.0 113.893 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 62.5 mtt180 -84.96 177.53 7.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.69 0.796 . . . . 0.0 111.04 175.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.9 p -116.71 170.78 8.33 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.343 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 94.9 mt -57.35 -47.97 80.21 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 47.4 t -62.18 -26.49 68.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.755 1.222 . . . . 0.0 111.6 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.432 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 7.7 t70 -61.25 -45.47 94.4 Favored 'General case' 0 C--N 1.357 0.932 0 CA-C-O 121.532 0.682 . . . . 0.0 109.654 177.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.4 15.95 7.11 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.589 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 71.22 8.06 6.3 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.475 1.51 . . . . 0.0 112.309 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mt -77.91 129.56 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -122.83 -176.63 3.45 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -59.16 143.5 48.66 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 68.19 13.3 9.05 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.885 1.274 . . . . 0.0 112.239 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.5 m -84.91 138.76 32.32 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 57.9 m -99.27 127.31 45.25 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 110.187 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.587 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -124.13 173.67 8.15 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.25 1.42 . . . . 0.0 108.585 176.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -108.97 154.96 21.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.496 0.718 . . . . 0.0 110.97 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD12 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -133.79 126.17 30.02 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.589 HG11 HD11 ' B' ' 220' ' ' LEU . 90.2 t -104.95 115.85 47.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 123.518 0.727 . . . . 0.0 109.993 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.471 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 86.8 mt -85.67 147.79 26.2 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.519 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -121.98 -45.64 2.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.249 1.02 . . . . 0.0 110.127 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 71' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.499 2.006 0 C-N-CA 124.501 1.121 . . . . 0.0 112.976 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' B' ' 201' ' ' LYS . 11.2 mptt . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.5 m -142.6 -178.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.289 1.036 . . . . 0.0 109.761 -166.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -118.73 146.31 44.86 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.256 0.622 . . . . 0.0 110.599 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.523 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.7 t -83.08 102.64 1.9 Allowed Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.518 ' HD2' HD21 ' B' ' 220' ' ' LEU . 43.7 Cg_endo -62.38 -9.6 15.96 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.319 2.679 . . . . 0.0 114.052 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.78 -65.09 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.311 0.644 . . . . 0.0 110.611 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 18.1 p -100.3 2.46 42.63 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.704 0.401 . . . . 0.0 112.061 -172.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 63.23 38.85 97.14 Favored Glycine 0 N--CA 1.477 1.388 0 N-CA-C 115.494 0.957 . . . . 0.0 115.494 170.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.65 134.41 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.077 0.551 . . . . 0.0 110.482 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -84.74 122.62 29.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.611 0.365 . . . . 0.0 110.029 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 6.0 pt -149.44 158.7 37.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 125.825 1.65 . . . . 0.0 109.484 -171.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.8 162.99 20.07 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.618 2.212 . . . . 0.0 112.839 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.546 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.5 tt0 -65.36 -36.18 83.24 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.459 1.504 . . . . 0.0 113.23 -169.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 34.2 t -69.0 -38.0 79.04 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.098 0.475 . . . . 0.0 110.04 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -76.26 -23.45 54.45 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.2 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' B' ' 220' ' ' LEU . 0.3 OUTLIER -70.91 -43.0 77.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -55.78 -52.87 62.49 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.016 0.823 . . . . 0.0 110.346 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -54.26 -47.48 72.25 Favored 'General case' 0 C--O 1.252 1.221 0 O-C-N 124.307 1.004 . . . . 0.0 111.82 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -35.06 79.13 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.991 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.589 HD11 HG11 ' A' ' 70' ' ' VAL . 71.3 mt -64.62 -51.95 60.01 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 123.529 0.518 . . . . 0.0 110.882 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -58.25 -29.41 65.75 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.569 1.168 . . . . 0.0 111.684 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 46.7 t -81.88 -43.5 18.11 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.435 0.694 . . . . 0.0 110.921 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 69.6 m -81.59 -19.03 42.77 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.251 1.02 . . . . 0.0 113.383 -170.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.491 1.595 0 CA-C-N 118.482 0.583 . . . . 0.0 111.182 -176.768 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 N--CA 1.476 0.825 0 CA-C-O 121.216 0.532 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 18.5 mp0 -92.91 124.57 36.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.488 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -122.5 157.56 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.338 1.455 . . . . 0.0 108.212 175.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 66' ' ' THR . 64.7 m-85 -116.81 105.51 12.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.431 -172.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 30' ' ' ILE . 40.3 t -95.08 122.26 46.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -108.9 120.04 41.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.309 0.644 . . . . 0.0 110.144 -173.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.652 HG22 HD12 ' A' ' 69' ' ' LEU . 31.6 p -77.77 167.08 22.12 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.465 0.65 . . . . 0.0 111.939 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 82.6 mt -71.28 -20.22 62.24 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.724 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -78.67 -16.94 56.7 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.954 0.502 . . . . 0.0 110.282 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.58 14.8 26.61 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -93.22 152.83 18.96 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.469 0.635 . . . . 0.0 109.436 176.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.9 m -96.29 143.25 27.53 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 7' ' ' THR . 5.0 mp -125.1 102.44 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.0 m -84.49 117.39 23.65 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -104.3 153.49 20.96 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.42 ' HG3' ' HG3' ' A' ' 2' ' ' GLN . 4.7 mp0 -114.37 90.63 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.777 HG21 HG22 ' A' ' 26' ' ' VAL . 9.2 m -139.32 169.04 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -90.13 153.13 46.73 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 42.5 Cg_endo -64.13 -26.32 65.29 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 121.975 1.783 . . . . 0.0 111.14 172.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.9 t -100.18 14.33 31.2 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.057 0.943 . . . . 0.0 110.365 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.73 -94.78 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.112 0.565 . . . . 0.0 109.57 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.2 t 179.58 145.65 0.19 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.521 1.128 . . . . 0.0 109.678 173.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.416 HG23 HD23 ' A' ' 43' ' ' LEU . 46.1 mm -61.8 -36.23 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.168 0.987 . . . . 0.0 111.196 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -57.71 -34.93 69.98 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.428 0.691 . . . . 0.0 111.009 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.416 ' H ' HG23 ' A' ' 22' ' ' THR . 15.7 t-20 -73.95 -43.29 58.73 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.152 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.777 HG22 HG21 ' A' ' 17' ' ' VAL . 38.6 t -57.71 -50.06 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 124.256 0.973 . . . . 0.0 110.735 -178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HE3' HG22 ' A' ' 23' ' ' ILE . 18.0 ptpt -67.41 -30.19 69.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.179 0.592 . . . . 0.0 111.232 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.62 78.84 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.653 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 7.2 mmpt? -73.82 -31.63 63.33 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 118.801 -0.618 . . . . 0.0 110.896 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 5' ' ' VAL . 1.7 mp -54.26 -47.87 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.638 0.654 . . . . 0.0 110.113 169.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -66.03 -30.81 71.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.395 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.24 -27.74 64.7 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.344 0.658 . . . . 0.0 111.627 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.6 mmtt -100.61 -68.84 0.79 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.711 0.404 . . . . 0.0 110.912 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -83.42 -22.36 32.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.412 0.285 . . . . 0.0 111.311 -175.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.73 6.98 57.0 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 113.883 0.313 . . . . 0.0 113.883 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -95.54 124.07 54.26 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.071 0.549 . . . . 0.0 109.764 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 40' ' ' GLN . 53.1 Cg_endo -64.31 155.91 62.87 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.525 2.817 . . . . 0.0 113.152 -174.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -56.5 -18.29 24.94 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 124.237 3.291 . . . . 0.0 113.94 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.53 -47.14 16.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.26 0.624 . . . . 0.0 110.748 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -78.59 -23.8 45.82 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.3 0.64 . . . . 0.0 111.056 -173.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.548 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.06 152.7 19.13 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.59 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 35.4 ttt180 -140.54 116.87 10.68 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 121.844 0.831 . . . . 0.0 109.032 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.729 ' HG ' HD12 ' A' ' 50' ' ' LEU . 10.6 tp -93.84 123.75 37.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.654 -162.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.533 HD11 HD21 ' B' ' 220' ' ' LEU . 96.2 mt -140.49 135.45 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 123.291 0.637 . . . . 0.0 110.775 -169.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 78.6 t80 -136.13 132.85 36.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.72 18.15 10.67 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.523 1.129 . . . . 0.0 112.61 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.67 15.48 65.71 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.86 -0.411 . . . . 0.0 113.593 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 13.6 ptpt -124.2 143.9 50.25 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.505 0.722 . . . . 0.0 109.148 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -75.5 130.67 39.27 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.779 0.431 . . . . 0.0 110.349 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.729 HD12 ' HG ' ' A' ' 43' ' ' LEU . 24.9 mt -78.49 122.03 25.33 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 123.21 0.604 . . . . 0.0 110.465 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -77.74 136.29 38.13 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.689 0.796 . . . . 0.0 108.91 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -61.62 -36.97 82.26 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.105 0.878 . . . . 0.0 112.521 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.25 -27.83 69.25 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.98 0.8 . . . . 0.0 113.166 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -76.04 176.83 7.58 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.127 0.571 . . . . 0.0 111.44 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.0 p -114.75 168.75 9.61 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.707 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 85.4 mt -55.71 -52.1 65.05 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.948 0.78 . . . . 0.0 109.532 172.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -59.13 -27.52 65.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.529 1.132 . . . . 0.0 111.83 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.13 -40.05 86.72 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.027 0.531 . . . . 0.0 110.017 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -90.39 21.37 3.91 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.918 0.887 . . . . 0.0 111.41 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 67.17 15.36 10.03 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.451 1.101 . . . . 0.0 111.884 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -88.11 134.36 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -122.9 -173.59 2.74 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.453 0.701 . . . . 0.0 109.266 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 11.7 ptmm? -59.04 144.0 46.7 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.918 170.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 65.05 7.6 4.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.614 1.566 . . . . 0.0 112.968 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -72.4 129.86 39.35 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 118.112 0.414 . . . . 0.0 109.897 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 20.0 m -99.43 140.91 32.91 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.531 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -143.58 173.87 11.27 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.09 0.956 . . . . 0.0 109.344 -175.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -97.54 154.63 17.39 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.691 0.758 . . . . 0.0 111.601 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.652 HD12 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -137.49 119.33 15.22 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.484 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.638 HG21 HD22 ' B' ' 220' ' ' LEU . 53.1 t -93.31 110.31 23.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.581 0.752 . . . . 0.0 110.368 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.6 mt -78.25 137.78 38.29 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.748 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -115.54 -48.62 2.77 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.19 0.996 . . . . 0.0 109.641 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.489 1.497 0 C-N-CA 125.185 1.394 . . . . 0.0 112.196 179.673 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 13.2 mptt . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 6.0 m -145.38 -177.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.135 1.374 . . . . 0.0 109.28 -162.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -115.18 137.2 52.29 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 122.464 0.306 . . . . 0.0 111.522 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.524 ' HA ' HD11 ' B' ' 216' ' ' ILE . 48.8 t -79.91 101.43 0.84 Allowed Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.406 ' HD3' HD11 ' B' ' 216' ' ' ILE . 91.9 Cg_endo -71.0 -1.09 8.95 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.796 2.33 . . . . 0.0 114.592 -159.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 23.3 t -93.88 -62.95 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.2 p -89.47 -10.51 46.09 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.745 0.418 . . . . 0.0 111.52 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.14 57.7 17.2 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 124.321 0.962 . . . . 0.0 114.195 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 32.6 m -117.94 135.62 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.399 0.68 . . . . 0.0 109.263 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -83.85 113.03 20.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.497 HD11 ' HB2' ' B' ' 204' ' ' CYS . 7.9 pt -142.5 156.04 63.73 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.808 1.243 . . . . 0.0 110.287 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.92 163.34 14.04 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.946 2.431 . . . . 0.0 113.186 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.576 ' O ' HG22 ' B' ' 216' ' ' ILE . 43.8 tt0 -65.47 -37.04 85.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.176 1.39 . . . . 0.0 113.131 -166.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 23.3 t -65.48 -43.6 89.72 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.369 0.605 . . . . 0.0 109.743 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -69.81 -25.01 63.57 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.402 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.576 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -70.24 -44.03 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -61.88 -46.43 89.46 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 123.686 0.616 . . . . 0.0 110.508 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -47.79 78.9 Favored 'General case' 0 C--O 1.25 1.093 0 O-C-N 124.0 0.813 . . . . 0.0 112.469 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.53 -37.75 88.49 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.569 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.638 HD22 HG21 ' A' ' 70' ' ' VAL . 62.6 tp -62.48 -42.59 99.59 Favored 'General case' 0 C--O 1.215 -0.723 0 O-C-N 124.28 0.988 . . . . 0.0 111.452 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -53.23 -40.35 64.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.856 0.722 . . . . 0.0 110.342 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.2 t -75.53 -41.87 53.99 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.324 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 96.0 m -77.9 -19.04 55.44 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.169 0.987 . . . . 0.0 112.878 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . 0.625 HD23 ' HG ' ' B' ' 220' ' ' LEU . 4.2 pp . . . . . 0 N--CA 1.482 1.17 0 C-N-CA 122.647 0.379 . . . . 0.0 110.73 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.928 0.394 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 77.7 mt-30 -104.72 123.22 47.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.516 0.726 . . . . 0.0 110.572 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -123.85 155.27 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.538 1.135 . . . . 0.0 109.623 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -108.28 103.88 13.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.921 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.614 HG12 ' HB2' ' A' ' 69' ' ' LEU . 92.3 t -104.65 100.17 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.99 122.52 43.01 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.595 0.758 . . . . 0.0 111.129 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.622 HG22 HD12 ' A' ' 69' ' ' LEU . 37.4 p -67.71 162.97 22.57 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.608 0.763 . . . . 0.0 112.219 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.33 -15.69 63.39 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.138 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.5 p -80.21 0.01 34.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.47 0.708 . . . . 0.0 111.202 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.53 9.3 75.71 Favored Glycine 0 C--N 1.351 1.39 0 C-N-CA 123.235 0.445 . . . . 0.0 113.376 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -94.23 141.6 28.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.036 0.934 . . . . 0.0 109.237 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 m -105.22 136.6 44.44 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.831 0.452 . . . . 0.0 110.534 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.34 109.84 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.086 0.954 . . . . 0.0 109.021 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.0 m -84.72 122.49 29.17 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.6 mm? -108.95 159.05 17.13 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -124.02 82.25 2.01 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.677 HG21 HG22 ' A' ' 26' ' ' VAL . 15.4 m -140.84 172.6 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.999 0.92 . . . . 0.0 109.775 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.93 149.15 35.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 30.1 Cg_endo -61.79 -27.06 80.18 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.085 1.856 . . . . 0.0 111.904 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.4 t -99.87 16.62 23.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.776 0.43 . . . . 0.0 110.308 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.79 -98.58 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 119.108 -0.472 . . . . 0.0 109.797 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -170.5 143.85 2.32 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 125.447 1.499 . . . . 0.0 108.786 175.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.37 -37.38 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.885 0.874 . . . . 0.0 110.639 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.98 -36.19 72.27 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.039 0.936 . . . . 0.0 110.849 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.475 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 24.3 t-20 -70.84 -46.42 62.76 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.397 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.677 HG22 HG21 ' A' ' 17' ' ' VAL . 67.0 t -55.87 -44.51 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 124.158 0.911 . . . . 0.0 110.85 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -71.93 -30.12 65.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.797 0.439 . . . . 0.0 111.748 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.68 -32.6 74.34 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.809 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 10.3 mmpt? -71.36 -35.21 71.04 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.526 0.516 . . . . 0.0 110.607 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.28 -46.04 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 122.877 0.471 . . . . 0.0 110.47 169.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -65.87 -23.3 66.63 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.3 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.08 -31.03 27.53 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.163 0.985 . . . . 0.0 111.327 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.1 mmtt -91.85 -70.43 0.69 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.621 0.368 . . . . 0.0 110.95 -174.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -86.72 -24.33 25.2 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.724 0.41 . . . . 0.0 111.236 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.48 35.71 8.47 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.436 0.46 . . . . 0.0 112.777 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -111.75 126.11 29.11 Favored Pre-proline 0 CA--C 1.556 1.188 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.49 151.49 79.86 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.221 2.614 . . . . 0.0 112.766 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.26 -13.94 26.82 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.137 3.225 . . . . 0.0 114.25 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.42 -43.66 39.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.377 0.671 . . . . 0.0 110.183 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.46 -35.59 30.37 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.629 0.772 . . . . 0.0 111.124 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.545 HE22 HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -88.76 148.73 23.79 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.813 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 39.8 ttt180 -135.47 130.96 35.52 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.333 0.653 . . . . 0.0 109.432 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.545 HD21 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -95.02 122.69 37.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.498 0.719 . . . . 0.0 110.232 -174.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -141.42 117.74 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.671 0.789 . . . . 0.0 110.027 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.52 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 88.5 t80 -117.38 126.98 53.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.307 1.043 . . . . 0.0 108.644 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.24 23.03 13.29 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.008 0.923 . . . . 0.0 112.691 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.79 1.64 65.5 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 114.274 0.47 . . . . 0.0 114.274 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.5 ptpt -112.56 145.81 39.66 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -80.76 140.97 35.22 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.513 HD21 ' HB3' ' A' ' 45' ' ' PHE . 19.8 mt -94.11 122.91 37.12 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.143 0.577 . . . . 0.0 110.538 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.49 140.31 29.66 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.346 1.058 . . . . 0.0 110.186 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.54 -52.04 56.78 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.57 1.548 . . . . 0.0 113.251 -173.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.67 -20.36 70.07 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 124.573 1.171 . . . . 0.0 113.922 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 -82.75 177.33 8.72 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.016 0.526 . . . . 0.0 110.681 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.8 p -116.82 168.79 9.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.317 0.647 . . . . 0.0 109.877 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 98.1 mt -57.21 -52.07 66.79 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -62.75 -25.16 68.06 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.302 1.041 . . . . 0.0 111.445 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.82 -40.95 96.02 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -91.16 17.03 8.68 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.153 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 69.54 17.16 8.01 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.578 1.151 . . . . 0.0 112.215 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.9 mt -87.52 139.78 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -137.6 -167.85 2.21 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -55.66 142.39 34.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.234 0.614 . . . . 0.0 112.031 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 56.24 14.62 1.6 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.248 1.419 . . . . 0.0 114.157 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 m -75.72 132.84 40.77 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.1 m -97.2 124.76 41.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.361 0.6 . . . . 0.0 110.012 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.52 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -127.42 174.67 8.82 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.178 1.391 . . . . 0.0 108.507 176.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -109.08 146.67 33.63 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.505 0.722 . . . . 0.0 111.102 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.622 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -122.28 125.71 46.59 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.813 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 79.5 t -105.26 124.27 59.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 123.62 0.768 . . . . 0.0 110.009 -175.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.556 ' HB3' HD23 ' A' ' 73' ' ' LEU . 83.1 mt -96.64 115.37 27.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.101 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -85.81 -46.06 11.01 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 169.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 71' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 125.42 1.488 . . . . 0.0 113.511 172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 12.2 mptt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . 0.402 HG23 HG13 ' B' ' 216' ' ' ILE . 2.9 m -146.59 152.56 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.841 1.256 . . . . 0.0 109.58 -171.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -90.67 146.78 23.74 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.121 0.568 . . . . 0.0 111.584 -173.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.658 ' HA ' HD11 ' B' ' 216' ' ' ILE . 37.4 t -88.69 97.91 0.98 Allowed Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.716 1.206 . . . . 0.0 108.184 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.608 ' HD2' HD21 ' B' ' 220' ' ' LEU . 33.2 Cg_endo -59.62 -14.96 28.56 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.37 2.713 . . . . 0.0 114.777 -168.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 33.4 t -84.37 -46.88 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 122.686 0.395 . . . . 0.0 111.245 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . 0.428 ' SG ' HG22 ' B' ' 209' ' ' VAL . 20.5 p -111.56 -3.36 15.14 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.93 42.75 84.92 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . 0.428 HG22 ' SG ' ' B' ' 207' ' ' CYS . 22.8 m -117.86 133.43 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 117.448 0.624 . . . . 0.0 110.418 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -86.63 121.88 29.76 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' B' ' 204' ' ' CYS . 5.9 pt -146.6 162.87 32.29 Favored Pre-proline 0 N--CA 1.484 1.264 0 C-N-CA 124.878 1.271 . . . . 0.0 110.673 -169.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -58.33 161.58 13.77 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.678 2.252 . . . . 0.0 113.505 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.569 ' O ' HG22 ' B' ' 216' ' ' ILE . 33.8 tt0 -65.62 -42.56 91.41 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.079 1.351 . . . . 0.0 112.788 -169.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 21.2 m -72.24 -35.89 68.95 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.623 -0.673 . . . . 0.0 110.432 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -74.5 -22.0 59.28 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.331 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.4 OUTLIER -69.09 -47.17 76.45 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -62.4 -39.2 92.46 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 123.77 0.669 . . . . 0.0 110.862 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -70.65 -42.91 70.2 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.104 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -36.69 84.08 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.608 HD21 ' HD2' ' B' ' 205' ' ' PRO . 87.3 mt -69.74 -42.46 73.89 Favored 'General case' 0 C--O 1.21 -0.995 0 O-C-N 124.321 1.013 . . . . 0.0 111.138 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -58.21 -25.54 61.76 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.505 1.128 . . . . 0.0 110.682 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 30.5 t -89.8 -44.08 10.21 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.056 170.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.8 m -70.19 -20.46 63.12 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.327 1.051 . . . . 0.0 113.062 -171.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.491 1.608 0 C-N-CA 122.909 0.484 . . . . 0.0 112.168 -173.564 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' HE3' ' A' ' 63' ' ' LYS . 21.2 mmt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.3 mp0 -95.92 128.56 42.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.693 -172.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.09 147.76 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.793 1.237 . . . . 0.0 108.425 173.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' THR . 31.2 m-85 -103.29 101.58 11.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.283 0.633 . . . . 0.0 109.778 -172.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 69' ' ' LEU . 11.5 t -96.99 117.93 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -108.28 124.94 51.08 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.442 0.697 . . . . 0.0 109.445 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.597 HG22 HD12 ' A' ' 69' ' ' LEU . 35.3 p -73.16 167.24 21.57 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.489 0.661 . . . . 0.0 111.314 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.456 HD11 HG22 ' A' ' 70' ' ' VAL . 43.2 mt -68.81 -24.05 64.34 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.79 172.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p -78.69 -14.24 59.4 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.6 0.76 . . . . 0.0 110.758 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.99 18.9 32.68 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.033 0.373 . . . . 0.0 114.033 170.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.17 153.16 18.8 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 m -102.0 145.9 28.63 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.042 0.449 . . . . 0.0 110.053 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.537 HD11 HG23 ' A' ' 7' ' ' THR . 5.3 mp -128.88 108.68 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 m -87.91 115.44 25.38 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -103.35 152.2 21.86 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -128.29 79.42 1.9 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -171.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.645 HG21 HG22 ' A' ' 26' ' ' VAL . 30.0 m -146.07 179.02 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.673 1.189 . . . . 0.0 109.081 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -85.31 153.12 59.01 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.2 Cg_endo -59.09 -32.82 98.02 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 121.827 1.685 . . . . 0.0 110.85 164.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -91.96 8.88 35.49 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.018 0.927 . . . . 0.0 111.479 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -74.46 -92.3 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.342 0.657 . . . . 0.0 110.074 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 26' ' ' VAL . 8.9 t 177.08 145.5 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.48 1.112 . . . . 0.0 109.84 171.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.75 -34.25 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.177 0.991 . . . . 0.0 110.684 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.68 -40.77 66.24 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.953 0.901 . . . . 0.0 110.66 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.477 ' H ' HG23 ' A' ' 22' ' ' THR . 10.5 t-20 -77.31 -43.39 33.27 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.031 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.645 HG22 HG21 ' A' ' 17' ' ' VAL . 99.4 t -56.86 -44.25 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 124.361 1.038 . . . . 0.0 110.442 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HB2' ' OE1' ' A' ' 41' ' ' GLN . 16.6 ptpt -71.78 -32.58 67.8 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.947 0.499 . . . . 0.0 110.609 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.09 -28.41 68.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.858 0.463 . . . . 0.0 111.164 169.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 9.8 mmpt? -72.78 -37.06 67.73 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 122.9 0.48 . . . . 0.0 110.247 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.442 HG13 HG21 ' A' ' 13' ' ' ILE . 2.2 mp -58.53 -42.58 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 118.413 0.551 . . . . 0.0 109.838 172.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.05 -27.98 69.77 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.326 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.33 -27.87 47.21 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.614 0.766 . . . . 0.0 111.622 174.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.3 mmtt -95.69 -68.02 0.82 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.986 -0.446 . . . . 0.0 111.025 -174.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 30' ' ' ILE . 15.1 pt-20 -85.51 -20.09 30.2 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.703 0.229 . . . . 0.0 111.549 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 24.76 35.68 Favored Glycine 0 C--N 1.347 1.17 0 O-C-N 122.946 0.154 . . . . 0.0 113.231 171.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.47 127.44 27.83 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.8 151.69 74.17 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.975 2.45 . . . . 0.0 112.486 -174.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 18.6 Cg_endo -57.43 -14.1 15.27 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.976 3.117 . . . . 0.0 114.782 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.21 -44.64 68.23 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 123.486 0.492 . . . . 0.0 110.202 172.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.11 -35.65 20.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.022 0.929 . . . . 0.0 111.882 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.715 HE21 HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -94.16 120.29 34.19 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.014 0.435 . . . . 0.0 109.849 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.604 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.1 ttt180 -106.86 128.7 54.51 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.048 0.939 . . . . 0.0 109.544 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.496 HD21 HE22 ' A' ' 41' ' ' GLN . 4.6 mm? -94.09 127.76 40.09 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.837 0.855 . . . . 0.0 109.653 -174.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -141.54 131.54 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.676 0.79 . . . . 0.0 110.199 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.577 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 74.2 t80 -136.79 128.4 28.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.68 21.79 11.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.512 1.125 . . . . 0.0 112.164 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.66 -0.03 73.18 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.446 -0.641 . . . . 0.0 114.047 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.7 ptpt -112.42 151.51 29.76 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 117.711 0.755 . . . . 0.0 110.394 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' HD22 ' B' ' 224' ' ' LEU . 29.5 tt0 -77.32 133.04 38.88 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.171 0.589 . . . . 0.0 110.343 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 45' ' ' PHE . 24.2 mt -85.95 120.47 27.38 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 122.764 0.426 . . . . 0.0 110.258 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.74 136.1 36.68 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 123.731 0.813 . . . . 0.0 109.102 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.42 -38.08 82.9 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.142 0.902 . . . . 0.0 111.591 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.61 -38.52 96.53 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.844 0.715 . . . . 0.0 112.867 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -75.07 177.57 6.3 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.733 0.813 . . . . 0.0 112.034 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.7 p -110.43 167.52 10.15 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.66 0.784 . . . . 0.0 110.093 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.1 mt -55.78 -51.4 67.57 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 t -63.19 -24.02 67.69 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.47 1.108 . . . . 0.0 111.771 -175.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.13 -31.65 66.2 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.182 0.515 . . . . 0.0 109.909 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -94.53 17.5 13.08 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.626 0.77 . . . . 0.0 111.747 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 68.75 16.65 8.92 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.447 1.099 . . . . 0.0 112.038 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.6 mt -88.05 119.48 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -99.36 179.77 4.47 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HE3' ' SD ' ' A' ' 1' ' ' MET . 8.7 ptmm? -60.3 142.78 54.2 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 170.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 68.33 9.5 7.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.918 1.287 . . . . 0.0 113.424 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -70.73 137.59 49.81 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 26.2 m -97.88 126.14 43.11 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.577 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -133.11 172.58 12.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.569 1.147 . . . . 0.0 108.854 -178.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -101.48 154.86 18.46 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.522 0.677 . . . . 0.0 111.68 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.715 HD21 HE21 ' A' ' 41' ' ' GLN . 2.2 tm? -135.88 132.81 37.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.206 -1.361 . . . . 0.0 107.936 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 99.5 t -117.0 124.04 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.929 0.892 . . . . 0.0 110.575 -175.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.434 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 86.5 mt -92.49 120.71 33.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.095 0.558 . . . . 0.0 109.685 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -90.72 -37.21 13.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.095 0.958 . . . . 0.0 109.612 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.434 ' HG ' ' HB3' ' A' ' 71' ' ' LEU . 92.8 mt . . . . . 0 N--CA 1.487 1.379 0 C-N-CA 125.357 1.463 . . . . 0.0 113.154 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.0 m -141.38 -176.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.388 1.075 . . . . 0.0 109.48 -170.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -123.67 143.37 50.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.283 0.633 . . . . 0.0 110.042 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.628 ' HA ' HD11 ' B' ' 216' ' ' ILE . 49.7 t -84.66 97.85 0.55 Allowed Pre-proline 0 N--CA 1.478 0.943 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.576 ' HD2' HD21 ' B' ' 220' ' ' LEU . 27.4 Cg_endo -57.57 -25.57 67.82 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 123.332 2.688 . . . . 0.0 113.563 -171.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.59 -52.39 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 O-C-N 123.692 0.62 . . . . 0.0 111.275 -172.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.2 p -107.41 -4.01 18.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.53 45.82 35.04 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 115.18 0.832 . . . . 0.0 115.18 169.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 34.5 m -119.82 139.44 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.536 0.734 . . . . 0.0 110.677 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -89.28 115.83 27.05 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.502 HD11 ' HB2' ' B' ' 204' ' ' CYS . 12.3 pt -145.14 156.16 54.59 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.939 1.296 . . . . 0.0 109.815 -171.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.95 165.45 23.74 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.852 2.368 . . . . 0.0 113.946 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.6 ' O ' HG22 ' B' ' 216' ' ' ILE . 32.9 tt0 -56.79 -47.02 81.14 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 126.376 1.87 . . . . 0.0 114.318 -167.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 14.6 m -69.9 -37.87 76.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.13 -0.981 . . . . 0.0 110.391 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -67.16 -31.43 71.85 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.949 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.628 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -69.66 -46.46 75.0 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -176.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.47 -43.43 98.87 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.55 0.531 . . . . 0.0 110.73 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -59.91 -51.58 69.09 Favored 'General case' 0 C--O 1.253 1.245 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.487 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -41.7 79.84 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.864 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 70' ' ' VAL . 96.7 mt -58.92 -53.86 53.62 Favored 'General case' 0 C--O 1.202 -1.398 0 O-C-N 124.399 1.062 . . . . 0.0 111.075 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.52 -30.18 60.22 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.767 1.292 . . . . 0.0 111.43 -171.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.8 t -83.44 -45.02 14.13 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.317 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 88.0 m -68.94 -29.02 67.17 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.63 1.172 . . . . 0.0 112.642 -173.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.2 pp . . . . . 0 N--CA 1.483 1.185 0 C-N-CA 123.6 0.76 . . . . 0.0 109.936 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -120.5 142.95 48.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.737 0.415 . . . . 0.0 110.744 176.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -132.29 155.15 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.702 1.201 . . . . 0.0 109.385 175.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' THR . 92.2 m-85 -112.99 108.45 17.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.694 0.797 . . . . 0.0 109.648 -174.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' A' ' 69' ' ' LEU . 69.6 t -105.86 119.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -106.87 125.66 51.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.806 0.842 . . . . 0.0 110.281 -171.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.703 HG22 HD12 ' A' ' 69' ' ' LEU . 77.2 p -76.45 168.61 19.77 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.367 0.531 . . . . 0.0 111.793 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.5 mt -70.62 -22.93 62.47 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.256 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -80.18 -5.6 56.35 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.277 0.631 . . . . 0.0 111.056 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.78 20.65 46.33 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.352 -0.385 . . . . 0.0 113.999 167.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.14 153.21 18.23 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.5 m -104.11 134.37 47.49 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.239 0.616 . . . . 0.0 110.791 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 7' ' ' THR . 5.3 mp -118.61 109.59 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.326 1.05 . . . . 0.0 108.44 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.0 m -91.21 119.26 31.15 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.136 0.575 . . . . 0.0 109.494 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.9 mm? -104.98 155.73 18.68 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.446 0.698 . . . . 0.0 109.631 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -121.9 72.55 1.03 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.957 0.903 . . . . 0.0 108.695 -174.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.81 HG21 HG22 ' A' ' 26' ' ' VAL . 31.3 m -138.57 -176.23 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.945 0.898 . . . . 0.0 109.382 -174.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -108.43 158.03 34.93 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 122.966 0.506 . . . . 0.0 110.592 -172.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 38.0 Cg_endo -63.18 -28.15 73.19 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.504 2.136 . . . . 0.0 111.925 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 t -109.14 25.21 12.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.508 0.723 . . . . 0.0 109.633 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.02 -99.71 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.267 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 26' ' ' VAL . 10.1 t 173.55 140.44 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.275 1.43 . . . . 0.0 108.812 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mm -58.67 -37.43 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.583 1.153 . . . . 0.0 111.984 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 43.5 tt0 -58.32 -38.22 76.68 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.508 0.723 . . . . 0.0 111.062 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.509 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 9.7 t30 -74.06 -41.92 61.0 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.043 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.81 HG22 HG21 ' A' ' 17' ' ' VAL . 48.5 t -58.74 -45.71 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 124.231 0.957 . . . . 0.0 110.623 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 30' ' ' ILE . 18.4 ptpt -73.92 -27.49 61.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.271 0.628 . . . . 0.0 111.602 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.94 79.16 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.397 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 67.9 mmtt -74.12 -27.52 60.9 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.753 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 27' ' ' LYS . 91.9 mt -67.0 -36.09 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 120.999 0.428 . . . . 0.0 110.028 175.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -65.39 -33.62 76.38 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.657 169.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.44 -23.01 62.65 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.435 0.694 . . . . 0.0 111.581 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 73.0 mmtt -98.66 -67.66 0.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.92 0.327 . . . . 0.0 110.984 -177.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.09 -24.37 30.38 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.03 7.82 55.95 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 120.013 -0.326 . . . . 0.0 113.846 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.22 124.92 43.28 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 73.3 Cg_endo -68.33 154.7 71.48 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.232 2.621 . . . . 0.0 112.773 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 13.7 Cg_endo -53.99 -15.66 7.8 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.961 3.107 . . . . 0.0 114.134 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.45 -41.96 37.79 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.852 0.861 . . . . 0.0 110.702 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -92.43 -19.02 22.47 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.91 0.884 . . . . 0.0 113.071 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.542 HE22 HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -103.14 149.73 24.34 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 173.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.488 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 38.5 ttt180 -134.68 129.99 35.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.26 0.624 . . . . 0.0 109.723 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.542 HD21 HE22 ' A' ' 41' ' ' GLN . 4.6 mm? -95.48 123.66 39.13 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.583 0.753 . . . . 0.0 110.549 -172.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.6 mt -141.93 124.71 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.672 0.789 . . . . 0.0 109.873 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 87.0 t80 -124.79 123.01 39.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.332 1.053 . . . . 0.0 108.191 175.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.02 25.92 15.19 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.837 0.855 . . . . 0.0 112.461 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.36 -21.5 45.16 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 122.956 0.313 . . . . 0.0 113.671 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 5.1 ptpt -91.11 134.47 34.49 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 117.362 0.581 . . . . 0.0 109.603 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.7 139.65 39.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 43' ' ' LEU . 24.3 mt -92.07 121.77 33.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.945 0.498 . . . . 0.0 110.96 -171.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.24 138.02 38.41 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.471 1.108 . . . . 0.0 109.973 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.0 m-20 -61.59 -42.49 98.94 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.3 1.04 . . . . 0.0 112.042 -172.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.84 -25.55 75.16 Favored Glycine 0 C--N 1.343 0.941 0 O-C-N 124.184 0.927 . . . . 0.0 113.467 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -78.86 177.24 8.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.997 0.519 . . . . 0.0 111.973 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.5 p -114.68 167.11 11.04 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.979 0.912 . . . . 0.0 110.228 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 87.9 mt -55.58 -56.23 22.77 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.704 0.628 . . . . 0.0 110.518 176.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 31.1 t -65.48 -18.35 65.25 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.981 0.912 . . . . 0.0 112.013 -174.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.0 -46.01 83.21 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.485 0.66 . . . . 0.0 109.34 173.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -86.21 18.66 3.02 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.094 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.455 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER 70.54 18.61 6.46 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.422 1.089 . . . . 0.0 111.802 176.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.4 mt -92.57 110.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -98.71 -174.7 2.86 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -65.14 135.59 55.68 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.95 0.405 . . . . 0.0 110.514 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 68.75 17.21 8.87 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.241 1.416 . . . . 0.0 111.811 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -72.27 139.08 47.88 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 168.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 41.1 m -101.36 128.38 47.56 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.531 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -133.48 168.09 19.26 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.27 1.028 . . . . 0.0 109.044 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -93.87 153.02 18.48 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.496 0.718 . . . . 0.0 111.406 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -134.21 129.45 35.75 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.587 HG21 HD11 ' B' ' 220' ' ' LEU . 95.4 t -112.09 117.56 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 123.424 0.69 . . . . 0.0 109.76 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.94 150.88 28.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.332 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -121.62 -49.86 2.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.816 0.847 . . . . 0.0 109.599 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.49 1.525 0 C-N-CA 124.664 1.185 . . . . 0.0 112.017 -177.115 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 9.7 m -140.74 -176.73 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.063 1.345 . . . . 0.0 108.858 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -120.21 147.03 45.46 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.652 0.381 . . . . 0.0 110.244 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.631 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.5 t -86.87 101.34 2.05 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.995 0.918 . . . . 0.0 109.087 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.503 ' HD2' HD21 ' B' ' 220' ' ' LEU . 96.6 Cg_endo -72.13 11.4 0.74 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.834 2.356 . . . . 0.0 115.126 -166.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 19.5 t -103.54 -52.78 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.562 0.745 . . . . 0.0 110.24 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.9 p -106.87 -6.3 17.74 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.126 0.57 . . . . 0.0 111.628 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 59.79 59.19 10.95 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 124.467 1.032 . . . . 0.0 115.405 176.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.89 134.78 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.228 0.611 . . . . 0.0 110.007 173.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -76.87 120.49 22.07 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.573 HD11 ' HB2' ' B' ' 204' ' ' CYS . 5.4 pt -148.97 162.15 30.17 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 125.443 1.497 . . . . 0.0 109.112 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -65.85 161.19 40.36 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.545 2.164 . . . . 0.0 112.184 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.502 ' O ' HG22 ' B' ' 216' ' ' ILE . 41.2 tt0 -65.47 -28.23 69.06 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.268 1.027 . . . . 0.0 112.063 -174.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 39.5 t -67.88 -46.36 71.91 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.381 0.61 . . . . 0.0 110.38 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -80.87 -14.44 58.02 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.643 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.631 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.9 -42.94 53.37 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -58.2 7.47 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 124.134 0.896 . . . . 0.0 109.111 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -57.69 -44.73 86.04 Favored 'General case' 0 C--O 1.255 1.364 0 O-C-N 124.456 1.098 . . . . 0.0 111.069 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -39.4 83.47 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.388 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 70' ' ' VAL . 88.9 mt -69.8 -36.45 75.7 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 124.029 0.831 . . . . 0.0 111.72 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -57.02 -33.64 67.37 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.799 0.687 . . . . 0.0 110.513 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.8 t -86.28 -38.05 17.93 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.402 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 65.4 m -81.33 -19.63 42.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.82 0.848 . . . . 0.0 112.986 -169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.487 1.404 0 C-N-CA 122.598 0.359 . . . . 0.0 110.564 -178.56 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.973 0.415 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.5 mp0 -109.65 144.35 38.13 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.649 0.78 . . . . 0.0 109.856 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.48 149.61 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.881 0.873 . . . . 0.0 109.154 169.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 66' ' ' THR . 64.4 m-85 -106.25 100.16 9.71 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.24 -173.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 69' ' ' LEU . 79.0 t -97.2 114.69 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -101.11 122.16 43.1 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.55 1.14 . . . . 0.0 110.337 -172.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.679 HG22 HD12 ' A' ' 69' ' ' LEU . 51.5 p -71.07 162.47 29.37 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.669 0.668 . . . . 0.0 111.069 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.517 HD11 HG22 ' A' ' 70' ' ' VAL . 84.1 mt -70.73 -20.24 62.67 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.047 171.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -80.34 -5.4 56.29 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.504 0.722 . . . . 0.0 111.206 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.47 15.28 51.1 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 114.457 0.543 . . . . 0.0 114.457 166.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.32 152.22 18.58 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.4 m -100.6 141.45 33.45 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.503 HD11 HG23 ' A' ' 7' ' ' THR . 5.4 mp -123.31 116.34 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.309 1.043 . . . . 0.0 108.297 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -101.38 117.16 34.4 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.518 0.727 . . . . 0.0 109.594 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -104.62 151.47 23.62 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.665 0.786 . . . . 0.0 109.515 -175.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -108.94 76.95 1.04 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 124.095 0.872 . . . . 0.0 109.338 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.719 HG21 HG22 ' A' ' 26' ' ' VAL . 3.6 m -140.7 170.38 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.429 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 15.9 mt-10 -91.8 157.88 40.88 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.491 0.716 . . . . 0.0 109.185 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 25.1 Cg_endo -61.24 -29.37 86.36 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.539 1.493 . . . . 0.0 111.206 168.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 t -99.28 19.86 14.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.731 0.812 . . . . 0.0 110.583 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 10.8 t70 -80.73 -94.74 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.2 t 177.05 143.87 0.09 Allowed 'General case' 0 C--N 1.364 1.238 0 C-N-CA 124.889 1.276 . . . . 0.0 109.734 173.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.415 HG22 ' HE3' ' A' ' 27' ' ' LYS . 47.8 mm -61.62 -38.01 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.539 1.136 . . . . 0.0 111.298 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -52.92 -40.45 63.59 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.968 0.907 . . . . 0.0 111.013 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.2 t-20 -72.72 -44.71 61.35 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.116 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.719 HG22 HG21 ' A' ' 17' ' ' VAL . 53.1 t -54.91 -47.68 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 124.479 1.112 . . . . 0.0 111.086 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HE3' HG22 ' A' ' 23' ' ' ILE . 17.7 ptpt -69.88 -34.06 73.05 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 122.879 0.472 . . . . 0.0 111.552 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -25.1 65.2 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.888 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 8.8 mmpt? -77.69 -32.35 52.97 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.58 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.472 HG13 HG21 ' A' ' 13' ' ' ILE . 1.9 mp -57.01 -43.13 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 119.078 0.854 . . . . 0.0 109.967 169.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -62.42 -30.67 71.39 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.635 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -73.76 -29.61 62.31 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.582 0.753 . . . . 0.0 111.833 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 69.8 mmtt -95.23 -67.98 0.82 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.38 -23.87 32.25 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.248 0.219 . . . . 0.0 110.923 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.6 40.8 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.195 174.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.53 125.08 35.02 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 72.5 Cg_endo -70.4 158.39 56.25 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.205 2.603 . . . . 0.0 112.698 -173.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.0 -16.27 20.16 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 123.804 3.003 . . . . 0.0 114.052 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.439 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 23.0 t70 -74.46 -28.07 60.87 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.874 0.87 . . . . 0.0 110.797 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -108.13 -17.59 13.99 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.823 1.249 . . . . 0.0 113.244 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB2' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -110.56 155.6 22.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.019 0.528 . . . . 0.0 110.218 176.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.469 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 41.7 ttt180 -139.54 125.0 19.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.94 0.496 . . . . 0.0 110.234 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.4 ' CD2' HE22 ' A' ' 41' ' ' GLN . 3.1 mm? -93.69 124.24 37.55 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.517 0.727 . . . . 0.0 110.032 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -142.45 130.56 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.152 0.981 . . . . 0.0 109.526 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.528 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 89.8 t80 -128.56 135.37 49.28 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 171.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.62 16.7 10.47 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.18 0.992 . . . . 0.0 112.378 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.23 21.82 58.09 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.234 0.334 . . . . 0.0 113.846 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 11.4 ptpt -130.8 145.27 51.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.29 0.636 . . . . 0.0 109.352 174.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -74.58 140.13 44.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.815 0.446 . . . . 0.0 110.104 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 45' ' ' PHE . 27.4 mt -91.6 125.05 36.19 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.205 0.602 . . . . 0.0 110.647 -176.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.41 138.46 32.83 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.826 0.85 . . . . 0.0 110.309 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.65 -46.56 84.05 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.653 1.181 . . . . 0.0 112.387 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.7 -26.41 72.04 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 124.142 0.902 . . . . 0.0 113.641 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.401 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 55.9 mtt180 -77.54 177.09 8.32 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.303 0.641 . . . . 0.0 111.582 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.7 p -116.1 169.07 9.55 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.652 0.781 . . . . 0.0 109.777 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.497 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.0 mt -55.99 -53.07 61.36 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.698 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 t -61.34 -24.89 66.78 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.567 1.147 . . . . 0.0 111.648 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 12.4 t70 -65.7 -41.83 91.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -91.47 20.77 5.03 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.812 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 72.6 8.01 5.61 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 124.745 1.218 . . . . 0.0 112.789 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 10.6 mt -84.61 116.91 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -106.48 -172.15 2.03 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -58.71 146.95 34.73 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.105 0.479 . . . . 0.0 110.557 172.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 62.9 5.57 1.86 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.636 1.574 . . . . 0.0 113.711 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.6 m -70.6 143.71 51.43 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 118.664 0.665 . . . . 0.0 111.198 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 27.2 m -108.54 134.3 51.49 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.15 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.517 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -144.77 173.13 12.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.988 1.315 . . . . 0.0 108.536 -176.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -102.97 153.43 20.23 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.701 0.762 . . . . 0.0 112.677 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.679 HD12 HG22 ' A' ' 7' ' ' THR . 2.3 tm? -130.52 126.07 35.9 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.517 HG22 HD11 ' A' ' 8' ' ' LEU . 73.8 t -110.79 124.61 67.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 123.275 0.63 . . . . 0.0 109.742 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -85.42 147.13 26.64 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.681 0.792 . . . . 0.0 110.355 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 39' ' ' ASP . 40.1 mtt180 -122.33 -44.18 2.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.703 0.801 . . . . 0.0 110.451 -173.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.487 1.423 0 C-N-CA 124.733 1.213 . . . . 0.0 112.081 -179.273 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 3.4 m -140.58 151.58 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.144 1.378 . . . . 0.0 110.047 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' B' ' 210' ' ' ASN . 4.8 m-20 -78.89 147.19 33.19 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.731 -175.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.658 ' HA ' HD11 ' B' ' 216' ' ' ILE . 24.8 t -89.77 98.33 1.3 Allowed Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.519 ' HD2' HD13 ' B' ' 220' ' ' LEU . 74.1 Cg_endo -68.45 9.01 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.521 2.814 . . . . 0.0 115.887 -163.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' B' ' 223' ' ' CYS . 29.9 t -104.61 -48.62 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 122.833 0.453 . . . . 0.0 110.654 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . 0.484 ' SG ' HG22 ' B' ' 209' ' ' VAL . 18.0 p -107.48 -7.95 16.4 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.901 0.48 . . . . 0.0 112.185 -173.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.63 41.55 64.66 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . 0.484 HG22 ' SG ' ' B' ' 207' ' ' CYS . 27.9 m -118.62 132.83 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 117.647 0.724 . . . . 0.0 110.072 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' B' ' 203' ' ' ASP . 25.3 t-20 -86.23 126.49 34.31 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 4.9 pt -148.92 159.45 37.54 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 125.865 1.666 . . . . 0.0 108.991 -169.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.473 ' HG2' ' HB2' ' B' ' 215' ' ' HIS . 17.8 Cg_endo -58.74 156.25 33.48 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.41 2.073 . . . . 0.0 111.964 174.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.54 ' O ' HG22 ' B' ' 216' ' ' ILE . 26.7 tt0 -66.32 -30.21 70.57 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.02 0.928 . . . . 0.0 112.033 -170.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 51.2 p -63.92 -49.98 70.51 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.581 0.705 . . . . 0.0 109.558 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . 0.473 ' HB2' ' HG2' ' B' ' 212' ' ' PRO . 47.1 m80 -76.11 -12.2 60.07 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.871 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -72.85 -51.6 26.45 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.274 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -63.87 -31.23 72.34 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.181 0.446 . . . . 0.0 111.727 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -66.13 -63.58 1.05 Allowed 'General case' 0 C--O 1.251 1.178 0 O-C-N 123.885 0.741 . . . . 0.0 111.556 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -43.27 69.79 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.319 1.048 . . . . 0.0 109.863 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.519 HD13 ' HD2' ' B' ' 205' ' ' PRO . 30.7 tp -63.31 -46.04 88.54 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 113.654 -1.612 . . . . 0.0 111.808 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.17 -35.28 64.63 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 124.316 1.01 . . . . 0.0 110.358 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.3 t -79.77 -38.31 33.46 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.995 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' B' ' 206' ' ' VAL . 93.9 m -74.24 -35.11 63.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.448 1.099 . . . . 0.0 112.633 -172.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . 0.422 HD23 ' HG ' ' B' ' 220' ' ' LEU . 4.0 pp . . . . . 0 N--CA 1.49 1.557 0 C-N-CA 123.559 0.743 . . . . 0.0 111.846 -168.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.85 0.357 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 17.4 mp0 -90.12 134.43 34.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.929 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.518 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -130.53 157.96 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.126 1.37 . . . . 0.0 108.586 172.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 72.8 m-85 -116.55 120.5 38.91 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.305 0.642 . . . . 0.0 109.783 -173.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 30' ' ' ILE . 68.9 t -109.9 130.89 62.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -118.16 117.02 28.01 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.573 HG23 HD11 ' A' ' 13' ' ' ILE . 43.5 p -70.15 165.68 21.53 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.286 0.565 . . . . 0.0 111.697 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.415 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 57.5 mt -68.92 -22.0 64.18 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.005 173.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.0 p -79.64 -15.89 56.78 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.387 0.675 . . . . 0.0 110.782 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.96 21.21 16.31 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.539 -0.59 . . . . 0.0 114.476 170.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -94.39 153.71 17.83 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.496 0.648 . . . . 0.0 109.599 174.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.9 m -100.53 144.22 29.77 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.324 0.65 . . . . 0.0 109.869 172.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.573 HD11 HG23 ' A' ' 7' ' ' THR . 5.3 mp -128.79 114.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.808 1.243 . . . . 0.0 108.408 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.1 m -99.58 121.85 41.79 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.504 0.722 . . . . 0.0 110.119 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -112.21 153.16 27.5 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -116.43 76.9 1.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 26' ' ' VAL . 20.5 m -140.04 177.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.375 0.67 . . . . 0.0 110.386 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -91.99 157.08 41.74 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 123.642 0.777 . . . . 0.0 109.75 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 24.3 Cg_endo -61.95 -34.68 80.6 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.536 1.491 . . . . 0.0 110.836 165.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -94.13 13.88 21.76 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.1 0.56 . . . . 0.0 110.67 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.42 -96.15 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.393 0.677 . . . . 0.0 110.867 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.1 t 169.52 138.26 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.6 1.56 . . . . 0.0 108.307 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.15 -34.33 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.759 0.824 . . . . 0.0 110.956 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 16.8 tp10 -60.25 -35.42 75.44 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.557 0.694 . . . . 0.0 111.399 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 12.2 t30 -76.47 -44.04 37.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.923 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.674 HG22 HG21 ' A' ' 17' ' ' VAL . 62.6 t -57.0 -43.88 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 124.316 1.01 . . . . 0.0 110.488 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.544 ' HB2' ' OE1' ' A' ' 41' ' ' GLN . 17.6 ptpt -71.08 -33.89 70.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.261 0.624 . . . . 0.0 110.576 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.63 -31.77 73.04 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.848 171.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 9.7 mmpt? -72.62 -35.49 67.84 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.578 HD11 HG21 ' A' ' 5' ' ' VAL . 1.8 mp -55.65 -43.64 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.486 0.585 . . . . 0.0 110.167 171.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -65.48 -29.26 69.9 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.317 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.1 -25.92 62.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.169 0.588 . . . . 0.0 111.234 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 68.5 mmtt -99.28 -69.03 0.78 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.733 0.242 . . . . 0.0 111.168 -175.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -85.18 -21.2 29.27 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.73 14.1 51.05 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 114.298 0.479 . . . . 0.0 114.298 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.1 127.71 32.69 Favored Pre-proline 0 N--CA 1.481 1.113 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.29 154.27 72.51 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.06 2.507 . . . . 0.0 112.976 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 15.6 Cg_endo -54.64 -14.84 8.09 Favored 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 124.295 3.33 . . . . 0.0 114.94 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -72.36 -48.53 41.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.962 0.505 . . . . 0.0 110.309 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -88.82 -22.7 23.1 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.968 0.907 . . . . 0.0 113.109 -171.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.694 HE21 HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -101.21 124.64 47.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.816 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 34.1 ttt180 -112.91 130.27 56.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.177 0.991 . . . . 0.0 108.826 -172.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 4.4 mm? -95.03 119.0 32.8 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.44 0.696 . . . . 0.0 110.533 -170.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.7 mt -140.95 127.73 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.562 0.745 . . . . 0.0 109.796 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.686 ' HB3' HD21 ' A' ' 50' ' ' LEU . 75.6 t80 -129.23 126.01 38.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.76 1.224 . . . . 0.0 108.448 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.41 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 61.8 18.45 9.73 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.107 0.963 . . . . 0.0 113.343 173.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.5 5.14 56.99 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.914 -0.381 . . . . 0.0 113.821 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.0 ptpt -118.02 146.98 43.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.367 0.667 . . . . 0.0 109.396 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -80.51 140.61 35.78 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.945 0.498 . . . . 0.0 109.98 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 45' ' ' PHE . 23.5 mt -94.96 114.93 26.82 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 122.931 0.493 . . . . 0.0 110.825 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -77.82 139.07 39.27 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.684 0.793 . . . . 0.0 110.199 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 11.2 p-10 -58.84 -39.54 81.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.522 1.129 . . . . 0.0 112.448 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.25 -18.25 80.06 Favored Glycine 0 C--N 1.354 1.536 0 O-C-N 124.126 0.891 . . . . 0.0 113.351 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HD3' ' OD2' ' A' ' 58' ' ' ASP . 99.6 mtt180 -86.13 177.11 7.64 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.46 0.704 . . . . 0.0 111.275 175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 p -116.19 168.44 10.11 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 123.864 0.865 . . . . 0.0 109.668 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.4 mt -56.23 -49.87 72.91 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 124.195 0.934 . . . . 0.0 109.65 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 35.7 t -63.67 -26.14 68.53 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.541 1.137 . . . . 0.0 111.548 -175.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.418 ' OD2' ' HD3' ' A' ' 54' ' ' ARG . 20.2 t70 -65.18 -41.61 94.42 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 121.544 0.688 . . . . 0.0 109.637 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -89.87 15.07 10.49 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.944 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 71.37 14.85 6.38 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.072 1.349 . . . . 0.0 112.399 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 8.8 mt -86.52 121.68 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -115.01 -172.53 2.14 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -57.44 143.56 39.88 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.293 0.37 . . . . 0.0 110.815 172.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 72.25 1.11 3.82 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.295 1.438 . . . . 0.0 112.31 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -75.62 135.57 40.48 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 118.09 0.404 . . . . 0.0 110.223 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.4 m -99.9 131.23 46.0 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.117 0.484 . . . . 0.0 110.603 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.511 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -124.57 175.7 7.0 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.866 1.266 . . . . 0.0 108.667 174.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -108.68 153.09 23.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.349 0.66 . . . . 0.0 111.423 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.694 HD21 HE21 ' A' ' 41' ' ' GLN . 2.1 tm? -131.21 126.25 35.07 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -175.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.816 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.4 t -105.28 109.2 26.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.802 0.841 . . . . 0.0 109.828 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -81.63 138.96 35.25 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.305 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.2 mtp180 -113.07 -47.48 3.03 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.898 0.879 . . . . 0.0 110.676 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.492 1.66 0 C-N-CA 123.939 0.896 . . . . 0.0 112.131 -178.176 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' B' ' 201' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.628 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . 0.665 HG23 HG13 ' B' ' 216' ' ' ILE . 0.9 OUTLIER -147.61 146.18 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.033 0.933 . . . . 0.0 111.036 -162.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -74.2 147.73 42.26 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.383 0.673 . . . . 0.0 111.492 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.457 ' HA ' HD11 ' B' ' 216' ' ' ILE . 20.0 t -91.7 97.59 1.51 Allowed Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.166 0.986 . . . . 0.0 108.902 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.453 ' HD2' HD11 ' B' ' 220' ' ' LEU . 32.3 Cg_endo -58.52 -5.45 2.41 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.679 2.919 . . . . 0.0 116.364 -166.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . 0.427 HG11 ' O ' ' B' ' 223' ' ' CYS . 41.0 t -94.67 -57.48 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 173.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . 0.505 ' SG ' HG22 ' B' ' 209' ' ' VAL . 11.7 p -106.12 9.45 32.31 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.56 -37.55 2.78 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.865 1.106 . . . . 0.0 115.865 171.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . 0.505 HG22 ' SG ' ' B' ' 207' ' ' CYS . 20.6 m -60.2 134.73 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -165.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -84.7 125.35 32.44 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.699 HG13 HG12 ' B' ' 216' ' ' ILE . 5.2 pt -148.56 156.08 41.98 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.464 1.506 . . . . 0.0 109.166 -171.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.04 151.55 77.61 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.698 2.266 . . . . 0.0 112.196 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.457 ' HA ' ' HB ' ' B' ' 216' ' ' ILE . 3.9 tm-20 -58.53 -43.65 89.3 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -166.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 27.1 t -65.71 -36.75 84.5 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.583 -0.698 . . . . 0.0 110.381 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -82.43 -11.47 58.51 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.107 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.699 HG12 HG13 ' B' ' 211' ' ' ILE . 0.4 OUTLIER -68.8 -45.94 80.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 172.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -74.21 -30.36 62.16 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.519 0.512 . . . . 0.0 111.974 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -68.4 -50.72 50.87 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.31 0.381 . . . . 0.0 110.888 172.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.13 -45.37 83.56 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.08 0.552 . . . . 0.0 109.543 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.548 HD13 HG21 ' A' ' 70' ' ' VAL . 60.7 mt -68.96 -34.36 75.21 Favored 'General case' 0 C--O 1.209 -1.078 0 O-C-N 124.528 1.142 . . . . 0.0 112.439 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.57 -31.23 65.94 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.907 0.754 . . . . 0.0 109.882 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 t -91.33 -36.24 13.97 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.782 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . 0.53 ' HB2' ' HA ' ' B' ' 220' ' ' LEU . 84.9 m -75.01 -28.25 60.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.675 0.79 . . . . 0.0 112.271 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 123.042 0.537 . . . . 0.0 110.903 -176.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 20.7 mp0 -98.48 136.74 38.17 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.723 0.409 . . . . 0.0 110.713 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.4 155.94 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.678 1.191 . . . . 0.0 108.568 173.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 66' ' ' THR . 90.2 m-85 -113.53 99.66 7.92 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.277 -170.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.525 HG12 ' HB2' ' A' ' 69' ' ' LEU . 93.6 t -99.45 100.01 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -94.65 123.49 38.12 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.899 0.88 . . . . 0.0 110.737 -171.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.689 HG22 HD12 ' A' ' 69' ' ' LEU . 39.5 p -70.59 166.94 19.58 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.715 0.769 . . . . 0.0 111.922 176.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.13 -19.64 65.65 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.721 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -79.59 -3.85 48.88 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.569 0.747 . . . . 0.0 111.309 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.15 5.78 67.37 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.054 0.359 . . . . 0.0 112.378 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -90.4 137.83 32.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.206 1.003 . . . . 0.0 109.621 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.7 m -107.05 129.1 54.86 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.252 0.621 . . . . 0.0 110.369 -176.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -108.06 113.27 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.024 0.93 . . . . 0.0 109.327 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 m -87.45 117.0 25.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.723 0.809 . . . . 0.0 109.123 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.8 mm? -104.54 160.24 15.1 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.655 0.782 . . . . 0.0 109.022 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.07 80.99 1.99 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.858 0.863 . . . . 0.0 108.795 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.756 HG21 HG22 ' A' ' 26' ' ' VAL . 3.1 m -138.19 175.52 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.612 1.165 . . . . 0.0 108.657 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 12.9 mt-10 -92.28 140.71 24.41 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 9.7 Cg_endo -55.57 -29.1 68.34 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.857 2.372 . . . . 0.0 112.038 167.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -92.92 4.19 54.37 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.85 0.86 . . . . 0.0 110.797 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 22.6 t70 -82.27 -87.52 0.09 Allowed 'General case' 0 C--N 1.358 0.955 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.275 -174.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 25' ' ' ASN . 10.0 t 179.02 149.98 0.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.75 0.82 . . . . 0.0 110.956 176.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.28 -34.0 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.754 1.222 . . . . 0.0 110.685 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -58.49 -38.46 77.67 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.068 0.947 . . . . 0.0 109.821 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.6 t30 -71.66 -44.76 63.73 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.078 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.756 HG22 HG21 ' A' ' 17' ' ' VAL . 61.4 t -55.06 -48.17 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 124.437 1.085 . . . . 0.0 110.825 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -69.1 -31.83 70.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.298 0.639 . . . . 0.0 111.429 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.61 74.38 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.797 0.685 . . . . 0.0 111.141 170.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 65.3 mmtt -78.09 -31.57 50.19 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.932 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -58.85 -44.08 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.351 0.978 . . . . 0.0 109.291 170.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.75 -31.28 72.19 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.539 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 8.6 t70 -71.54 -35.21 70.59 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.639 0.776 . . . . 0.0 111.564 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.4 mmtt -88.72 -67.02 0.86 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.575 0.35 . . . . 0.0 110.968 -171.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -88.06 -22.33 24.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.301 0.24 . . . . 0.0 111.512 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.96 12.38 46.64 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.993 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -98.62 122.19 54.06 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -69.82 155.86 64.67 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.524 2.816 . . . . 0.0 113.059 -172.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.94 -13.1 10.8 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 124.482 3.455 . . . . 0.0 114.621 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.21 -47.33 14.81 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -77.64 -27.99 51.18 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.304 0.641 . . . . 0.0 111.286 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -96.65 147.68 23.64 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.643 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 42.9 ttt180 -137.66 129.25 28.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.527 HD21 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -92.2 125.73 36.99 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -173.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.422 HD11 ' HG ' ' B' ' 220' ' ' LEU . 97.6 mt -142.78 131.54 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.911 0.884 . . . . 0.0 110.071 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.559 ' HB3' HD21 ' A' ' 50' ' ' LEU . 86.0 t80 -135.81 128.36 30.63 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 65.45 21.3 11.84 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.834 0.854 . . . . 0.0 111.938 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.56 2.33 82.34 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.448 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 9.9 ptpt -108.99 142.16 40.05 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB2' HD22 ' B' ' 224' ' ' LEU . 9.7 tt0 -76.86 126.47 31.04 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.028 0.531 . . . . 0.0 110.081 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.7 mt -77.83 119.6 21.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.173 0.589 . . . . 0.0 110.352 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.0 138.37 42.18 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.742 0.651 . . . . 0.0 109.562 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.511 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 10.4 p-10 -61.1 -40.03 92.19 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 124.126 0.891 . . . . 0.0 112.037 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.57 -27.24 73.94 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.624 0.578 . . . . 0.0 113.374 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -77.48 176.77 8.58 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.214 0.606 . . . . 0.0 111.919 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.5 p -110.07 167.22 10.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.437 0.695 . . . . 0.0 109.765 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 81.4 mt -58.3 -51.46 69.69 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 56.2 m -59.6 -25.98 65.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.932 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.53 -34.25 73.98 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.074 0.464 . . . . 0.0 110.044 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -92.6 15.94 13.21 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.754 0.822 . . . . 0.0 111.768 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 66.67 30.04 8.43 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.239 1.016 . . . . 0.0 111.639 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -101.16 118.01 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -102.89 -175.99 2.96 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -58.18 141.5 50.33 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.125 171.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 72.49 0.34 3.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.509 1.523 . . . . 0.0 112.669 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.8 m -73.46 137.35 44.47 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 118.236 0.471 . . . . 0.0 110.705 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 15.0 m -95.53 137.04 35.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.875 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.73 174.54 10.41 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.945 1.298 . . . . 0.0 108.454 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -101.76 158.56 16.02 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.849 0.833 . . . . 0.0 112.185 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.689 HD12 HG22 ' A' ' 7' ' ' THR . 2.7 tm? -138.35 125.82 21.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.215 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.643 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 91.0 t -99.93 120.61 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 123.301 0.64 . . . . 0.0 110.224 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 93.0 mt -89.29 140.41 29.52 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.349 1.031 . . . . 0.0 109.883 174.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -119.14 -28.34 5.49 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.002 0.921 . . . . 0.0 111.476 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 71' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.496 1.829 0 C-N-CA 125.657 1.583 . . . . 0.0 113.978 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.8 m -138.01 172.08 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 125.505 1.522 . . . . 0.0 108.441 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.47 146.52 31.64 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 122.373 -0.204 . . . . 0.0 110.624 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.583 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.9 t -83.7 105.72 6.17 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.711 0.805 . . . . 0.0 109.019 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.549 ' HD2' HD11 ' B' ' 220' ' ' LEU . 40.5 Cg_endo -63.12 -1.0 2.52 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 124.087 3.191 . . . . 0.0 115.401 -171.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.95 -51.08 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.377 0.671 . . . . 0.0 111.427 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.9 p -113.88 1.07 14.64 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.009 0.523 . . . . 0.0 111.8 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 56.28 55.3 30.21 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 124.48 1.038 . . . . 0.0 115.195 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.72 127.2 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.166 0.586 . . . . 0.0 109.512 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.96 110.47 15.37 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 8.6 pt -138.6 160.87 61.66 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 125.715 1.606 . . . . 0.0 109.721 -173.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.75 159.77 23.54 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.841 2.361 . . . . 0.0 113.124 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.509 ' O ' HG22 ' B' ' 216' ' ' ILE . 34.4 tt0 -63.14 -33.49 75.58 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.993 1.317 . . . . 0.0 112.686 -172.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.0 t -66.23 -46.35 77.47 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.508 0.67 . . . . 0.0 110.594 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.19 -13.0 57.8 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.891 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.47 -44.82 53.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 174.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -55.07 28.44 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 124.502 1.126 . . . . 0.0 109.152 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -61.62 -39.18 90.34 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 124.446 1.091 . . . . 0.0 112.145 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -36.26 80.05 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.297 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.549 HD11 ' HD2' ' B' ' 205' ' ' PRO . 0.0 OUTLIER -63.71 -50.44 69.13 Favored 'General case' 0 C--O 1.21 -1.009 0 O-C-N 123.789 0.681 . . . . 0.0 110.249 177.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -54.49 -27.33 37.12 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 123.924 0.765 . . . . 0.0 112.048 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.1 t -89.1 -39.77 13.39 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.589 0.756 . . . . 0.0 111.217 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.55 -18.96 43.12 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.393 1.077 . . . . 0.0 113.511 -171.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' B' ' 220' ' ' LEU . 4.4 pp . . . . . 0 N--CA 1.494 1.728 0 CA-C-N 118.625 0.648 . . . . 0.0 110.105 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 75.8 mt-30 -119.42 132.63 55.85 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.3 0.64 . . . . 0.0 110.78 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.562 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -128.24 156.4 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.133 1.373 . . . . 0.0 108.951 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 66' ' ' THR . 50.1 m-85 -115.2 112.2 22.13 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.401 0.619 . . . . 0.0 110.073 -173.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.7 t -104.06 120.88 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -111.11 125.11 53.42 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.554 0.741 . . . . 0.0 109.82 -173.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.649 HG22 HD12 ' A' ' 69' ' ' LEU . 66.7 p -78.33 168.81 19.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.303 0.573 . . . . 0.0 112.067 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.43 HD11 HG22 ' A' ' 70' ' ' VAL . 60.7 mt -67.32 -27.68 67.35 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.345 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -79.34 -9.4 59.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.651 0.78 . . . . 0.0 110.987 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.69 22.98 37.58 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 114.17 0.428 . . . . 0.0 114.17 168.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 152.42 18.51 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.7 m -101.54 139.51 37.1 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.121 0.568 . . . . 0.0 109.994 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 7' ' ' THR . 5.2 mp -124.87 105.59 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.443 1.097 . . . . 0.0 108.181 176.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.1 m -86.96 122.97 31.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -105.8 156.29 18.46 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -120.34 69.66 0.87 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.442 1.097 . . . . 0.0 109.023 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.744 HG21 HG22 ' A' ' 26' ' ' VAL . 7.1 m -136.95 175.05 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -90.96 149.8 40.77 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.549 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 12.1 Cg_endo -58.96 -31.71 96.14 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.62 1.546 . . . . 0.0 111.733 164.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 t -97.36 18.09 15.98 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.905 0.482 . . . . 0.0 110.548 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.73 -96.73 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.827 0.851 . . . . 0.0 109.975 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 26' ' ' VAL . 5.2 t 174.36 140.37 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.2 1.4 . . . . 0.0 109.244 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.92 -37.11 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.879 0.871 . . . . 0.0 111.486 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 35.5 tt0 -54.92 -40.54 69.97 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.805 0.812 . . . . 0.0 110.792 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 11.5 t30 -73.54 -43.32 60.19 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.417 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.744 HG22 HG21 ' A' ' 17' ' ' VAL . 60.5 t -55.95 -48.63 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 124.311 1.007 . . . . 0.0 110.6 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.474 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.7 ptpt -68.41 -33.66 74.62 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.014 0.526 . . . . 0.0 111.602 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.64 -33.65 70.3 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.98 170.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 34.7 mmtm -76.64 -31.01 57.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.436 -0.793 . . . . 0.0 112.464 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.8 mp -60.49 -39.63 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 119.682 1.128 . . . . 0.0 109.129 170.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.64 -34.18 77.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.311 0.644 . . . . 0.0 111.207 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.05 -36.55 75.08 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.479 0.712 . . . . 0.0 111.5 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.6 mmtt -88.23 -65.7 0.99 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.83 0.452 . . . . 0.0 111.243 -170.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -84.18 -24.04 30.32 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.923 0.328 . . . . 0.0 111.272 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.0 17.84 31.18 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.173 0.295 . . . . 0.0 113.554 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.82 127.36 27.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.482 0.713 . . . . 0.0 109.36 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 58.8 Cg_endo -67.09 154.53 74.18 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.057 2.504 . . . . 0.0 112.697 -173.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 37.3 Cg_endo -61.14 -13.79 30.0 Favored 'Trans proline' 0 C--N 1.388 2.634 0 C-N-CA 123.666 2.911 . . . . 0.0 113.88 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.96 -32.18 51.3 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.742 0.817 . . . . 0.0 110.703 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -96.53 -18.33 19.88 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.855 1.262 . . . . 0.0 112.437 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.641 ' HB2' HD11 ' A' ' 69' ' ' LEU . 3.5 pp0? -118.96 133.57 55.74 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.165 0.507 . . . . 0.0 110.82 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.644 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 56.1 ttt180 -120.95 128.71 52.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.26 1.024 . . . . 0.0 109.788 -169.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.01 126.98 38.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.697 0.799 . . . . 0.0 109.656 -171.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.7 mt -142.15 132.03 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.292 0.637 . . . . 0.0 109.952 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.563 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 72.4 t80 -137.9 131.58 31.17 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 171.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.12 19.32 10.44 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.031 0.932 . . . . 0.0 112.013 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 6.53 79.57 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.975 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 13.8 ptpt -118.81 145.06 45.93 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.648 0.724 . . . . 0.0 109.998 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.538 ' HB2' HD22 ' B' ' 224' ' ' LEU . 0.4 OUTLIER -77.67 122.91 25.98 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -175.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' A' ' 45' ' ' PHE . 27.6 mt -72.11 119.52 16.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.405 0.682 . . . . 0.0 111.187 -175.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -81.54 138.77 35.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.233 1.013 . . . . 0.0 110.288 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 1.7 m-20 -60.22 -43.05 96.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.472 1.109 . . . . 0.0 112.613 -173.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.02 -8.77 74.7 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 124.36 1.037 . . . . 0.0 114.112 -177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 86.0 mtt-85 -95.1 177.33 5.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.99 0.916 . . . . 0.0 111.416 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -114.82 170.65 8.17 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.044 0.938 . . . . 0.0 109.509 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.9 mt -60.28 -52.16 66.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 40.7 m -54.62 -29.47 52.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.189 1.396 . . . . 0.0 112.633 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 12.7 t70 -65.67 -43.57 88.9 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 123.759 0.662 . . . . 0.0 109.761 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -87.93 21.23 2.76 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.916 0.887 . . . . 0.0 111.395 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 70.93 13.57 7.0 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.503 1.121 . . . . 0.0 111.982 176.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 14.6 mt -88.18 118.23 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.695 0.798 . . . . 0.0 109.001 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -102.5 -174.94 2.68 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -58.2 140.52 52.88 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.192 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 70.09 7.45 6.23 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.919 1.288 . . . . 0.0 112.954 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -69.46 135.88 50.78 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 117.901 0.319 . . . . 0.0 110.649 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.5 m -93.99 125.65 38.74 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.432 0.693 . . . . 0.0 109.617 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -127.46 167.92 15.61 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.347 1.059 . . . . 0.0 109.393 177.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -94.63 150.48 20.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.49 0.662 . . . . 0.0 110.93 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.649 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -133.85 126.68 31.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.696 HG21 HD11 ' B' ' 220' ' ' LEU . 69.8 t -101.9 109.07 25.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.441 0.697 . . . . 0.0 110.12 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.518 ' HB3' HD23 ' A' ' 73' ' ' LEU . 67.1 mt -80.73 144.9 31.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.241 173.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -121.08 -48.14 2.24 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.062 0.945 . . . . 0.0 109.249 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 71' ' ' LEU . 4.6 mm? . . . . . 0 N--CA 1.486 1.353 0 C-N-CA 124.678 1.191 . . . . 0.0 112.109 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.89 -176.29 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.919 1.288 . . . . 0.0 109.319 -170.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -113.07 144.26 42.92 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.787 0.435 . . . . 0.0 110.326 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.546 ' HA ' HD11 ' B' ' 216' ' ' ILE . 53.5 t -86.14 98.03 0.71 Allowed Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.489 ' HD2' HD21 ' B' ' 220' ' ' LEU . 20.7 Cg_endo -55.22 -24.67 42.8 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.122 2.548 . . . . 0.0 114.413 -164.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 10.8 t -74.48 -63.42 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 122.861 0.464 . . . . 0.0 110.608 -173.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 22.7 p -91.6 -9.76 42.95 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.025 0.53 . . . . 0.0 111.24 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.92 58.77 12.03 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 124.073 0.844 . . . . 0.0 114.203 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 33.2 m -118.98 135.66 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.586 0.754 . . . . 0.0 109.553 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -83.44 104.81 13.88 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.091 0.472 . . . . 0.0 110.095 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' B' ' 204' ' ' CYS . 15.9 pt -137.01 152.21 73.52 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 125.308 1.443 . . . . 0.0 110.057 -174.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.09 163.36 16.93 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.012 2.475 . . . . 0.0 113.339 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.599 ' O ' HG22 ' B' ' 216' ' ' ILE . 5.6 tm-20 -62.64 -39.93 95.42 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -167.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 52.3 m -65.53 -39.87 92.29 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.7 -1.25 . . . . 0.0 110.295 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . 0.414 ' O ' ' HB2' ' B' ' 219' ' ' HIS . 8.0 m80 -68.24 -28.14 66.96 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.815 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.599 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -69.09 -48.41 69.51 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -176.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -67.13 -37.66 84.24 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.472 0.482 . . . . 0.0 111.387 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -42.22 83.53 Favored 'General case' 0 C--O 1.255 1.366 0 O-C-N 123.533 0.521 . . . . 0.0 111.212 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' B' ' 215' ' ' HIS . 0.1 OUTLIER -59.93 -37.52 79.75 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.41 177.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.696 HD11 HG21 ' A' ' 70' ' ' VAL . 96.7 mt -63.03 -45.39 92.49 Favored 'General case' 0 C--O 1.206 -1.218 0 O-C-N 124.014 0.821 . . . . 0.0 110.935 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -56.53 -28.37 59.86 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.445 0.466 . . . . 0.0 111.516 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.8 t -89.21 -41.18 12.37 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.312 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.2 m -79.04 -28.21 43.21 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.959 0.904 . . . . 0.0 112.971 -167.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 49' ' ' GLN . 3.7 pp . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 123.383 0.673 . . . . 0.0 109.3 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 mmt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 88.7 mt-30 -120.1 151.57 38.86 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.854 0.462 . . . . 0.0 111.388 172.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -141.13 159.54 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.223 1.409 . . . . 0.0 109.701 177.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' THR . 86.7 m-85 -107.58 109.8 21.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.032 0.933 . . . . 0.0 109.68 -176.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 30' ' ' ILE . 19.4 t -101.51 111.42 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 tptt -110.93 117.15 32.58 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.511 0.725 . . . . 0.0 109.981 -171.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.606 HG22 HD12 ' A' ' 69' ' ' LEU . 80.4 p -69.51 161.29 29.82 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.165 0.507 . . . . 0.0 111.716 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.49 HD11 HG22 ' A' ' 70' ' ' VAL . 87.0 mt -66.36 -17.54 64.83 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.853 175.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -83.16 -26.88 30.5 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.975 0.51 . . . . 0.0 110.714 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.05 9.59 11.91 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.123 0.409 . . . . 0.0 114.123 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 147.35 35.97 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -108.77 139.35 43.71 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.93 106.54 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.7 m -88.97 120.49 30.43 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -105.45 155.63 18.96 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.95 75.48 1.0 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.489 0.716 . . . . 0.0 109.423 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.821 HG21 HG22 ' A' ' 26' ' ' VAL . 11.3 m -137.96 167.38 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.097 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.423 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 2.4 mt-10 -86.74 155.34 56.09 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.156 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.53 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 13.0 Cg_endo -57.48 -35.58 98.83 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 121.968 1.779 . . . . 0.0 111.198 165.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 t -97.66 19.36 13.68 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.027 0.931 . . . . 0.0 110.875 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 15.8 t70 -77.14 -94.82 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.366 0.666 . . . . 0.0 109.692 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 26' ' ' VAL . 10.1 t 176.23 141.14 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.135 1.374 . . . . 0.0 109.57 172.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.567 HG22 ' HE3' ' A' ' 27' ' ' LYS . 45.1 mm -61.63 -37.69 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.527 1.131 . . . . 0.0 111.571 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -50.09 -44.64 52.07 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.239 1.016 . . . . 0.0 110.686 177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 7.9 t30 -71.78 -43.62 65.39 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.035 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.821 HG22 HG21 ' A' ' 17' ' ' VAL . 60.9 t -54.76 -50.78 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 124.207 0.942 . . . . 0.0 110.953 -177.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HE3' HG22 ' A' ' 23' ' ' ILE . 16.5 ptpt -68.6 -35.56 77.5 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.678 0.391 . . . . 0.0 111.257 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.0 -28.08 68.77 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.118 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 9.5 mmpt? -74.06 -37.42 64.25 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 118.765 -0.635 . . . . 0.0 111.134 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 5' ' ' VAL . 3.5 mp -60.86 -40.4 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-N 118.865 0.757 . . . . 0.0 109.131 173.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.99 -25.65 67.95 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.365 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -81.21 -32.47 33.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.189 0.595 . . . . 0.0 111.117 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.0 mmtt -88.24 -69.06 0.72 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.608 0.363 . . . . 0.0 110.895 -172.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.89 -26.1 34.44 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 120.481 0.181 . . . . 0.0 110.819 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.4 24.15 19.64 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.908 171.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.31 131.71 21.69 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.178 0.591 . . . . 0.0 109.476 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 53.9 Cg_endo -64.74 149.87 89.04 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.34 2.693 . . . . 0.0 113.135 -173.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 37.2 Cg_endo -61.27 -12.26 22.8 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.784 2.989 . . . . 0.0 113.724 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.35 -43.0 61.57 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.424 0.69 . . . . 0.0 110.535 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.5 mp0 -85.11 -28.9 25.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.051 0.94 . . . . 0.0 111.772 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' HB2' HD11 ' A' ' 69' ' ' LEU . 3.5 pp0? -109.0 123.22 48.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.306 0.642 . . . . 0.0 109.921 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.516 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 55.2 ttt180 -112.31 128.02 56.16 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.143 0.977 . . . . 0.0 110.184 -168.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.64 120.03 33.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.311 0.644 . . . . 0.0 110.486 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.2 mt -141.98 135.55 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.417 1.087 . . . . 0.0 109.88 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.515 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 88.3 t80 -131.69 123.46 27.81 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.36 1.064 . . . . 0.0 108.133 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 60.44 20.0 9.68 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.645 0.778 . . . . 0.0 112.608 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.558 ' HA2' HG22 ' B' ' 206' ' ' VAL . . . 101.23 -18.8 53.53 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 114.499 0.559 . . . . 0.0 114.499 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.1 ptpt -86.46 137.64 32.38 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.57 0.685 . . . . 0.0 109.709 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.585 ' HB2' HD22 ' B' ' 224' ' ' LEU . 27.4 tt0 -81.64 135.53 35.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.58 117.16 26.2 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 122.737 0.415 . . . . 0.0 111.298 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.65 138.86 31.85 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.581 1.152 . . . . 0.0 109.639 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.88 -47.55 64.49 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.78 1.232 . . . . 0.0 112.968 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.68 -30.97 78.42 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.905 0.753 . . . . 0.0 113.76 -174.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.488 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 97.2 mtt180 -80.04 177.77 8.7 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.516 0.726 . . . . 0.0 112.037 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -112.51 168.28 9.77 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.785 0.834 . . . . 0.0 109.915 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.6 mt -59.0 -50.48 73.94 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 21.9 m -54.93 -31.13 60.01 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.971 1.309 . . . . 0.0 112.778 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.92 -41.39 91.44 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.201 0.525 . . . . 0.0 109.826 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 34.8 m-85 -86.41 13.02 8.91 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.436 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 70.11 27.79 4.19 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.55 1.14 . . . . 0.0 111.122 178.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 10.4 mt -99.44 144.95 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -135.27 -173.81 3.44 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -62.88 146.81 51.96 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 120.681 0.276 . . . . 0.0 110.637 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 68.57 5.51 4.89 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.268 1.427 . . . . 0.0 112.174 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -71.86 139.01 48.67 Favored 'General case' 0 C--N 1.362 1.126 0 CA-C-N 117.963 0.347 . . . . 0.0 110.118 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 21.4 m -100.52 117.05 33.89 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.515 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -121.6 142.14 50.41 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.183 0.993 . . . . 0.0 109.484 -177.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -77.91 130.01 36.06 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.648 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.606 HD12 HG22 ' A' ' 7' ' ' THR . 2.5 tm? -103.73 129.34 51.08 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.54 HG21 HD11 ' B' ' 220' ' ' LEU . 84.3 t -111.67 121.04 63.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.238 0.615 . . . . 0.0 109.922 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.86 156.84 23.38 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.523 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.406 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 51.6 mtt180 -128.57 -47.24 1.29 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.701 0.8 . . . . 0.0 110.385 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.49 1.57 0 C-N-CA 124.763 1.225 . . . . 0.0 112.433 -178.073 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 57.9 mttm . . . . . 0 C--O 1.239 0.52 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 7.0 m -143.08 179.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.466 1.106 . . . . 0.0 109.595 -169.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.94 142.26 47.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.954 0.502 . . . . 0.0 110.739 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.598 ' HA ' HD11 ' B' ' 216' ' ' ILE . 49.0 t -76.01 104.76 1.67 Allowed Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 124.327 1.051 . . . . 0.0 108.648 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.559 ' HD2' HD21 ' B' ' 220' ' ' LEU . 38.2 Cg_endo -61.79 -12.96 27.79 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.559 2.839 . . . . 0.0 114.808 -168.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . 0.558 HG22 ' HA2' ' A' ' 47' ' ' GLY . 5.6 t -85.8 -61.28 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.133 0.573 . . . . 0.0 110.257 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 21.1 p -99.74 -5.54 28.56 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 112.224 0.454 . . . . 0.0 112.224 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 68.07 45.17 73.95 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 115.023 0.769 . . . . 0.0 115.023 173.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.24 133.44 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 117.342 0.571 . . . . 0.0 110.321 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -81.78 122.52 27.79 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.011 0.524 . . . . 0.0 110.17 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' B' ' 204' ' ' CYS . 3.4 pt -150.23 159.66 34.7 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.757 1.623 . . . . 0.0 108.924 -172.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.35 157.75 43.98 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.199 1.932 . . . . 0.0 112.061 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.573 ' O ' HG22 ' B' ' 216' ' ' ILE . 43.1 tt0 -60.9 -31.35 70.85 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.743 1.217 . . . . 0.0 112.093 -174.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 23.5 p -64.0 -50.95 66.5 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 121.653 0.739 . . . . 0.0 110.277 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -80.15 -10.96 59.79 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.16 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.1 OUTLIER -73.78 -48.36 39.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . 0.523 ' HA ' HD12 ' B' ' 220' ' ' LEU . 52.3 m-80 -63.39 -36.52 83.98 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.407 0.442 . . . . 0.0 110.843 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -57.57 -52.76 64.11 Favored 'General case' 0 C--O 1.254 1.3 0 O-C-N 123.96 0.788 . . . . 0.0 111.212 172.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -30.66 70.68 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.731 -176.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.559 HD21 ' HD2' ' B' ' 205' ' ' PRO . 96.3 mt -64.52 -50.48 67.21 Favored 'General case' 0 C--O 1.206 -1.186 0 O-C-N 123.887 0.742 . . . . 0.0 111.181 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -57.38 -27.79 62.63 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 123.87 0.731 . . . . 0.0 111.69 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.1 t -80.03 -45.74 17.83 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.552 173.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 67.0 m -81.12 -22.94 38.71 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.626 1.17 . . . . 0.0 113.811 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.2 pp . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 120.851 0.358 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 21.6 mp0 -98.52 152.85 19.11 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.497 0.319 . . . . 0.0 110.512 173.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.18 150.6 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.345 1.058 . . . . 0.0 108.728 171.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.0 101.75 11.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.4 0.68 . . . . 0.0 109.787 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 69' ' ' LEU . 88.4 t -98.76 103.16 14.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -101.39 124.93 47.87 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.439 0.696 . . . . 0.0 110.901 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.734 HG22 HD12 ' A' ' 69' ' ' LEU . 60.2 p -65.53 157.74 28.86 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.316 0.647 . . . . 0.0 111.765 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.527 HD11 HG22 ' A' ' 70' ' ' VAL . 81.0 mt -66.47 -17.78 64.99 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.686 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -79.63 -11.31 59.87 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.342 0.657 . . . . 0.0 110.928 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.49 7.34 39.94 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 123.25 0.452 . . . . 0.0 113.863 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.43 143.02 26.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.626 0.77 . . . . 0.0 109.193 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 m -103.51 141.19 36.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.857 0.463 . . . . 0.0 110.684 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.81 113.27 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.431 1.092 . . . . 0.0 108.504 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.3 m -91.57 120.34 32.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.922 0.489 . . . . 0.0 109.716 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -106.19 163.9 12.43 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.018 0.927 . . . . 0.0 109.261 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -130.82 82.47 2.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.376 0.67 . . . . 0.0 109.562 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.803 HG21 HG22 ' A' ' 26' ' ' VAL . 16.7 m -140.9 172.03 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.242 1.017 . . . . 0.0 109.085 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -86.02 150.71 53.24 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.742 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -60.79 -25.14 80.59 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.998 1.799 . . . . 0.0 111.332 166.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 t -95.12 5.65 51.24 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.038 0.935 . . . . 0.0 111.449 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.01 -96.62 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.139 0.576 . . . . 0.0 110.123 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 26' ' ' VAL . 11.1 t 177.85 146.13 0.13 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.676 1.191 . . . . 0.0 109.31 172.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -62.63 -36.26 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.598 1.159 . . . . 0.0 111.56 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.31 -36.51 71.17 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.712 0.767 . . . . 0.0 110.878 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.0 t-20 -76.07 -42.02 48.71 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.341 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.803 HG22 HG21 ' A' ' 17' ' ' VAL . 58.4 t -55.75 -48.16 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 124.342 1.026 . . . . 0.0 110.371 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.9 ptpt -69.93 -35.15 74.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.977 0.511 . . . . 0.0 110.945 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.05 -36.03 70.01 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.613 0.365 . . . . 0.0 110.921 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 74.0 mmtt -69.58 -33.92 73.41 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 118.59 -0.719 . . . . 0.0 112.394 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.7 mp -60.0 -41.22 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 119.404 1.002 . . . . 0.0 109.662 172.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -67.98 -24.71 65.18 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.526 0.731 . . . . 0.0 111.311 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -77.7 -30.26 51.77 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.849 0.859 . . . . 0.0 111.021 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.5 mmtt -94.58 -67.63 0.84 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.828 0.451 . . . . 0.0 111.093 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -84.41 -26.62 28.19 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.201 0.2 . . . . 0.0 111.115 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.75 23.68 22.68 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 116.547 -0.297 . . . . 0.0 112.851 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.79 129.04 25.59 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 73.9 Cg_endo -68.39 155.24 69.88 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.166 2.577 . . . . 0.0 112.766 -174.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 38.3 Cg_endo -61.16 -16.21 44.73 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.675 2.917 . . . . 0.0 114.082 -176.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.0 -24.71 43.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.829 0.852 . . . . 0.0 110.664 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.453 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.7 mp0 -99.9 -31.69 11.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.218 1.007 . . . . 0.0 111.954 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.521 ' HB2' HD21 ' A' ' 69' ' ' LEU . 3.1 pp0? -103.94 123.8 47.82 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.236 0.541 . . . . 0.0 110.419 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.701 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 67.2 ttt180 -115.06 128.58 56.33 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.393 1.077 . . . . 0.0 109.86 -169.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.6 mm? -94.16 121.18 35.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.552 0.741 . . . . 0.0 110.577 -171.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.0 mt -142.62 125.96 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.023 0.929 . . . . 0.0 109.988 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.633 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 85.0 t80 -121.73 122.72 40.18 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.47 1.108 . . . . 0.0 108.962 177.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.66 22.84 10.35 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.699 0.8 . . . . 0.0 112.754 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.17 -13.02 60.4 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.343 0.497 . . . . 0.0 114.343 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.9 ptpt -93.34 133.1 36.93 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.623 0.711 . . . . 0.0 109.298 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -76.08 136.81 39.89 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 43' ' ' LEU . 22.7 mt -92.34 119.39 31.86 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 121.117 0.484 . . . . 0.0 111.164 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.441 ' H ' ' HE2' ' A' ' 59' ' ' TYR . 36.0 tt0 -86.87 139.46 30.63 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.252 1.421 . . . . 0.0 110.892 -176.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.84 -45.37 82.43 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.802 1.241 . . . . 0.0 112.838 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.82 -27.03 73.69 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 124.072 0.857 . . . . 0.0 113.481 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 78.2 mtt180 -80.84 177.59 8.94 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.826 0.851 . . . . 0.0 111.93 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.7 p -113.99 167.83 10.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.817 0.847 . . . . 0.0 110.159 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 93.7 mt -56.72 -52.33 65.37 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.615 173.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.4 t -63.9 -22.78 67.08 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.283 1.033 . . . . 0.0 111.543 -176.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.03 -42.63 89.35 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.46 0.647 . . . . 0.0 109.488 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.441 ' HE2' ' H ' ' A' ' 51' ' ' GLU . 30.0 m-85 -89.25 15.64 8.65 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.887 -1.052 . . . . 0.0 112.147 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.474 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.7 OUTLIER 73.49 14.08 4.41 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.027 1.331 . . . . 0.0 112.175 175.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 7.9 mt -84.29 137.79 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -130.7 -173.93 3.22 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -56.53 141.24 43.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 122.866 0.466 . . . . 0.0 111.364 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 67.3 5.83 4.47 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.591 1.556 . . . . 0.0 113.268 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.3 m -70.48 133.19 46.59 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 118.204 0.457 . . . . 0.0 110.708 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.8 m -97.16 121.22 38.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.35 0.66 . . . . 0.0 109.278 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.633 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -123.24 175.05 6.9 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.897 1.279 . . . . 0.0 109.424 176.137 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -105.61 149.29 26.44 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.667 0.787 . . . . 0.0 110.665 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.734 HD12 HG22 ' A' ' 7' ' ' THR . 3.0 tm? -127.82 122.23 32.15 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.701 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 60.3 t -101.02 112.82 35.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 123.384 0.674 . . . . 0.0 109.779 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.85 145.89 36.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.728 173.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 67.2 mtp85 -122.25 -28.15 4.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.666 0.786 . . . . 0.0 111.124 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 N--CA 1.493 1.71 0 C-N-CA 124.532 1.133 . . . . 0.0 113.235 176.918 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.0 m -144.93 -177.41 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.833 1.253 . . . . 0.0 109.536 -169.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -112.86 147.34 37.21 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.679 0.391 . . . . 0.0 110.971 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.579 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.4 t -87.31 101.95 2.78 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 124.379 1.072 . . . . 0.0 108.692 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.562 ' HD2' HD21 ' B' ' 220' ' ' LEU . 55.2 Cg_endo -65.55 2.71 1.43 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.272 2.648 . . . . 0.0 115.335 -172.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.13 -51.8 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.691 0.396 . . . . 0.0 110.901 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 14.6 p -114.59 9.0 16.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 58.56 42.17 95.91 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 115.907 1.123 . . . . 0.0 115.907 169.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.1 141.26 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 117.331 0.566 . . . . 0.0 110.644 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -88.17 112.55 22.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.006 0.522 . . . . 0.0 110.078 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.9 pt -141.66 156.26 66.33 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.489 1.515 . . . . 0.0 109.641 -173.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.75 162.6 33.93 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.704 2.269 . . . . 0.0 111.965 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.548 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.9 tm-20 -66.69 -38.69 87.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.979 0.911 . . . . 0.0 112.934 -166.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 43.1 t -56.39 -44.97 80.75 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.762 0.791 . . . . 0.0 109.868 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -80.33 -16.22 55.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.935 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.579 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.21 -50.34 32.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . 0.418 ' HA ' HD12 ' B' ' 220' ' ' LEU . 44.9 m-80 -67.14 -36.91 82.88 Favored 'General case' 0 C--N 1.347 0.461 0 O-C-N 123.645 0.591 . . . . 0.0 111.075 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -60.82 -46.99 88.37 Favored 'General case' 0 C--O 1.253 1.266 0 O-C-N 123.675 0.609 . . . . 0.0 110.905 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -40.32 82.62 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.167 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.562 HD21 ' HD2' ' B' ' 205' ' ' PRO . 96.0 mt -60.75 -49.71 76.4 Favored 'General case' 0 C--O 1.211 -0.948 0 O-C-N 123.958 0.786 . . . . 0.0 111.584 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.65 -24.5 67.81 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 123.93 0.769 . . . . 0.0 112.072 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 30.1 t -81.89 -41.8 20.44 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.16 0.505 . . . . 0.0 110.564 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 94.2 m -81.49 -27.45 34.54 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.292 1.037 . . . . 0.0 113.179 -167.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.486 1.35 0 C-N-CA 123.032 0.533 . . . . 0.0 110.828 -173.187 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.998 0.428 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -106.5 144.74 32.74 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.621 0.368 . . . . 0.0 111.237 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.4 HD13 ' N ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -137.75 157.65 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.991 1.316 . . . . 0.0 108.964 175.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 66' ' ' THR . 72.2 m-85 -110.84 101.33 9.94 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.493 0.717 . . . . 0.0 110.026 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 69' ' ' LEU . 74.6 t -97.44 106.77 19.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -107.11 129.13 54.87 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.325 0.65 . . . . 0.0 110.499 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.704 HG22 HD12 ' A' ' 69' ' ' LEU . 71.8 p -72.25 165.28 24.75 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.362 0.601 . . . . 0.0 111.841 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.504 HD11 HG22 ' A' ' 70' ' ' VAL . 70.0 mt -67.17 -25.79 66.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.924 172.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -78.09 -14.14 59.6 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.34 0.656 . . . . 0.0 110.553 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.99 14.47 39.49 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 114.884 0.714 . . . . 0.0 114.884 165.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.31 151.65 24.62 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 m -107.61 132.0 53.77 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.95 112.44 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 m -92.16 116.09 28.65 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.424 0.69 . . . . 0.0 109.424 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.5 mm? -104.79 157.19 17.37 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.635 0.774 . . . . 0.0 109.483 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.09 86.76 2.63 Favored 'General case' 0 C--O 1.244 0.784 0 O-C-N 124.248 0.968 . . . . 0.0 108.436 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.792 HG21 HG22 ' A' ' 26' ' ' VAL . 13.7 m -140.71 176.65 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 124.374 1.07 . . . . 0.0 108.345 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -92.72 148.68 36.55 Favored Pre-proline 0 N--CA 1.475 0.782 0 O-C-N 121.69 -0.631 . . . . 0.0 109.379 172.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 19.5 Cg_endo -58.45 -28.32 84.88 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.171 1.914 . . . . 0.0 111.71 169.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.7 t -101.93 16.09 27.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.909 0.484 . . . . 0.0 110.979 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.98 -92.08 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -178.85 145.61 0.29 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.503 1.121 . . . . 0.0 109.825 173.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.54 -37.81 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.451 1.1 . . . . 0.0 111.359 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -58.55 -35.17 71.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.397 0.679 . . . . 0.0 110.807 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 16.2 t-20 -72.39 -44.95 61.78 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.331 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.792 HG22 HG21 ' A' ' 17' ' ' VAL . 45.3 t -54.2 -50.32 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 124.372 1.045 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.2 ptpt -68.94 -31.35 70.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.075 0.55 . . . . 0.0 111.802 -175.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.31 -39.61 79.86 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.978 0.418 . . . . 0.0 110.662 170.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 35.6 mmtm -68.88 -36.83 78.55 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.531 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.9 mp -59.13 -41.78 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 119.473 1.033 . . . . 0.0 110.17 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -62.97 -33.15 74.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.56 -26.01 57.59 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.278 0.631 . . . . 0.0 111.319 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.8 mmtt -94.5 -66.38 0.92 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.866 0.466 . . . . 0.0 110.889 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.89 -16.01 32.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.74 20.24 51.44 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 170.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.67 127.83 27.71 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 43.2 Cg_endo -63.31 152.01 82.04 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.244 2.629 . . . . 0.0 112.989 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 43.6 Cg_endo -61.83 -17.14 53.56 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.983 3.122 . . . . 0.0 113.932 -174.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.22 -37.66 63.78 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.832 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HG3' ' H ' ' A' ' 73' ' ' LEU . 2.6 mp0 -89.29 -32.2 17.48 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.276 1.03 . . . . 0.0 112.091 -174.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.538 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 3.0 pp0? -99.77 128.95 45.84 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 55.7 ttt180 -117.18 128.88 55.55 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.4 1.08 . . . . 0.0 109.174 -168.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.48 125.42 38.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 109.892 -172.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -142.22 133.96 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.087 0.955 . . . . 0.0 110.135 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.602 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 79.0 t80 -132.87 129.52 38.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 172.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.48 19.33 11.77 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.985 0.914 . . . . 0.0 113.073 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.33 17.07 54.24 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 114.282 0.473 . . . . 0.0 114.282 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 4.0 ptpt -130.01 148.64 51.89 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.731 0.766 . . . . 0.0 109.982 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -74.11 140.57 45.36 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.779 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 45' ' ' PHE . 24.7 mt -88.64 119.22 28.91 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.015 0.526 . . . . 0.0 109.76 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.05 138.77 38.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.689 0.796 . . . . 0.0 109.989 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.88 -40.93 85.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.002 0.921 . . . . 0.0 111.616 -173.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.04 -23.95 77.59 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.256 0.972 . . . . 0.0 113.923 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.408 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 61.6 mtt180 -80.3 177.48 8.94 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.485 0.714 . . . . 0.0 112.268 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.1 p -113.21 168.46 9.71 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.774 0.829 . . . . 0.0 109.795 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 92.0 mt -59.56 -50.09 75.26 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 t -59.72 -26.71 65.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.927 1.291 . . . . 0.0 111.317 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 14.8 t70 -64.7 -43.16 94.37 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.224 0.61 . . . . 0.0 109.968 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.81 19.51 4.01 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.769 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 69.54 18.66 7.7 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.353 1.061 . . . . 0.0 111.744 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.44 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 14.5 mt -91.88 117.45 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -102.82 -178.29 3.63 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -61.67 142.97 56.85 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.137 170.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 74.2 3.31 4.35 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.612 1.565 . . . . 0.0 112.126 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -71.94 134.32 45.91 Favored 'General case' 0 C--N 1.363 1.155 0 CA-C-N 118.322 0.51 . . . . 0.0 110.513 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 52.3 m -95.13 126.27 40.35 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.602 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -128.26 174.41 9.31 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.528 1.131 . . . . 0.0 109.313 177.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -100.02 149.6 23.31 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.177 0.591 . . . . 0.0 111.629 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.704 HD12 HG22 ' A' ' 7' ' ' THR . 2.9 tm? -129.61 130.44 45.65 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.536 HG21 HD11 ' B' ' 220' ' ' LEU . 64.8 t -114.11 128.68 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 123.406 0.682 . . . . 0.0 110.153 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.631 ' HB3' HD23 ' A' ' 73' ' ' LEU . 77.6 mt -89.94 149.17 22.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.619 0.768 . . . . 0.0 110.793 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -118.99 -59.9 1.81 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.843 0.857 . . . . 0.0 109.298 172.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 71' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.494 1.727 0 C-N-CA 124.343 1.057 . . . . 0.0 111.384 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.0 m -142.73 -176.46 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.869 0.868 . . . . 0.0 110.751 -168.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.84 147.76 43.6 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.682 0.793 . . . . 0.0 110.225 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.596 ' HA ' HD11 ' B' ' 216' ' ' ILE . 46.2 t -89.63 101.56 3.42 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.095 0.958 . . . . 0.0 108.635 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.639 ' HD2' HD21 ' B' ' 220' ' ' LEU . 89.3 Cg_exo -49.09 -27.52 12.39 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 124.277 3.318 . . . . 0.0 115.006 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . 0.406 HG11 ' O ' ' B' ' 223' ' ' CYS . 6.3 t -80.66 -64.5 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.381 -173.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 18.1 p -96.56 1.04 50.93 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.73 45.46 95.7 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 115.061 0.784 . . . . 0.0 115.061 171.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.71 138.11 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.052 0.541 . . . . 0.0 110.223 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -87.54 117.47 26.36 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.479 HD11 ' HB2' ' B' ' 204' ' ' CYS . 7.4 pt -145.59 162.17 37.65 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.157 1.383 . . . . 0.0 110.17 -170.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.35 162.43 33.57 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.64 2.227 . . . . 0.0 112.98 174.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.616 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.9 tt0 -65.07 -39.45 93.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.61 1.164 . . . . 0.0 113.665 -169.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 14.9 m -65.76 -43.44 88.89 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.361 -0.837 . . . . 0.0 109.901 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -75.6 -18.58 59.67 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.831 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.616 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -71.21 -47.62 59.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -68.43 -36.12 78.6 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.313 0.383 . . . . 0.0 111.859 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -63.34 -44.56 94.52 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.157 0.286 . . . . 0.0 110.353 172.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -43.48 86.66 Favored 'General case' 0 C--O 1.211 -0.963 0 O-C-N 123.836 0.71 . . . . 0.0 109.841 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.639 HD21 ' HD2' ' B' ' 205' ' ' PRO . 93.0 mt -60.69 -46.5 90.14 Favored 'General case' 0 C--O 1.21 -1.02 0 O-C-N 124.059 0.849 . . . . 0.0 110.876 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -60.25 -31.22 70.0 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.842 1.339 . . . . 0.0 110.464 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 t -86.49 -37.43 18.26 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.127 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . 0.406 ' O ' HG11 ' B' ' 206' ' ' VAL . 88.2 m -79.51 -22.15 44.34 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.002 0.921 . . . . 0.0 112.282 -171.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 123.026 0.53 . . . . 0.0 110.462 -176.668 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 21.9 mp0 -108.85 142.13 39.88 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.926 -0.484 . . . . 0.0 111.212 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.01 159.44 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.735 1.214 . . . . 0.0 108.874 174.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 66' ' ' THR . 94.0 m-85 -109.36 105.92 15.5 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.443 0.697 . . . . 0.0 109.953 -175.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 69' ' ' LEU . 2.6 t -95.59 114.88 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -102.3 113.1 26.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.668 0.787 . . . . 0.0 109.326 -174.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.66 HG22 HD12 ' A' ' 69' ' ' LEU . 23.5 p -68.91 157.93 35.62 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.849 0.356 . . . . 0.0 110.4 174.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.423 HD11 HG22 ' A' ' 70' ' ' VAL . 96.2 mt -58.73 -25.2 62.71 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.941 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.3 p -79.08 3.05 18.59 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.562 0.745 . . . . 0.0 111.799 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 12.39 74.84 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 116.42 -0.355 . . . . 0.0 113.124 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -95.54 147.73 23.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.014 0.926 . . . . 0.0 110.207 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 m -108.02 140.98 40.38 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.561 0.744 . . . . 0.0 109.75 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -125.7 115.6 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.683 1.193 . . . . 0.0 107.978 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 m -92.1 117.64 30.05 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -104.04 156.18 18.07 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -123.85 82.45 2.02 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.906 0.753 . . . . 0.0 109.155 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.75 HG21 HG22 ' A' ' 26' ' ' VAL . 9.6 m -139.63 178.96 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 124.773 1.229 . . . . 0.0 107.969 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 10.1 mt-10 -96.29 152.82 39.0 Favored Pre-proline 0 N--CA 1.482 1.166 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.483 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.8 Cg_endo -61.63 -30.61 85.9 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.098 1.865 . . . . 0.0 111.168 171.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t -102.5 18.97 19.87 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.057 0.543 . . . . 0.0 110.026 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 16.1 t70 -81.04 -88.5 0.08 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.128 0.571 . . . . 0.0 109.49 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 26' ' ' VAL . 7.1 t 177.37 147.53 0.13 Allowed 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.539 1.136 . . . . 0.0 110.183 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -66.03 -34.39 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.251 1.02 . . . . 0.0 111.031 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 36.2 tt0 -62.59 -31.45 72.28 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.311 0.576 . . . . 0.0 110.858 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 12.7 t-20 -75.17 -42.07 56.69 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.862 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.75 HG22 HG21 ' A' ' 17' ' ' VAL . 59.0 t -55.57 -46.93 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 124.283 0.989 . . . . 0.0 110.3 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HA ' HD13 ' A' ' 30' ' ' ILE . 17.9 ptpt -71.22 -29.36 65.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.266 0.626 . . . . 0.0 111.592 -176.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -33.29 75.68 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.519 169.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 68.1 mmtt -75.62 -27.56 58.49 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.229 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.9 mp -58.14 -45.66 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 119.348 0.976 . . . . 0.0 109.281 166.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.2 tt0 -67.21 -20.81 65.75 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.579 177.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 23.0 t70 -81.42 -37.0 28.79 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.742 0.817 . . . . 0.0 111.369 174.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.8 mmtt -91.78 -61.92 1.53 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.794 0.437 . . . . 0.0 111.024 -170.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -92.55 -25.12 18.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.422 0.289 . . . . 0.0 111.184 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 97.2 13.83 44.14 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 116.546 -0.297 . . . . 0.0 113.83 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.87 125.88 55.57 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -63.55 152.59 79.52 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.745 2.297 . . . . 0.0 112.097 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -62.01 -16.47 50.2 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.469 2.78 . . . . 0.0 113.694 -173.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -75.4 -42.58 53.4 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.249 0.62 . . . . 0.0 110.616 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -81.74 -22.04 37.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.158 0.983 . . . . 0.0 112.52 -173.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -102.39 148.01 26.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.428 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.576 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 52.2 ttt180 -132.31 129.73 39.89 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.426 0.69 . . . . 0.0 109.556 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.64 125.69 37.38 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.373 0.669 . . . . 0.0 109.303 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.9 mt -142.6 130.99 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.158 0.983 . . . . 0.0 109.749 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.476 ' HB3' HD21 ' A' ' 50' ' ' LEU . 92.5 t80 -129.84 124.12 32.52 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.13 19.85 11.87 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.31 1.044 . . . . 0.0 112.651 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.78 -12.09 60.98 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-O 120.005 -0.33 . . . . 0.0 113.891 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.8 ptpt -99.87 142.28 31.56 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -75.4 140.82 43.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.352 0.261 . . . . 0.0 110.34 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.6 mt -88.15 134.05 33.86 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.137 0.575 . . . . 0.0 109.905 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.529 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 27.8 tt0 -85.16 137.37 33.06 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 9.2 p-10 -61.46 -33.49 73.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.112 0.965 . . . . 0.0 111.892 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.529 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -72.82 -29.5 65.13 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.856 0.723 . . . . 0.0 113.409 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -80.04 177.18 9.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.381 0.672 . . . . 0.0 111.548 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -111.06 167.46 10.24 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.738 0.815 . . . . 0.0 110.254 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 90.4 mt -56.22 -49.82 73.02 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.924 0.765 . . . . 0.0 109.135 172.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -61.3 -27.56 68.56 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.896 1.278 . . . . 0.0 111.572 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.85 -39.2 83.82 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -91.99 20.65 5.6 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.367 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 65.74 25.96 11.39 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.512 1.125 . . . . 0.0 112.194 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.88 118.27 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -106.84 -175.09 2.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -56.38 138.21 51.42 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.381 171.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 71.34 9.67 6.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.211 1.404 . . . . 0.0 112.501 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.1 m -78.57 138.55 38.42 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.147 0.43 . . . . 0.0 110.604 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 46.8 m -95.49 130.37 42.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.23 0.612 . . . . 0.0 109.928 175.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.66 159.32 37.57 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.781 1.232 . . . . 0.0 108.66 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -87.33 152.61 22.13 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.451 0.643 . . . . 0.0 111.299 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.66 HD12 HG22 ' A' ' 7' ' ' THR . 2.8 tm? -134.89 131.53 37.43 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 73.8 t -110.23 113.7 44.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.029 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.38 152.48 32.24 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.993 174.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.434 ' HA ' ' HG2' ' B' ' 213' ' ' GLU . 53.7 mtp180 -129.79 -40.17 1.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.026 0.93 . . . . 0.0 109.883 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 125.035 1.334 . . . . 0.0 112.914 177.71 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.8 m -143.1 163.52 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.375 1.07 . . . . 0.0 110.736 -167.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -96.29 147.34 23.89 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.808 0.843 . . . . 0.0 111.409 -172.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.614 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.5 t -88.2 103.92 6.02 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.553 ' HD2' HD21 ' B' ' 220' ' ' LEU . 36.2 Cg_endo -60.52 -12.54 21.26 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.478 2.785 . . . . 0.0 114.816 -168.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 t -88.47 -54.27 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.032 0.533 . . . . 0.0 110.755 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 15.8 p -108.48 1.74 21.79 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -174.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 63.01 46.58 93.22 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 115.632 1.013 . . . . 0.0 115.632 170.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.5 m -119.0 132.84 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.265 0.626 . . . . 0.0 110.764 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -84.76 119.23 25.05 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 5.2 pt -142.91 161.06 50.68 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.71 1.604 . . . . 0.0 108.875 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.46 153.08 56.82 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.229 1.953 . . . . 0.0 112.249 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.565 ' O ' HG22 ' B' ' 216' ' ' ILE . 33.5 tt0 -64.79 -32.64 74.43 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.384 1.474 . . . . 0.0 113.156 -168.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 38.6 t -64.33 -44.3 91.94 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.661 0.743 . . . . 0.0 109.924 172.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -77.0 -19.34 57.4 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.374 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -71.1 -46.5 66.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -60.68 -45.18 95.13 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.477 0.486 . . . . 0.0 110.121 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -56.62 -46.64 80.83 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 124.373 1.046 . . . . 0.0 111.945 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -36.91 81.21 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.246 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 70' ' ' VAL . 93.4 mt -63.58 -46.48 85.64 Favored 'General case' 0 C--O 1.21 -0.986 0 O-C-N 124.186 0.929 . . . . 0.0 111.481 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -54.22 -34.13 59.93 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.251 0.97 . . . . 0.0 111.009 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 34.5 t -82.91 -39.52 21.4 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.268 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 81.3 m -80.05 -18.0 51.24 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.12 0.968 . . . . 0.0 112.612 -170.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 122.857 0.463 . . . . 0.0 110.499 -179.831 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 121.045 0.45 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 93.0 mt-30 -103.47 122.65 45.34 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.626 0.77 . . . . 0.0 109.972 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.555 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -125.39 152.13 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.732 1.213 . . . . 0.0 108.559 177.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.7 m-85 -111.9 113.11 25.23 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.563 0.697 . . . . 0.0 110.204 -170.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.9 t -105.84 119.74 55.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -111.76 119.12 37.55 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.622 0.769 . . . . 0.0 109.535 -174.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.61 HG22 HD12 ' A' ' 69' ' ' LEU . 68.1 p -70.58 167.11 19.21 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.212 0.53 . . . . 0.0 111.628 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.527 HD11 HG22 ' A' ' 70' ' ' VAL . 84.0 mt -73.33 -19.35 61.04 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.936 173.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.1 p -79.05 -12.99 60.03 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.132 0.573 . . . . 0.0 110.39 171.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 26.29 19.79 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.712 -0.677 . . . . 0.0 114.144 169.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.4 152.57 18.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.6 m -97.72 141.11 31.14 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.893 0.477 . . . . 0.0 110.492 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.484 HD11 HG23 ' A' ' 7' ' ' THR . 5.2 mp -127.68 109.82 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.902 1.281 . . . . 0.0 107.68 174.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.1 m -91.5 123.58 35.02 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.7 mm? -106.97 156.02 19.16 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.172 0.589 . . . . 0.0 109.617 -177.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -118.96 76.88 1.14 Allowed 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.371 1.044 . . . . 0.0 109.301 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.707 HG21 HG22 ' A' ' 26' ' ' VAL . 28.9 m -147.43 173.14 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 123.733 0.813 . . . . 0.0 110.236 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.503 ' O ' HD12 ' A' ' 56' ' ' LEU . 9.6 mt-10 -95.72 160.02 31.2 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.139 0.576 . . . . 0.0 109.864 -169.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.91 -17.05 55.01 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 121.758 1.638 . . . . 0.0 111.89 169.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 t -103.41 3.11 34.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.45 157.91 28.81 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 168.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.3 t -102.04 150.23 23.44 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.291 -165.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.1 -36.26 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.624 0.77 . . . . 0.0 112.156 -171.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.03 -34.63 75.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.455 0.645 . . . . 0.0 110.934 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.423 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.2 t30 -73.36 -45.17 56.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.866 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.707 HG22 HG21 ' A' ' 17' ' ' VAL . 65.7 t -55.93 -43.68 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 124.144 0.978 . . . . 0.0 111.361 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -71.74 -33.17 68.47 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.867 0.467 . . . . 0.0 111.473 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.91 68.96 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.143 169.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 10.3 mmpt? -76.51 -32.57 58.36 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.188 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.25 -42.93 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 118.404 0.547 . . . . 0.0 110.057 170.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.31 -35.38 78.86 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.154 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.72 -24.66 63.59 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.961 0.904 . . . . 0.0 111.689 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 72.1 mmtt -101.03 -69.51 0.77 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.01 -19.47 31.97 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.665 0.211 . . . . 0.0 111.44 -175.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.95 17.76 46.44 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.028 0.205 . . . . 0.0 113.062 173.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.62 125.86 34.64 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 123.394 0.678 . . . . 0.0 109.567 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -71.82 159.1 51.52 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.102 2.535 . . . . 0.0 112.095 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 29.3 Cg_endo -58.84 -15.26 25.93 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.549 2.832 . . . . 0.0 113.689 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.58 -44.71 70.23 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.366 1.066 . . . . 0.0 110.653 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.81 -33.2 19.95 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.817 0.847 . . . . 0.0 111.963 -175.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -94.2 150.39 20.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.648 0.379 . . . . 0.0 110.408 -179.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.585 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 44.9 ttt180 -140.17 129.98 24.55 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.233 0.613 . . . . 0.0 109.666 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.6 mm? -93.45 123.02 36.47 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.522 0.729 . . . . 0.0 109.721 -173.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -141.73 121.73 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.071 0.948 . . . . 0.0 109.716 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.622 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 91.1 t80 -119.51 121.32 39.13 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 66.27 17.88 10.8 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.263 1.025 . . . . 0.0 113.5 173.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.95 14.05 47.45 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 113.983 0.353 . . . . 0.0 113.983 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 1.6 ptpt -124.27 139.24 54.11 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' NE2' ' HE ' ' A' ' 42' ' ' ARG . 63.7 tt0 -74.79 132.08 41.29 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 45' ' ' PHE . 32.0 mt -78.37 118.77 20.86 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.036 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.78 138.46 42.66 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.992 0.917 . . . . 0.0 110.357 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.15 -44.81 83.79 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.886 1.275 . . . . 0.0 112.116 -172.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 -28.22 73.5 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 124.574 1.171 . . . . 0.0 113.747 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -77.65 175.23 10.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.087 0.555 . . . . 0.0 111.813 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 26.2 p -115.85 165.26 13.28 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.486 0.715 . . . . 0.0 109.746 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 18' ' ' GLU . 83.8 mt -55.51 -56.29 21.96 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 123.635 0.584 . . . . 0.0 110.495 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 t -61.91 -22.16 65.34 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.122 0.969 . . . . 0.0 112.057 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.1 -39.25 79.09 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.763 0.425 . . . . 0.0 110.096 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -87.26 13.53 9.5 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.342 172.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 67.63 25.45 8.22 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.912 1.285 . . . . 0.0 111.691 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 mt -91.12 112.96 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.408 1.083 . . . . 0.0 108.472 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -101.45 -172.76 2.21 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -61.65 140.28 58.18 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 70.65 3.22 4.45 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.809 1.244 . . . . 0.0 113.306 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -64.74 130.23 42.77 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 20.6 m -99.68 131.23 45.8 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.763 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.622 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -134.19 174.18 10.79 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.07 0.948 . . . . 0.0 110.107 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -98.55 148.21 24.0 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.332 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -127.32 130.63 49.85 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 67.1 t -108.68 111.55 36.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.21 0.604 . . . . 0.0 109.833 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.2 mt -79.2 149.75 31.85 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 124.191 0.932 . . . . 0.0 109.011 171.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -118.98 -39.43 2.94 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.445 0.698 . . . . 0.0 110.72 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.485 1.298 0 C-N-CA 124.645 1.178 . . . . 0.0 111.89 -178.012 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 m -144.46 -178.04 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.382 1.073 . . . . 0.0 110.072 -165.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -113.57 148.06 36.84 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.219 0.608 . . . . 0.0 110.314 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.627 ' HA ' HD11 ' B' ' 216' ' ' ILE . 46.2 t -85.4 100.81 1.35 Allowed Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.079 0.952 . . . . 0.0 109.501 176.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.58 ' HD2' HD21 ' B' ' 220' ' ' LEU . 65.3 Cg_endo -68.0 8.29 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.392 2.728 . . . . 0.0 115.361 -168.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.07 -50.63 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 122.971 0.509 . . . . 0.0 110.716 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.9 p -114.03 -4.61 13.17 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 122.746 0.418 . . . . 0.0 111.945 -172.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.36 58.25 14.95 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 124.288 0.947 . . . . 0.0 114.956 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.07 129.83 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.201 0.601 . . . . 0.0 109.57 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -82.59 115.42 21.55 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.8 pt -143.95 160.77 48.61 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.491 1.516 . . . . 0.0 109.746 -170.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' B' ' 215' ' ' HIS . 28.4 Cg_endo -60.92 155.92 46.92 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.704 2.27 . . . . 0.0 112.199 172.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.516 ' O ' HG22 ' B' ' 216' ' ' ILE . 35.7 tt0 -68.51 -28.32 66.9 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.69 1.196 . . . . 0.0 113.466 -170.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 40.9 t -65.78 -44.22 86.42 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.657 0.741 . . . . 0.0 109.724 171.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . 0.401 ' HB2' ' HG2' ' B' ' 212' ' ' PRO . 70.6 m-70 -80.35 -16.51 54.38 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.046 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -72.55 -44.5 61.06 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 175.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -54.38 -54.47 40.15 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.023 0.827 . . . . 0.0 109.999 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -57.24 -44.84 84.19 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 124.48 1.113 . . . . 0.0 112.558 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -33.93 74.87 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.105 -177.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.58 HD21 ' HD2' ' B' ' 205' ' ' PRO . 78.8 mt -68.49 -42.95 77.9 Favored 'General case' 0 C--O 1.212 -0.901 0 O-C-N 123.557 0.536 . . . . 0.0 111.521 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -57.58 -28.4 63.56 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 124.027 0.829 . . . . 0.0 111.259 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 43.4 t -86.38 -42.27 13.8 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.692 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.9 m -80.7 -26.54 37.42 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -167.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.489 1.519 0 C-N-CA 123.053 0.541 . . . . 0.0 110.222 -175.313 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 65.8 mt-30 -111.13 147.72 34.27 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.273 0.629 . . . . 0.0 110.641 176.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.506 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -138.93 155.29 26.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 125.396 1.478 . . . . 0.0 107.841 174.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 66' ' ' THR . 89.8 m-85 -112.34 116.78 30.9 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.734 -174.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 55.6 t -105.32 131.96 53.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tpmt? -123.26 124.57 43.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.242 0.617 . . . . 0.0 109.972 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.657 HG22 HD12 ' A' ' 69' ' ' LEU . 42.8 p -73.27 169.49 16.99 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.259 0.552 . . . . 0.0 111.495 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.4 mt -65.59 -26.41 67.84 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.036 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.9 p -80.55 -15.9 55.53 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.637 0.775 . . . . 0.0 111.189 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.23 11.64 38.59 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 114.781 0.673 . . . . 0.0 114.781 167.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 152.27 31.25 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.743 0.771 . . . . 0.0 109.609 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.4 m -95.26 141.78 28.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.177 0.591 . . . . 0.0 109.693 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.55 HD11 HG23 ' A' ' 7' ' ' THR . 4.4 mp -132.37 100.9 4.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.7 m -95.06 121.36 36.61 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -105.65 152.77 22.71 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -117.45 82.73 1.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.752 HG21 HG22 ' A' ' 26' ' ' VAL . 24.6 m -141.74 177.32 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.72 1.208 . . . . 0.0 108.509 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -92.61 153.42 42.44 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.55 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 24.0 Cg_endo -61.98 -28.61 80.88 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.829 1.686 . . . . 0.0 110.742 164.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -94.13 13.54 22.82 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.019 0.928 . . . . 0.0 111.24 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.71 -99.19 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.163 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.0 t 171.86 140.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.967 1.307 . . . . 0.0 109.324 177.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.415 HD12 HD13 ' A' ' 50' ' ' LEU . 39.9 mm -60.54 -36.81 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.578 1.151 . . . . 0.0 112.034 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.01 -34.84 76.94 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.564 0.697 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.5 t30 -75.82 -41.0 53.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.107 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.752 HG22 HG21 ' A' ' 17' ' ' VAL . 58.4 t -57.97 -45.86 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 124.441 1.088 . . . . 0.0 110.042 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.1 ptpt -72.39 -28.68 63.14 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.026 0.53 . . . . 0.0 111.313 -176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.33 75.13 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.218 0.324 . . . . 0.0 110.434 169.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 71.6 mmtt -74.03 -36.13 64.41 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.95 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.9 mp -57.23 -41.57 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.532 1.06 . . . . 0.0 109.511 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -60.4 -39.09 86.08 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.447 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.43 -32.09 73.52 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.207 0.603 . . . . 0.0 111.481 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 70.4 mmtt -91.4 -67.97 0.82 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.626 0.37 . . . . 0.0 111.624 -171.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -80.39 -22.95 40.77 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.768 0.258 . . . . 0.0 111.06 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.86 18.67 39.62 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.222 0.326 . . . . 0.0 113.037 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.598 HG13 HD11 ' A' ' 73' ' ' LEU . 1.9 mp -108.79 127.52 27.21 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.68 156.13 67.25 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.907 2.404 . . . . 0.0 112.287 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 46.3 Cg_endo -62.17 -13.32 31.27 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 123.636 2.891 . . . . 0.0 113.967 -173.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 7.4 t70 -76.23 -46.13 29.61 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.893 0.746 . . . . 0.0 109.943 174.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.9 mp0 -83.8 -23.09 31.59 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.521 0.728 . . . . 0.0 112.366 -172.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.568 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 2.9 pp0? -104.74 133.27 49.85 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.973 0.509 . . . . 0.0 109.857 173.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.562 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.2 ttt180 -120.26 130.74 54.63 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.975 0.91 . . . . 0.0 110.238 -170.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -94.28 117.42 30.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.634 0.774 . . . . 0.0 110.546 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -141.85 127.54 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 124.27 1.028 . . . . 0.0 109.547 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.538 ' HB3' HD21 ' A' ' 50' ' ' LEU . 81.2 t80 -123.17 124.08 42.25 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.142 0.977 . . . . 0.0 109.236 177.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.94 16.06 9.61 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.031 1.332 . . . . 0.0 112.972 176.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.09 -8.48 60.97 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.929 -0.373 . . . . 0.0 113.171 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.5 ptpt -96.03 135.79 37.33 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -76.39 131.58 39.21 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.538 HD21 ' HB3' ' A' ' 45' ' ' PHE . 30.5 mt -74.34 153.84 39.13 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.436 0.294 . . . . 0.0 110.466 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' H ' ' HE2' ' A' ' 59' ' ' TYR . 37.5 tt0 -116.34 137.35 52.22 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.397 0.679 . . . . 0.0 109.194 -176.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.92 -44.18 86.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.673 1.189 . . . . 0.0 112.075 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.27 -25.04 75.8 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 124.43 1.081 . . . . 0.0 113.478 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -81.31 177.57 8.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.301 0.64 . . . . 0.0 111.789 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 73.1 p -110.36 169.68 8.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.663 0.785 . . . . 0.0 109.795 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 95.4 mt -57.32 -54.8 42.7 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.893 0.746 . . . . 0.0 109.46 172.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.511 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 24.3 t -62.59 -19.28 63.57 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.733 1.213 . . . . 0.0 111.971 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -66.91 -41.4 87.17 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.451 ' HE2' ' H ' ' A' ' 51' ' ' GLU . 38.1 m-85 -90.98 17.87 7.38 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.09 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 68.39 16.69 9.23 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.18 1.392 . . . . 0.0 112.17 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.1 mt -85.16 102.01 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -86.48 -177.23 6.13 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -62.34 144.95 55.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 76.6 -3.34 2.55 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.61 1.564 . . . . 0.0 111.81 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -68.72 133.69 48.75 Favored 'General case' 0 C--N 1.366 1.306 0 CA-C-N 117.971 0.351 . . . . 0.0 110.713 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 18.0 m -99.43 140.21 33.95 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.796 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.404 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -140.79 173.35 11.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.939 0.896 . . . . 0.0 109.699 -178.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -97.32 147.16 24.44 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.371 0.668 . . . . 0.0 110.88 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.657 HD12 HG22 ' A' ' 7' ' ' THR . 2.5 tm? -129.19 127.74 41.94 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.574 HG21 HD11 ' B' ' 220' ' ' LEU . 96.0 t -108.78 126.77 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 123.282 0.633 . . . . 0.0 110.109 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.518 ' HB3' HD23 ' A' ' 73' ' ' LEU . 66.4 mt -86.25 147.04 26.27 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.771 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.428 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 37.3 mtp-105 -136.29 6.4 3.05 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.475 1.11 . . . . 0.0 110.243 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD11 HG13 ' A' ' 36' ' ' ILE . 4.2 mm? . . . . . 0 N--CA 1.489 1.516 0 C-N-CA 126.467 1.907 . . . . 0.0 114.27 -169.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' B' ' 212' ' ' PRO . 11.6 mptt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.13 -176.91 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.87 1.668 . . . . 0.0 109.093 -172.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -111.23 146.08 37.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.936 -0.478 . . . . 0.0 110.915 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.664 ' HA ' HD11 ' B' ' 216' ' ' ILE . 35.1 t -94.72 101.12 6.31 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.445 ' HD2' HD21 ' B' ' 220' ' ' LEU . 66.3 Cg_endo -67.49 -4.65 12.35 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.173 2.582 . . . . 0.0 114.765 -164.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . 0.451 HG11 ' O ' ' B' ' 223' ' ' CYS . 11.6 t -95.25 -58.01 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 122.793 0.437 . . . . 0.0 110.661 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.3 p -99.19 -4.63 31.65 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 66.85 47.01 69.11 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 172.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.25 144.22 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 117.514 0.657 . . . . 0.0 110.842 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -90.26 108.75 19.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.078 0.951 . . . . 0.0 110.026 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' B' ' 204' ' ' CYS . 10.0 pt -144.25 153.42 56.12 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.864 1.266 . . . . 0.0 110.419 -172.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' B' ' 201' ' ' LYS . 54.6 Cg_endo -65.17 165.3 22.37 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.439 2.76 . . . . 0.0 114.366 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.593 ' O ' HG22 ' B' ' 216' ' ' ILE . 31.6 tt0 -62.25 -41.83 98.78 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 125.341 1.456 . . . . 0.0 114.31 -164.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.0 m -76.11 -29.7 57.98 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.812 -1.18 . . . . 0.0 110.712 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -81.63 -23.96 36.66 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.047 0.539 . . . . 0.0 109.997 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.664 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.1 OUTLIER -72.64 -42.79 62.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -65.11 -42.93 93.49 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.851 0.719 . . . . 0.0 110.923 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -64.09 -37.62 88.12 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.654 0.596 . . . . 0.0 110.969 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -39.88 88.58 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.401 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.574 HD11 HG21 ' A' ' 70' ' ' VAL . 80.0 mt -71.19 -32.38 68.78 Favored 'General case' 0 C--O 1.214 -0.763 0 O-C-N 124.201 0.938 . . . . 0.0 111.581 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -58.65 -27.29 64.61 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 123.847 0.717 . . . . 0.0 109.892 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.3 t -95.51 -36.03 11.45 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 123.473 0.709 . . . . 0.0 112.4 172.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' B' ' 220' ' ' LEU . 91.6 m -81.96 -17.79 45.76 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.142 0.977 . . . . 0.0 112.614 -168.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 N--CA 1.488 1.442 0 C-N-CA 122.582 0.353 . . . . 0.0 111.052 177.962 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 mmt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.4 mp0 -95.06 131.03 41.49 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.791 0.436 . . . . 0.0 111.456 -173.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.24 147.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.013 1.325 . . . . 0.0 108.539 172.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' THR . 96.1 m-85 -111.49 103.63 11.99 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.316 0.647 . . . . 0.0 110.211 -169.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 69' ' ' LEU . 84.0 t -103.01 106.06 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.896 0.878 . . . . 0.0 108.978 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -89.22 118.29 28.8 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.816 1.246 . . . . 0.0 110.426 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.58 HG22 HD12 ' A' ' 69' ' ' LEU . 7.8 p -70.95 167.36 19.27 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.61 0.719 . . . . 0.0 112.131 175.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.539 HD11 HG22 ' A' ' 70' ' ' VAL . 89.2 mt -70.2 -11.23 60.75 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.675 172.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.7 p -86.47 -4.43 59.17 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.478 0.711 . . . . 0.0 111.504 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.49 15.63 73.23 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.262 0.352 . . . . 0.0 112.868 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -93.53 151.59 19.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.472 1.109 . . . . 0.0 109.923 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -109.51 128.74 55.4 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.141 0.576 . . . . 0.0 110.288 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.96 106.71 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.685 0.794 . . . . 0.0 108.949 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.7 m -88.78 118.03 28.18 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.069 0.947 . . . . 0.0 109.834 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.2 mm? -105.53 159.67 15.76 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.491 0.716 . . . . 0.0 109.458 178.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -126.7 83.19 2.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.775 0.83 . . . . 0.0 108.839 -174.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.702 HG21 HG22 ' A' ' 26' ' ' VAL . 32.2 m -147.73 -177.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 124.168 0.987 . . . . 0.0 110.056 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -96.21 155.95 37.54 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 123.253 0.621 . . . . 0.0 110.247 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 28.9 Cg_endo -61.52 -31.64 87.66 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 121.984 1.789 . . . . 0.0 111.322 167.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -95.65 10.59 36.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.585 0.754 . . . . 0.0 110.939 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.47 -96.36 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.924 0.889 . . . . 0.0 110.334 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.6 t 172.72 144.63 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.327 1.451 . . . . 0.0 108.98 173.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.06 -35.98 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.806 0.843 . . . . 0.0 111.616 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.09 -35.54 75.42 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.606 0.717 . . . . 0.0 110.777 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 6.2 t30 -74.57 -42.32 58.95 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.712 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.702 HG22 HG21 ' A' ' 17' ' ' VAL . 72.8 t -56.75 -44.05 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 124.367 1.042 . . . . 0.0 110.479 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 17.9 ptpt -74.32 -26.45 60.17 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.653 0.381 . . . . 0.0 111.498 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.6 -32.03 72.47 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.635 168.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -68.96 -38.65 79.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.152 0.581 . . . . 0.0 111.134 175.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.16 -43.7 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 118.249 0.477 . . . . 0.0 109.99 173.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.433 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.3 tt0 -65.73 -24.97 67.09 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.236 0.541 . . . . 0.0 111.542 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.92 -31.81 59.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.852 0.461 . . . . 0.0 110.76 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.7 mmtt -91.12 -67.2 0.87 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.611 0.364 . . . . 0.0 110.526 -172.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -86.44 -26.59 24.61 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.384 0.274 . . . . 0.0 111.547 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 93.24 17.4 43.18 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 120.048 -0.307 . . . . 0.0 113.619 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.05 126.77 47.64 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.76 152.46 78.36 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.954 2.436 . . . . 0.0 112.109 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -58.73 -15.76 27.73 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.324 2.682 . . . . 0.0 113.509 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.27 -36.12 63.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.827 0.851 . . . . 0.0 111.432 175.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -97.05 -28.64 14.05 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.158 0.983 . . . . 0.0 112.81 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.486 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -90.69 149.86 21.89 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.031 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.602 ' HD3' HD23 ' B' ' 220' ' ' LEU . 10.4 ttt180 -140.85 127.01 19.6 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.48 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -92.38 126.22 37.37 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.919 0.888 . . . . 0.0 109.337 -171.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.614 HD11 HD21 ' B' ' 220' ' ' LEU . 90.5 mt -140.78 118.62 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.097 0.559 . . . . 0.0 110.704 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.556 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 71.8 t80 -122.01 129.28 52.32 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.28 20.65 12.39 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.708 0.803 . . . . 0.0 112.605 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.77 22.5 55.54 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 119.881 -0.4 . . . . 0.0 113.692 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.5 ptpt -128.96 146.09 51.06 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 173.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.616 ' HB2' ' HB2' ' B' ' 224' ' ' LEU . 0.3 OUTLIER -82.83 138.5 33.92 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 43' ' ' LEU . 26.6 mt -90.82 120.14 31.61 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.56 -172.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -75.53 138.85 41.8 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.4 1.08 . . . . 0.0 110.51 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.17 -49.7 63.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.636 1.174 . . . . 0.0 111.919 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.69 -29.77 76.12 Favored Glycine 0 C--N 1.352 1.471 0 O-C-N 124.367 1.042 . . . . 0.0 113.962 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -79.31 177.46 8.82 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.568 0.747 . . . . 0.0 111.402 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -118.72 166.59 12.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.604 0.762 . . . . 0.0 110.234 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 93.2 mt -55.76 -54.2 47.35 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 124.104 0.877 . . . . 0.0 109.677 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 15.7 t -60.89 -26.02 67.13 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.591 1.156 . . . . 0.0 111.514 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -68.6 -41.22 79.87 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 122.867 0.467 . . . . 0.0 109.834 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -85.86 15.11 5.13 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.631 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 68.36 25.8 6.92 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.69 1.196 . . . . 0.0 111.69 176.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 56' ' ' LEU . 14.1 mt -93.42 127.89 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.394 1.078 . . . . 0.0 108.256 175.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -110.08 -178.21 3.46 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 172.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -60.1 137.03 58.19 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.044 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 73.15 10.04 5.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.277 1.431 . . . . 0.0 112.467 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -68.11 138.89 56.09 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 170.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 24.9 m -101.29 129.57 47.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.384 0.674 . . . . 0.0 109.613 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.556 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -143.96 154.35 43.21 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.006 0.923 . . . . 0.0 109.909 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -80.58 154.59 27.37 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.462 0.648 . . . . 0.0 112.455 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.58 HD12 HG22 ' A' ' 7' ' ' THR . 2.2 tm? -131.58 121.67 24.79 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.576 HG21 HD22 ' B' ' 220' ' ' LEU . 57.1 t -98.25 119.36 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.53 0.732 . . . . 0.0 110.397 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -85.97 147.65 26.12 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.853 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -121.41 -40.64 2.56 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.497 0.719 . . . . 0.0 110.874 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.5 2.044 0 C-N-CA 125.022 1.329 . . . . 0.0 113.017 -178.969 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 8.3 m -148.25 -177.58 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.666 1.186 . . . . 0.0 109.326 -167.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -120.95 138.59 54.06 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.722 0.409 . . . . 0.0 111.134 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 204' ' ' CYS . . . . . 0.536 ' HA ' HD11 ' B' ' 216' ' ' ILE . 37.1 t -78.73 100.25 0.52 Allowed Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 124.303 1.041 . . . . 0.0 108.263 174.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . 0.507 ' HD3' HD11 ' B' ' 216' ' ' ILE . 44.5 Cg_endo -81.99 20.49 1.07 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.071 2.514 . . . . 0.0 114.116 -159.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 53.9 t -105.32 -58.24 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.333 0.653 . . . . 0.0 109.691 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 28.8 p -91.97 -23.84 19.43 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.072 0.549 . . . . 0.0 111.22 -175.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.89 52.52 3.83 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 114.299 0.48 . . . . 0.0 114.299 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.76 134.76 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.264 0.626 . . . . 0.0 110.172 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -87.92 114.06 24.17 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' B' ' 204' ' ' CYS . 8.9 pt -143.89 160.41 50.08 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 124.866 1.266 . . . . 0.0 110.376 -171.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.4 156.19 32.11 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.153 2.569 . . . . 0.0 112.774 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' GLU . . . . . 0.5 ' O ' HG22 ' B' ' 216' ' ' ILE . 33.2 tt0 -66.18 -29.39 69.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.522 1.129 . . . . 0.0 113.499 -171.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 15.7 m -64.11 -43.68 94.58 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.882 0.849 . . . . 0.0 110.057 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -81.17 -21.53 39.62 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.304 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -69.82 -41.13 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -58.97 -51.68 69.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.15 0.906 . . . . 0.0 109.973 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -64.95 -47.93 75.88 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.966 -174.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -33.76 76.73 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.505 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.614 HD21 HD11 ' A' ' 44' ' ' ILE . 46.6 tp -68.23 -39.34 82.37 Favored 'General case' 0 C--O 1.214 -0.777 0 O-C-N 124.249 0.968 . . . . 0.0 111.447 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.14 -36.32 63.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.044 0.538 . . . . 0.0 110.822 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.4 t -77.93 -43.92 28.49 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.668 174.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 75.1 m -77.38 -21.09 53.75 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 3.9 pp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.094 0 N-CA-C 112.694 -0.162 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 19.8 m -87.08 -177.04 5.93 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.577 0.751 . . . . 0.0 109.875 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 19.3 p80 -141.36 116.03 9.66 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt -105.32 150.09 25.48 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.2 mp0 -99.47 130.39 45.73 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.041 -174.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.422 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -128.7 146.81 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.636 1.174 . . . . 0.0 109.355 176.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 66' ' ' THR . 73.7 m-85 -103.19 100.11 10.0 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.761 0.824 . . . . 0.0 109.89 -173.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 69' ' ' LEU . 93.6 t -101.67 99.91 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -98.89 123.49 43.19 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.587 -169.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.757 HG22 HD12 ' A' ' 69' ' ' LEU . 41.3 p -67.84 166.75 14.85 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.822 0.849 . . . . 0.0 112.927 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.51 -17.03 64.51 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.073 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.4 p -85.87 2.96 43.84 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.335 0.654 . . . . 0.0 111.113 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.05 85.61 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 113.888 0.315 . . . . 0.0 113.888 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.5 135.98 34.22 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.84 0.856 . . . . 0.0 109.841 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.6 m -101.34 124.58 47.24 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.035 0.534 . . . . 0.0 110.683 -174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.7 mp -107.53 110.54 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.9 0.88 . . . . 0.0 109.495 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -87.03 118.69 26.58 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.568 0.747 . . . . 0.0 109.755 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.59 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.6 mm? -103.78 162.37 13.15 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.491 0.716 . . . . 0.0 109.217 177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 0' ' ' HIS . 45.7 mt-10 -125.25 72.0 1.23 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.49 0.716 . . . . 0.0 109.223 -175.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.686 HG21 HG22 ' A' ' 26' ' ' VAL . 2.4 m -134.11 174.16 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.313 0.645 . . . . 0.0 109.572 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 2.7 mm-40 -85.96 148.68 48.7 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.132 0.573 . . . . 0.0 109.61 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 20.5 Cg_endo -61.19 -31.38 89.93 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 121.687 1.592 . . . . 0.0 111.287 167.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.6 t -98.52 17.92 17.89 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.397 0.679 . . . . 0.0 110.563 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 12.1 t0 -74.89 -94.96 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 25' ' ' ASN . 12.0 t 176.95 149.28 0.14 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 125.027 1.331 . . . . 0.0 108.828 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.431 HG22 ' HE3' ' A' ' 27' ' ' LYS . 50.3 mm -65.49 -36.09 76.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.856 0.862 . . . . 0.0 110.848 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.15 -40.71 64.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.902 0.881 . . . . 0.0 110.847 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.516 ' H ' HG23 ' A' ' 22' ' ' THR . 10.3 t30 -70.95 -46.03 63.09 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.126 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.686 HG22 HG21 ' A' ' 17' ' ' VAL . 61.1 t -55.19 -49.52 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 124.173 0.921 . . . . 0.0 111.022 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HE3' HG22 ' A' ' 23' ' ' ILE . 16.7 ptpt -67.21 -33.71 75.94 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.318 0.647 . . . . 0.0 111.929 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.25 -30.1 70.87 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.236 171.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 68.8 mmtt -80.79 -28.15 36.41 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.94 -40.44 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-N 119.577 1.08 . . . . 0.0 108.805 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -60.76 -35.25 75.93 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.304 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 27.1 t70 -71.14 -26.4 62.99 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.778 0.831 . . . . 0.0 112.065 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -95.1 -70.1 0.73 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.415 0.286 . . . . 0.0 111.381 -175.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -83.4 -24.36 31.98 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.23 26.79 13.2 Favored Glycine 0 C--N 1.349 1.259 0 O-C-N 123.224 0.327 . . . . 0.0 113.036 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.8 125.79 29.31 Favored Pre-proline 0 N--CA 1.481 1.115 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.95 155.8 68.32 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.888 2.392 . . . . 0.0 112.686 -171.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.26 -11.57 19.75 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.672 2.915 . . . . 0.0 113.918 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.59 -42.53 58.52 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.205 0.602 . . . . 0.0 110.333 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -89.44 -12.54 39.92 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.829 0.852 . . . . 0.0 112.709 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.566 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -114.86 152.75 31.67 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 123.127 0.571 . . . . 0.0 109.956 173.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.503 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 41.8 ttt180 -136.09 134.56 38.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.117 0.567 . . . . 0.0 110.3 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.503 HD21 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -94.66 123.35 38.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.873 0.869 . . . . 0.0 110.452 -173.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.5 mt -142.91 126.7 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.078 0.951 . . . . 0.0 109.915 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.5 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 84.8 t80 -121.96 124.84 44.98 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.271 1.029 . . . . 0.0 108.9 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.6 17.96 7.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.07 0.948 . . . . 0.0 112.964 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.79 -7.14 59.05 Favored Glycine 0 C--N 1.351 1.385 0 C-N-CA 122.992 0.329 . . . . 0.0 113.88 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.8 ptpt -95.43 135.21 37.35 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -73.69 138.98 45.05 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.457 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 18.5 mt -92.03 110.22 21.58 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.876 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -74.89 139.44 43.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.285 1.034 . . . . 0.0 110.524 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.38 -47.06 69.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.696 1.198 . . . . 0.0 112.362 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.01 -26.11 73.29 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 124.123 0.889 . . . . 0.0 114.019 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 80.0 mtt180 -83.24 176.34 9.23 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.28 0.632 . . . . 0.0 111.794 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.8 p -111.13 167.13 10.51 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.607 0.763 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 91.3 mt -57.75 -51.33 69.99 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.0 t -57.59 -29.95 64.89 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.727 1.211 . . . . 0.0 111.733 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 10.4 t70 -61.06 -48.26 82.54 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.778 0.799 . . . . 0.0 109.645 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 29.9 m-85 -87.29 18.85 3.49 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.628 -174.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.438 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.7 OUTLIER 72.0 22.2 3.83 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.303 1.041 . . . . 0.0 111.805 177.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -98.94 118.64 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.83 -179.56 4.21 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 10.8 ptmm? -62.97 140.87 58.9 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.618 170.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 64.2 23.57 13.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.164 1.386 . . . . 0.0 112.678 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -75.72 142.12 42.52 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 166.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 61.3 m -101.15 125.76 47.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.5 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -130.84 173.36 11.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.987 1.315 . . . . 0.0 108.876 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -100.45 151.07 21.98 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.762 0.792 . . . . 0.0 111.726 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.757 HD12 HG22 ' A' ' 7' ' ' THR . 3.1 tm? -129.86 123.74 31.55 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.521 HG21 HD11 ' B' ' 220' ' ' LEU . 90.9 t -98.73 112.09 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.324 0.65 . . . . 0.0 110.5 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt -78.22 143.72 36.89 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.961 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.589 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 72.4 mtp180 -124.98 -42.35 2.04 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.724 0.81 . . . . 0.0 110.062 -175.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 48.53 35.25 5.74 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.565 0.746 . . . . 0.0 111.89 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.589 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 4.0 mmp_? -64.08 -29.41 70.54 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.944 -175.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.37 -28.84 67.83 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.824 0.703 . . . . 0.0 113.456 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.307 0 C-N-CA 123.241 0.448 . . . . 0.0 113.89 174.974 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.814 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 39.2 m -88.81 101.18 13.78 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.642 0.777 . . . . 0.0 109.532 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -82.88 73.96 9.88 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.545 0.688 . . . . 0.0 109.584 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -164.95 153.12 11.84 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 114.55 -1.204 . . . . 0.0 108.961 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.84 119.64 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 169.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . 0.477 HG22 HG13 ' B' ' 202' ' ' VAL . 34.6 m -77.07 127.7 33.14 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.882 0.873 . . . . 0.0 110.655 -175.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.71 123.45 39.28 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . 0.477 HG13 HG22 ' B' ' 200' ' ' THR . 5.9 m -143.64 167.33 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 125.193 1.397 . . . . 0.0 110.023 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -94.38 146.48 24.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.171 0.588 . . . . 0.0 111.685 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.63 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.5 t -90.22 102.49 4.96 Favored Pre-proline 0 N--CA 1.472 0.644 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.525 ' HD2' HD21 ' B' ' 220' ' ' LEU . 61.2 Cg_endo -66.62 -2.89 8.21 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.115 2.543 . . . . 0.0 114.599 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.24 -64.09 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.003 0.521 . . . . 0.0 110.338 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.2 p -98.84 4.32 47.53 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.67 0.388 . . . . 0.0 111.835 -174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.06 44.51 97.67 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 115.181 0.832 . . . . 0.0 115.181 169.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.13 136.57 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-N 117.472 0.636 . . . . 0.0 110.973 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -87.38 123.4 32.29 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' B' ' 204' ' ' CYS . 3.9 pt -148.79 162.98 27.79 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.543 1.537 . . . . 0.0 109.013 -169.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.55 153.98 71.6 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.049 1.833 . . . . 0.0 111.333 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.563 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.6 tm-20 -66.97 -36.22 81.72 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.34 1.056 . . . . 0.0 113.217 -168.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 16.7 p -58.82 -41.12 86.08 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.88 0.848 . . . . 0.0 110.14 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -81.03 -19.16 44.48 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.464 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.63 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -71.48 -44.75 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -59.3 -52.65 64.74 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.952 0.901 . . . . 0.0 109.967 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -60.61 -40.13 90.74 Favored 'General case' 0 C--O 1.254 1.296 0 O-C-N 124.401 1.063 . . . . 0.0 111.608 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -43.62 80.4 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.92 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' B' ' 216' ' ' ILE . 83.4 mt -62.23 -47.04 86.19 Favored 'General case' 0 C--O 1.213 -0.847 0 O-C-N 124.167 0.917 . . . . 0.0 111.144 -177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -53.83 -32.21 52.06 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 124.112 0.882 . . . . 0.0 111.636 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.3 t -85.06 -39.35 18.09 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.442 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 92.9 m -79.8 -24.84 41.14 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.24 1.016 . . . . 0.0 112.462 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.09 -12.89 42.86 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.072 0.549 . . . . 0.0 110.223 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 46.4 m -68.24 86.15 0.27 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -105.22 169.94 8.16 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.461 1.104 . . . . 0.0 110.522 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.561 1.368 0 C-N-CA 124.693 1.197 . . . . 0.0 110.676 -173.008 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.941 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 83.4 p 54.6 -164.34 0.11 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.863 1.265 . . . . 0.0 111.825 -176.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -161.6 141.12 10.15 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.886 0.474 . . . . 0.0 110.415 171.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt -106.19 154.14 21.13 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 14.9 mp0 -102.85 124.97 49.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.181 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -121.91 159.36 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.475 1.11 . . . . 0.0 108.605 175.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 66' ' ' THR . 61.3 m-85 -114.23 116.3 28.82 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.367 0.603 . . . . 0.0 110.463 -172.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.723 HG13 ' HB2' ' A' ' 69' ' ' LEU . 2.1 t -104.26 117.79 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -109.58 110.31 21.34 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.73 0.812 . . . . 0.0 108.822 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.605 HG22 HD12 ' A' ' 69' ' ' LEU . 40.7 p -66.64 163.16 19.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.481 0.313 . . . . 0.0 111.136 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.36 -19.6 65.58 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.894 175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.5 p -78.72 -9.86 59.56 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.959 0.504 . . . . 0.0 110.908 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.44 8.84 62.23 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.683 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -84.32 146.76 27.56 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.428 0.691 . . . . 0.0 110.267 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -108.27 140.03 42.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.271 0.628 . . . . 0.0 109.903 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -129.99 116.6 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.082 1.353 . . . . 0.0 107.72 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -93.63 120.8 34.35 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -104.64 156.47 17.95 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -127.25 83.02 2.13 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.702 HG21 HG22 ' A' ' 26' ' ' VAL . 33.7 m -146.07 178.75 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.967 0.907 . . . . 0.0 110.25 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -95.4 155.38 38.8 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.485 0.714 . . . . 0.0 109.801 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.526 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 21.3 Cg_endo -62.43 -26.97 76.86 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 121.774 1.649 . . . . 0.0 111.833 166.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.3 t -93.2 5.16 52.47 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.726 0.81 . . . . 0.0 111.321 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.82 -98.32 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.923 0.889 . . . . 0.0 110.734 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.5 t 170.11 143.54 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.353 1.461 . . . . 0.0 109.246 175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.8 mm -62.99 -32.82 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.602 0.761 . . . . 0.0 110.54 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -54.98 -41.42 71.16 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.361 1.064 . . . . 0.0 110.091 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 9.4 t30 -79.26 -40.68 29.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.136 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.702 HG22 HG21 ' A' ' 17' ' ' VAL . 85.6 t -56.35 -44.43 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 124.112 0.883 . . . . 0.0 110.856 178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 17.6 ptpt -73.45 -29.61 62.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.93 0.492 . . . . 0.0 111.231 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.78 71.84 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.731 168.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 10.0 mmpt? -72.16 -37.88 69.28 Favored 'General case' 0 C--N 1.357 0.905 0 CA-C-O 119.181 -0.437 . . . . 0.0 110.785 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.568 HD11 HG21 ' A' ' 5' ' ' VAL . 2.0 mp -55.22 -45.99 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.006 0.431 . . . . 0.0 110.054 172.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -61.9 -33.43 74.22 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.49 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -72.12 -32.31 66.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.543 0.737 . . . . 0.0 111.646 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.3 mmtt -90.65 -66.31 0.94 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.613 0.365 . . . . 0.0 110.975 -172.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -87.91 -26.84 22.52 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.92 29.35 10.63 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.06 126.02 30.25 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.7 154.05 75.82 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.841 2.361 . . . . 0.0 112.473 -173.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 20.7 Cg_endo -56.94 -19.43 32.07 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.557 2.838 . . . . 0.0 113.251 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.61 -35.74 70.57 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.876 0.87 . . . . 0.0 111.024 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -95.2 -27.92 15.29 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 123.486 0.714 . . . . 0.0 112.198 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.537 ' HB2' HD21 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -92.5 140.63 29.37 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.637 0.653 . . . . 0.0 109.809 178.084 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.444 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 19.7 ttt180 -127.8 127.89 44.32 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -96.28 123.21 39.83 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.595 0.758 . . . . 0.0 110.371 -169.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -141.5 129.42 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.017 0.527 . . . . 0.0 109.864 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.56 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 93.7 t80 -130.81 121.98 26.31 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.19 20.81 11.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.718 0.807 . . . . 0.0 113.122 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.09 -16.96 57.77 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.0 ptpt -90.34 135.15 33.86 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.09 135.42 35.32 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.2 mt -89.29 114.21 25.57 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.689 -172.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 31.0 tt0 -76.95 138.24 39.55 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 123.603 0.761 . . . . 0.0 109.637 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.5 -37.79 82.23 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.124 0.89 . . . . 0.0 111.93 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -67.27 -22.07 72.54 Favored Glycine 0 C--N 1.348 1.235 0 O-C-N 123.675 0.609 . . . . 0.0 114.183 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.565 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 78.7 mtt180 -89.59 177.22 6.6 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.393 0.677 . . . . 0.0 111.511 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 55.6 p -109.9 169.78 8.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.522 0.729 . . . . 0.0 110.43 176.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 87.1 mt -55.83 -54.86 39.34 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.59 0.556 . . . . 0.0 109.705 173.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 22.8 t -61.73 -22.73 65.62 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.333 1.053 . . . . 0.0 111.798 -176.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.1 -47.39 83.04 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.565 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 36.2 m-85 -86.33 17.02 3.95 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.148 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.7 OUTLIER 72.96 9.76 5.39 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.144 1.378 . . . . 0.0 112.404 176.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.1 mt -81.66 123.09 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.7 0.8 . . . . 0.0 108.958 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -110.0 -174.18 2.43 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.181 0.592 . . . . 0.0 109.712 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 10.2 ptmm? -58.7 144.34 43.84 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.713 172.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 62.33 10.82 4.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.937 1.295 . . . . 0.0 113.644 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.9 m -70.06 132.57 46.07 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-N 118.17 0.441 . . . . 0.0 110.223 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 29.0 m -93.89 130.97 39.75 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.08 160.46 38.89 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.973 0.909 . . . . 0.0 109.416 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -88.7 138.69 31.19 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.203 0.525 . . . . 0.0 111.423 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.723 ' HB2' HG13 ' A' ' 5' ' ' VAL . 2.7 tm? -119.62 135.26 54.88 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.641 HG21 HD11 ' B' ' 220' ' ' LEU . 90.8 t -115.6 115.54 49.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.591 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.517 ' HB3' HD23 ' A' ' 73' ' ' LEU . 67.2 mt -81.27 99.44 8.63 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.128 173.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -67.69 -40.52 84.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.67 1.188 . . . . 0.0 109.144 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 71' ' ' LEU . 0.2 OUTLIER 58.37 29.93 18.87 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.037 1.335 . . . . 0.0 112.082 172.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -79.74 -7.24 58.51 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.066 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.3 36.58 1.64 Allowed Glycine 0 C--N 1.341 0.849 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.337 0 O-C-N 124.02 0.482 . . . . 0.0 113.816 174.744 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.736 0 CA-C-O 120.93 0.184 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 35.0 p -98.94 87.19 3.65 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.35 1.06 . . . . 0.0 108.967 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -116.67 -56.28 2.29 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.918 0.887 . . . . 0.0 109.641 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -94.17 165.08 12.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.694 0.798 . . . . 0.0 109.912 175.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' B' ' 213' ' ' GLU . 5.6 p -61.17 118.78 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.154 0.502 . . . . 0.0 110.072 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 20.1 m -76.68 146.75 37.88 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.958 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' B' ' 201' ' ' LYS . 9.4 mptt -97.7 122.22 40.54 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 172.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.27 -178.5 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.72 0.808 . . . . 0.0 110.314 -165.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -124.95 144.72 50.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.72 0.808 . . . . 0.0 109.352 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.642 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.0 t -91.09 100.46 2.99 Favored Pre-proline 0 N--CA 1.481 1.093 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.514 ' HD2' HD21 ' B' ' 220' ' ' LEU . 30.1 Cg_endo -58.56 -23.65 65.98 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.983 2.456 . . . . 0.0 114.137 -169.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.37 -53.59 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 C-N-CA 122.22 0.208 . . . . 0.0 111.555 -174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 17.8 p -103.34 -6.72 21.69 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.7 50.86 39.45 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.527 0.517 . . . . 0.0 114.286 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.0 m -119.09 138.97 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 123.232 0.613 . . . . 0.0 110.271 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -87.44 125.27 34.19 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.5 pt -153.47 157.04 32.8 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 125.136 1.375 . . . . 0.0 109.371 -169.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.19 165.0 31.81 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.417 2.078 . . . . 0.0 112.974 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.537 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.8 tt0 -60.03 -42.1 93.66 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.69 1.596 . . . . 0.0 115.006 -166.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 35.9 t -70.5 -33.58 71.36 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.369 -0.832 . . . . 0.0 109.976 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -71.35 -29.34 64.86 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.327 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.642 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -71.8 -37.0 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -57.49 -54.21 49.4 Favored 'General case' 0 C--O 1.244 0.806 0 O-C-N 123.803 0.689 . . . . 0.0 110.365 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -69.54 -33.3 72.59 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.973 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -46.46 90.52 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.641 HD11 HG21 ' A' ' 70' ' ' VAL . 91.2 mt -67.91 -37.43 81.7 Favored 'General case' 0 C--O 1.208 -1.09 0 O-C-N 124.129 0.893 . . . . 0.0 111.232 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.04 -32.31 63.91 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 124.538 1.149 . . . . 0.0 110.675 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 33.2 t -93.49 -36.36 12.48 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.513 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 96.9 m -77.8 -24.13 48.91 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.607 0.763 . . . . 0.0 112.802 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.4 -21.16 63.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.928 0.491 . . . . 0.0 110.459 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 14.0 m -69.14 111.04 4.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.295 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -144.56 37.69 1.22 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.275 1.03 . . . . 0.0 109.043 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.558 1.283 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.864 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 18' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.889 0 CA-C-O 120.683 0.046 . . . . 0.0 113.081 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 71.3 m -72.55 119.97 17.52 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.914 0.486 . . . . 0.0 109.862 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -153.44 -73.65 0.13 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 21.9 mmt -81.41 166.9 19.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.06 0.544 . . . . 0.0 110.356 -175.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.6 mp0 -114.07 136.91 52.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.262 0.625 . . . . 0.0 110.552 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.411 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -128.82 164.14 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 124.811 1.244 . . . . 0.0 108.721 172.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 66' ' ' THR . 69.4 m-85 -119.72 110.18 16.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.137 -174.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.502 HG21 HD11 ' A' ' 30' ' ' ILE . 50.8 t -97.03 135.22 31.9 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -122.09 123.77 42.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.837 0.455 . . . . 0.0 110.214 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.637 HG22 HD12 ' A' ' 69' ' ' LEU . 57.0 p -81.18 165.37 21.59 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.974 0.416 . . . . 0.0 111.728 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 70' ' ' VAL . 85.8 mt -71.38 -19.53 62.26 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.459 172.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.0 p -78.57 -17.88 55.45 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.724 0.41 . . . . 0.0 109.967 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.86 23.9 14.42 Favored Glycine 0 C--N 1.352 1.449 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 167.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 153.01 18.28 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 172.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -100.4 144.56 29.26 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 170.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.567 HD11 HG23 ' A' ' 7' ' ' THR . 5.1 mp -124.97 113.44 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.826 1.251 . . . . 0.0 107.911 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.0 m -89.45 122.04 32.26 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.3 mm? -111.19 152.36 27.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.561 0.744 . . . . 0.0 109.156 177.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 1' ' ' MET . 3.0 mp0 -112.81 95.32 5.35 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.626 HG21 HG22 ' A' ' 26' ' ' VAL . 33.5 m -146.34 -174.01 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.434 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 16.0 mt-10 -102.09 155.77 36.05 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 19.7 Cg_endo -57.98 -32.29 94.94 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.018 1.812 . . . . 0.0 111.118 167.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -98.1 18.62 15.7 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.312 0.645 . . . . 0.0 110.808 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 14.7 t70 -82.13 -92.57 0.06 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.046 0.538 . . . . 0.0 109.808 -178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.518 HG23 ' H ' ' A' ' 25' ' ' ASN . 15.3 t 177.81 149.49 0.18 Allowed 'General case' 0 C--N 1.367 1.361 0 C-N-CA 124.526 1.13 . . . . 0.0 110.762 174.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.0 mm -65.83 -37.19 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.591 1.157 . . . . 0.0 110.81 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -55.6 -38.57 69.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.181 0.992 . . . . 0.0 111.056 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.518 ' H ' HG23 ' A' ' 22' ' ' THR . 4.9 t-20 -76.64 -39.14 53.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.277 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 17' ' ' VAL . 64.4 t -57.67 -46.9 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 124.471 1.107 . . . . 0.0 110.759 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HA ' HD12 ' A' ' 30' ' ' ILE . 17.2 ptpt -71.3 -27.56 63.49 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.944 0.498 . . . . 0.0 111.795 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.27 -39.43 89.41 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.505 0.503 . . . . 0.0 110.911 169.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 4.4 mmtm -66.15 -37.27 85.25 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.652 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.502 HD11 HG21 ' A' ' 5' ' ' VAL . 94.3 mt -64.05 -38.42 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.649 0.78 . . . . 0.0 110.915 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.8 tt0 -64.92 -31.1 72.18 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.036 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -69.31 -38.91 78.48 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.398 0.279 . . . . 0.0 110.984 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.5 mmtt -85.31 -69.43 0.66 Allowed 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.078 0.237 . . . . 0.0 110.699 -168.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.7 -20.49 31.12 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 122.087 0.155 . . . . 0.0 111.08 -176.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 88.06 25.96 30.15 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.451 0.469 . . . . 0.0 113.359 171.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.11 125.88 30.15 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -65.47 149.83 87.47 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.939 2.426 . . . . 0.0 112.438 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.05 -17.6 11.56 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 124.325 3.35 . . . . 0.0 114.339 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -74.49 -41.91 59.9 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.302 0.641 . . . . 0.0 111.2 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.12 -33.56 22.36 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.731 0.812 . . . . 0.0 111.489 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.479 HE22 HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -89.78 149.34 22.75 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 176.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.43 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 44.3 ttt180 -132.75 131.12 40.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.941 0.496 . . . . 0.0 110.207 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.479 HD21 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -94.84 124.84 39.11 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.687 0.795 . . . . 0.0 110.122 -174.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.7 mt -142.52 132.81 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.003 0.921 . . . . 0.0 109.139 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.552 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 86.6 t80 -135.21 132.31 37.75 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 171.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.49 23.28 12.93 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.889 0.876 . . . . 0.0 112.197 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.33 -7.97 75.29 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 114.516 0.566 . . . . 0.0 114.516 175.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.8 ptpt -103.28 141.34 36.08 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 117.494 0.647 . . . . 0.0 109.448 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' NE2' HD22 ' B' ' 224' ' ' LEU . 8.0 tt0 -74.43 131.41 41.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.3 mt -83.25 117.97 23.31 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.407 0.283 . . . . 0.0 110.245 -176.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.76 137.96 38.0 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 123.945 0.898 . . . . 0.0 109.674 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.3 -50.26 67.73 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.726 1.211 . . . . 0.0 111.843 -174.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.64 -27.39 70.93 Favored Glycine 0 C--N 1.35 1.32 0 O-C-N 124.273 0.983 . . . . 0.0 114.072 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.445 ' HD3' ' OD2' ' A' ' 58' ' ' ASP . 54.5 mtt180 -77.3 175.73 9.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.316 0.646 . . . . 0.0 112.013 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 65.8 p -111.27 164.08 13.27 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.013 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 90.9 mt -55.44 -53.33 57.59 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.807 174.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 9.4 t -66.56 -20.64 66.06 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.263 1.025 . . . . 0.0 111.339 -173.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' OD2' ' HD3' ' A' ' 54' ' ' ARG . 12.2 t70 -67.26 -42.18 84.31 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -86.78 16.18 5.05 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.813 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.429 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 70.94 17.43 6.28 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.033 1.333 . . . . 0.0 112.301 176.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 11.1 mt -90.45 103.66 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -84.97 -178.97 6.97 Favored 'General case' 0 C--O 1.251 1.15 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -59.4 143.47 49.62 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 64.28 11.83 6.69 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.13 1.372 . . . . 0.0 113.573 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.9 m -75.25 149.57 38.82 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.275 0.489 . . . . 0.0 110.614 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.7 m -101.02 130.12 46.97 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.974 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.61 154.85 48.46 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.95 1.3 . . . . 0.0 108.181 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -87.85 158.7 18.66 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.44 0.638 . . . . 0.0 111.888 -174.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.637 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -141.94 129.47 21.38 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.545 -1.207 . . . . 0.0 107.829 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.577 HG21 HD11 ' B' ' 220' ' ' LEU . 98.4 t -111.0 117.18 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.755 0.822 . . . . 0.0 110.112 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.68 139.86 30.36 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.123 0.969 . . . . 0.0 110.673 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.528 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 18.6 mtm180 -118.18 -44.92 2.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.748 0.819 . . . . 0.0 111.583 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.49 32.4 20.69 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.201 1.0 . . . . 0.0 112.425 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 88.0 mmt-85 -61.09 -58.04 10.04 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.725 0.81 . . . . 0.0 109.951 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.27 32.24 6.9 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 114.768 -1.106 . . . . 0.0 112.135 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.609 0 CA-C-N 116.514 0.157 . . . . 0.0 113.439 179.057 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.764 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 28.0 p -70.28 90.78 0.7 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.429 0.692 . . . . 0.0 110.124 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . 0.437 HH22 ' HD3' ' A' ' 74' ' ' ARG . 56.9 ttt180 -75.56 124.98 28.12 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.121 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -127.26 175.34 8.24 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.269 1.027 . . . . 0.0 109.232 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 6.3 p -70.71 83.63 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 CA-C-O 122.422 1.106 . . . . 0.0 109.264 171.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 42.3 m -78.4 136.73 37.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.856 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.53 123.68 42.83 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . 0.441 HG23 HG13 ' B' ' 216' ' ' ILE . 6.6 m -134.12 -178.86 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 125.379 1.472 . . . . 0.0 109.173 -176.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -109.64 146.18 35.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.19 0.596 . . . . 0.0 111.097 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.567 ' HA ' HD11 ' B' ' 216' ' ' ILE . 49.7 t -89.46 102.36 4.32 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.322 1.049 . . . . 0.0 109.236 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.531 ' HD2' HD21 ' B' ' 220' ' ' LEU . 45.8 Cg_endo -62.28 -10.09 17.34 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.776 2.984 . . . . 0.0 114.984 -166.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 42.4 t -84.07 -60.47 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 123.054 0.542 . . . . 0.0 110.769 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 22.3 p -101.3 -6.99 23.42 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.804 0.441 . . . . 0.0 112.038 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.66 51.05 38.36 Favored Glycine 0 C--N 1.346 1.138 0 C-N-CA 123.435 0.54 . . . . 0.0 114.207 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.12 142.22 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 123.008 0.523 . . . . 0.0 110.746 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -92.47 122.36 34.84 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.491 0.717 . . . . 0.0 109.903 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.534 HD11 ' HB2' ' B' ' 204' ' ' CYS . 3.8 pt -152.67 160.99 30.39 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 125.767 1.627 . . . . 0.0 109.387 -169.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.26 158.8 46.67 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.156 1.904 . . . . 0.0 111.629 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.537 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.9 tm-20 -69.75 -28.41 65.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.055 0.942 . . . . 0.0 112.104 -169.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 37.2 p -60.79 -45.82 92.9 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.657 0.741 . . . . 0.0 110.058 169.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -76.8 -18.3 58.5 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.815 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -72.21 -50.16 38.26 Favored 'Isoleucine or valine' 0 C--N 1.364 1.214 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -67.75 -35.61 79.04 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.205 0.316 . . . . 0.0 110.467 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -45.47 94.03 Favored 'General case' 0 C--O 1.254 1.313 0 O-C-N 123.886 0.741 . . . . 0.0 110.967 172.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . 0.414 ' HB3' ' SG ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -59.57 -38.58 81.53 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.78 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.577 HD11 HG21 ' A' ' 70' ' ' VAL . 79.4 mt -66.21 -39.56 89.7 Favored 'General case' 0 C--O 1.208 -1.089 0 O-C-N 123.972 0.795 . . . . 0.0 111.295 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -55.56 -38.71 69.68 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.945 0.778 . . . . 0.0 110.88 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 23.2 t -88.24 -31.54 18.98 Favored 'General case' 0 CA--C 1.56 1.344 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.829 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 63.6 m -82.47 -19.73 38.29 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.645 0.778 . . . . 0.0 112.967 -173.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.48 HD22 ' NE2' ' A' ' 49' ' ' GLN . 4.6 pp -76.42 -8.65 57.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 122.676 0.39 . . . . 0.0 110.928 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 17.0 m -63.7 2.38 0.47 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.031 1.333 . . . . 0.0 113.185 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -57.14 98.5 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.284 1.034 . . . . 0.0 109.776 168.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--O 1.248 1.006 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -174.549 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 28.9 t -93.74 -46.17 7.35 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.376 0.67 . . . . 0.0 111.807 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.541 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 2.9 m80 70.57 132.61 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.62 1.168 . . . . 0.0 111.634 -170.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt -132.11 -174.39 3.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.679 1.191 . . . . 0.0 109.769 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.1 mp0 -112.35 155.61 23.85 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.469 0.708 . . . . 0.0 110.201 174.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.436 HD11 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -142.8 157.08 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 124.793 1.237 . . . . 0.0 109.218 167.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 66' ' ' THR . 39.0 m-85 -112.57 100.49 8.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.372 0.669 . . . . 0.0 110.322 -175.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 69' ' ' LEU . 95.2 t -101.77 104.84 16.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -102.16 127.3 49.15 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.732 0.813 . . . . 0.0 111.137 -172.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.655 HG22 HD12 ' A' ' 69' ' ' LEU . 49.2 p -70.85 166.46 21.02 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-O 121.599 0.714 . . . . 0.0 112.782 -179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.421 HD11 HG22 ' A' ' 70' ' ' VAL . 68.4 mt -67.82 -23.52 65.19 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.297 171.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.7 p -78.63 -16.54 57.23 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.308 0.643 . . . . 0.0 110.397 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.41 5.71 39.54 Favored Glycine 0 C--N 1.351 1.411 0 CA-C-O 119.182 -0.788 . . . . 0.0 114.856 167.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.47 151.13 24.82 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.063 0.932 . . . . 0.0 108.586 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.1 m -107.01 126.04 51.81 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.013 0.525 . . . . 0.0 110.3 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.414 HD11 HG23 ' A' ' 7' ' ' THR . 4.7 mp -107.27 110.75 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.797 0.839 . . . . 0.0 109.006 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.9 m -90.31 120.44 31.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.278 0.631 . . . . 0.0 109.446 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.5 mm? -106.9 151.75 24.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.01 0.524 . . . . 0.0 109.833 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -110.69 78.29 1.11 Allowed 'General case' 0 C--O 1.239 0.53 0 O-C-N 124.205 0.941 . . . . 0.0 108.618 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.734 HG21 HG22 ' A' ' 26' ' ' VAL . 3.4 m -144.77 172.07 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.702 0.801 . . . . 0.0 108.981 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 0' ' ' HIS . 8.1 mt-10 -93.11 158.0 38.08 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -57.65 -34.16 97.73 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.139 1.893 . . . . 0.0 112.074 169.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.2 t -102.03 21.35 14.93 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.881 0.472 . . . . 0.0 110.611 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 6.2 t70 -73.03 -87.33 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 25' ' ' ASN . 7.4 t 173.65 148.86 0.07 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.461 1.504 . . . . 0.0 109.081 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.508 HG22 ' HE3' ' A' ' 27' ' ' LYS . 44.3 mm -63.19 -38.53 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.322 1.049 . . . . 0.0 110.42 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -60.03 -33.06 71.5 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.374 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.2 t-20 -74.53 -43.26 56.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.734 HG22 HG21 ' A' ' 17' ' ' VAL . 60.6 t -56.35 -47.31 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 124.387 1.054 . . . . 0.0 110.093 -178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HE3' HG22 ' A' ' 23' ' ' ILE . 17.6 ptpt -74.18 -25.93 59.99 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.37 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.62 -34.26 77.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.28 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 73.6 mmtt -72.52 -32.59 66.25 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.557 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.4 mp -53.42 -45.0 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 CA-C-N 119.05 0.841 . . . . 0.0 110.076 168.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.97 -32.99 74.72 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.507 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.99 -34.88 66.71 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.099 0.56 . . . . 0.0 111.328 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.76 -68.7 0.78 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.046 0.539 . . . . 0.0 110.952 -171.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -83.35 -21.74 33.03 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.78 20.8 35.76 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.753 -0.203 . . . . 0.0 112.942 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -107.98 122.72 39.88 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -65.35 153.43 78.25 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.645 2.23 . . . . 0.0 112.333 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HA ' ' HG3' ' A' ' 41' ' ' GLN . 18.4 Cg_endo -56.32 -14.38 12.17 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.715 2.943 . . . . 0.0 113.761 177.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -75.07 -48.78 22.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.033 0.933 . . . . 0.0 110.628 173.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -80.84 -23.83 38.86 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.511 0.724 . . . . 0.0 111.911 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.506 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -93.43 153.71 18.34 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 174.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.601 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 32.9 ttt180 -134.89 126.48 28.81 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.726 ' HG ' HD12 ' A' ' 50' ' ' LEU . 5.3 tp -100.84 122.61 43.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.839 -166.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.1 mt -139.32 133.05 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.727 0.811 . . . . 0.0 109.954 -173.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.601 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 82.6 t80 -135.32 131.97 37.11 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.78 21.62 12.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.857 0.863 . . . . 0.0 112.468 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.58 10.4 79.58 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-N 116.449 -0.341 . . . . 0.0 113.819 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 12.7 ptpt -118.39 147.57 43.41 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.286 0.634 . . . . 0.0 109.373 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.529 ' HB2' HD22 ' B' ' 224' ' ' LEU . 8.0 tt0 -75.94 127.2 32.48 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.127 0.571 . . . . 0.0 109.779 178.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.726 HD12 ' HG ' ' A' ' 43' ' ' LEU . 25.0 mt -80.75 123.65 28.39 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.039 0.536 . . . . 0.0 109.998 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.75 138.44 32.09 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.152 0.981 . . . . 0.0 109.707 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.53 -39.2 92.82 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.627 1.171 . . . . 0.0 112.28 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.14 -18.57 76.64 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.218 0.949 . . . . 0.0 113.816 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -88.35 178.1 6.66 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.823 0.849 . . . . 0.0 111.563 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.6 p -116.59 168.67 9.97 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.717 0.807 . . . . 0.0 109.874 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.5 mt -57.54 -50.73 72.13 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.1 t -61.55 -25.64 67.43 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.379 1.072 . . . . 0.0 111.554 -177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -64.64 -45.98 84.49 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 121.127 0.489 . . . . 0.0 109.688 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -85.59 17.23 3.36 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.473 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 65.73 19.98 11.45 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.402 1.081 . . . . 0.0 111.776 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.6 mt -85.58 132.68 31.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -115.8 -175.2 2.68 Favored 'General case' 0 C--O 1.249 1.033 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -61.96 130.41 45.49 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.238 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 72.58 18.18 4.42 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.258 1.423 . . . . 0.0 111.965 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.4 m -71.05 139.92 50.58 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 53.1 m -93.72 129.66 39.98 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.456 0.473 . . . . 0.0 109.986 176.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.601 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -137.84 166.07 24.92 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.696 1.198 . . . . 0.0 108.891 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 -96.65 148.3 23.01 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.349 0.595 . . . . 0.0 111.267 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.655 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -127.12 130.85 50.6 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 94.0 t -114.02 130.42 68.25 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 124.207 1.003 . . . . 0.0 109.936 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 92.1 mt -98.34 146.29 25.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.317 0.647 . . . . 0.0 110.95 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.623 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 65.2 mtp180 -117.18 -40.46 3.09 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.28 1.032 . . . . 0.0 110.627 177.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 71' ' ' LEU . 4.2 mm? 48.19 34.31 4.32 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.989 1.316 . . . . 0.0 113.191 -177.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.623 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 26.1 mmm180 -74.09 -42.47 60.09 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.586 0.707 . . . . 0.0 109.271 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.74 64.67 0.49 Allowed Glycine 0 C--N 1.34 0.805 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.13 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.046 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 175.69 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.728 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 23.5 m -69.27 146.69 52.07 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.771 0.828 . . . . 0.0 111.369 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -162.46 -33.65 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.661 0.784 . . . . 0.0 109.802 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -85.92 156.8 20.35 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.8 0.84 . . . . 0.0 109.165 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.47 117.17 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 121.253 0.549 . . . . 0.0 110.543 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . 0.531 HG22 HG13 ' B' ' 202' ' ' VAL . 29.5 m -72.49 131.86 43.09 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.096 -173.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -83.94 122.68 29.07 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . 0.531 HG13 HG22 ' B' ' 200' ' ' THR . 3.6 m -145.59 -177.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.902 0.881 . . . . 0.0 110.179 -168.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -125.81 146.7 49.68 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.58 0.752 . . . . 0.0 110.907 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.627 ' HA ' HD11 ' B' ' 216' ' ' ILE . 48.7 t -92.95 96.09 1.29 Allowed Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 124.651 1.18 . . . . 0.0 107.998 177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.56 ' HD2' HD21 ' B' ' 220' ' ' LEU . 34.2 Cg_endo -59.79 -17.36 42.76 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.234 2.622 . . . . 0.0 114.483 -168.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 23.6 t -79.16 -56.93 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 122.789 0.436 . . . . 0.0 110.851 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 14.9 p -103.65 -0.65 29.26 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.435 0.294 . . . . 0.0 111.555 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 69.05 42.11 78.47 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 115.153 0.821 . . . . 0.0 115.153 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.01 137.51 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.318 0.559 . . . . 0.0 110.894 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -89.13 123.77 33.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.211 0.604 . . . . 0.0 109.684 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.2 pt -153.55 160.11 31.32 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.845 1.258 . . . . 0.0 110.434 -168.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.18 161.22 16.83 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.172 2.581 . . . . 0.0 113.563 171.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.571 ' O ' HG22 ' B' ' 216' ' ' ILE . 40.3 tt0 -62.79 -44.72 95.42 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.412 1.485 . . . . 0.0 113.096 -172.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 20.3 m -62.66 -40.99 98.78 Favored 'General case' 0 C--O 1.254 1.304 0 CA-C-O 121.978 0.894 . . . . 0.0 110.347 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -73.58 -26.3 60.75 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.249 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -69.54 -43.68 80.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -178.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -67.29 -37.42 83.38 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 123.394 0.434 . . . . 0.0 110.421 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -69.59 -40.59 76.61 Favored 'General case' 0 C--O 1.247 0.945 0 O-C-N 123.226 0.329 . . . . 0.0 111.57 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -45.45 93.15 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.48 -177.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.56 HD21 ' HD2' ' B' ' 205' ' ' PRO . 96.3 mt -61.82 -43.62 98.48 Favored 'General case' 0 C--O 1.206 -1.196 0 O-C-N 124.431 1.082 . . . . 0.0 111.153 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.45 -27.21 56.2 Favored 'General case' 0 CA--C 1.553 1.094 0 O-C-N 124.578 1.173 . . . . 0.0 110.767 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.4 t -91.57 -39.8 11.7 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.642 0.777 . . . . 0.0 111.454 172.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 91.4 m -75.04 -23.0 58.07 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.333 1.053 . . . . 0.0 112.899 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.5 pp -85.92 -23.9 26.81 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 32.1 m -71.49 84.37 0.83 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.697 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . 0.506 ' HG3' ' HG3' ' B' ' 227' ' ' GLU . 6.6 ptm180 -99.59 -36.02 9.66 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.979 -177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . 0.506 ' HG3' ' HG3' ' B' ' 226' ' ' ARG . 42.7 mt-10 . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 124.05 0.94 . . . . 0.0 108.484 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.038 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.8 m -84.09 115.84 22.58 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.692 0.797 . . . . 0.0 111.076 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -72.17 106.77 4.51 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.806 0.842 . . . . 0.0 109.67 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt -86.52 171.67 10.9 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.071 0.949 . . . . 0.0 111.044 -176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.475 HE21 HG21 ' A' ' 14' ' ' THR . 54.9 mt-30 -107.2 138.5 43.27 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.678 0.791 . . . . 0.0 110.635 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.585 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -137.57 153.59 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.299 1.04 . . . . 0.0 109.746 176.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 66' ' ' THR . 81.8 m-85 -105.79 107.78 18.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.033 0.933 . . . . 0.0 109.445 -175.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.451 HG21 HD11 ' A' ' 30' ' ' ILE . 56.1 t -103.67 117.58 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -108.11 119.6 39.95 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.844 0.857 . . . . 0.0 109.615 -171.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.635 HG22 HD12 ' A' ' 69' ' ' LEU . 38.5 p -72.1 165.0 25.19 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.296 0.569 . . . . 0.0 111.461 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 70' ' ' VAL . 88.4 mt -70.37 -18.7 63.06 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.165 171.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -79.64 -12.86 59.81 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.908 0.483 . . . . 0.0 110.809 172.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.54 18.78 37.19 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.908 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 153.44 18.16 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.7 m -100.58 134.28 43.78 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.585 0.754 . . . . 0.0 110.022 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 7' ' ' THR . 5.2 mp -120.41 109.93 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 124.96 1.304 . . . . 0.0 107.53 174.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.475 HG21 HE21 ' A' ' 2' ' ' GLN . 76.2 m -94.78 130.35 41.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -112.62 154.48 25.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.72 0.808 . . . . 0.0 109.28 -177.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -110.6 71.87 0.77 Allowed 'General case' 0 C--O 1.242 0.706 0 O-C-N 124.512 1.132 . . . . 0.0 108.887 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.794 HG21 HG22 ' A' ' 26' ' ' VAL . 20.3 m -140.47 172.63 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.514 0.726 . . . . 0.0 110.169 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -102.87 161.88 21.83 Favored Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 123.639 0.775 . . . . 0.0 109.95 -172.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 29.1 Cg_endo -59.41 -37.05 92.22 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 121.868 1.712 . . . . 0.0 111.03 171.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.4 p -96.64 15.72 20.93 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.872 0.869 . . . . 0.0 111.092 -174.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.75 -98.97 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.771 0.828 . . . . 0.0 109.576 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.1 t 174.75 142.45 0.05 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.989 1.316 . . . . 0.0 109.091 173.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.4 mm -61.0 -38.84 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.208 1.003 . . . . 0.0 111.848 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 42.7 tt0 -57.47 -35.22 69.89 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.563 0.697 . . . . 0.0 111.483 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.4 t30 -75.99 -42.23 48.86 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.213 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.794 HG22 HG21 ' A' ' 17' ' ' VAL . 61.8 t -55.27 -47.3 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 124.606 1.191 . . . . 0.0 110.367 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -69.45 -32.2 70.99 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.079 0.551 . . . . 0.0 111.696 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.48 70.44 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.387 0.429 . . . . 0.0 110.838 170.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 8.8 mmpt? -75.96 -35.81 59.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.906 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 5' ' ' VAL . 2.2 mp -57.09 -43.4 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 118.915 0.78 . . . . 0.0 109.666 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.11 -31.76 72.26 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.353 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.36 -30.77 66.56 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.42 0.688 . . . . 0.0 111.541 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 72.2 mmtt -93.55 -70.37 0.71 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 117.624 0.193 . . . . 0.0 110.715 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -80.38 -25.93 38.85 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.24 0.216 . . . . 0.0 111.274 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.32 18.55 30.68 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.311 0.382 . . . . 0.0 113.928 174.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.75 123.83 41.07 Favored Pre-proline 0 CA--C 1.552 1.025 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -70.29 156.64 61.52 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.112 2.541 . . . . 0.0 112.375 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.23 -16.43 17.36 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.713 2.942 . . . . 0.0 114.072 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -71.8 -47.09 55.75 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 120.949 0.404 . . . . 0.0 110.197 173.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -83.2 -21.3 33.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.895 0.878 . . . . 0.0 112.216 -172.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.502 HE22 HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -109.18 153.0 24.39 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.105 0.562 . . . . 0.0 110.515 177.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -138.72 138.08 37.37 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.119 0.567 . . . . 0.0 110.263 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.502 HD21 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -98.06 125.08 42.88 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.788 0.835 . . . . 0.0 110.373 -174.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -142.86 125.04 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.015 0.926 . . . . 0.0 109.586 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.643 ' HB3' HD21 ' A' ' 50' ' ' LEU . 79.4 t80 -124.67 124.96 43.31 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.43 1.092 . . . . 0.0 108.148 177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.447 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 60.44 27.0 16.6 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.893 0.877 . . . . 0.0 112.812 175.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.52 -15.89 61.99 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 2.5 ptpt -98.73 142.32 30.43 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -83.18 132.96 35.04 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.643 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.7 mt -82.51 116.64 22.04 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.426 0.691 . . . . 0.0 110.996 -175.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -83.87 139.45 32.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.485 1.114 . . . . 0.0 110.466 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.5 m-20 -56.25 -47.92 77.57 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.603 1.161 . . . . 0.0 112.795 -172.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.49 -18.2 71.5 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 124.758 1.286 . . . . 0.0 113.893 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 62.5 mtt180 -84.96 177.53 7.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.69 0.796 . . . . 0.0 111.04 175.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.9 p -116.71 170.78 8.33 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.343 177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 94.9 mt -57.35 -47.97 80.21 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 171.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 47.4 t -62.18 -26.49 68.37 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.755 1.222 . . . . 0.0 111.6 -176.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 7.7 t70 -61.25 -45.47 94.4 Favored 'General case' 0 C--N 1.357 0.932 0 CA-C-O 121.532 0.682 . . . . 0.0 109.654 177.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.4 15.95 7.11 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.589 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 71.22 8.06 6.3 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.475 1.51 . . . . 0.0 112.309 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mt -77.91 129.56 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -122.83 -176.63 3.45 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -59.16 143.5 48.66 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 68.19 13.3 9.05 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.885 1.274 . . . . 0.0 112.239 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.5 m -84.91 138.76 32.32 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 171.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 57.9 m -99.27 127.31 45.25 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 110.187 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.587 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -124.13 173.67 8.15 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.25 1.42 . . . . 0.0 108.585 176.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -108.97 154.96 21.44 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.496 0.718 . . . . 0.0 110.97 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD12 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -133.79 126.17 30.02 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.589 HG11 HD11 ' B' ' 220' ' ' LEU . 90.2 t -104.95 115.85 47.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 123.518 0.727 . . . . 0.0 109.993 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.471 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 86.8 mt -85.67 147.79 26.2 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.519 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 54.9 mtp180 -121.98 -45.64 2.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.249 1.02 . . . . 0.0 110.127 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.611 ' HB3' ' HD2' ' B' ' 197' ' ' ARG . 3.9 mm? 52.46 29.27 6.8 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.501 1.121 . . . . 0.0 112.976 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.603 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 4.8 mmp_? -64.7 -43.67 92.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.577 0.751 . . . . 0.0 110.545 -176.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.95 35.85 4.47 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.831 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.453 0 CA-C-O 120.169 -0.24 . . . . 0.0 112.786 -178.192 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.08 0 CA-C-O 120.121 -0.266 . . . . 0.0 113.183 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 22.6 p -72.13 119.55 16.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.487 0.715 . . . . 0.0 110.108 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . 0.611 ' HD2' ' HB3' ' A' ' 73' ' ' LEU . 34.7 mmt180 -85.65 73.63 10.4 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.216 0.532 . . . . 0.0 110.307 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.17 149.91 28.9 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.352 170.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 4.8 p -61.06 104.1 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-O 121.472 0.653 . . . . 0.0 109.614 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . 0.403 HG22 HG13 ' B' ' 202' ' ' VAL . 22.8 m -68.46 143.59 54.96 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.886 -174.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' B' ' 201' ' ' LYS . 11.2 mptt -94.94 122.29 37.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . 0.403 HG13 HG22 ' B' ' 200' ' ' THR . 3.5 m -142.6 -178.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.289 1.036 . . . . 0.0 109.761 -166.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -118.73 146.31 44.86 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.256 0.622 . . . . 0.0 110.599 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.523 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.7 t -83.08 102.64 1.9 Allowed Pre-proline 0 N--CA 1.471 0.584 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.518 ' HD2' HD21 ' B' ' 220' ' ' LEU . 43.7 Cg_endo -62.38 -9.6 15.96 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.319 2.679 . . . . 0.0 114.052 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.78 -65.09 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.311 0.644 . . . . 0.0 110.611 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 18.1 p -100.3 2.46 42.63 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.704 0.401 . . . . 0.0 112.061 -172.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 63.23 38.85 97.14 Favored Glycine 0 N--CA 1.477 1.388 0 N-CA-C 115.494 0.957 . . . . 0.0 115.494 170.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.65 134.41 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 123.077 0.551 . . . . 0.0 110.482 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -84.74 122.62 29.36 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.611 0.365 . . . . 0.0 110.029 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 6.0 pt -149.44 158.7 37.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 125.825 1.65 . . . . 0.0 109.484 -171.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.8 162.99 20.07 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.618 2.212 . . . . 0.0 112.839 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.546 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.5 tt0 -65.36 -36.18 83.24 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.459 1.504 . . . . 0.0 113.23 -169.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 34.2 t -69.0 -38.0 79.04 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.098 0.475 . . . . 0.0 110.04 174.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -76.26 -23.45 54.45 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.2 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' B' ' 220' ' ' LEU . 0.3 OUTLIER -70.91 -43.0 77.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -55.78 -52.87 62.49 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.016 0.823 . . . . 0.0 110.346 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -54.26 -47.48 72.25 Favored 'General case' 0 C--O 1.252 1.221 0 O-C-N 124.307 1.004 . . . . 0.0 111.82 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -35.06 79.13 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.991 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.589 HD11 HG11 ' A' ' 70' ' ' VAL . 71.3 mt -64.62 -51.95 60.01 Favored 'General case' 0 C--O 1.213 -0.858 0 O-C-N 123.529 0.518 . . . . 0.0 110.882 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -58.25 -29.41 65.75 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.569 1.168 . . . . 0.0 111.684 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 46.7 t -81.88 -43.5 18.11 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.435 0.694 . . . . 0.0 110.921 174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 69.6 m -81.59 -19.03 42.77 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.251 1.02 . . . . 0.0 113.383 -170.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp -83.82 2.16 39.62 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.482 0.583 . . . . 0.0 111.182 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 32.1 t -51.62 103.93 0.07 Allowed 'General case' 0 C--N 1.357 0.901 0 C-N-CA 124.58 1.152 . . . . 0.0 111.107 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 -67.79 127.49 32.97 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.565 175.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 124.372 1.069 . . . . 0.0 109.611 177.446 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.145 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 60.0 m -138.76 26.4 2.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.805 0.842 . . . . 0.0 111.201 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -75.68 97.81 3.91 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 mmt -84.99 155.98 21.34 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.991 0.916 . . . . 0.0 111.065 -172.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 18.5 mp0 -92.91 124.57 36.99 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.488 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.507 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -122.5 157.56 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.338 1.455 . . . . 0.0 108.212 175.418 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 66' ' ' THR . 64.7 m-85 -116.81 105.51 12.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.431 -172.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 30' ' ' ILE . 40.3 t -95.08 122.26 46.38 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -108.9 120.04 41.33 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.309 0.644 . . . . 0.0 110.144 -173.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.652 HG22 HD12 ' A' ' 69' ' ' LEU . 31.6 p -77.77 167.08 22.12 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.465 0.65 . . . . 0.0 111.939 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 82.6 mt -71.28 -20.22 62.24 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.724 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -78.67 -16.94 56.7 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.954 0.502 . . . . 0.0 110.282 174.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.58 14.8 26.61 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -93.22 152.83 18.96 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.469 0.635 . . . . 0.0 109.436 176.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.9 m -96.29 143.25 27.53 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 7' ' ' THR . 5.0 mp -125.1 102.44 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.0 m -84.49 117.39 23.65 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -104.3 153.49 20.96 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.42 ' HG3' ' HG3' ' A' ' 2' ' ' GLN . 4.7 mp0 -114.37 90.63 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.777 HG21 HG22 ' A' ' 26' ' ' VAL . 9.2 m -139.32 169.04 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 175.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -90.13 153.13 46.73 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 42.5 Cg_endo -64.13 -26.32 65.29 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 121.975 1.783 . . . . 0.0 111.14 172.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.9 t -100.18 14.33 31.2 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.057 0.943 . . . . 0.0 110.365 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.73 -94.78 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.112 0.565 . . . . 0.0 109.57 -175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.2 t 179.58 145.65 0.19 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.521 1.128 . . . . 0.0 109.678 173.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.416 HG23 HD23 ' A' ' 43' ' ' LEU . 46.1 mm -61.8 -36.23 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.168 0.987 . . . . 0.0 111.196 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -57.71 -34.93 69.98 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.428 0.691 . . . . 0.0 111.009 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.416 ' H ' HG23 ' A' ' 22' ' ' THR . 15.7 t-20 -73.95 -43.29 58.73 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.152 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.777 HG22 HG21 ' A' ' 17' ' ' VAL . 38.6 t -57.71 -50.06 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 124.256 0.973 . . . . 0.0 110.735 -178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.4 ' HE3' HG22 ' A' ' 23' ' ' ILE . 18.0 ptpt -67.41 -30.19 69.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.179 0.592 . . . . 0.0 111.232 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.62 78.84 Favored 'General case' 0 C--N 1.359 1.01 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.653 171.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 7.2 mmpt? -73.82 -31.63 63.33 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 118.801 -0.618 . . . . 0.0 110.896 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 5' ' ' VAL . 1.7 mp -54.26 -47.87 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.638 0.654 . . . . 0.0 110.113 169.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -66.03 -30.81 71.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.395 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.24 -27.74 64.7 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.344 0.658 . . . . 0.0 111.627 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.6 mmtt -100.61 -68.84 0.79 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.711 0.404 . . . . 0.0 110.912 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -83.42 -22.36 32.7 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.412 0.285 . . . . 0.0 111.311 -175.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.73 6.98 57.0 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 113.883 0.313 . . . . 0.0 113.883 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -95.54 124.07 54.26 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.071 0.549 . . . . 0.0 109.764 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 40' ' ' GLN . 53.1 Cg_endo -64.31 155.91 62.87 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.525 2.817 . . . . 0.0 113.152 -174.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -56.5 -18.29 24.94 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 124.237 3.291 . . . . 0.0 113.94 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.53 -47.14 16.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.26 0.624 . . . . 0.0 110.748 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -78.59 -23.8 45.82 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.3 0.64 . . . . 0.0 111.056 -173.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.548 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -93.06 152.7 19.13 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.59 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 35.4 ttt180 -140.54 116.87 10.68 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 121.844 0.831 . . . . 0.0 109.032 175.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.729 ' HG ' HD12 ' A' ' 50' ' ' LEU . 10.6 tp -93.84 123.75 37.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.654 -162.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.533 HD11 HD21 ' B' ' 220' ' ' LEU . 96.2 mt -140.49 135.45 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 123.291 0.637 . . . . 0.0 110.775 -169.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 78.6 t80 -136.13 132.85 36.59 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.72 18.15 10.67 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.523 1.129 . . . . 0.0 112.61 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.67 15.48 65.71 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 119.86 -0.411 . . . . 0.0 113.593 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 13.6 ptpt -124.2 143.9 50.25 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.505 0.722 . . . . 0.0 109.148 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -75.5 130.67 39.27 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.779 0.431 . . . . 0.0 110.349 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.729 HD12 ' HG ' ' A' ' 43' ' ' LEU . 24.9 mt -78.49 122.03 25.33 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 123.21 0.604 . . . . 0.0 110.465 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -77.74 136.29 38.13 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 123.689 0.796 . . . . 0.0 108.91 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -61.62 -36.97 82.26 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.105 0.878 . . . . 0.0 112.521 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.25 -27.83 69.25 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.98 0.8 . . . . 0.0 113.166 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -76.04 176.83 7.58 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.127 0.571 . . . . 0.0 111.44 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.0 p -114.75 168.75 9.61 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.707 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 85.4 mt -55.71 -52.1 65.05 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 123.948 0.78 . . . . 0.0 109.532 172.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -59.13 -27.52 65.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.529 1.132 . . . . 0.0 111.83 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.13 -40.05 86.72 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.027 0.531 . . . . 0.0 110.017 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -90.39 21.37 3.91 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.918 0.887 . . . . 0.0 111.41 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 67.17 15.36 10.03 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.451 1.101 . . . . 0.0 111.884 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -88.11 134.36 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -122.9 -173.59 2.74 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.453 0.701 . . . . 0.0 109.266 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . 11.7 ptmm? -59.04 144.0 46.7 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.918 170.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 65.05 7.6 4.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.614 1.566 . . . . 0.0 112.968 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -72.4 129.86 39.35 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 118.112 0.414 . . . . 0.0 109.897 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 20.0 m -99.43 140.91 32.91 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.531 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -143.58 173.87 11.27 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.09 0.956 . . . . 0.0 109.344 -175.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -97.54 154.63 17.39 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.691 0.758 . . . . 0.0 111.601 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.652 HD12 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -137.49 119.33 15.22 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.484 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.638 HG21 HD22 ' B' ' 220' ' ' LEU . 53.1 t -93.31 110.31 23.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.581 0.752 . . . . 0.0 110.368 177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.6 mt -78.25 137.78 38.29 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.748 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -115.54 -48.62 2.77 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.19 0.996 . . . . 0.0 109.641 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 48.75 45.83 21.77 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.185 1.394 . . . . 0.0 112.196 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -68.74 -36.09 77.95 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.316 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.13 14.83 56.47 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.274 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.586 0 CA-C-N 117.195 0.497 . . . . 0.0 112.185 178.392 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.101 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 60.8 p -78.04 79.31 4.51 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.531 0.681 . . . . 0.0 109.944 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -64.71 -35.01 79.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.162 0.985 . . . . 0.0 110.17 175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -128.32 158.39 38.33 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.793 1.237 . . . . 0.0 107.794 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 2.4 p -58.06 108.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 CA-C-O 121.377 0.608 . . . . 0.0 110.678 173.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 5.6 m -69.6 138.03 52.79 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.0 -174.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -95.54 127.32 41.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 171.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 6.0 m -145.38 -177.56 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.135 1.374 . . . . 0.0 109.28 -162.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -115.18 137.2 52.29 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 122.464 0.306 . . . . 0.0 111.522 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.524 ' HA ' HD11 ' B' ' 216' ' ' ILE . 48.8 t -79.91 101.43 0.84 Allowed Pre-proline 0 N--CA 1.477 0.907 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.406 ' HD3' HD11 ' B' ' 216' ' ' ILE . 91.9 Cg_endo -71.0 -1.09 8.95 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.796 2.33 . . . . 0.0 114.592 -159.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 23.3 t -93.88 -62.95 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.2 p -89.47 -10.51 46.09 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.745 0.418 . . . . 0.0 111.52 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 61.14 57.7 17.2 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 124.321 0.962 . . . . 0.0 114.195 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 32.6 m -117.94 135.62 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.399 0.68 . . . . 0.0 109.263 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -83.85 113.03 20.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.497 HD11 ' HB2' ' B' ' 204' ' ' CYS . 7.9 pt -142.5 156.04 63.73 Favored Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 124.808 1.243 . . . . 0.0 110.287 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.92 163.34 14.04 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.946 2.431 . . . . 0.0 113.186 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.576 ' O ' HG22 ' B' ' 216' ' ' ILE . 43.8 tt0 -65.47 -37.04 85.66 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.176 1.39 . . . . 0.0 113.131 -166.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 23.3 t -65.48 -43.6 89.72 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-O 121.369 0.605 . . . . 0.0 109.743 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -69.81 -25.01 63.57 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.402 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.576 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -70.24 -44.03 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -61.88 -46.43 89.46 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 123.686 0.616 . . . . 0.0 110.508 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -47.79 78.9 Favored 'General case' 0 C--O 1.25 1.093 0 O-C-N 124.0 0.813 . . . . 0.0 112.469 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.53 -37.75 88.49 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.569 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.638 HD22 HG21 ' A' ' 70' ' ' VAL . 62.6 tp -62.48 -42.59 99.59 Favored 'General case' 0 C--O 1.215 -0.723 0 O-C-N 124.28 0.988 . . . . 0.0 111.452 176.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -53.23 -40.35 64.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.856 0.722 . . . . 0.0 110.342 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.2 t -75.53 -41.87 53.99 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.324 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 96.0 m -77.9 -19.04 55.44 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.169 0.987 . . . . 0.0 112.878 -171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.625 HD23 ' HG ' ' B' ' 220' ' ' LEU . 4.2 pp -90.15 -5.22 56.7 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.647 0.379 . . . . 0.0 110.73 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 20.8 t -71.52 87.52 0.9 Allowed 'General case' 0 C--N 1.356 0.878 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -113.59 138.68 49.82 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.185 0.994 . . . . 0.0 110.427 -172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 . . . . . 0 CA--C 1.559 1.318 0 C-N-CA 124.002 0.921 . . . . 0.0 109.93 -176.26 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 22.7 t -69.73 122.51 19.32 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -81.11 119.04 23.06 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.035 0.934 . . . . 0.0 110.421 -173.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt -80.0 158.48 26.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.487 1.115 . . . . 0.0 110.338 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 77.7 mt-30 -104.72 123.22 47.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.516 0.726 . . . . 0.0 110.572 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -123.85 155.27 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.538 1.135 . . . . 0.0 109.623 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -108.28 103.88 13.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.921 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.614 HG12 ' HB2' ' A' ' 69' ' ' LEU . 92.3 t -104.65 100.17 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.99 122.52 43.01 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.595 0.758 . . . . 0.0 111.129 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.622 HG22 HD12 ' A' ' 69' ' ' LEU . 37.4 p -67.71 162.97 22.57 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.608 0.763 . . . . 0.0 112.219 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.33 -15.69 63.39 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.138 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.5 p -80.21 0.01 34.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.47 0.708 . . . . 0.0 111.202 174.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.53 9.3 75.71 Favored Glycine 0 C--N 1.351 1.39 0 C-N-CA 123.235 0.445 . . . . 0.0 113.376 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -94.23 141.6 28.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.036 0.934 . . . . 0.0 109.237 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 m -105.22 136.6 44.44 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.831 0.452 . . . . 0.0 110.534 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.34 109.84 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.086 0.954 . . . . 0.0 109.021 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.0 m -84.72 122.49 29.17 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.6 mm? -108.95 159.05 17.13 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -124.02 82.25 2.01 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.677 HG21 HG22 ' A' ' 26' ' ' VAL . 15.4 m -140.84 172.6 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.999 0.92 . . . . 0.0 109.775 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.93 149.15 35.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 30.1 Cg_endo -61.79 -27.06 80.18 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.085 1.856 . . . . 0.0 111.904 175.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.4 t -99.87 16.62 23.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.776 0.43 . . . . 0.0 110.308 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.79 -98.58 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 119.108 -0.472 . . . . 0.0 109.797 -176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -170.5 143.85 2.32 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 125.447 1.499 . . . . 0.0 108.786 175.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.37 -37.38 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.885 0.874 . . . . 0.0 110.639 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.98 -36.19 72.27 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.039 0.936 . . . . 0.0 110.849 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.475 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 24.3 t-20 -70.84 -46.42 62.76 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.397 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.677 HG22 HG21 ' A' ' 17' ' ' VAL . 67.0 t -55.87 -44.51 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 124.158 0.911 . . . . 0.0 110.85 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -71.93 -30.12 65.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.797 0.439 . . . . 0.0 111.748 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.68 -32.6 74.34 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.809 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 10.3 mmpt? -71.36 -35.21 71.04 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.526 0.516 . . . . 0.0 110.607 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.28 -46.04 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 122.877 0.471 . . . . 0.0 110.47 169.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -65.87 -23.3 66.63 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.3 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -83.08 -31.03 27.53 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.163 0.985 . . . . 0.0 111.327 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.1 mmtt -91.85 -70.43 0.69 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.621 0.368 . . . . 0.0 110.95 -174.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -86.72 -24.33 25.2 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.724 0.41 . . . . 0.0 111.236 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.48 35.71 8.47 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 123.436 0.46 . . . . 0.0 112.777 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -111.75 126.11 29.11 Favored Pre-proline 0 CA--C 1.556 1.188 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.49 151.49 79.86 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.221 2.614 . . . . 0.0 112.766 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -60.26 -13.94 26.82 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 124.137 3.225 . . . . 0.0 114.25 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.42 -43.66 39.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.377 0.671 . . . . 0.0 110.183 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.46 -35.59 30.37 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.629 0.772 . . . . 0.0 111.124 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.545 HE22 HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -88.76 148.73 23.79 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 177.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.813 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 39.8 ttt180 -135.47 130.96 35.52 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.333 0.653 . . . . 0.0 109.432 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.545 HD21 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -95.02 122.69 37.93 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.498 0.719 . . . . 0.0 110.232 -174.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -141.42 117.74 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.671 0.789 . . . . 0.0 110.027 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.52 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 88.5 t80 -117.38 126.98 53.58 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.307 1.043 . . . . 0.0 108.644 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.24 23.03 13.29 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.008 0.923 . . . . 0.0 112.691 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.79 1.64 65.5 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 114.274 0.47 . . . . 0.0 114.274 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.5 ptpt -112.56 145.81 39.66 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -80.76 140.97 35.22 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.513 HD21 ' HB3' ' A' ' 45' ' ' PHE . 19.8 mt -94.11 122.91 37.12 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.143 0.577 . . . . 0.0 110.538 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -87.49 140.31 29.66 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.346 1.058 . . . . 0.0 110.186 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.54 -52.04 56.78 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.57 1.548 . . . . 0.0 113.251 -173.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.67 -20.36 70.07 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 124.573 1.171 . . . . 0.0 113.922 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.2 mtt-85 -82.75 177.33 8.72 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.016 0.526 . . . . 0.0 110.681 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.8 p -116.82 168.79 9.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.317 0.647 . . . . 0.0 109.877 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 98.1 mt -57.21 -52.07 66.79 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 t -62.75 -25.16 68.06 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.302 1.041 . . . . 0.0 111.445 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -64.82 -40.95 96.02 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -91.16 17.03 8.68 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.153 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 69.54 17.16 8.01 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.578 1.151 . . . . 0.0 112.215 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.9 mt -87.52 139.78 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -137.6 -167.85 2.21 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -55.66 142.39 34.22 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.234 0.614 . . . . 0.0 112.031 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 56.24 14.62 1.6 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.248 1.419 . . . . 0.0 114.157 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.6 m -75.72 132.84 40.77 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.1 m -97.2 124.76 41.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.361 0.6 . . . . 0.0 110.012 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.52 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -127.42 174.67 8.82 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.178 1.391 . . . . 0.0 108.507 176.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -109.08 146.67 33.63 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.505 0.722 . . . . 0.0 111.102 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.622 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -122.28 125.71 46.59 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.813 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 79.5 t -105.26 124.27 59.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 123.62 0.768 . . . . 0.0 110.009 -175.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.556 ' HB3' HD23 ' A' ' 73' ' ' LEU . 83.1 mt -96.64 115.37 27.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.101 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -85.81 -46.06 11.01 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 169.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 71' ' ' LEU . 2.8 mm? 50.44 45.84 25.95 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.42 1.488 . . . . 0.0 113.511 172.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -67.64 87.06 0.21 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.227 166.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.48 -39.79 0.74 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.855 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.281 0 N-CA-C 112.418 -0.273 . . . . 0.0 112.418 -177.822 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.637 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 36.7 t -75.6 133.73 40.84 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.113 0.565 . . . . 0.0 110.43 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -117.07 11.24 14.17 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.965 0.906 . . . . 0.0 108.99 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -121.9 175.02 6.52 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.743 0.817 . . . . 0.0 110.773 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.82 99.02 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.397 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . 0.438 HG22 HG13 ' B' ' 202' ' ' VAL . 18.1 m -71.2 135.43 47.54 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.578 0.751 . . . . 0.0 110.096 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -95.76 123.88 39.53 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . 0.438 HG13 HG22 ' B' ' 200' ' ' THR . 2.9 m -146.59 152.56 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.841 1.256 . . . . 0.0 109.58 -171.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -90.67 146.78 23.74 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.121 0.568 . . . . 0.0 111.584 -173.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.658 ' HA ' HD11 ' B' ' 216' ' ' ILE . 37.4 t -88.69 97.91 0.98 Allowed Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.716 1.206 . . . . 0.0 108.184 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.608 ' HD2' HD21 ' B' ' 220' ' ' LEU . 33.2 Cg_endo -59.62 -14.96 28.56 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.37 2.713 . . . . 0.0 114.777 -168.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 33.4 t -84.37 -46.88 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 122.686 0.395 . . . . 0.0 111.245 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . 0.428 ' SG ' HG22 ' B' ' 209' ' ' VAL . 20.5 p -111.56 -3.36 15.14 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 67.93 42.75 84.92 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . 0.428 HG22 ' SG ' ' B' ' 207' ' ' CYS . 22.8 m -117.86 133.43 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 117.448 0.624 . . . . 0.0 110.418 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -86.63 121.88 29.76 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' B' ' 204' ' ' CYS . 5.9 pt -146.6 162.87 32.29 Favored Pre-proline 0 N--CA 1.484 1.264 0 C-N-CA 124.878 1.271 . . . . 0.0 110.673 -169.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -58.33 161.58 13.77 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.678 2.252 . . . . 0.0 113.505 172.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.569 ' O ' HG22 ' B' ' 216' ' ' ILE . 33.8 tt0 -65.62 -42.56 91.41 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.079 1.351 . . . . 0.0 112.788 -169.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 21.2 m -72.24 -35.89 68.95 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 121.623 -0.673 . . . . 0.0 110.432 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -74.5 -22.0 59.28 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.331 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.4 OUTLIER -69.09 -47.17 76.45 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -62.4 -39.2 92.46 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 123.77 0.669 . . . . 0.0 110.862 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -70.65 -42.91 70.2 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.104 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -36.69 84.08 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.608 HD21 ' HD2' ' B' ' 205' ' ' PRO . 87.3 mt -69.74 -42.46 73.89 Favored 'General case' 0 C--O 1.21 -0.995 0 O-C-N 124.321 1.013 . . . . 0.0 111.138 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -58.21 -25.54 61.76 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.505 1.128 . . . . 0.0 110.682 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 30.5 t -89.8 -44.08 10.21 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.056 170.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.8 m -70.19 -20.46 63.12 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.327 1.051 . . . . 0.0 113.062 -171.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.99 -1.3 57.91 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.909 0.484 . . . . 0.0 112.168 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 70.5 p -69.49 83.75 0.41 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.811 0.815 . . . . 0.0 109.86 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 19.4 mmm-85 -110.77 -20.45 12.49 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.377 1.071 . . . . 0.0 110.86 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 123.829 0.851 . . . . 0.0 112.126 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 112.596 -0.202 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.6 m -69.28 106.05 2.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.864 0.866 . . . . 0.0 109.38 173.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 6.3 p80 -71.76 96.89 1.68 Allowed 'General case' 0 CA--C 1.556 1.198 0 CA-C-O 121.762 0.792 . . . . 0.0 110.566 -171.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' HE3' ' A' ' 63' ' ' LYS . 21.2 mmt -101.43 146.76 27.18 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 172.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.3 mp0 -95.92 128.56 42.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.693 -172.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.09 147.76 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.793 1.237 . . . . 0.0 108.425 173.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' THR . 31.2 m-85 -103.29 101.58 11.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.283 0.633 . . . . 0.0 109.778 -172.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 69' ' ' LEU . 11.5 t -96.99 117.93 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -108.28 124.94 51.08 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.442 0.697 . . . . 0.0 109.445 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.597 HG22 HD12 ' A' ' 69' ' ' LEU . 35.3 p -73.16 167.24 21.57 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.489 0.661 . . . . 0.0 111.314 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.456 HD11 HG22 ' A' ' 70' ' ' VAL . 43.2 mt -68.81 -24.05 64.34 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.79 172.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p -78.69 -14.24 59.4 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.6 0.76 . . . . 0.0 110.758 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.99 18.9 32.68 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.033 0.373 . . . . 0.0 114.033 170.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.17 153.16 18.8 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 m -102.0 145.9 28.63 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.042 0.449 . . . . 0.0 110.053 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.537 HD11 HG23 ' A' ' 7' ' ' THR . 5.3 mp -128.88 108.68 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 m -87.91 115.44 25.38 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -103.35 152.2 21.86 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 176.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.66 ' HB3' ' HB2' ' A' ' 0' ' ' HIS . 37.1 mt-10 -128.29 79.42 1.9 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -171.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.645 HG21 HG22 ' A' ' 26' ' ' VAL . 30.0 m -146.07 179.02 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 124.673 1.189 . . . . 0.0 109.081 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -85.31 153.12 59.01 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.2 Cg_endo -59.09 -32.82 98.02 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 121.827 1.685 . . . . 0.0 110.85 164.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -91.96 8.88 35.49 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.018 0.927 . . . . 0.0 111.479 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -74.46 -92.3 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.342 0.657 . . . . 0.0 110.074 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 26' ' ' VAL . 8.9 t 177.08 145.5 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.48 1.112 . . . . 0.0 109.84 171.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -62.75 -34.25 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.177 0.991 . . . . 0.0 110.684 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -53.68 -40.77 66.24 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.953 0.901 . . . . 0.0 110.66 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.477 ' H ' HG23 ' A' ' 22' ' ' THR . 10.5 t-20 -77.31 -43.39 33.27 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.031 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.645 HG22 HG21 ' A' ' 17' ' ' VAL . 99.4 t -56.86 -44.25 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 O-C-N 124.361 1.038 . . . . 0.0 110.442 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HB2' ' OE1' ' A' ' 41' ' ' GLN . 16.6 ptpt -71.78 -32.58 67.8 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.947 0.499 . . . . 0.0 110.609 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.09 -28.41 68.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.858 0.463 . . . . 0.0 111.164 169.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 9.8 mmpt? -72.78 -37.06 67.73 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 122.9 0.48 . . . . 0.0 110.247 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.442 HG13 HG21 ' A' ' 13' ' ' ILE . 2.2 mp -58.53 -42.58 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 118.413 0.551 . . . . 0.0 109.838 172.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.05 -27.98 69.77 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.326 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.33 -27.87 47.21 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.614 0.766 . . . . 0.0 111.622 174.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.3 mmtt -95.69 -68.02 0.82 Allowed 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.986 -0.446 . . . . 0.0 111.025 -174.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 30' ' ' ILE . 15.1 pt-20 -85.51 -20.09 30.2 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.703 0.229 . . . . 0.0 111.549 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.31 24.76 35.68 Favored Glycine 0 C--N 1.347 1.17 0 O-C-N 122.946 0.154 . . . . 0.0 113.231 171.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.47 127.44 27.83 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.8 151.69 74.17 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.975 2.45 . . . . 0.0 112.486 -174.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 18.6 Cg_endo -57.43 -14.1 15.27 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.976 3.117 . . . . 0.0 114.782 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.21 -44.64 68.23 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 123.486 0.492 . . . . 0.0 110.202 172.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.11 -35.65 20.07 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.022 0.929 . . . . 0.0 111.882 -174.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.715 HE21 HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -94.16 120.29 34.19 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.014 0.435 . . . . 0.0 109.849 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.604 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.1 ttt180 -106.86 128.7 54.51 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.048 0.939 . . . . 0.0 109.544 -173.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.496 HD21 HE22 ' A' ' 41' ' ' GLN . 4.6 mm? -94.09 127.76 40.09 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.837 0.855 . . . . 0.0 109.653 -174.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.4 mt -141.54 131.54 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.676 0.79 . . . . 0.0 110.199 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.577 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 74.2 t80 -136.79 128.4 28.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.68 21.79 11.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.512 1.125 . . . . 0.0 112.164 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.66 -0.03 73.18 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.446 -0.641 . . . . 0.0 114.047 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.7 ptpt -112.42 151.51 29.76 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 117.711 0.755 . . . . 0.0 110.394 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' HD22 ' B' ' 224' ' ' LEU . 29.5 tt0 -77.32 133.04 38.88 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.171 0.589 . . . . 0.0 110.343 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 45' ' ' PHE . 24.2 mt -85.95 120.47 27.38 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 122.764 0.426 . . . . 0.0 110.258 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -79.74 136.1 36.68 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 123.731 0.813 . . . . 0.0 109.102 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.42 -38.08 82.9 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.142 0.902 . . . . 0.0 111.591 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.61 -38.52 96.53 Favored Glycine 0 C--N 1.348 1.211 0 O-C-N 123.844 0.715 . . . . 0.0 112.867 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -75.07 177.57 6.3 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.733 0.813 . . . . 0.0 112.034 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.7 p -110.43 167.52 10.15 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.66 0.784 . . . . 0.0 110.093 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.1 mt -55.78 -51.4 67.57 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.0 t -63.19 -24.02 67.69 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.47 1.108 . . . . 0.0 111.771 -175.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.13 -31.65 66.2 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.182 0.515 . . . . 0.0 109.909 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -94.53 17.5 13.08 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.626 0.77 . . . . 0.0 111.747 176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 68.75 16.65 8.92 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.447 1.099 . . . . 0.0 112.038 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.6 mt -88.05 119.48 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -99.36 179.77 4.47 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HE3' ' SD ' ' A' ' 1' ' ' MET . 8.7 ptmm? -60.3 142.78 54.2 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 170.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 68.33 9.5 7.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.918 1.287 . . . . 0.0 113.424 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -70.73 137.59 49.81 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 26.2 m -97.88 126.14 43.11 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.577 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -133.11 172.58 12.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.569 1.147 . . . . 0.0 108.854 -178.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -101.48 154.86 18.46 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.522 0.677 . . . . 0.0 111.68 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.715 HD21 HE21 ' A' ' 41' ' ' GLN . 2.2 tm? -135.88 132.81 37.03 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.206 -1.361 . . . . 0.0 107.936 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 99.5 t -117.0 124.04 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.929 0.892 . . . . 0.0 110.575 -175.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.434 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 86.5 mt -92.49 120.71 33.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.095 0.558 . . . . 0.0 109.685 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -90.72 -37.21 13.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.095 0.958 . . . . 0.0 109.612 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.434 ' HG ' ' HB3' ' A' ' 71' ' ' LEU . 92.8 mt 47.89 35.93 5.46 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.357 1.463 . . . . 0.0 113.154 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -58.4 -26.2 62.97 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.754 1.222 . . . . 0.0 112.013 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.53 45.24 0.66 Allowed Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 171.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.235 0 N-CA-C 112.309 -0.316 . . . . 0.0 112.309 -175.206 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.764 0 N-CA-C 112.096 -0.401 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 20.5 m -82.32 92.54 6.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.491 0.716 . . . . 0.0 110.569 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -94.25 -6.21 45.08 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.519 0.728 . . . . 0.0 109.454 170.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -123.46 162.62 22.47 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.213 1.405 . . . . 0.0 108.732 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.49 115.03 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.267 0.556 . . . . 0.0 109.66 175.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . 0.559 HG22 HG13 ' B' ' 202' ' ' VAL . 25.0 m -71.51 133.76 46.05 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.236 -168.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -87.76 123.24 32.36 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . 0.559 HG13 HG22 ' B' ' 200' ' ' THR . 4.0 m -141.38 -176.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.388 1.075 . . . . 0.0 109.48 -170.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -123.67 143.37 50.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.283 0.633 . . . . 0.0 110.042 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.628 ' HA ' HD11 ' B' ' 216' ' ' ILE . 49.7 t -84.66 97.85 0.55 Allowed Pre-proline 0 N--CA 1.478 0.943 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.576 ' HD2' HD21 ' B' ' 220' ' ' LEU . 27.4 Cg_endo -57.57 -25.57 67.82 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 123.332 2.688 . . . . 0.0 113.563 -171.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.59 -52.39 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 O-C-N 123.692 0.62 . . . . 0.0 111.275 -172.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.2 p -107.41 -4.01 18.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 72.53 45.82 35.04 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 115.18 0.832 . . . . 0.0 115.18 169.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 34.5 m -119.82 139.44 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.536 0.734 . . . . 0.0 110.677 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -89.28 115.83 27.05 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.502 HD11 ' HB2' ' B' ' 204' ' ' CYS . 12.3 pt -145.14 156.16 54.59 Favored Pre-proline 0 N--CA 1.483 1.181 0 C-N-CA 124.939 1.296 . . . . 0.0 109.815 -171.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.95 165.45 23.74 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.852 2.368 . . . . 0.0 113.946 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.6 ' O ' HG22 ' B' ' 216' ' ' ILE . 32.9 tt0 -56.79 -47.02 81.14 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 126.376 1.87 . . . . 0.0 114.318 -167.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 14.6 m -69.9 -37.87 76.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.13 -0.981 . . . . 0.0 110.391 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -67.16 -31.43 71.85 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.949 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.628 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -69.66 -46.46 75.0 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -176.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -61.47 -43.43 98.87 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.55 0.531 . . . . 0.0 110.73 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -59.91 -51.58 69.09 Favored 'General case' 0 C--O 1.253 1.245 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.487 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . 0.4 ' O ' ' SG ' ' B' ' 223' ' ' CYS . 0.2 OUTLIER -57.19 -41.7 79.84 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.864 -175.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 70' ' ' VAL . 96.7 mt -58.92 -53.86 53.62 Favored 'General case' 0 C--O 1.202 -1.398 0 O-C-N 124.399 1.062 . . . . 0.0 111.075 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.52 -30.18 60.22 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.767 1.292 . . . . 0.0 111.43 -171.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.8 t -83.44 -45.02 14.13 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.317 174.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' B' ' 219' ' ' HIS . 88.0 m -68.94 -29.02 67.17 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 124.63 1.172 . . . . 0.0 112.642 -173.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.2 pp -94.4 -23.64 17.68 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.6 0.76 . . . . 0.0 109.936 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 27.0 t -67.44 -30.38 70.09 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.537 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.16 77.6 3.7 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 167.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.494 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 23.2 p -70.98 113.95 8.54 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.594 0.757 . . . . 0.0 111.128 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -107.89 178.19 4.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.366 0.666 . . . . 0.0 109.888 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt -113.42 167.45 10.57 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.568 0.747 . . . . 0.0 109.651 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -120.5 142.95 48.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.737 0.415 . . . . 0.0 110.744 176.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -132.29 155.15 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.702 1.201 . . . . 0.0 109.385 175.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' THR . 92.2 m-85 -112.99 108.45 17.37 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.694 0.797 . . . . 0.0 109.648 -174.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' A' ' 69' ' ' LEU . 69.6 t -105.86 119.96 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -106.87 125.66 51.3 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.806 0.842 . . . . 0.0 110.281 -171.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.703 HG22 HD12 ' A' ' 69' ' ' LEU . 77.2 p -76.45 168.61 19.77 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.367 0.531 . . . . 0.0 111.793 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.5 mt -70.62 -22.93 62.47 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.256 171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -80.18 -5.6 56.35 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.277 0.631 . . . . 0.0 111.056 173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.78 20.65 46.33 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.352 -0.385 . . . . 0.0 113.999 167.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.14 153.21 18.23 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.5 m -104.11 134.37 47.49 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.239 0.616 . . . . 0.0 110.791 175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 7' ' ' THR . 5.3 mp -118.61 109.59 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.326 1.05 . . . . 0.0 108.44 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.0 m -91.21 119.26 31.15 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.136 0.575 . . . . 0.0 109.494 176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.9 mm? -104.98 155.73 18.68 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.446 0.698 . . . . 0.0 109.631 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -121.9 72.55 1.03 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.957 0.903 . . . . 0.0 108.695 -174.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.81 HG21 HG22 ' A' ' 26' ' ' VAL . 31.3 m -138.57 -176.23 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.945 0.898 . . . . 0.0 109.382 -174.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -108.43 158.03 34.93 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 122.966 0.506 . . . . 0.0 110.592 -172.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 38.0 Cg_endo -63.18 -28.15 73.19 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.504 2.136 . . . . 0.0 111.925 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 t -109.14 25.21 12.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.508 0.723 . . . . 0.0 109.633 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.02 -99.71 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.267 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 26' ' ' VAL . 10.1 t 173.55 140.44 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.275 1.43 . . . . 0.0 108.812 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mm -58.67 -37.43 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.583 1.153 . . . . 0.0 111.984 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 43.5 tt0 -58.32 -38.22 76.68 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.508 0.723 . . . . 0.0 111.062 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.509 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 9.7 t30 -74.06 -41.92 61.0 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.043 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.81 HG22 HG21 ' A' ' 17' ' ' VAL . 48.5 t -58.74 -45.71 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 124.231 0.957 . . . . 0.0 110.623 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 30' ' ' ILE . 18.4 ptpt -73.92 -27.49 61.06 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.271 0.628 . . . . 0.0 111.602 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.94 79.16 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.397 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 67.9 mmtt -74.12 -27.52 60.9 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.753 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 27' ' ' LYS . 91.9 mt -67.0 -36.09 76.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 120.999 0.428 . . . . 0.0 110.028 175.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -65.39 -33.62 76.38 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.657 169.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.44 -23.01 62.65 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.435 0.694 . . . . 0.0 111.581 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 73.0 mmtt -98.66 -67.66 0.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.92 0.327 . . . . 0.0 110.984 -177.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -84.09 -24.37 30.38 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.03 7.82 55.95 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 120.013 -0.326 . . . . 0.0 113.846 174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.22 124.92 43.28 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 73.3 Cg_endo -68.33 154.7 71.48 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.232 2.621 . . . . 0.0 112.773 -171.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 13.7 Cg_endo -53.99 -15.66 7.8 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.961 3.107 . . . . 0.0 114.134 177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.45 -41.96 37.79 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.852 0.861 . . . . 0.0 110.702 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -92.43 -19.02 22.47 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.91 0.884 . . . . 0.0 113.071 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.542 HE22 HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -103.14 149.73 24.34 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 173.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.488 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 38.5 ttt180 -134.68 129.99 35.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.26 0.624 . . . . 0.0 109.723 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.542 HD21 HE22 ' A' ' 41' ' ' GLN . 4.6 mm? -95.48 123.66 39.13 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.583 0.753 . . . . 0.0 110.549 -172.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.6 mt -141.93 124.71 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.672 0.789 . . . . 0.0 109.873 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 87.0 t80 -124.79 123.01 39.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.332 1.053 . . . . 0.0 108.191 175.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.02 25.92 15.19 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.837 0.855 . . . . 0.0 112.461 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.36 -21.5 45.16 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 122.956 0.313 . . . . 0.0 113.671 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 5.1 ptpt -91.11 134.47 34.49 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 117.362 0.581 . . . . 0.0 109.603 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.7 139.65 39.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 43' ' ' LEU . 24.3 mt -92.07 121.77 33.94 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.945 0.498 . . . . 0.0 110.96 -171.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.24 138.02 38.41 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.471 1.108 . . . . 0.0 109.973 -177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.0 m-20 -61.59 -42.49 98.94 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.3 1.04 . . . . 0.0 112.042 -172.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.84 -25.55 75.16 Favored Glycine 0 C--N 1.343 0.941 0 O-C-N 124.184 0.927 . . . . 0.0 113.467 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -78.86 177.24 8.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.997 0.519 . . . . 0.0 111.973 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.5 p -114.68 167.11 11.04 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.979 0.912 . . . . 0.0 110.228 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 87.9 mt -55.58 -56.23 22.77 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 123.704 0.628 . . . . 0.0 110.518 176.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 31.1 t -65.48 -18.35 65.25 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.981 0.912 . . . . 0.0 112.013 -174.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -65.0 -46.01 83.21 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.485 0.66 . . . . 0.0 109.34 173.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -86.21 18.66 3.02 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.094 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.455 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.6 OUTLIER 70.54 18.61 6.46 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.422 1.089 . . . . 0.0 111.802 176.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.4 mt -92.57 110.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -98.71 -174.7 2.86 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -65.14 135.59 55.68 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 120.95 0.405 . . . . 0.0 110.514 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 68.75 17.21 8.87 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.241 1.416 . . . . 0.0 111.811 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -72.27 139.08 47.88 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 168.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 41.1 m -101.36 128.38 47.56 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.531 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -133.48 168.09 19.26 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.27 1.028 . . . . 0.0 109.044 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -93.87 153.02 18.48 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.496 0.718 . . . . 0.0 111.406 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -134.21 129.45 35.75 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.587 HG21 HD11 ' B' ' 220' ' ' LEU . 95.4 t -112.09 117.56 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 123.424 0.69 . . . . 0.0 109.76 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.94 150.88 28.8 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.332 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.744 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 80.0 mtp180 -121.62 -49.86 2.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.816 0.847 . . . . 0.0 109.599 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 55.51 30.93 16.07 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.664 1.185 . . . . 0.0 112.017 -177.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.744 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 27.4 mmm180 -75.48 -24.43 56.93 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.251 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.63 15.76 56.92 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.973 172.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.524 0 CA-C-O 120.169 -0.239 . . . . 0.0 112.564 -176.012 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.785 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 25.8 m -80.36 98.72 7.59 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.954 0.502 . . . . 0.0 110.204 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -76.83 -16.37 59.45 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.697 0.799 . . . . 0.0 111.27 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -70.72 174.22 6.25 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.86 0.864 . . . . 0.0 111.874 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.1 p -55.34 101.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.36 0 C-N-CA 124.33 1.052 . . . . 0.0 111.759 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 70.3 m -85.87 128.3 34.79 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.871 0.868 . . . . 0.0 110.555 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -86.33 124.43 32.68 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 9.7 m -140.74 -176.73 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.063 1.345 . . . . 0.0 108.858 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -120.21 147.03 45.46 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.652 0.381 . . . . 0.0 110.244 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.631 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.5 t -86.87 101.34 2.05 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 123.995 0.918 . . . . 0.0 109.087 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.503 ' HD2' HD21 ' B' ' 220' ' ' LEU . 96.6 Cg_endo -72.13 11.4 0.74 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.834 2.356 . . . . 0.0 115.126 -166.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 19.5 t -103.54 -52.78 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.562 0.745 . . . . 0.0 110.24 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.9 p -106.87 -6.3 17.74 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.126 0.57 . . . . 0.0 111.628 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 59.79 59.19 10.95 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 124.467 1.032 . . . . 0.0 115.405 176.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.89 134.78 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.228 0.611 . . . . 0.0 110.007 173.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -76.87 120.49 22.07 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.573 HD11 ' HB2' ' B' ' 204' ' ' CYS . 5.4 pt -148.97 162.15 30.17 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 125.443 1.497 . . . . 0.0 109.112 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -65.85 161.19 40.36 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.545 2.164 . . . . 0.0 112.184 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.502 ' O ' HG22 ' B' ' 216' ' ' ILE . 41.2 tt0 -65.47 -28.23 69.06 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.268 1.027 . . . . 0.0 112.063 -174.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 39.5 t -67.88 -46.36 71.91 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.381 0.61 . . . . 0.0 110.38 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -80.87 -14.44 58.02 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.643 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.631 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.9 -42.94 53.37 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -58.2 7.47 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 124.134 0.896 . . . . 0.0 109.111 172.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -57.69 -44.73 86.04 Favored 'General case' 0 C--O 1.255 1.364 0 O-C-N 124.456 1.098 . . . . 0.0 111.069 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -39.4 83.47 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.388 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 70' ' ' VAL . 88.9 mt -69.8 -36.45 75.7 Favored 'General case' 0 C--O 1.212 -0.892 0 O-C-N 124.029 0.831 . . . . 0.0 111.72 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -57.02 -33.64 67.37 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.799 0.687 . . . . 0.0 110.513 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.8 t -86.28 -38.05 17.93 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.402 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 65.4 m -81.33 -19.63 42.41 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.82 0.848 . . . . 0.0 112.986 -169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp -76.44 -19.38 58.13 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.598 0.359 . . . . 0.0 110.564 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 32.7 t -64.57 115.46 5.21 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -124.63 165.32 18.1 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.978 0.911 . . . . 0.0 109.664 -169.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 . . . . . 0 C--O 1.254 1.32 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.334 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.995 0 CA-C-O 119.447 -0.641 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 37.0 m -65.93 97.84 0.38 Allowed 'General case' 0 C--N 1.354 0.799 0 C-N-CA 123.809 0.844 . . . . 0.0 110.373 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -116.89 152.9 33.53 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.177 0.991 . . . . 0.0 110.484 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -101.45 178.6 4.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.08 0.952 . . . . 0.0 110.242 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 22.5 mp0 -109.65 144.35 38.13 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.649 0.78 . . . . 0.0 109.856 175.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.48 149.61 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.881 0.873 . . . . 0.0 109.154 169.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 66' ' ' THR . 64.4 m-85 -106.25 100.16 9.71 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.24 -173.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.513 HG12 ' HB2' ' A' ' 69' ' ' LEU . 79.0 t -97.2 114.69 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -101.11 122.16 43.1 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.55 1.14 . . . . 0.0 110.337 -172.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.679 HG22 HD12 ' A' ' 69' ' ' LEU . 51.5 p -71.07 162.47 29.37 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.669 0.668 . . . . 0.0 111.069 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.517 HD11 HG22 ' A' ' 70' ' ' VAL . 84.1 mt -70.73 -20.24 62.67 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.047 171.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -80.34 -5.4 56.29 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.504 0.722 . . . . 0.0 111.206 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.47 15.28 51.1 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 114.457 0.543 . . . . 0.0 114.457 166.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.32 152.22 18.58 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.4 m -100.6 141.45 33.45 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.503 HD11 HG23 ' A' ' 7' ' ' THR . 5.4 mp -123.31 116.34 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.309 1.043 . . . . 0.0 108.297 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -101.38 117.16 34.4 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.518 0.727 . . . . 0.0 109.594 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -104.62 151.47 23.62 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.665 0.786 . . . . 0.0 109.515 -175.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -108.94 76.95 1.04 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 124.095 0.872 . . . . 0.0 109.338 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.719 HG21 HG22 ' A' ' 26' ' ' VAL . 3.6 m -140.7 170.38 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.429 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 15.9 mt-10 -91.8 157.88 40.88 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.491 0.716 . . . . 0.0 109.185 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 25.1 Cg_endo -61.24 -29.37 86.36 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.539 1.493 . . . . 0.0 111.206 168.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 t -99.28 19.86 14.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.731 0.812 . . . . 0.0 110.583 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 10.8 t70 -80.73 -94.74 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.2 t 177.05 143.87 0.09 Allowed 'General case' 0 C--N 1.364 1.238 0 C-N-CA 124.889 1.276 . . . . 0.0 109.734 173.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.415 HG22 ' HE3' ' A' ' 27' ' ' LYS . 47.8 mm -61.62 -38.01 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.539 1.136 . . . . 0.0 111.298 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -52.92 -40.45 63.59 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.968 0.907 . . . . 0.0 111.013 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.2 t-20 -72.72 -44.71 61.35 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.116 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.719 HG22 HG21 ' A' ' 17' ' ' VAL . 53.1 t -54.91 -47.68 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 124.479 1.112 . . . . 0.0 111.086 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HE3' HG22 ' A' ' 23' ' ' ILE . 17.7 ptpt -69.88 -34.06 73.05 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 122.879 0.472 . . . . 0.0 111.552 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -25.1 65.2 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.888 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 8.8 mmpt? -77.69 -32.35 52.97 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.58 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.472 HG13 HG21 ' A' ' 13' ' ' ILE . 1.9 mp -57.01 -43.13 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 119.078 0.854 . . . . 0.0 109.967 169.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -62.42 -30.67 71.39 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.635 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -73.76 -29.61 62.31 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.582 0.753 . . . . 0.0 111.833 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 69.8 mmtt -95.23 -67.98 0.82 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -83.38 -23.87 32.25 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.248 0.219 . . . . 0.0 110.923 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.6 40.8 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.195 174.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.53 125.08 35.02 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 72.5 Cg_endo -70.4 158.39 56.25 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.205 2.603 . . . . 0.0 112.698 -173.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.0 -16.27 20.16 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 123.804 3.003 . . . . 0.0 114.052 176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.439 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 23.0 t70 -74.46 -28.07 60.87 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.874 0.87 . . . . 0.0 110.797 175.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.402 ' OE1' ' HB2' ' A' ' 74' ' ' ARG . 2.7 mp0 -108.13 -17.59 13.99 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.823 1.249 . . . . 0.0 113.244 -175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB2' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -110.56 155.6 22.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.019 0.528 . . . . 0.0 110.218 176.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.469 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 41.7 ttt180 -139.54 125.0 19.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.94 0.496 . . . . 0.0 110.234 -174.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.4 ' CD2' HE22 ' A' ' 41' ' ' GLN . 3.1 mm? -93.69 124.24 37.55 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.517 0.727 . . . . 0.0 110.032 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -142.45 130.56 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.152 0.981 . . . . 0.0 109.526 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.528 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 89.8 t80 -128.56 135.37 49.28 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 171.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.62 16.7 10.47 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.18 0.992 . . . . 0.0 112.378 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.23 21.82 58.09 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.234 0.334 . . . . 0.0 113.846 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 11.4 ptpt -130.8 145.27 51.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.29 0.636 . . . . 0.0 109.352 174.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -74.58 140.13 44.17 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.815 0.446 . . . . 0.0 110.104 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 45' ' ' PHE . 27.4 mt -91.6 125.05 36.19 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.205 0.602 . . . . 0.0 110.647 -176.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.41 138.46 32.83 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 123.826 0.85 . . . . 0.0 110.309 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.65 -46.56 84.05 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.653 1.181 . . . . 0.0 112.387 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.7 -26.41 72.04 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 124.142 0.902 . . . . 0.0 113.641 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.401 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 55.9 mtt180 -77.54 177.09 8.32 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.303 0.641 . . . . 0.0 111.582 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.7 p -116.1 169.07 9.55 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.652 0.781 . . . . 0.0 109.777 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.497 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.0 mt -55.99 -53.07 61.36 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.698 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 t -61.34 -24.89 66.78 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.567 1.147 . . . . 0.0 111.648 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 12.4 t70 -65.7 -41.83 91.91 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -91.47 20.77 5.03 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.812 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 72.6 8.01 5.61 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 124.745 1.218 . . . . 0.0 112.789 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 10.6 mt -84.61 116.91 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -106.48 -172.15 2.03 Favored 'General case' 0 C--O 1.246 0.889 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -58.71 146.95 34.73 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.105 0.479 . . . . 0.0 110.557 172.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 62.9 5.57 1.86 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.636 1.574 . . . . 0.0 113.711 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.6 m -70.6 143.71 51.43 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 118.664 0.665 . . . . 0.0 111.198 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 27.2 m -108.54 134.3 51.49 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.15 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.517 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -144.77 173.13 12.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.988 1.315 . . . . 0.0 108.536 -176.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -102.97 153.43 20.23 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 121.701 0.762 . . . . 0.0 112.677 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.679 HD12 HG22 ' A' ' 7' ' ' THR . 2.3 tm? -130.52 126.07 35.9 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.517 HG22 HD11 ' A' ' 8' ' ' LEU . 73.8 t -110.79 124.61 67.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 123.275 0.63 . . . . 0.0 109.742 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -85.42 147.13 26.64 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.681 0.792 . . . . 0.0 110.355 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 39' ' ' ASP . 40.1 mtt180 -122.33 -44.18 2.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.703 0.801 . . . . 0.0 110.451 -173.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' B' ' 196' ' ' SER . 4.1 mm? 57.26 40.01 28.2 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.733 1.213 . . . . 0.0 112.081 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.402 ' HB2' ' OE1' ' A' ' 40' ' ' GLN . 18.8 mmm180 -68.97 -58.8 3.63 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.861 0.864 . . . . 0.0 110.355 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.48 14.41 39.12 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.994 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.737 0 CA-C-N 117.034 0.417 . . . . 0.0 113.692 178.977 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.693 0 N-CA-C 112.119 -0.393 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . 0.457 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 38.7 p -79.01 75.82 5.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.703 0.763 . . . . 0.0 110.374 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -102.61 10.7 38.57 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.904 0.882 . . . . 0.0 110.771 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -163.27 171.77 15.68 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.97 0.908 . . . . 0.0 110.075 -172.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.26 92.77 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 163.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . 0.512 HG22 HG13 ' B' ' 202' ' ' VAL . 8.2 m -66.7 130.83 44.46 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.984 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -93.94 123.99 37.65 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 169.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 8' ' ' LEU . 3.4 m -140.58 151.58 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.144 1.378 . . . . 0.0 110.047 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' B' ' 210' ' ' ASN . 4.8 m-20 -78.89 147.19 33.19 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.731 -175.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.658 ' HA ' HD11 ' B' ' 216' ' ' ILE . 24.8 t -89.77 98.33 1.3 Allowed Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.519 ' HD2' HD13 ' B' ' 220' ' ' LEU . 74.1 Cg_endo -68.45 9.01 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.521 2.814 . . . . 0.0 115.887 -163.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' B' ' 223' ' ' CYS . 29.9 t -104.61 -48.62 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 122.833 0.453 . . . . 0.0 110.654 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . 0.484 ' SG ' HG22 ' B' ' 209' ' ' VAL . 18.0 p -107.48 -7.95 16.4 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 122.901 0.48 . . . . 0.0 112.185 -173.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 70.63 41.55 64.66 Favored Glycine 0 N--CA 1.479 1.527 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . 0.484 HG22 ' SG ' ' B' ' 207' ' ' CYS . 27.9 m -118.62 132.83 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-N 117.647 0.724 . . . . 0.0 110.072 175.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' B' ' 203' ' ' ASP . 25.3 t-20 -86.23 126.49 34.31 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 4.9 pt -148.92 159.45 37.54 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 125.865 1.666 . . . . 0.0 108.991 -169.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.473 ' HG2' ' HB2' ' B' ' 215' ' ' HIS . 17.8 Cg_endo -58.74 156.25 33.48 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.41 2.073 . . . . 0.0 111.964 174.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.54 ' O ' HG22 ' B' ' 216' ' ' ILE . 26.7 tt0 -66.32 -30.21 70.57 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.02 0.928 . . . . 0.0 112.033 -170.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 51.2 p -63.92 -49.98 70.51 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.581 0.705 . . . . 0.0 109.558 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . 0.473 ' HB2' ' HG2' ' B' ' 212' ' ' PRO . 47.1 m80 -76.11 -12.2 60.07 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.871 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.3 OUTLIER -72.85 -51.6 26.45 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.274 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -63.87 -31.23 72.34 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 118.181 0.446 . . . . 0.0 111.727 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -66.13 -63.58 1.05 Allowed 'General case' 0 C--O 1.251 1.178 0 O-C-N 123.885 0.741 . . . . 0.0 111.556 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -43.27 69.79 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.319 1.048 . . . . 0.0 109.863 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.519 HD13 ' HD2' ' B' ' 205' ' ' PRO . 30.7 tp -63.31 -46.04 88.54 Favored 'General case' 0 C--O 1.215 -0.743 0 CA-C-N 113.654 -1.612 . . . . 0.0 111.808 -177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -55.17 -35.28 64.63 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 124.316 1.01 . . . . 0.0 110.358 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.3 t -79.77 -38.31 33.46 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.995 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' B' ' 206' ' ' VAL . 93.9 m -74.24 -35.11 63.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.448 1.099 . . . . 0.0 112.633 -172.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.422 HD23 ' HG ' ' B' ' 220' ' ' LEU . 4.0 pp -73.4 -9.08 58.32 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.559 0.743 . . . . 0.0 111.846 -168.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 40.5 m -72.65 87.03 1.22 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 173.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -125.91 122.96 37.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.084 0.953 . . . . 0.0 109.586 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.255 1.389 0 C-N-CA 123.669 0.788 . . . . 0.0 109.907 179.321 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.429 0 N-CA-C 112.312 -0.315 . . . . 0.0 112.312 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 60.9 m -153.94 177.26 11.23 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.695 1.198 . . . . 0.0 109.909 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -152.71 114.56 4.35 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 164.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mmt -123.39 160.22 27.26 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.163 0.985 . . . . 0.0 110.147 -173.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 17.4 mp0 -90.12 134.43 34.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.929 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.518 HD11 HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -130.53 157.96 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.126 1.37 . . . . 0.0 108.586 172.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 72.8 m-85 -116.55 120.5 38.91 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.305 0.642 . . . . 0.0 109.783 -173.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.578 HG21 HD11 ' A' ' 30' ' ' ILE . 68.9 t -109.9 130.89 62.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -118.16 117.02 28.01 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.573 HG23 HD11 ' A' ' 13' ' ' ILE . 43.5 p -70.15 165.68 21.53 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.286 0.565 . . . . 0.0 111.697 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.415 ' HB3' ' HB ' ' B' ' 202' ' ' VAL . 57.5 mt -68.92 -22.0 64.18 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.005 173.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.0 p -79.64 -15.89 56.78 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.387 0.675 . . . . 0.0 110.782 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.96 21.21 16.31 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-O 119.539 -0.59 . . . . 0.0 114.476 170.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -94.39 153.71 17.83 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 117.496 0.648 . . . . 0.0 109.599 174.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.9 m -100.53 144.22 29.77 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.324 0.65 . . . . 0.0 109.869 172.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.573 HD11 HG23 ' A' ' 7' ' ' THR . 5.3 mp -128.79 114.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.808 1.243 . . . . 0.0 108.408 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.1 m -99.58 121.85 41.79 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.504 0.722 . . . . 0.0 110.119 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -112.21 153.16 27.5 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -116.43 76.9 1.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 26' ' ' VAL . 20.5 m -140.04 177.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.375 0.67 . . . . 0.0 110.386 -177.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -91.99 157.08 41.74 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 123.642 0.777 . . . . 0.0 109.75 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 24.3 Cg_endo -61.95 -34.68 80.6 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.536 1.491 . . . . 0.0 110.836 165.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -94.13 13.88 21.76 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.1 0.56 . . . . 0.0 110.67 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.42 -96.15 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.393 0.677 . . . . 0.0 110.867 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.1 t 169.52 138.26 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.6 1.56 . . . . 0.0 108.307 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mm -61.15 -34.33 59.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 123.759 0.824 . . . . 0.0 110.956 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 16.8 tp10 -60.25 -35.42 75.44 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.557 0.694 . . . . 0.0 111.399 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 12.2 t30 -76.47 -44.04 37.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.923 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.674 HG22 HG21 ' A' ' 17' ' ' VAL . 62.6 t -57.0 -43.88 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 O-C-N 124.316 1.01 . . . . 0.0 110.488 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.544 ' HB2' ' OE1' ' A' ' 41' ' ' GLN . 17.6 ptpt -71.08 -33.89 70.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.261 0.624 . . . . 0.0 110.576 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.63 -31.77 73.04 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.848 171.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 9.7 mmpt? -72.62 -35.49 67.84 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.703 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.578 HD11 HG21 ' A' ' 5' ' ' VAL . 1.8 mp -55.65 -43.64 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 118.486 0.585 . . . . 0.0 110.167 171.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -65.48 -29.26 69.9 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.317 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.1 -25.92 62.81 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.169 0.588 . . . . 0.0 111.234 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 68.5 mmtt -99.28 -69.03 0.78 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.733 0.242 . . . . 0.0 111.168 -175.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -85.18 -21.2 29.27 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.73 14.1 51.05 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 114.298 0.479 . . . . 0.0 114.298 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -100.1 127.71 32.69 Favored Pre-proline 0 N--CA 1.481 1.113 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -177.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.29 154.27 72.51 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.06 2.507 . . . . 0.0 112.976 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HA ' ' OE1' ' A' ' 41' ' ' GLN . 15.6 Cg_endo -54.64 -14.84 8.09 Favored 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 124.295 3.33 . . . . 0.0 114.94 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -72.36 -48.53 41.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.962 0.505 . . . . 0.0 110.309 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 2.9 mp0 -88.82 -22.7 23.1 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.968 0.907 . . . . 0.0 113.109 -171.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.694 HE21 HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -101.21 124.64 47.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 174.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.816 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 34.1 ttt180 -112.91 130.27 56.17 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.177 0.991 . . . . 0.0 108.826 -172.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 50' ' ' LEU . 4.4 mm? -95.03 119.0 32.8 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.44 0.696 . . . . 0.0 110.533 -170.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.7 mt -140.95 127.73 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.562 0.745 . . . . 0.0 109.796 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.686 ' HB3' HD21 ' A' ' 50' ' ' LEU . 75.6 t80 -129.23 126.01 38.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.76 1.224 . . . . 0.0 108.448 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.41 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 61.8 18.45 9.73 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.107 0.963 . . . . 0.0 113.343 173.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.5 5.14 56.99 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.914 -0.381 . . . . 0.0 113.821 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.0 ptpt -118.02 146.98 43.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.367 0.667 . . . . 0.0 109.396 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -80.51 140.61 35.78 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.945 0.498 . . . . 0.0 109.98 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 45' ' ' PHE . 23.5 mt -94.96 114.93 26.82 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 122.931 0.493 . . . . 0.0 110.825 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -77.82 139.07 39.27 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.684 0.793 . . . . 0.0 110.199 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 11.2 p-10 -58.84 -39.54 81.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.522 1.129 . . . . 0.0 112.448 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.25 -18.25 80.06 Favored Glycine 0 C--N 1.354 1.536 0 O-C-N 124.126 0.891 . . . . 0.0 113.351 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HD3' ' OD2' ' A' ' 58' ' ' ASP . 99.6 mtt180 -86.13 177.11 7.64 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.46 0.704 . . . . 0.0 111.275 175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.2 p -116.19 168.44 10.11 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 123.864 0.865 . . . . 0.0 109.668 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.4 mt -56.23 -49.87 72.91 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 124.195 0.934 . . . . 0.0 109.65 173.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 35.7 t -63.67 -26.14 68.53 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.541 1.137 . . . . 0.0 111.548 -175.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' OD2' ' HD3' ' A' ' 54' ' ' ARG . 20.2 t70 -65.18 -41.61 94.42 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 121.544 0.688 . . . . 0.0 109.637 177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -89.87 15.07 10.49 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.944 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 71.37 14.85 6.38 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.072 1.349 . . . . 0.0 112.399 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 8.8 mt -86.52 121.68 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -115.01 -172.53 2.14 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 172.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -57.44 143.56 39.88 Favored 'General case' 0 C--O 1.245 0.825 0 O-C-N 123.293 0.37 . . . . 0.0 110.815 172.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 72.25 1.11 3.82 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.295 1.438 . . . . 0.0 112.31 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -75.62 135.57 40.48 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 118.09 0.404 . . . . 0.0 110.223 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.4 m -99.9 131.23 46.0 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.117 0.484 . . . . 0.0 110.603 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.511 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -124.57 175.7 7.0 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.866 1.266 . . . . 0.0 108.667 174.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -108.68 153.09 23.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.349 0.66 . . . . 0.0 111.423 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.694 HD21 HE21 ' A' ' 41' ' ' GLN . 2.1 tm? -131.21 126.25 35.07 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -175.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.816 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 84.4 t -105.28 109.2 26.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.802 0.841 . . . . 0.0 109.828 -177.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -81.63 138.96 35.25 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.305 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.717 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 61.2 mtp180 -113.07 -47.48 3.03 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.898 0.879 . . . . 0.0 110.676 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 57.93 21.98 8.25 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.939 0.896 . . . . 0.0 112.131 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.717 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 3.5 mmp_? -65.41 -49.84 67.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.48 0.712 . . . . 0.0 110.319 -174.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.3 -21.77 37.07 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.979 172.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--N 1.35 1.354 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.503 0 N-CA-C 112.296 -0.321 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 46.0 t -154.39 133.95 12.78 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 123.543 0.737 . . . . 0.0 109.871 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -174.44 90.89 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.244 1.018 . . . . 0.0 109.324 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -114.79 160.33 19.56 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.9 p -53.69 99.83 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 C-N-CA 124.246 1.018 . . . . 0.0 111.926 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . 0.563 HG22 HG13 ' B' ' 202' ' ' VAL . 38.5 m -84.06 133.55 34.65 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.805 0.842 . . . . 0.0 110.723 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' B' ' 201' ' ' LYS . 0.1 OUTLIER -93.67 123.6 37.11 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . 0.665 HG23 HG13 ' B' ' 216' ' ' ILE . 0.9 OUTLIER -147.61 146.18 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.033 0.933 . . . . 0.0 111.036 -162.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -74.2 147.73 42.26 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.383 0.673 . . . . 0.0 111.492 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.457 ' HA ' HD11 ' B' ' 216' ' ' ILE . 20.0 t -91.7 97.59 1.51 Allowed Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.166 0.986 . . . . 0.0 108.902 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.453 ' HD2' HD11 ' B' ' 220' ' ' LEU . 32.3 Cg_endo -58.52 -5.45 2.41 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.679 2.919 . . . . 0.0 116.364 -166.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . 0.427 HG11 ' O ' ' B' ' 223' ' ' CYS . 41.0 t -94.67 -57.48 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 173.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . 0.505 ' SG ' HG22 ' B' ' 209' ' ' VAL . 11.7 p -106.12 9.45 32.31 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -170.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.56 -37.55 2.78 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.865 1.106 . . . . 0.0 115.865 171.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . 0.505 HG22 ' SG ' ' B' ' 207' ' ' CYS . 20.6 m -60.2 134.73 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -165.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -84.7 125.35 32.44 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.699 HG13 HG12 ' B' ' 216' ' ' ILE . 5.2 pt -148.56 156.08 41.98 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 125.464 1.506 . . . . 0.0 109.166 -171.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.04 151.55 77.61 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.698 2.266 . . . . 0.0 112.196 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.457 ' HA ' ' HB ' ' B' ' 216' ' ' ILE . 3.9 tm-20 -58.53 -43.65 89.3 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -166.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 27.1 t -65.71 -36.75 84.5 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 121.583 -0.698 . . . . 0.0 110.381 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -82.43 -11.47 58.51 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.107 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.699 HG12 HG13 ' B' ' 211' ' ' ILE . 0.4 OUTLIER -68.8 -45.94 80.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 172.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -74.21 -30.36 62.16 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.519 0.512 . . . . 0.0 111.974 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -68.4 -50.72 50.87 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 123.31 0.381 . . . . 0.0 110.888 172.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.13 -45.37 83.56 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.08 0.552 . . . . 0.0 109.543 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.548 HD13 HG21 ' A' ' 70' ' ' VAL . 60.7 mt -68.96 -34.36 75.21 Favored 'General case' 0 C--O 1.209 -1.078 0 O-C-N 124.528 1.142 . . . . 0.0 112.439 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.57 -31.23 65.94 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.907 0.754 . . . . 0.0 109.882 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 t -91.33 -36.24 13.97 Favored 'General case' 0 CA--C 1.558 1.256 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.782 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . 0.53 ' HB2' ' HA ' ' B' ' 220' ' ' LEU . 84.9 m -75.01 -28.25 60.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.675 0.79 . . . . 0.0 112.271 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.79 -9.51 58.62 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.042 0.537 . . . . 0.0 110.903 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 36.0 t -65.15 83.03 0.05 OUTLIER 'General case' 0 C--N 1.36 1.026 0 C-N-CA 123.819 0.848 . . . . 0.0 109.62 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -75.58 -29.12 59.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.107 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 . . . . . 0 C--O 1.248 1.0 0 C-N-CA 124.711 1.204 . . . . 0.0 108.461 177.292 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.459 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.2 p -96.01 104.54 16.49 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.25 1.02 . . . . 0.0 109.905 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 37.7 p-80 -73.65 98.52 2.88 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.797 0.808 . . . . 0.0 111.345 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt -89.2 156.79 18.55 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.291 174.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 20.7 mp0 -98.48 136.74 38.17 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.723 0.409 . . . . 0.0 110.713 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -136.4 155.94 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.678 1.191 . . . . 0.0 108.568 173.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 66' ' ' THR . 90.2 m-85 -113.53 99.66 7.92 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.277 -170.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.525 HG12 ' HB2' ' A' ' 69' ' ' LEU . 93.6 t -99.45 100.01 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -94.65 123.49 38.12 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.899 0.88 . . . . 0.0 110.737 -171.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.689 HG22 HD12 ' A' ' 69' ' ' LEU . 39.5 p -70.59 166.94 19.58 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.715 0.769 . . . . 0.0 111.922 176.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.13 -19.64 65.65 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.187 -1.37 . . . . 0.0 111.721 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -79.59 -3.85 48.88 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.569 0.747 . . . . 0.0 111.309 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.15 5.78 67.37 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.054 0.359 . . . . 0.0 112.378 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -90.4 137.83 32.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.206 1.003 . . . . 0.0 109.621 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.7 m -107.05 129.1 54.86 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.252 0.621 . . . . 0.0 110.369 -176.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mp -108.06 113.27 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.024 0.93 . . . . 0.0 109.327 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 m -87.45 117.0 25.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.723 0.809 . . . . 0.0 109.123 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.8 mm? -104.54 160.24 15.1 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.655 0.782 . . . . 0.0 109.022 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 0' ' ' HIS . 33.9 mt-10 -127.07 80.99 1.99 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.858 0.863 . . . . 0.0 108.795 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.756 HG21 HG22 ' A' ' 26' ' ' VAL . 3.1 m -138.19 175.52 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.612 1.165 . . . . 0.0 108.657 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 12.9 mt-10 -92.28 140.71 24.41 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 9.7 Cg_endo -55.57 -29.1 68.34 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.857 2.372 . . . . 0.0 112.038 167.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -92.92 4.19 54.37 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.85 0.86 . . . . 0.0 110.797 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 22.6 t70 -82.27 -87.52 0.09 Allowed 'General case' 0 C--N 1.358 0.955 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.275 -174.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 25' ' ' ASN . 10.0 t 179.02 149.98 0.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.75 0.82 . . . . 0.0 110.956 176.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.28 -34.0 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.754 1.222 . . . . 0.0 110.685 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -58.49 -38.46 77.67 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.068 0.947 . . . . 0.0 109.821 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 10.6 t30 -71.66 -44.76 63.73 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.078 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.756 HG22 HG21 ' A' ' 17' ' ' VAL . 61.4 t -55.06 -48.17 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 124.437 1.085 . . . . 0.0 110.825 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -69.1 -31.83 70.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.298 0.639 . . . . 0.0 111.429 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.61 74.38 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.797 0.685 . . . . 0.0 111.141 170.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 65.3 mmtt -78.09 -31.57 50.19 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.932 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mp -58.85 -44.08 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.351 0.978 . . . . 0.0 109.291 170.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -62.75 -31.28 72.19 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.539 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 8.6 t70 -71.54 -35.21 70.59 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.639 0.776 . . . . 0.0 111.564 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.4 mmtt -88.72 -67.02 0.86 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.575 0.35 . . . . 0.0 110.968 -171.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -88.06 -22.33 24.24 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.301 0.24 . . . . 0.0 111.512 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.96 12.38 46.64 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.993 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -98.62 122.19 54.06 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -69.82 155.86 64.67 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 123.524 2.816 . . . . 0.0 113.059 -172.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -56.94 -13.1 10.8 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 124.482 3.455 . . . . 0.0 114.621 -175.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.21 -47.33 14.81 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 74' ' ' ARG . 2.8 mp0 -77.64 -27.99 51.18 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.304 0.641 . . . . 0.0 111.286 -174.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -96.65 147.68 23.64 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.643 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 42.9 ttt180 -137.66 129.25 28.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.527 HD21 HE22 ' A' ' 41' ' ' GLN . 4.5 mm? -92.2 125.73 36.99 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -173.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.422 HD11 ' HG ' ' B' ' 220' ' ' LEU . 97.6 mt -142.78 131.54 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.911 0.884 . . . . 0.0 110.071 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.559 ' HB3' HD21 ' A' ' 50' ' ' LEU . 86.0 t80 -135.81 128.36 30.63 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 172.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 65.45 21.3 11.84 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.834 0.854 . . . . 0.0 111.938 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.56 2.33 82.34 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.448 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 9.9 ptpt -108.99 142.16 40.05 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB2' HD22 ' B' ' 224' ' ' LEU . 9.7 tt0 -76.86 126.47 31.04 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.028 0.531 . . . . 0.0 110.081 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.7 mt -77.83 119.6 21.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.173 0.589 . . . . 0.0 110.352 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.0 138.37 42.18 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.742 0.651 . . . . 0.0 109.562 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.511 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 10.4 p-10 -61.1 -40.03 92.19 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 124.126 0.891 . . . . 0.0 112.037 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.57 -27.24 73.94 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.624 0.578 . . . . 0.0 113.374 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -77.48 176.77 8.58 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.214 0.606 . . . . 0.0 111.919 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.5 p -110.07 167.22 10.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.437 0.695 . . . . 0.0 109.765 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 81.4 mt -58.3 -51.46 69.69 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 56.2 m -59.6 -25.98 65.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.932 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -69.53 -34.25 73.98 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.074 0.464 . . . . 0.0 110.044 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -92.6 15.94 13.21 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.754 0.822 . . . . 0.0 111.768 175.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 66.67 30.04 8.43 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.239 1.016 . . . . 0.0 111.639 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -101.16 118.01 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -102.89 -175.99 2.96 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -58.18 141.5 50.33 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.125 171.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 72.49 0.34 3.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.509 1.523 . . . . 0.0 112.669 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.8 m -73.46 137.35 44.47 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 118.236 0.471 . . . . 0.0 110.705 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 15.0 m -95.53 137.04 35.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.875 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.73 174.54 10.41 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.945 1.298 . . . . 0.0 108.454 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -101.76 158.56 16.02 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.849 0.833 . . . . 0.0 112.185 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.689 HD12 HG22 ' A' ' 7' ' ' THR . 2.7 tm? -138.35 125.82 21.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.215 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.643 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 91.0 t -99.93 120.61 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 123.301 0.64 . . . . 0.0 110.224 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.461 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 93.0 mt -89.29 140.41 29.52 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 124.349 1.031 . . . . 0.0 109.883 174.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -119.14 -28.34 5.49 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.002 0.921 . . . . 0.0 111.476 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 71' ' ' LEU . 3.6 mm? 44.3 46.45 7.64 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 125.657 1.583 . . . . 0.0 113.978 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.416 ' H ' ' HG3' ' A' ' 40' ' ' GLN . 24.5 mmt85 -65.66 -23.11 66.72 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.704 174.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.48 -11.49 38.38 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.778 174.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.479 0 C-N-CA 123.191 0.424 . . . . 0.0 112.965 -176.884 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.851 0 CA-C-O 120.035 -0.314 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . 0.421 ' HB3' ' HG ' ' A' ' 73' ' ' LEU . 66.6 m -75.72 78.19 2.68 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.559 0.744 . . . . 0.0 109.929 174.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -134.71 6.21 3.44 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.035 1.334 . . . . 0.0 110.03 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -133.61 175.09 9.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.702 0.801 . . . . 0.0 110.495 -172.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.4 p -69.19 95.13 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-O 121.665 0.745 . . . . 0.0 110.44 175.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . 0.482 HG22 HG13 ' B' ' 202' ' ' VAL . 50.4 m -80.05 120.11 23.77 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.69 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -83.25 123.27 29.42 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . 0.482 HG13 HG22 ' B' ' 200' ' ' THR . 3.8 m -138.01 172.08 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 125.505 1.522 . . . . 0.0 108.441 -173.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -107.47 146.52 31.64 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 122.373 -0.204 . . . . 0.0 110.624 -176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.583 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.9 t -83.7 105.72 6.17 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.711 0.805 . . . . 0.0 109.019 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.549 ' HD2' HD11 ' B' ' 220' ' ' LEU . 40.5 Cg_endo -63.12 -1.0 2.52 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 124.087 3.191 . . . . 0.0 115.401 -171.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 15.8 t -100.95 -51.08 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.377 0.671 . . . . 0.0 111.427 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 19.9 p -113.88 1.07 14.64 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.009 0.523 . . . . 0.0 111.8 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 56.28 55.3 30.21 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 124.48 1.038 . . . . 0.0 115.195 175.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.72 127.2 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.166 0.586 . . . . 0.0 109.512 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.96 110.47 15.37 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 8.6 pt -138.6 160.87 61.66 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 125.715 1.606 . . . . 0.0 109.721 -173.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.75 159.77 23.54 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.841 2.361 . . . . 0.0 113.124 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.509 ' O ' HG22 ' B' ' 216' ' ' ILE . 34.4 tt0 -63.14 -33.49 75.58 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.993 1.317 . . . . 0.0 112.686 -172.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.0 t -66.23 -46.35 77.47 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.508 0.67 . . . . 0.0 110.594 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.19 -13.0 57.8 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.891 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.47 -44.82 53.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 174.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -55.07 28.44 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 124.502 1.126 . . . . 0.0 109.152 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -61.62 -39.18 90.34 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 124.446 1.091 . . . . 0.0 112.145 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -36.26 80.05 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.297 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.549 HD11 ' HD2' ' B' ' 205' ' ' PRO . 0.0 OUTLIER -63.71 -50.44 69.13 Favored 'General case' 0 C--O 1.21 -1.009 0 O-C-N 123.789 0.681 . . . . 0.0 110.249 177.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -54.49 -27.33 37.12 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 123.924 0.765 . . . . 0.0 112.048 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.1 t -89.1 -39.77 13.39 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.589 0.756 . . . . 0.0 111.217 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.55 -18.96 43.12 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.393 1.077 . . . . 0.0 113.511 -171.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' B' ' 220' ' ' LEU . 4.4 pp -94.93 13.81 23.69 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.625 0.648 . . . . 0.0 110.105 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 30.0 m -75.0 20.1 0.14 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.46 1.104 . . . . 0.0 112.665 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -149.48 151.49 34.03 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.07 0.948 . . . . 0.0 108.864 170.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.287 0 C-N-CA 124.367 1.067 . . . . 0.0 109.232 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.427 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.7 t -130.48 79.72 1.91 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.486 0.715 . . . . 0.0 109.921 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -84.58 152.18 24.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.88 174.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt -108.6 178.71 4.4 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.85 0.86 . . . . 0.0 110.209 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 75.8 mt-30 -119.42 132.63 55.85 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.3 0.64 . . . . 0.0 110.78 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.562 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -128.24 156.4 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.133 1.373 . . . . 0.0 108.951 178.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 66' ' ' THR . 50.1 m-85 -115.2 112.2 22.13 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.401 0.619 . . . . 0.0 110.073 -173.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.7 t -104.06 120.88 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -111.11 125.11 53.42 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.554 0.741 . . . . 0.0 109.82 -173.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.649 HG22 HD12 ' A' ' 69' ' ' LEU . 66.7 p -78.33 168.81 19.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.303 0.573 . . . . 0.0 112.067 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.43 HD11 HG22 ' A' ' 70' ' ' VAL . 60.7 mt -67.32 -27.68 67.35 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.345 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.4 p -79.34 -9.4 59.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.651 0.78 . . . . 0.0 110.987 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.69 22.98 37.58 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 114.17 0.428 . . . . 0.0 114.17 168.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 152.42 18.51 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 173.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.7 m -101.54 139.51 37.1 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.121 0.568 . . . . 0.0 109.994 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 7' ' ' THR . 5.2 mp -124.87 105.59 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.443 1.097 . . . . 0.0 108.181 176.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.1 m -86.96 122.97 31.54 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -105.8 156.29 18.46 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -120.34 69.66 0.87 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.442 1.097 . . . . 0.0 109.023 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.744 HG21 HG22 ' A' ' 26' ' ' VAL . 7.1 m -136.95 175.05 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -90.96 149.8 40.77 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.549 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 12.1 Cg_endo -58.96 -31.71 96.14 Favored 'Trans proline' 0 CA--C 1.559 1.75 0 C-N-CA 121.62 1.546 . . . . 0.0 111.733 164.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 t -97.36 18.09 15.98 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.905 0.482 . . . . 0.0 110.548 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.73 -96.73 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.827 0.851 . . . . 0.0 109.975 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 26' ' ' VAL . 5.2 t 174.36 140.37 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.2 1.4 . . . . 0.0 109.244 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -61.92 -37.11 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.879 0.871 . . . . 0.0 111.486 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 35.5 tt0 -54.92 -40.54 69.97 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.805 0.812 . . . . 0.0 110.792 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 11.5 t30 -73.54 -43.32 60.19 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.417 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.744 HG22 HG21 ' A' ' 17' ' ' VAL . 60.5 t -55.95 -48.63 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 124.311 1.007 . . . . 0.0 110.6 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.474 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.7 ptpt -68.41 -33.66 74.62 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.014 0.526 . . . . 0.0 111.602 -178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.64 -33.65 70.3 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.98 170.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 34.7 mmtm -76.64 -31.01 57.08 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.436 -0.793 . . . . 0.0 112.464 177.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.8 mp -60.49 -39.63 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 119.682 1.128 . . . . 0.0 109.129 170.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.64 -34.18 77.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.311 0.644 . . . . 0.0 111.207 174.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.05 -36.55 75.08 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.479 0.712 . . . . 0.0 111.5 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.6 mmtt -88.23 -65.7 0.99 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.83 0.452 . . . . 0.0 111.243 -170.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -84.18 -24.04 30.32 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.923 0.328 . . . . 0.0 111.272 -177.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.0 17.84 31.18 Favored Glycine 0 C--N 1.35 1.347 0 O-C-N 123.173 0.295 . . . . 0.0 113.554 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.82 127.36 27.86 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.482 0.713 . . . . 0.0 109.36 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 58.8 Cg_endo -67.09 154.53 74.18 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.057 2.504 . . . . 0.0 112.697 -173.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 37.3 Cg_endo -61.14 -13.79 30.0 Favored 'Trans proline' 0 C--N 1.388 2.634 0 C-N-CA 123.666 2.911 . . . . 0.0 113.88 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.96 -32.18 51.3 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.742 0.817 . . . . 0.0 110.703 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -96.53 -18.33 19.88 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.855 1.262 . . . . 0.0 112.437 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.641 ' HB2' HD11 ' A' ' 69' ' ' LEU . 3.5 pp0? -118.96 133.57 55.74 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.165 0.507 . . . . 0.0 110.82 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.644 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 56.1 ttt180 -120.95 128.71 52.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.26 1.024 . . . . 0.0 109.788 -169.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.01 126.98 38.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.697 0.799 . . . . 0.0 109.656 -171.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.7 mt -142.15 132.03 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.292 0.637 . . . . 0.0 109.952 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.563 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 72.4 t80 -137.9 131.58 31.17 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 171.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.12 19.32 10.44 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.031 0.932 . . . . 0.0 112.013 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 6.53 79.57 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.975 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 13.8 ptpt -118.81 145.06 45.93 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.648 0.724 . . . . 0.0 109.998 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.538 ' HB2' HD22 ' B' ' 224' ' ' LEU . 0.4 OUTLIER -77.67 122.91 25.98 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -175.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' A' ' 45' ' ' PHE . 27.6 mt -72.11 119.52 16.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.405 0.682 . . . . 0.0 111.187 -175.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -81.54 138.77 35.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.233 1.013 . . . . 0.0 110.288 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 1.7 m-20 -60.22 -43.05 96.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.472 1.109 . . . . 0.0 112.613 -173.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.02 -8.77 74.7 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 124.36 1.037 . . . . 0.0 114.112 -177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 86.0 mtt-85 -95.1 177.33 5.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.99 0.916 . . . . 0.0 111.416 174.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -114.82 170.65 8.17 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.044 0.938 . . . . 0.0 109.509 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.9 mt -60.28 -52.16 66.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 40.7 m -54.62 -29.47 52.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.189 1.396 . . . . 0.0 112.633 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 12.7 t70 -65.67 -43.57 88.9 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 123.759 0.662 . . . . 0.0 109.761 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -87.93 21.23 2.76 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.916 0.887 . . . . 0.0 111.395 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 70.93 13.57 7.0 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.503 1.121 . . . . 0.0 111.982 176.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 14.6 mt -88.18 118.23 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.695 0.798 . . . . 0.0 109.001 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -102.5 -174.94 2.68 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -58.2 140.52 52.88 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.192 172.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 70.09 7.45 6.23 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.919 1.288 . . . . 0.0 112.954 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -69.46 135.88 50.78 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-N 117.901 0.319 . . . . 0.0 110.649 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 28.5 m -93.99 125.65 38.74 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.432 0.693 . . . . 0.0 109.617 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -127.46 167.92 15.61 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.347 1.059 . . . . 0.0 109.393 177.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -94.63 150.48 20.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.49 0.662 . . . . 0.0 110.93 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.649 HD12 HG22 ' A' ' 7' ' ' THR . 2.4 tm? -133.85 126.68 31.02 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.696 HG21 HD11 ' B' ' 220' ' ' LEU . 69.8 t -101.9 109.07 25.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.441 0.697 . . . . 0.0 110.12 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.518 ' HB3' HD23 ' A' ' 73' ' ' LEU . 67.1 mt -80.73 144.9 31.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.241 173.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -121.08 -48.14 2.24 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.062 0.945 . . . . 0.0 109.249 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 71' ' ' LEU . 4.6 mm? 51.72 45.5 28.05 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.678 1.191 . . . . 0.0 112.109 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -70.04 -17.72 63.27 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.025 175.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.91 5.45 84.87 Favored Glycine 0 C--N 1.35 1.307 0 CA-C-O 119.658 -0.523 . . . . 0.0 113.337 172.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.396 0 C-N-CA 123.302 0.477 . . . . 0.0 112.536 179.324 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.828 0 N-CA-C 112.07 -0.412 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 29.3 t -151.9 103.03 2.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.264 0.626 . . . . 0.0 109.464 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -78.9 -28.96 44.05 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.941 0.896 . . . . 0.0 110.151 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -66.87 157.71 32.42 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.854 0.862 . . . . 0.0 111.015 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.25 101.89 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 O-C-N 124.047 0.842 . . . . 0.0 108.814 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . 0.416 HG22 HG13 ' B' ' 202' ' ' VAL . 20.8 m -81.27 114.07 19.82 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.794 -172.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.68 124.61 28.17 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . 0.416 HG13 HG22 ' B' ' 200' ' ' THR . 6.1 m -140.89 -176.29 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.919 1.288 . . . . 0.0 109.319 -170.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -113.07 144.26 42.92 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.787 0.435 . . . . 0.0 110.326 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.546 ' HA ' HD11 ' B' ' 216' ' ' ILE . 53.5 t -86.14 98.03 0.71 Allowed Pre-proline 0 N--CA 1.473 0.692 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.489 ' HD2' HD21 ' B' ' 220' ' ' LEU . 20.7 Cg_endo -55.22 -24.67 42.8 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.122 2.548 . . . . 0.0 114.413 -164.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 10.8 t -74.48 -63.42 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 122.861 0.464 . . . . 0.0 110.608 -173.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 22.7 p -91.6 -9.76 42.95 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.025 0.53 . . . . 0.0 111.24 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.92 58.77 12.03 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 124.073 0.844 . . . . 0.0 114.203 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 33.2 m -118.98 135.66 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.586 0.754 . . . . 0.0 109.553 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -83.44 104.81 13.88 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.091 0.472 . . . . 0.0 110.095 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' B' ' 204' ' ' CYS . 15.9 pt -137.01 152.21 73.52 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 125.308 1.443 . . . . 0.0 110.057 -174.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.09 163.36 16.93 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.012 2.475 . . . . 0.0 113.339 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.599 ' O ' HG22 ' B' ' 216' ' ' ILE . 5.6 tm-20 -62.64 -39.93 95.42 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -167.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 52.3 m -65.53 -39.87 92.29 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.7 -1.25 . . . . 0.0 110.295 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . 0.414 ' O ' ' HB2' ' B' ' 219' ' ' HIS . 8.0 m80 -68.24 -28.14 66.96 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.815 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.599 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -69.09 -48.41 69.51 Favored 'Isoleucine or valine' 0 C--N 1.359 0.992 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -176.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -67.13 -37.66 84.24 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.472 0.482 . . . . 0.0 111.387 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.43 -42.22 83.53 Favored 'General case' 0 C--O 1.255 1.366 0 O-C-N 123.533 0.521 . . . . 0.0 111.212 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' B' ' 215' ' ' HIS . 0.1 OUTLIER -59.93 -37.52 79.75 Favored 'General case' 0 C--N 1.358 0.949 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.41 177.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.696 HD11 HG21 ' A' ' 70' ' ' VAL . 96.7 mt -63.03 -45.39 92.49 Favored 'General case' 0 C--O 1.206 -1.218 0 O-C-N 124.014 0.821 . . . . 0.0 110.935 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -56.53 -28.37 59.86 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.445 0.466 . . . . 0.0 111.516 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 35.8 t -89.21 -41.18 12.37 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.312 173.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.2 m -79.04 -28.21 43.21 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.959 0.904 . . . . 0.0 112.971 -167.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 49' ' ' GLN . 3.7 pp -82.29 -16.56 48.98 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.383 0.673 . . . . 0.0 109.3 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 23.0 t -75.72 74.45 2.69 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 123.993 0.917 . . . . 0.0 109.142 176.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 34.1 ttt-85 -93.9 -45.39 7.65 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.62 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 CA--C 1.555 1.16 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.274 -167.447 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.83 -0.508 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 33.3 t -162.38 -51.7 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.776 0.83 . . . . 0.0 109.914 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.613 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 80.6 m80 68.54 116.46 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.051 1.34 . . . . 0.0 111.599 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 mmt -106.11 -170.22 1.7 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.6 1.16 . . . . 0.0 109.32 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 88.7 mt-30 -120.1 151.57 38.86 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.854 0.462 . . . . 0.0 111.388 172.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -141.13 159.54 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 125.223 1.409 . . . . 0.0 109.701 177.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' THR . 86.7 m-85 -107.58 109.8 21.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.032 0.933 . . . . 0.0 109.68 -176.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 30' ' ' ILE . 19.4 t -101.51 111.42 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 tptt -110.93 117.15 32.58 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.511 0.725 . . . . 0.0 109.981 -171.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.606 HG22 HD12 ' A' ' 69' ' ' LEU . 80.4 p -69.51 161.29 29.82 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-O 121.165 0.507 . . . . 0.0 111.716 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.49 HD11 HG22 ' A' ' 70' ' ' VAL . 87.0 mt -66.36 -17.54 64.83 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.853 175.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -83.16 -26.88 30.5 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.975 0.51 . . . . 0.0 110.714 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.05 9.59 11.91 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.123 0.409 . . . . 0.0 114.123 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.46 147.35 35.97 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 175.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -108.77 139.35 43.71 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.93 106.54 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.7 m -88.97 120.49 30.43 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.0 OUTLIER -105.45 155.63 18.96 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.95 75.48 1.0 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.489 0.716 . . . . 0.0 109.423 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.821 HG21 HG22 ' A' ' 26' ' ' VAL . 11.3 m -137.96 167.38 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.097 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 0' ' ' HIS . 2.4 mt-10 -86.74 155.34 56.09 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.156 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 13.0 Cg_endo -57.48 -35.58 98.83 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 121.968 1.779 . . . . 0.0 111.198 165.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.0 t -97.66 19.36 13.68 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.027 0.931 . . . . 0.0 110.875 -177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 15.8 t70 -77.14 -94.82 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.366 0.666 . . . . 0.0 109.692 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 26' ' ' VAL . 10.1 t 176.23 141.14 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.135 1.374 . . . . 0.0 109.57 172.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.567 HG22 ' HE3' ' A' ' 27' ' ' LYS . 45.1 mm -61.63 -37.69 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.527 1.131 . . . . 0.0 111.571 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -50.09 -44.64 52.07 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.239 1.016 . . . . 0.0 110.686 177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 7.9 t30 -71.78 -43.62 65.39 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.035 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.821 HG22 HG21 ' A' ' 17' ' ' VAL . 60.9 t -54.76 -50.78 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 124.207 0.942 . . . . 0.0 110.953 -177.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HE3' HG22 ' A' ' 23' ' ' ILE . 16.5 ptpt -68.6 -35.56 77.5 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.678 0.391 . . . . 0.0 111.257 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.0 -28.08 68.77 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.118 169.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 9.5 mmpt? -74.06 -37.42 64.25 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 118.765 -0.635 . . . . 0.0 111.134 177.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 5' ' ' VAL . 3.5 mp -60.86 -40.4 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-N 118.865 0.757 . . . . 0.0 109.131 173.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.99 -25.65 67.95 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.365 175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -81.21 -32.47 33.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.189 0.595 . . . . 0.0 111.117 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.0 mmtt -88.24 -69.06 0.72 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.608 0.363 . . . . 0.0 110.895 -172.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.89 -26.1 34.44 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-O 120.481 0.181 . . . . 0.0 110.819 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.4 24.15 19.64 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 116.396 -0.365 . . . . 0.0 112.908 171.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.31 131.71 21.69 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.178 0.591 . . . . 0.0 109.476 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 53.9 Cg_endo -64.74 149.87 89.04 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 123.34 2.693 . . . . 0.0 113.135 -173.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 37.2 Cg_endo -61.27 -12.26 22.8 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 123.784 2.989 . . . . 0.0 113.724 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -73.35 -43.0 61.57 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.424 0.69 . . . . 0.0 110.535 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.5 mp0 -85.11 -28.9 25.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.051 0.94 . . . . 0.0 111.772 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' HB2' HD11 ' A' ' 69' ' ' LEU . 3.5 pp0? -109.0 123.22 48.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.306 0.642 . . . . 0.0 109.921 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.516 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 55.2 ttt180 -112.31 128.02 56.16 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.143 0.977 . . . . 0.0 110.184 -168.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.64 120.03 33.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.311 0.644 . . . . 0.0 110.486 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.2 mt -141.98 135.55 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.417 1.087 . . . . 0.0 109.88 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.515 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 88.3 t80 -131.69 123.46 27.81 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.36 1.064 . . . . 0.0 108.133 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 60.44 20.0 9.68 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.645 0.778 . . . . 0.0 112.608 175.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.558 ' HA2' HG22 ' B' ' 206' ' ' VAL . . . 101.23 -18.8 53.53 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 114.499 0.559 . . . . 0.0 114.499 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.1 ptpt -86.46 137.64 32.38 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.57 0.685 . . . . 0.0 109.709 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.585 ' HB2' HD22 ' B' ' 224' ' ' LEU . 27.4 tt0 -81.64 135.53 35.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.58 117.16 26.2 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 122.737 0.415 . . . . 0.0 111.298 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.65 138.86 31.85 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.581 1.152 . . . . 0.0 109.639 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -51.88 -47.55 64.49 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.78 1.232 . . . . 0.0 112.968 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.68 -30.97 78.42 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.905 0.753 . . . . 0.0 113.76 -174.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.488 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 97.2 mtt180 -80.04 177.77 8.7 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.516 0.726 . . . . 0.0 112.037 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.8 p -112.51 168.28 9.77 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.785 0.834 . . . . 0.0 109.915 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 88.6 mt -59.0 -50.48 73.94 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 19' ' ' PRO . 21.9 m -54.93 -31.13 60.01 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.971 1.309 . . . . 0.0 112.778 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -65.92 -41.39 91.44 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.201 0.525 . . . . 0.0 109.826 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 34.8 m-85 -86.41 13.02 8.91 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.436 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 70.11 27.79 4.19 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.55 1.14 . . . . 0.0 111.122 178.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 10.4 mt -99.44 144.95 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -135.27 -173.81 3.44 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -62.88 146.81 51.96 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 120.681 0.276 . . . . 0.0 110.637 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 68.57 5.51 4.89 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.268 1.427 . . . . 0.0 112.174 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -71.86 139.01 48.67 Favored 'General case' 0 C--N 1.362 1.126 0 CA-C-N 117.963 0.347 . . . . 0.0 110.118 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 21.4 m -100.52 117.05 33.89 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.515 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -121.6 142.14 50.41 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.183 0.993 . . . . 0.0 109.484 -177.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -77.91 130.01 36.06 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.648 -174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.606 HD12 HG22 ' A' ' 7' ' ' THR . 2.5 tm? -103.73 129.34 51.08 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 174.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.54 HG21 HD11 ' B' ' 220' ' ' LEU . 84.3 t -111.67 121.04 63.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.238 0.615 . . . . 0.0 109.922 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.86 156.84 23.38 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.523 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.495 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 51.6 mtt180 -128.57 -47.24 1.29 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.701 0.8 . . . . 0.0 110.385 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 51.18 36.03 14.79 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.763 1.225 . . . . 0.0 112.433 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.495 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 26.5 mmm180 -73.33 -23.57 60.26 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.856 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.43 0.1 77.21 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.628 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.263 0 C-N-CA 123.074 0.369 . . . . 0.0 112.431 -173.597 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.84 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 29.3 t -168.43 153.43 6.38 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.428 1.091 . . . . 0.0 109.647 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -148.49 24.28 1.0 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.039 0.936 . . . . 0.0 109.36 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -149.99 164.68 34.84 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.13 0.972 . . . . 0.0 109.634 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.23 126.31 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 28.6 m -87.81 138.32 31.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.103 0.561 . . . . 0.0 110.509 -176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -85.73 122.07 29.29 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 7.0 m -143.08 179.68 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.466 1.106 . . . . 0.0 109.595 -169.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.94 142.26 47.93 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.954 0.502 . . . . 0.0 110.739 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.598 ' HA ' HD11 ' B' ' 216' ' ' ILE . 49.0 t -76.01 104.76 1.67 Allowed Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 124.327 1.051 . . . . 0.0 108.648 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.559 ' HD2' HD21 ' B' ' 220' ' ' LEU . 38.2 Cg_endo -61.79 -12.96 27.79 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.559 2.839 . . . . 0.0 114.808 -168.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . 0.558 HG22 ' HA2' ' A' ' 47' ' ' GLY . 5.6 t -85.8 -61.28 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.133 0.573 . . . . 0.0 110.257 -176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 21.1 p -99.74 -5.54 28.56 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 112.224 0.454 . . . . 0.0 112.224 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 68.07 45.17 73.95 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 115.023 0.769 . . . . 0.0 115.023 173.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.24 133.44 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-N 117.342 0.571 . . . . 0.0 110.321 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -81.78 122.52 27.79 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.011 0.524 . . . . 0.0 110.17 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' B' ' 204' ' ' CYS . 3.4 pt -150.23 159.66 34.7 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.757 1.623 . . . . 0.0 108.924 -172.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.35 157.75 43.98 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.199 1.932 . . . . 0.0 112.061 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.573 ' O ' HG22 ' B' ' 216' ' ' ILE . 43.1 tt0 -60.9 -31.35 70.85 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.743 1.217 . . . . 0.0 112.093 -174.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 23.5 p -64.0 -50.95 66.5 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 121.653 0.739 . . . . 0.0 110.277 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -80.15 -10.96 59.79 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.16 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.1 OUTLIER -73.78 -48.36 39.95 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . 0.523 ' HA ' HD12 ' B' ' 220' ' ' LEU . 52.3 m-80 -63.39 -36.52 83.98 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.407 0.442 . . . . 0.0 110.843 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -57.57 -52.76 64.11 Favored 'General case' 0 C--O 1.254 1.3 0 O-C-N 123.96 0.788 . . . . 0.0 111.212 172.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -30.66 70.68 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.731 -176.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.559 HD21 ' HD2' ' B' ' 205' ' ' PRO . 96.3 mt -64.52 -50.48 67.21 Favored 'General case' 0 C--O 1.206 -1.186 0 O-C-N 123.887 0.742 . . . . 0.0 111.181 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -57.38 -27.79 62.63 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 123.87 0.731 . . . . 0.0 111.69 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.1 t -80.03 -45.74 17.83 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.552 173.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 67.0 m -81.12 -22.94 38.71 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.626 1.17 . . . . 0.0 113.811 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 49' ' ' GLN . 4.2 pp -88.3 -23.09 23.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 47.7 t -71.82 74.67 0.86 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.228 1.011 . . . . 0.0 108.625 172.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.54 96.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 -172.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.198 0 C-N-CA 124.504 1.121 . . . . 0.0 108.622 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.5 m -76.46 109.27 10.04 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.456 0.703 . . . . 0.0 110.828 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -81.37 100.78 9.42 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.697 0.799 . . . . 0.0 109.526 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt -78.44 170.13 17.13 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.393 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 21.6 mp0 -98.52 152.85 19.11 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.497 0.319 . . . . 0.0 110.512 173.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.18 150.6 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.345 1.058 . . . . 0.0 108.728 171.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -105.0 101.75 11.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.4 0.68 . . . . 0.0 109.787 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 69' ' ' LEU . 88.4 t -98.76 103.16 14.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.493 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -101.39 124.93 47.87 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.439 0.696 . . . . 0.0 110.901 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.734 HG22 HD12 ' A' ' 69' ' ' LEU . 60.2 p -65.53 157.74 28.86 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.316 0.647 . . . . 0.0 111.765 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.527 HD11 HG22 ' A' ' 70' ' ' VAL . 81.0 mt -66.47 -17.78 64.99 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.686 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -79.63 -11.31 59.87 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.342 0.657 . . . . 0.0 110.928 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.49 7.34 39.94 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 123.25 0.452 . . . . 0.0 113.863 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.43 143.02 26.67 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.626 0.77 . . . . 0.0 109.193 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 m -103.51 141.19 36.43 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.857 0.463 . . . . 0.0 110.684 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.0 mp -120.81 113.27 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.431 1.092 . . . . 0.0 108.504 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.3 m -91.57 120.34 32.28 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.922 0.489 . . . . 0.0 109.716 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -106.19 163.9 12.43 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.018 0.927 . . . . 0.0 109.261 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -130.82 82.47 2.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.376 0.67 . . . . 0.0 109.562 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.803 HG21 HG22 ' A' ' 26' ' ' VAL . 16.7 m -140.9 172.03 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.242 1.017 . . . . 0.0 109.085 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -86.02 150.71 53.24 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.742 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -60.79 -25.14 80.59 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 121.998 1.799 . . . . 0.0 111.332 166.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 t -95.12 5.65 51.24 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.038 0.935 . . . . 0.0 111.449 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.01 -96.62 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.139 0.576 . . . . 0.0 110.123 -173.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 26' ' ' VAL . 11.1 t 177.85 146.13 0.13 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.676 1.191 . . . . 0.0 109.31 172.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -62.63 -36.26 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.598 1.159 . . . . 0.0 111.56 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -57.31 -36.51 71.17 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.712 0.767 . . . . 0.0 110.878 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 15.0 t-20 -76.07 -42.02 48.71 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.341 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.803 HG22 HG21 ' A' ' 17' ' ' VAL . 58.4 t -55.75 -48.16 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 124.342 1.026 . . . . 0.0 110.371 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.9 ptpt -69.93 -35.15 74.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.977 0.511 . . . . 0.0 110.945 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.05 -36.03 70.01 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.613 0.365 . . . . 0.0 110.921 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 74.0 mmtt -69.58 -33.92 73.41 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 118.59 -0.719 . . . . 0.0 112.394 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.7 mp -60.0 -41.22 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 119.404 1.002 . . . . 0.0 109.662 172.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -67.98 -24.71 65.18 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.526 0.731 . . . . 0.0 111.311 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -77.7 -30.26 51.77 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.849 0.859 . . . . 0.0 111.021 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.5 mmtt -94.58 -67.63 0.84 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.828 0.451 . . . . 0.0 111.093 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -84.41 -26.62 28.19 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.201 0.2 . . . . 0.0 111.115 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.75 23.68 22.68 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 116.547 -0.297 . . . . 0.0 112.851 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.79 129.04 25.59 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 73.9 Cg_endo -68.39 155.24 69.88 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.166 2.577 . . . . 0.0 112.766 -174.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 38.3 Cg_endo -61.16 -16.21 44.73 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.675 2.917 . . . . 0.0 114.082 -176.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -79.0 -24.71 43.56 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.829 0.852 . . . . 0.0 110.664 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.453 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.7 mp0 -99.9 -31.69 11.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.218 1.007 . . . . 0.0 111.954 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' HB2' HD21 ' A' ' 69' ' ' LEU . 3.1 pp0? -103.94 123.8 47.82 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.236 0.541 . . . . 0.0 110.419 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.701 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 67.2 ttt180 -115.06 128.58 56.33 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.393 1.077 . . . . 0.0 109.86 -169.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.6 mm? -94.16 121.18 35.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.552 0.741 . . . . 0.0 110.577 -171.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.0 mt -142.62 125.96 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.023 0.929 . . . . 0.0 109.988 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.633 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 85.0 t80 -121.73 122.72 40.18 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.47 1.108 . . . . 0.0 108.962 177.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.66 22.84 10.35 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.699 0.8 . . . . 0.0 112.754 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.17 -13.02 60.4 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 114.343 0.497 . . . . 0.0 114.343 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.9 ptpt -93.34 133.1 36.93 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.623 0.711 . . . . 0.0 109.298 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -76.08 136.81 39.89 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 43' ' ' LEU . 22.7 mt -92.34 119.39 31.86 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 121.117 0.484 . . . . 0.0 111.164 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.441 ' H ' ' HE2' ' A' ' 59' ' ' TYR . 36.0 tt0 -86.87 139.46 30.63 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.252 1.421 . . . . 0.0 110.892 -176.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.84 -45.37 82.43 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.802 1.241 . . . . 0.0 112.838 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.82 -27.03 73.69 Favored Glycine 0 C--N 1.345 1.052 0 O-C-N 124.072 0.857 . . . . 0.0 113.481 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 78.2 mtt180 -80.84 177.59 8.94 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.826 0.851 . . . . 0.0 111.93 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.7 p -113.99 167.83 10.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.817 0.847 . . . . 0.0 110.159 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 93.7 mt -56.72 -52.33 65.37 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.615 173.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.4 t -63.9 -22.78 67.08 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.283 1.033 . . . . 0.0 111.543 -176.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.03 -42.63 89.35 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.46 0.647 . . . . 0.0 109.488 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.441 ' HE2' ' H ' ' A' ' 51' ' ' GLU . 30.0 m-85 -89.25 15.64 8.65 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.887 -1.052 . . . . 0.0 112.147 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.474 HD22 ' N ' ' A' ' 60' ' ' ASN . 0.7 OUTLIER 73.49 14.08 4.41 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.027 1.331 . . . . 0.0 112.175 175.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 7.9 mt -84.29 137.79 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -130.7 -173.93 3.22 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -56.53 141.24 43.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 122.866 0.466 . . . . 0.0 111.364 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 67.3 5.83 4.47 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.591 1.556 . . . . 0.0 113.268 177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.3 m -70.48 133.19 46.59 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 118.204 0.457 . . . . 0.0 110.708 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.8 m -97.16 121.22 38.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.35 0.66 . . . . 0.0 109.278 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.633 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -123.24 175.05 6.9 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.897 1.279 . . . . 0.0 109.424 176.137 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -105.61 149.29 26.44 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.667 0.787 . . . . 0.0 110.665 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.734 HD12 HG22 ' A' ' 7' ' ' THR . 3.0 tm? -127.82 122.23 32.15 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.701 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 60.3 t -101.02 112.82 35.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 123.384 0.674 . . . . 0.0 109.779 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -77.85 145.89 36.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.728 173.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 67.2 mtp85 -122.25 -28.15 4.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.666 0.786 . . . . 0.0 111.124 -176.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 50.94 28.86 4.02 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.532 1.133 . . . . 0.0 113.235 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.4 mmt-85 -73.19 -14.68 61.4 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.243 0.544 . . . . 0.0 109.997 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.65 26.52 1.49 Allowed Glycine 0 C--N 1.343 0.933 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.634 0 C-N-CA 123.631 0.634 . . . . 0.0 113.43 -178.967 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 36.1 t -158.94 144.73 16.5 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.952 0.901 . . . . 0.0 109.151 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -113.77 -51.22 2.8 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.047 0.939 . . . . 0.0 110.472 -176.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -86.03 175.4 8.6 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.815 0.846 . . . . 0.0 111.554 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 3.7 p -55.56 115.02 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 124.104 0.961 . . . . 0.0 110.824 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . 0.487 HG22 HG13 ' B' ' 202' ' ' VAL . 4.4 m -97.07 111.86 23.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.084 0.554 . . . . 0.0 110.157 -171.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -85.3 123.13 30.43 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . 0.487 HG13 HG22 ' B' ' 200' ' ' THR . 4.0 m -144.93 -177.41 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.833 1.253 . . . . 0.0 109.536 -169.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -112.86 147.34 37.21 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.679 0.391 . . . . 0.0 110.971 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.579 ' HA ' HD11 ' B' ' 216' ' ' ILE . 42.4 t -87.31 101.95 2.78 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 124.379 1.072 . . . . 0.0 108.692 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.562 ' HD2' HD21 ' B' ' 220' ' ' LEU . 55.2 Cg_endo -65.55 2.71 1.43 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.272 2.648 . . . . 0.0 115.335 -172.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.13 -51.8 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.691 0.396 . . . . 0.0 110.901 176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 14.6 p -114.59 9.0 16.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 58.56 42.17 95.91 Favored Glycine 0 N--CA 1.482 1.711 0 N-CA-C 115.907 1.123 . . . . 0.0 115.907 169.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.1 141.26 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 117.331 0.566 . . . . 0.0 110.644 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -88.17 112.55 22.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.006 0.522 . . . . 0.0 110.078 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.9 pt -141.66 156.26 66.33 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.489 1.515 . . . . 0.0 109.641 -173.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.75 162.6 33.93 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.704 2.269 . . . . 0.0 111.965 175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.548 ' O ' HG22 ' B' ' 216' ' ' ILE . 2.9 tm-20 -66.69 -38.69 87.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.979 0.911 . . . . 0.0 112.934 -166.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 43.1 t -56.39 -44.97 80.75 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.762 0.791 . . . . 0.0 109.868 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -80.33 -16.22 55.09 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.935 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.579 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -73.21 -50.34 32.14 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . 0.418 ' HA ' HD12 ' B' ' 220' ' ' LEU . 44.9 m-80 -67.14 -36.91 82.88 Favored 'General case' 0 C--N 1.347 0.461 0 O-C-N 123.645 0.591 . . . . 0.0 111.075 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -60.82 -46.99 88.37 Favored 'General case' 0 C--O 1.253 1.266 0 O-C-N 123.675 0.609 . . . . 0.0 110.905 174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -40.32 82.62 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.167 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.562 HD21 ' HD2' ' B' ' 205' ' ' PRO . 96.0 mt -60.75 -49.71 76.4 Favored 'General case' 0 C--O 1.211 -0.948 0 O-C-N 123.958 0.786 . . . . 0.0 111.584 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.65 -24.5 67.81 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 123.93 0.769 . . . . 0.0 112.072 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 30.1 t -81.89 -41.8 20.44 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.16 0.505 . . . . 0.0 110.564 171.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 94.2 m -81.49 -27.45 34.54 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.292 1.037 . . . . 0.0 113.179 -167.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 pp -79.45 -1.22 36.37 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.032 0.533 . . . . 0.0 110.828 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 18.4 m -66.09 83.41 0.08 Allowed 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.362 1.065 . . . . 0.0 110.199 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -64.62 -37.14 86.55 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.268 173.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 . . . . . 0 C--O 1.25 1.131 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.221 -177.176 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 59.7 m -140.96 146.39 37.27 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.826 0.85 . . . . 0.0 109.77 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -81.5 109.4 15.93 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt -74.9 163.11 28.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.477 0.711 . . . . 0.0 110.345 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -106.5 144.74 32.74 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.621 0.368 . . . . 0.0 111.237 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.4 HD13 ' N ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -137.75 157.65 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.991 1.316 . . . . 0.0 108.964 175.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 66' ' ' THR . 72.2 m-85 -110.84 101.33 9.94 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.493 0.717 . . . . 0.0 110.026 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 69' ' ' LEU . 74.6 t -97.44 106.77 19.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -107.11 129.13 54.87 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.325 0.65 . . . . 0.0 110.499 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.704 HG22 HD12 ' A' ' 69' ' ' LEU . 71.8 p -72.25 165.28 24.75 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.362 0.601 . . . . 0.0 111.841 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.504 HD11 HG22 ' A' ' 70' ' ' VAL . 70.0 mt -67.17 -25.79 66.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.924 172.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -78.09 -14.14 59.6 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.34 0.656 . . . . 0.0 110.553 175.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.99 14.47 39.49 Favored Glycine 0 C--N 1.35 1.322 0 N-CA-C 114.884 0.714 . . . . 0.0 114.884 165.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.31 151.65 24.62 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 m -107.61 132.0 53.77 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.95 112.44 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 m -92.16 116.09 28.65 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.424 0.69 . . . . 0.0 109.424 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.5 mm? -104.79 157.19 17.37 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.635 0.774 . . . . 0.0 109.483 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.09 86.76 2.63 Favored 'General case' 0 C--O 1.244 0.784 0 O-C-N 124.248 0.968 . . . . 0.0 108.436 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.792 HG21 HG22 ' A' ' 26' ' ' VAL . 13.7 m -140.71 176.65 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 124.374 1.07 . . . . 0.0 108.345 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -92.72 148.68 36.55 Favored Pre-proline 0 N--CA 1.475 0.782 0 O-C-N 121.69 -0.631 . . . . 0.0 109.379 172.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 19.5 Cg_endo -58.45 -28.32 84.88 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.171 1.914 . . . . 0.0 111.71 169.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.7 t -101.93 16.09 27.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.909 0.484 . . . . 0.0 110.979 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.98 -92.08 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.5 t -178.85 145.61 0.29 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.503 1.121 . . . . 0.0 109.825 173.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -61.54 -37.81 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.451 1.1 . . . . 0.0 111.359 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -58.55 -35.17 71.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.397 0.679 . . . . 0.0 110.807 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 16.2 t-20 -72.39 -44.95 61.78 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.331 177.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.792 HG22 HG21 ' A' ' 17' ' ' VAL . 45.3 t -54.2 -50.32 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 124.372 1.045 . . . . 0.0 110.178 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.2 ptpt -68.94 -31.35 70.18 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.075 0.55 . . . . 0.0 111.802 -175.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.31 -39.61 79.86 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.978 0.418 . . . . 0.0 110.662 170.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 35.6 mmtm -68.88 -36.83 78.55 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.531 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.9 mp -59.13 -41.78 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-N 119.473 1.033 . . . . 0.0 110.17 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -62.97 -33.15 74.77 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.56 -26.01 57.59 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.278 0.631 . . . . 0.0 111.319 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 74.8 mmtt -94.5 -66.38 0.92 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.866 0.466 . . . . 0.0 110.889 -174.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.89 -16.01 32.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.74 20.24 51.44 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 170.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.67 127.83 27.71 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 43.2 Cg_endo -63.31 152.01 82.04 Favored 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.244 2.629 . . . . 0.0 112.989 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 43.6 Cg_endo -61.83 -17.14 53.56 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.983 3.122 . . . . 0.0 113.932 -174.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -74.22 -37.66 63.78 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.832 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' HG3' ' H ' ' A' ' 73' ' ' LEU . 2.6 mp0 -89.29 -32.2 17.48 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.276 1.03 . . . . 0.0 112.091 -174.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.538 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 3.0 pp0? -99.77 128.95 45.84 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 55.7 ttt180 -117.18 128.88 55.55 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.4 1.08 . . . . 0.0 109.174 -168.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.48 125.42 38.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 109.892 -172.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -142.22 133.96 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.087 0.955 . . . . 0.0 110.135 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.602 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 79.0 t80 -132.87 129.52 38.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 172.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.48 19.33 11.77 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.985 0.914 . . . . 0.0 113.073 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.33 17.07 54.24 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 114.282 0.473 . . . . 0.0 114.282 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 4.0 ptpt -130.01 148.64 51.89 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 117.731 0.766 . . . . 0.0 109.982 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -74.11 140.57 45.36 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.779 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 45' ' ' PHE . 24.7 mt -88.64 119.22 28.91 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.015 0.526 . . . . 0.0 109.76 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -78.05 138.77 38.96 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.689 0.796 . . . . 0.0 109.989 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.88 -40.93 85.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.002 0.921 . . . . 0.0 111.616 -173.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.04 -23.95 77.59 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 124.256 0.972 . . . . 0.0 113.923 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.408 ' HD3' ' OD1' ' A' ' 58' ' ' ASP . 61.6 mtt180 -80.3 177.48 8.94 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.485 0.714 . . . . 0.0 112.268 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.1 p -113.21 168.46 9.71 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.774 0.829 . . . . 0.0 109.795 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 92.0 mt -59.56 -50.09 75.26 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 173.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 t -59.72 -26.71 65.85 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.927 1.291 . . . . 0.0 111.317 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 14.8 t70 -64.7 -43.16 94.37 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 123.224 0.61 . . . . 0.0 109.968 178.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -88.81 19.51 4.01 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.769 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 69.54 18.66 7.7 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 124.353 1.061 . . . . 0.0 111.744 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.44 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 14.5 mt -91.88 117.45 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -102.82 -178.29 3.63 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -61.67 142.97 56.85 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.137 170.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 74.2 3.31 4.35 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.612 1.565 . . . . 0.0 112.126 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -71.94 134.32 45.91 Favored 'General case' 0 C--N 1.363 1.155 0 CA-C-N 118.322 0.51 . . . . 0.0 110.513 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 52.3 m -95.13 126.27 40.35 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.602 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -128.26 174.41 9.31 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.528 1.131 . . . . 0.0 109.313 177.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -100.02 149.6 23.31 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.177 0.591 . . . . 0.0 111.629 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.704 HD12 HG22 ' A' ' 7' ' ' THR . 2.9 tm? -129.61 130.44 45.65 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.536 HG21 HD11 ' B' ' 220' ' ' LEU . 64.8 t -114.11 128.68 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 123.406 0.682 . . . . 0.0 110.153 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.631 ' HB3' HD23 ' A' ' 73' ' ' LEU . 77.6 mt -89.94 149.17 22.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.619 0.768 . . . . 0.0 110.793 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 72.6 mtp180 -118.99 -59.9 1.81 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.843 0.857 . . . . 0.0 109.298 172.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 71' ' ' LEU . 3.7 mm? 53.75 40.18 31.17 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.343 1.057 . . . . 0.0 111.384 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.491 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 6.0 mmp_? -62.97 -49.81 73.24 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.804 0.842 . . . . 0.0 112.433 -169.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.67 -19.45 37.57 Favored Glycine 0 N--CA 1.47 0.908 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.331 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.434 0 C-N-CA 123.005 0.336 . . . . 0.0 112.314 -175.918 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 N-CA-C 113.481 0.152 . . . . 0.0 113.481 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 48.1 t -164.56 -44.06 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.884 0.874 . . . . 0.0 109.383 178.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -149.37 112.6 4.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.207 0.603 . . . . 0.0 109.921 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -137.0 158.13 45.17 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.271 1.028 . . . . 0.0 109.636 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 5.7 p -101.23 106.49 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 165.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . 0.497 HG22 HG13 ' B' ' 202' ' ' VAL . 13.6 m -75.22 141.03 43.61 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.238 -172.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -99.75 124.95 45.53 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . 0.497 HG13 HG22 ' B' ' 200' ' ' THR . 4.0 m -142.73 -176.46 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.869 0.868 . . . . 0.0 110.751 -168.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.84 147.76 43.6 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.682 0.793 . . . . 0.0 110.225 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.596 ' HA ' HD11 ' B' ' 216' ' ' ILE . 46.2 t -89.63 101.56 3.42 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.095 0.958 . . . . 0.0 108.635 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.639 ' HD2' HD21 ' B' ' 220' ' ' LEU . 89.3 Cg_exo -49.09 -27.52 12.39 Favored 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 124.277 3.318 . . . . 0.0 115.006 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . 0.406 HG11 ' O ' ' B' ' 223' ' ' CYS . 6.3 t -80.66 -64.5 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.381 -173.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 18.1 p -96.56 1.04 50.93 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.73 45.46 95.7 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 115.061 0.784 . . . . 0.0 115.061 171.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.71 138.11 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.052 0.541 . . . . 0.0 110.223 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -87.54 117.47 26.36 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.479 HD11 ' HB2' ' B' ' 204' ' ' CYS . 7.4 pt -145.59 162.17 37.65 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.157 1.383 . . . . 0.0 110.17 -170.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.35 162.43 33.57 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.64 2.227 . . . . 0.0 112.98 174.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.616 ' O ' HG22 ' B' ' 216' ' ' ILE . 39.9 tt0 -65.07 -39.45 93.25 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.61 1.164 . . . . 0.0 113.665 -169.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 14.9 m -65.76 -43.44 88.89 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.361 -0.837 . . . . 0.0 109.901 177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -75.6 -18.58 59.67 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.831 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.616 HG22 ' O ' ' B' ' 213' ' ' GLU . 0.2 OUTLIER -71.21 -47.62 59.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -68.43 -36.12 78.6 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.313 0.383 . . . . 0.0 111.859 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -63.34 -44.56 94.52 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 123.157 0.286 . . . . 0.0 110.353 172.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.0 -43.48 86.66 Favored 'General case' 0 C--O 1.211 -0.963 0 O-C-N 123.836 0.71 . . . . 0.0 109.841 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.639 HD21 ' HD2' ' B' ' 205' ' ' PRO . 93.0 mt -60.69 -46.5 90.14 Favored 'General case' 0 C--O 1.21 -1.02 0 O-C-N 124.059 0.849 . . . . 0.0 110.876 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -60.25 -31.22 70.0 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.842 1.339 . . . . 0.0 110.464 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 32.6 t -86.49 -37.43 18.26 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.127 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . 0.406 ' O ' HG11 ' B' ' 206' ' ' VAL . 88.2 m -79.51 -22.15 44.34 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.002 0.921 . . . . 0.0 112.282 -171.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp -79.64 -4.63 52.52 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.026 0.53 . . . . 0.0 110.462 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 34.9 t -64.49 84.91 0.04 OUTLIER 'General case' 0 C--N 1.359 0.981 0 C-N-CA 123.957 0.903 . . . . 0.0 109.34 172.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.04 159.16 34.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.294 1.037 . . . . 0.0 111.254 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 123.917 0.887 . . . . 0.0 109.248 172.669 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.101 0 N-CA-C 112.254 -0.338 . . . . 0.0 112.254 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 22.7 p -71.31 107.67 4.4 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.708 0.803 . . . . 0.0 111.237 -175.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 17.9 p80 -75.84 91.75 3.01 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.636 0.731 . . . . 0.0 110.921 -175.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt -79.63 158.31 27.09 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 21.9 mp0 -108.85 142.13 39.88 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.926 -0.484 . . . . 0.0 111.212 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.01 159.44 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.735 1.214 . . . . 0.0 108.874 174.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 66' ' ' THR . 94.0 m-85 -109.36 105.92 15.5 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.443 0.697 . . . . 0.0 109.953 -175.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 69' ' ' LEU . 2.6 t -95.59 114.88 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 173.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -102.3 113.1 26.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.668 0.787 . . . . 0.0 109.326 -174.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.66 HG22 HD12 ' A' ' 69' ' ' LEU . 23.5 p -68.91 157.93 35.62 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.849 0.356 . . . . 0.0 110.4 174.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.423 HD11 HG22 ' A' ' 70' ' ' VAL . 96.2 mt -58.73 -25.2 62.71 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.941 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.3 p -79.08 3.05 18.59 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.562 0.745 . . . . 0.0 111.799 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 12.39 74.84 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 116.42 -0.355 . . . . 0.0 113.124 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -95.54 147.73 23.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.014 0.926 . . . . 0.0 110.207 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 m -108.02 140.98 40.38 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.561 0.744 . . . . 0.0 109.75 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mp -125.7 115.6 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.683 1.193 . . . . 0.0 107.978 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 m -92.1 117.64 30.05 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.4 mm? -104.04 156.18 18.07 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 0' ' ' HIS . 47.0 mt-10 -123.85 82.45 2.02 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.906 0.753 . . . . 0.0 109.155 -177.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.75 HG21 HG22 ' A' ' 26' ' ' VAL . 9.6 m -139.63 178.96 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 124.773 1.229 . . . . 0.0 107.969 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 21' ' ' ASP . 10.1 mt-10 -96.29 152.82 39.0 Favored Pre-proline 0 N--CA 1.482 1.166 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.483 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 31.8 Cg_endo -61.63 -30.61 85.9 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.098 1.865 . . . . 0.0 111.168 171.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t -102.5 18.97 19.87 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.057 0.543 . . . . 0.0 110.026 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' HB2' ' A' ' 18' ' ' GLU . 16.1 t70 -81.04 -88.5 0.08 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.128 0.571 . . . . 0.0 109.49 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 26' ' ' VAL . 7.1 t 177.37 147.53 0.13 Allowed 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.539 1.136 . . . . 0.0 110.183 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -66.03 -34.39 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.251 1.02 . . . . 0.0 111.031 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 36.2 tt0 -62.59 -31.45 72.28 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.311 0.576 . . . . 0.0 110.858 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 12.7 t-20 -75.17 -42.07 56.69 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.862 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.75 HG22 HG21 ' A' ' 17' ' ' VAL . 59.0 t -55.57 -46.93 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 124.283 0.989 . . . . 0.0 110.3 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HA ' HD13 ' A' ' 30' ' ' ILE . 17.9 ptpt -71.22 -29.36 65.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.266 0.626 . . . . 0.0 111.592 -176.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.07 -33.29 75.68 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.519 169.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 68.1 mmtt -75.62 -27.56 58.49 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.229 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.9 mp -58.14 -45.66 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 119.348 0.976 . . . . 0.0 109.281 166.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.2 tt0 -67.21 -20.81 65.75 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.579 177.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 23.0 t70 -81.42 -37.0 28.79 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.742 0.817 . . . . 0.0 111.369 174.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.8 mmtt -91.78 -61.92 1.53 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.794 0.437 . . . . 0.0 111.024 -170.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -92.55 -25.12 18.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.422 0.289 . . . . 0.0 111.184 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 97.2 13.83 44.14 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 116.546 -0.297 . . . . 0.0 113.83 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.87 125.88 55.57 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -63.55 152.59 79.52 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.745 2.297 . . . . 0.0 112.097 -174.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -62.01 -16.47 50.2 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.469 2.78 . . . . 0.0 113.694 -173.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -75.4 -42.58 53.4 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.249 0.62 . . . . 0.0 110.616 174.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -81.74 -22.04 37.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.158 0.983 . . . . 0.0 112.52 -173.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HB2' HD11 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -102.39 148.01 26.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.428 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.576 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 52.2 ttt180 -132.31 129.73 39.89 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.426 0.69 . . . . 0.0 109.556 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.64 125.69 37.38 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.373 0.669 . . . . 0.0 109.303 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 94.9 mt -142.6 130.99 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.158 0.983 . . . . 0.0 109.749 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.476 ' HB3' HD21 ' A' ' 50' ' ' LEU . 92.5 t80 -129.84 124.12 32.52 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.13 19.85 11.87 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.31 1.044 . . . . 0.0 112.651 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.78 -12.09 60.98 Favored Glycine 0 C--N 1.353 1.506 0 CA-C-O 120.005 -0.33 . . . . 0.0 113.891 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 7.8 ptpt -99.87 142.28 31.56 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -75.4 140.82 43.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.352 0.261 . . . . 0.0 110.34 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.6 mt -88.15 134.05 33.86 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.137 0.575 . . . . 0.0 109.905 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.529 ' HG2' ' H ' ' A' ' 53' ' ' GLY . 27.8 tt0 -85.16 137.37 33.06 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 24' ' ' GLU . 9.2 p-10 -61.46 -33.49 73.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.112 0.965 . . . . 0.0 111.892 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.529 ' H ' ' HG2' ' A' ' 51' ' ' GLU . . . -72.82 -29.5 65.13 Favored Glycine 0 C--N 1.347 1.189 0 O-C-N 123.856 0.723 . . . . 0.0 113.409 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -80.04 177.18 9.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.381 0.672 . . . . 0.0 111.548 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -111.06 167.46 10.24 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 123.738 0.815 . . . . 0.0 110.254 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 90.4 mt -56.22 -49.82 73.02 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.924 0.765 . . . . 0.0 109.135 172.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -61.3 -27.56 68.56 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.896 1.278 . . . . 0.0 111.572 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.85 -39.2 83.82 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -91.99 20.65 5.6 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.367 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 65.74 25.96 11.39 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.512 1.125 . . . . 0.0 112.194 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.9 mt -98.88 118.27 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -106.84 -175.09 2.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -56.38 138.21 51.42 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.381 171.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 71.34 9.67 6.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.211 1.404 . . . . 0.0 112.501 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.1 m -78.57 138.55 38.42 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.147 0.43 . . . . 0.0 110.604 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 46.8 m -95.49 130.37 42.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.23 0.612 . . . . 0.0 109.928 175.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.66 159.32 37.57 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.781 1.232 . . . . 0.0 108.66 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -87.33 152.61 22.13 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.451 0.643 . . . . 0.0 111.299 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.66 HD12 HG22 ' A' ' 7' ' ' THR . 2.8 tm? -134.89 131.53 37.43 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 73.8 t -110.23 113.7 44.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.029 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.38 152.48 32.24 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.993 174.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.434 ' HA ' ' HG2' ' B' ' 213' ' ' GLU . 53.7 mtp180 -129.79 -40.17 1.39 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.026 0.93 . . . . 0.0 109.883 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 53.41 32.2 13.47 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.035 1.334 . . . . 0.0 112.914 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 25.3 mmm180 -75.67 80.53 2.64 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.18 -11.2 0.26 Allowed Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.356 -173.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 1.786 0 C-N-CA 123.042 0.353 . . . . 0.0 113.406 177.033 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 CA-C-O 119.949 -0.361 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 55.8 p -157.41 154.39 28.75 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.117 0.567 . . . . 0.0 110.689 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -74.33 -22.04 59.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.182 0.993 . . . . 0.0 111.109 172.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -93.57 167.82 11.43 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.479 0.712 . . . . 0.0 110.825 177.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 14.0 p -78.02 135.93 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.76 0.824 . . . . 0.0 110.071 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 15.4 m -88.2 155.08 19.95 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.279 0.632 . . . . 0.0 109.421 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.86 120.92 43.64 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 171.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 3.8 m -143.1 163.52 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.375 1.07 . . . . 0.0 110.736 -167.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -96.29 147.34 23.89 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.808 0.843 . . . . 0.0 111.409 -172.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.614 ' HA ' HD11 ' B' ' 216' ' ' ILE . 43.5 t -88.2 103.92 6.02 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.553 ' HD2' HD21 ' B' ' 220' ' ' LEU . 36.2 Cg_endo -60.52 -12.54 21.26 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.478 2.785 . . . . 0.0 114.816 -168.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 17.0 t -88.47 -54.27 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.032 0.533 . . . . 0.0 110.755 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 15.8 p -108.48 1.74 21.79 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -174.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 63.01 46.58 93.22 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 115.632 1.013 . . . . 0.0 115.632 170.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.5 m -119.0 132.84 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.265 0.626 . . . . 0.0 110.764 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -84.76 119.23 25.05 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . . . . . . . . . 5.2 pt -142.91 161.06 50.68 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.71 1.604 . . . . 0.0 108.875 -172.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.46 153.08 56.82 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.229 1.953 . . . . 0.0 112.249 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.565 ' O ' HG22 ' B' ' 216' ' ' ILE . 33.5 tt0 -64.79 -32.64 74.43 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.384 1.474 . . . . 0.0 113.156 -168.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 38.6 t -64.33 -44.3 91.94 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.661 0.743 . . . . 0.0 109.924 172.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -77.0 -19.34 57.4 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.374 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -71.1 -46.5 66.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -60.68 -45.18 95.13 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.477 0.486 . . . . 0.0 110.121 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -56.62 -46.64 80.83 Favored 'General case' 0 C--O 1.256 1.396 0 O-C-N 124.373 1.046 . . . . 0.0 111.945 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -36.91 81.21 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.246 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 70' ' ' VAL . 93.4 mt -63.58 -46.48 85.64 Favored 'General case' 0 C--O 1.21 -0.986 0 O-C-N 124.186 0.929 . . . . 0.0 111.481 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -54.22 -34.13 59.93 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.251 0.97 . . . . 0.0 111.009 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 34.5 t -82.91 -39.52 21.4 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.268 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 81.3 m -80.05 -18.0 51.24 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.12 0.968 . . . . 0.0 112.612 -170.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 pp -95.27 -2.78 48.73 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.857 0.463 . . . . 0.0 110.499 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 34.0 m -71.94 81.47 0.92 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.653 0.781 . . . . 0.0 110.402 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -80.03 148.22 31.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.584 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.441 0.696 . . . . 0.0 109.475 -175.876 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.873 0 CA-C-O 119.584 -0.564 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 55.6 p -63.25 100.46 0.24 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.755 0.822 . . . . 0.0 110.904 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -75.11 134.18 41.37 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.499 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt -103.89 162.82 12.8 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.597 0.759 . . . . 0.0 110.09 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 93.0 mt-30 -103.47 122.65 45.34 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.626 0.77 . . . . 0.0 109.972 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.555 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -125.39 152.13 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.732 1.213 . . . . 0.0 108.559 177.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.7 m-85 -111.9 113.11 25.23 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.563 0.697 . . . . 0.0 110.204 -170.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.9 t -105.84 119.74 55.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -111.76 119.12 37.55 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.622 0.769 . . . . 0.0 109.535 -174.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.61 HG22 HD12 ' A' ' 69' ' ' LEU . 68.1 p -70.58 167.11 19.21 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.212 0.53 . . . . 0.0 111.628 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.527 HD11 HG22 ' A' ' 70' ' ' VAL . 84.0 mt -73.33 -19.35 61.04 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.936 173.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.476 HG22 HG21 ' B' ' 200' ' ' THR . 44.1 p -79.05 -12.99 60.03 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.132 0.573 . . . . 0.0 110.39 171.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 26.29 19.79 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.712 -0.677 . . . . 0.0 114.144 169.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.4 152.57 18.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.6 m -97.72 141.11 31.14 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.893 0.477 . . . . 0.0 110.492 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.484 HD11 HG23 ' A' ' 7' ' ' THR . 5.2 mp -127.68 109.82 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.902 1.281 . . . . 0.0 107.68 174.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.1 m -91.5 123.58 35.02 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.7 mm? -106.97 156.02 19.16 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.172 0.589 . . . . 0.0 109.617 -177.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -118.96 76.88 1.14 Allowed 'General case' 0 C--O 1.241 0.608 0 O-C-N 124.371 1.044 . . . . 0.0 109.301 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.707 HG21 HG22 ' A' ' 26' ' ' VAL . 28.9 m -147.43 173.14 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 123.733 0.813 . . . . 0.0 110.236 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.503 ' O ' HD12 ' A' ' 56' ' ' LEU . 9.6 mt-10 -95.72 160.02 31.2 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.139 0.576 . . . . 0.0 109.864 -169.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.91 -17.05 55.01 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 121.758 1.638 . . . . 0.0 111.89 169.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 t -103.41 3.11 34.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.45 157.91 28.81 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 168.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.3 t -102.04 150.23 23.44 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.46 -1.7 . . . . 0.0 110.291 -165.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.1 -36.26 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 123.624 0.77 . . . . 0.0 112.156 -171.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.03 -34.63 75.16 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.455 0.645 . . . . 0.0 110.934 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.423 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.2 t30 -73.36 -45.17 56.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.866 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.707 HG22 HG21 ' A' ' 17' ' ' VAL . 65.7 t -55.93 -43.68 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 124.144 0.978 . . . . 0.0 111.361 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -71.74 -33.17 68.47 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.867 0.467 . . . . 0.0 111.473 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.38 -26.91 68.96 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.143 169.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 10.3 mmpt? -76.51 -32.57 58.36 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.188 176.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.25 -42.93 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 118.404 0.547 . . . . 0.0 110.057 170.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.31 -35.38 78.86 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.154 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.72 -24.66 63.59 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.961 0.904 . . . . 0.0 111.689 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 72.1 mmtt -101.03 -69.51 0.77 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -85.01 -19.47 31.97 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.665 0.211 . . . . 0.0 111.44 -175.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.95 17.76 46.44 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.028 0.205 . . . . 0.0 113.062 173.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.62 125.86 34.64 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 123.394 0.678 . . . . 0.0 109.567 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -71.82 159.1 51.52 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.102 2.535 . . . . 0.0 112.095 -174.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 29.3 Cg_endo -58.84 -15.26 25.93 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.549 2.832 . . . . 0.0 113.689 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.58 -44.71 70.23 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.366 1.066 . . . . 0.0 110.653 174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.81 -33.2 19.95 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.817 0.847 . . . . 0.0 111.963 -175.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -94.2 150.39 20.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.648 0.379 . . . . 0.0 110.408 -179.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.585 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 44.9 ttt180 -140.17 129.98 24.55 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.233 0.613 . . . . 0.0 109.666 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.6 mm? -93.45 123.02 36.47 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.522 0.729 . . . . 0.0 109.721 -173.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -141.73 121.73 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.071 0.948 . . . . 0.0 109.716 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.622 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 91.1 t80 -119.51 121.32 39.13 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 66.27 17.88 10.8 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.263 1.025 . . . . 0.0 113.5 173.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.95 14.05 47.45 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 113.983 0.353 . . . . 0.0 113.983 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 1.6 ptpt -124.27 139.24 54.11 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 172.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' NE2' ' HE ' ' A' ' 42' ' ' ARG . 63.7 tt0 -74.79 132.08 41.29 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 45' ' ' PHE . 32.0 mt -78.37 118.77 20.86 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.036 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.78 138.46 42.66 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.992 0.917 . . . . 0.0 110.357 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.15 -44.81 83.79 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.886 1.275 . . . . 0.0 112.116 -172.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.86 -28.22 73.5 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 124.574 1.171 . . . . 0.0 113.747 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -77.65 175.23 10.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.087 0.555 . . . . 0.0 111.813 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 26.2 p -115.85 165.26 13.28 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.486 0.715 . . . . 0.0 109.746 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 18' ' ' GLU . 83.8 mt -55.51 -56.29 21.96 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 123.635 0.584 . . . . 0.0 110.495 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.8 t -61.91 -22.16 65.34 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.122 0.969 . . . . 0.0 112.057 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.1 -39.25 79.09 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.763 0.425 . . . . 0.0 110.096 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -87.26 13.53 9.5 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.342 172.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 67.63 25.45 8.22 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.912 1.285 . . . . 0.0 111.691 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 mt -91.12 112.96 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.408 1.083 . . . . 0.0 108.472 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -101.45 -172.76 2.21 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -61.65 140.28 58.18 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 70.65 3.22 4.45 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.809 1.244 . . . . 0.0 113.306 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -64.74 130.23 42.77 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 20.6 m -99.68 131.23 45.8 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.763 -178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.622 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -134.19 174.18 10.79 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.07 0.948 . . . . 0.0 110.107 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -98.55 148.21 24.0 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.332 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 7' ' ' THR . 2.6 tm? -127.32 130.63 49.85 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 67.1 t -108.68 111.55 36.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 123.21 0.604 . . . . 0.0 109.833 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.2 mt -79.2 149.75 31.85 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 124.191 0.932 . . . . 0.0 109.011 171.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -118.98 -39.43 2.94 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.445 0.698 . . . . 0.0 110.72 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 52.68 49.94 19.24 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.645 1.178 . . . . 0.0 111.89 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -57.56 -40.94 80.05 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.363 0.665 . . . . 0.0 111.286 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.63 12.92 50.68 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.087 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.37 0 N-CA-C 112.276 -0.33 . . . . 0.0 112.276 -174.379 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.546 0 CA-C-O 119.139 -0.812 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 20.1 m 62.36 15.87 8.05 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.098 1.359 . . . . 0.0 113.12 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -96.39 -33.91 11.74 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.602 0.761 . . . . 0.0 111.138 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -103.39 179.8 4.17 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.185 0.594 . . . . 0.0 110.915 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 4.8 p -72.92 116.84 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . 0.476 HG21 HG22 ' A' ' 9' ' ' THR . 9.0 m -78.48 153.85 31.05 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.236 0.615 . . . . 0.0 110.692 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.79 123.52 44.12 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 168.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 7.7 m -144.46 -178.04 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.382 1.073 . . . . 0.0 110.072 -165.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -113.57 148.06 36.84 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.219 0.608 . . . . 0.0 110.314 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.627 ' HA ' HD11 ' B' ' 216' ' ' ILE . 46.2 t -85.4 100.81 1.35 Allowed Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.079 0.952 . . . . 0.0 109.501 176.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.58 ' HD2' HD21 ' B' ' 220' ' ' LEU . 65.3 Cg_endo -68.0 8.29 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 123.392 2.728 . . . . 0.0 115.361 -168.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 48.5 t -100.07 -50.63 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 122.971 0.509 . . . . 0.0 110.716 174.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.9 p -114.03 -4.61 13.17 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 122.746 0.418 . . . . 0.0 111.945 -172.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 60.36 58.25 14.95 Favored Glycine 0 C--N 1.346 1.091 0 C-N-CA 124.288 0.947 . . . . 0.0 114.956 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.07 129.83 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 123.201 0.601 . . . . 0.0 109.57 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -82.59 115.42 21.55 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' B' ' 204' ' ' CYS . 6.8 pt -143.95 160.77 48.61 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.491 1.516 . . . . 0.0 109.746 -170.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' B' ' 215' ' ' HIS . 28.4 Cg_endo -60.92 155.92 46.92 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.704 2.27 . . . . 0.0 112.199 172.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.516 ' O ' HG22 ' B' ' 216' ' ' ILE . 35.7 tt0 -68.51 -28.32 66.9 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.69 1.196 . . . . 0.0 113.466 -170.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 40.9 t -65.78 -44.22 86.42 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-O 121.657 0.741 . . . . 0.0 109.724 171.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . 0.401 ' HB2' ' HG2' ' B' ' 212' ' ' PRO . 70.6 m-70 -80.35 -16.51 54.38 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.046 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -72.55 -44.5 61.06 Favored 'Isoleucine or valine' 0 C--N 1.352 0.711 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 175.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -54.38 -54.47 40.15 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 124.023 0.827 . . . . 0.0 109.999 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -57.24 -44.84 84.19 Favored 'General case' 0 C--O 1.249 1.035 0 O-C-N 124.48 1.113 . . . . 0.0 112.558 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -33.93 74.87 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.105 -177.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.58 HD21 ' HD2' ' B' ' 205' ' ' PRO . 78.8 mt -68.49 -42.95 77.9 Favored 'General case' 0 C--O 1.212 -0.901 0 O-C-N 123.557 0.536 . . . . 0.0 111.521 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -57.58 -28.4 63.56 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 124.027 0.829 . . . . 0.0 111.259 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 43.4 t -86.38 -42.27 13.8 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.692 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 66.9 m -80.7 -26.54 37.42 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -167.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.5 -25.33 63.09 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.053 0.541 . . . . 0.0 110.222 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 22.7 t -73.08 82.94 1.28 Allowed 'General case' 0 C--N 1.348 0.535 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 172.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -86.13 79.46 9.12 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.573 -176.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 C--O 1.248 1.009 0 CA-C-N 114.204 -1.362 . . . . 0.0 107.994 179.134 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.357 0 N-CA-C 112.202 -0.359 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.7 t -158.93 -33.72 0.06 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.702 0.801 . . . . 0.0 110.237 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -75.09 130.16 38.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.878 0.871 . . . . 0.0 110.989 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt -98.53 178.65 4.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.791 0.837 . . . . 0.0 110.052 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 65.8 mt-30 -111.13 147.72 34.27 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.273 0.629 . . . . 0.0 110.641 176.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.506 HD11 HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -138.93 155.29 26.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 125.396 1.478 . . . . 0.0 107.841 174.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 66' ' ' THR . 89.8 m-85 -112.34 116.78 30.9 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.734 -174.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 55.6 t -105.32 131.96 53.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tpmt? -123.26 124.57 43.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.242 0.617 . . . . 0.0 109.972 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.657 HG22 HD12 ' A' ' 69' ' ' LEU . 42.8 p -73.27 169.49 16.99 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.259 0.552 . . . . 0.0 111.495 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.4 mt -65.59 -26.41 67.84 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.036 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.9 p -80.55 -15.9 55.53 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.637 0.775 . . . . 0.0 111.189 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.23 11.64 38.59 Favored Glycine 0 C--N 1.349 1.272 0 N-CA-C 114.781 0.673 . . . . 0.0 114.781 167.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.91 152.27 31.25 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.743 0.771 . . . . 0.0 109.609 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.4 m -95.26 141.78 28.44 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.177 0.591 . . . . 0.0 109.693 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.55 HD11 HG23 ' A' ' 7' ' ' THR . 4.4 mp -132.37 100.9 4.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.7 m -95.06 121.36 36.61 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -105.65 152.77 22.71 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -117.45 82.73 1.87 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.752 HG21 HG22 ' A' ' 26' ' ' VAL . 24.6 m -141.74 177.32 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.72 1.208 . . . . 0.0 108.509 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -92.61 153.42 42.44 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.55 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 24.0 Cg_endo -61.98 -28.61 80.88 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.829 1.686 . . . . 0.0 110.742 164.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -94.13 13.54 22.82 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.019 0.928 . . . . 0.0 111.24 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -75.71 -99.19 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.163 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.0 t 171.86 140.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.967 1.307 . . . . 0.0 109.324 177.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.415 HD12 HD13 ' A' ' 50' ' ' LEU . 39.9 mm -60.54 -36.81 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.578 1.151 . . . . 0.0 112.034 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.01 -34.84 76.94 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.564 0.697 . . . . 0.0 111.065 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 8.5 t30 -75.82 -41.0 53.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.107 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.752 HG22 HG21 ' A' ' 17' ' ' VAL . 58.4 t -57.97 -45.86 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 124.441 1.088 . . . . 0.0 110.042 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HB2' HE22 ' A' ' 41' ' ' GLN . 17.1 ptpt -72.39 -28.68 63.14 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.026 0.53 . . . . 0.0 111.313 -176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.33 75.13 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.218 0.324 . . . . 0.0 110.434 169.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 71.6 mmtt -74.03 -36.13 64.41 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.95 177.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 27' ' ' LYS . 2.9 mp -57.23 -41.57 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.532 1.06 . . . . 0.0 109.511 173.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -60.4 -39.09 86.08 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.447 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.43 -32.09 73.52 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.207 0.603 . . . . 0.0 111.481 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 70.4 mmtt -91.4 -67.97 0.82 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.626 0.37 . . . . 0.0 111.624 -171.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -80.39 -22.95 40.77 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.768 0.258 . . . . 0.0 111.06 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.86 18.67 39.62 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.222 0.326 . . . . 0.0 113.037 175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.598 HG13 HD11 ' A' ' 73' ' ' LEU . 1.9 mp -108.79 127.52 27.21 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -177.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.68 156.13 67.25 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.907 2.404 . . . . 0.0 112.287 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 46.3 Cg_endo -62.17 -13.32 31.27 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 123.636 2.891 . . . . 0.0 113.967 -173.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.423 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 7.4 t70 -76.23 -46.13 29.61 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.893 0.746 . . . . 0.0 109.943 174.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 72' ' ' ARG . 2.9 mp0 -83.8 -23.09 31.59 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.521 0.728 . . . . 0.0 112.366 -172.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.568 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 2.9 pp0? -104.74 133.27 49.85 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.973 0.509 . . . . 0.0 109.857 173.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.562 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.2 ttt180 -120.26 130.74 54.63 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.975 0.91 . . . . 0.0 110.238 -170.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -94.28 117.42 30.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.634 0.774 . . . . 0.0 110.546 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -141.85 127.54 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 124.27 1.028 . . . . 0.0 109.547 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.538 ' HB3' HD21 ' A' ' 50' ' ' LEU . 81.2 t80 -123.17 124.08 42.25 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.142 0.977 . . . . 0.0 109.236 177.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.94 16.06 9.61 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.031 1.332 . . . . 0.0 112.972 176.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.09 -8.48 60.97 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.929 -0.373 . . . . 0.0 113.171 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 8.5 ptpt -96.03 135.79 37.33 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -76.39 131.58 39.21 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.538 HD21 ' HB3' ' A' ' 45' ' ' PHE . 30.5 mt -74.34 153.84 39.13 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.436 0.294 . . . . 0.0 110.466 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' H ' ' HE2' ' A' ' 59' ' ' TYR . 37.5 tt0 -116.34 137.35 52.22 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.397 0.679 . . . . 0.0 109.194 -176.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.92 -44.18 86.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.673 1.189 . . . . 0.0 112.075 -172.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.27 -25.04 75.8 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 124.43 1.081 . . . . 0.0 113.478 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -81.31 177.57 8.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.301 0.64 . . . . 0.0 111.789 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 73.1 p -110.36 169.68 8.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.663 0.785 . . . . 0.0 109.795 176.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 95.4 mt -57.32 -54.8 42.7 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.893 0.746 . . . . 0.0 109.46 172.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.511 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 24.3 t -62.59 -19.28 63.57 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.733 1.213 . . . . 0.0 111.971 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -66.91 -41.4 87.17 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.451 ' HE2' ' H ' ' A' ' 51' ' ' GLU . 38.1 m-85 -90.98 17.87 7.38 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.09 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 68.39 16.69 9.23 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.18 1.392 . . . . 0.0 112.17 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.1 mt -85.16 102.01 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -86.48 -177.23 6.13 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -62.34 144.95 55.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 169.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 76.6 -3.34 2.55 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.61 1.564 . . . . 0.0 111.81 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -68.72 133.69 48.75 Favored 'General case' 0 C--N 1.366 1.306 0 CA-C-N 117.971 0.351 . . . . 0.0 110.713 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 18.0 m -99.43 140.21 33.95 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.796 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.404 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -140.79 173.35 11.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.939 0.896 . . . . 0.0 109.699 -178.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -97.32 147.16 24.44 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.371 0.668 . . . . 0.0 110.88 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.657 HD12 HG22 ' A' ' 7' ' ' THR . 2.5 tm? -129.19 127.74 41.94 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.574 HG21 HD11 ' B' ' 220' ' ' LEU . 96.0 t -108.78 126.77 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 123.282 0.633 . . . . 0.0 110.109 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.518 ' HB3' HD23 ' A' ' 73' ' ' LEU . 66.4 mt -86.25 147.04 26.27 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.771 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.428 ' HB2' ' HA ' ' A' ' 40' ' ' GLN . 37.3 mtp-105 -136.29 6.4 3.05 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.475 1.11 . . . . 0.0 110.243 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD11 HG13 ' A' ' 36' ' ' ILE . 4.2 mm? -33.04 104.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 126.467 1.907 . . . . 0.0 114.27 -169.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -75.71 -59.16 2.87 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.967 -177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.99 14.52 63.21 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.065 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.502 0 CA-C-N 116.795 0.297 . . . . 0.0 113.28 179.784 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.675 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 31.4 m -70.31 94.75 0.96 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.993 0.917 . . . . 0.0 109.809 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -65.83 123.55 20.08 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.804 177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -154.49 169.36 23.98 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.92 0.888 . . . . 0.0 109.671 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.36 77.42 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 124.098 0.959 . . . . 0.0 110.575 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 95.7 m -72.26 124.96 26.15 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.251 1.021 . . . . 0.0 111.867 -171.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' B' ' 212' ' ' PRO . 11.6 mptt -82.57 124.72 30.4 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.321 0.649 . . . . 0.0 109.368 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.13 -176.91 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 125.87 1.668 . . . . 0.0 109.093 -172.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -111.23 146.08 37.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.936 -0.478 . . . . 0.0 110.915 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.664 ' HA ' HD11 ' B' ' 216' ' ' ILE . 35.1 t -94.72 101.12 6.31 Favored Pre-proline 0 N--CA 1.477 0.883 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.445 ' HD2' HD21 ' B' ' 220' ' ' LEU . 66.3 Cg_endo -67.49 -4.65 12.35 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.173 2.582 . . . . 0.0 114.765 -164.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . 0.451 HG11 ' O ' ' B' ' 223' ' ' CYS . 11.6 t -95.25 -58.01 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 122.793 0.437 . . . . 0.0 110.661 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 16.3 p -99.19 -4.63 31.65 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 66.85 47.01 69.11 Favored Glycine 0 C--N 1.352 1.434 0 N-CA-C 115.11 0.804 . . . . 0.0 115.11 172.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.25 144.22 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 117.514 0.657 . . . . 0.0 110.842 177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -90.26 108.75 19.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.078 0.951 . . . . 0.0 110.026 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' B' ' 204' ' ' CYS . 10.0 pt -144.25 153.42 56.12 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 124.864 1.266 . . . . 0.0 110.419 -172.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' B' ' 201' ' ' LYS . 54.6 Cg_endo -65.17 165.3 22.37 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.439 2.76 . . . . 0.0 114.366 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.593 ' O ' HG22 ' B' ' 216' ' ' ILE . 31.6 tt0 -62.25 -41.83 98.78 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 125.341 1.456 . . . . 0.0 114.31 -164.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.0 m -76.11 -29.7 57.98 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.812 -1.18 . . . . 0.0 110.712 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -81.63 -23.96 36.66 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.047 0.539 . . . . 0.0 109.997 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.664 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.1 OUTLIER -72.64 -42.79 62.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -65.11 -42.93 93.49 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.851 0.719 . . . . 0.0 110.923 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -64.09 -37.62 88.12 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.654 0.596 . . . . 0.0 110.969 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -39.88 88.58 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.401 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.574 HD11 HG21 ' A' ' 70' ' ' VAL . 80.0 mt -71.19 -32.38 68.78 Favored 'General case' 0 C--O 1.214 -0.763 0 O-C-N 124.201 0.938 . . . . 0.0 111.581 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -58.65 -27.29 64.61 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 123.847 0.717 . . . . 0.0 109.892 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 22.3 t -95.51 -36.03 11.45 Favored 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 123.473 0.709 . . . . 0.0 112.4 172.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' B' ' 220' ' ' LEU . 91.6 m -81.96 -17.79 45.76 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.142 0.977 . . . . 0.0 112.614 -168.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.98 -7.97 51.82 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.582 0.353 . . . . 0.0 111.052 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 11.2 m -78.68 47.51 0.74 Allowed 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.55 1.14 . . . . 0.0 110.645 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -73.65 87.05 1.65 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.814 0.846 . . . . 0.0 108.889 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 124.23 1.012 . . . . 0.0 109.506 -174.463 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.372 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 22.7 t -87.42 175.32 8.03 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.175 0.59 . . . . 0.0 110.788 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.597 ' HB3' ' HB3' ' A' ' 16' ' ' GLU . 3.9 m-70 -130.69 101.19 5.57 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.633 0.773 . . . . 0.0 110.804 -177.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 mmt -101.24 152.03 21.16 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.606 0.762 . . . . 0.0 109.037 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 1.4 mp0 -95.06 131.03 41.49 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.791 0.436 . . . . 0.0 111.456 -173.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.24 147.05 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.013 1.325 . . . . 0.0 108.539 172.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' THR . 96.1 m-85 -111.49 103.63 11.99 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.316 0.647 . . . . 0.0 110.211 -169.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 69' ' ' LEU . 84.0 t -103.01 106.06 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.896 0.878 . . . . 0.0 108.978 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -89.22 118.29 28.8 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.816 1.246 . . . . 0.0 110.426 -173.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.58 HG22 HD12 ' A' ' 69' ' ' LEU . 7.8 p -70.95 167.36 19.27 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.61 0.719 . . . . 0.0 112.131 175.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.539 HD11 HG22 ' A' ' 70' ' ' VAL . 89.2 mt -70.2 -11.23 60.75 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.675 172.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.7 p -86.47 -4.43 59.17 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.478 0.711 . . . . 0.0 111.504 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.49 15.63 73.23 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.262 0.352 . . . . 0.0 112.868 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -93.53 151.59 19.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.472 1.109 . . . . 0.0 109.923 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -109.51 128.74 55.4 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.141 0.576 . . . . 0.0 110.288 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.96 106.71 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.685 0.794 . . . . 0.0 108.949 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.7 m -88.78 118.03 28.18 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.069 0.947 . . . . 0.0 109.834 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 1.2 mm? -105.53 159.67 15.76 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.491 0.716 . . . . 0.0 109.458 178.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 0' ' ' HIS . 38.1 mt-10 -126.7 83.19 2.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.775 0.83 . . . . 0.0 108.839 -174.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.702 HG21 HG22 ' A' ' 26' ' ' VAL . 32.2 m -147.73 -177.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 124.168 0.987 . . . . 0.0 110.056 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -96.21 155.95 37.54 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 123.253 0.621 . . . . 0.0 110.247 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 28.9 Cg_endo -61.52 -31.64 87.66 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 121.984 1.789 . . . . 0.0 111.322 167.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -95.65 10.59 36.28 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.585 0.754 . . . . 0.0 110.939 -177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.47 -96.36 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.924 0.889 . . . . 0.0 110.334 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 26' ' ' VAL . 9.6 t 172.72 144.63 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.327 1.451 . . . . 0.0 108.98 173.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.06 -35.98 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.806 0.843 . . . . 0.0 111.616 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.09 -35.54 75.42 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 121.606 0.717 . . . . 0.0 110.777 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 6.2 t30 -74.57 -42.32 58.95 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.712 177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.702 HG22 HG21 ' A' ' 17' ' ' VAL . 72.8 t -56.75 -44.05 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 124.367 1.042 . . . . 0.0 110.479 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' ' NE2' ' A' ' 41' ' ' GLN . 17.9 ptpt -74.32 -26.45 60.17 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.653 0.381 . . . . 0.0 111.498 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.6 -32.03 72.47 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.635 168.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -68.96 -38.65 79.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.152 0.581 . . . . 0.0 111.134 175.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 mp -59.16 -43.7 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 118.249 0.477 . . . . 0.0 109.99 173.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.433 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 9.3 tt0 -65.73 -24.97 67.09 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.236 0.541 . . . . 0.0 111.542 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.92 -31.81 59.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.852 0.461 . . . . 0.0 110.76 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 75.7 mmtt -91.12 -67.2 0.87 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.611 0.364 . . . . 0.0 110.526 -172.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -86.44 -26.59 24.61 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.384 0.274 . . . . 0.0 111.547 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 93.24 17.4 43.18 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 120.048 -0.307 . . . . 0.0 113.619 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.05 126.77 47.64 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.76 152.46 78.36 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.954 2.436 . . . . 0.0 112.109 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -58.73 -15.76 27.73 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.324 2.682 . . . . 0.0 113.509 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.27 -36.12 63.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.827 0.851 . . . . 0.0 111.432 175.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -97.05 -28.64 14.05 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.158 0.983 . . . . 0.0 112.81 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.486 ' HB2' HD11 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -90.69 149.86 21.89 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.031 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.602 ' HD3' HD23 ' B' ' 220' ' ' LEU . 10.4 ttt180 -140.85 127.01 19.6 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.48 ' HB3' HD12 ' A' ' 50' ' ' LEU . 4.5 mm? -92.38 126.22 37.37 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.919 0.888 . . . . 0.0 109.337 -171.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.614 HD11 HD21 ' B' ' 220' ' ' LEU . 90.5 mt -140.78 118.62 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.097 0.559 . . . . 0.0 110.704 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.556 ' HD1' ' HB3' ' A' ' 67' ' ' LEU . 71.8 t80 -122.01 129.28 52.32 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.28 20.65 12.39 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.708 0.803 . . . . 0.0 112.605 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.77 22.5 55.54 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-O 119.881 -0.4 . . . . 0.0 113.692 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 10.5 ptpt -128.96 146.09 51.06 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 173.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.616 ' HB2' ' HB2' ' B' ' 224' ' ' LEU . 0.3 OUTLIER -82.83 138.5 33.92 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 43' ' ' LEU . 26.6 mt -90.82 120.14 31.61 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.56 -172.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -75.53 138.85 41.8 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.4 1.08 . . . . 0.0 110.51 -175.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -52.17 -49.7 63.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.636 1.174 . . . . 0.0 111.919 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.69 -29.77 76.12 Favored Glycine 0 C--N 1.352 1.471 0 O-C-N 124.367 1.042 . . . . 0.0 113.962 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -79.31 177.46 8.82 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.568 0.747 . . . . 0.0 111.402 -178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -118.72 166.59 12.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.604 0.762 . . . . 0.0 110.234 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 93.2 mt -55.76 -54.2 47.35 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 124.104 0.877 . . . . 0.0 109.677 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 15.7 t -60.89 -26.02 67.13 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.591 1.156 . . . . 0.0 111.514 -176.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -68.6 -41.22 79.87 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 122.867 0.467 . . . . 0.0 109.834 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -85.86 15.11 5.13 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.631 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 68.36 25.8 6.92 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.69 1.196 . . . . 0.0 111.69 176.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 56' ' ' LEU . 14.1 mt -93.42 127.89 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.394 1.078 . . . . 0.0 108.256 175.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -110.08 -178.21 3.46 Favored 'General case' 0 C--O 1.245 0.827 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 172.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -60.1 137.03 58.19 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.044 171.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 73.15 10.04 5.23 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.277 1.431 . . . . 0.0 112.467 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.1 m -68.11 138.89 56.09 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 170.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 24.9 m -101.29 129.57 47.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.384 0.674 . . . . 0.0 109.613 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.556 ' HB3' ' HD1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -143.96 154.35 43.21 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.006 0.923 . . . . 0.0 109.909 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -80.58 154.59 27.37 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.462 0.648 . . . . 0.0 112.455 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.58 HD12 HG22 ' A' ' 7' ' ' THR . 2.2 tm? -131.58 121.67 24.79 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.576 HG21 HD22 ' B' ' 220' ' ' LEU . 57.1 t -98.25 119.36 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 123.53 0.732 . . . . 0.0 110.397 176.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.3 mt -85.97 147.65 26.12 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.853 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -121.41 -40.64 2.56 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.497 0.719 . . . . 0.0 110.874 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 52.34 30.86 8.62 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 125.022 1.329 . . . . 0.0 113.017 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -68.96 -56.58 7.4 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.821 0.848 . . . . 0.0 109.472 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.44 35.56 4.89 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.682 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.486 0 N-CA-C 114.051 0.38 . . . . 0.0 114.051 175.884 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 195' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 196' ' ' SER . . . . . . . . . . . . . 56.0 p -83.72 121.81 27.78 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.366 0.666 . . . . 0.0 110.616 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 197' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -101.78 -5.55 24.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.86 0.864 . . . . 0.0 111.119 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -111.86 169.48 8.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.674 0.789 . . . . 0.0 110.467 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 199' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.06 110.67 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 11.5 m -79.89 134.65 36.31 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.718 0.807 . . . . 0.0 111.072 -170.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -79.11 122.87 26.78 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' VAL . . . . . . . . . . . . . 8.3 m -148.25 -177.58 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.666 1.186 . . . . 0.0 109.326 -167.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -120.95 138.59 54.06 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.722 0.409 . . . . 0.0 111.134 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' CYS . . . . . 0.536 ' HA ' HD11 ' B' ' 216' ' ' ILE . 37.1 t -78.73 100.25 0.52 Allowed Pre-proline 0 N--CA 1.47 0.543 0 C-N-CA 124.303 1.041 . . . . 0.0 108.263 174.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . 0.507 ' HD3' HD11 ' B' ' 216' ' ' ILE . 44.5 Cg_endo -81.99 20.49 1.07 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.071 2.514 . . . . 0.0 114.116 -159.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 53.9 t -105.32 -58.24 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.333 0.653 . . . . 0.0 109.691 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' CYS . . . . . . . . . . . . . 28.8 p -91.97 -23.84 19.43 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.072 0.549 . . . . 0.0 111.22 -175.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.89 52.52 3.83 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 114.299 0.48 . . . . 0.0 114.299 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.76 134.76 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 123.264 0.626 . . . . 0.0 110.172 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -87.92 114.06 24.17 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' ILE . . . . . 0.453 HD11 ' HB2' ' B' ' 204' ' ' CYS . 8.9 pt -143.89 160.41 50.08 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 124.866 1.266 . . . . 0.0 110.376 -171.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.4 156.19 32.11 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.153 2.569 . . . . 0.0 112.774 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . 0.5 ' O ' HG22 ' B' ' 216' ' ' ILE . 33.2 tt0 -66.18 -29.39 69.66 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.522 1.129 . . . . 0.0 113.499 -171.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 15.7 m -64.11 -43.68 94.58 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.882 0.849 . . . . 0.0 110.057 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -81.17 -21.53 39.62 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.304 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' B' ' 204' ' ' CYS . 0.2 OUTLIER -69.82 -41.13 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -58.97 -51.68 69.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.15 0.906 . . . . 0.0 109.973 176.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -64.95 -47.93 75.88 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.966 -174.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -33.76 76.73 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.505 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.614 HD21 HD11 ' A' ' 44' ' ' ILE . 46.6 tp -68.23 -39.34 82.37 Favored 'General case' 0 C--O 1.214 -0.777 0 O-C-N 124.249 0.968 . . . . 0.0 111.447 178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.14 -36.32 63.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.044 0.538 . . . . 0.0 110.822 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . . . . . . . . . 48.4 t -77.93 -43.92 28.49 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.668 174.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' CYS . . . . . . . . . . . . . 75.1 m -77.38 -21.09 53.75 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 3.9 pp -87.4 -31.54 20.03 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -176.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' SER . . . . . . . . . . . . . 21.6 t -80.77 79.18 7.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.446 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -73.82 -22.5 59.77 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.727 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 CA--C 1.567 1.609 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.494 168.105 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_